data_1btv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1btv _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.528 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.574 HG11 ' N ' ' A' ' 3' ' ' PHE . 78.9 t -79.08 156.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.574 ' N ' HG11 ' A' ' 2' ' ' VAL . 75.9 m-85 -119.61 137.38 53.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.529 -0.732 . . . . 0.0 109.965 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.454 ' OD1' ' HE2' ' A' ' 119' ' ' LYS . 3.6 t30 -101.19 91.53 4.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 0.0 110.358 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CE1' HG13 ' A' ' 128' ' ' VAL . 29.3 m-85 -86.97 74.12 9.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -0.92 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 91.54 3.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.479 ' CG2' ' HE2' ' A' ' 137' ' ' LYS . 14.4 t -112.85 -169.75 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.03 167.16 12.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.451 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -137.16 179.13 6.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 109.911 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.14 141.13 51.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.428 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 5.7 t -142.57 143.36 32.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 110.162 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -31.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.513 ' O ' HD11 ' A' ' 18' ' ' LEU . 3.3 mm -66.08 140.82 97.16 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 36.2 Cg_endo -60.32 158.34 31.54 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.795 1.419 . . . . 0.0 110.617 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.51 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -53.91 -70.08 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 0.0 111.732 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.62 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -37.97 -62.07 0.59 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.309 -0.869 . . . . 0.0 111.808 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.556 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.2 mpt_? -52.73 -57.45 10.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.866 -1.146 . . . . 0.0 110.673 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -48.45 -30.66 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.183 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.641 ' CE2' HD23 ' A' ' 24' ' ' LEU . 68.3 t80 -74.01 -57.09 4.2 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.038 -1.039 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.0 mtmt -59.73 -23.02 62.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.73 . . . . 0.0 111.883 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.586 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -107.96 -53.25 2.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.578 -1.327 . . . . 0.0 112.226 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 27.4 t80 -83.89 -14.07 52.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.059 . . . . 0.0 112.38 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.535 HG23 ' CE1' ' A' ' 19' ' ' PHE . 28.2 mt -124.5 -14.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.573 -1.33 . . . . 0.0 110.868 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.641 HD23 ' CE2' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -111.74 -17.01 13.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.032 . . . . 0.0 109.967 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.484 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 4.7 t0 -137.16 43.83 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 110.151 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.36 -23.16 71.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.52 -30.53 69.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -1.166 . . . . 0.0 110.365 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' HD11 ' A' ' 29' ' ' LEU . 10.7 p-10 -105.04 25.15 10.89 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 30' ' ' PHE . 3.1 tp -141.56 -63.23 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.668 -0.645 . . . . 0.0 110.354 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.567 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 6.1 m-30 -34.24 -52.96 0.94 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.782 -0.574 . . . . 0.0 110.746 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 50.9 Cg_endo -68.03 -50.25 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.468 1.246 . . . . 0.0 110.742 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -65.82 -69.52 0.29 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.286 -0.884 . . . . 0.0 110.615 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.589 HG13 ' CD1' ' A' ' 150' ' ' TYR . 12.2 m -68.05 -11.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 111.409 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 30' ' ' PHE . . . -146.73 66.17 10.52 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.3 Cg_endo -69.81 -11.86 31.64 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.846 1.445 . . . . 0.0 109.45 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -83.21 -14.63 52.92 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.332 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 143' ' ' LEU . . . -112.36 -48.04 3.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.044 -1.035 . . . . 0.0 111.126 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 2.2 mp -116.94 163.56 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.985 -1.072 . . . . 0.0 110.596 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -124.07 -33.79 3.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.94 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER 169.95 141.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.536 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 56' ' ' ILE . 3.2 p -103.37 148.03 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.159 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.495 1.795 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.056 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.215 0.531 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 54' ' ' LYS . 1.1 mp -125.27 168.43 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.515 ' CG ' ' HB2' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -149.11 147.56 28.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.397 -0.815 . . . . 0.0 109.914 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 2.4 tttp -111.53 92.04 3.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.91 -1.119 . . . . 0.0 110.537 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.518 ' HB ' HG21 ' A' ' 67' ' ' VAL . 1.8 mp -79.52 133.03 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.069 -1.019 . . . . 0.0 109.576 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.33 120.25 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 0.0 110.635 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CE2' HG23 ' A' ' 67' ' ' VAL . 16.6 m-85 -83.08 169.62 17.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.588 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 44.7 Cg_endo -71.15 173.96 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.628 1.33 . . . . 0.0 110.023 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.464 ' O ' HD21 ' A' ' 62' ' ' LEU . 6.3 tt0 -58.74 179.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.26 2.09 86.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -84.62 138.61 38.14 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -1.219 . . . . 0.0 110.599 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.67 -12.84 26.97 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.023 1.539 . . . . 0.0 109.81 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.537 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 18.8 m-30 -110.77 -139.54 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.96 -37.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 0.1 OUTLIER 178.44 -166.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG23 ' CE2' ' A' ' 58' ' ' PHE . 3.5 m -159.92 123.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.562 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -92.36 130.72 37.97 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.515 ' HB2' ' CG ' ' A' ' 54' ' ' LYS . 3.6 m-20 -118.0 151.08 38.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.907 -1.121 . . . . 0.0 111.449 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.56 114.34 27.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.474 ' CG2' HG22 ' A' ' 74' ' ' VAL . 8.9 p -58.49 -27.74 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER 42.04 51.28 4.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.0 mt-10 65.14 158.97 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.339 -0.85 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.474 HG22 ' CG2' ' A' ' 71' ' ' VAL . 90.0 t -144.07 159.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -109.41 -150.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.215 -0.928 . . . . 0.0 110.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.633 ' CE1' ' CD1' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 179.98 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 0.0 110.18 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -55.54 -52.72 62.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.231 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -90.28 15.59 10.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.223 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.62 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 11.6 m-85 47.09 69.32 0.51 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.507 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -126.57 143.83 51.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.929 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -141.7 100.77 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 71' ' ' VAL . 9.8 t-20 -96.72 104.17 16.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 109.563 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 8.4 p90 -132.02 -169.5 2.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 109.983 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 98' ' ' ILE . 1.7 t -149.09 165.8 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.218 -0.926 . . . . 0.0 110.772 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 55.3 t -105.03 -26.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.382 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 85' ' ' VAL . 41.8 pt 37.05 -139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.162 0.506 . . . . 0.0 110.81 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 86' ' ' ILE . 1.4 mm-40 -60.61 135.43 57.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.996 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 136.66 142.72 4.49 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.358 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.547 ' N ' HG11 ' A' ' 67' ' ' VAL . . . 88.18 -142.79 17.69 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 52.2 Cg_endo -83.16 27.85 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.127 1.593 . . . . 0.0 110.993 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.15 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.474 -0.766 . . . . 0.0 110.581 -179.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 89.84 -163.77 30.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 1.3 m-20 56.44 -91.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -1.077 . . . . 0.0 110.484 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.469 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 76.3 p -142.12 47.37 1.62 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.438 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 94' ' ' THR . 1.4 mt -170.2 90.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.49 -49.97 6.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.573 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 1.9 ttpp -113.69 161.2 17.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 97' ' ' LYS . 15.5 mt -158.39 113.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.473 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 4.3 m -104.32 122.2 44.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.166 -0.959 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.434 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 50.4 m-20 -116.29 133.5 55.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 111.601 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 82' ' ' ASN . 3.2 tp10 -118.57 129.49 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.427 ' C ' ' HG3' ' A' ' 103' ' ' LYS . 19.6 mt -116.91 146.96 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 0.0 110.783 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.447 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 49.4 mtpt -142.69 106.53 4.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.769 . . . . 0.0 109.784 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.525 ' CD1' HD13 ' A' ' 23' ' ' ILE . 14.5 mt -79.39 144.32 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.645 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.462 HG22 ' HD2' ' A' ' 115' ' ' LYS . 22.1 t -130.07 127.52 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 110.157 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.6 132.83 34.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.116 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -111.13 153.03 44.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.386 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.33 -19.96 49.24 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.06 1.558 . . . . 0.0 110.703 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.414 ' O ' ' OD2' ' A' ' 109' ' ' ASP . 3.0 p-10 -158.43 44.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.92 21.59 0.78 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.85 -113.65 5.94 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 72.3 m -152.41 137.21 17.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.449 -1.03 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.4 mt -104.09 133.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.737 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.606 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.2 mp -95.25 99.91 11.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 110.002 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HD2' HG22 ' A' ' 105' ' ' VAL . 14.1 mttm -75.29 103.17 5.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.716 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.468 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 25.8 mt -94.51 137.95 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 110.875 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.84 91.06 3.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.458 -0.776 . . . . 0.0 109.028 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 m-80 -84.48 92.24 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 111.387 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HD2' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -84.73 103.37 13.76 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.465 ' O ' HG12 ' A' ' 2' ' ' VAL . 3.2 m-85 -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.007 . . . . 0.0 111.468 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 32.7 m-70 -121.36 84.09 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 109.443 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 94' ' ' THR . 11.3 p -84.25 -164.74 0.99 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.357 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -137.42 88.02 2.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.34 -135.04 45.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.419 ' OD2' HG21 ' A' ' 94' ' ' THR . 17.6 t0 50.87 -141.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -1.125 . . . . 0.0 110.142 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.446 ' HB2' HG23 ' A' ' 94' ' ' THR . 43.8 m-70 -83.29 179.48 7.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -95.96 161.03 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.266 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 5' ' ' TYR . 39.6 t -50.4 139.56 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.036 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 31.4 mtmt -94.32 117.63 30.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -46.68 -43.79 18.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.153 -0.967 . . . . 0.0 109.853 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -46.04 64.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.062 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.443 ' NE2' HD11 ' A' ' 95' ' ' LEU . 1.5 tt0 -59.99 -44.93 94.2 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.537 HG13 ' CD2' ' A' ' 5' ' ' TYR . 54.4 t -59.66 -23.64 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.67 0.747 . . . . 0.0 109.163 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -79.35 -43.64 23.11 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.81 -0.557 . . . . 0.0 110.542 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.6 -53.79 46.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 t -61.15 -45.15 95.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.479 ' HE2' ' CG2' ' A' ' 7' ' ' THR . 0.1 OUTLIER -62.76 -18.42 62.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.865 . . . . 0.0 108.722 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -77.82 -51.21 10.84 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 40.0 mmm -60.22 -33.38 72.19 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.193 -1.003 . . . . 0.0 108.78 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.58 -44.87 69.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -67.08 -39.88 86.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.808 -1.407 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -45.93 90.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.339 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 37' ' ' ALA . 1.1 mm? -60.97 -52.62 64.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.337 -0.852 . . . . 0.0 109.324 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.526 ' CD2' HG22 ' A' ' 9' ' ' THR . 10.3 tp -46.81 -43.27 18.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -40.46 97.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 0.0 109.657 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -59.4 -61.33 2.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 22' ' ' PHE . 9.6 t -62.75 -18.38 20.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.463 -0.773 . . . . 0.0 109.89 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.502 ' O ' ' CD2' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -72.61 -46.1 55.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 81.1 p -87.18 -15.0 39.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.589 ' CD1' HG13 ' A' ' 33' ' ' VAL . 3.7 t80 -67.01 -39.89 87.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.995 . . . . 0.0 109.6 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.456 HD13 HG13 ' A' ' 13' ' ' ILE . 42.7 mt -63.1 -36.34 83.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.402 -0.811 . . . . 0.0 110.596 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -75.96 -51.98 11.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.311 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -53.77 -54.1 43.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -67.28 -163.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 44.8 m -94.09 59.37 2.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 0.1 OUTLIER 61.6 41.21 12.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.472 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -42.41 151.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 110.244 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.586 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 81.9 m-85 57.87 57.38 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.34 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.155 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.564 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 40.4 t 50.71 170.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.56 -0.965 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.564 ' CD1' ' C ' ' A' ' 2' ' ' VAL . 97.4 m-85 -150.93 150.37 30.75 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -111.7 103.8 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE2' HG23 ' A' ' 133' ' ' VAL . 55.3 m-85 -100.79 87.21 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.45 108.51 19.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -127.99 -172.12 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.19 -170.87 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.867 . . . . 0.0 109.943 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.57 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 5.0 t -165.95 173.66 10.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 0.0 109.75 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.76 142.69 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.011 . . . . 0.0 110.491 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.495 ' CB ' HD13 ' A' ' 18' ' ' LEU . 20.2 t -132.13 144.15 50.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -77.47 -7.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.337 -0.852 . . . . 0.0 110.116 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.575 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 7.2 mm -94.78 145.27 29.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 110.473 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 30.9 Cg_endo -56.25 160.69 10.35 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.789 1.415 . . . . 0.0 110.686 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -63.26 -78.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 111.415 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.587 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -32.04 -54.6 0.3 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.664 -0.648 . . . . 0.0 111.421 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -57.41 -55.7 31.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.0 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.575 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 5.4 mt -51.01 -28.74 10.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.608 ' CE2' HD23 ' A' ' 24' ' ' LEU . 19.0 t80 -73.07 -67.47 0.57 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.68 -25.11 9.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.225 -0.922 . . . . 0.0 112.317 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -101.33 -58.16 1.94 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.541 -1.349 . . . . 0.0 111.443 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.511 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 24.2 t80 -80.59 -83.14 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.03 -1.044 . . . . 0.0 111.47 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 19' ' ' PHE . 2.4 mp -46.36 -21.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.18 -0.95 . . . . 0.0 111.876 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.608 HD23 ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -106.67 -77.81 0.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.664 -1.273 . . . . 0.0 110.043 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 21' ' ' ALA . 2.8 t0 -73.15 83.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 0.0 110.212 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.63 -27.94 4.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.14 -12.75 60.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.271 . . . . 0.0 110.278 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -118.79 7.13 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.576 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.546 HD13 ' CG ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -122.36 -40.32 2.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.803 . . . . 0.0 110.228 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.586 ' CD1' HD11 ' A' ' 143' ' ' LEU . 6.1 m-30 -61.39 -54.66 50.67 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.919 . . . . 0.0 111.35 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.4 Cg_endo -65.66 -6.13 13.19 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.306 1.161 . . . . 0.0 111.262 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -103.82 -67.61 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 110.592 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG21 ' N ' ' A' ' 34' ' ' ALA . 12.0 m -74.76 -20.91 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 110.82 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.51 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -122.4 61.65 15.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 110.675 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.1 Cg_endo -67.86 -23.29 41.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.101 1.58 . . . . 0.0 109.136 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -73.6 -15.87 61.26 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -108.67 -66.16 1.07 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 110.75 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.522 HG13 ' CE1' ' A' ' 58' ' ' PHE . 4.0 mp -114.47 172.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.525 ' HB3' ' CG ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -163.97 -25.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 111.472 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.4 t -133.45 138.76 46.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.588 -1.32 . . . . 0.0 111.122 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.57 128.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.587 -0.696 . . . . 0.0 109.41 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.009 . . . . 0.0 110.137 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.323 0.582 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.523 HG21 ' N ' ' A' ' 54' ' ' LYS . 16.5 mm -117.11 165.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' N ' HG21 ' A' ' 53' ' ' ILE . 4.4 pttp -179.66 142.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.006 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -140.58 108.84 5.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.831 -0.543 . . . . 0.0 109.601 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.519 HD13 ' N ' ' A' ' 56' ' ' ILE . 1.7 mp -82.87 152.42 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.909 . . . . 0.0 110.59 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -127.38 139.83 52.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.99 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.582 ' CE2' HG23 ' A' ' 67' ' ' VAL . 24.1 m-85 -109.96 103.83 54.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.441 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 46.1 Cg_endo -72.82 -159.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.031 1.543 . . . . 0.0 110.198 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.554 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER 44.51 -172.53 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.094 -1.004 . . . . 0.0 111.526 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.554 ' N ' ' HG3' ' A' ' 60' ' ' GLU . . . -45.06 -18.26 0.13 Allowed Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.737 -0.602 . . . . 0.0 112.992 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -42.82 125.75 3.14 Favored Pre-proline 0 N--CA 1.501 2.097 0 CA-C-N 119.672 1.736 . . . . 0.0 110.302 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 64' ' ' PHE . 50.4 Cg_endo -74.99 -156.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 109.846 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 63' ' ' PRO . 3.4 m-85 57.18 168.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.068 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -104.96 -39.82 6.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.89 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 29.1 p90 179.56 -175.11 0.25 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.74 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.582 HG23 ' CE2' ' A' ' 58' ' ' PHE . 8.2 m -150.93 106.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.961 -1.087 . . . . 0.0 110.779 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 12.1 tttt -107.35 139.41 41.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' HE3' ' A' ' 54' ' ' LYS . 2.7 p30 -159.71 166.13 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.907 -1.121 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HD2' HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -104.69 145.99 29.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.599 -0.688 . . . . 0.0 109.362 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -83.11 -38.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.986 -1.072 . . . . 0.0 110.154 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.05 -33.93 0.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.731 -0.606 . . . . 0.0 111.646 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 6.0 pt-20 174.54 160.42 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.761 -1.212 . . . . 0.0 110.292 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.495 HG21 ' CE1' ' A' ' 81' ' ' TYR . 44.5 t -151.99 92.5 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.827 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -66.56 -169.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.185 -0.947 . . . . 0.0 110.541 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.414 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -153.75 -52.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.5 m -48.38 -34.81 11.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 75.3 m-20 -118.93 6.06 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.388 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 9.0 m-85 58.9 40.6 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.982 . . . . 0.0 110.059 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 103' ' ' LYS . 1.4 tttt -89.02 117.46 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.988 . . . . 0.0 110.65 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.498 ' O ' ' CD1' ' A' ' 102' ' ' ILE . 25.1 t80 -118.4 132.93 56.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' VAL . 4.0 t30 -144.19 104.89 4.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 109.956 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.8 p90 -125.0 164.18 20.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.01 136.37 51.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.756 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.87 114.3 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.504 -0.748 . . . . 0.0 109.199 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 pt -113.94 6.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.029 -1.044 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.1 144.18 5.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.013 -1.054 . . . . 0.0 110.308 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.526 ' N ' HD13 ' A' ' 91' ' ' ILE . . . 84.0 133.48 2.43 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.476 ' CA ' HG11 ' A' ' 67' ' ' VAL . . . 124.18 -134.5 9.2 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' ILE . 45.0 Cg_endo -72.54 -6.32 18.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.919 1.484 . . . . 0.0 110.631 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -35.97 157.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.32 23.91 18.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.1 -146.36 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -1.187 . . . . 0.0 110.089 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.472 ' O ' ' HB ' ' A' ' 122' ' ' THR . 1.2 p -87.22 44.41 1.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -132.59 124.14 27.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.9 OUTLIER -105.72 -71.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.93 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -125.7 132.59 52.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.819 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.481 HG12 HD13 ' A' ' 95' ' ' LEU . 59.8 mt -121.98 121.81 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.264 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.27 157.16 16.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.975 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.13 109.47 5.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.001 -1.062 . . . . 0.0 110.689 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.623 ' O ' HG22 ' A' ' 102' ' ' ILE . 33.6 tt0 -125.95 137.07 53.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.354 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.752 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER 175.71 -157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.242 -0.911 . . . . 0.0 112.837 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.488 ' CB ' ' HA ' ' A' ' 80' ' ' LYS . 14.8 ptmt -172.59 179.52 2.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.26 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.525 HD13 ' CD1' ' A' ' 114' ' ' LEU . 14.8 mm -110.57 146.3 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.614 -0.679 . . . . 0.0 109.832 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.462 HG22 ' HD2' ' A' ' 115' ' ' LYS . 56.8 t -122.12 142.82 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.446 ' HA ' ' OG ' ' A' ' 112' ' ' SER . . . -110.1 133.03 53.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.0 110.424 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 39.5 p -93.82 164.07 21.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 43.3 Cg_endo -64.91 -22.57 62.89 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.915 1.482 . . . . 0.0 111.149 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 22.4 p-10 -175.58 88.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.027 -1.045 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.82 -30.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.05 -133.77 6.2 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -147.84 140.18 24.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -1.128 . . . . 0.0 110.059 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 mt -95.72 120.48 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.863 . . . . 0.0 110.245 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.57 ' HB2' ' CG2' ' A' ' 9' ' ' THR . 3.8 mp -83.25 108.04 16.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.773 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.752 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 18.1 mttt -94.44 121.68 36.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.683 -1.26 . . . . 0.0 109.17 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.741 ' CA ' HG23 ' A' ' 102' ' ' ILE . 34.1 mm -120.98 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.607 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.564 ' N ' HG22 ' A' ' 102' ' ' ILE . 13.0 m -119.06 126.4 51.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.495 -1.378 . . . . 0.0 109.275 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.7 150.32 40.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.948 . . . . 0.0 111.191 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.49 109.54 12.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.453 ' O ' HG11 ' A' ' 2' ' ' VAL . 4.6 m-85 -86.9 135.06 33.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 111.556 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 96' ' ' GLU . 76.6 m-70 -123.08 86.49 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.481 ' CG2' HG21 ' A' ' 128' ' ' VAL . 8.9 p -86.9 -179.2 6.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -0.761 . . . . 0.0 110.902 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -60.04 -147.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.437 -0.789 . . . . 0.0 110.449 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.38 77.9 0.38 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.88 -71.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 109.918 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -85.54 173.65 10.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.896 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 52.8 mt-10 -110.25 -174.15 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 110.431 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.503 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 46.6 t -83.78 145.18 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.33 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -90.42 112.35 23.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.37 -41.82 14.08 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.168 -0.958 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.49 -46.82 76.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.296 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -58.83 -42.59 89.58 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.573 HG23 ' CE2' ' A' ' 5' ' ' TYR . 70.3 t -62.83 -25.81 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.748 0.785 . . . . 0.0 109.224 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.8 ttmt -73.83 -56.95 4.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.705 -0.622 . . . . 0.0 110.492 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -35.64 -52.1 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.688 -0.633 . . . . 0.0 110.952 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 t -57.49 -47.82 80.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -61.42 -28.63 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 135' ' ' ALA . 14.0 mm-40 -69.88 -57.83 4.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.281 -0.887 . . . . 0.0 109.351 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 2.7 mtp -54.81 -35.63 64.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.221 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.69 -39.04 95.12 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.79 -45.93 48.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.869 -1.371 . . . . 0.0 110.888 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 -41.01 92.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.027 -1.046 . . . . 0.0 109.49 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' A' ' 30' ' ' PHE . 1.5 mm? -68.35 -53.8 21.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.511 -0.743 . . . . 0.0 109.887 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 16.1 tp -46.21 -43.72 15.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.145 -0.972 . . . . 0.0 108.811 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.449 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 2.2 ttp180 -66.22 -39.94 89.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.388 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.488 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -55.52 -62.36 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -0.843 . . . . 0.0 109.359 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 60.4 t -62.57 -23.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -61.79 -55.93 24.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.372 -0.83 . . . . 0.0 110.085 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -23.37 53.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.546 ' CG ' HD13 ' A' ' 29' ' ' LEU . 11.3 t80 -56.08 -37.82 69.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.117 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.5 -25.62 62.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.174 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 2.1 mp -88.89 -19.12 26.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.79 -38.41 14.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.838 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.56 156.27 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.846 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 3.3 p -44.26 -53.54 6.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 155' ' ' SER . 23.3 t70 -177.1 64.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.195 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.64 146.29 46.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 110.358 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 63.0 m-85 54.45 70.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 110.48 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.35 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 120' ' ' TYR . 7.9 p -88.03 157.16 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -1.103 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.451 ' CD1' ' CG2' ' A' ' 128' ' ' VAL . 87.7 m-85 -123.6 122.78 39.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 110.03 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.59 98.82 10.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.54 ' CD1' HG13 ' A' ' 133' ' ' VAL . 46.7 m-85 -100.45 103.71 15.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 109.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -108.59 122.28 46.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.953 -1.092 . . . . 0.0 110.109 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 6.2 t -130.54 166.73 19.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 110.541 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.467 ' CG ' ' O ' ' A' ' 7' ' ' THR . 75.1 mt-10 -155.18 157.69 37.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.564 HG21 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -142.37 -178.51 5.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.015 . . . . 0.0 110.27 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.0 141.8 50.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.039 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.44 ' HB3' HD13 ' A' ' 18' ' ' LEU . 19.6 t -134.42 142.25 47.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.46 0.33 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.54 -0.725 . . . . 0.0 110.124 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.587 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 11.1 mm -96.69 147.99 33.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 33.9 Cg_endo -56.55 157.81 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.885 1.466 . . . . 0.0 110.033 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HA ' HG23 ' A' ' 104' ' ' ILE . . . -68.5 -64.04 0.94 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.072 -1.017 . . . . 0.0 110.886 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.59 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -43.35 -50.52 6.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.732 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.551 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.17 -52.18 65.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 6.0 mt -52.31 -24.1 6.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 108.773 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE2' HD23 ' A' ' 24' ' ' LEU . 43.5 t80 -77.66 -55.66 5.17 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.466 -0.772 . . . . 0.0 110.384 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 5.0 mmmt -61.25 -21.76 64.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.569 -0.707 . . . . 0.0 111.884 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HB1' ' CG ' ' A' ' 158' ' ' TYR . . . -111.39 -47.26 3.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.685 -1.259 . . . . 0.0 112.774 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 39.2 t80 -89.68 -22.08 22.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.718 -1.239 . . . . 0.0 112.482 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.563 HG23 ' CE1' ' A' ' 19' ' ' PHE . 2.1 mp -116.56 -13.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.649 -1.282 . . . . 0.0 110.378 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.636 HD23 ' CE2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -111.96 -12.91 13.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.483 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 9.6 t0 -146.67 47.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.547 ' CA ' ' CE1' ' A' ' 30' ' ' PHE . . . -83.25 -31.16 28.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -76.77 2.96 12.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -1.088 . . . . 0.0 110.321 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.3 t30 -138.62 50.47 1.86 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.574 HD12 ' CE2' ' A' ' 150' ' ' TYR . 1.1 tp 173.06 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.581 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' CA ' ' A' ' 26' ' ' GLY . 3.0 m-30 -52.18 -59.29 8.74 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.919 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -67.06 -11.97 34.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 111.211 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -90.06 -31.58 17.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 111.031 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.557 HG13 ' CD1' ' A' ' 150' ' ' TYR . 10.5 m -103.82 -11.81 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.94 66.6 40.15 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.808 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.4 -5.37 14.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.967 1.509 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -94.9 -12.61 26.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.411 -0.806 . . . . 0.0 109.625 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.02 -28.93 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.668 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 6.7 mm -125.75 178.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.967 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 t -136.35 -45.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 t -174.85 165.16 3.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.5 t -118.58 124.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 110.034 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 42' ' ' GLU . 3.5 tp10 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.417 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.457 HG23 ' HE3' ' A' ' 54' ' ' LYS . 87.1 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.28 0.562 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 3.9 mp -97.06 136.71 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' A' ' 52' ' ' THR . 84.6 mttt -139.41 148.99 43.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 6.7 tttt -117.45 96.03 5.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.82 . . . . 0.0 110.653 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 57' ' ' SER . 1.4 mp -73.47 148.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.446 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 27.5 t -124.75 169.38 12.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.271 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 39.4 m-85 -134.33 153.68 79.47 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.601 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 38' ' ' ILE . 48.4 Cg_endo -76.36 169.72 21.39 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.185 1.624 . . . . 0.0 109.615 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 167.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 110.061 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.03 -43.41 3.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 58' ' ' PHE . 8.5 mt -79.96 155.36 75.24 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.083 -1.245 . . . . 0.0 110.65 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 64' ' ' PHE . 50.8 Cg_endo -81.88 162.36 18.48 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.193 1.628 . . . . 0.0 110.971 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 63' ' ' PRO . 11.6 m-85 65.69 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 0.0 110.634 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -69.1 -9.5 52.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.482 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 30.1 p90 -175.75 -170.34 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 110.176 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.552 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 7.3 p -170.93 109.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 3.3 mtmm -96.15 138.42 33.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.751 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.18 -176.06 4.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.691 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -138.75 127.91 24.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 109.902 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 55.7 t -68.25 -44.38 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.323 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 1.4 m-20 77.98 -38.2 0.25 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.803 -0.56 . . . . 0.0 111.419 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 179.0 -167.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.696 -1.253 . . . . 0.0 111.001 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.485 HG22 ' CD1' ' A' ' 81' ' ' TYR . 12.2 p -167.91 118.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.628 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -77.26 -49.75 14.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.174 -0.953 . . . . 0.0 110.955 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 0.1 OUTLIER 77.94 -71.16 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.634 -0.666 . . . . 0.0 110.506 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -57.77 -42.49 84.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.316 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 79' ' ' PHE . 15.6 m120 -97.03 18.0 15.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 23.2 m-30 43.49 27.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.525 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.5 ttpt -95.29 107.62 19.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.161 -0.962 . . . . 0.0 109.874 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.485 ' CD1' HG22 ' A' ' 74' ' ' VAL . 20.4 t80 -110.79 96.82 6.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.596 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.2 m-20 -84.39 161.22 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.839 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 13.4 p90 -179.33 152.42 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.44 -0.787 . . . . 0.0 109.768 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.66 146.66 48.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.206 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.6 t -104.97 73.11 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.257 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.413 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 5.4 pt -62.06 -42.51 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.345 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 2.6 mt-10 -139.66 94.91 2.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.898 -1.126 . . . . 0.0 110.709 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.462 ' O ' HD12 ' A' ' 91' ' ' ILE . . . 167.96 120.35 0.52 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.97 -147.35 16.85 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 91' ' ' ILE . 47.7 Cg_endo -72.43 -3.41 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 124.033 1.544 . . . . 0.0 110.22 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -34.85 157.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 121.535 0.683 . . . . 0.0 110.596 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.95 -8.05 59.25 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -108.66 -85.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -1.147 . . . . 0.0 110.396 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.1 -18.89 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.931 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.576 HD23 ' CD2' ' A' ' 120' ' ' TYR . 2.3 mt -80.9 83.35 6.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 110.195 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.88 -52.33 63.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -137.32 165.71 25.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.199 -0.938 . . . . 0.0 110.531 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.415 HD12 HD23 ' A' ' 95' ' ' LEU . 23.1 mt -150.73 122.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.078 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -99.19 135.08 41.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.908 . . . . 0.0 109.761 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 32.9 m120 -137.71 140.89 40.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.75 -1.218 . . . . 0.0 110.972 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 7.0 pt-20 -138.26 154.03 49.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.76 . . . . 0.0 109.546 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.572 HD13 ' CE1' ' A' ' 83' ' ' TYR . 2.9 mt -128.13 155.13 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.469 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 22.9 mtmt -149.1 103.77 3.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 109.502 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 104' ' ' ILE . 2.9 mm -81.53 120.19 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 109.871 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' CD ' ' A' ' 115' ' ' LYS . 61.3 t -105.14 123.08 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.99 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.22 140.31 34.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 44.3 p -113.16 162.17 23.3 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.87 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 48.9 Cg_endo -66.62 -30.62 42.27 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.961 1.506 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -162.86 44.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.31 23.39 2.05 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.96 -135.84 26.65 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.5 p -132.81 134.62 44.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -1.14 . . . . 0.0 110.326 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.411 HG21 ' O ' ' A' ' 9' ' ' THR . 13.2 mt -95.13 124.06 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.564 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.0 OUTLIER -81.86 96.09 7.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 110.964 -179.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' CD ' HG23 ' A' ' 105' ' ' VAL . 3.9 mttp -87.47 107.86 18.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mt -116.78 132.54 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.22 144.06 36.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.519 -0.738 . . . . 0.0 109.589 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 5' ' ' TYR . 44.2 m-80 -136.78 143.46 43.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 110.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.47 108.92 9.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.576 ' CD2' HD23 ' A' ' 95' ' ' LEU . 5.4 m-85 -87.12 114.18 23.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.835 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -101.21 92.12 4.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.224 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.459 ' CG2' HG21 ' A' ' 128' ' ' VAL . 7.6 p -85.27 -151.75 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.827 . . . . 0.0 110.748 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.42 3.07 15.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 110.566 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 96.45 -157.24 21.33 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -1.017 . . . . 0.0 110.248 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 124' ' ' GLY . 1.6 m-70 -81.1 166.21 20.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.895 -1.128 . . . . 0.0 110.009 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -109.58 167.84 9.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.431 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.521 HG12 ' CE2' ' A' ' 5' ' ' TYR . 23.4 t -63.39 150.51 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 110.248 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 132' ' ' GLN . 40.8 mtmt -83.57 102.79 12.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.87 -56.42 3.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.133 -0.98 . . . . 0.0 109.912 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.3 tt0 -44.83 -45.34 10.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.227 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -58.11 -44.71 87.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 108.921 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.54 HG13 ' CD1' ' A' ' 5' ' ' TYR . 79.0 t -60.67 -25.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 135' ' ' ALA . 1.9 tttm -81.88 -68.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.966 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.53 -40.76 0.41 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 110.325 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -51.25 68.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.047 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 6.6 mptt -56.07 -30.65 62.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.489 -0.757 . . . . 0.0 109.557 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 109.876 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 57.0 mmm -67.62 -34.34 76.79 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.864 . . . . 0.0 108.813 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -71.01 -43.32 57.66 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -66.48 -33.76 76.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -1.157 . . . . 0.0 110.108 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 2.0 p -70.59 -43.45 69.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.271 -0.893 . . . . 0.0 109.23 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -70.08 -25.27 63.44 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.548 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.532 ' CD2' HG22 ' A' ' 9' ' ' THR . 17.2 tp -73.3 -43.32 61.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 108.901 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.576 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -72.32 -25.64 61.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.576 ' N ' ' HG3' ' A' ' 145' ' ' ARG . . . -70.84 -53.94 13.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 109.028 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.51 ' CG1' HD22 ' A' ' 29' ' ' LEU . 62.1 t -70.61 -21.86 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.154 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 149' ' ' SER . 0.4 OUTLIER -69.55 -52.39 26.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.315 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.478 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 88.9 p -74.87 -23.13 58.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.333 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.574 ' CE2' HD12 ' A' ' 29' ' ' LEU . 9.1 t80 -59.04 -41.8 88.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.94 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.09 -27.7 69.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.435 HD21 ' HA ' ' A' ' 149' ' ' SER . 0.3 OUTLIER -86.35 -23.63 26.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.15 -55.49 5.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.227 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.472 ' O ' ' HB3' ' A' ' 155' ' ' SER . 15.9 m-70 -73.8 -34.11 64.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 110.064 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 23.1 t 59.36 15.02 4.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 156' ' ' ASP . 1.7 p30 -145.48 12.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.95 . . . . 0.0 110.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.571 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.85 131.16 48.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.494 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 41.4 m-85 58.03 48.02 13.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.421 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.209 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.519 HG11 ' N ' ' A' ' 3' ' ' PHE . 47.1 t -105.72 165.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -1.21 . . . . 0.0 110.537 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 53.6 m-85 -125.29 148.4 48.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.785 . . . . 0.0 109.65 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -117.2 110.08 17.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 110.539 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.583 ' CD2' HG12 ' A' ' 133' ' ' VAL . 23.0 m-85 -108.75 76.7 1.03 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.598 -0.689 . . . . 0.0 109.527 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 85.7 mt-10 -84.05 96.72 8.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 110.879 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.423 HG21 ' HB ' ' A' ' 116' ' ' ILE . 5.0 t -106.29 163.17 13.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.836 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -135.33 144.44 46.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.146 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.595 HG21 ' CB ' ' A' ' 114' ' ' LEU . 1.1 t -134.39 161.48 34.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.86 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.433 HG22 HG22 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -123.52 143.64 50.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.99 . . . . 0.0 110.341 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -135.8 147.33 48.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 110.24 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.03 -20.93 19.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 109.772 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.536 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 6.4 mm -75.93 140.0 70.08 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.7 Cg_endo -57.22 148.95 67.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.807 1.425 . . . . 0.0 110.568 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' CG2' ' A' ' 104' ' ' ILE . . . -55.08 -46.09 75.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 0.0 111.275 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.0 -58.98 5.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 111.009 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.513 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 6.4 mtm180 -53.95 -57.35 11.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 109.671 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.48 -32.11 7.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.561 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.574 ' CE1' HD23 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -68.34 -62.77 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.525 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 26.5 mtpp -59.54 -23.06 62.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.519 -0.738 . . . . 0.0 112.842 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.583 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -106.08 -55.73 2.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.481 -1.387 . . . . 0.0 111.943 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 57.7 t80 -79.19 -9.33 59.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 0.0 112.07 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.526 HG23 ' CE1' ' A' ' 19' ' ' PHE . 71.4 mt -130.07 -21.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.627 -1.296 . . . . 0.0 111.63 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.574 HD23 ' CE1' ' A' ' 19' ' ' PHE . 2.7 mt -106.18 -14.93 15.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.224 . . . . 0.0 109.536 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.515 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -138.39 30.67 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.441 -0.787 . . . . 0.0 110.416 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.3 -36.95 93.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' HB3' HG13 ' A' ' 41' ' ' VAL . 52.1 m-20 -60.89 -14.57 23.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -1.047 . . . . 0.0 109.815 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t30 -122.47 52.12 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.586 HD22 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -172.4 -52.26 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.493 -0.755 . . . . 0.0 110.102 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.554 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 7.1 m-30 -43.73 -53.91 11.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 111.093 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -67.02 -29.57 40.19 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.346 1.182 . . . . 0.0 111.065 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -77.42 -71.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 111.17 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' CG1' ' CD1' ' A' ' 150' ' ' TYR . 22.2 m -71.99 -20.49 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 111.596 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -126.18 63.17 48.99 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.897 -1.127 . . . . 0.0 111.106 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.7 Cg_endo -69.26 -11.42 31.44 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.858 1.451 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.5 OUTLIER -87.08 -8.18 57.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.501 -0.749 . . . . 0.0 109.578 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' CB ' HD22 ' A' ' 143' ' ' LEU . . . -117.53 -48.53 2.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.974 . . . . 0.0 110.392 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HE2' ' A' ' 139' ' ' MET . 2.9 mp -117.69 156.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.077 -1.014 . . . . 0.0 110.199 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -113.55 -31.04 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER 169.53 159.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.81 . . . . 0.0 109.905 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 27' ' ' ASP . 3.4 p -126.9 129.51 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.925 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 110.589 -179.468 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.233 0.54 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.2 mm -106.37 116.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.731 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.47 162.4 18.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.074 . . . . 0.0 110.708 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -134.21 113.49 12.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.579 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.54 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 1.9 mp -81.49 144.7 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.403 ' N ' HG21 ' A' ' 56' ' ' ILE . 10.1 t -125.9 101.43 6.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.622 -0.674 . . . . 0.0 109.844 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 38.6 m-85 -70.06 140.23 88.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 50.5 Cg_endo -82.74 48.28 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.165 1.613 . . . . 0.0 110.4 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 5.1 tt0 -135.04 -170.82 2.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.382 -0.824 . . . . 0.0 110.357 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.08 37.36 3.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' A' ' 60' ' ' GLU . 79.1 mt -56.1 163.2 2.4 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.311 -1.111 . . . . 0.0 110.168 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 64' ' ' PHE . 46.6 Cg_endo -73.38 -9.47 23.06 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.021 1.538 . . . . 0.0 110.257 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 3.8 m-85 -114.88 -34.51 5.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.128 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 1.5 ttpt 74.45 -0.41 3.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.603 -0.685 . . . . 0.0 109.997 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 32.9 p90 179.88 -161.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.583 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 8.7 p -179.45 118.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.308 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HG3' ' HG3' ' A' ' 55' ' ' LYS . 2.7 tttt -87.67 138.57 31.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -140.29 163.89 31.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.087 -1.008 . . . . 0.0 110.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 5.8 mtm180 -121.82 139.54 53.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.384 -0.822 . . . . 0.0 109.943 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' ASP . 24.6 t -73.21 -17.92 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.942 . . . . 0.0 110.262 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER 44.99 27.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.959 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.7 mt-10 65.76 148.6 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 81' ' ' TYR . 27.3 m -123.23 -170.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.545 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.04 152.28 42.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.39 -52.61 2.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.021 -1.05 . . . . 0.0 110.633 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.3 m -61.4 -10.91 8.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.856 -1.152 . . . . 0.0 110.599 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -125.19 6.44 7.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.015 -1.053 . . . . 0.0 110.535 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.539 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.7 m-30 46.83 54.97 8.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 29.3 tttt -124.14 105.52 9.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 111.143 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.595 ' CD1' ' CG1' ' A' ' 74' ' ' VAL . 74.2 t80 -89.72 178.23 6.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 109.315 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.427 ' N ' ' CG ' ' A' ' 81' ' ' TYR . 5.9 t30 -179.2 129.81 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.788 -1.195 . . . . 0.0 110.642 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 3.8 p90 -137.77 152.46 49.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.802 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.18 132.4 44.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.643 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.55 133.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 109.331 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.3 -14.96 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 111.328 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' CA ' HD11 ' A' ' 91' ' ' ILE . 1.4 mm-40 -150.67 107.57 3.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.93 -1.106 . . . . 0.0 110.917 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.586 ' N ' ' CD1' ' A' ' 91' ' ' ILE . . . 127.04 -137.75 10.12 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 64' ' ' PHE . . . 26.69 -128.22 0.05 OUTLIER Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.567 ' O ' ' C ' ' A' ' 91' ' ' ILE . 42.8 Cg_endo -70.86 -59.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.877 1.462 . . . . 0.0 109.376 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 88' ' ' GLY . 1.8 mt 4.59 90.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 121.746 0.784 . . . . 0.0 112.893 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.95 -149.34 6.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.98 -18.82 5.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.287 . . . . 0.0 109.435 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.515 ' CG2' ' HB2' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -128.12 136.26 50.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.81 . . . . 0.0 109.964 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.507 ' CD1' ' CD2' ' A' ' 120' ' ' TYR . 4.6 mt 63.38 92.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.294 -0.878 . . . . 0.0 110.063 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.78 -34.88 21.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -140.77 150.01 42.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.017 . . . . 0.0 110.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.521 HD12 ' CG ' ' A' ' 90' ' ' PRO . 58.9 mt -139.59 126.23 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.5 m -117.41 110.44 18.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 118' ' ' ASN . 1.9 m120 -106.86 119.45 39.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.905 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.413 ' O ' HD12 ' A' ' 102' ' ' ILE . 53.7 mt-10 -105.51 132.37 51.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 109.418 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 116' ' ' ILE . 20.0 mm -124.31 155.95 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.093 -1.004 . . . . 0.0 110.915 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 2.8 ttmt -148.2 114.5 5.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.796 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 15' ' ' ALA . 1.5 mp -77.41 121.27 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.01 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.532 HG22 ' CG ' ' A' ' 115' ' ' LYS . 61.9 t -104.45 133.4 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 110.435 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.26 132.37 44.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.0 p -106.68 157.87 34.12 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.018 . . . . 0.0 110.625 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 109' ' ' ASP . 49.6 Cg_endo -67.63 81.88 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.156 1.609 . . . . 0.0 110.218 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 7.6 t70 71.02 49.69 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.567 -0.708 . . . . 0.0 110.275 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.65 13.9 1.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.87 -159.21 34.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.488 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 3.4 p -126.38 131.09 51.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -1.129 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 10' ' ' THR . 6.1 mt -93.79 116.89 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.595 ' CB ' HG21 ' A' ' 9' ' ' THR . 0.7 OUTLIER -77.69 106.4 9.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 110.703 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' CG ' HG22 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -82.06 115.63 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.881 -1.137 . . . . 0.0 108.952 178.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.473 ' HA ' HD11 ' A' ' 102' ' ' ILE . 81.7 mt -113.79 127.99 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 111.199 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -126.72 95.55 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.524 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 72.2 m-20 -93.08 108.29 19.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 111.403 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 124.94 39.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 109.322 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 2.6 m-85 -103.34 112.22 25.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 111.115 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -96.19 98.15 10.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.68 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.492 ' CG2' HG22 ' A' ' 128' ' ' VAL . 11.3 p -82.69 -173.1 4.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.334 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' THR . 0.0 OUTLIER 170.27 43.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.46 -152.14 5.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.62 -69.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -1.14 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.515 ' HB2' ' CG2' ' A' ' 94' ' ' THR . 7.1 m-70 -80.53 176.28 9.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.182 -0.949 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 11.8 mp0 -106.02 -99.98 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.548 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 122' ' ' THR . 40.1 t -126.41 151.5 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.704 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 130' ' ' ALA . 6.4 mtmt -104.43 99.3 9.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.02 -42.8 2.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.328 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 9.4 tt0 -54.81 -49.01 72.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.043 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -58.92 -46.37 88.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 109.45 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 5' ' ' TYR . 38.5 t -62.23 -20.74 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.15 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.0 tttm -81.14 -68.57 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.6 -40.57 0.41 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 110.189 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.45 -51.61 66.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.179 -0.951 . . . . 0.0 109.105 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -54.92 -52.57 62.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 109.981 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -50.27 -46.45 55.08 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.432 ' HE2' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -60.79 -34.99 75.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.29 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.53 -34.46 89.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -71.83 -45.45 61.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -1.192 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -37.1 80.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 108.857 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.528 HD22 ' CB ' ' A' ' 37' ' ' ALA . 1.3 mm? -69.24 -37.92 78.24 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.504 HD23 HG22 ' A' ' 9' ' ' THR . 13.6 tp -62.08 -34.62 76.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -33.91 61.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.649 -0.657 . . . . 0.0 109.728 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.49 -50.06 66.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.844 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.465 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 34.4 t -74.74 -27.88 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.793 . . . . 0.0 109.772 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.475 ' HG3' HG12 ' A' ' 13' ' ' ILE . 10.7 tt0 -65.61 -44.42 86.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 34.5 m -86.79 -21.32 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 109.939 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.586 ' CD2' HD22 ' A' ' 29' ' ' LEU . 5.3 t80 -58.81 -44.42 90.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.573 HD21 ' CD2' ' A' ' 150' ' ' TYR . 52.6 mt -63.08 -24.41 67.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.96 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.6 mp -82.36 -36.86 26.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 110.361 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.46 -53.86 10.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.0 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.456 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 44.6 m-70 -75.39 -32.35 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.993 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.5 t 46.48 23.68 0.24 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 154' ' ' HIS . 4.7 m-20 -141.51 9.18 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -113.18 128.81 56.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.583 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 28.2 m-85 61.93 41.72 11.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.477 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.216 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.526 HG11 ' N ' ' A' ' 3' ' ' PHE . 54.8 t -82.63 152.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 83.2 m-85 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -108.18 116.04 31.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.995 -1.065 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 3' ' ' PHE . 21.3 m-85 -114.98 86.34 2.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 0.0 110.729 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.477 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.9 mt-10 -51.25 147.15 5.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 108.917 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.488 ' HB ' ' OD1' ' A' ' 118' ' ' ASN . 12.3 t -141.06 173.52 11.4 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.51 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER 178.31 126.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.452 0.644 . . . . 0.0 110.07 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -129.95 158.23 40.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 140.21 49.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.832 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.513 ' CB ' HD13 ' A' ' 18' ' ' LEU . 92.7 p -132.48 148.33 52.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.622 -0.674 . . . . 0.0 109.786 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -23.05 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 110.297 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.542 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 14.8 mm -81.85 143.1 49.52 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.576 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -57.17 150.51 56.95 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.04 1.547 . . . . 0.0 110.946 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . . . -51.84 -49.07 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 110.699 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -54.42 -55.09 32.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.971 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 9.6 mmt85 -54.9 -55.75 27.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.111 -0.993 . . . . 0.0 110.657 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.542 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 9.9 mt -58.87 -24.49 62.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.908 -1.12 . . . . 0.0 109.483 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.534 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -67.64 -56.02 11.02 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.58 -0.7 . . . . 0.0 109.789 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.5 mtpt -68.9 -25.09 64.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.618 -0.676 . . . . 0.0 112.128 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -103.89 -55.85 2.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.658 -1.276 . . . . 0.0 111.625 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.4 t80 -84.1 -1.41 54.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 112.203 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 12.8 mt -134.4 -22.95 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.555 -1.34 . . . . 0.0 111.38 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -105.87 -22.78 12.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 108.87 178.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -131.98 70.04 1.47 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.699 -0.626 . . . . 0.0 109.899 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -97.44 -43.31 2.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -69.9 -9.99 56.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -1.111 . . . . 0.0 110.337 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 11.7 t30 -130.56 52.02 2.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.78 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.611 HD22 ' CE2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER 173.49 -26.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.675 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.544 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.8 m-30 -56.78 -58.74 15.42 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.253 -0.904 . . . . 0.0 110.601 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.4 Cg_endo -64.67 -29.95 60.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.829 1.436 . . . . 0.0 111.205 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -16.18 63.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.092 -1.005 . . . . 0.0 110.552 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.597 HG13 ' CD1' ' A' ' 150' ' ' TYR . 9.0 m -123.63 -10.75 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.943 . . . . 0.0 110.271 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.11 66.66 46.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.803 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.67 -9.71 26.96 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.871 1.458 . . . . 0.0 109.821 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -88.98 -10.87 46.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -118.03 -57.42 2.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 109.946 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 30' ' ' PHE . 13.5 mm -95.14 170.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 0.0 110.45 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.63 -41.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.2 t -169.13 171.93 7.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 42' ' ' GLU . 60.1 t -136.8 149.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 55' ' ' LYS . 3.9 tt0 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.463 -0.773 . . . . 0.0 109.498 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.1 m . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.24 0.543 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.513 HG21 ' N ' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -112.41 156.13 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' N ' HG21 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -139.85 153.3 47.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.866 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG2' ' CG ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.81 87.97 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 110.6 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.518 ' HB ' HG11 ' A' ' 67' ' ' VAL . 1.9 mp -69.68 146.92 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.005 -1.06 . . . . 0.0 109.873 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.45 155.52 46.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.607 -0.683 . . . . 0.0 109.885 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.606 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 30.1 m-85 -119.02 161.46 36.36 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.067 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' GLU . 47.5 Cg_endo -74.9 -164.73 0.24 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.059 1.557 . . . . 0.0 110.08 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER 40.0 -166.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.483 -0.761 . . . . 0.0 111.183 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.542 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -109.48 62.26 0.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.565 ' CD1' ' CB ' ' A' ' 58' ' ' PHE . 13.3 mt -40.84 167.01 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.953 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 42.2 Cg_endo -68.97 -6.68 18.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.88 1.463 . . . . 0.0 110.277 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 18.7 m-30 -114.0 -100.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 166.09 -28.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 108.992 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 30.2 p90 -177.01 -164.55 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.606 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 3.6 p -166.25 128.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 0.0 110.547 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.549 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -103.03 147.35 27.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -145.01 146.01 31.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HD3' HD13 ' A' ' 53' ' ' ILE . 12.0 ttp180 -117.32 134.4 54.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.3 131.1 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 110.271 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -103.31 52.03 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 16.2 mm-40 59.22 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.297 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 81' ' ' TYR . 35.1 t -105.4 147.84 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.638 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.7 OUTLIER -63.25 -51.64 65.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 73.25 -75.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.546 -0.721 . . . . 0.0 110.887 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -60.53 -11.7 7.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.839 -1.163 . . . . 0.0 110.638 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -122.3 5.06 9.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 0.0 110.474 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.469 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.2 m-30 54.92 65.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.317 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 75' ' ' ASP . 5.1 mttp -142.66 108.82 5.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.658 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.507 ' CE1' HG23 ' A' ' 74' ' ' VAL . 7.4 t80 -95.25 123.57 38.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 110.838 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -119.94 123.37 43.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.486 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 84' ' ' SER . 2.7 p90 -148.89 174.06 12.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 110.698 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.41 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 10.5 p -140.2 167.66 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.593 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 23.5 t -92.64 -54.2 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.593 ' CG1' ' O ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER 69.67 -18.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 2.1 tt0 170.68 162.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.543 -1.348 . . . . 0.0 110.403 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.444 ' O ' ' CG1' ' A' ' 91' ' ' ILE . . . 81.76 -173.08 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.79 -147.96 47.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 49.4 Cg_endo -81.39 32.67 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.99 1.521 . . . . 0.0 110.94 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.444 ' CG1' ' O ' ' A' ' 88' ' ' GLY 0.297 1.5 mm -67.55 138.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 142.89 -165.94 26.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 44.6 -141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 122' ' ' THR . 1.8 p -89.06 72.15 8.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.584 HD23 ' CD2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -168.36 82.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.333 -0.854 . . . . 0.0 110.044 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.501 ' OE2' ' CE ' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -63.62 -59.0 5.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.434 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HG3' ' HB2' ' A' ' 121' ' ' HIS . 1.6 pttm -135.97 162.26 33.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.969 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.532 HG22 ' CE1' ' A' ' 120' ' ' TYR . 95.7 mt -139.15 122.23 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 111.289 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.6 151.96 20.59 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.517 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 53.6 t30 -154.75 147.48 24.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.873 -1.142 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.581 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -141.25 152.63 44.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.689 -0.632 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.74 ' HA ' ' HB ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -152.62 144.6 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.294 0.569 . . . . 0.0 110.044 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.548 ' N ' HG12 ' A' ' 116' ' ' ILE . 4.1 ptmm? -116.13 134.6 54.76 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.901 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.551 ' CD1' ' HG ' ' A' ' 114' ' ' LEU . 10.9 mm -92.18 90.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.673 -0.642 . . . . 0.0 109.86 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CG2' ' HG3' ' A' ' 103' ' ' LYS . 17.2 t -87.02 133.97 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.349 -0.844 . . . . 0.0 110.372 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.93 133.1 35.99 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.632 -0.668 . . . . 0.0 109.668 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.1 p -87.65 155.93 53.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.297 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.27 -11.55 32.62 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -175.43 86.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 170.48 -88.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.03 -135.18 1.77 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.518 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 5.0 p -124.93 170.42 11.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -1.156 . . . . 0.0 109.889 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.53 ' CG2' ' OE2' ' A' ' 8' ' ' GLU . 36.5 mt -139.22 123.55 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 111.203 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 5.6 mp -93.43 93.83 8.36 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.623 ' O ' HG12 ' A' ' 116' ' ' ILE . 5.6 pttt -131.45 138.24 48.96 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.821 -1.152 . . . . 0.0 113.589 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.74 ' HB ' ' HA ' ' A' ' 102' ' ' ILE . 1.2 mm -178.71 -95.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.579 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -175.07 177.4 1.94 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.835 -1.166 . . . . 0.0 112.686 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.1 m120 -142.44 106.56 4.74 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -92.5 122.88 35.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 111.06 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.584 ' CD2' HD23 ' A' ' 95' ' ' LEU . 2.5 m-85 -96.81 109.33 22.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.404 -0.81 . . . . 0.0 109.646 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.484 ' HB2' ' HG3' ' A' ' 97' ' ' LYS . 76.6 m-70 -89.06 104.02 16.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.461 HG23 ' HG ' ' A' ' 95' ' ' LEU . 3.0 p -116.43 -158.04 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.491 -0.755 . . . . 0.0 109.881 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.501 ' CE ' ' OE2' ' A' ' 96' ' ' GLU . 3.5 pttp -177.12 143.77 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 129.15 -98.0 0.43 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.19 -48.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -56.83 144.5 32.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' VAL . 52.3 mt-10 -89.86 148.86 22.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 110.403 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 3' ' ' PHE . 13.3 t -41.34 164.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.499 -0.751 . . . . 0.0 110.174 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.458 ' N ' ' CG1' ' A' ' 128' ' ' VAL . 5.0 mtmt -111.49 131.53 55.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.38 -44.88 84.84 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.033 -1.042 . . . . 0.0 109.413 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -31.51 16.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.469 ' NE2' HD11 ' A' ' 95' ' ' LEU . 25.9 mt-30 -79.23 -40.67 30.09 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.233 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.551 HG23 ' CE2' ' A' ' 5' ' ' TYR . 2.6 t -78.84 -0.3 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.655 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.27 -42.52 4.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.8 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -57.79 -44.91 86.58 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.72 86.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.344 -0.848 . . . . 0.0 109.533 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -64.34 -21.85 66.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 108.984 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 5.7 tm-20 -77.61 -44.92 26.74 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.657 -0.652 . . . . 0.0 109.299 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.449 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 40.2 mmm -64.5 -34.53 78.44 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.13 -42.74 75.21 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.78 -27.52 64.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.092 -1.24 . . . . 0.0 109.877 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -75.76 -35.33 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 108.965 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -77.18 -28.15 53.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.136 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.529 ' CD2' HG22 ' A' ' 9' ' ' THR . 11.4 tp -70.89 -42.51 69.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.1 ttt85 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.453 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -60.06 -58.27 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.053 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 87.2 t -62.53 -25.09 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.619 -0.676 . . . . 0.0 109.67 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 2.9 mt-10 -65.31 -50.55 65.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -15.74 53.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.611 ' CE2' HD22 ' A' ' 29' ' ' LEU . 10.9 t80 -67.44 -37.42 82.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 109.811 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 150' ' ' TYR . 65.5 mt -67.87 -18.43 64.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.976 -1.078 . . . . 0.0 109.321 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.498 ' N ' HD11 ' A' ' 152' ' ' LEU . 3.0 mp -89.79 -40.71 12.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.657 -0.652 . . . . 0.0 110.955 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.96 -47.86 14.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 111.03 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.522 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 62.1 m-70 -79.94 81.44 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.274 -0.891 . . . . 0.0 110.936 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 154' ' ' HIS . 58.4 m 38.23 -94.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 111.033 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.516 ' HB3' ' ND2' ' A' ' 159' ' ' ASN . 24.9 m-20 -155.12 51.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.682 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.54 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -49.29 145.12 4.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.961 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.592 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 70.2 m-85 57.03 69.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.257 -0.902 . . . . 0.0 110.273 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 156' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.219 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.578 HG23 ' CE1' ' A' ' 121' ' ' HIS . 61.7 t -47.15 156.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 64.8 m-85 -117.97 96.56 5.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.868 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.5 121.68 19.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.054 -1.029 . . . . 0.0 111.469 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 3' ' ' PHE . 22.0 m-85 -117.01 112.06 20.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.36 132.84 52.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 111.489 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -157.69 173.32 17.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.3 pp20? -145.68 149.94 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.806 -1.184 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.505 ' CG2' ' CD2' ' A' ' 144' ' ' LEU . 0.6 OUTLIER -124.56 172.86 8.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.88 142.22 51.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.992 -1.068 . . . . 0.0 111.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.451 ' HB3' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -131.81 147.6 52.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.665 -0.647 . . . . 0.0 109.622 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -18.18 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.331 -0.856 . . . . 0.0 109.921 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.491 ' O ' HD13 ' A' ' 18' ' ' LEU . 5.7 mm -83.33 140.86 42.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.479 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 35.6 Cg_endo -59.03 152.61 57.49 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.848 1.446 . . . . 0.0 111.17 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . . . -53.06 -47.92 68.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 111.24 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -57.55 -59.04 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.564 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.542 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 2.6 mmt180 -47.18 -57.81 4.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 109.904 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.566 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -51.4 -37.19 47.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 109.625 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.681 ' CE1' ' CD2' ' A' ' 24' ' ' LEU . 3.8 t80 -62.13 -69.14 0.27 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.851 -1.156 . . . . 0.0 109.848 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 7.1 mtmt -50.99 -24.82 3.99 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 112.1 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.576 ' HA ' ' CE1' ' A' ' 158' ' ' TYR . . . -113.66 -63.53 1.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.584 -1.322 . . . . 0.0 111.459 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 24.7 t80 -60.55 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.742 -1.224 . . . . 0.0 110.207 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.549 ' CG2' HD22 ' A' ' 24' ' ' LEU . 31.2 mm -48.24 -81.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.763 -1.211 . . . . 0.0 108.129 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.681 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 2.5 mt -57.76 160.4 4.53 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.244 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER 44.85 54.57 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.107 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -99.74 -35.11 4.72 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -81.66 15.4 2.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -1.139 . . . . 0.0 110.635 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 8.2 t30 -135.0 42.96 2.74 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.6 HD12 ' CE2' ' A' ' 150' ' ' TYR . 1.0 OUTLIER 175.26 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 4.7 m-30 -42.25 -55.55 6.43 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.763 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.7 Cg_endo -65.82 -49.28 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.708 1.373 . . . . 0.0 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -45.47 -52.56 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 111.159 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.574 HG13 ' CD1' ' A' ' 150' ' ' TYR . 9.3 m -86.21 -16.76 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.93 . . . . 0.0 110.847 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.453 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -135.69 71.96 63.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.74 -19.51 41.25 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.887 1.467 . . . . 0.0 109.464 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -83.98 -9.74 58.44 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.602 -0.686 . . . . 0.0 109.149 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -105.84 -57.22 2.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.523 ' CD1' HD22 ' A' ' 143' ' ' LEU . 2.0 mp -117.62 165.93 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 110.152 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.497 ' N ' HG21 ' A' ' 38' ' ' ILE . 4.4 m -130.26 -46.98 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 169.11 24.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.888 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -137.34 119.62 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.199 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 7.5 mt-10 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 110.139 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.401 HG23 ' HD2' ' A' ' 54' ' ' LYS . 2.7 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.208 0.528 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.497 HG22 HD12 ' A' ' 53' ' ' ILE . 1.1 mt -115.08 118.85 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.859 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 8.8 mttp -143.11 154.08 43.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 42' ' ' GLU . 76.0 mttt -120.36 140.6 51.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.592 -0.693 . . . . 0.0 110.161 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.516 HG23 ' CE1' ' A' ' 58' ' ' PHE . 1.4 mp -113.2 123.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -104.69 115.91 31.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.463 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.612 ' CD2' ' CD1' ' A' ' 62' ' ' LEU . 13.1 m-85 -75.22 167.38 37.31 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.183 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 60' ' ' GLU . 49.6 Cg_endo -81.91 66.21 8.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.011 1.532 . . . . 0.0 109.854 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' PRO . 3.8 tt0 44.37 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.473 -0.767 . . . . 0.0 111.103 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.3 -51.98 1.85 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.612 ' CD1' ' CD2' ' A' ' 58' ' ' PHE . 4.0 mt -60.25 163.55 8.15 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.273 -1.133 . . . . 0.0 110.395 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.4 -25.0 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.934 1.492 . . . . 0.0 109.237 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.2 m-85 -103.44 -148.15 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.336 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.3 tttt -137.93 -10.36 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.971 -1.081 . . . . 0.0 111.402 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 47.5 p90 -176.83 -157.93 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.656 -1.277 . . . . 0.0 111.011 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 8.3 p -169.44 113.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.524 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 7.1 tttt -87.75 153.1 21.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.982 -1.074 . . . . 0.0 109.809 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.524 ' N ' ' HG2' ' A' ' 68' ' ' LYS . 4.9 p-10 -136.88 148.89 47.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.04 -1.037 . . . . 0.0 110.626 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.479 ' NE ' HD12 ' A' ' 86' ' ' ILE . 22.4 mtt180 -128.01 104.27 7.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 72' ' ' ASP . 52.6 t -73.51 148.88 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.122 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.454 ' N ' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -121.2 -14.0 8.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.382 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.82 170.8 3.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 7.4 p -170.67 108.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 6.0 t0 -74.81 -156.19 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.928 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -159.76 -57.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 0.0 110.796 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.9 m -50.57 -42.05 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.39 3.51 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.559 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 18.8 m-85 57.03 91.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.142 -0.974 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.459 ' HB2' ' NZ ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -139.66 106.19 5.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 0.0 110.289 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -101.07 152.6 20.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.08 -1.013 . . . . 0.0 109.68 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.405 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 0.8 OUTLIER -152.74 132.75 13.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.115 -0.99 . . . . 0.0 110.722 -179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.3 169.26 24.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 109.719 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -134.57 157.9 45.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 110.281 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.488 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 3.5 t -104.83 136.34 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 109.039 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.488 ' CG2' ' C ' ' A' ' 85' ' ' VAL . 6.0 pt -148.61 14.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.794 -1.191 . . . . 0.0 111.432 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -169.42 89.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.82 -1.175 . . . . 0.0 110.921 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.544 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 126.05 -148.79 17.18 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 88' ' ' GLY . . . 29.85 -118.56 0.08 OUTLIER Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.558 ' O ' ' C ' ' A' ' 91' ' ' ILE . 39.3 Cg_endo -69.46 -73.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.975 1.513 . . . . 0.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.558 ' C ' ' O ' ' A' ' 90' ' ' PRO . 1.5 mm 9.6 59.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.687 0.756 . . . . 0.0 112.863 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' PRO . . . -158.09 152.02 23.18 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' THR . 7.4 t70 63.59 -162.29 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.243 . . . . 0.0 109.954 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.417 ' C ' ' O ' ' A' ' 93' ' ' ASP . 44.1 p -43.01 -44.07 4.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.144 -0.973 . . . . 0.0 110.108 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.49 119.63 4.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.79 -55.4 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.163 -0.96 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.511 ' C ' ' CG1' ' A' ' 98' ' ' ILE . 5.2 mmtt -113.44 157.12 22.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.195 -0.941 . . . . 0.0 109.829 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.534 ' CD1' ' HG2' ' A' ' 90' ' ' PRO . 8.5 mt -154.11 122.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.147 -0.971 . . . . 0.0 110.406 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 1.4 t -107.31 123.6 48.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 109.856 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.71 108.38 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 111.28 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.54 ' O ' ' CG1' ' A' ' 102' ' ' ILE . 43.2 mt-10 -99.05 165.15 11.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.815 . . . . 0.0 109.37 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 101' ' ' GLU . 12.4 mt -157.17 137.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -138.61 109.52 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 110.173 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 79' ' ' PHE . 50.8 mt -75.43 151.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.478 HG22 ' HG2' ' A' ' 115' ' ' LYS . 3.6 t -131.2 131.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.068 -1.02 . . . . 0.0 110.766 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.69 136.86 36.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.611 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.5 p -121.11 144.66 40.02 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.917 . . . . 0.0 110.581 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.32 -7.96 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.137 1.599 . . . . 0.0 110.739 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 10.5 p30 -166.89 85.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.13 -23.11 0.23 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.26 -139.61 15.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.464 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 79.9 p -115.0 172.06 7.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.262 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 4.9 mt -140.47 122.76 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.807 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 114' ' ' LEU . 3.7 mm? -84.85 102.16 12.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.616 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 103' ' ' LYS . 7.0 mmmt -79.11 91.55 4.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.4 mm -79.08 138.32 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.344 -0.847 . . . . 0.0 111.078 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.35 139.5 37.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' A' ' 5' ' ' TYR . 3.8 p-10 -164.58 109.33 0.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.69 -1.256 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HD3' ' NE2' ' A' ' 121' ' ' HIS . 12.9 ptpt -98.22 132.08 44.02 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.288 -0.882 . . . . 0.0 109.207 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.529 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 2.2 m-85 -90.54 141.72 28.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.578 ' CE1' HG23 ' A' ' 2' ' ' VAL . 28.3 m-70 -117.38 92.57 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.659 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 p -102.01 -170.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -140.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.961 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.77 33.79 5.96 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 126' ' ' HIS . 1.1 t0 -160.71 163.01 32.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 110.081 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.472 ' O ' ' O ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER 53.2 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.109 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' VAL . 3.1 pt-20 -77.6 147.42 35.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.118 -0.989 . . . . 0.0 110.247 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 3' ' ' PHE . 92.5 t -42.31 155.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 110.248 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 129' ' ' LYS . 8.5 mtpp -101.16 106.79 18.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.87 -40.34 9.82 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.005 -1.06 . . . . 0.0 109.899 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.46 -45.42 80.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.413 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -63.76 -43.9 95.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.533 HG12 ' CD2' ' A' ' 5' ' ' TYR . 5.8 t -67.91 -16.33 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -86.17 -41.44 14.69 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 110.356 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -52.63 -47.97 66.69 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.983 . . . . 0.0 109.55 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -49.16 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.724 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -61.86 -20.56 63.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 11.9 tm-20 -76.27 -56.95 4.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.6 -0.687 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.478 ' HG3' ' N ' ' A' ' 140' ' ' GLY . 2.3 ppp? -59.29 -28.66 66.97 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 108.504 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.478 ' N ' ' HG3' ' A' ' 139' ' ' MET . . . -69.53 -45.28 60.38 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.79 -32.19 73.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.263 . . . . 0.0 109.774 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 2.1 p -69.99 -38.0 75.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.173 -0.955 . . . . 0.0 108.862 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 38' ' ' ILE . 0.8 OUTLIER -71.84 -31.57 66.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.505 ' CD2' ' CG2' ' A' ' 9' ' ' THR . 11.0 tp -67.18 -41.06 86.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -35.03 73.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.536 -0.728 . . . . 0.0 109.289 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.503 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -62.22 -50.64 70.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.485 -0.759 . . . . 0.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.501 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 12.8 t -70.74 -30.44 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.84 -55.26 36.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.461 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -74.68 -23.8 58.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.575 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.763 ' CD1' ' CE1' ' A' ' 154' ' ' HIS . 45.0 t80 -58.89 -62.2 2.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.799 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.457 HD13 HG22 ' A' ' 13' ' ' ILE . 34.3 mt -44.42 -26.61 0.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.079 . . . . 0.0 110.414 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.471 ' N ' HD11 ' A' ' 152' ' ' LEU . 9.1 mp -79.22 -52.61 7.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 110.95 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.31 -27.86 69.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.763 ' CE1' ' CD1' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -122.88 104.16 9.09 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.825 -0.547 . . . . 0.0 109.926 -178.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 58.1 m -88.91 16.33 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 110.156 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -108.72 -22.18 12.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.468 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -84.6 130.26 34.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.462 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.576 ' CE1' ' HA ' ' A' ' 21' ' ' ALA . 37.1 m-85 59.93 48.64 8.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.637 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.226 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.496 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.532 HG11 ' N ' ' A' ' 3' ' ' PHE . 95.6 t -54.6 151.99 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.579 ' CE1' HG21 ' A' ' 128' ' ' VAL . 80.3 m-85 -114.15 149.14 36.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 110.066 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.98 84.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.586 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 45.5 m-85 -88.43 78.62 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.02 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 7' ' ' THR . 98.7 mt-10 -90.02 165.93 13.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.353 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 12.3 t -179.8 172.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.835 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.458 ' OE1' ' HD2' ' A' ' 115' ' ' LYS . 23.5 tt0 -155.89 147.08 22.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.13 -0.981 . . . . 0.0 110.336 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.55 HG21 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.92 172.31 11.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.887 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.79 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.965 -1.084 . . . . 0.0 110.132 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.54 ' OG ' ' CD1' ' A' ' 18' ' ' LEU . 63.9 p -129.1 150.83 50.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.26 -22.88 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 109.774 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 19.3 mm -80.25 142.87 55.37 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 35.5 Cg_endo -58.02 148.58 76.18 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.749 1.394 . . . . 0.0 110.732 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' CA ' HG23 ' A' ' 104' ' ' ILE . . . -55.07 -36.69 65.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.03 70.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -62.88 -50.84 69.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 110.61 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.557 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 14.4 mt -57.23 -39.22 75.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.946 -1.096 . . . . 0.0 109.766 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CE1' HG23 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -61.36 -63.99 1.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.098 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.27 -30.29 50.11 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.552 -0.718 . . . . 0.0 112.223 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -105.69 -64.61 1.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.758 -1.214 . . . . 0.0 111.44 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.574 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 63.3 t80 -70.29 5.47 1.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 112.449 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.584 HG23 ' CE1' ' A' ' 19' ' ' PHE . 28.7 mm -142.81 -26.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.307 -1.495 . . . . 0.0 111.882 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 19' ' ' PHE . 4.2 mt -102.31 -34.44 9.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.62 -1.3 . . . . 0.0 109.833 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.484 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 5.9 t0 -119.64 31.96 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -71.31 -25.14 76.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.498 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 20.6 m-20 -76.6 3.52 11.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 5.5 t30 -140.16 52.73 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.61 HD12 ' CZ ' ' A' ' 150' ' ' TYR . 1.5 tp 170.62 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.516 -0.74 . . . . 0.0 109.26 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.4 m-30 -42.97 -59.82 2.79 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.874 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.1 Cg_endo -66.22 -29.45 47.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.915 1.482 . . . . 0.0 111.189 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -36.3 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.9 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 150' ' ' TYR . 15.9 m -104.12 -9.21 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.062 -1.024 . . . . 0.0 110.409 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.41 63.89 56.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.965 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.53 -7.82 20.39 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.97 1.51 . . . . 0.0 110.139 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -92.11 -18.33 23.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.424 -0.798 . . . . 0.0 109.167 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.1 -58.41 2.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.514 HD12 ' CE ' ' A' ' 139' ' ' MET . 10.0 mm -95.68 179.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.384 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.47 -49.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.959 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.27 142.61 30.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 27' ' ' ASP . 7.6 p -120.99 121.55 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 110.419 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 tt0 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 109.929 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.214 0.53 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.437 HG21 ' N ' ' A' ' 54' ' ' LYS . 3.6 mp -102.56 143.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.616 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 2.4 mttt -130.76 150.13 52.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -117.9 97.97 6.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.412 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.558 HG23 ' CE1' ' A' ' 58' ' ' PHE . 1.5 mp -78.58 131.81 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -115.28 141.14 48.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CD2' HD22 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -107.69 135.19 19.8 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 110.538 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 38' ' ' ILE . 50.9 Cg_endo -84.34 47.93 2.33 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.952 1.501 . . . . 0.0 109.965 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.71 -171.48 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 0.0 110.627 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.36 35.44 4.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -54.19 -176.49 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -1.052 . . . . 0.0 110.324 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.635 ' HD2' ' HB2' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -82.46 -20.95 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.04 1.021 . . . . 0.0 110.462 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 2.4 m-85 -97.08 -154.92 0.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -131.27 -33.95 1.45 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.448 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 36.6 p90 -169.04 -153.53 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.521 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 8.9 p -168.37 111.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 111.149 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.7 ttpp -99.7 149.15 23.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.19 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 29.8 p30 -154.26 148.18 25.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.984 -1.072 . . . . 0.0 110.964 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 83' ' ' TYR . 4.6 ttp180 -103.6 154.27 19.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 109.584 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 15.6 t -99.39 -44.53 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.113 -0.992 . . . . 0.0 110.359 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER 76.94 -38.13 0.3 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.848 -0.532 . . . . 0.0 111.721 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 1.2 pt-20 178.28 155.95 0.4 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.686 -1.259 . . . . 0.0 110.505 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -146.05 153.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.818 . . . . 0.0 109.901 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.65 164.46 15.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.723 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.478 ' NE2' HD13 ' A' ' 24' ' ' LEU . 3.8 m80 -134.4 -40.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.51 -0.744 . . . . 0.0 109.856 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -55.42 -38.55 69.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.253 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -108.25 12.8 26.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.511 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 52.11 60.59 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' A' ' 81' ' ' TYR . 1.4 tppt? -123.35 155.51 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.39 -0.819 . . . . 0.0 110.586 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.507 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 64.6 t80 -144.06 162.2 36.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.58 -0.7 . . . . 0.0 109.162 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 71' ' ' VAL . 28.0 t30 -167.52 128.63 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.913 -1.117 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 32.7 p90 -143.23 142.44 31.4 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.383 -0.823 . . . . 0.0 109.941 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.45 126.25 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.775 . . . . 0.0 110.173 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.05 128.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.465 ' N ' HD11 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -124.7 10.64 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.962 . . . . 0.0 109.865 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 2.2 mm-40 -176.65 170.72 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.492 ' O ' HG13 ' A' ' 91' ' ' ILE . . . 73.12 173.33 25.03 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.467 ' O ' HD13 ' A' ' 91' ' ' ILE . . . 78.82 -144.19 27.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.4 Cg_endo -84.8 34.27 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.067 1.561 . . . . 0.0 110.735 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.515 ' N ' HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -50.25 172.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.985 . . . . 0.0 110.437 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 45.7 63.48 2.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 7.5 t0 -177.83 82.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -1.164 . . . . 0.0 110.422 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' ASP . 18.8 p 43.65 29.0 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.278 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.507 ' CD1' ' CD2' ' A' ' 120' ' ' TYR . 1.9 tp -150.61 95.77 2.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.171 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.5 -49.83 44.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.643 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -152.62 165.54 34.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.321 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.554 HD13 ' CD2' ' A' ' 120' ' ' TYR . 24.2 mm -140.76 116.78 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.833 . . . . 0.0 110.442 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -96.33 143.2 27.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 108.946 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 36.0 t-20 -143.04 149.53 38.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.259 -1.376 . . . . 0.0 112.126 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 25.3 mt-10 -129.03 152.47 48.6 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 12.1 mt -142.0 124.03 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 0.0 110.635 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -115.41 130.96 57.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 0.0 109.738 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.571 HD12 ' CD2' ' A' ' 19' ' ' PHE . 1.3 mp -99.43 118.95 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.036 -1.04 . . . . 0.0 109.782 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 112' ' ' SER . 6.6 t -107.34 129.56 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.24 140.92 29.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.757 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -104.47 148.96 36.85 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 110.397 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.0 -8.62 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.09 1.574 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -165.01 83.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.43 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.14 -85.83 0.1 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.91 -113.29 0.3 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.528 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 4.5 p -138.9 176.82 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -1.192 . . . . 0.0 109.972 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.472 HG21 ' O ' ' A' ' 9' ' ' THR . 15.9 mt -139.28 123.35 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.271 -0.893 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.55 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.19 90.72 8.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.458 ' HD2' ' OE1' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -85.22 99.51 11.15 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.436 HG13 HG12 ' A' ' 102' ' ' ILE . 1.2 mp -99.84 155.02 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.061 -1.024 . . . . 0.0 111.679 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 m -140.14 107.71 5.6 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 100' ' ' ASN . 3.3 t-20 -105.85 105.77 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 112.034 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HG3' ' CG1' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -88.47 107.64 18.97 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.554 ' CD2' HD13 ' A' ' 98' ' ' ILE . 2.7 m-85 -82.52 142.94 31.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.924 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.483 ' ND1' HG23 ' A' ' 2' ' ' VAL . 83.6 m-70 -126.31 100.37 6.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.766 -0.584 . . . . 0.0 109.566 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 4.9 p -110.53 -166.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 110.35 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 122' ' ' THR . 0.0 OUTLIER 174.69 67.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 -149.67 5.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -68.98 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.448 -1.031 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -75.67 -174.49 2.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 12.2 mp0 -115.46 -171.7 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 110.284 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.579 HG21 ' CE1' ' A' ' 3' ' ' PHE . 88.6 t -54.13 152.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.472 ' NZ ' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -98.85 108.21 20.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.434 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -41.91 -59.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 110.422 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 2.5 tt0 -43.17 -45.25 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.782 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -45.23 94.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.586 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 76.4 t -58.04 -24.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -76.82 -51.42 11.36 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.751 -0.593 . . . . 0.0 110.108 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -43.8 -43.82 6.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.872 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.1 t -60.45 -54.82 40.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.569 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -53.45 -27.87 27.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.745 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.474 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.72 -46.87 43.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.527 -0.733 . . . . 0.0 110.392 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.514 ' CE ' HD12 ' A' ' 38' ' ' ILE . 4.6 mtp -63.19 -30.46 71.6 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.846 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.6 -45.43 53.34 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -72.32 -30.07 64.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.359 . . . . 0.0 110.614 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 1.2 p -72.99 -40.35 65.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.794 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 143' ' ' LEU . 1.1 mm? -80.03 -25.84 40.02 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.354 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.437 HD13 HD12 ' A' ' 18' ' ' LEU . 16.4 tp -70.75 -39.95 72.98 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -44.36 59.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.52 -55.51 31.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.507 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 69.3 t -66.02 -32.31 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.466 ' HG2' HG12 ' A' ' 13' ' ' ILE . 1.2 tm-20 -58.48 -52.13 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.3 p -75.99 -26.67 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.61 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 8.5 t80 -57.71 -45.75 85.33 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.724 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.7 mt -58.05 -24.81 59.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 6.0 mp -93.01 -19.68 21.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 110.516 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.5 -34.03 23.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 155' ' ' SER . 10.0 m-70 -91.86 166.2 12.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 110.6 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.48 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 22.9 m -43.48 -56.81 3.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 110.608 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 155' ' ' SER . 2.4 m-20 -177.94 65.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -67.76 133.58 49.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.354 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.591 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 56.5 m-85 60.59 19.9 9.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 110.587 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.065 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.547 ' CG2' ' HG3' ' A' ' 119' ' ' LYS . 11.7 p -55.36 154.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.16 . . . . 0.0 110.456 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 1' ' ' GLY . 53.9 m-85 -115.88 158.75 22.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -117.37 118.69 32.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.586 ' CE2' HG23 ' A' ' 133' ' ' VAL . 37.2 m-85 -122.63 89.51 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -99.82 155.13 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.467 HG21 ' HB ' ' A' ' 116' ' ' ILE . 11.8 t -171.24 170.21 6.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.171 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.441 ' CG ' ' C ' ' A' ' 7' ' ' THR . 27.6 mt-10 -148.04 118.97 7.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.526 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -100.58 -177.73 3.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 109.815 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.532 HG21 ' CD1' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -124.0 137.93 54.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.0 110.424 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.484 ' HB2' HD22 ' A' ' 114' ' ' LEU . 36.4 t -125.01 139.44 53.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.5 -2.66 4.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.457 -0.777 . . . . 0.0 110.161 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.561 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 7.9 mm -96.11 149.31 35.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.253 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -56.68 155.66 25.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.019 1.536 . . . . 0.0 110.518 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.553 ' CB ' HG23 ' A' ' 104' ' ' ILE . . . -64.17 -71.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 111.268 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -39.3 -51.43 2.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.686 . . . . 0.0 110.951 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.556 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 6.7 ttm180 -57.33 -54.97 40.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.812 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.561 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 8.7 mt -50.43 -29.2 9.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.184 -1.006 . . . . 0.0 108.822 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.612 ' CE1' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -69.76 -67.35 0.49 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.545 -0.722 . . . . 0.0 110.678 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 25.5 mtpt -57.34 -21.36 34.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.377 -0.827 . . . . 0.0 112.717 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.576 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -110.58 -58.98 2.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.46 -1.4 . . . . 0.0 112.512 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.53 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 34.1 t80 -73.24 -11.51 60.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.893 -1.129 . . . . 0.0 112.353 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.565 ' CG2' HD22 ' A' ' 24' ' ' LEU . 23.0 mt -121.77 -80.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.674 -1.267 . . . . 0.0 110.393 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.612 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 2.3 mt -45.44 -56.72 4.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.865 -1.147 . . . . 0.0 110.032 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.48 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -100.21 66.54 1.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -101.96 -30.95 5.56 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' HB3' HG13 ' A' ' 41' ' ' VAL . 99.4 m-20 -81.39 13.49 2.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 110.456 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.5 t30 -138.68 45.06 2.05 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.578 HD12 ' CE2' ' A' ' 150' ' ' TYR . 1.2 tp 173.55 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 109.441 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.562 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.9 m-30 -48.41 -61.01 3.57 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.367 -0.833 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.3 Cg_endo -65.95 -22.96 54.94 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.8 1.421 . . . . 0.0 111.464 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -71.73 -50.91 25.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 150' ' ' TYR . 19.5 m -89.54 -8.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 110.243 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.96 62.43 52.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.505 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.98 -15.7 43.95 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 109.358 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -83.88 -16.74 43.24 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.543 0.687 . . . . 0.0 109.192 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.472 ' O ' HD13 ' A' ' 62' ' ' LEU . . . -111.51 -64.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 110.595 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 31' ' ' PRO . 10.5 mm -93.73 169.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.456 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -136.16 -36.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 109.986 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.39 160.77 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.522 ' CG2' HD13 ' A' ' 56' ' ' ILE . 3.7 p -140.57 154.25 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.028 -1.045 . . . . 0.0 110.647 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.459 -0.776 . . . . 0.0 109.603 179.59 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 53' ' ' ILE . 1.2 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.138 0.494 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.571 ' N ' ' CG2' ' A' ' 52' ' ' THR . 1.0 OUTLIER 30.55 31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.587 0.708 . . . . 0.0 112.477 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' A' ' 52' ' ' THR . 14.5 mttt -75.53 152.41 37.8 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -124.7 91.5 3.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.892 -1.13 . . . . 0.0 111.053 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.522 HD13 ' CG2' ' A' ' 41' ' ' VAL . 1.2 mp -77.51 158.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.586 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.459 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -144.63 171.3 14.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 15.9 m-85 -134.72 157.09 77.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 47.3 Cg_endo -77.19 177.62 8.65 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.907 1.477 . . . . 0.0 109.835 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.07 175.43 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.0 110.142 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.34 -47.37 3.29 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' CD1' ' HB3' ' A' ' 58' ' ' PHE . 13.5 mt -78.38 139.52 59.81 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.71 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.75 -7.09 19.01 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.009 1.531 . . . . 0.0 110.217 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.462 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 3.6 m-30 -97.32 135.07 39.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 110.155 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -87.94 -42.63 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 0.0 110.365 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.551 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 30.3 p90 -167.55 -173.76 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.003 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.551 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -166.07 124.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -0.786 . . . . 0.0 110.693 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -81.12 92.85 6.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.464 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -84.35 96.19 8.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.477 ' HG3' ' HA ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.67 83.64 7.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.872 . . . . 0.0 110.043 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -45.44 -60.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 109.54 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.558 ' N ' ' CG1' ' A' ' 71' ' ' VAL . 0.1 OUTLIER 73.07 -28.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -167.5 171.84 10.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.211 -1.555 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.57 HG22 ' CD1' ' A' ' 81' ' ' TYR . 3.2 p -165.56 146.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.671 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.444 ' N ' HG21 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -101.02 -171.53 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 0.0 110.146 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 -56.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 110.376 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 m -59.46 -20.14 52.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.835 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -118.27 8.38 12.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 110.564 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.595 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.6 m-30 54.49 54.21 9.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.994 . . . . 0.0 109.863 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.64 147.3 47.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CD1' HG22 ' A' ' 74' ' ' VAL . 14.4 t80 -133.2 105.0 6.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -1.0 . . . . 0.0 110.693 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -101.59 115.55 30.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 7.4 p90 -138.91 155.3 48.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.101 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -109.29 136.36 48.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 110.856 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.459 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 73.0 t -111.53 121.12 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.459 ' CG2' ' C ' ' A' ' 85' ' ' VAL . 8.4 pt -147.16 164.43 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.962 -1.086 . . . . 0.0 111.281 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER 64.76 133.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 110.847 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 66' ' ' TYR . . . 56.29 178.08 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . 80.89 -133.25 11.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.511 ' HG2' ' CD1' ' A' ' 98' ' ' ILE . 48.7 Cg_endo -78.91 1.6 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.054 1.555 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 96' ' ' GLU 0.293 1.3 mm -61.27 140.92 18.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.223 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 159.15 -92.97 0.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.466 ' O ' ' OG1' ' A' ' 94' ' ' THR . 5.8 m-20 -117.68 145.0 44.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -1.15 . . . . 0.0 110.315 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 6.5 p 50.79 50.39 19.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.524 ' CB ' ' O ' ' A' ' 94' ' ' THR . 0.5 OUTLIER 167.14 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.341 -0.85 . . . . 0.0 110.379 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' O ' HD13 ' A' ' 91' ' ' ILE . 8.2 tt0 -96.13 -39.59 9.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.27 136.81 50.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.56 HG22 ' CE1' ' A' ' 120' ' ' TYR . 29.8 mt -131.94 113.06 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.861 . . . . 0.0 110.361 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 135.85 33.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 0.0 109.205 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.492 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 4.9 m120 -132.14 139.23 48.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.786 -1.196 . . . . 0.0 110.88 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' TYR . 2.0 mt-10 -137.05 130.93 32.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.105 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.56 HD13 ' CE1' ' A' ' 83' ' ' TYR . 7.4 mt -118.93 127.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 tmtt? -115.14 118.13 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.746 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.574 ' CD1' ' CD1' ' A' ' 114' ' ' LEU . 38.7 mm -79.36 115.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 110.283 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.404 HG22 ' HG3' ' A' ' 115' ' ' LYS . 63.0 t -108.93 123.72 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 110.117 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.69 135.99 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.235 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.6 p -106.76 150.19 39.38 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 48.4 Cg_endo -66.84 81.13 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.181 1.622 . . . . 0.0 110.698 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 18.9 t0 -179.93 -62.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 0.0 110.284 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.19 38.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.33 28.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.551 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -127.95 130.38 48.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -1.217 . . . . 0.0 110.464 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.698 ' N ' ' CD1' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -85.47 143.99 10.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 109.548 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 3.8 mm? -97.66 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -85.43 99.77 11.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.094 -1.004 . . . . 0.0 109.425 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.467 ' HB ' HG21 ' A' ' 7' ' ' THR . 7.6 mt -98.37 131.19 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.839 -1.163 . . . . 0.0 111.678 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 m -123.56 129.89 51.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 9.9 m-20 -131.25 105.85 7.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.993 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.572 ' HG2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -90.79 107.92 19.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.56 ' CE1' HG22 ' A' ' 98' ' ' ILE . 2.8 m-85 -88.19 95.02 10.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 111.864 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.572 ' CE1' ' HG2' ' A' ' 119' ' ' LYS . 72.4 m-70 -79.95 95.95 6.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 108.882 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 5.6 p -102.67 -56.22 2.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.17 -0.956 . . . . 0.0 111.017 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 122' ' ' THR . 18.1 pttm 35.29 72.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.624 -0.673 . . . . 0.0 111.246 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.65 -72.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.48 ' O ' ' CG2' ' A' ' 94' ' ' THR . 14.8 t70 -153.99 150.62 28.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 51.83 -167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.08 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -121.49 170.09 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.883 . . . . 0.0 110.486 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.555 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 64.8 t -61.95 135.31 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.224 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.3 mtmt -82.33 115.57 21.44 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -45.34 -42.01 9.51 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 10.2 tm-20 -54.79 -47.28 74.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.41 -39.39 83.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.278 -0.889 . . . . 0.0 108.921 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.586 HG23 ' CE2' ' A' ' 5' ' ' TYR . 84.2 t -66.7 -23.46 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 135' ' ' ALA . 14.5 tttt -79.06 -63.04 1.51 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.684 -0.635 . . . . 0.0 110.499 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.22 -46.06 1.03 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -0.817 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m -60.61 -47.84 84.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.466 ' HE2' HG23 ' A' ' 7' ' ' THR . 36.0 mttt -59.96 -28.55 67.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.43 -39.76 64.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.464 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.0 OUTLIER -65.3 -37.3 86.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 108.783 178.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.47 -42.64 93.6 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -32.19 72.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.214 -1.168 . . . . 0.0 110.182 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 1.7 p -70.6 -39.18 73.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.324 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -75.14 -28.13 60.04 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.6 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 23.9 tp -71.18 -39.94 71.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 0.0 108.594 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 1.3 ptm85 -73.76 -32.68 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 109.472 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 145' ' ' ARG . . . -65.83 -58.12 6.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.1 -1.0 . . . . 0.0 109.059 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 22' ' ' PHE . 47.7 t -64.95 -28.12 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.554 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -63.64 -49.45 73.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.814 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.413 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 1.3 t -78.69 -20.89 49.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 110.044 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.578 ' CE2' HD12 ' A' ' 29' ' ' LEU . 12.0 t80 -62.55 -41.07 98.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.525 HD22 ' CD2' ' A' ' 150' ' ' TYR . 65.9 mt -67.45 -22.29 65.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 109.917 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 mp -82.72 -38.35 23.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.04 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.0 -46.18 62.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 154' ' ' HIS . 19.0 m-70 -81.63 -39.03 25.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.887 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.9 m 58.06 19.54 6.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 2.6 p30 -138.51 -33.45 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 156' ' ' ASP . . . -60.36 131.92 52.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 41.5 m-85 55.69 49.3 16.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 110.868 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.22 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.555 HG22 ' CE1' ' A' ' 121' ' ' HIS . 8.1 p -132.46 165.41 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.189 . . . . 0.0 110.259 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.552 ' CD1' HG21 ' A' ' 128' ' ' VAL . 45.6 m-85 -129.02 148.57 50.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.11 86.8 2.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 0.0 111.004 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.633 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 18.3 m-85 -84.82 73.45 10.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.464 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.24 118.17 21.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.917 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -132.13 -168.9 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.88 163.44 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 0.0 110.177 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.556 HG21 ' HB2' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -141.51 173.39 11.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.4 141.58 50.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.957 . . . . 0.0 110.662 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' HD12 ' A' ' 18' ' ' LEU . 2.8 t -136.71 147.1 46.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 109.929 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.76 -20.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.504 ' O ' HD13 ' A' ' 18' ' ' LEU . 5.4 mm -79.03 140.91 57.93 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 110.705 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -57.53 151.91 51.09 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.659 1.573 . . . . 0.0 111.173 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' N ' ' HB3' ' A' ' 112' ' ' SER . . . -56.67 -48.59 77.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 111.455 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -52.31 -61.78 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.037 -1.039 . . . . 0.0 111.045 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.539 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.6 ttp180 -54.07 -57.73 10.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.022 . . . . 0.0 109.944 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -48.08 -29.25 3.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CE1' ' CD2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.09 -63.12 1.12 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 109.326 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.68 -46.05 19.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 110.481 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.638 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . . . -83.94 -70.82 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.698 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 22.0 t80 -76.0 142.61 41.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 108.941 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.698 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 14.7 mt 81.29 -46.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 CA-C-O 120.914 0.387 . . . . 0.0 110.922 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.639 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -86.71 -77.15 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.957 -1.089 . . . . 0.0 109.484 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 29' ' ' LEU . 9.5 t70 -57.5 -96.35 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.05 -1.031 . . . . 0.0 109.193 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.583 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . 79.11 -74.0 2.26 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.837 -1.164 . . . . 0.0 110.936 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' OD1' HG11 ' A' ' 41' ' ' VAL . 6.5 t70 -65.54 -4.47 6.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.977 -1.308 . . . . 0.0 111.106 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 12.3 t30 -135.96 51.71 2.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.645 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.62 HD22 ' CE2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER 171.15 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.89 . . . . 0.0 109.554 -179.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 5.3 m-30 -65.14 -58.09 13.5 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.95 . . . . 0.0 110.229 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.558 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 44.0 Cg_endo -65.1 -35.3 42.89 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.808 1.425 . . . . 0.0 110.604 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.55 -37.87 76.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 146' ' ' ALA . 6.0 m -106.71 2.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.83 66.15 6.04 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 59' ' ' PRO . 42.0 Cg_endo -67.91 -24.22 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.903 1.475 . . . . 0.0 109.439 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -81.21 -9.46 59.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.438 ' HB2' HD22 ' A' ' 143' ' ' LEU . . . -104.0 -57.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -124.79 168.05 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.168 -0.957 . . . . 0.0 110.984 -179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.503 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 1.4 t -131.48 -37.45 1.21 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.653 -0.654 . . . . 0.0 109.398 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 39' ' ' SER . 7.5 t -177.42 142.79 0.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 0.0 109.862 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 2.5 p -132.95 116.04 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.028 -1.045 . . . . 0.0 110.753 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.6 tt0 . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.834 . . . . 0.0 110.504 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 64.5 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.4 mm -53.59 119.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 111.123 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 52' ' ' THR . 21.6 mtmt -144.39 144.27 31.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.567 -0.708 . . . . 0.0 109.327 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 42' ' ' GLU . 4.2 ttpp -115.01 116.97 29.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.915 . . . . 0.0 110.255 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 2.0 mp -90.52 115.94 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 110.03 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 t -113.84 126.89 55.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 110.561 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CE2' HG23 ' A' ' 67' ' ' VAL . 42.5 m-85 -94.5 143.1 25.71 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 49.1 Cg_endo -88.53 37.88 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.81 1.426 . . . . 0.0 110.638 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -150.41 -177.29 5.87 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.578 0.704 . . . . 0.0 110.084 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.608 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -70.07 -59.01 5.72 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 58' ' ' PHE . 10.7 mt 53.42 168.25 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.366 -1.079 . . . . 0.0 110.115 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -72.61 -21.68 21.82 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.789 1.415 . . . . 0.0 109.897 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.516 ' CE2' ' HD3' ' A' ' 90' ' ' PRO . 11.0 m-85 -129.53 160.9 31.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.503 -0.748 . . . . 0.0 109.66 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -20.06 30.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.318 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 27.6 p90 -173.8 -171.7 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.591 HG23 ' CE2' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -161.08 108.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.765 . . . . 0.0 110.602 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -76.81 155.22 33.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.303 -0.873 . . . . 0.0 109.012 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.74 131.11 12.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.671 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 84' ' ' SER . 0.7 OUTLIER -104.43 87.76 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 83' ' ' TYR . 45.1 t -82.05 -104.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.22 162.96 0.24 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.552 -0.717 . . . . 0.0 110.811 -178.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER 73.75 136.56 0.05 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.578 HG22 ' CD2' ' A' ' 81' ' ' TYR . 6.3 p -173.2 103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.31 161.67 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.34 -48.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.234 -0.916 . . . . 0.0 110.564 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 m -59.35 -24.13 63.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.753 -1.217 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -118.38 14.96 13.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.962 . . . . 0.0 110.348 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.574 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 8.2 m-30 44.25 63.38 1.66 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.278 -0.888 . . . . 0.0 110.585 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 13.3 tttt -122.05 141.82 50.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.698 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.578 ' CD2' HG22 ' A' ' 74' ' ' VAL . 22.5 t80 -148.59 98.36 2.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.087 -1.008 . . . . 0.0 110.82 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.51 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -111.76 143.14 43.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.603 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 15.8 p90 -134.75 163.53 29.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -104.54 112.08 25.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.535 -0.728 . . . . 0.0 111.143 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.422 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.4 t -94.64 104.11 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 87' ' ' GLU . 49.0 pt -93.81 -34.58 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.8 mt-10 -146.81 169.41 19.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.003 -1.06 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.563 ' CA ' ' HA ' ' A' ' 67' ' ' VAL . . . 112.41 115.9 3.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.492 ' HA2' ' CD2' ' A' ' 64' ' ' PHE . . . 124.48 -143.93 15.0 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.516 ' HD3' ' CE2' ' A' ' 64' ' ' PHE . 53.1 Cg_endo -83.51 26.87 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.092 1.575 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -27.69 145.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.436 0.636 . . . . 0.0 111.358 -179.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.36 -100.45 0.16 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.475 ' O ' ' OG1' ' A' ' 94' ' ' THR . 29.5 m-20 -125.86 -176.28 3.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -1.098 . . . . 0.0 110.395 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 46.1 p 46.23 22.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.581 HD22 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -172.16 96.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.419 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -114.02 -21.46 10.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.0 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -142.18 147.96 37.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 110.083 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.525 ' CD1' HD22 ' A' ' 95' ' ' LEU . 35.5 mm -145.43 131.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.0 m -116.34 131.37 56.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 109.144 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 1.3 m-20 -126.3 147.63 49.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.043 -1.035 . . . . 0.0 111.267 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 3.8 tt0 -138.02 132.33 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.693 -0.629 . . . . 0.0 109.573 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.463 HG21 ' N ' ' A' ' 103' ' ' LYS . 77.2 mt -118.66 165.7 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.463 ' N ' HG21 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -157.69 111.86 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 110.551 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.539 HG12 ' CD1' ' A' ' 23' ' ' ILE . 2.8 mp -87.93 112.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 0.0 109.944 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.491 HG22 ' CE ' ' A' ' 115' ' ' LYS . 90.4 t -103.58 139.09 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.078 -1.014 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.72 132.01 41.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.0 109.961 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.4 p -105.57 154.22 39.31 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.435 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 48.3 Cg_endo -66.59 -33.2 36.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.016 1.535 . . . . 0.0 110.509 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 108' ' ' PRO . 5.3 m-20 -151.75 67.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.75 35.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.12 -140.3 46.68 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.528 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 80.0 p -128.06 155.18 44.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -1.14 . . . . 0.0 110.052 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 9' ' ' THR . 18.4 mt -112.53 126.83 69.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 110.43 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.556 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.2 tp -88.53 89.2 7.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.795 -0.566 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.491 ' CE ' HG22 ' A' ' 105' ' ' VAL . 9.1 mttt -73.77 128.77 36.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.404 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.7 mt -128.23 150.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 111.18 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 t -138.89 120.36 14.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.176 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.506 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 2.5 m-20 -112.79 94.7 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 0.0 111.53 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.521 ' HG3' ' CG2' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -82.42 106.18 14.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.001 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.581 ' CD2' HD22 ' A' ' 95' ' ' LEU . 1.5 m-85 -85.15 111.14 19.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.962 -1.086 . . . . 0.0 111.461 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.555 ' CE1' HG22 ' A' ' 2' ' ' VAL . 97.1 m-70 -90.25 102.05 14.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.335 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 94' ' ' THR . 7.5 p -103.23 162.33 13.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -145.97 37.65 1.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.46 -147.44 7.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.88 -65.05 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -56.1 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.348 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.484 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 17.3 pt-20 -111.23 -169.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.552 HG21 ' CD1' ' A' ' 3' ' ' PHE . 24.9 t -68.64 163.72 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.1 101.49 10.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 110.004 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.2 -32.25 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 4.3 tt0 -59.96 -50.48 73.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.404 ' OE1' HD12 ' A' ' 95' ' ' LEU . 48.4 tt0 -61.04 -40.79 94.94 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.633 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 61.4 t -62.4 -23.66 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 135' ' ' ALA . 1.8 tptt -78.72 -59.23 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.837 -0.539 . . . . 0.0 110.898 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.37 -45.93 1.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.394 -0.816 . . . . 0.0 110.842 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -59.99 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.095 -1.003 . . . . 0.0 109.652 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 133' ' ' VAL . 16.9 mtmt -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.838 . . . . 0.0 110.318 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.36 -54.3 15.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -0.915 . . . . 0.0 110.135 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.467 ' SD ' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -57.32 -37.77 73.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.061 -1.024 . . . . 0.0 109.287 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.31 -39.8 97.32 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -72.16 -38.72 69.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.999 -1.295 . . . . 0.0 111.003 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.234 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.473 HD22 HD11 ' A' ' 38' ' ' ILE . 1.3 mm? -77.41 -31.15 53.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.112 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.544 ' CD2' HG22 ' A' ' 9' ' ' THR . 20.4 tp -68.64 -32.54 72.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 108.696 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -77.62 -41.21 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.527 -0.733 . . . . 0.0 109.517 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.498 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -61.09 -43.88 98.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.506 -0.746 . . . . 0.0 110.012 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.521 HG23 ' CD1' ' A' ' 29' ' ' LEU . 21.2 t -75.33 -43.16 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.954 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.463 ' HG2' HG12 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -53.86 -41.89 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -0.825 . . . . 0.0 110.221 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.6 p -85.19 -29.68 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 0.0 110.173 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.676 ' CD1' ' CD2' ' A' ' 154' ' ' HIS . 4.5 t80 -58.17 -35.99 72.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.024 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 11.5 mt -71.11 -22.1 62.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 0.0 110.025 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.504 ' N ' HD11 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -91.62 -23.65 19.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.861 . . . . 0.0 110.303 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.93 -49.12 7.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.629 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.676 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 30.1 m-70 -63.25 -97.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.085 -1.01 . . . . 0.0 110.528 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.404 ' OG ' ' C ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -160.51 -70.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 110.385 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.508 ' HB2' ' ND2' ' A' ' 159' ' ' ASN . 3.4 p-10 -142.41 31.49 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.223 -0.923 . . . . 0.0 110.556 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.542 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -52.53 131.08 33.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 0.0 109.767 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 21' ' ' ALA . 51.3 m-85 59.25 66.32 1.05 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 156' ' ' ASP . 1.1 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.204 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 3' ' ' PHE . 45.4 t -79.75 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.343 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.579 ' CD2' HG22 ' A' ' 128' ' ' VAL . 90.8 m-85 -137.74 144.46 41.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.28 110.0 20.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.421 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 3' ' ' PHE . 19.2 m-30 -112.3 88.23 2.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.739 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.01 128.3 38.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.481 HG23 ' CE ' ' A' ' 137' ' ' LYS . 2.9 t -147.16 -172.28 3.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 110.765 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -165.68 173.87 10.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.85 . . . . 0.0 110.782 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.582 HG21 ' CB ' ' A' ' 114' ' ' LEU . 13.1 t -151.58 168.46 24.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.45 139.82 52.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.794 -1.191 . . . . 0.0 111.08 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.441 ' OG ' HD12 ' A' ' 18' ' ' LEU . 43.3 t -134.99 153.89 51.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 110.257 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.85 -22.12 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.213 -0.929 . . . . 0.0 110.04 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.481 HG21 ' HD2' ' A' ' 14' ' ' PRO . 4.3 mm -75.84 140.98 71.24 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.636 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.503 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 33.1 Cg_endo -57.73 154.53 36.88 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.024 1.539 . . . . 0.0 111.196 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -54.65 -64.46 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 111.172 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -40.87 -62.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 0.0 111.113 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -50.36 -58.56 5.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.083 -1.011 . . . . 0.0 110.761 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -49.39 -31.3 9.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 110.924 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.665 ' CE2' HD23 ' A' ' 24' ' ' LEU . 24.9 t80 -74.21 -55.86 5.57 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.415 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 4.3 mtmm -52.09 -42.98 63.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.07 -1.019 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -83.78 -71.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 108.398 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.632 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 27.2 t80 -79.49 147.24 32.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.315 -0.865 . . . . 0.0 108.696 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.632 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 38.0 mt 81.93 -44.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.665 HD23 ' CE2' ' A' ' 19' ' ' PHE . 1.2 mt -97.97 -56.44 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.982 . . . . 0.0 109.933 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -102.91 80.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.199 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.76 -23.02 10.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' OD2' ' OD1' ' A' ' 28' ' ' ASN . 7.8 p-10 -78.24 -22.12 48.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' OD1' ' OD2' ' A' ' 27' ' ' ASP . 30.5 m-20 -105.75 4.68 30.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.561 HD13 ' CD1' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -128.27 -42.23 1.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.574 ' HB2' ' CD ' ' A' ' 31' ' ' PRO . 8.1 m-30 -54.35 -58.24 14.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.774 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.574 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 52.5 Cg_endo -68.45 -5.54 15.38 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.249 1.131 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 1.1 mmpt? -106.14 -14.01 15.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 111.308 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.538 HG22 ' CB ' ' A' ' 146' ' ' ALA . 15.8 m -134.41 6.27 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.008 -1.058 . . . . 0.0 110.051 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.11 62.63 2.45 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.26 -20.67 55.55 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.893 1.47 . . . . 0.0 109.623 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -75.43 -19.14 59.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.46 ' CB ' ' SD ' ' A' ' 139' ' ' MET . . . -101.67 -52.45 3.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.547 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 39' ' ' SER . 1.4 mp -109.74 166.0 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.968 . . . . 0.0 110.675 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.472 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -124.51 -46.16 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 109.891 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -165.45 159.06 16.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 42' ' ' GLU . 73.1 t -111.41 160.87 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.922 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 10.0 mt-10 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.964 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.0 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.244 0.545 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 53' ' ' ILE . 28.2 mm -79.65 125.94 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 111.125 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -133.06 148.8 52.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.46 -0.775 . . . . 0.0 109.288 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 4.7 tttp -124.58 117.1 23.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.902 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.4 mp -94.92 130.62 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.723 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -117.61 124.25 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.1 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CB ' ' CD1' ' A' ' 62' ' ' LEU . 12.7 m-85 -91.11 166.75 17.72 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.15 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -72.83 178.1 6.82 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.854 1.45 . . . . 0.0 110.177 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.77 173.58 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.497 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.23 52.61 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.593 ' CD1' ' CB ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -76.72 152.68 83.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.213 -1.169 . . . . 0.0 110.366 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.07 -22.58 19.24 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.136 1.598 . . . . 0.0 109.889 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 18.6 m-85 -123.28 -159.81 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.47 -0.769 . . . . 0.0 109.655 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -122.26 -26.85 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 110.423 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 16.0 p90 -176.98 -175.73 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.314 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.485 HG21 ' HB ' ' A' ' 56' ' ' ILE . 7.5 m -153.81 122.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.445 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 18.9 mtmt -93.82 133.61 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -114.93 144.69 43.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.848 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.52 ' NH2' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -113.52 103.9 11.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 110.03 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.01 125.9 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 110.19 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 70' ' ' ARG . 1.2 m-20 -97.34 52.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.85 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.5 OUTLIER 63.54 77.68 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.081 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.1 m -56.71 -177.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.375 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 1.8 t0 -123.06 -168.01 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.837 . . . . 0.0 109.748 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.487 ' CE1' HD12 ' A' ' 24' ' ' LEU . 5.0 m80 -144.83 -53.95 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.2 m -51.95 -57.35 9.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.54 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 19.2 m-80 -91.16 17.69 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.538 ' CD2' ' HB2' ' A' ' 15' ' ' ALA . 16.2 m-85 42.47 48.72 4.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 109.997 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.0 tppt? -93.44 123.79 36.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 110.805 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -120.53 112.55 19.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 31.4 t-20 -127.3 108.34 10.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.8 p90 -136.81 165.51 25.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 109.982 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -117.16 141.11 48.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.536 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 86' ' ' ILE . 40.2 t -86.39 78.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.734 . . . . 0.0 109.266 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.526 HG13 ' N ' ' A' ' 87' ' ' GLU . 43.1 pt -59.61 -131.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.503 -0.748 . . . . 0.0 110.751 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' N ' HG13 ' A' ' 86' ' ' ILE . 28.3 mm-40 -67.64 160.95 26.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 102.8 152.29 23.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.474 ' O ' HD13 ' A' ' 91' ' ' ILE . . . 96.04 -147.0 18.49 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.8 Cg_endo -84.23 29.08 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.984 1.518 . . . . 0.0 110.84 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.553 HD11 ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -41.24 163.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.119 -0.988 . . . . 0.0 109.95 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.4 -170.55 14.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.492 ' O ' ' OG1' ' A' ' 94' ' ' THR . 36.7 p-10 -55.12 173.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -1.075 . . . . 0.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 5.4 p 54.23 15.13 0.86 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 94' ' ' THR . 1.2 mt 167.56 92.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.022 -1.049 . . . . 0.0 110.089 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 2.6 tp10 -91.08 -34.14 15.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 110.332 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 96' ' ' GLU . 13.2 mttp -149.69 153.25 36.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.423 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.575 HD12 ' CE2' ' A' ' 120' ' ' TYR . 75.5 mt -137.47 150.71 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.85 . . . . 0.0 109.731 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.511 ' N ' HG21 ' A' ' 98' ' ' ILE . 1.3 m -134.35 143.91 47.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' TYR . 37.8 t-20 -136.47 133.17 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 0.0 110.244 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.776 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 3.1 pt-20 -151.69 149.72 29.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.128 -0.982 . . . . 0.0 109.794 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.776 ' HB ' ' O ' ' A' ' 101' ' ' GLU . 8.0 tp 168.46 -138.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.619 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.588 ' N ' ' CG2' ' A' ' 102' ' ' ILE . 20.5 ptmt -179.82 -171.07 0.17 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.907 -1.121 . . . . 0.0 111.506 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.534 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 66.1 mt -120.0 163.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.231 -0.918 . . . . 0.0 109.685 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.454 HG22 ' HD2' ' A' ' 115' ' ' LYS . 3.9 t -132.0 124.4 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.911 -1.118 . . . . 0.0 110.425 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.19 131.9 35.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.6 p -108.92 155.55 40.6 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.668 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 47.1 Cg_endo -66.28 82.2 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.251 1.658 . . . . 0.0 110.817 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 1.4 m-20 70.71 25.97 3.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.524 -0.735 . . . . 0.0 110.346 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.73 -2.68 18.96 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.89 -170.74 22.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 12.6 m -120.94 130.09 53.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.299 -1.118 . . . . 0.0 109.918 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.3 mt -99.86 121.48 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 109.854 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.582 ' CB ' HG21 ' A' ' 9' ' ' THR . 1.0 OUTLIER -86.89 108.48 18.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.651 -0.655 . . . . 0.0 109.672 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.729 ' O ' HG22 ' A' ' 102' ' ' ILE . 1.3 ptmt -102.44 133.87 46.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.565 -1.335 . . . . 0.0 108.533 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.707 ' HA ' ' CG2' ' A' ' 102' ' ' ILE . 6.7 mt -135.8 139.42 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.46 ' H ' ' HB ' ' A' ' 102' ' ' ILE . 8.7 t -112.6 107.79 16.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 6.9 m-80 -107.04 108.3 19.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.836 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.519 ' HD2' ' CG1' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.99 132.51 46.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.826 179.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.575 ' CE2' HD12 ' A' ' 98' ' ' ILE . 3.6 m-85 -101.73 129.37 47.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.4 m-70 -110.41 101.68 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.771 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.417 HG21 ' HG ' ' A' ' 95' ' ' LEU . 16.2 p -101.82 -165.19 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.366 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -160.39 126.08 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 128.63 -129.4 6.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -124.11 -53.7 1.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.146 -1.208 . . . . 0.0 110.129 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 125' ' ' ASP . 90.4 m-70 -44.22 168.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 109.929 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.93 163.31 21.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 0.0 110.596 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.579 HG22 ' CD2' ' A' ' 3' ' ' PHE . 24.4 t -53.41 157.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -102.5 108.29 19.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.04 -47.32 8.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -0.981 . . . . 0.0 109.953 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.79 -46.62 59.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -35.55 80.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.863 . . . . 0.0 109.648 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.465 HG12 ' CD2' ' A' ' 5' ' ' TYR . 21.8 t -76.99 -12.22 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.459 -0.775 . . . . 0.0 109.775 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -46.74 7.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.447 -0.783 . . . . 0.0 110.808 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -54.38 -49.47 69.79 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.066 -1.021 . . . . 0.0 109.572 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -57.99 -43.94 86.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.925 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.481 ' CE ' HG23 ' A' ' 7' ' ' THR . 4.9 mmtp -66.1 -23.66 66.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.166 -0.959 . . . . 0.0 109.361 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 3.1 tt0 -73.07 -43.71 61.51 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.46 ' SD ' ' CB ' ' A' ' 37' ' ' ALA . 5.3 mmm -64.27 -35.94 82.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.41 -44.2 97.97 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.27 -45.97 75.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.053 -1.263 . . . . 0.0 110.262 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -37.65 68.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 108.897 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.17 -52.98 28.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.434 -0.791 . . . . 0.0 109.578 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.4 tp -47.6 -36.8 11.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.877 -1.14 . . . . 0.0 108.519 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 15.2 mtt180 -71.76 -38.77 70.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 0.0 109.367 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.538 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -58.51 -57.93 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.521 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.484 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 17.7 t -66.92 -27.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.473 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.462 ' OE2' HG12 ' A' ' 13' ' ' ILE . 16.3 tp10 -59.43 -54.98 40.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 109.976 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.406 ' HA ' HD21 ' A' ' 152' ' ' LEU . 22.5 p -75.71 -27.24 58.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.045 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.561 ' CD1' HD13 ' A' ' 29' ' ' LEU . 7.1 t80 -53.8 -45.92 70.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 79.7 mt -61.1 -29.93 70.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.763 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 152' ' ' LEU . 0.3 OUTLIER -89.0 -18.78 26.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 110.703 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.58 -52.75 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.477 ' O ' ' HB3' ' A' ' 155' ' ' SER . 9.2 m-70 -63.97 -111.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 156' ' ' ASP . 92.0 p -178.11 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.851 -1.155 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 155' ' ' SER . 0.0 OUTLIER 71.94 20.65 4.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 111.457 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -52.45 137.28 30.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.619 -1.301 . . . . 0.0 109.462 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.541 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 72.2 m-85 58.72 81.8 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.403 ' O ' ' HE3' ' A' ' 20' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.222 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.501 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 10.9 p -117.71 167.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.605 ' CD1' ' CG2' ' A' ' 128' ' ' VAL . 29.0 m-85 -132.44 108.64 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.414 -0.803 . . . . 0.0 110.098 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -62.84 142.69 58.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.522 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CD1' HG13 ' A' ' 133' ' ' VAL . 23.9 m-85 -150.05 69.05 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.0 109.657 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 72.3 mt-10 -94.72 141.89 28.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.594 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.441 HG21 ' HB ' ' A' ' 116' ' ' ILE . 15.1 t -159.9 -178.22 6.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.45 -0.781 . . . . 0.0 109.59 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 7' ' ' THR . 1.8 pm0 -155.42 154.75 32.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.057 -1.027 . . . . 0.0 110.425 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.518 HG22 ' CD1' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -129.34 158.58 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.664 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.472 HG21 HG12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -120.41 139.69 52.45 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.05 -1.032 . . . . 0.0 110.48 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.423 ' HB2' HD23 ' A' ' 144' ' ' LEU . 30.1 t -135.05 141.22 46.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.549 -0.719 . . . . 0.0 109.872 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.12 -15.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.578 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 15.0 mm -75.72 147.14 80.97 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 110.018 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 32.0 Cg_endo -56.38 155.23 26.05 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.902 1.475 . . . . 0.0 110.683 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . . . -63.47 -69.29 0.28 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 111.311 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -39.26 -46.43 1.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.29 -0.881 . . . . 0.0 111.538 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 41.7 mtt180 -64.95 -50.5 66.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.115 . . . . 0.0 110.052 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 9.8 mt -56.1 -25.89 47.6 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.939 0.876 . . . . 0.0 109.547 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.654 ' CE2' HD23 ' A' ' 24' ' ' LEU . 21.4 t80 -79.46 -48.62 13.62 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.2 -0.937 . . . . 0.0 110.902 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -67.46 -27.47 67.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.501 -0.749 . . . . 0.0 112.117 -178.422 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.593 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -110.11 -29.84 8.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.553 -1.342 . . . . 0.0 112.165 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.584 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 88.2 t80 -109.14 5.0 23.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.785 -1.197 . . . . 0.0 111.582 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.58 HG22 ' CE1' ' A' ' 19' ' ' PHE . 41.2 mt -141.77 -19.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.942 -1.099 . . . . 0.0 111.23 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.654 HD23 ' CE2' ' A' ' 19' ' ' PHE . 1.8 mt -110.68 -37.09 5.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.966 -1.084 . . . . 0.0 109.904 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.6 42.43 2.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -40.4 71.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.528 ' HB2' ' CG1' ' A' ' 41' ' ' VAL . 2.2 p30 -70.45 -0.8 9.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -1.127 . . . . 0.0 110.929 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 13.9 t30 -138.93 47.98 1.91 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.588 HD22 ' CE2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER 177.37 -30.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.511 -0.743 . . . . 0.0 109.077 -178.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.566 ' HB2' ' CD ' ' A' ' 31' ' ' PRO . 5.9 m-30 -56.24 -59.14 12.78 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.566 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -67.58 -11.28 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.741 1.39 . . . . 0.0 110.635 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -16.33 38.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.605 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.545 HG13 ' CD1' ' A' ' 150' ' ' TYR . 25.7 m -127.19 -3.09 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.328 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.77 65.19 8.18 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.055 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.85 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.054 1.555 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -90.13 -14.47 33.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.559 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB2' ' HE2' ' A' ' 139' ' ' MET . . . -115.29 -29.79 6.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.018 -1.051 . . . . 0.0 110.576 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.5 mm -120.82 161.11 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.49 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.3 OUTLIER -127.6 -49.29 1.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 109.254 179.057 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' SER . 12.5 t 174.19 138.54 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.566 -0.709 . . . . 0.0 110.276 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 27' ' ' ASP . 8.6 p -109.13 162.54 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 108.979 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 9.8 tt0 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 120.795 -1.191 . . . . 0.0 111.377 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.295 0.569 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.476 HD11 ' CG ' ' A' ' 70' ' ' ARG . 18.3 mm -82.73 148.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 14.0 mtmt -148.17 141.26 24.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 110.421 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -114.23 132.22 56.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 110.251 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.577 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 1.8 mp -107.22 112.33 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.351 -0.843 . . . . 0.0 110.097 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 39' ' ' SER . 9.2 t -103.57 136.42 43.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.952 -1.093 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CZ ' HG23 ' A' ' 56' ' ' ILE . 17.9 m-85 -103.26 166.02 12.54 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.86 . . . . 0.0 109.763 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -73.14 175.14 10.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.873 1.459 . . . . 0.0 110.413 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.18 178.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 110.374 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.72 -38.29 3.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -62.09 133.13 94.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.139 -1.213 . . . . 0.0 110.29 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.3 -13.76 16.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.175 1.618 . . . . 0.0 110.346 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -101.01 -163.88 1.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -117.88 -39.12 3.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.121 -0.987 . . . . 0.0 110.686 -179.543 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 21.2 p90 -177.31 -171.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.705 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 66' ' ' TYR . 12.2 t -147.08 99.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.485 -0.76 . . . . 0.0 111.043 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -89.99 139.77 30.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.016 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -157.42 162.05 38.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.476 ' CG ' HD11 ' A' ' 53' ' ' ILE . 4.3 mtm105 -112.47 155.97 23.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.204 -0.935 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.35 161.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 5.4 m-20 -124.1 54.03 1.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.6 mt-10 65.88 115.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.519 HG22 ' CD2' ' A' ' 24' ' ' LEU . 4.4 p -90.68 145.6 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -92.47 -151.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.083 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.495 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -168.1 -62.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 m -50.63 -56.11 13.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.825 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 79' ' ' PHE . 2.1 m-80 -95.84 18.37 13.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 0.0 110.672 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.645 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 6.2 m-85 42.47 72.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 0.0 109.924 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.1 tttp -123.92 115.41 21.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.023 -1.048 . . . . 0.0 110.707 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -113.4 173.21 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 54.5 t-20 -176.35 123.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 36.7 p90 -135.28 157.58 46.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.2 135.37 55.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 73.3 t -108.01 110.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.253 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.81 -14.06 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 68' ' ' LYS . 5.4 mt-10 -139.68 140.92 36.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.179 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.439 ' C ' HG12 ' A' ' 91' ' ' ILE . . . 103.2 177.23 26.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.18 -135.01 20.64 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.512 ' HG3' ' NE2' ' A' ' 132' ' ' GLN . 51.6 Cg_endo -86.48 29.84 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 111.46 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.474 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -37.66 157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.28 -132.38 4.63 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.428 ' O ' HG21 ' A' ' 94' ' ' THR . 5.4 p-10 -114.66 55.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 0.0 110.625 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 93' ' ' ASP . 0.8 OUTLIER -150.57 -70.26 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.56 HD23 ' CD2' ' A' ' 120' ' ' TYR . 2.6 mt -98.7 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 109.873 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -93.19 -39.8 10.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 110.517 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.533 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.9 tttm -134.47 164.56 27.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 0.0 110.868 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 97' ' ' LYS . 13.0 mt -158.82 132.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.28 116.34 27.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.898 -1.127 . . . . 0.0 110.523 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 11.1 t-20 -116.35 126.67 53.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -116.38 149.24 39.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.461 -0.775 . . . . 0.0 109.673 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.5 mt -136.29 134.16 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.469 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -131.62 99.85 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.445 -0.785 . . . . 0.0 109.829 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 1.7 mp -77.29 113.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.269 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.6 t -102.28 122.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.288 -0.882 . . . . 0.0 109.725 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.472 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . . . -78.61 134.49 37.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.601 -0.687 . . . . 0.0 110.102 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 110' ' ' GLY . 71.2 p -104.85 156.1 36.52 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.845 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.36 -2.87 8.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -173.07 -25.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 111.269 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.431 ' C ' ' OG1' ' A' ' 107' ' ' THR . . . -83.55 45.54 3.48 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 52.21 -114.91 3.64 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 3.1 m -150.57 158.52 44.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.409 -1.054 . . . . 0.0 109.557 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.472 HG12 HG21 ' A' ' 10' ' ' THR . 20.7 mt -126.02 122.32 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.873 -1.142 . . . . 0.0 110.832 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 114' ' ' LEU . 7.1 mp -84.63 105.11 15.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.708 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -84.32 100.65 11.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.778 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.441 ' HB ' HG21 ' A' ' 7' ' ' THR . 3.8 mt -92.76 155.03 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.868 . . . . 0.0 110.864 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 36.3 t -151.34 91.21 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.488 -0.758 . . . . 0.0 109.297 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 100' ' ' ASN . 36.3 t-20 -101.82 145.83 28.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 111.444 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.45 ' CG ' HG22 ' A' ' 2' ' ' VAL . 2.1 ttmt -131.96 118.94 20.42 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CD2' HG12 ' A' ' 128' ' ' VAL . 2.7 m-85 -86.14 107.92 18.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.934 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -92.22 96.8 10.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.457 HG22 HG21 ' A' ' 128' ' ' VAL . 20.8 p -92.12 -136.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 110.083 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -40.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 160.68 -149.35 18.47 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 126' ' ' HIS . 5.2 t0 47.09 -92.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -1.082 . . . . 0.0 110.135 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 124' ' ' GLY . 35.9 m170 -87.52 172.0 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -124.21 179.54 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.605 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 99.3 t -78.13 153.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.123 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -106.95 110.22 22.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.316 -0.865 . . . . 0.0 109.816 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.29 -40.62 3.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.0 tt0 -55.27 -49.1 72.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.512 ' NE2' ' HG3' ' A' ' 90' ' ' PRO . 1.1 tt0 -60.32 -39.7 87.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 108.954 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.593 HG13 ' CD1' ' A' ' 5' ' ' TYR . 64.4 t -64.91 -22.82 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.754 0.787 . . . . 0.0 109.162 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -83.64 -67.63 0.78 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.628 -0.67 . . . . 0.0 110.693 -179.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -33.5 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.501 -0.749 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -67.1 -55.18 15.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 108.724 178.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 134' ' ' LYS . 8.9 mptt -53.42 -55.42 25.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.815 . . . . 0.0 109.073 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -46.69 -47.07 20.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.585 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.468 ' HE2' ' HB2' ' A' ' 37' ' ' ALA . 2.6 tpp -56.19 -44.1 79.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.116 -0.99 . . . . 0.0 108.799 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.54 92.83 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.83 -31.41 66.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.066 -1.255 . . . . 0.0 110.804 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.1 OUTLIER -68.6 -43.9 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.954 -1.091 . . . . 0.0 109.056 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 143' ' ' LEU . 1.5 mm? -70.5 -33.36 71.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.246 -0.909 . . . . 0.0 109.189 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 9' ' ' THR . 0.8 OUTLIER -61.62 -41.53 97.6 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.74 -47.05 76.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.606 -0.684 . . . . 0.0 110.063 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.68 -59.6 4.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.494 ' CG2' HD13 ' A' ' 29' ' ' LEU . 40.7 t -65.63 -19.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.492 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 22.1 tt0 -71.99 -46.21 58.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.1 -1.0 . . . . 0.0 110.072 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.73 -12.3 37.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 110.291 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.588 ' CE2' HD22 ' A' ' 29' ' ' LEU . 8.5 t80 -69.58 -36.4 76.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.075 -1.016 . . . . 0.0 109.637 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.559 HD22 ' CD2' ' A' ' 150' ' ' TYR . 38.7 mt -72.6 -19.94 61.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.173 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.2 mp -87.46 -33.26 19.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.233 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.42 -48.66 13.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.858 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.518 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 54.8 m-70 -76.71 -22.5 53.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.825 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 154' ' ' HIS . 17.0 p 41.93 51.1 4.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.333 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -168.83 -37.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.604 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.556 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -64.15 130.86 45.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.383 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 58.4 m-85 55.75 62.85 2.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.261 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.541 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 12.1 p -132.77 157.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -1.143 . . . . 0.0 110.564 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.544 ' CD1' HG21 ' A' ' 128' ' ' VAL . 68.1 m-85 -130.82 156.7 44.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -120.16 91.44 3.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.162 -0.961 . . . . 0.0 110.234 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CD2' ' CG1' ' A' ' 133' ' ' VAL . 31.3 m-85 -87.52 146.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.059 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.86 149.73 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.398 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.451 ' C ' ' CG ' ' A' ' 8' ' ' GLU . 8.6 t -169.13 167.63 10.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 109.903 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' CG ' ' C ' ' A' ' 7' ' ' THR . 32.0 mt-10 -148.8 146.97 28.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.604 HG21 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.9 178.24 5.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 109.853 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.46 149.49 51.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.678 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' OG ' HD22 ' A' ' 144' ' ' LEU . 0.5 OUTLIER -143.73 142.54 30.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.341 -0.849 . . . . 0.0 109.905 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -71.66 -6.17 7.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.573 -0.705 . . . . 0.0 110.4 -179.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.575 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 15.6 mm -89.5 143.17 30.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.104 -0.998 . . . . 0.0 109.952 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 33.0 Cg_endo -56.94 154.75 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.739 1.389 . . . . 0.0 110.06 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB3' HG21 ' A' ' 104' ' ' ILE . . . -62.02 -39.73 93.29 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.099 -1.001 . . . . 0.0 110.812 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 -60.86 3.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.615 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.5 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -55.91 -47.44 77.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.575 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 9.4 mt -53.32 -37.89 62.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.964 -1.085 . . . . 0.0 109.075 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.619 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -70.17 -69.91 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.027 -1.046 . . . . 0.0 110.227 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HA ' HD11 ' A' ' 24' ' ' LEU . 4.7 mtpt -52.37 -19.37 2.09 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.669 -1.269 . . . . 0.0 113.279 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.58 ' HA ' ' CE1' ' A' ' 158' ' ' TYR . . . -114.06 -56.36 2.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.49 -1.381 . . . . 0.0 112.176 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 19.2 t80 -73.64 -85.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.489 -1.382 . . . . 0.0 110.82 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.564 ' CG2' ' CD2' ' A' ' 81' ' ' TYR . 21.9 mm -37.42 -48.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.512 -0.742 . . . . 0.0 110.221 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.619 HD13 ' CD1' ' A' ' 19' ' ' PHE . 4.5 mt -100.53 -170.64 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 32.88 34.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.726 -0.609 . . . . 0.0 111.588 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' A' ' 30' ' ' PHE . . . -92.26 -12.95 58.08 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.482 ' HB2' HG13 ' A' ' 41' ' ' VAL . 52.2 p30 -67.33 -7.39 24.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.459 -1.024 . . . . 0.0 111.07 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -130.23 16.59 5.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.091 -1.005 . . . . 0.0 108.532 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 33' ' ' VAL . 5.9 tp -131.54 -50.33 0.99 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.452 -0.78 . . . . 0.0 110.746 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.578 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.0 m-30 -42.71 -53.74 9.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.419 -0.801 . . . . 0.0 110.315 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -67.04 -38.01 17.41 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.408 1.215 . . . . 0.0 110.957 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 2.4 mtmt -75.23 -73.3 0.26 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.977 -1.077 . . . . 0.0 110.907 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.497 HG21 ' N ' ' A' ' 34' ' ' ALA . 26.0 m -62.94 -21.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.729 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 30' ' ' PHE . . . -126.16 69.48 67.12 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.049 -1.032 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 43.7 Cg_endo -69.45 -21.92 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.891 1.469 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -83.92 -3.2 57.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.308 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB3' HD22 ' A' ' 143' ' ' LEU . . . -114.12 -51.18 2.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 111.124 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.523 ' CG2' ' CG2' ' A' ' 56' ' ' ILE . 3.9 mp -138.95 172.46 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.871 -1.143 . . . . 0.0 110.761 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.529 ' HB3' ' CG ' ' A' ' 59' ' ' PRO . 29.6 t -133.37 -31.05 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.582 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -158.89 166.7 31.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 2.2 p -133.32 140.1 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.021 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 110.655 -179.463 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.216 0.531 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.467 HD12 ' HG2' ' A' ' 70' ' ' ARG . 10.1 mm -97.15 129.72 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 1.7 ptmt -127.59 149.05 50.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.34 -0.85 . . . . 0.0 110.082 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' CG ' ' HG2' ' A' ' 68' ' ' LYS . 4.0 mttp -140.4 100.95 4.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.676 -0.64 . . . . 0.0 109.311 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.577 HG23 ' CE1' ' A' ' 58' ' ' PHE . 2.0 mp -82.74 156.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.82 -1.175 . . . . 0.0 110.206 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 85.1 p -115.55 145.22 42.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.965 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE1' HG23 ' A' ' 56' ' ' ILE . 4.8 m-85 -118.99 72.94 12.06 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.233 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.529 ' CG ' ' HB3' ' A' ' 39' ' ' SER . 45.5 Cg_endo -75.51 68.7 6.11 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.627 1.856 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.0 -163.37 1.76 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.278 -0.889 . . . . 0.0 110.288 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.75 69.62 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.4 mt -65.37 158.74 71.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.12 -1.223 . . . . 0.0 110.353 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.78 -35.13 4.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.961 1.506 . . . . 0.0 109.959 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 9.4 m-30 -79.94 150.54 30.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.848 . . . . 0.0 110.044 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -113.94 -6.22 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.843 179.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.571 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 20.7 p90 179.23 176.26 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.541 -0.724 . . . . 0.0 109.394 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.574 ' CG2' ' HB ' ' A' ' 56' ' ' ILE . 35.6 m -159.11 109.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 109.283 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.571 ' HE2' ' CE1' ' A' ' 66' ' ' TYR . 7.6 mttm -96.2 139.48 32.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 109.503 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 14.3 m-20 -156.78 132.62 9.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 0.0 111.233 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.467 ' HG2' HD12 ' A' ' 53' ' ' ILE . 47.6 mtt180 -73.21 156.46 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.072 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.4 p -94.27 -17.7 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.938 -1.101 . . . . 0.0 111.039 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 61.1 -87.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 72' ' ' ASP . 0.1 OUTLIER 179.24 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.085 -1.009 . . . . 0.0 110.351 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 75' ' ' ASP . 49.7 t -66.87 161.02 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.386 -0.821 . . . . 0.0 110.223 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 76' ' ' HIS . 6.3 t70 -103.16 -57.55 2.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.594 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER 75.58 -58.9 0.54 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.265 -0.272 . . . . 0.0 111.092 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 m -52.08 -55.08 23.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 110.011 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -95.02 16.04 17.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.37 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 52.66 52.59 13.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.182 -0.948 . . . . 0.0 109.867 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 102' ' ' ILE . 17.7 ttpt -124.44 127.24 47.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CD2' ' CG2' ' A' ' 23' ' ' ILE . 70.6 t80 -128.58 125.79 38.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.51 145.2 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.702 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.629 ' CE1' ' CB ' ' A' ' 100' ' ' ASN . 18.1 p90 -136.11 158.33 44.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.31 138.14 41.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.517 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 24.9 t -107.42 69.47 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.817 . . . . 0.0 109.823 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -66.6 -11.19 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.474 ' CA ' HD12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER 172.47 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.534 ' O ' ' CG1' ' A' ' 91' ' ' ILE . . . -106.31 -146.22 13.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . -91.57 -38.28 5.91 Favored Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.334 -1.098 . . . . 0.0 111.382 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -76.46 -9.91 18.81 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.128 1.067 . . . . 0.0 111.981 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -41.61 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.997 -1.064 . . . . 0.0 110.706 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.53 -168.07 41.15 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 3.6 m-20 -66.03 -175.18 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -1.182 . . . . 0.0 110.333 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 18.6 p 48.83 21.18 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 110.985 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 98' ' ' ILE . 0.9 OUTLIER -161.25 133.4 5.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.028 . . . . 0.0 110.143 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.67 -60.4 1.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.482 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HG2' ' N ' ' A' ' 98' ' ' ILE . 17.1 ttmt -127.23 160.05 32.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.056 -1.027 . . . . 0.0 110.43 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.525 ' CD1' HD23 ' A' ' 95' ' ' LEU . 24.0 mt -152.39 142.79 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.5 t -119.1 143.04 47.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -126.02 125.76 43.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 111.124 -179.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.34 135.81 53.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.454 -0.778 . . . . 0.0 109.404 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 81' ' ' TYR . 22.7 mt -130.54 157.87 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.825 -1.172 . . . . 0.0 110.916 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 13.4 ttmt -151.12 110.83 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 15' ' ' ALA . 4.7 mt -84.4 128.94 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.097 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 112' ' ' SER . 6.6 t -119.83 151.58 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.732 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.99 135.3 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 109.754 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.427 ' OG1' ' CG ' ' A' ' 109' ' ' ASP . 11.6 p -138.36 142.61 35.6 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.002 . . . . 0.0 110.768 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.38 -3.59 12.72 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.279 1.673 . . . . 0.0 110.533 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 109' ' ' ASP . 10.6 p30 -80.11 2.81 22.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.287 -0.883 . . . . 0.0 111.004 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.85 -82.28 0.15 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.41 -134.47 3.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 60.4 p -113.42 175.63 5.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.51 HG23 HD11 ' A' ' 113' ' ' ILE . 9.8 mt -130.61 132.97 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.604 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.1 tp -91.59 100.44 13.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.568 -0.708 . . . . 0.0 110.419 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 102' ' ' ILE . 45.8 mttt -79.71 130.01 34.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.44 HG13 ' C ' ' A' ' 115' ' ' LYS . 3.8 mt -132.84 140.88 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 111.305 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.62 117.59 16.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 2.0 m-80 -107.93 106.41 16.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 111.423 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.541 ' HD2' ' CG2' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -88.85 122.35 32.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.51 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 4.9 m-85 -102.97 144.06 31.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.0 111.004 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -131.84 89.08 2.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.644 -0.66 . . . . 0.0 109.708 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.474 HG21 ' HA ' ' A' ' 95' ' ' LEU . 7.3 p -95.81 -159.96 0.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -83.28 -66.75 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.123 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.69 -32.37 0.62 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -69.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -1.154 . . . . 0.0 110.13 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -99.51 -170.72 1.94 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 0.0 110.114 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 mm-40 -115.81 171.15 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.538 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.572 HG13 ' CE1' ' A' ' 5' ' ' TYR . 3.4 t -67.15 156.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 4.2 mppt? -90.86 102.5 15.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.842 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -44.32 -51.17 8.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.44 -44.77 62.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.166 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 2.7 tt0 -56.52 -41.98 77.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 108.753 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.597 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 78.6 t -63.26 -30.09 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.825 0.821 . . . . 0.0 108.944 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' ALA . 4.1 tttt -68.69 -51.53 40.78 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.772 -0.58 . . . . 0.0 110.267 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.55 -56.55 3.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.04 -43.74 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.433 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 4.5 mtpp -60.5 -38.1 83.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.805 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -65.54 -54.63 25.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 110.074 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -35.61 65.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.06 -1.025 . . . . 0.0 109.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.86 -38.95 93.31 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 1.0 OUTLIER -74.22 -35.6 63.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.314 . . . . 0.0 110.934 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.3 p -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.18 -0.95 . . . . 0.0 109.785 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -73.32 -51.05 18.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 15.5 tp -50.7 -44.16 57.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -62.91 -44.48 95.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 109.511 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 143' ' ' LEU . . . -51.27 -58.98 4.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.481 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 21.9 t -66.36 -21.81 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.78 -51.05 64.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.07 -1.018 . . . . 0.0 109.736 179.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 3.1 t -75.33 -31.03 60.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.891 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.492 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 14.7 t80 -55.96 -50.85 69.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.3 mt -56.13 -29.94 61.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 109.96 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 148' ' ' GLU . 8.6 mp -72.01 -55.67 7.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 110.241 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -55.32 -41.23 72.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.466 -0.772 . . . . 0.0 110.544 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.581 ' CD2' ' N ' ' A' ' 154' ' ' HIS . 4.5 m-70 -105.55 122.52 46.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.82 30.57 2.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.855 . . . . 0.0 109.911 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -132.13 -26.9 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.809 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.477 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -69.99 128.49 36.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.964 -1.085 . . . . 0.0 110.589 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 21' ' ' ALA . 40.3 m-85 56.68 81.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.264 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.508 HG23 ' ND1' ' A' ' 121' ' ' HIS . 56.1 t -44.74 156.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -1.213 . . . . 0.0 110.162 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 97.4 m-85 -120.48 164.62 16.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 110.274 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 4' ' ' ASN . 3.4 t-20 -127.51 105.76 8.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.913 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.589 ' CG ' HG12 ' A' ' 133' ' ' VAL . 25.6 m-85 -99.01 92.75 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.983 . . . . 0.0 110.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 2.2 mp0 -53.8 141.15 27.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.85 . . . . 0.0 109.969 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.49 ' CG2' HG21 ' A' ' 102' ' ' ILE . 4.8 t -125.47 162.94 23.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.804 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 4.0 tm-20 178.49 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.307 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.542 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -120.64 162.6 19.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 0.0 109.835 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.468 HG21 HG12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -122.92 145.89 48.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.753 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.426 ' OG ' HD13 ' A' ' 18' ' ' LEU . 35.4 t -142.19 149.17 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.885 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.86 -25.96 29.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.793 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.506 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 5.2 mm -72.5 142.01 83.53 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 34.5 Cg_endo -57.97 151.79 55.28 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.76 1.4 . . . . 0.0 110.521 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' N ' ' HB3' ' A' ' 112' ' ' SER . . . -58.13 -45.63 87.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.88 . . . . 0.0 110.99 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.448 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -58.43 -59.78 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 110.535 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.524 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -51.0 -59.57 4.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.496 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -46.28 -35.57 5.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.364 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CE1' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -65.67 -64.26 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.448 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 20.9 mtmt -54.39 -21.66 10.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.458 -0.776 . . . . 0.0 112.305 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -112.65 -59.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CA ' HG12 ' A' ' 147' ' ' VAL . 64.6 t80 -69.22 -44.0 72.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.717 -1.239 . . . . 0.0 111.859 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.56 HG23 ' CE1' ' A' ' 19' ' ' PHE . 46.9 mm -82.8 -82.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 111.296 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.544 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.7 mt -40.56 -68.4 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -55.33 -67.6 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.427 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.605 ' HA2' ' CE1' ' A' ' 30' ' ' PHE . . . 49.18 -86.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.548 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 4.6 p30 -73.99 27.12 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.586 -0.95 . . . . 0.0 112.349 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 11.5 t30 -139.72 38.16 2.01 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 150' ' ' TYR . 0.8 OUTLIER 174.25 -30.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.609 -177.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CE1' ' HA2' ' A' ' 26' ' ' GLY . 2.6 m-30 -38.92 -62.52 0.74 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.385 -0.822 . . . . 0.0 111.304 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.7 Cg_endo -65.89 -27.44 51.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.762 1.401 . . . . 0.0 110.288 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -72.75 -16.56 61.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.83 . . . . 0.0 110.484 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.593 HG13 ' CD1' ' A' ' 150' ' ' TYR . 19.1 m -124.25 -4.12 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.338 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.69 65.37 12.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 -10.16 27.71 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 123.835 1.439 . . . . 0.0 109.657 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -86.08 -20.42 28.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 109.127 179.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.422 ' HB2' ' CE ' ' A' ' 139' ' ' MET . . . -107.79 -61.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.593 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.473 HG13 ' HB3' ' A' ' 30' ' ' PHE . 7.7 mm -94.55 166.65 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.617 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -131.46 -40.17 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 p -160.16 155.9 25.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 109.944 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 27' ' ' ASP . 2.7 p -121.33 146.63 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 109.966 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 2.4 mm-40 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.642 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.407 ' O ' HD12 ' A' ' 53' ' ' ILE . 7.6 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.176 0.512 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 HD11 ' HG2' ' A' ' 70' ' ' ARG . 45.8 mm -131.4 154.87 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.95 . . . . 0.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.502 ' NZ ' ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -141.97 143.51 33.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.52 -0.737 . . . . 0.0 109.869 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 31.2 tttp -118.99 110.4 17.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.628 -0.67 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.501 ' HB ' ' CG2' ' A' ' 67' ' ' VAL . 9.8 mm -98.72 109.43 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.82 -1.175 . . . . 0.0 110.611 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 39' ' ' SER . 0.8 OUTLIER -103.07 124.87 49.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 110.405 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.479 ' CE2' HG12 ' A' ' 67' ' ' VAL . 32.1 m-85 -84.58 164.66 41.69 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.403 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.3 Cg_endo -74.47 -163.23 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.14 1.6 . . . . 0.0 109.726 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER 38.61 -162.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.569 -0.707 . . . . 0.0 111.133 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -99.58 -34.74 4.89 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 58' ' ' PHE . 11.0 mt 55.71 165.4 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.105 -1.232 . . . . 0.0 109.934 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 45.5 Cg_endo -72.15 -24.96 19.6 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.846 1.446 . . . . 0.0 109.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.5 ' HB3' ' CA ' ' A' ' 89' ' ' GLY . 18.0 m-30 -106.45 -140.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.814 . . . . 0.0 109.818 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 22.7 mttt -144.67 -32.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 111.16 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 176.65 177.44 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.56 HG11 ' O ' ' A' ' 66' ' ' TYR . 35.7 m -142.25 117.98 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -93.57 162.81 13.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.945 . . . . 0.0 109.342 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -144.64 154.48 42.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.844 -1.16 . . . . 0.0 111.627 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HG2' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -122.29 134.68 54.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.675 -0.641 . . . . 0.0 109.386 179.392 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.502 ' HB ' ' NZ ' ' A' ' 54' ' ' LYS . 2.6 p -89.89 136.71 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.003 . . . . 0.0 110.671 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -113.94 55.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 109.401 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.4 mt-10 60.28 117.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 0.0 109.842 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.97 125.52 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 15.1 t0 -68.63 -170.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.572 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.07 -48.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 110.152 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 m -57.5 -16.1 8.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 110.089 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.524 ' CB ' ' HD2' ' A' ' 80' ' ' LYS . 97.3 m-20 -130.31 6.74 4.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 3.7 m-85 57.56 55.32 5.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 110.737 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.524 ' HD2' ' CB ' ' A' ' 78' ' ' ASN . 6.8 mttt -117.63 121.72 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.366 -0.834 . . . . 0.0 110.026 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.403 ' CD2' HG22 ' A' ' 23' ' ' ILE . 17.9 t80 -114.18 161.2 18.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.456 ' CB ' ' OE2' ' A' ' 101' ' ' GLU . 8.0 p30 -163.83 138.09 5.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.261 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 10.9 p90 -147.5 172.49 13.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 4.6 p -139.42 135.3 33.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.736 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.07 81.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.487 ' O ' ' CG ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -66.57 -10.88 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -173.4 157.34 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.782 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.508 ' O ' ' CG1' ' A' ' 91' ' ' ILE . . . 168.38 -137.57 4.66 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.239 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.607 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . -95.28 -38.16 4.88 Favored Glycine 0 N--CA 1.489 2.168 0 O-C-N 121.727 -0.866 . . . . 0.0 111.92 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -77.48 -1.59 11.77 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.0 1.0 . . . . 0.0 111.202 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.527 ' N ' HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -46.82 176.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.156 -0.965 . . . . 0.0 110.221 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 94' ' ' THR . . . 157.19 74.12 0.02 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.513 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 94' ' ' THR . 2.8 m-20 40.25 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.442 -1.034 . . . . 0.0 111.188 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 92' ' ' GLY . 3.2 p -31.41 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.789 -0.569 . . . . 0.0 111.102 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.565 HD22 ' CE2' ' A' ' 120' ' ' TYR . 15.6 tp -64.49 88.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.081 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.78 -49.64 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.542 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 142.87 45.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.545 HG22 ' CD1' ' A' ' 120' ' ' TYR . 44.2 mt -136.24 114.99 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -0.948 . . . . 0.0 110.604 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 1.4 m -112.18 111.56 22.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 109.424 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.528 ' CB ' ' HA ' ' A' ' 118' ' ' ASN . 25.4 m-20 -121.27 147.3 45.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.308 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 116' ' ' ILE . 12.3 mt-10 -136.02 141.48 44.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.532 -0.73 . . . . 0.0 109.68 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.645 ' HA ' ' HB ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -136.3 177.93 5.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 113' ' ' ILE . 75.1 tttt -140.0 137.42 34.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.349 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.527 ' CD1' ' HG ' ' A' ' 114' ' ' LEU . 6.1 mm -96.82 80.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 112' ' ' SER . 90.7 t -71.39 130.97 35.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 110.702 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.411 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . . . -91.87 141.28 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.505 ' OG1' ' CA ' ' A' ' 110' ' ' GLY . 38.0 p -127.42 156.51 74.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.34 -34.74 34.11 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.071 1.564 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.45 37.49 2.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.295 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.505 ' CA ' ' OG1' ' A' ' 107' ' ' THR . . . -148.43 30.48 1.3 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 45.84 -103.94 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.535 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 2.6 p -142.99 170.25 16.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 110.355 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 9' ' ' THR . 9.7 mt -138.68 129.77 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.602 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 8.0 mp -97.55 94.45 7.01 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 116' ' ' ILE . 1.0 OUTLIER -124.1 -176.83 3.59 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.779 -1.168 . . . . 0.0 112.721 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' A' ' 102' ' ' ILE . 21.6 mm 120.63 -102.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.236 1.414 . . . . 0.0 109.853 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.519 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 4.7 m -168.79 177.22 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.725 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.528 ' HA ' ' CB ' ' A' ' 100' ' ' ASN . 4.6 m120 -139.49 96.71 3.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 99' ' ' SER . 4.9 mttt -75.66 129.08 36.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 111.271 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CE2' HD22 ' A' ' 95' ' ' LEU . 2.6 m-85 -105.75 106.23 16.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.508 ' ND1' HG23 ' A' ' 2' ' ' VAL . 60.3 m-70 -90.9 95.05 9.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.843 . . . . 0.0 110.307 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p -79.34 -170.88 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 -72.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 110.249 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.88 60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -153.24 -114.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -1.153 . . . . 0.0 109.79 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -71.13 161.22 31.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.975 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.5 mp0 -77.43 -164.36 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.906 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.554 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 55.6 t -90.7 141.42 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -81.65 119.48 23.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -0.91 . . . . 0.0 109.887 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.06 83.24 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.132 -0.98 . . . . 0.0 109.958 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.99 -29.24 59.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -1.0 . . . . 0.0 108.839 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 90' ' ' PRO . 37.3 tt0 -77.8 -40.16 41.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.589 HG12 ' CG ' ' A' ' 5' ' ' TYR . 96.7 t -69.25 -14.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.082 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.07 -49.27 6.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.655 -0.653 . . . . 0.0 109.979 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -50.71 -45.46 58.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 t -59.14 -47.58 84.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 109.349 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.412 ' HE2' ' ND2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -63.3 -22.09 66.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.643 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 74.2 tt0 -75.2 -47.6 27.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.361 -0.837 . . . . 0.0 109.416 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 42.3 mmm -65.86 -30.83 71.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.25 -0.906 . . . . 0.0 108.867 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.43 -35.5 56.06 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.66 -34.92 65.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.884 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 p -72.23 -37.94 69.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.246 -0.908 . . . . 0.0 108.807 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 139' ' ' MET . 0.6 OUTLIER -72.05 -31.4 66.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.531 ' CD2' HG22 ' A' ' 9' ' ' THR . 11.7 tp -67.57 -41.96 83.32 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -68.74 -33.1 73.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -63.84 -60.99 2.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.457 -0.777 . . . . 0.0 109.245 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.536 HG12 ' CA ' ' A' ' 22' ' ' PHE . 63.4 t -60.82 -28.62 43.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.451 -0.78 . . . . 0.0 109.697 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -50.0 72.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.945 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.49 -11.99 56.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.593 ' CD1' HG13 ' A' ' 33' ' ' VAL . 6.5 t80 -69.53 -37.24 77.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.6 -24.58 60.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.488 ' N ' HD11 ' A' ' 152' ' ' LEU . 4.7 mp -81.64 -36.27 29.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.52 -41.66 45.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.469 ' O ' ' HB3' ' A' ' 155' ' ' SER . 59.7 m-70 -86.1 -48.44 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.372 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 7.9 t 62.22 14.34 6.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.259 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -131.95 4.08 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.371 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.491 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -106.69 143.36 34.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.288 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 41.8 m-85 50.56 33.51 8.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.523 HG11 ' N ' ' A' ' 3' ' ' PHE . 95.7 t -63.63 152.14 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -1.172 . . . . 0.0 110.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.637 ' CD2' HG22 ' A' ' 128' ' ' VAL . 23.1 m-85 -113.38 164.47 13.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.494 -0.754 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.471 ' HA ' ' HG2' ' A' ' 119' ' ' LYS . 61.9 t-20 -148.99 98.79 2.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.083 -1.011 . . . . 0.0 111.37 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.69 ' CE2' HG23 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -95.59 134.34 38.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.163 -0.961 . . . . 0.0 108.944 178.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -119.01 117.45 28.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 110.779 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 116' ' ' ILE . 7.9 t -142.6 -161.19 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 109.845 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.522 ' CB ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -173.63 158.92 3.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.011 -1.056 . . . . 0.0 110.538 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -122.68 175.44 6.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.156 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.44 145.29 51.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 110.242 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.461 ' HB3' HD13 ' A' ' 18' ' ' LEU . 16.5 t -143.52 142.45 31.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.377 -0.827 . . . . 0.0 110.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -75.11 -10.28 13.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.639 -0.663 . . . . 0.0 110.256 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.57 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 15.6 mm -86.72 149.34 48.2 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.568 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 33.3 Cg_endo -56.19 156.36 21.05 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 121.555 1.503 . . . . 0.0 110.444 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -69.5 -51.05 39.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.26 -52.57 51.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.937 -1.102 . . . . 0.0 110.298 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.517 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -60.63 -55.18 36.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 7.7 mt -47.48 -34.69 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.008 . . . . 0.0 109.318 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE1' HD23 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.93 -61.9 1.6 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 110.482 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 mtpt -54.44 -25.21 23.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.376 -0.828 . . . . 0.0 112.581 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.586 ' HB1' ' CG ' ' A' ' 158' ' ' TYR . . . -110.49 -56.4 2.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.446 -1.409 . . . . 0.0 111.904 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.513 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 73.6 t80 -78.92 0.79 25.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 112.267 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.576 HG23 ' CE1' ' A' ' 19' ' ' PHE . 4.5 mt -138.81 -22.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.689 -1.257 . . . . 0.0 111.471 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.58 HD23 ' CE1' ' A' ' 19' ' ' PHE . 2.8 mt -100.54 -35.84 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.728 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.488 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.6 OUTLIER -117.02 88.76 2.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.75 -0.594 . . . . 0.0 109.613 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -113.56 -35.9 1.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB2' HG13 ' A' ' 41' ' ' VAL . 2.9 p30 -73.99 0.36 13.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.421 -1.046 . . . . 0.0 110.821 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 2.5 t30 -139.82 7.76 2.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.977 . . . . 0.0 109.935 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.611 HD22 ' CE2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -142.15 -14.66 0.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.894 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 8.4 m-30 -71.88 -57.04 4.26 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.739 -1.225 . . . . 0.0 110.435 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.21 -34.67 44.56 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.685 1.36 . . . . 0.0 110.732 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' C ' HG11 ' A' ' 33' ' ' VAL . 18.4 mttt -60.14 -15.21 21.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 0.0 109.98 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.521 ' CG1' ' HB2' ' A' ' 150' ' ' TYR . 6.4 m -130.56 -4.05 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -148.4 62.63 6.63 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.082 -1.011 . . . . 0.0 110.709 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.72 -24.19 41.33 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.844 1.444 . . . . 0.0 109.632 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -74.38 -13.04 60.67 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.573 -0.705 . . . . 0.0 109.227 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 62' ' ' LEU . . . -109.08 -63.05 1.39 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.166 -0.959 . . . . 0.0 110.396 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.426 HG21 ' N ' ' A' ' 39' ' ' SER . 0.8 OUTLIER -100.48 154.48 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.905 -1.122 . . . . 0.0 110.14 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.521 ' HB3' ' N ' ' A' ' 59' ' ' PRO . 54.4 p -108.49 -45.12 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.777 . . . . 0.0 110.187 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 p -174.59 -169.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 27' ' ' ASP . 7.6 p -147.84 162.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.953 . . . . 0.0 110.065 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 109.895 -179.787 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.408 HG21 ' N ' ' A' ' 53' ' ' ILE . 24.3 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.143 0.497 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.486 ' CD1' ' HG2' ' A' ' 70' ' ' ARG . 19.3 mm -126.74 124.04 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.61 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.52 144.81 49.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 0.0 110.424 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -111.29 111.26 22.19 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.94 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.527 ' HB ' ' CG2' ' A' ' 67' ' ' VAL . 5.2 mm -89.5 127.92 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.97 -1.081 . . . . 0.0 109.782 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 m -111.19 145.72 38.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 0.0 109.786 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.551 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 79.2 m-85 -121.18 155.12 58.65 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 110.775 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.521 ' N ' ' HB3' ' A' ' 39' ' ' SER . 48.9 Cg_endo -78.47 -169.05 0.7 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.155 1.608 . . . . 0.0 109.497 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 168.42 10.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 0.0 110.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.58 -52.7 2.36 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.551 ' CD1' ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.11 142.11 86.03 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.147 . . . . 0.0 109.972 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 48.8 Cg_endo -81.84 27.92 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.082 1.569 . . . . 0.0 111.08 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 63' ' ' PRO . 82.3 m-85 -156.08 141.09 17.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.042 -1.036 . . . . 0.0 110.21 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -75.68 -34.68 60.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 23.6 p90 -173.09 -178.12 1.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 27.8 m -157.71 125.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.307 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -85.35 131.52 34.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 108.794 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -130.29 141.54 50.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.867 -1.145 . . . . 0.0 111.664 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.486 ' HG2' ' CD1' ' A' ' 53' ' ' ILE . 60.6 mtm180 -110.69 132.34 54.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.589 -0.694 . . . . 0.0 109.129 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.583 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -73.08 -37.48 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.84 -1.163 . . . . 0.0 110.052 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.6 OUTLIER 78.76 -39.76 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.115 -0.366 . . . . 0.0 111.103 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 5.4 pt-20 173.34 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.71 -1.244 . . . . 0.0 111.077 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.532 HG22 ' CG1' ' A' ' 71' ' ' VAL . 39.3 t 60.59 139.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.37 -0.831 . . . . 0.0 109.657 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.23 164.38 13.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.073 -1.017 . . . . 0.0 110.87 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -142.03 -45.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -57.45 -34.42 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 78' ' ' ASN . 1.9 m120 -109.42 12.41 24.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.51 39.16 27.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.977 . . . . 0.0 109.786 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HG2' ' HG2' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -105.19 153.47 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.392 -0.817 . . . . 0.0 110.324 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 102' ' ' ILE . 15.4 t80 -144.62 111.38 5.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.808 . . . . 0.0 109.612 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.509 ' ND2' ' CG ' ' A' ' 101' ' ' GLU . 60.6 t-20 -121.2 126.85 50.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 18.8 p90 -139.67 154.67 47.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.66 164.19 11.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.098 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 86' ' ' ILE . 97.8 t -107.94 -14.88 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 85' ' ' VAL . 25.9 pt 33.02 -120.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.744 -0.597 . . . . 0.0 111.075 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.0 mp0 -84.47 164.25 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 110.227 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.51 149.66 19.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.63 -146.3 17.85 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.0 Cg_endo -81.86 23.59 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.092 1.575 . . . . 0.0 111.238 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.06 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.448 -0.783 . . . . 0.0 111.015 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' ASP . . . 102.53 -51.28 0.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 92' ' ' GLY . 6.4 m-20 -57.59 -155.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -1.149 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.468 ' O ' ' HB ' ' A' ' 122' ' ' THR . 73.0 p -81.42 2.37 28.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.559 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.587 ' CD2' ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -106.58 107.61 18.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.988 . . . . 0.0 109.932 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.454 ' OE1' ' HE3' ' A' ' 123' ' ' LYS . 20.3 tt0 -94.29 -37.02 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.836 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -135.21 165.29 25.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.975 -1.078 . . . . 0.0 110.655 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.595 HG22 ' CD1' ' A' ' 120' ' ' TYR . 13.7 mt -155.83 122.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -104.61 131.51 51.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.476 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -123.15 135.43 54.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.973 -1.079 . . . . 0.0 111.216 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.509 ' CG ' ' ND2' ' A' ' 82' ' ' ASN . 11.5 mt-10 -120.98 152.21 38.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 58.1 mt -140.05 159.08 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.919 -1.113 . . . . 0.0 110.482 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 1.1 ttmt -149.42 101.5 3.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.28 111.14 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.371 -0.831 . . . . 0.0 110.182 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.526 HG22 ' CE ' ' A' ' 115' ' ' LYS . 15.5 t -110.52 130.78 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.46 ' HB1' ' HB1' ' A' ' 15' ' ' ALA . . . -82.46 144.54 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -119.7 158.02 50.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.029 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.15 -38.39 21.75 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.988 1.52 . . . . 0.0 110.709 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 14.3 t70 -143.88 36.14 1.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 110.327 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.11 14.6 3.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.55 -101.04 0.86 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 69.8 m -161.52 138.48 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 0.0 110.204 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.1 mt -109.09 130.13 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.605 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 6.6 mp -95.84 89.52 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.643 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.526 ' CE ' HG22 ' A' ' 105' ' ' VAL . 2.1 mttm -64.36 118.05 8.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 108.352 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.512 HG23 ' ND2' ' A' ' 118' ' ' ASN . 43.4 mt -119.65 118.32 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 111.791 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.01 106.2 18.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.512 ' ND2' HG23 ' A' ' 116' ' ' ILE . 1.5 m-80 -90.12 92.99 9.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 111.171 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -87.74 135.2 33.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.595 ' CD1' HG22 ' A' ' 98' ' ' ILE . 2.5 m-85 -111.96 167.13 10.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.915 -1.115 . . . . 0.0 110.834 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.516 ' CE1' HG23 ' A' ' 2' ' ' VAL . 16.0 m-70 -139.35 89.53 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 94' ' ' THR . 3.0 p -92.8 -170.56 2.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 110.04 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.454 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -111.9 -3.01 14.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 110.091 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 124.67 -141.55 13.3 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' GLY . 3.5 t70 42.69 -139.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.111 . . . . 0.0 110.16 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -48.58 158.86 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.033 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -89.37 -137.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.574 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.637 HG22 ' CD2' ' A' ' 3' ' ' PHE . 90.8 t -105.97 154.23 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.806 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.544 ' N ' HG11 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -102.53 117.35 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.863 . . . . 0.0 109.892 179.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.16 -42.04 63.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -49.58 -42.33 44.15 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.109 -0.995 . . . . 0.0 108.692 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 21.7 mt-30 -67.52 -44.55 78.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.571 -0.706 . . . . 0.0 109.315 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.69 HG23 ' CE2' ' A' ' 5' ' ' TYR . 21.2 t -70.24 -6.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.738 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.9 tttt -98.0 -65.98 0.93 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.286 -0.884 . . . . 0.0 110.821 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -32.52 -45.75 0.12 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -51.45 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.286 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 134' ' ' LYS . 1.7 ttmt -55.86 -32.49 63.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.961 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.2 -52.93 28.71 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.477 -0.765 . . . . 0.0 109.618 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.463 ' HE3' ' CB ' ' A' ' 37' ' ' ALA . 39.7 mmm -54.64 -39.0 67.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.29 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.49 98.03 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.76 -39.52 87.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.283 . . . . 0.0 110.522 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -34.3 76.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.079 -1.013 . . . . 0.0 109.031 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.467 HD23 ' CB ' ' A' ' 34' ' ' ALA . 1.6 mm? -77.78 -24.09 49.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.335 -0.853 . . . . 0.0 109.085 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 18.3 tp -75.58 -33.89 60.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.429 ' HA ' ' HB3' ' A' ' 148' ' ' GLU . 8.6 ttt180 -80.93 -31.25 35.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.428 ' HB3' HG21 ' A' ' 33' ' ' VAL . . . -69.17 -45.59 69.61 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.529 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 96.7 t -76.19 -30.33 20.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.507 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.88 -37.82 88.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.444 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.462 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -89.13 -22.45 22.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.632 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.611 ' CE2' HD22 ' A' ' 29' ' ' LEU . 6.9 t80 -63.6 -38.32 90.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 109.672 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 50.9 mt -73.72 -19.9 60.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 4.8 mp -92.94 -19.21 21.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.98 -31.25 13.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.145 -0.972 . . . . 0.0 110.335 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -80.87 -165.0 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.868 . . . . 0.0 110.293 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 1.2 p -86.5 -57.21 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.493 ' N ' ' OG ' ' A' ' 155' ' ' SER . 13.6 m-20 -166.02 54.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.181 -0.95 . . . . 0.0 110.665 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.477 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -68.55 136.41 53.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.168 -0.958 . . . . 0.0 109.919 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.586 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 60.5 m-85 58.81 53.95 5.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.47 ' OD1' ' HD3' ' A' ' 17' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.275 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 3' ' ' PHE . 84.0 t -85.52 171.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -1.214 . . . . 0.0 110.567 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 97.9 m-85 -141.98 171.57 13.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.492 -0.755 . . . . 0.0 110.136 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -138.87 122.04 16.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.37 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CE2' HG23 ' A' ' 133' ' ' VAL . 36.5 m-85 -116.81 97.81 6.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 109.557 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.58 129.56 37.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.714 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.1 -174.0 4.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 3.0 pt-20 -166.43 166.3 16.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.636 ' O ' ' CB ' ' A' ' 10' ' ' THR . 10.8 t -175.1 -126.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.088 -1.008 . . . . 0.0 111.43 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.636 ' CB ' ' O ' ' A' ' 9' ' ' THR . 4.4 m 94.7 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 123.069 0.548 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 10' ' ' THR . 0.5 OUTLIER 169.43 -167.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.568 -1.333 . . . . 0.0 111.534 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.474 ' HA ' ' CA ' ' A' ' 111' ' ' GLY . 0.9 OUTLIER -72.89 -16.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.85 -0.531 . . . . 0.0 110.009 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.546 HG21 ' CD ' ' A' ' 14' ' ' PRO . 4.3 mm -63.26 145.56 96.85 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.001 -1.062 . . . . 0.0 109.058 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' CD ' HG21 ' A' ' 13' ' ' ILE . 31.6 Cg_endo -54.75 148.53 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.848 1.446 . . . . 0.0 111.266 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -62.29 -43.57 98.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.641 -0.662 . . . . 0.0 110.789 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.46 -51.76 68.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 110.814 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.67 -55.51 29.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 109.769 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.591 HD11 ' CG2' ' A' ' 10' ' ' THR . 0.3 OUTLIER -53.3 -27.04 20.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.709 179.094 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.658 ' CE1' ' CD2' ' A' ' 24' ' ' LEU . 1.1 t80 -73.45 -70.98 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.589 . . . . 0.0 110.478 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.519 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 11.1 mtpt -55.1 -22.43 16.45 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.69 -0.631 . . . . 0.0 112.636 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.569 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -102.52 -48.13 4.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.0 112.188 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.0 t80 -95.46 9.79 38.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.807 -1.183 . . . . 0.0 112.017 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.558 ' CG2' HD22 ' A' ' 24' ' ' LEU . 7.1 mt -143.39 -27.89 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.711 -1.243 . . . . 0.0 110.838 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.658 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 6.6 mt -106.22 -17.36 14.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.795 -1.19 . . . . 0.0 109.292 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 3.0 t0 -132.11 94.97 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.898 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.485 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -120.16 -35.84 0.85 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.78 6.6 10.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.97 -1.312 . . . . 0.0 110.147 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 5.7 t30 -143.15 25.06 1.77 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.572 HD22 ' CE2' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -159.33 -32.21 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.136 -178.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.57 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 12.2 m-30 -60.26 -55.36 46.1 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 0.0 110.233 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.6 Cg_endo -65.53 -35.92 36.3 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.539 1.284 . . . . 0.0 110.823 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -62.92 -15.49 55.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.507 ' CG1' ' CD1' ' A' ' 150' ' ' TYR . 17.8 m -128.66 -2.4 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 110.553 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.43 68.95 6.57 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.949 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.05 -13.59 38.58 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.879 1.463 . . . . 0.0 109.248 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -82.76 -19.77 37.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.66 -54.91 2.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.33 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.61 150.71 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.053 -1.029 . . . . 0.0 110.319 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.406 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 t -110.59 -37.26 5.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.994 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -173.07 -179.58 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.518 HG11 ' CD1' ' A' ' 56' ' ' ILE . 91.6 t -143.65 165.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.431 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.935 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.284 0.564 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.0 mm -101.86 119.04 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.955 . . . . 0.0 110.117 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -121.86 147.39 46.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 17.0 tttt -115.93 107.29 14.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.518 ' CD1' HG11 ' A' ' 41' ' ' VAL . 4.8 mm -82.58 147.23 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.479 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.09 140.45 52.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.504 -0.747 . . . . 0.0 109.518 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.495 ' HB3' HD13 ' A' ' 62' ' ' LEU . 69.3 m-85 -116.54 142.06 28.98 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 39' ' ' SER . 48.5 Cg_endo -74.6 -171.18 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.014 1.534 . . . . 0.0 110.143 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.8 160.77 13.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 110.451 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -41.01 2.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.495 HD13 ' HB3' ' A' ' 58' ' ' PHE . 3.0 mt -83.14 164.16 47.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.236 . . . . 0.0 110.321 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 46.0 Cg_endo -76.92 -82.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.238 1.651 . . . . 0.0 111.207 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 m-30 -56.51 161.12 2.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.018 . . . . 0.0 110.716 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.21 -22.74 18.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 110.445 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 16.3 p90 -173.78 -176.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.928 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 13.5 m -160.42 161.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.396 -0.815 . . . . 0.0 110.734 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -119.72 117.45 28.27 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD2' ' CD1' ' A' ' 83' ' ' TYR . 15.6 t70 -120.37 153.55 36.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.969 -1.082 . . . . 0.0 111.542 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.69 126.99 51.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.67 -0.643 . . . . 0.0 109.409 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 82' ' ' ASN . 6.1 p -61.01 -22.61 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.919 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 45.13 52.07 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.001 . . . . 0.0 109.564 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.5 mt-10 58.25 154.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 110.172 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.45 120.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -74.19 178.05 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.921 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.403 ' O ' ' HD1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -152.65 -41.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 110.773 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -52.22 -48.72 64.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.638 -1.289 . . . . 0.0 110.44 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -105.46 19.72 20.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.611 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 6.7 m-30 51.86 75.04 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.276 -0.89 . . . . 0.0 110.557 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 17.5 mtmt -131.55 124.77 30.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.428 ' HB3' ' HB ' ' A' ' 102' ' ' ILE . 2.7 t80 -117.08 113.22 22.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' VAL . 88.1 m-20 -112.0 105.33 13.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 110.719 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' OD2' ' A' ' 69' ' ' ASP . 1.4 p90 -122.46 169.55 10.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -151.46 140.92 21.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.868 -1.145 . . . . 0.0 111.708 -179.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.499 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 44.5 t -95.93 145.14 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.54 ' CD1' ' N ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -150.99 24.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.74 -1.225 . . . . 0.0 111.654 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.58 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -172.89 147.66 1.7 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.612 -1.305 . . . . 0.0 111.066 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' GLU . . . 49.79 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.541 ' CA ' HG11 ' A' ' 67' ' ' VAL . . . 78.44 -134.31 14.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.27 -17.15 31.23 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.108 1.583 . . . . 0.0 110.634 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 87' ' ' GLU 0.31 4.7 mt -66.66 114.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.13 89.7 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.1 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.1 t0 62.45 5.84 1.75 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -1.087 . . . . 0.0 111.998 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -135.32 -78.74 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.765 -1.209 . . . . 0.0 109.992 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -78.56 108.42 11.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.974 . . . . 0.0 109.691 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -90.08 -45.4 9.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.419 ' C ' HG13 ' A' ' 98' ' ' ILE . 52.4 mttt -119.84 147.4 44.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 98' ' ' ILE . 45.9 mt -152.17 110.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.727 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 1.3 t -93.04 157.05 16.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.307 -0.871 . . . . 0.0 109.228 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.65 108.43 3.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 110.407 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 102' ' ' ILE . 17.9 mt-10 -97.91 156.06 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 101' ' ' GLU . 4.5 mt -140.84 146.95 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.287 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 7.4 ttmt -139.04 115.67 10.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.446 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 1.3 mp -92.27 129.2 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.57 124.5 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 110.629 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.75 142.03 49.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 111' ' ' GLY . 61.0 p -94.18 153.19 40.7 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.82 -7.1 15.65 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -99.3 -85.85 0.38 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.235 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.41 87.36 0.09 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.474 ' CA ' ' HA ' ' A' ' 12' ' ' VAL . . . 153.98 146.91 4.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.521 ' O ' ' HB ' ' A' ' 10' ' ' THR . 77.3 p -104.08 152.53 21.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.389 -1.065 . . . . 0.0 109.186 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 2.9 mt -122.01 156.25 26.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.604 ' N ' ' OG1' ' A' ' 10' ' ' THR . 0.5 OUTLIER -115.05 137.92 51.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.115 -0.991 . . . . 0.0 109.862 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 42.7 mttm -122.68 106.97 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.2 mp -115.67 139.88 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.112 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.33 112.82 22.08 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.56 102.94 14.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 111.43 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -83.7 111.74 19.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.94 . . . . 0.0 109.059 178.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.544 ' CD2' HD23 ' A' ' 95' ' ' LEU . 3.4 m-85 -98.32 104.27 16.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 111.048 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -95.76 96.18 8.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.522 -0.736 . . . . 0.0 109.407 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 19.5 p -78.36 -149.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.496 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.97 53.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.635 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 71.48 -83.55 0.45 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 126' ' ' HIS . 10.9 t70 -39.54 115.89 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -1.018 . . . . 0.0 110.514 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.532 ' HB3' ' CG2' ' A' ' 94' ' ' THR . 0.1 OUTLIER 53.98 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.966 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 61.8 mt-10 -123.86 -144.47 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.527 ' CG1' ' OH ' ' A' ' 5' ' ' TYR . 98.9 t -95.08 133.03 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.265 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.5 mtmt -98.57 123.57 42.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.944 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.96 -46.37 8.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 110.305 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -52.17 -46.27 65.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 109.463 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.7 77.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 108.826 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.591 HG23 ' CE2' ' A' ' 5' ' ' TYR . 72.6 t -72.59 -19.36 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.794 0.807 . . . . 0.0 109.284 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.6 tttp -84.67 -60.13 2.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.507 -0.746 . . . . 0.0 111.2 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.79 -51.81 1.28 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 110.673 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.2 m -57.0 -47.37 80.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 110.162 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -64.44 -21.73 66.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 8.0 tt0 -77.23 -44.64 29.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.728 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.429 ' HE3' HD12 ' A' ' 62' ' ' LEU . 72.1 mmm -66.36 -37.88 86.3 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.69 -39.75 93.79 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -70.96 -40.55 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.814 -1.404 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -62.7 -40.61 97.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 108.971 179.398 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 147' ' ' VAL . 1.1 mm? -71.48 -33.39 69.24 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.591 ' HA ' ' CE1' ' A' ' 22' ' ' PHE . 45.0 tp -62.28 -40.63 96.9 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.096 -1.002 . . . . 0.0 109.038 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.062 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.83 -55.14 33.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.105 -0.997 . . . . 0.0 109.546 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 143' ' ' LEU . 48.5 t -63.36 -37.03 78.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -55.99 -46.13 78.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 110.132 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -83.75 -19.25 35.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.572 ' CE2' HD22 ' A' ' 29' ' ' LEU . 9.8 t80 -66.64 -39.71 88.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.539 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.495 HD22 ' CD2' ' A' ' 150' ' ' TYR . 80.8 mt -62.33 -33.11 74.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.027 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 5.2 mp -77.65 -42.53 34.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.569 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.22 80.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.148 -0.97 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.26 -25.43 39.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.7 t 44.79 44.01 7.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 110.029 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -166.2 -41.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.525 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -59.05 133.81 56.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 48.0 m-85 56.43 68.8 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.341 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.166 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.3 t -69.21 170.88 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -1.144 . . . . 0.0 110.691 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.595 ' CG ' HG22 ' A' ' 128' ' ' VAL . 24.1 m-85 -126.07 154.34 43.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -125.63 97.13 5.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.063 -1.023 . . . . 0.0 111.205 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.575 ' CD2' HG12 ' A' ' 133' ' ' VAL . 37.4 m-85 -100.94 81.63 2.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.286 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -84.15 113.94 21.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.81 . . . . 0.0 110.96 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.426 HG22 ' HB ' ' A' ' 116' ' ' ILE . 5.1 t -132.97 -176.37 4.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.4 -0.812 . . . . 0.0 109.624 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -157.01 153.4 27.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.115 -0.99 . . . . 0.0 110.222 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.79 156.23 44.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 110.12 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.32 152.84 29.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.416 ' CB ' HD13 ' A' ' 18' ' ' LEU . 45.6 t -142.0 135.72 29.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.72 -3.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.708 -0.62 . . . . 0.0 109.977 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.58 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 8.8 mm -95.77 149.12 35.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.558 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 33.0 Cg_endo -56.7 162.72 8.11 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.952 1.501 . . . . 0.0 110.437 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -71.53 -66.43 0.63 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 111.025 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -41.65 -53.63 3.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.558 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -59.63 -51.71 68.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.979 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.58 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 5.9 mt -51.15 -27.04 7.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 108.693 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.574 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -74.1 -68.63 0.5 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.447 0.642 . . . . 0.0 109.991 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 11.6 mtmm -47.66 -36.17 10.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.855 -1.153 . . . . 0.0 111.322 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -90.35 -67.99 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.951 -1.093 . . . . 0.0 109.172 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.694 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 20.6 t80 -82.94 150.39 26.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 108.989 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 8.3 mt 82.4 -47.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 CA-C-O 121.24 0.543 . . . . 0.0 110.327 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.574 HD13 ' CD1' ' A' ' 19' ' ' PHE . 17.2 mt -97.74 -50.8 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -104.41 89.81 3.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.031 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -122.14 -33.54 0.89 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 41' ' ' VAL . 52.8 m-20 -71.82 -1.25 13.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.101 -1.235 . . . . 0.0 110.615 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -123.88 13.02 9.15 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.084 -1.01 . . . . 0.0 108.829 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.482 ' O ' ' C ' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -146.61 -51.41 0.22 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 110.971 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.542 ' HB2' ' CD ' ' A' ' 31' ' ' PRO . 5.3 m-30 -29.81 -58.71 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.542 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -67.82 -38.99 12.26 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.609 1.321 . . . . 0.0 111.414 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 12.7 mmtt -66.97 -66.61 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.102 -0.999 . . . . 0.0 111.219 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.551 ' CG1' ' HB2' ' A' ' 150' ' ' TYR . 16.5 m -70.69 -19.94 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.254 -0.904 . . . . 0.0 111.02 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -127.09 65.75 65.4 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.383 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.69 -6.44 17.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.859 1.452 . . . . 0.0 110.128 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -96.45 0.75 50.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.02 -50.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 110.778 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 30' ' ' PHE . 11.3 mm -109.15 163.17 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 110.613 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.4 OUTLIER -138.07 -43.69 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 0.0 110.138 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 39' ' ' SER . 11.3 t -178.28 133.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.343 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 3.6 p -92.73 146.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 30.6 mt-10 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.112 0.482 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.49 HG22 HD11 ' A' ' 53' ' ' ILE . 21.4 mm -83.05 130.69 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.913 . . . . 0.0 109.886 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 2.5 ptpp? -132.98 152.86 51.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 6.9 ttmt -120.29 88.57 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.578 HG23 ' CE1' ' A' ' 58' ' ' PHE . 1.7 mp -64.73 123.13 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.145 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -109.44 102.53 11.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.612 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 3.0 m-85 -64.08 173.81 1.31 Allowed Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.099 -1.001 . . . . 0.0 109.231 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -75.72 -172.45 1.32 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.706 1.372 . . . . 0.0 109.715 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -77.24 168.15 20.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.546 ' N ' ' HG2' ' A' ' 60' ' ' GLU . . . 104.43 -39.86 2.67 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 58' ' ' PHE . 13.2 mt -62.13 157.94 49.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.106 -1.232 . . . . 0.0 110.478 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.55 -18.63 19.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.132 1.596 . . . . 0.0 110.473 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.53 -161.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.93 . . . . 0.0 110.425 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 12.0 tptt -121.44 -24.08 5.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 53.6 p90 -179.32 -152.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 109.906 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.612 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 9.1 p -172.04 120.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 111.191 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 2.8 mttp -98.01 137.82 36.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.471 -0.768 . . . . 0.0 109.047 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 1.5 m-20 -142.18 148.84 38.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HD2' HD13 ' A' ' 53' ' ' ILE . 25.9 ttt180 -108.5 130.0 55.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.536 -0.727 . . . . 0.0 109.392 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 -24.18 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 16.3 m-20 45.96 43.79 10.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.972 . . . . 0.0 109.942 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 11.4 mt-10 58.27 151.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.464 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.594 HG13 ' CD2' ' A' ' 81' ' ' TYR . 6.4 m -138.78 148.98 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' CB ' ' HB3' ' A' ' 80' ' ' LYS . 4.2 t0 -69.08 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.054 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.35 -47.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 m -54.24 -35.91 62.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.411 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 1.9 m-80 -115.31 17.15 16.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 110.199 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.569 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 10.1 m-30 55.46 57.48 5.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HB3' ' CB ' ' A' ' 75' ' ' ASP . 30.1 tttm -118.89 98.54 6.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.833 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.606 ' CG ' ' CG2' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -91.16 177.94 6.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.122 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 81' ' ' TYR . 22.5 p-10 -178.82 142.5 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.501 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 12.4 p90 -154.39 172.87 17.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.388 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -136.1 149.99 48.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.817 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.474 ' CG2' ' HB ' ' A' ' 98' ' ' ILE . 4.2 m -110.21 94.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.461 -0.774 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.471 ' C ' ' CD1' ' A' ' 91' ' ' ILE . 1.3 pp -100.65 -2.63 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.778 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.415 ' N ' HD13 ' A' ' 91' ' ' ILE . 1.9 tt0 -155.83 140.31 16.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . 65.63 -176.02 15.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.472 ' CA ' HG21 ' A' ' 67' ' ' VAL . . . 76.51 -141.56 26.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.6 -6.69 18.6 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.092 1.575 . . . . 0.0 111.019 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.502 HG22 HD11 ' A' ' 91' ' ' ILE 0.292 1.8 mt -63.31 117.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.104 -0.998 . . . . 0.0 110.362 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 137.23 42.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' ' OG1' ' A' ' 94' ' ' THR . 0.9 OUTLIER 179.19 96.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -1.191 . . . . 0.0 110.546 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 40.0 p 42.35 28.3 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 110.63 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.575 HD12 ' CD2' ' A' ' 120' ' ' TYR . 6.5 mt -144.24 74.65 1.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 95' ' ' LEU . 10.3 tp10 -42.42 -58.33 2.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 110.56 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.529 ' CG ' ' HB2' ' A' ' 121' ' ' HIS . 28.8 pttt -144.53 162.37 36.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.516 HG22 ' CE1' ' A' ' 120' ' ' TYR . 39.7 mt -145.81 138.67 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 110.513 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.9 m -117.23 152.36 34.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 109.175 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -144.08 139.89 29.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.723 -1.236 . . . . 0.0 111.37 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.414 ' O ' HG13 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -117.81 154.58 31.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.396 179.19 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 101' ' ' GLU . 1.3 mp -144.25 136.8 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -135.79 105.6 6.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.778 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.513 HD12 ' CD1' ' A' ' 23' ' ' ILE . 4.4 mp -81.12 109.94 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 110.532 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.425 HG22 ' HE3' ' A' ' 115' ' ' LYS . 86.5 t -101.49 131.19 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.17 129.93 34.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.867 . . . . 0.0 110.053 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 17.7 p -86.46 164.41 37.94 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 49.0 Cg_endo -66.76 81.06 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.114 1.586 . . . . 0.0 110.371 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 60.5 t0 58.01 65.01 1.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 110.166 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.11 27.62 0.13 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.21 -165.48 31.53 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -131.45 174.9 9.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.335 -1.097 . . . . 0.0 110.041 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CG2' ' CD ' ' A' ' 8' ' ' GLU . 26.2 mt -136.75 121.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.989 . . . . 0.0 110.686 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.529 ' HB2' ' CG2' ' A' ' 9' ' ' THR . 7.6 mt -86.17 93.42 9.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.891 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HE3' HG22 ' A' ' 105' ' ' VAL . 4.1 mttm -69.22 117.99 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.302 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.426 ' HB ' HG22 ' A' ' 7' ' ' THR . 94.3 mt -109.2 146.62 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.87 -1.144 . . . . 0.0 111.84 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.18 94.58 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -93.52 100.28 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 112.518 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -82.3 131.2 35.23 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.575 ' CD2' HD12 ' A' ' 95' ' ' LEU . 3.2 m-85 -110.88 112.85 24.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.775 -1.203 . . . . 0.0 110.715 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.529 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 63.2 m-70 -92.83 103.24 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.576 HG22 ' CD1' ' A' ' 3' ' ' PHE . 4.5 p -102.13 153.35 20.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.813 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 26.39 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.012 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.43 -162.74 14.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.33 -38.25 15.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -1.168 . . . . 0.0 110.309 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -74.34 -172.51 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.387 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 60.1 mp0 -124.0 -169.98 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 110.346 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.595 HG22 ' CG ' ' A' ' 3' ' ' PHE . 55.7 t -69.27 150.28 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 130' ' ' ALA . 3.9 mtmm -105.01 116.01 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.765 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.64 -52.79 4.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.26 -0.9 . . . . 0.0 110.366 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.6 -46.79 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 109.77 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.463 ' OE1' HD11 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -62.14 -45.03 95.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 108.996 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.575 HG12 ' CD2' ' A' ' 5' ' ' TYR . 53.0 t -62.42 -16.29 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.269 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.6 ttmt -86.42 -60.59 1.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.489 -0.757 . . . . 0.0 110.683 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -41.32 -50.16 3.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 110.092 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.6 t -56.11 -44.32 78.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 110.012 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -27.12 68.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.458 ' O ' ' OG1' ' A' ' 142' ' ' THR . 2.0 tt0 -77.25 -33.9 55.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.422 -0.799 . . . . 0.0 109.924 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.443 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.32 -39.63 65.11 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.602 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.17 85.73 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.32 -32.44 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.273 . . . . 0.0 109.743 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 1.3 p -70.4 -34.81 72.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.247 -0.908 . . . . 0.0 108.802 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.536 HD13 ' CG ' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -71.17 -53.69 13.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.188 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.462 HD12 HD13 ' A' ' 114' ' ' LEU . 9.4 tp -51.4 -39.08 56.51 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -65.09 -38.21 90.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.569 -0.707 . . . . 0.0 109.426 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . . . -61.48 -60.1 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 21.6 t -61.81 -24.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' HD11 ' A' ' 152' ' ' LEU . 1.5 tt0 -68.14 -48.02 66.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.05 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.9 t -81.26 -17.05 50.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.551 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 9.8 t80 -69.7 -43.93 71.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.713 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 28.1 mt -63.95 -26.05 68.41 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.784 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -80.87 -42.47 21.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.098 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.12 -50.93 66.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.107 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -76.88 -162.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.195 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 6.5 t -92.39 54.19 2.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.537 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER 60.81 53.3 3.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.883 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 156' ' ' ASP . . . -40.91 166.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.716 -0.615 . . . . 0.0 110.761 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 85.4 m-85 57.75 48.27 14.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.447 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.206 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.588 HG12 ' CE1' ' A' ' 121' ' ' HIS . 92.5 t -101.03 153.27 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.156 -1.202 . . . . 0.0 110.426 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.588 ' CD1' HG21 ' A' ' 128' ' ' VAL . 92.3 m-85 -116.07 151.41 35.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.507 -0.745 . . . . 0.0 109.895 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -117.33 99.47 7.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 110.246 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.611 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 45.6 m-85 -97.18 99.93 11.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.419 ' OE1' ' HB3' ' A' ' 117' ' ' SER . 3.3 mt-10 -109.42 136.3 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.97 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 -171.51 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.386 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' OE1' ' CG2' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -165.21 156.31 14.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 110.705 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.553 HG22 ' CD2' ' A' ' 144' ' ' LEU . 0.9 OUTLIER -129.12 173.59 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.329 -0.857 . . . . 0.0 110.155 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.05 143.28 51.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.155 -0.966 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -140.25 147.48 40.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.101 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -21.35 15.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.601 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 36.7 mm -77.16 145.92 73.98 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.035 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 32.7 Cg_endo -56.72 157.93 18.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.91 1.479 . . . . 0.0 110.313 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.577 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -69.48 -47.93 62.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.471 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.574 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -56.33 -44.92 80.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.942 -1.099 . . . . 0.0 110.782 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 1.3 mtt85 -68.78 -49.95 54.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.936 -1.103 . . . . 0.0 109.777 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.601 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 mt -52.08 -30.86 27.88 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.28 1.038 . . . . 0.0 108.518 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.691 ' CE1' ' CD2' ' A' ' 24' ' ' LEU . 8.9 t80 -72.44 -72.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.554 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 11.2 mtpt -45.1 -20.56 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 112.102 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.583 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -115.98 -61.83 1.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.537 -1.352 . . . . 0.0 112.11 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 9.8 t80 -65.51 -80.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.341 -1.475 . . . . 0.0 110.211 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.581 ' CG2' HD22 ' A' ' 24' ' ' LEU . 2.7 mt -43.98 -71.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.858 -1.151 . . . . 0.0 108.495 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.691 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -61.68 -179.47 0.19 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER 66.11 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.126 -0.984 . . . . 0.0 108.95 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' CG ' ' A' ' 25' ' ' ASP . . . 52.4 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 O-C-N 120.723 -1.235 . . . . 0.0 111.08 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.5 p30 -47.46 -20.37 0.23 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -1.092 . . . . 0.0 111.524 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.542 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 53.5 t30 -110.38 38.89 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 109.779 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -161.07 -49.34 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.465 -0.772 . . . . 0.0 110.56 -179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CD1' HD11 ' A' ' 143' ' ' LEU . 8.0 m-30 -56.39 -53.64 61.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 0.0 111.531 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.1 -4.38 8.93 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 O-C-N 123.293 1.154 . . . . 0.0 111.83 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 13.6 mmtt -109.33 -66.24 1.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.801 -1.187 . . . . 0.0 110.692 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 150' ' ' TYR . 13.7 m -75.72 -14.19 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -139.87 64.3 27.82 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.04 -1.038 . . . . 0.0 110.849 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.1 -8.5 22.92 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 109.764 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.4 tt0 -86.28 -17.4 34.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.564 -0.71 . . . . 0.0 109.432 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' HB2' ' CE ' ' A' ' 139' ' ' MET . . . -108.65 -37.99 5.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.451 HG21 ' N ' ' A' ' 39' ' ' SER . 2.2 mp -127.7 164.87 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.451 ' N ' HG21 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -138.14 -47.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 110.284 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.9 t -161.9 130.17 4.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.118 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 55' ' ' LYS . 54.2 t -95.84 129.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.138 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 14.8 tt0 . . . . . 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.227 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 53' ' ' ILE . 1.1 m . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.69 0.757 . . . . 0.0 111.641 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 52' ' ' THR . 20.5 mm 33.36 101.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.948 0.88 . . . . 0.0 111.932 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -134.43 158.07 44.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -129.39 142.27 50.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.472 -1.393 . . . . 0.0 111.839 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.53 ' HB ' ' CG1' ' A' ' 67' ' ' VAL . 1.2 mp -121.64 115.85 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 101.03 10.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.831 . . . . 0.0 110.817 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.598 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . 8.6 m-85 -56.46 177.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.229 -0.919 . . . . 0.0 108.933 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -75.85 145.84 29.06 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.387 1.204 . . . . 0.0 109.962 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' PRO . 1.1 tt0 -41.88 165.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.62 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.27 36.13 15.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.561 ' CD1' ' HB2' ' A' ' 58' ' ' PHE . 3.4 mt -106.31 156.03 37.63 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.127 -1.219 . . . . 0.0 110.561 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.74 -30.77 9.17 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.081 1.569 . . . . 0.0 109.199 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 20.0 m-30 -101.23 -96.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.632 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 179.92 -35.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.806 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 51.5 p90 -179.54 -158.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.375 -0.828 . . . . 0.0 109.687 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.578 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 7.0 p -163.16 108.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.565 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -99.05 160.91 13.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 2.6 p-10 -173.15 139.3 0.79 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.841 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -87.38 146.71 25.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.043 -1.036 . . . . 0.0 110.341 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG11 ' N ' ' A' ' 72' ' ' ASP . 1.2 t -102.22 167.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.307 -0.87 . . . . 0.0 109.706 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.559 ' N ' HG11 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -140.55 56.68 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 110.235 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 74' ' ' VAL . 1.9 mt-10 63.19 177.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.927 . . . . 0.0 109.918 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 73' ' ' GLU . 5.2 t -151.06 137.85 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 111.063 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.453 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -80.43 179.98 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.141 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.489 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 4.1 m-70 -136.08 -49.86 0.69 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.786 -1.196 . . . . 0.0 111.114 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -49.91 -57.6 7.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.908 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -96.0 21.28 8.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.087 -1.008 . . . . 0.0 110.843 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 15' ' ' ALA . 11.4 m-85 41.24 73.74 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 0.0 109.912 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 2.6 tttt -117.76 106.74 13.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 110.746 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.48 ' CD2' HG22 ' A' ' 23' ' ' ILE . 11.0 t80 -111.42 105.47 14.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -113.46 153.88 27.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.861 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.536 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 33.7 p90 -165.29 173.4 11.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 109.924 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.97 121.94 26.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.187 -0.946 . . . . 0.0 111.086 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 85' ' ' VAL . 15.5 m -95.51 122.52 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.487 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.1 pp -123.19 -0.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 8.2 mt-10 -158.33 150.85 22.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.493 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.475 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 90.6 -179.45 43.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.65 -145.74 31.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 51.0 Cg_endo -85.93 31.49 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.55 . . . . 0.0 110.834 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -33.21 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.468 0.652 . . . . 0.0 110.905 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.02 -168.38 40.22 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 11.2 m-20 -87.68 -9.75 53.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -1.142 . . . . 0.0 110.47 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 58.8 p -101.64 41.68 1.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.509 HD23 ' CG1' ' A' ' 98' ' ' ILE . 1.5 mt 169.16 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.13 -45.94 3.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 110.764 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 14.3 mtpp -131.47 143.13 50.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 110.514 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.509 ' CG1' HD23 ' A' ' 95' ' ' LEU . 81.3 mt -140.21 118.4 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.998 -1.064 . . . . 0.0 110.564 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.51 160.43 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 109.793 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.536 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 20.8 t-20 -149.35 145.3 26.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.027 -1.045 . . . . 0.0 111.257 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -132.46 129.2 38.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.522 -0.736 . . . . 0.0 109.078 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 26.8 mm -113.38 135.92 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 0.0 110.396 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.465 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 2.4 mtpm? -139.0 105.39 5.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 110.301 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.516 HD13 ' CD1' ' A' ' 23' ' ' ILE . 72.1 mt -83.84 148.89 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 110.05 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.95 128.71 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.03 132.93 34.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.128 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -107.43 152.44 41.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.414 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.75 -21.79 44.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.291 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.15 -50.77 69.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 142.35 54.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.46 -167.99 34.65 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -148.69 145.43 27.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -1.124 . . . . 0.0 109.856 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.515 ' CG2' ' OE1' ' A' ' 8' ' ' GLU . 8.9 mt -109.14 135.19 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 5.5 mp -99.18 108.47 21.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -0.906 . . . . 0.0 110.022 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.79 118.76 26.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 109.749 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.3 mt -110.04 121.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.419 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -118.66 100.86 7.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 109.35 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -103.31 115.6 30.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.168 -0.957 . . . . 0.0 111.078 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.443 ' CG ' ' NE2' ' A' ' 121' ' ' HIS . 1.9 tptt -95.7 115.65 27.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.408 -0.808 . . . . 0.0 108.951 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.539 ' HB3' ' CG2' ' A' ' 128' ' ' VAL . 5.4 m-85 -90.41 147.2 23.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.117 -0.989 . . . . 0.0 111.012 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.588 ' CE1' HG12 ' A' ' 2' ' ' VAL . 73.4 m-70 -133.71 91.48 2.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.604 -0.685 . . . . 0.0 109.21 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.431 ' CG2' HG21 ' A' ' 128' ' ' VAL . 9.7 p -83.03 -179.49 7.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.638 -0.664 . . . . 0.0 110.465 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -84.87 6.1 26.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.094 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 101.72 -166.23 18.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 t0 50.15 -91.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 110.29 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' GLY . 62.7 m-70 -66.24 156.63 33.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 110.145 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 27.0 mt-10 -107.99 169.45 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 3' ' ' PHE . 55.7 t -59.09 151.27 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.054 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 130' ' ' ALA . 46.0 mtmt -96.06 117.22 30.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 0.0 110.419 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -46.13 -38.24 7.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -56.4 -47.59 78.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.838 . . . . 0.0 109.38 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.455 ' OE1' ' HB2' ' A' ' 90' ' ' PRO . 21.5 mt-30 -61.78 -38.31 87.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.611 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 96.1 t -68.78 -19.5 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.768 0.794 . . . . 0.0 109.421 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -85.99 -66.89 0.85 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.463 -0.773 . . . . 0.0 110.921 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -34.47 -40.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.482 -0.761 . . . . 0.0 110.88 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 t -64.36 -52.79 56.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -54.86 -45.88 74.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.128 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 139' ' ' MET . 3.2 mt-10 -56.72 -59.58 4.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.196 -0.94 . . . . 0.0 109.743 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.497 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -44.99 -49.19 11.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.058 -1.027 . . . . 0.0 109.651 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.2 92.84 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 142' ' ' THR . 35.2 tt0 -74.78 -65.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.313 . . . . 0.0 110.501 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -42.28 -46.45 4.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.587 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 30' ' ' PHE . 3.5 mm? -63.88 -55.23 24.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 109.84 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.553 ' CD2' HG22 ' A' ' 9' ' ' THR . 22.5 tp -40.45 -46.17 2.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.432 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -43.33 92.07 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.804 . . . . 0.0 109.55 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.496 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -56.2 -61.75 2.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 110.085 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.474 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 24.7 t -67.49 -18.26 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.815 . . . . 0.0 110.644 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 18.1 tt0 -70.98 -47.1 60.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 0.0 109.557 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 -21.77 31.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.547 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 10.6 t80 -57.6 -49.52 76.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.475 -0.765 . . . . 0.0 109.699 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 150' ' ' TYR . 65.3 mt -54.98 -25.71 31.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.582 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -84.64 -33.16 23.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.892 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.32 -46.82 69.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.22 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 154' ' ' HIS . 19.2 m-70 -90.27 -24.75 20.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' HIS . 1.4 p 44.24 30.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.312 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -152.34 15.32 0.61 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.598 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -110.5 131.53 54.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.076 -1.015 . . . . 0.0 110.112 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.583 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 37.7 m-85 63.88 9.33 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.397 -0.814 . . . . 0.0 110.458 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.189 -179.803 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.464 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.528 HG11 ' N ' ' A' ' 3' ' ' PHE . 97.2 t -72.62 151.14 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -1.083 . . . . 0.0 110.347 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 56.9 m-85 -109.74 131.7 54.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 109.607 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -95.25 95.53 8.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.886 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 3' ' ' PHE . 23.2 m-30 -101.6 95.75 6.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.83 . . . . 0.0 110.24 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -88.01 126.37 35.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.303 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 t -145.4 178.33 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.18 . . . . 0.0 111.191 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -168.43 159.19 10.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.543 -0.723 . . . . 0.0 109.688 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 HD23 ' A' ' 144' ' ' LEU . 1.9 t -132.16 162.63 30.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.458 HG21 HG12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -113.48 142.57 45.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.435 ' HB3' HD13 ' A' ' 18' ' ' LEU . 48.0 t -140.73 143.36 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.983 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -72.47 -2.04 2.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 109.968 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.577 ' CG2' ' NE ' ' A' ' 17' ' ' ARG . 19.2 mm -91.95 146.42 32.84 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 110.243 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -57.39 153.82 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 0.0 110.162 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' CB ' HG23 ' A' ' 104' ' ' ILE . . . -62.81 -59.47 4.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -0.996 . . . . 0.0 110.479 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -42.96 -59.92 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 151' ' ' LEU . 6.7 ttp180 -53.03 -57.71 9.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.554 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 10.7 mt -45.6 -32.71 2.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CE1' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -72.41 -55.54 6.88 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 110.687 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -60.1 -33.41 72.07 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB1' ' CG ' ' A' ' 158' ' ' TYR . . . -107.74 -34.78 6.87 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.264 -1.523 . . . . 0.0 112.551 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 81.3 t80 -102.53 9.45 39.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.731 -1.231 . . . . 0.0 111.873 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.567 HG23 ' CE1' ' A' ' 19' ' ' PHE . 29.2 mm -142.98 -26.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.823 -1.173 . . . . 0.0 110.968 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 19' ' ' PHE . 4.1 mt -103.8 -35.89 8.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.713 -1.242 . . . . 0.0 109.16 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.487 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -112.97 41.08 2.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.585 -0.697 . . . . 0.0 110.535 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.24 -30.36 62.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD1' ' CG1' ' A' ' 41' ' ' VAL . 3.2 t70 -69.1 -6.41 28.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 2.5 t30 -126.01 13.91 7.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.571 HD12 ' CD2' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -130.98 -43.91 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.573 ' CD1' HD11 ' A' ' 143' ' ' LEU . 7.6 m-30 -57.58 -54.41 55.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 111.197 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -66.97 -15.21 46.34 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.34 1.179 . . . . 0.0 111.293 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 4.8 mptt -91.08 -71.81 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 110.736 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.579 ' CG1' ' CD1' ' A' ' 150' ' ' TYR . 17.4 m -75.52 -18.25 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.839 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.463 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -118.59 60.6 4.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.624 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.9 Cg_endo -67.61 -19.91 47.63 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.934 1.492 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 2.2 tt0 -82.62 -16.42 48.41 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.662 0.744 . . . . 0.0 109.073 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.588 ' CB ' ' CD2' ' A' ' 143' ' ' LEU . . . -100.18 -63.15 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.286 -0.884 . . . . 0.0 110.574 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.473 HD11 ' HB2' ' A' ' 37' ' ' ALA . 3.7 mp -115.63 153.94 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.693 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 -38.15 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 109.631 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 57' ' ' SER . 47.7 p -177.64 151.91 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.533 -0.729 . . . . 0.0 109.681 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.53 ' CG1' ' OD1' ' A' ' 27' ' ' ASP . 3.7 p -141.46 129.15 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.972 . . . . 0.0 110.571 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.915 . . . . 0.0 110.991 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.179 0.514 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.415 HG21 ' HE2' ' A' ' 68' ' ' LYS . 38.6 mm -113.33 108.96 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.271 -0.893 . . . . 0.0 110.251 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -150.17 168.55 23.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 20.5 ttpt -121.4 113.51 19.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.584 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 2.1 mp -72.75 144.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -131.7 165.52 23.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.58 -0.7 . . . . 0.0 109.697 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CZ ' HG21 ' A' ' 56' ' ' ILE . 30.7 m-85 -137.9 157.04 73.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.042 -1.037 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 60' ' ' GLU . 50.4 Cg_endo -75.48 154.74 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.159 1.61 . . . . 0.0 109.901 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 59' ' ' PRO . 4.7 pt-20 -42.78 157.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.283 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.13 -58.8 0.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.478 HD13 ' HB3' ' A' ' 58' ' ' PHE . 11.6 mt -62.18 161.17 26.03 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.161 -1.199 . . . . 0.0 110.35 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.16 -38.6 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.152 1.606 . . . . 0.0 110.4 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 9.2 m-30 -92.91 153.39 18.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -104.19 -17.36 14.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.484 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 29.1 p90 -174.14 -173.34 0.79 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.718 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -177.66 115.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 109.947 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -68.98 134.16 49.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -128.5 127.27 42.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 110.951 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -127.94 103.32 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.414 -0.804 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 32.2 m -57.01 -32.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.287 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 64.08 5.75 2.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -0.917 . . . . 0.0 110.729 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 167.36 177.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -179.23 125.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 109.658 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -104.58 -176.74 3.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.24 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.73 -67.28 0.32 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.3 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.8 m -58.12 -36.32 72.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 0.0 110.532 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 5.5 m-80 -93.73 0.77 56.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.006 . . . . 0.0 110.694 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 19.8 m-30 57.06 14.92 2.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 110.552 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HA ' ' CB ' ' A' ' 103' ' ' LYS . 16.5 mttm -71.61 136.53 47.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.086 . . . . 0.0 109.744 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 67.8 t80 -149.72 121.82 8.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 110.462 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.572 ' HA ' ' CB ' ' A' ' 101' ' ' GLU . 4.6 m-20 -125.29 142.94 51.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.88 . . . . 0.0 110.558 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -152.34 149.49 28.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.105 -0.997 . . . . 0.0 111.102 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.58 135.78 54.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.553 -0.717 . . . . 0.0 109.691 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.571 ' CG1' ' HB ' ' A' ' 98' ' ' ILE . 2.2 p -103.62 123.91 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.545 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 1.5 pp -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 1.8 tt0 73.91 138.49 0.06 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 0.0 110.603 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.435 ' C ' HG11 ' A' ' 67' ' ' VAL . . . 81.08 162.85 29.32 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.83 -144.65 17.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.9 Cg_endo -81.9 22.57 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.98 1.516 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -38.83 164.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.359 -0.838 . . . . 0.0 111.116 -179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.6 38.14 7.16 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.469 ' O ' ' OG1' ' A' ' 94' ' ' THR . 9.7 t0 -155.37 68.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.48 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 13.9 p 48.28 38.18 9.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -159.92 60.38 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -49.09 -72.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -128.35 159.98 33.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.585 HG22 ' CD1' ' A' ' 120' ' ' TYR . 71.3 mt -137.39 117.27 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.85 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.45 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 28.8 t -103.92 128.19 51.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 0.0 110.607 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.575 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 19.0 m-20 -129.19 134.07 47.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.594 ' O ' HG12 ' A' ' 102' ' ' ILE . 6.6 pt-20 -175.56 149.09 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 117.881 -1.528 . . . . 0.0 113.312 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -178.58 -95.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.591 ' N ' ' CG2' ' A' ' 102' ' ' ILE . 0.7 OUTLIER 176.0 -176.49 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 0.0 110.625 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.531 ' CG2' HD21 ' A' ' 114' ' ' LEU . 36.2 mt -113.76 124.79 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 108.915 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.515 ' CG2' ' HD2' ' A' ' 115' ' ' LYS . 64.6 t -96.92 125.72 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.3 131.78 37.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.668 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' A' ' 111' ' ' GLY . 67.6 p -78.67 162.51 65.23 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 47.7 Cg_endo -66.92 -18.16 52.11 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.066 1.561 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -171.04 -30.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 111.239 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.26 -88.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.533 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . -151.09 -95.45 0.12 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 11.9 m -171.12 137.0 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.323 -1.104 . . . . 0.0 109.83 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 10' ' ' THR . 2.2 mt -100.95 114.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.095 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.531 HD21 ' CG2' ' A' ' 104' ' ' ILE . 45.8 mt -71.71 103.01 2.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.58 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HD2' ' CG2' ' A' ' 105' ' ' VAL . 78.6 mttt -86.64 126.16 34.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.853 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.531 HG23 ' ND2' ' A' ' 118' ' ' ASN . 16.4 mt -137.25 130.27 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.518 ' N ' HG12 ' A' ' 102' ' ' ILE . 36.6 m -96.28 102.48 14.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.082 -1.011 . . . . 0.0 108.963 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.531 ' ND2' HG23 ' A' ' 116' ' ' ILE . 1.5 m-80 -83.63 143.74 29.9 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.435 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 117.8 9.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.585 ' CD1' HG22 ' A' ' 98' ' ' ILE . 2.7 m-85 -92.98 99.86 12.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.018 -1.051 . . . . 0.0 111.115 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.462 ' HA ' HG23 ' A' ' 2' ' ' VAL . 73.5 m-70 -82.04 83.88 7.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.409 -0.807 . . . . 0.0 109.192 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.508 HG23 ' CG2' ' A' ' 128' ' ' VAL . 11.7 p -82.21 -146.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.843 . . . . 0.0 110.571 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.79 18.98 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 0.0 110.708 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.67 -143.55 16.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.3 t0 48.53 -144.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -1.148 . . . . 0.0 110.116 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -50.04 149.71 2.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.833 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.53 170.9 13.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 110.492 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.597 HG22 ' CE1' ' A' ' 3' ' ' PHE . 35.4 t -62.27 143.27 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.426 ' HE3' ' OE1' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -85.91 110.01 19.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.52 -49.03 10.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.154 -0.966 . . . . 0.0 109.795 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.15 -43.25 74.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.011 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.432 ' NE2' ' HB2' ' A' ' 90' ' ' PRO . 42.6 tt0 -58.34 -38.55 77.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -0.753 . . . . 0.0 109.478 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.569 HG12 ' CD2' ' A' ' 5' ' ' TYR . 4.0 t -77.5 -17.6 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 109.798 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.1 tptt -81.35 -61.9 1.81 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -0.791 . . . . 0.0 110.369 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -39.23 -50.49 1.95 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.338 -0.851 . . . . 0.0 110.163 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -48.18 74.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.355 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -36.39 69.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -61.89 -59.95 4.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.144 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.456 ' CE ' HD13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -46.13 -42.83 14.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.158 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.53 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.01 -47.53 71.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -1.224 . . . . 0.0 110.907 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.5 -38.34 63.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.021 -1.05 . . . . 0.0 109.186 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.588 ' CD2' ' CB ' ' A' ' 37' ' ' ALA . 1.5 mm? -69.99 -50.21 43.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.836 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.549 ' HA ' ' CE1' ' A' ' 22' ' ' PHE . 14.5 tp -51.14 -30.87 17.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 108.792 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -43.73 34.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 110.075 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.51 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -56.91 -48.32 78.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 109.896 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.457 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 27.7 t -74.03 -36.5 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.41 -0.806 . . . . 0.0 110.111 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.457 ' HG3' ' CG1' ' A' ' 13' ' ' ILE . 19.6 tt0 -57.19 -41.03 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.52 -25.52 21.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.93 . . . . 0.0 110.083 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.614 ' CD2' HD21 ' A' ' 151' ' ' LEU . 7.3 t80 -57.39 -33.71 68.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.746 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.614 HD21 ' CD2' ' A' ' 150' ' ' TYR . 20.1 mt -79.07 -26.19 43.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.201 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 8.1 mp -78.53 -22.38 47.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.22 -45.43 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -72.37 171.9 11.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 110.697 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.6 t -54.01 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 3.8 p-10 -155.53 54.34 0.61 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 110.756 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.571 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -59.08 133.95 56.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.875 -1.14 . . . . 0.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.589 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 53.2 m-85 62.37 62.3 1.17 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.679 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.175 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.534 HG11 ' N ' ' A' ' 3' ' ' PHE . 78.2 t -76.69 151.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -1.195 . . . . 0.0 110.046 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 127' ' ' GLU . 87.1 m-85 -115.28 129.46 56.63 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 110.206 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.25 105.1 16.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.578 ' CD1' HG13 ' A' ' 133' ' ' VAL . 23.5 m-85 -106.58 82.11 1.68 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -88.04 157.41 18.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 0.0 110.937 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.541 ' CG2' ' HB ' ' A' ' 116' ' ' ILE . 11.5 t -173.39 -174.02 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 0.0 109.693 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 7' ' ' THR . 6.9 mt-10 -140.19 149.9 43.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.107 -0.996 . . . . 0.0 110.335 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.795 ' O ' ' HB2' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -158.5 136.5 10.59 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.239 -0.913 . . . . 0.0 109.21 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.66 ' CB ' ' HA ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER 175.88 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 119.778 -1.826 . . . . 0.0 113.967 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.481 ' OG ' ' C ' ' A' ' 10' ' ' THR . 0.5 OUTLIER -169.38 -175.52 2.24 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.935 -178.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -72.79 -15.76 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.21 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.564 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 4.6 mm -61.51 140.87 94.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 110.045 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -56.08 158.54 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.029 1.542 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.563 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -70.24 -32.84 70.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.685 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.32 90.83 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 110.686 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.488 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 19.2 mtm180 -79.25 -50.33 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.078 . . . . 0.0 109.893 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.564 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -57.69 -30.94 65.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.66 ' CE2' HD23 ' A' ' 24' ' ' LEU . 61.8 t80 -79.11 -46.3 18.31 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.624 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -68.19 -20.95 64.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.773 . . . . 0.0 112.155 -178.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.631 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . . . -111.71 -31.66 6.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.678 -1.264 . . . . 0.0 112.15 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 86.0 t80 -107.16 -13.25 15.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.682 -1.261 . . . . 0.0 111.934 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.593 HG22 ' CE1' ' A' ' 19' ' ' PHE . 39.4 mm -122.46 -16.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.794 -1.192 . . . . 0.0 110.486 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.66 HD23 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -112.38 -29.48 7.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.231 -0.918 . . . . 0.0 110.173 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.483 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -137.15 66.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.886 -179.54 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -83.56 -25.48 46.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -80.18 13.73 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.515 -0.991 . . . . 0.0 110.834 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 89.7 m-20 -135.97 37.77 2.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.826 -1.171 . . . . 0.0 108.15 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.653 ' CD1' ' CG ' ' A' ' 150' ' ' TYR . 0.3 OUTLIER 174.68 -36.42 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.188 -177.033 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 3.2 m-30 -38.79 -62.09 0.79 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.62 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 55.6 Cg_endo -69.83 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.902 1.475 . . . . 0.0 110.725 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.8 mmtt -49.74 -25.9 3.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 111.14 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 150' ' ' TYR . 3.6 m -120.16 -10.13 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.049 . . . . 0.0 110.789 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.05 65.51 36.83 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.045 -1.034 . . . . 0.0 110.459 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.67 -13.63 37.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.05 1.553 . . . . 0.0 109.542 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -82.98 -14.96 53.03 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB2' HD22 ' A' ' 143' ' ' LEU . . . -110.48 -58.53 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.23 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.466 HD11 HD22 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -115.35 125.82 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.008 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.484 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 8.1 t -82.9 -38.74 22.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.826 . . . . 0.0 110.354 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 p -172.45 151.22 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.328 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.61 129.49 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.644 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HB3' ' CB ' ' A' ' 55' ' ' LYS . 13.4 tp10 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.581 -0.699 . . . . 0.0 109.647 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.2 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.144 0.497 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.547 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.8 mp -114.93 134.66 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 110.676 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -123.32 148.06 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.885 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 42' ' ' GLU . 28.7 mttp -121.76 84.72 2.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.869 . . . . 0.0 110.223 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.491 ' CG2' ' HE1' ' A' ' 58' ' ' PHE . 1.6 mp -66.42 125.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.867 -1.146 . . . . 0.0 109.141 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -105.78 126.31 52.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.631 -1.293 . . . . 0.0 111.318 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.595 ' CZ ' ' CG2' ' A' ' 67' ' ' VAL . 10.8 m-30 -84.82 141.93 38.72 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.458 -0.777 . . . . 0.0 110.59 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 39' ' ' SER . 43.7 Cg_endo -70.48 -179.23 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.936 1.493 . . . . 0.0 108.77 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.24 163.82 12.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.723 -1.236 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.61 -47.92 3.9 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -49.83 159.07 0.79 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 111.041 -179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HD2' ' CD1' ' A' ' 62' ' ' LEU . 45.0 Cg_endo -72.1 152.37 56.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.187 1.625 . . . . 0.0 108.586 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.403 ' CD2' ' HB2' ' A' ' 63' ' ' PRO . 21.9 m-85 52.84 -136.19 1.41 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.158 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -152.25 -3.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.901 -1.124 . . . . 0.0 112.093 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.586 ' CE2' ' CA ' ' A' ' 88' ' ' GLY . 43.9 p90 178.02 -158.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.837 -1.165 . . . . 0.0 110.442 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.595 ' CG2' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -173.07 130.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.53 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -95.85 154.12 17.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.566 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.85 127.16 12.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.01 -1.056 . . . . 0.0 111.241 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.68 142.02 31.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 109.127 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.21 137.97 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 111.157 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -110.98 47.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.379 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.6 mt-10 63.69 110.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 109.863 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.554 HG13 ' CD1' ' A' ' 81' ' ' TYR . 3.8 m -82.72 168.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.329 -0.857 . . . . 0.0 110.499 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -102.89 139.51 38.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.829 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -102.42 -48.8 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.36 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.7 m -53.59 -42.31 67.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.909 -1.119 . . . . 0.0 110.928 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 79' ' ' PHE . 17.9 m120 -105.73 15.2 27.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.053 . . . . 0.0 110.811 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 76' ' ' HIS . 12.3 m-30 41.58 59.23 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 110.291 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -115.53 164.85 13.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 0.0 109.942 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.554 ' CD1' HG13 ' A' ' 74' ' ' VAL . 10.1 t80 -147.69 143.0 27.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.913 . . . . 0.0 110.5 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -145.56 100.41 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.824 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.538 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 38.2 p90 -128.59 168.97 14.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.51 135.39 53.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.473 HG22 ' OD1' ' A' ' 100' ' ' ASN . 21.4 t -94.92 112.34 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.529 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 18.6 pt -132.32 150.67 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' OE1' ' CG1' ' A' ' 86' ' ' ILE . 27.7 mp0 58.65 156.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 110.722 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.586 ' CA ' ' CE2' ' A' ' 66' ' ' TYR . . . 61.04 149.06 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.11 -141.45 15.6 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ILE . 50.1 Cg_endo -84.2 26.62 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.022 1.538 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.35 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.531 -0.73 . . . . 0.0 110.517 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.45 -160.23 28.23 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -93.83 -30.74 14.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.452 ' O ' ' HB ' ' A' ' 122' ' ' THR . 71.0 p -59.75 -24.45 64.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.485 HD21 ' CG1' ' A' ' 98' ' ' ILE . 1.7 mt -146.18 86.74 1.71 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -81.42 -41.66 21.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.902 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.7 mmtt -123.0 158.49 30.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.997 -1.064 . . . . 0.0 110.527 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 97' ' ' LYS . 12.9 mt -158.27 115.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.485 -0.759 . . . . 0.0 109.996 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 t -103.69 114.28 28.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 109.96 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.473 ' OD1' HG22 ' A' ' 85' ' ' VAL . 7.1 m120 -116.67 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.051 -1.03 . . . . 0.0 110.964 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.446 ' O ' HD13 ' A' ' 102' ' ' ILE . 3.9 pt-20 -141.98 145.48 34.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.492 -0.755 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.462 ' CG2' ' HG ' ' A' ' 114' ' ' LEU . 1.3 mp -126.14 135.25 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.832 -1.168 . . . . 0.0 110.193 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 ttpt -115.89 101.33 8.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.375 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.539 ' CG1' HD13 ' A' ' 114' ' ' LEU . 4.7 mp -78.81 135.67 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.964 -1.085 . . . . 0.0 109.785 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 104' ' ' ILE . 44.5 t -140.85 125.94 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.442 ' HB1' ' HB1' ' A' ' 15' ' ' ALA . . . -81.25 140.04 35.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.336 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.6 p -100.35 157.43 33.81 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.968 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.07 -16.87 50.33 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.034 1.544 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -161.64 83.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.026 -1.046 . . . . 0.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 168.98 -87.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -173.68 -153.17 9.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.646 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.4 OUTLIER -108.26 143.78 36.64 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.174 -1.192 . . . . 0.0 109.344 179.06 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.66 ' HA ' ' CB ' ' A' ' 10' ' ' THR . 1.8 mt -119.68 137.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.401 0.62 . . . . 0.0 111.373 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.795 ' HB2' ' O ' ' A' ' 9' ' ' THR . 2.5 mp -101.27 110.33 22.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.447 -0.783 . . . . 0.0 109.513 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 1.8 mptp? -81.14 104.98 11.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 77.5 mt -93.47 112.83 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.661 0.743 . . . . 0.0 112.23 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.1 111.66 23.41 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.45 ' OD1' HG23 ' A' ' 116' ' ' ILE . 16.5 m120 -110.42 96.58 6.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 111.216 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -84.56 99.69 10.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.478 ' O ' HG11 ' A' ' 2' ' ' VAL . 3.2 m-85 -75.83 132.8 40.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.772 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.53 ' CE1' HG22 ' A' ' 2' ' ' VAL . 55.4 m-70 -114.49 100.07 8.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.535 ' CG2' HG21 ' A' ' 128' ' ' VAL . 6.3 p -104.6 179.48 4.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 110.332 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 122' ' ' THR . 1.1 ptpm? 175.21 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 159.62 126.47 0.85 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.18 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 47.89 -150.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -1.075 . . . . 0.0 110.824 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 125' ' ' ASP . 4.3 m-70 -42.13 166.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.359 -0.838 . . . . 0.0 110.533 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -107.44 -121.21 0.24 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 110.141 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.535 HG21 ' CG2' ' A' ' 122' ' ' THR . 97.7 t -103.2 141.8 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.822 -1.174 . . . . 0.0 110.492 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 130' ' ' ALA . 37.5 mtmt -107.29 124.22 49.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.699 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.32 -41.31 5.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.173 -0.955 . . . . 0.0 109.786 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 tm-20 -52.03 -49.53 63.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.209 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.422 ' OE1' ' HE3' ' A' ' 129' ' ' LYS . 7.6 mt-30 -61.87 -43.29 99.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.195 -0.94 . . . . 0.0 109.007 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.578 HG13 ' CD1' ' A' ' 5' ' ' TYR . 96.9 t -62.0 -18.33 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.137 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 23.3 ttpt -87.72 -63.61 1.28 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 110.694 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.12 -47.98 0.79 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.697 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -47.22 87.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -64.77 -19.37 65.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 24.4 tt0 -78.7 -45.47 21.21 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.454 ' HE2' HD13 ' A' ' 38' ' ' ILE . 44.0 mmm -64.0 -35.18 79.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.532 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.43 -42.62 73.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.17 -33.35 74.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.999 -1.295 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.25 70.4 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.164 -0.96 . . . . 0.0 109.045 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.466 HD22 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -69.96 -29.31 66.4 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.485 ' CD2' HG21 ' A' ' 9' ' ' THR . 15.9 tp -69.13 -46.07 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -33.4 75.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.39 -0.819 . . . . 0.0 108.945 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -62.52 -54.65 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.822 . . . . 0.0 109.273 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.539 ' CG1' HD22 ' A' ' 29' ' ' LEU . 39.2 t -70.99 -16.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -0.768 . . . . 0.0 109.968 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.456 ' HG3' ' HB3' ' A' ' 11' ' ' SER . 5.5 tm-20 -75.17 -44.33 47.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.635 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -15.29 32.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.404 -0.81 . . . . 0.0 109.707 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.653 ' CG ' ' CD1' ' A' ' 29' ' ' LEU . 4.1 t80 -64.69 -52.12 58.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.352 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.575 HD22 ' CE2' ' A' ' 150' ' ' TYR . 84.8 mt -53.46 -30.71 42.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.706 -0.621 . . . . 0.0 110.167 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.26 -51.76 10.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.701 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 154' ' ' HIS . . . -55.24 -53.76 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.451 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 153' ' ' ALA . 46.2 m-70 -60.01 -122.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.038 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 9.6 t -175.02 -31.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.59 -1.319 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -144.54 39.94 1.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 110.938 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.5 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -85.0 128.4 34.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.776 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.631 ' CD2' ' CB ' ' A' ' 21' ' ' ALA . 44.4 m-85 56.16 49.26 15.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.286 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 120' ' ' TYR . 9.2 p -144.66 161.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -1.12 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 76.5 m-85 -132.82 161.4 34.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.382 -0.824 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.59 106.82 10.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -0.963 . . . . 0.0 110.437 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CD1' HG13 ' A' ' 133' ' ' VAL . 44.7 m-85 -108.14 86.8 2.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.398 -0.814 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -101.76 156.34 17.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.666 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.451 HG21 ' HB ' ' A' ' 116' ' ' ILE . 5.5 t -166.15 176.63 7.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.972 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.2 mp0 -146.35 137.05 24.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 1.5 t -118.26 166.43 12.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.87 142.31 51.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.698 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -141.19 147.95 39.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.448 HG11 ' N ' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -72.49 -39.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.433 -0.792 . . . . 0.0 110.174 -179.364 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.542 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 3.4 mm -58.88 141.91 85.17 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' ' 13' ' ' ILE . 35.7 Cg_endo -57.89 155.27 33.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.912 1.48 . . . . 0.0 110.804 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -60.68 -36.68 79.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 110.103 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . . . -62.68 -56.24 19.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 110.735 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.458 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 51.7 mtt180 -61.3 -55.17 34.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.151 -0.968 . . . . 0.0 110.245 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.542 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -52.27 -33.72 43.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.221 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.637 ' CE2' HD23 ' A' ' 24' ' ' LEU . 75.7 t80 -69.88 -52.6 23.43 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 11.5 mtmm -61.26 -25.34 67.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 0.0 111.552 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.646 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.66 -61.12 1.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 111.522 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 80.7 t80 -76.28 -4.9 44.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.304 -0.872 . . . . 0.0 112.253 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 34.9 mm -132.95 -20.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.642 -1.286 . . . . 0.0 111.123 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.637 HD23 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -111.19 -5.69 14.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -154.75 53.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 110.557 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.36 -21.78 55.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 49.8 p30 -68.21 -15.44 63.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -1.086 . . . . 0.0 110.449 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -122.77 10.75 9.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.77 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.594 HD13 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -122.27 -42.68 2.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.339 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 7.3 m-30 -60.7 -51.8 77.12 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.87 . . . . 0.0 111.684 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.9 Cg_endo -65.42 -4.82 10.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.224 1.118 . . . . 0.0 111.741 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -107.93 -64.11 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.898 -1.126 . . . . 0.0 110.5 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.499 HG22 ' CB ' ' A' ' 146' ' ' ALA . 18.5 m -71.95 -17.71 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.472 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -132.97 66.3 75.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.101 -0.999 . . . . 0.0 110.872 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.0 Cg_endo -68.39 -19.96 42.78 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 109.466 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -83.9 -9.57 58.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.558 -0.714 . . . . 0.0 109.548 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' HB2' HD13 ' A' ' 38' ' ' ILE . . . -105.56 -59.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.968 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.456 HD12 ' HE3' ' A' ' 139' ' ' MET . 1.4 mp -119.16 161.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.489 ' HB2' ' N ' ' A' ' 59' ' ' PRO . 42.8 t -111.15 -57.44 2.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.055 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.38 144.48 3.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.914 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.481 HG13 ' HB2' ' A' ' 27' ' ' ASP . 12.8 p -109.29 139.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.163 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 5.1 mt-10 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.129 -0.982 . . . . 0.0 109.87 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.2 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.277 0.561 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.523 ' CD1' ' HG3' ' A' ' 70' ' ' ARG . 22.8 mm -85.68 121.7 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.099 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -137.76 154.31 49.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.495 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' CG ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -125.38 107.24 10.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.392 -0.817 . . . . 0.0 110.173 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.534 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 1.7 mp -73.44 136.34 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 109.664 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -119.04 162.16 19.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 110.356 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 19.5 m-85 -128.05 161.57 55.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.489 ' N ' ' HB2' ' A' ' 39' ' ' SER . 43.0 Cg_endo -71.21 159.92 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.981 1.516 . . . . 0.0 110.017 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.69 164.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 110.627 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.61 -45.47 3.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.454 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -66.16 145.23 98.98 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.195 -1.179 . . . . 0.0 110.797 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 64' ' ' PHE . 47.5 Cg_endo -75.57 -163.65 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 110.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 5.2 m-30 51.83 103.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.376 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.6 tppt? -56.78 -17.62 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.604 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 175.6 -175.05 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG21 ' C ' ' A' ' 66' ' ' TYR . 53.8 t -147.64 80.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -79.44 133.59 36.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 84' ' ' SER . 4.8 p-10 -163.39 -177.77 5.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG3' ' CD1' ' A' ' 53' ' ' ILE . 6.4 mtp180 -121.8 159.73 26.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 4.6 p -85.93 -25.44 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.933 . . . . 0.0 111.042 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 72.14 -80.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -168.73 157.77 8.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 178.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 81' ' ' TYR . 14.6 p -128.45 109.79 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.96 154.86 41.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 109.464 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.41 -59.06 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 110.61 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.9 m -63.0 -8.23 6.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 0.0 110.993 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.475 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 73.3 m-20 -121.29 6.87 10.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.91 -1.119 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 8.6 m-30 44.66 67.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.475 ' HE2' ' HB3' ' A' ' 78' ' ' ASN . 3.0 mtmt -137.1 122.29 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.883 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.532 ' CD1' HG22 ' A' ' 74' ' ' VAL . 4.3 t80 -111.05 128.98 56.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.556 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.0 143.85 30.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.607 ' CZ ' ' CG2' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -149.3 115.96 5.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.417 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -103.27 127.47 50.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.607 ' CG2' ' CZ ' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -102.45 95.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.435 -0.791 . . . . 0.0 109.783 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 87' ' ' GLU . 25.0 pt -87.44 -29.6 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 0.0 110.414 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -156.48 102.58 2.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.898 . . . . 0.0 110.363 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 143.79 166.3 11.25 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 91' ' ' ILE . . . 86.1 -121.43 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 91' ' ' ILE . 47.4 Cg_endo -74.24 -52.26 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.788 1.415 . . . . 0.0 110.584 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.2 OUTLIER 30.03 -156.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.875 0.845 . . . . 0.0 111.862 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.83 -161.67 2.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 94' ' ' THR . 3.4 m-20 51.68 -95.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -1.142 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 126' ' ' HIS . 18.3 p -156.23 22.25 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 110.516 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.464 HD12 ' CE2' ' A' ' 120' ' ' TYR . 9.9 mt -94.93 95.49 8.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.205 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 4.6 mt-10 -76.6 -43.34 38.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 98' ' ' ILE . 9.1 tttp -129.43 152.13 49.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.005 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 97' ' ' LYS . 13.3 mt -153.74 122.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 110.635 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.53 127.34 48.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 109.872 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 2.3 m-80 -121.54 114.65 21.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.621 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.01 159.0 16.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 109.703 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.452 ' C ' ' HG3' ' A' ' 103' ' ' LYS . 13.7 mt -141.89 142.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HE3' ' HD3' ' A' ' 80' ' ' LYS . 1.8 mtpp -138.09 151.86 48.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.147 -0.971 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.509 HG22 ' CD2' ' A' ' 114' ' ' LEU . 4.9 mp -130.84 125.85 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.002 . . . . 0.0 109.927 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.425 HG22 ' HD2' ' A' ' 115' ' ' LYS . 13.0 t -116.41 133.23 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.02 21.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 p -128.96 152.85 79.89 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.843 . . . . 0.0 110.115 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.99 -32.38 28.55 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.024 1.539 . . . . 0.0 110.706 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 p30 -149.99 43.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.81 14.21 0.89 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.47 -138.07 29.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -128.58 136.56 50.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -1.157 . . . . 0.0 110.571 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.11 125.79 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.803 . . . . 0.0 109.211 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.513 ' HB2' ' CG2' ' A' ' 9' ' ' THR . 20.1 mt -89.72 108.19 19.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.001 . . . . 0.0 111.134 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 10.2 mttp -81.65 106.47 13.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.451 ' HB ' HG21 ' A' ' 7' ' ' THR . 43.4 mm -101.38 151.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.08 132.08 35.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 4.9 m120 -129.53 88.17 2.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.125 -0.984 . . . . 0.0 110.725 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HD2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -81.29 124.27 29.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.571 ' CD2' HG12 ' A' ' 128' ' ' VAL . 3.3 m-85 -103.67 149.38 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.911 -1.118 . . . . 0.0 110.401 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.467 ' ND1' HG22 ' A' ' 2' ' ' VAL . 87.0 m-70 -134.33 93.48 3.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 2.0 p -86.14 -162.9 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.87 . . . . 0.0 109.717 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 122' ' ' THR . 5.2 ttpp -177.26 97.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.041 . . . . 0.0 110.854 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.42 160.59 12.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 56.08 -161.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -1.021 . . . . 0.0 110.635 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.475 ' N ' HG23 ' A' ' 94' ' ' THR . 81.1 m-70 -48.96 -179.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 110.436 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 5.5 mm-40 -127.32 -112.98 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.931 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.571 HG12 ' CD2' ' A' ' 120' ' ' TYR . 60.5 t -118.23 138.03 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.805 -1.185 . . . . 0.0 110.256 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 130' ' ' ALA . 5.5 mtmt -101.66 111.4 23.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -41.36 -50.31 3.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.696 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -46.44 -48.27 18.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.902 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.521 ' NE2' ' HB2' ' A' ' 90' ' ' PRO . 2.9 tt0 -63.36 -39.44 94.54 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.597 HG13 ' CD1' ' A' ' 5' ' ' TYR . 79.5 t -65.92 -17.22 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.757 0.789 . . . . 0.0 109.169 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 135' ' ' ALA . 2.0 ttmt -85.54 -58.13 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.499 -0.75 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.38 -50.64 5.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 109.916 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.43 -45.86 69.58 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.13 -31.68 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.701 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.77 -39.68 80.09 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.332 -0.855 . . . . 0.0 109.369 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.456 ' HE3' HD12 ' A' ' 38' ' ' ILE . 1.3 mtp -66.18 -38.43 88.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.21 -0.931 . . . . 0.0 109.05 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.21 -38.18 93.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -74.77 -35.02 62.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.896 -1.355 . . . . 0.0 110.158 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -39.77 90.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 108.743 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.559 HD11 ' CD1' ' A' ' 30' ' ' PHE . 1.1 mm? -68.66 -48.97 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.165 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.48 HD23 HG22 ' A' ' 9' ' ' THR . 13.3 tp -49.58 -42.89 45.62 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.204 -0.935 . . . . 0.0 108.849 178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -65.79 -42.64 90.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.83 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.499 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -56.5 -62.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.358 -0.838 . . . . 0.0 109.734 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 84.6 t -59.01 -28.61 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.555 -0.715 . . . . 0.0 110.09 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -61.95 -53.06 60.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 0.0 109.958 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.4 p -76.7 -18.59 58.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 109.9 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CD2' HD13 ' A' ' 29' ' ' LEU . 5.7 t80 -64.44 -47.95 77.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.627 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.56 HD21 ' CD2' ' A' ' 150' ' ' TYR . 68.4 mt -61.38 -24.97 66.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.469 ' CD1' HD13 ' A' ' 13' ' ' ILE . 5.9 mp -81.76 -35.21 29.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.244 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.12 -55.14 6.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.461 ' O ' ' CB ' ' A' ' 155' ' ' SER . 35.9 m-70 -66.14 -44.42 84.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.873 . . . . 0.0 109.808 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER 66.74 20.55 10.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.459 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -159.11 19.9 0.19 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.568 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.464 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.63 130.65 48.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.077 -1.014 . . . . 0.0 110.336 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.646 ' CD2' ' CB ' ' A' ' 21' ' ' ALA . 48.4 m-85 58.24 53.13 6.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.116 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.528 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG11 ' N ' ' A' ' 3' ' ' PHE . 78.9 t -79.08 156.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.574 ' N ' HG11 ' A' ' 2' ' ' VAL . 75.9 m-85 -119.61 137.38 53.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.529 -0.732 . . . . 0.0 109.965 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.454 ' OD1' ' HE2' ' A' ' 119' ' ' LYS . 3.6 t30 -101.19 91.53 4.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 0.0 110.358 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CE1' HG13 ' A' ' 128' ' ' VAL . 29.3 m-85 -86.97 74.12 9.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -0.92 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 91.54 3.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.479 ' CG2' ' HE2' ' A' ' 137' ' ' LYS . 14.4 t -112.85 -169.75 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.03 167.16 12.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.451 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -137.16 179.13 6.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 109.911 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.14 141.13 51.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.428 ' OG ' ' CD ' ' A' ' 148' ' ' GLU . 5.7 t -142.57 143.36 32.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 110.162 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -31.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.513 ' O ' HD11 ' A' ' 18' ' ' LEU . 3.3 mm -66.08 140.82 97.16 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 36.2 Cg_endo -60.32 158.34 31.54 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.795 1.419 . . . . 0.0 110.617 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.51 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -53.91 -70.08 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 0.0 111.732 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.62 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -37.97 -62.07 0.59 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.309 -0.869 . . . . 0.0 111.808 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.556 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.2 mpt_? -52.73 -57.45 10.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.866 -1.146 . . . . 0.0 110.673 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -48.45 -30.66 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.183 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.641 ' CE2' HD23 ' A' ' 24' ' ' LEU . 68.3 t80 -74.01 -57.09 4.2 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.038 -1.039 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.0 mtmt -59.73 -23.02 62.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.73 . . . . 0.0 111.883 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.586 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -107.96 -53.25 2.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.578 -1.327 . . . . 0.0 112.226 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 27.4 t80 -83.89 -14.07 52.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.059 . . . . 0.0 112.38 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.535 HG23 ' CE1' ' A' ' 19' ' ' PHE . 28.2 mt -124.5 -14.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.573 -1.33 . . . . 0.0 110.868 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.641 HD23 ' CE2' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -111.74 -17.01 13.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.032 . . . . 0.0 109.967 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.484 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 4.7 t0 -137.16 43.83 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 110.151 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.36 -23.16 71.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.52 -30.53 69.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -1.166 . . . . 0.0 110.365 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' HD11 ' A' ' 29' ' ' LEU . 10.7 p-10 -105.04 25.15 10.89 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.491 ' O ' ' C ' ' A' ' 30' ' ' PHE . 3.1 tp -141.56 -63.23 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.668 -0.645 . . . . 0.0 110.354 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.567 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 6.1 m-30 -34.24 -52.96 0.94 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.782 -0.574 . . . . 0.0 110.746 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 50.9 Cg_endo -68.03 -50.25 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.468 1.246 . . . . 0.0 110.742 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -65.82 -69.52 0.29 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.286 -0.884 . . . . 0.0 110.615 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG13 ' CD1' ' A' ' 150' ' ' TYR . 12.2 m -68.05 -11.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 111.409 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 30' ' ' PHE . . . -146.73 66.17 10.52 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.3 Cg_endo -69.81 -11.86 31.64 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.846 1.445 . . . . 0.0 109.45 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -83.21 -14.63 52.92 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.332 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 143' ' ' LEU . . . -112.36 -48.04 3.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.044 -1.035 . . . . 0.0 111.126 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 2.2 mp -116.94 163.56 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.985 -1.072 . . . . 0.0 110.596 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -124.07 -33.79 3.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.94 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER 169.95 141.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.536 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.446 HG22 HD13 ' A' ' 56' ' ' ILE . 3.2 p -103.37 148.03 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.159 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.616 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 3.4 mt-10 -141.53 116.82 10.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.616 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.6 OUTLIER 147.24 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 43' ' ' ASN . 1.3 tp 32.78 38.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.516 -0.74 . . . . 0.0 111.298 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 43' ' ' ASN . 13.5 pt-20 -79.34 -176.37 5.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.314 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.98 65.05 0.25 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -108.37 -27.85 9.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.21 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.468 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -131.2 1.84 5.41 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.411 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . 46.87 -104.2 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 48' ' ' GLY . 48.5 Cg_endo -73.05 87.0 1.05 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.025 1.54 . . . . 0.0 110.513 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.02 27.02 1.44 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 49' ' ' GLY . 1.3 m -75.31 -171.18 1.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -1.181 . . . . 0.0 110.119 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 54' ' ' LYS . 1.1 mp -125.27 168.43 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.549 ' HA ' ' CB ' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -149.11 147.56 28.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.397 -0.815 . . . . 0.0 109.914 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.471 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 2.4 tttp -111.53 92.04 3.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.91 -1.119 . . . . 0.0 110.537 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.518 ' HB ' HG21 ' A' ' 67' ' ' VAL . 1.8 mp -79.52 133.03 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.069 -1.019 . . . . 0.0 109.576 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.33 120.25 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 0.0 110.635 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CE2' HG23 ' A' ' 67' ' ' VAL . 16.6 m-85 -83.08 169.62 17.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.588 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 44.7 Cg_endo -71.15 173.96 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.628 1.33 . . . . 0.0 110.023 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' O ' HD21 ' A' ' 62' ' ' LEU . 6.3 tt0 -58.74 179.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.26 2.09 86.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -84.62 138.61 38.14 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -1.219 . . . . 0.0 110.599 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.67 -12.84 26.97 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.023 1.539 . . . . 0.0 109.81 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.537 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 18.8 m-30 -110.77 -139.54 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.96 -37.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 0.1 OUTLIER 178.44 -166.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG23 ' CE2' ' A' ' 58' ' ' PHE . 3.5 m -159.92 123.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.562 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -92.36 130.72 37.97 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' HB2' ' CG ' ' A' ' 54' ' ' LYS . 3.6 m-20 -118.0 151.08 38.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.907 -1.121 . . . . 0.0 111.449 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.56 114.34 27.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.474 ' CG2' HG22 ' A' ' 74' ' ' VAL . 8.9 p -58.49 -27.74 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER 42.04 51.28 4.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.0 mt-10 65.14 158.97 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.339 -0.85 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.474 HG22 ' CG2' ' A' ' 71' ' ' VAL . 90.0 t -144.07 159.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -109.41 -150.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.215 -0.928 . . . . 0.0 110.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.633 ' CE1' ' CD1' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 179.98 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 0.0 110.18 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -55.54 -52.72 62.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.231 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -90.28 15.59 10.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.223 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.62 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 11.6 m-85 47.09 69.32 0.51 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.507 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -126.57 143.83 51.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.929 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -141.7 100.77 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 71' ' ' VAL . 9.8 t-20 -96.72 104.17 16.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 109.563 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 8.4 p90 -132.02 -169.5 2.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 109.983 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 98' ' ' ILE . 1.7 t -149.09 165.8 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.218 -0.926 . . . . 0.0 110.772 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 55.3 t -105.03 -26.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.382 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 85' ' ' VAL . 41.8 pt 37.05 -139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.162 0.506 . . . . 0.0 110.81 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.455 ' N ' HG13 ' A' ' 86' ' ' ILE . 1.4 mm-40 -60.61 135.43 57.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.996 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 136.66 142.72 4.49 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.358 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.547 ' N ' HG11 ' A' ' 67' ' ' VAL . . . 88.18 -142.79 17.69 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 52.2 Cg_endo -83.16 27.85 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.127 1.593 . . . . 0.0 110.993 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.15 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.474 -0.766 . . . . 0.0 110.581 -179.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 89.84 -163.77 30.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 1.3 m-20 56.44 -91.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -1.077 . . . . 0.0 110.484 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.469 ' O ' ' HG ' ' A' ' 95' ' ' LEU . 76.3 p -142.12 47.37 1.62 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.438 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 94' ' ' THR . 1.4 mt -170.2 90.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.49 -49.97 6.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.573 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 1.9 ttpp -113.69 161.2 17.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 97' ' ' LYS . 15.5 mt -158.39 113.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.473 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 4.3 m -104.32 122.2 44.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.166 -0.959 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.434 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 50.4 m-20 -116.29 133.5 55.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 111.601 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 82' ' ' ASN . 3.2 tp10 -118.57 129.49 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.427 ' C ' ' HG3' ' A' ' 103' ' ' LYS . 19.6 mt -116.91 146.96 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 0.0 110.783 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.447 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 49.4 mtpt -142.69 106.53 4.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.769 . . . . 0.0 109.784 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.525 ' CD1' HD13 ' A' ' 23' ' ' ILE . 14.5 mt -79.39 144.32 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.645 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.462 HG22 ' HD2' ' A' ' 115' ' ' LYS . 22.1 t -130.07 127.52 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 110.157 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.6 132.83 34.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.116 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -111.13 153.03 44.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.386 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.33 -19.96 49.24 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.06 1.558 . . . . 0.0 110.703 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.414 ' O ' ' OD2' ' A' ' 109' ' ' ASP . 3.0 p-10 -158.43 44.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.92 21.59 0.78 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.85 -113.65 5.94 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 72.3 m -152.41 137.21 17.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.449 -1.03 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.4 mt -104.09 133.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.737 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.606 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.2 mp -95.25 99.91 11.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 110.002 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HD2' HG22 ' A' ' 105' ' ' VAL . 14.1 mttm -75.29 103.17 5.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.716 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.468 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 25.8 mt -94.51 137.95 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 110.875 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.84 91.06 3.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.458 -0.776 . . . . 0.0 109.028 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 m-80 -84.48 92.24 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 111.387 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HD2' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -84.73 103.37 13.76 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.465 ' O ' HG12 ' A' ' 2' ' ' VAL . 3.2 m-85 -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.007 . . . . 0.0 111.468 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 32.7 m-70 -121.36 84.09 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 109.443 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 94' ' ' THR . 11.3 p -84.25 -164.74 0.99 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.357 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -137.42 88.02 2.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.34 -135.04 45.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.419 ' OD2' HG21 ' A' ' 94' ' ' THR . 17.6 t0 50.87 -141.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -1.125 . . . . 0.0 110.142 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.446 ' HB2' HG23 ' A' ' 94' ' ' THR . 43.8 m-70 -83.29 179.48 7.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -95.96 161.03 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.266 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 5' ' ' TYR . 39.6 t -50.4 139.56 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.036 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 31.4 mtmt -94.32 117.63 30.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -46.68 -43.79 18.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.153 -0.967 . . . . 0.0 109.853 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -46.04 64.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.062 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.443 ' NE2' HD11 ' A' ' 95' ' ' LEU . 1.5 tt0 -59.99 -44.93 94.2 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.537 HG13 ' CD2' ' A' ' 5' ' ' TYR . 54.4 t -59.66 -23.64 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.67 0.747 . . . . 0.0 109.163 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -79.35 -43.64 23.11 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.81 -0.557 . . . . 0.0 110.542 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.6 -53.79 46.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 t -61.15 -45.15 95.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.479 ' HE2' ' CG2' ' A' ' 7' ' ' THR . 0.1 OUTLIER -62.76 -18.42 62.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.865 . . . . 0.0 108.722 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -77.82 -51.21 10.84 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 40.0 mmm -60.22 -33.38 72.19 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.193 -1.003 . . . . 0.0 108.78 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.58 -44.87 69.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -67.08 -39.88 86.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.808 -1.407 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -45.93 90.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.339 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 37' ' ' ALA . 1.1 mm? -60.97 -52.62 64.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.337 -0.852 . . . . 0.0 109.324 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.526 ' CD2' HG22 ' A' ' 9' ' ' THR . 10.3 tp -46.81 -43.27 18.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -40.46 97.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 0.0 109.657 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -59.4 -61.33 2.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 22' ' ' PHE . 9.6 t -62.75 -18.38 20.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.463 -0.773 . . . . 0.0 109.89 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' O ' ' CD2' ' A' ' 152' ' ' LEU . 0.7 OUTLIER -72.61 -46.1 55.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 81.1 p -87.18 -15.0 39.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.589 ' CD1' HG13 ' A' ' 33' ' ' VAL . 3.7 t80 -67.01 -39.89 87.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.995 . . . . 0.0 109.6 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.456 HD13 HG13 ' A' ' 13' ' ' ILE . 42.7 mt -63.1 -36.34 83.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.402 -0.811 . . . . 0.0 110.596 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -75.96 -51.98 11.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.311 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -53.77 -54.1 43.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -67.28 -163.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 44.8 m -94.09 59.37 2.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 0.1 OUTLIER 61.6 41.21 12.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.472 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -42.41 151.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 110.244 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.586 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 81.9 m-85 57.87 57.38 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.34 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.155 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.564 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 40.4 t 50.71 170.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.56 -0.965 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.564 ' CD1' ' C ' ' A' ' 2' ' ' VAL . 97.4 m-85 -150.93 150.37 30.75 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -111.7 103.8 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE2' HG23 ' A' ' 133' ' ' VAL . 55.3 m-85 -100.79 87.21 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.45 108.51 19.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -127.99 -172.12 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.19 -170.87 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.867 . . . . 0.0 109.943 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.57 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 5.0 t -165.95 173.66 10.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 0.0 109.75 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.76 142.69 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.011 . . . . 0.0 110.491 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.495 ' CB ' HD13 ' A' ' 18' ' ' LEU . 20.2 t -132.13 144.15 50.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -77.47 -7.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.337 -0.852 . . . . 0.0 110.116 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.575 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 7.2 mm -94.78 145.27 29.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 110.473 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 30.9 Cg_endo -56.25 160.69 10.35 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.789 1.415 . . . . 0.0 110.686 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -63.26 -78.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 111.415 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.587 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -32.04 -54.6 0.3 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.664 -0.648 . . . . 0.0 111.421 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -57.41 -55.7 31.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.0 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.575 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 5.4 mt -51.01 -28.74 10.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.608 ' CE2' HD23 ' A' ' 24' ' ' LEU . 19.0 t80 -73.07 -67.47 0.57 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.68 -25.11 9.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.225 -0.922 . . . . 0.0 112.317 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -101.33 -58.16 1.94 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.541 -1.349 . . . . 0.0 111.443 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.511 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 24.2 t80 -80.59 -83.14 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.03 -1.044 . . . . 0.0 111.47 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 19' ' ' PHE . 2.4 mp -46.36 -21.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.18 -0.95 . . . . 0.0 111.876 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.608 HD23 ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -106.67 -77.81 0.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.664 -1.273 . . . . 0.0 110.043 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 21' ' ' ALA . 2.8 t0 -73.15 83.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 0.0 110.212 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.63 -27.94 4.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' CB ' HD12 ' A' ' 44' ' ' ILE . 5.2 p-10 -74.14 -12.75 60.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.271 . . . . 0.0 110.278 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -118.79 7.13 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.576 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.546 HD13 ' CG ' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -122.36 -40.32 2.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.803 . . . . 0.0 110.228 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.586 ' CD1' HD11 ' A' ' 143' ' ' LEU . 6.1 m-30 -61.39 -54.66 50.67 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.919 . . . . 0.0 111.35 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.4 Cg_endo -65.66 -6.13 13.19 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.306 1.161 . . . . 0.0 111.262 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -103.82 -67.61 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 110.592 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG21 ' N ' ' A' ' 34' ' ' ALA . 12.0 m -74.76 -20.91 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 110.82 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.51 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -122.4 61.65 15.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 110.675 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.1 Cg_endo -67.86 -23.29 41.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.101 1.58 . . . . 0.0 109.136 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -73.6 -15.87 61.26 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -108.67 -66.16 1.07 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 110.75 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.522 HG13 ' CE1' ' A' ' 58' ' ' PHE . 4.0 mp -114.47 172.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.525 ' HB3' ' CG ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -163.97 -25.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 111.472 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.4 t -133.45 138.76 46.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.588 -1.32 . . . . 0.0 111.122 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG13 ' HB ' ' A' ' 44' ' ' ILE . 19.4 t -124.57 128.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.587 -0.696 . . . . 0.0 109.41 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -133.17 148.37 52.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.009 . . . . 0.0 110.137 -179.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.545 ' O ' HG21 ' A' ' 53' ' ' ILE . 0.8 OUTLIER 69.48 22.79 6.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.524 HD12 ' CB ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -71.56 -26.55 26.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.221 -0.925 . . . . 0.0 111.043 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 44' ' ' ILE . 2.7 mp0 48.52 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.051 -1.03 . . . . 0.0 109.611 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -86.21 52.22 4.49 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 9.6 p30 178.48 39.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.241 -1.153 . . . . 0.0 110.258 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.32 -12.84 20.77 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.26 -108.87 0.28 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.23 89.87 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.872 1.459 . . . . 0.0 110.702 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.51 5.59 7.72 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.099 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -50.07 158.44 0.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.048 -1.266 . . . . 0.0 110.172 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.545 HG21 ' O ' ' A' ' 43' ' ' ASN . 16.5 mm -117.11 165.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' N ' HG21 ' A' ' 53' ' ' ILE . 4.4 pttp -179.66 142.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.006 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -140.58 108.84 5.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.831 -0.543 . . . . 0.0 109.601 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.519 HD13 ' N ' ' A' ' 56' ' ' ILE . 1.7 mp -82.87 152.42 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.909 . . . . 0.0 110.59 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -127.38 139.83 52.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.99 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.582 ' CE2' HG23 ' A' ' 67' ' ' VAL . 24.1 m-85 -109.96 103.83 54.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.441 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 46.1 Cg_endo -72.82 -159.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.031 1.543 . . . . 0.0 110.198 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.554 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER 44.51 -172.53 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.094 -1.004 . . . . 0.0 111.526 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.554 ' N ' ' HG3' ' A' ' 60' ' ' GLU . . . -45.06 -18.26 0.13 Allowed Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.737 -0.602 . . . . 0.0 112.992 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -42.82 125.75 3.14 Favored Pre-proline 0 N--CA 1.501 2.097 0 CA-C-N 119.672 1.736 . . . . 0.0 110.302 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 64' ' ' PHE . 50.4 Cg_endo -74.99 -156.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 109.846 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 63' ' ' PRO . 3.4 m-85 57.18 168.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.068 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -104.96 -39.82 6.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.89 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 29.1 p90 179.56 -175.11 0.25 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.74 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.582 HG23 ' CE2' ' A' ' 58' ' ' PHE . 8.2 m -150.93 106.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.961 -1.087 . . . . 0.0 110.779 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 12.1 tttt -107.35 139.41 41.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' HE3' ' A' ' 54' ' ' LYS . 2.7 p30 -159.71 166.13 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.907 -1.121 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HD2' HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -104.69 145.99 29.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.599 -0.688 . . . . 0.0 109.362 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -83.11 -38.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.986 -1.072 . . . . 0.0 110.154 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.05 -33.93 0.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.731 -0.606 . . . . 0.0 111.646 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 6.0 pt-20 174.54 160.42 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.761 -1.212 . . . . 0.0 110.292 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.495 HG21 ' CE1' ' A' ' 81' ' ' TYR . 44.5 t -151.99 92.5 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.827 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -66.56 -169.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.185 -0.947 . . . . 0.0 110.541 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.414 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -153.75 -52.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.5 m -48.38 -34.81 11.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 75.3 m-20 -118.93 6.06 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.388 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 9.0 m-85 58.9 40.6 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.982 . . . . 0.0 110.059 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 103' ' ' LYS . 1.4 tttt -89.02 117.46 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.988 . . . . 0.0 110.65 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.498 ' O ' ' CD1' ' A' ' 102' ' ' ILE . 25.1 t80 -118.4 132.93 56.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' VAL . 4.0 t30 -144.19 104.89 4.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 109.956 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.8 p90 -125.0 164.18 20.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.01 136.37 51.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.756 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.87 114.3 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.504 -0.748 . . . . 0.0 109.199 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 pt -113.94 6.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.029 -1.044 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.1 144.18 5.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.013 -1.054 . . . . 0.0 110.308 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.526 ' N ' HD13 ' A' ' 91' ' ' ILE . . . 84.0 133.48 2.43 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.476 ' CA ' HG11 ' A' ' 67' ' ' VAL . . . 124.18 -134.5 9.2 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' ILE . 45.0 Cg_endo -72.54 -6.32 18.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.919 1.484 . . . . 0.0 110.631 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -35.97 157.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.32 23.91 18.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.1 -146.36 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -1.187 . . . . 0.0 110.089 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.472 ' O ' ' HB ' ' A' ' 122' ' ' THR . 1.2 p -87.22 44.41 1.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -132.59 124.14 27.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.9 OUTLIER -105.72 -71.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.93 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -125.7 132.59 52.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.819 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.481 HG12 HD13 ' A' ' 95' ' ' LEU . 59.8 mt -121.98 121.81 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.264 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.27 157.16 16.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.975 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.13 109.47 5.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.001 -1.062 . . . . 0.0 110.689 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.623 ' O ' HG22 ' A' ' 102' ' ' ILE . 33.6 tt0 -125.95 137.07 53.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.354 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.752 ' HB ' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER 175.71 -157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.242 -0.911 . . . . 0.0 112.837 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.488 ' CB ' ' HA ' ' A' ' 80' ' ' LYS . 14.8 ptmt -172.59 179.52 2.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.26 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.525 HD13 ' CD1' ' A' ' 114' ' ' LEU . 14.8 mm -110.57 146.3 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.614 -0.679 . . . . 0.0 109.832 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.462 HG22 ' HD2' ' A' ' 115' ' ' LYS . 56.8 t -122.12 142.82 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.446 ' HA ' ' OG ' ' A' ' 112' ' ' SER . . . -110.1 133.03 53.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.0 110.424 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 39.5 p -93.82 164.07 21.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 43.3 Cg_endo -64.91 -22.57 62.89 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.915 1.482 . . . . 0.0 111.149 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 22.4 p-10 -175.58 88.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.027 -1.045 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.82 -30.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.05 -133.77 6.2 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -147.84 140.18 24.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -1.128 . . . . 0.0 110.059 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 mt -95.72 120.48 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.863 . . . . 0.0 110.245 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.57 ' HB2' ' CG2' ' A' ' 9' ' ' THR . 3.8 mp -83.25 108.04 16.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.773 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.752 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 18.1 mttt -94.44 121.68 36.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.683 -1.26 . . . . 0.0 109.17 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.741 ' CA ' HG23 ' A' ' 102' ' ' ILE . 34.1 mm -120.98 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.607 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.564 ' N ' HG22 ' A' ' 102' ' ' ILE . 13.0 m -119.06 126.4 51.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.495 -1.378 . . . . 0.0 109.275 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.7 150.32 40.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.948 . . . . 0.0 111.191 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.49 109.54 12.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.453 ' O ' HG11 ' A' ' 2' ' ' VAL . 4.6 m-85 -86.9 135.06 33.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 111.556 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 96' ' ' GLU . 76.6 m-70 -123.08 86.49 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.481 ' CG2' HG21 ' A' ' 128' ' ' VAL . 8.9 p -86.9 -179.2 6.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -0.761 . . . . 0.0 110.902 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -60.04 -147.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.437 -0.789 . . . . 0.0 110.449 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.38 77.9 0.38 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.88 -71.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 109.918 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -85.54 173.65 10.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.896 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 52.8 mt-10 -110.25 -174.15 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 110.431 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.503 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 46.6 t -83.78 145.18 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.33 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -90.42 112.35 23.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.37 -41.82 14.08 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.168 -0.958 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.49 -46.82 76.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.296 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -58.83 -42.59 89.58 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.573 HG23 ' CE2' ' A' ' 5' ' ' TYR . 70.3 t -62.83 -25.81 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.748 0.785 . . . . 0.0 109.224 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.8 ttmt -73.83 -56.95 4.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.705 -0.622 . . . . 0.0 110.492 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -35.64 -52.1 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.688 -0.633 . . . . 0.0 110.952 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 t -57.49 -47.82 80.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -61.42 -28.63 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 135' ' ' ALA . 14.0 mm-40 -69.88 -57.83 4.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.281 -0.887 . . . . 0.0 109.351 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 2.7 mtp -54.81 -35.63 64.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.221 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.69 -39.04 95.12 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.79 -45.93 48.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.869 -1.371 . . . . 0.0 110.888 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 -41.01 92.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.027 -1.046 . . . . 0.0 109.49 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' A' ' 30' ' ' PHE . 1.5 mm? -68.35 -53.8 21.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.511 -0.743 . . . . 0.0 109.887 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 16.1 tp -46.21 -43.72 15.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.145 -0.972 . . . . 0.0 108.811 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.449 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 2.2 ttp180 -66.22 -39.94 89.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.388 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.488 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -55.52 -62.36 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -0.843 . . . . 0.0 109.359 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 60.4 t -62.57 -23.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -61.79 -55.93 24.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.372 -0.83 . . . . 0.0 110.085 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -23.37 53.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.546 ' CG ' HD13 ' A' ' 29' ' ' LEU . 11.3 t80 -56.08 -37.82 69.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.117 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.5 -25.62 62.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.174 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 2.1 mp -88.89 -19.12 26.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.79 -38.41 14.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.838 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.56 156.27 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.846 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 3.3 p -44.26 -53.54 6.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 155' ' ' SER . 23.3 t70 -177.1 64.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.195 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.64 146.29 46.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 110.358 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 63.0 m-85 54.45 70.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 110.48 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.35 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 120' ' ' TYR . 7.9 p -88.03 157.16 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -1.103 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.451 ' CD1' ' CG2' ' A' ' 128' ' ' VAL . 87.7 m-85 -123.6 122.78 39.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 110.03 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.59 98.82 10.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.54 ' CD1' HG13 ' A' ' 133' ' ' VAL . 46.7 m-85 -100.45 103.71 15.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 109.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -108.59 122.28 46.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.953 -1.092 . . . . 0.0 110.109 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.467 ' O ' ' CG ' ' A' ' 8' ' ' GLU . 6.2 t -130.54 166.73 19.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 110.541 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.467 ' CG ' ' O ' ' A' ' 7' ' ' THR . 75.1 mt-10 -155.18 157.69 37.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.564 HG21 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -142.37 -178.51 5.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.015 . . . . 0.0 110.27 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.0 141.8 50.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.039 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.44 ' HB3' HD13 ' A' ' 18' ' ' LEU . 19.6 t -134.42 142.25 47.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.46 0.33 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.54 -0.725 . . . . 0.0 110.124 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.587 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 11.1 mm -96.69 147.99 33.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 33.9 Cg_endo -56.55 157.81 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.885 1.466 . . . . 0.0 110.033 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HA ' HG23 ' A' ' 104' ' ' ILE . . . -68.5 -64.04 0.94 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.072 -1.017 . . . . 0.0 110.886 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.59 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -43.35 -50.52 6.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.732 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.551 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.17 -52.18 65.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 6.0 mt -52.31 -24.1 6.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 108.773 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.636 ' CE2' HD23 ' A' ' 24' ' ' LEU . 43.5 t80 -77.66 -55.66 5.17 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.466 -0.772 . . . . 0.0 110.384 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 5.0 mmmt -61.25 -21.76 64.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.569 -0.707 . . . . 0.0 111.884 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HB1' ' CG ' ' A' ' 158' ' ' TYR . . . -111.39 -47.26 3.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.685 -1.259 . . . . 0.0 112.774 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 39.2 t80 -89.68 -22.08 22.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.718 -1.239 . . . . 0.0 112.482 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.563 HG23 ' CE1' ' A' ' 19' ' ' PHE . 2.1 mp -116.56 -13.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.649 -1.282 . . . . 0.0 110.378 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.636 HD23 ' CE2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -111.96 -12.91 13.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.483 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 9.6 t0 -146.67 47.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.547 ' CA ' ' CE1' ' A' ' 30' ' ' PHE . . . -83.25 -31.16 28.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -76.77 2.96 12.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -1.088 . . . . 0.0 110.321 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.3 t30 -138.62 50.47 1.86 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.574 HD12 ' CE2' ' A' ' 150' ' ' TYR . 1.1 tp 173.06 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.581 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' CA ' ' A' ' 26' ' ' GLY . 3.0 m-30 -52.18 -59.29 8.74 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.919 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -67.06 -11.97 34.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 111.211 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -90.06 -31.58 17.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 111.031 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.557 HG13 ' CD1' ' A' ' 150' ' ' TYR . 10.5 m -103.82 -11.81 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.94 66.6 40.15 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.808 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.4 -5.37 14.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.967 1.509 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -94.9 -12.61 26.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.411 -0.806 . . . . 0.0 109.625 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.02 -28.93 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.668 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 6.7 mm -125.75 178.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.967 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 t -136.35 -45.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 t -174.85 165.16 3.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.5 t -118.58 124.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 110.034 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 42' ' ' GLU . 3.5 tp10 -97.06 124.21 41.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.417 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.84 91.12 8.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.485 HG21 ' N ' ' A' ' 45' ' ' GLU . 6.3 tp -81.52 -24.7 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 110.31 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.485 ' N ' HG21 ' A' ' 44' ' ' ILE . 6.5 tp10 -159.49 75.77 0.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.171 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.78 98.78 1.32 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -81.19 -70.64 0.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -1.149 . . . . 0.0 110.196 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.07 68.14 0.09 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 129.03 -137.83 9.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.99 102.97 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.935 1.492 . . . . 0.0 110.389 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.423 ' HA2' ' NH2' ' A' ' 70' ' ' ARG . . . 126.51 31.39 0.78 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.457 HG23 ' HE3' ' A' ' 54' ' ' LYS . 87.1 m -103.43 117.24 34.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -1.227 . . . . 0.0 110.107 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 45' ' ' GLU . 3.9 mp -97.06 136.71 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' A' ' 52' ' ' THR . 84.6 mttt -139.41 148.99 43.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 6.7 tttt -117.45 96.03 5.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.82 . . . . 0.0 110.653 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 57' ' ' SER . 1.4 mp -73.47 148.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.446 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 27.5 t -124.75 169.38 12.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.271 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 39.4 m-85 -134.33 153.68 79.47 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.601 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 38' ' ' ILE . 48.4 Cg_endo -76.36 169.72 21.39 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.185 1.624 . . . . 0.0 109.615 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 167.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 110.061 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.03 -43.41 3.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 58' ' ' PHE . 8.5 mt -79.96 155.36 75.24 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.083 -1.245 . . . . 0.0 110.65 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 64' ' ' PHE . 50.8 Cg_endo -81.88 162.36 18.48 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.193 1.628 . . . . 0.0 110.971 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 63' ' ' PRO . 11.6 m-85 65.69 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 0.0 110.634 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -69.1 -9.5 52.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.482 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 30.1 p90 -175.75 -170.34 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 110.176 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.552 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 7.3 p -170.93 109.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 3.3 mtmm -96.15 138.42 33.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.751 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.18 -176.06 4.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.691 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' NH2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -138.75 127.91 24.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 109.902 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 55.7 t -68.25 -44.38 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.323 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 1.4 m-20 77.98 -38.2 0.25 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.803 -0.56 . . . . 0.0 111.419 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 179.0 -167.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.696 -1.253 . . . . 0.0 111.001 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.485 HG22 ' CD1' ' A' ' 81' ' ' TYR . 12.2 p -167.91 118.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.628 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -77.26 -49.75 14.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.174 -0.953 . . . . 0.0 110.955 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 0.1 OUTLIER 77.94 -71.16 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.634 -0.666 . . . . 0.0 110.506 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -57.77 -42.49 84.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.316 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 79' ' ' PHE . 15.6 m120 -97.03 18.0 15.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 23.2 m-30 43.49 27.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.525 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.5 ttpt -95.29 107.62 19.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.161 -0.962 . . . . 0.0 109.874 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.485 ' CD1' HG22 ' A' ' 74' ' ' VAL . 20.4 t80 -110.79 96.82 6.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.596 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.2 m-20 -84.39 161.22 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.839 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 13.4 p90 -179.33 152.42 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.44 -0.787 . . . . 0.0 109.768 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.66 146.66 48.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.206 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.6 t -104.97 73.11 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.257 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.413 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 5.4 pt -62.06 -42.51 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.345 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 2.6 mt-10 -139.66 94.91 2.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.898 -1.126 . . . . 0.0 110.709 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.462 ' O ' HD12 ' A' ' 91' ' ' ILE . . . 167.96 120.35 0.52 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.97 -147.35 16.85 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 91' ' ' ILE . 47.7 Cg_endo -72.43 -3.41 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 124.033 1.544 . . . . 0.0 110.22 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -34.85 157.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 121.535 0.683 . . . . 0.0 110.596 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.95 -8.05 59.25 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -108.66 -85.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -1.147 . . . . 0.0 110.396 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.1 -18.89 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.931 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.576 HD23 ' CD2' ' A' ' 120' ' ' TYR . 2.3 mt -80.9 83.35 6.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 110.195 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.88 -52.33 63.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -137.32 165.71 25.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.199 -0.938 . . . . 0.0 110.531 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.415 HD12 HD23 ' A' ' 95' ' ' LEU . 23.1 mt -150.73 122.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.078 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -99.19 135.08 41.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.908 . . . . 0.0 109.761 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 32.9 m120 -137.71 140.89 40.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.75 -1.218 . . . . 0.0 110.972 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 7.0 pt-20 -138.26 154.03 49.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.76 . . . . 0.0 109.546 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.572 HD13 ' CE1' ' A' ' 83' ' ' TYR . 2.9 mt -128.13 155.13 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.469 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 22.9 mtmt -149.1 103.77 3.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 109.502 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 104' ' ' ILE . 2.9 mm -81.53 120.19 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 109.871 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' CD ' ' A' ' 115' ' ' LYS . 61.3 t -105.14 123.08 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.99 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.22 140.31 34.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 44.3 p -113.16 162.17 23.3 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.87 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 48.9 Cg_endo -66.62 -30.62 42.27 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.961 1.506 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -162.86 44.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.31 23.39 2.05 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.96 -135.84 26.65 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.5 p -132.81 134.62 44.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -1.14 . . . . 0.0 110.326 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.411 HG21 ' O ' ' A' ' 9' ' ' THR . 13.2 mt -95.13 124.06 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.564 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.0 OUTLIER -81.86 96.09 7.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 110.964 -179.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' CD ' HG23 ' A' ' 105' ' ' VAL . 3.9 mttp -87.47 107.86 18.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mt -116.78 132.54 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.22 144.06 36.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.519 -0.738 . . . . 0.0 109.589 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 5' ' ' TYR . 44.2 m-80 -136.78 143.46 43.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 110.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.47 108.92 9.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.576 ' CD2' HD23 ' A' ' 95' ' ' LEU . 5.4 m-85 -87.12 114.18 23.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.835 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -101.21 92.12 4.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.224 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.459 ' CG2' HG21 ' A' ' 128' ' ' VAL . 7.6 p -85.27 -151.75 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.827 . . . . 0.0 110.748 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.42 3.07 15.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 110.566 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 96.45 -157.24 21.33 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -1.017 . . . . 0.0 110.248 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 124' ' ' GLY . 1.6 m-70 -81.1 166.21 20.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.895 -1.128 . . . . 0.0 110.009 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -109.58 167.84 9.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.431 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.521 HG12 ' CE2' ' A' ' 5' ' ' TYR . 23.4 t -63.39 150.51 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 110.248 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 132' ' ' GLN . 40.8 mtmt -83.57 102.79 12.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.87 -56.42 3.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.133 -0.98 . . . . 0.0 109.912 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.3 tt0 -44.83 -45.34 10.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.227 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -58.11 -44.71 87.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 108.921 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.54 HG13 ' CD1' ' A' ' 5' ' ' TYR . 79.0 t -60.67 -25.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 135' ' ' ALA . 1.9 tttm -81.88 -68.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.966 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.53 -40.76 0.41 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 110.325 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -51.25 68.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.047 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 6.6 mptt -56.07 -30.65 62.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.489 -0.757 . . . . 0.0 109.557 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 109.876 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 57.0 mmm -67.62 -34.34 76.79 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.864 . . . . 0.0 108.813 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -71.01 -43.32 57.66 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -66.48 -33.76 76.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -1.157 . . . . 0.0 110.108 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 2.0 p -70.59 -43.45 69.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.271 -0.893 . . . . 0.0 109.23 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -70.08 -25.27 63.44 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.548 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.532 ' CD2' HG22 ' A' ' 9' ' ' THR . 17.2 tp -73.3 -43.32 61.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 108.901 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.576 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -72.32 -25.64 61.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.576 ' N ' ' HG3' ' A' ' 145' ' ' ARG . . . -70.84 -53.94 13.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 109.028 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.51 ' CG1' HD22 ' A' ' 29' ' ' LEU . 62.1 t -70.61 -21.86 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.154 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 149' ' ' SER . 0.4 OUTLIER -69.55 -52.39 26.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.315 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.478 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 88.9 p -74.87 -23.13 58.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.333 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.574 ' CE2' HD12 ' A' ' 29' ' ' LEU . 9.1 t80 -59.04 -41.8 88.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.94 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.09 -27.7 69.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.435 HD21 ' HA ' ' A' ' 149' ' ' SER . 0.3 OUTLIER -86.35 -23.63 26.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.15 -55.49 5.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.227 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.472 ' O ' ' HB3' ' A' ' 155' ' ' SER . 15.9 m-70 -73.8 -34.11 64.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 110.064 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 23.1 t 59.36 15.02 4.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 156' ' ' ASP . 1.7 p30 -145.48 12.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.95 . . . . 0.0 110.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.571 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.85 131.16 48.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.494 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 41.4 m-85 58.03 48.02 13.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.421 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.209 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG11 ' N ' ' A' ' 3' ' ' PHE . 47.1 t -105.72 165.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -1.21 . . . . 0.0 110.537 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 53.6 m-85 -125.29 148.4 48.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.785 . . . . 0.0 109.65 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -117.2 110.08 17.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 110.539 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.583 ' CD2' HG12 ' A' ' 133' ' ' VAL . 23.0 m-85 -108.75 76.7 1.03 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.598 -0.689 . . . . 0.0 109.527 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 85.7 mt-10 -84.05 96.72 8.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 110.879 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.423 HG21 ' HB ' ' A' ' 116' ' ' ILE . 5.0 t -106.29 163.17 13.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.836 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -135.33 144.44 46.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.146 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.595 HG21 ' CB ' ' A' ' 114' ' ' LEU . 1.1 t -134.39 161.48 34.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.86 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.433 HG22 HG22 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -123.52 143.64 50.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.99 . . . . 0.0 110.341 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -135.8 147.33 48.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 110.24 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.03 -20.93 19.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 109.772 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.536 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 6.4 mm -75.93 140.0 70.08 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.7 Cg_endo -57.22 148.95 67.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.807 1.425 . . . . 0.0 110.568 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' CG2' ' A' ' 104' ' ' ILE . . . -55.08 -46.09 75.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 0.0 111.275 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.0 -58.98 5.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 111.009 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.513 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 6.4 mtm180 -53.95 -57.35 11.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 109.671 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.536 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.48 -32.11 7.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.561 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.574 ' CE1' HD23 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -68.34 -62.77 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.525 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 26.5 mtpp -59.54 -23.06 62.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.519 -0.738 . . . . 0.0 112.842 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.583 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -106.08 -55.73 2.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.481 -1.387 . . . . 0.0 111.943 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 57.7 t80 -79.19 -9.33 59.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 0.0 112.07 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.526 HG23 ' CE1' ' A' ' 19' ' ' PHE . 71.4 mt -130.07 -21.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.627 -1.296 . . . . 0.0 111.63 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.574 HD23 ' CE1' ' A' ' 19' ' ' PHE . 2.7 mt -106.18 -14.93 15.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.224 . . . . 0.0 109.536 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.515 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -138.39 30.67 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.441 -0.787 . . . . 0.0 110.416 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.3 -36.95 93.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' HB3' HG13 ' A' ' 41' ' ' VAL . 52.1 m-20 -60.89 -14.57 23.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -1.047 . . . . 0.0 109.815 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t30 -122.47 52.12 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.586 HD22 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -172.4 -52.26 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.493 -0.755 . . . . 0.0 110.102 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.554 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 7.1 m-30 -43.73 -53.91 11.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 111.093 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -67.02 -29.57 40.19 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.346 1.182 . . . . 0.0 111.065 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -77.42 -71.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 111.17 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' CG1' ' CD1' ' A' ' 150' ' ' TYR . 22.2 m -71.99 -20.49 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 111.596 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -126.18 63.17 48.99 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.897 -1.127 . . . . 0.0 111.106 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.7 Cg_endo -69.26 -11.42 31.44 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.858 1.451 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.5 OUTLIER -87.08 -8.18 57.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.501 -0.749 . . . . 0.0 109.578 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' CB ' HD22 ' A' ' 143' ' ' LEU . . . -117.53 -48.53 2.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.974 . . . . 0.0 110.392 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HE2' ' A' ' 139' ' ' MET . 2.9 mp -117.69 156.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.077 -1.014 . . . . 0.0 110.199 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -113.55 -31.04 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER 169.53 159.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.81 . . . . 0.0 109.905 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 27' ' ' ASP . 3.4 p -126.9 129.51 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.925 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -105.65 141.41 37.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 110.589 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -99.9 108.7 21.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.978 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -85.08 -33.02 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.499 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -149.06 92.21 1.94 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.173 -0.954 . . . . 0.0 110.54 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.92 161.76 9.53 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -125.04 22.53 7.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.262 -1.14 . . . . 0.0 110.313 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.34 147.51 18.47 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.88 -166.39 20.28 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . 45.7 Cg_endo -72.35 126.9 12.06 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.074 1.565 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.29 7.54 55.91 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.4 m -91.09 132.39 36.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -1.17 . . . . 0.0 110.353 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.2 mm -106.37 116.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.731 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.47 162.4 18.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.074 . . . . 0.0 110.708 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -134.21 113.49 12.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.579 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.54 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 1.9 mp -81.49 144.7 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.403 ' N ' HG21 ' A' ' 56' ' ' ILE . 10.1 t -125.9 101.43 6.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.622 -0.674 . . . . 0.0 109.844 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 38.6 m-85 -70.06 140.23 88.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 50.5 Cg_endo -82.74 48.28 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.165 1.613 . . . . 0.0 110.4 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 5.1 tt0 -135.04 -170.82 2.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.382 -0.824 . . . . 0.0 110.357 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.08 37.36 3.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' A' ' 60' ' ' GLU . 79.1 mt -56.1 163.2 2.4 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.311 -1.111 . . . . 0.0 110.168 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 64' ' ' PHE . 46.6 Cg_endo -73.38 -9.47 23.06 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.021 1.538 . . . . 0.0 110.257 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 3.8 m-85 -114.88 -34.51 5.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.128 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 1.5 ttpt 74.45 -0.41 3.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.603 -0.685 . . . . 0.0 109.997 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 32.9 p90 179.88 -161.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.583 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 8.7 p -179.45 118.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.308 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HG3' ' HG3' ' A' ' 55' ' ' LYS . 2.7 tttt -87.67 138.57 31.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -140.29 163.89 31.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.087 -1.008 . . . . 0.0 110.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 83' ' ' TYR . 5.8 mtm180 -121.82 139.54 53.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.384 -0.822 . . . . 0.0 109.943 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' ASP . 24.6 t -73.21 -17.92 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.942 . . . . 0.0 110.262 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER 44.99 27.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.959 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.7 mt-10 65.76 148.6 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.595 ' CG1' ' CD1' ' A' ' 81' ' ' TYR . 27.3 m -123.23 -170.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.545 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.04 152.28 42.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.39 -52.61 2.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.021 -1.05 . . . . 0.0 110.633 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.3 m -61.4 -10.91 8.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.856 -1.152 . . . . 0.0 110.599 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -125.19 6.44 7.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.015 -1.053 . . . . 0.0 110.535 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.539 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.7 m-30 46.83 54.97 8.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 29.3 tttt -124.14 105.52 9.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 111.143 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.595 ' CD1' ' CG1' ' A' ' 74' ' ' VAL . 74.2 t80 -89.72 178.23 6.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 109.315 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.427 ' N ' ' CG ' ' A' ' 81' ' ' TYR . 5.9 t30 -179.2 129.81 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.788 -1.195 . . . . 0.0 110.642 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 3.8 p90 -137.77 152.46 49.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.802 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.18 132.4 44.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.643 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.55 133.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 109.331 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.3 -14.96 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 111.328 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' CA ' HD11 ' A' ' 91' ' ' ILE . 1.4 mm-40 -150.67 107.57 3.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.93 -1.106 . . . . 0.0 110.917 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.586 ' N ' ' CD1' ' A' ' 91' ' ' ILE . . . 127.04 -137.75 10.12 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 64' ' ' PHE . . . 26.69 -128.22 0.05 OUTLIER Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.567 ' O ' ' C ' ' A' ' 91' ' ' ILE . 42.8 Cg_endo -70.86 -59.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.877 1.462 . . . . 0.0 109.376 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 88' ' ' GLY . 1.8 mt 4.59 90.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 121.746 0.784 . . . . 0.0 112.893 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.95 -149.34 6.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.98 -18.82 5.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.287 . . . . 0.0 109.435 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.515 ' CG2' ' HB2' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -128.12 136.26 50.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.81 . . . . 0.0 109.964 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.507 ' CD1' ' CD2' ' A' ' 120' ' ' TYR . 4.6 mt 63.38 92.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.294 -0.878 . . . . 0.0 110.063 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.78 -34.88 21.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -140.77 150.01 42.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.017 . . . . 0.0 110.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.521 HD12 ' CG ' ' A' ' 90' ' ' PRO . 58.9 mt -139.59 126.23 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.5 m -117.41 110.44 18.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' ' 118' ' ' ASN . 1.9 m120 -106.86 119.45 39.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.905 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.413 ' O ' HD12 ' A' ' 102' ' ' ILE . 53.7 mt-10 -105.51 132.37 51.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 109.418 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 116' ' ' ILE . 20.0 mm -124.31 155.95 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.093 -1.004 . . . . 0.0 110.915 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 2.8 ttmt -148.2 114.5 5.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.796 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 15' ' ' ALA . 1.5 mp -77.41 121.27 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.01 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.532 HG22 ' CG ' ' A' ' 115' ' ' LYS . 61.9 t -104.45 133.4 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 110.435 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.26 132.37 44.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.0 p -106.68 157.87 34.12 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.018 . . . . 0.0 110.625 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 109' ' ' ASP . 49.6 Cg_endo -67.63 81.88 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.156 1.609 . . . . 0.0 110.218 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 7.6 t70 71.02 49.69 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.567 -0.708 . . . . 0.0 110.275 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.65 13.9 1.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.87 -159.21 34.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.488 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 3.4 p -126.38 131.09 51.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -1.129 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 10' ' ' THR . 6.1 mt -93.79 116.89 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.595 ' CB ' HG21 ' A' ' 9' ' ' THR . 0.7 OUTLIER -77.69 106.4 9.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 110.703 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' CG ' HG22 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -82.06 115.63 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.881 -1.137 . . . . 0.0 108.952 178.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.473 ' HA ' HD11 ' A' ' 102' ' ' ILE . 81.7 mt -113.79 127.99 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 111.199 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -126.72 95.55 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.524 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 72.2 m-20 -93.08 108.29 19.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 111.403 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 124.94 39.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 109.322 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' CD2' ' CD1' ' A' ' 95' ' ' LEU . 2.6 m-85 -103.34 112.22 25.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 111.115 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -96.19 98.15 10.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.68 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.492 ' CG2' HG22 ' A' ' 128' ' ' VAL . 11.3 p -82.69 -173.1 4.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.334 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' THR . 0.0 OUTLIER 170.27 43.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.46 -152.14 5.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.62 -69.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -1.14 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.515 ' HB2' ' CG2' ' A' ' 94' ' ' THR . 7.1 m-70 -80.53 176.28 9.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.182 -0.949 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 11.8 mp0 -106.02 -99.98 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.548 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 122' ' ' THR . 40.1 t -126.41 151.5 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.704 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 130' ' ' ALA . 6.4 mtmt -104.43 99.3 9.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.02 -42.8 2.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.328 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 9.4 tt0 -54.81 -49.01 72.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.043 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -58.92 -46.37 88.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 109.45 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 5' ' ' TYR . 38.5 t -62.23 -20.74 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.15 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.0 tttm -81.14 -68.57 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.6 -40.57 0.41 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 110.189 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.45 -51.61 66.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.179 -0.951 . . . . 0.0 109.105 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -54.92 -52.57 62.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 109.981 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -50.27 -46.45 55.08 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.432 ' HE2' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -60.79 -34.99 75.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.29 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.53 -34.46 89.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -71.83 -45.45 61.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -1.192 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -37.1 80.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 108.857 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.528 HD22 ' CB ' ' A' ' 37' ' ' ALA . 1.3 mm? -69.24 -37.92 78.24 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.504 HD23 HG22 ' A' ' 9' ' ' THR . 13.6 tp -62.08 -34.62 76.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -33.91 61.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.649 -0.657 . . . . 0.0 109.728 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.49 -50.06 66.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.844 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.465 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 34.4 t -74.74 -27.88 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.793 . . . . 0.0 109.772 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.475 ' HG3' HG12 ' A' ' 13' ' ' ILE . 10.7 tt0 -65.61 -44.42 86.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 34.5 m -86.79 -21.32 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 109.939 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.586 ' CD2' HD22 ' A' ' 29' ' ' LEU . 5.3 t80 -58.81 -44.42 90.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.573 HD21 ' CD2' ' A' ' 150' ' ' TYR . 52.6 mt -63.08 -24.41 67.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.96 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.6 mp -82.36 -36.86 26.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 110.361 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.46 -53.86 10.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.0 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.456 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 44.6 m-70 -75.39 -32.35 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.993 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.5 t 46.48 23.68 0.24 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 154' ' ' HIS . 4.7 m-20 -141.51 9.18 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.485 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -113.18 128.81 56.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.583 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 28.2 m-85 61.93 41.72 11.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.477 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.216 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.526 HG11 ' N ' ' A' ' 3' ' ' PHE . 54.8 t -82.63 152.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 83.2 m-85 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -108.18 116.04 31.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.995 -1.065 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 3' ' ' PHE . 21.3 m-85 -114.98 86.34 2.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 0.0 110.729 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.477 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.9 mt-10 -51.25 147.15 5.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 108.917 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.488 ' HB ' ' OD1' ' A' ' 118' ' ' ASN . 12.3 t -141.06 173.52 11.4 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.51 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER 178.31 126.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.452 0.644 . . . . 0.0 110.07 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -129.95 158.23 40.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 140.21 49.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.832 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.513 ' CB ' HD13 ' A' ' 18' ' ' LEU . 92.7 p -132.48 148.33 52.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.622 -0.674 . . . . 0.0 109.786 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -23.05 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 110.297 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.542 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 14.8 mm -81.85 143.1 49.52 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.576 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -57.17 150.51 56.95 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.04 1.547 . . . . 0.0 110.946 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB3' ' CG2' ' A' ' 104' ' ' ILE . . . -51.84 -49.07 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 110.699 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -54.42 -55.09 32.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.971 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 9.6 mmt85 -54.9 -55.75 27.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.111 -0.993 . . . . 0.0 110.657 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.542 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 9.9 mt -58.87 -24.49 62.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.908 -1.12 . . . . 0.0 109.483 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.534 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -67.64 -56.02 11.02 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.58 -0.7 . . . . 0.0 109.789 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.5 mtpt -68.9 -25.09 64.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.618 -0.676 . . . . 0.0 112.128 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -103.89 -55.85 2.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.658 -1.276 . . . . 0.0 111.625 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.526 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.4 t80 -84.1 -1.41 54.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 112.203 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 12.8 mt -134.4 -22.95 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.555 -1.34 . . . . 0.0 111.38 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -105.87 -22.78 12.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 108.87 178.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -131.98 70.04 1.47 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.699 -0.626 . . . . 0.0 109.899 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -97.44 -43.31 2.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -69.9 -9.99 56.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -1.111 . . . . 0.0 110.337 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 11.7 t30 -130.56 52.02 2.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.78 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.611 HD22 ' CE2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER 173.49 -26.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.675 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.544 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 3.8 m-30 -56.78 -58.74 15.42 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.253 -0.904 . . . . 0.0 110.601 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.4 Cg_endo -64.67 -29.95 60.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.829 1.436 . . . . 0.0 111.205 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -16.18 63.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.092 -1.005 . . . . 0.0 110.552 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.597 HG13 ' CD1' ' A' ' 150' ' ' TYR . 9.0 m -123.63 -10.75 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.943 . . . . 0.0 110.271 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.11 66.66 46.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.803 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.67 -9.71 26.96 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.871 1.458 . . . . 0.0 109.821 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -88.98 -10.87 46.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -118.03 -57.42 2.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 109.946 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 30' ' ' PHE . 13.5 mm -95.14 170.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 0.0 110.45 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.63 -41.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.2 t -169.13 171.93 7.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 42' ' ' GLU . 60.1 t -136.8 149.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 55' ' ' LYS . 3.9 tt0 -119.1 104.14 10.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.463 -0.773 . . . . 0.0 109.498 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 1.6 m-20 -90.16 104.77 17.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.333 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.425 HG22 ' OE1' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -65.89 -21.52 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 110.058 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 6.4 pt-20 -172.92 129.24 0.49 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 0.0 109.916 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.58 58.44 0.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -144.72 11.97 1.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -1.181 . . . . 0.0 110.231 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.79 -154.49 18.43 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.27 -80.75 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.79 60.07 7.42 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.24 1.653 . . . . 0.0 110.44 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' CD1' ' A' ' 53' ' ' ILE . . . 168.79 -25.61 0.11 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.125 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 51' ' ' GLY . 77.1 m -39.39 128.3 1.84 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.273 -1.133 . . . . 0.0 110.752 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.539 ' CD1' ' O ' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -112.41 156.13 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' N ' HG21 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -139.85 153.3 47.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.866 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HG2' ' CG ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.81 87.97 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 110.6 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.518 ' HB ' HG11 ' A' ' 67' ' ' VAL . 1.9 mp -69.68 146.92 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.005 -1.06 . . . . 0.0 109.873 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.45 155.52 46.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.607 -0.683 . . . . 0.0 109.885 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.606 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 30.1 m-85 -119.02 161.46 36.36 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.067 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' GLU . 47.5 Cg_endo -74.9 -164.73 0.24 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.059 1.557 . . . . 0.0 110.08 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER 40.0 -166.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.483 -0.761 . . . . 0.0 111.183 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.542 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -109.48 62.26 0.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.565 ' CD1' ' CB ' ' A' ' 58' ' ' PHE . 13.3 mt -40.84 167.01 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.953 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 42.2 Cg_endo -68.97 -6.68 18.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.88 1.463 . . . . 0.0 110.277 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 18.7 m-30 -114.0 -100.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 166.09 -28.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 108.992 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 30.2 p90 -177.01 -164.55 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.606 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 3.6 p -166.25 128.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 0.0 110.547 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.549 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -103.03 147.35 27.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -145.01 146.01 31.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HD3' HD13 ' A' ' 53' ' ' ILE . 12.0 ttp180 -117.32 134.4 54.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.3 131.1 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 110.271 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -103.31 52.03 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 16.2 mm-40 59.22 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.297 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 81' ' ' TYR . 35.1 t -105.4 147.84 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.638 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.7 OUTLIER -63.25 -51.64 65.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 73.25 -75.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.546 -0.721 . . . . 0.0 110.887 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -60.53 -11.7 7.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.839 -1.163 . . . . 0.0 110.638 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -122.3 5.06 9.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 0.0 110.474 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.469 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.2 m-30 54.92 65.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.317 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HB2' ' CB ' ' A' ' 75' ' ' ASP . 5.1 mttp -142.66 108.82 5.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.658 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.507 ' CE1' HG23 ' A' ' 74' ' ' VAL . 7.4 t80 -95.25 123.57 38.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 110.838 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -119.94 123.37 43.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.486 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 84' ' ' SER . 2.7 p90 -148.89 174.06 12.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 110.698 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.41 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 10.5 p -140.2 167.66 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.593 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 23.5 t -92.64 -54.2 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.593 ' CG1' ' O ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER 69.67 -18.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 2.1 tt0 170.68 162.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.543 -1.348 . . . . 0.0 110.403 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.444 ' O ' ' CG1' ' A' ' 91' ' ' ILE . . . 81.76 -173.08 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.79 -147.96 47.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 49.4 Cg_endo -81.39 32.67 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.99 1.521 . . . . 0.0 110.94 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.444 ' CG1' ' O ' ' A' ' 88' ' ' GLY 0.297 1.5 mm -67.55 138.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 142.89 -165.94 26.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 44.6 -141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 122' ' ' THR . 1.8 p -89.06 72.15 8.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.584 HD23 ' CD2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -168.36 82.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.333 -0.854 . . . . 0.0 110.044 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.501 ' OE2' ' CE ' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -63.62 -59.0 5.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.434 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HG3' ' HB2' ' A' ' 121' ' ' HIS . 1.6 pttm -135.97 162.26 33.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.969 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.532 HG22 ' CE1' ' A' ' 120' ' ' TYR . 95.7 mt -139.15 122.23 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 111.289 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.6 151.96 20.59 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.517 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 53.6 t30 -154.75 147.48 24.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.873 -1.142 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.581 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -141.25 152.63 44.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.689 -0.632 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.74 ' HA ' ' HB ' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -152.62 144.6 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.294 0.569 . . . . 0.0 110.044 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.548 ' N ' HG12 ' A' ' 116' ' ' ILE . 4.1 ptmm? -116.13 134.6 54.76 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.901 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.551 ' CD1' ' HG ' ' A' ' 114' ' ' LEU . 10.9 mm -92.18 90.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.673 -0.642 . . . . 0.0 109.86 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CG2' ' HG3' ' A' ' 103' ' ' LYS . 17.2 t -87.02 133.97 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.349 -0.844 . . . . 0.0 110.372 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.93 133.1 35.99 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.632 -0.668 . . . . 0.0 109.668 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.1 p -87.65 155.93 53.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.297 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.27 -11.55 32.62 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -175.43 86.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 170.48 -88.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.03 -135.18 1.77 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.518 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 5.0 p -124.93 170.42 11.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -1.156 . . . . 0.0 109.889 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.53 ' CG2' ' OE2' ' A' ' 8' ' ' GLU . 36.5 mt -139.22 123.55 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 111.203 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 5.6 mp -93.43 93.83 8.36 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.623 ' O ' HG12 ' A' ' 116' ' ' ILE . 5.6 pttt -131.45 138.24 48.96 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.821 -1.152 . . . . 0.0 113.589 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.74 ' HB ' ' HA ' ' A' ' 102' ' ' ILE . 1.2 mm -178.71 -95.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.579 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 0.8 OUTLIER -175.07 177.4 1.94 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.835 -1.166 . . . . 0.0 112.686 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.1 m120 -142.44 106.56 4.74 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -92.5 122.88 35.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 111.06 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.584 ' CD2' HD23 ' A' ' 95' ' ' LEU . 2.5 m-85 -96.81 109.33 22.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.404 -0.81 . . . . 0.0 109.646 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.484 ' HB2' ' HG3' ' A' ' 97' ' ' LYS . 76.6 m-70 -89.06 104.02 16.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.461 HG23 ' HG ' ' A' ' 95' ' ' LEU . 3.0 p -116.43 -158.04 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.491 -0.755 . . . . 0.0 109.881 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.501 ' CE ' ' OE2' ' A' ' 96' ' ' GLU . 3.5 pttp -177.12 143.77 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 129.15 -98.0 0.43 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.19 -48.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -56.83 144.5 32.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' VAL . 52.3 mt-10 -89.86 148.86 22.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 110.403 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 3' ' ' PHE . 13.3 t -41.34 164.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.499 -0.751 . . . . 0.0 110.174 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.458 ' N ' ' CG1' ' A' ' 128' ' ' VAL . 5.0 mtmt -111.49 131.53 55.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.38 -44.88 84.84 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.033 -1.042 . . . . 0.0 109.413 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -31.51 16.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.469 ' NE2' HD11 ' A' ' 95' ' ' LEU . 25.9 mt-30 -79.23 -40.67 30.09 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.233 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.551 HG23 ' CE2' ' A' ' 5' ' ' TYR . 2.6 t -78.84 -0.3 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.655 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.27 -42.52 4.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.8 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -57.79 -44.91 86.58 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.72 86.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.344 -0.848 . . . . 0.0 109.533 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -64.34 -21.85 66.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 108.984 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 5.7 tm-20 -77.61 -44.92 26.74 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.657 -0.652 . . . . 0.0 109.299 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.449 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 40.2 mmm -64.5 -34.53 78.44 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.13 -42.74 75.21 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.78 -27.52 64.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.092 -1.24 . . . . 0.0 109.877 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -75.76 -35.33 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 108.965 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -77.18 -28.15 53.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.136 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.529 ' CD2' HG22 ' A' ' 9' ' ' THR . 11.4 tp -70.89 -42.51 69.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.1 ttt85 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.453 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -60.06 -58.27 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.053 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 87.2 t -62.53 -25.09 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.619 -0.676 . . . . 0.0 109.67 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 2.9 mt-10 -65.31 -50.55 65.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -15.74 53.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.611 ' CE2' HD22 ' A' ' 29' ' ' LEU . 10.9 t80 -67.44 -37.42 82.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 109.811 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 150' ' ' TYR . 65.5 mt -67.87 -18.43 64.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.976 -1.078 . . . . 0.0 109.321 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.498 ' N ' HD11 ' A' ' 152' ' ' LEU . 3.0 mp -89.79 -40.71 12.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.657 -0.652 . . . . 0.0 110.955 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.96 -47.86 14.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 111.03 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.522 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 62.1 m-70 -79.94 81.44 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.274 -0.891 . . . . 0.0 110.936 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 154' ' ' HIS . 58.4 m 38.23 -94.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 111.033 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.516 ' HB3' ' ND2' ' A' ' 159' ' ' ASN . 24.9 m-20 -155.12 51.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.682 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.54 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -49.29 145.12 4.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.961 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.592 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 70.2 m-85 57.03 69.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.257 -0.902 . . . . 0.0 110.273 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 156' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.219 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.578 HG23 ' CE1' ' A' ' 121' ' ' HIS . 61.7 t -47.15 156.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 64.8 m-85 -117.97 96.56 5.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.868 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.5 121.68 19.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.054 -1.029 . . . . 0.0 111.469 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 3' ' ' PHE . 22.0 m-85 -117.01 112.06 20.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.36 132.84 52.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 111.489 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -157.69 173.32 17.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.3 pp20? -145.68 149.94 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.806 -1.184 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.505 ' CG2' ' CD2' ' A' ' 144' ' ' LEU . 0.6 OUTLIER -124.56 172.86 8.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.88 142.22 51.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.992 -1.068 . . . . 0.0 111.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.451 ' HB3' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -131.81 147.6 52.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.665 -0.647 . . . . 0.0 109.622 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -18.18 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.331 -0.856 . . . . 0.0 109.921 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.491 ' O ' HD13 ' A' ' 18' ' ' LEU . 5.7 mm -83.33 140.86 42.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.479 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 35.6 Cg_endo -59.03 152.61 57.49 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.848 1.446 . . . . 0.0 111.17 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . . . -53.06 -47.92 68.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 111.24 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -57.55 -59.04 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.564 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.542 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 2.6 mmt180 -47.18 -57.81 4.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 109.904 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.566 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -51.4 -37.19 47.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 109.625 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.681 ' CE1' ' CD2' ' A' ' 24' ' ' LEU . 3.8 t80 -62.13 -69.14 0.27 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.851 -1.156 . . . . 0.0 109.848 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 7.1 mtmt -50.99 -24.82 3.99 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 112.1 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.576 ' HA ' ' CE1' ' A' ' 158' ' ' TYR . . . -113.66 -63.53 1.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.584 -1.322 . . . . 0.0 111.459 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 24.7 t80 -60.55 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.742 -1.224 . . . . 0.0 110.207 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.549 ' CG2' HD22 ' A' ' 24' ' ' LEU . 31.2 mm -48.24 -81.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.763 -1.211 . . . . 0.0 108.129 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.681 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 2.5 mt -57.76 160.4 4.53 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.244 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER 44.85 54.57 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.107 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -99.74 -35.11 4.72 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -81.66 15.4 2.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -1.139 . . . . 0.0 110.635 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 8.2 t30 -135.0 42.96 2.74 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.6 HD12 ' CE2' ' A' ' 150' ' ' TYR . 1.0 OUTLIER 175.26 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 4.7 m-30 -42.25 -55.55 6.43 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.763 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.7 Cg_endo -65.82 -49.28 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.708 1.373 . . . . 0.0 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -45.47 -52.56 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 111.159 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.574 HG13 ' CD1' ' A' ' 150' ' ' TYR . 9.3 m -86.21 -16.76 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.93 . . . . 0.0 110.847 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.453 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -135.69 71.96 63.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.74 -19.51 41.25 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.887 1.467 . . . . 0.0 109.464 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -83.98 -9.74 58.44 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.602 -0.686 . . . . 0.0 109.149 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -105.84 -57.22 2.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.523 ' CD1' HD22 ' A' ' 143' ' ' LEU . 2.0 mp -117.62 165.93 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 110.152 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.497 ' N ' HG21 ' A' ' 38' ' ' ILE . 4.4 m -130.26 -46.98 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 169.11 24.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.888 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -137.34 119.62 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.199 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 7.5 mt-10 -86.91 116.07 24.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 110.139 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -94.32 99.44 11.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.409 -0.807 . . . . 0.0 110.212 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 45' ' ' GLU . 1.5 tp -71.47 -3.96 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 0.0 110.019 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER 68.81 111.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 110.286 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.97 -117.59 1.7 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -81.04 -38.22 27.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 0.0 110.084 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.17 -26.34 11.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.46 -81.25 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.27 88.81 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.164 1.612 . . . . 0.0 110.257 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 71' ' ' VAL . . . 102.77 38.36 2.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.401 HG23 ' HD2' ' A' ' 54' ' ' LYS . 2.7 m -81.42 146.37 30.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -1.063 . . . . 0.0 110.455 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.497 HG22 HD12 ' A' ' 53' ' ' ILE . 1.1 mt -115.08 118.85 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.859 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 8.8 mttp -143.11 154.08 43.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 42' ' ' GLU . 76.0 mttt -120.36 140.6 51.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.592 -0.693 . . . . 0.0 110.161 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.516 HG23 ' CE1' ' A' ' 58' ' ' PHE . 1.4 mp -113.2 123.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -104.69 115.91 31.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.463 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.612 ' CD2' ' CD1' ' A' ' 62' ' ' LEU . 13.1 m-85 -75.22 167.38 37.31 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.183 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 60' ' ' GLU . 49.6 Cg_endo -81.91 66.21 8.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.011 1.532 . . . . 0.0 109.854 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' PRO . 3.8 tt0 44.37 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.473 -0.767 . . . . 0.0 111.103 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.3 -51.98 1.85 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.612 ' CD1' ' CD2' ' A' ' 58' ' ' PHE . 4.0 mt -60.25 163.55 8.15 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.273 -1.133 . . . . 0.0 110.395 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.4 -25.0 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.934 1.492 . . . . 0.0 109.237 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.2 m-85 -103.44 -148.15 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.336 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.3 tttt -137.93 -10.36 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.971 -1.081 . . . . 0.0 111.402 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 47.5 p90 -176.83 -157.93 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.656 -1.277 . . . . 0.0 111.011 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 8.3 p -169.44 113.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.524 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 7.1 tttt -87.75 153.1 21.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.982 -1.074 . . . . 0.0 109.809 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.524 ' N ' ' HG2' ' A' ' 68' ' ' LYS . 4.9 p-10 -136.88 148.89 47.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.04 -1.037 . . . . 0.0 110.626 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.479 ' NE ' HD12 ' A' ' 86' ' ' ILE . 22.4 mtt180 -128.01 104.27 7.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 72' ' ' ASP . 52.6 t -73.51 148.88 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.122 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.454 ' N ' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -121.2 -14.0 8.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.382 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.82 170.8 3.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 7.4 p -170.67 108.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 6.0 t0 -74.81 -156.19 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.928 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -159.76 -57.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 0.0 110.796 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.9 m -50.57 -42.05 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.39 3.51 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.559 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 18.8 m-85 57.03 91.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.142 -0.974 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.459 ' HB2' ' NZ ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -139.66 106.19 5.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 0.0 110.289 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -101.07 152.6 20.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.08 -1.013 . . . . 0.0 109.68 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.405 ' ND2' ' HG2' ' A' ' 101' ' ' GLU . 0.8 OUTLIER -152.74 132.75 13.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.115 -0.99 . . . . 0.0 110.722 -179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.3 169.26 24.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 109.719 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -134.57 157.9 45.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 110.281 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.488 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 3.5 t -104.83 136.34 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 109.039 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.488 ' CG2' ' C ' ' A' ' 85' ' ' VAL . 6.0 pt -148.61 14.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.794 -1.191 . . . . 0.0 111.432 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -169.42 89.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.82 -1.175 . . . . 0.0 110.921 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.544 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 126.05 -148.79 17.18 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 88' ' ' GLY . . . 29.85 -118.56 0.08 OUTLIER Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.558 ' O ' ' C ' ' A' ' 91' ' ' ILE . 39.3 Cg_endo -69.46 -73.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.975 1.513 . . . . 0.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.558 ' C ' ' O ' ' A' ' 90' ' ' PRO . 1.5 mm 9.6 59.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.687 0.756 . . . . 0.0 112.863 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' PRO . . . -158.09 152.02 23.18 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' THR . 7.4 t70 63.59 -162.29 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.243 . . . . 0.0 109.954 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.417 ' C ' ' O ' ' A' ' 93' ' ' ASP . 44.1 p -43.01 -44.07 4.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.144 -0.973 . . . . 0.0 110.108 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.49 119.63 4.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.79 -55.4 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.163 -0.96 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.511 ' C ' ' CG1' ' A' ' 98' ' ' ILE . 5.2 mmtt -113.44 157.12 22.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.195 -0.941 . . . . 0.0 109.829 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.534 ' CD1' ' HG2' ' A' ' 90' ' ' PRO . 8.5 mt -154.11 122.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.147 -0.971 . . . . 0.0 110.406 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 1.4 t -107.31 123.6 48.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 109.856 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.71 108.38 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 111.28 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.54 ' O ' ' CG1' ' A' ' 102' ' ' ILE . 43.2 mt-10 -99.05 165.15 11.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.815 . . . . 0.0 109.37 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 101' ' ' GLU . 12.4 mt -157.17 137.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -138.61 109.52 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 110.173 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 79' ' ' PHE . 50.8 mt -75.43 151.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.478 HG22 ' HG2' ' A' ' 115' ' ' LYS . 3.6 t -131.2 131.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.068 -1.02 . . . . 0.0 110.766 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.69 136.86 36.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.611 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.5 p -121.11 144.66 40.02 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.917 . . . . 0.0 110.581 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.32 -7.96 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.137 1.599 . . . . 0.0 110.739 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 10.5 p30 -166.89 85.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.13 -23.11 0.23 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.26 -139.61 15.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.464 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 79.9 p -115.0 172.06 7.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.262 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 4.9 mt -140.47 122.76 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.807 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 114' ' ' LEU . 3.7 mm? -84.85 102.16 12.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.616 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 103' ' ' LYS . 7.0 mmmt -79.11 91.55 4.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.4 mm -79.08 138.32 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.344 -0.847 . . . . 0.0 111.078 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.35 139.5 37.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' A' ' 5' ' ' TYR . 3.8 p-10 -164.58 109.33 0.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.69 -1.256 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HD3' ' NE2' ' A' ' 121' ' ' HIS . 12.9 ptpt -98.22 132.08 44.02 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.288 -0.882 . . . . 0.0 109.207 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.529 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 2.2 m-85 -90.54 141.72 28.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.578 ' CE1' HG23 ' A' ' 2' ' ' VAL . 28.3 m-70 -117.38 92.57 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.659 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 p -102.01 -170.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -140.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.961 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.77 33.79 5.96 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 126' ' ' HIS . 1.1 t0 -160.71 163.01 32.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 110.081 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.472 ' O ' ' O ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER 53.2 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.109 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' VAL . 3.1 pt-20 -77.6 147.42 35.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.118 -0.989 . . . . 0.0 110.247 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 3' ' ' PHE . 92.5 t -42.31 155.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 110.248 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 129' ' ' LYS . 8.5 mtpp -101.16 106.79 18.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.87 -40.34 9.82 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.005 -1.06 . . . . 0.0 109.899 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.46 -45.42 80.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.413 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -63.76 -43.9 95.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.533 HG12 ' CD2' ' A' ' 5' ' ' TYR . 5.8 t -67.91 -16.33 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -86.17 -41.44 14.69 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 110.356 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -52.63 -47.97 66.69 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.983 . . . . 0.0 109.55 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -49.16 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.724 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -61.86 -20.56 63.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 11.9 tm-20 -76.27 -56.95 4.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.6 -0.687 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.478 ' HG3' ' N ' ' A' ' 140' ' ' GLY . 2.3 ppp? -59.29 -28.66 66.97 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 108.504 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.478 ' N ' ' HG3' ' A' ' 139' ' ' MET . . . -69.53 -45.28 60.38 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.79 -32.19 73.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.263 . . . . 0.0 109.774 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 2.1 p -69.99 -38.0 75.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.173 -0.955 . . . . 0.0 108.862 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 38' ' ' ILE . 0.8 OUTLIER -71.84 -31.57 66.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.505 ' CD2' ' CG2' ' A' ' 9' ' ' THR . 11.0 tp -67.18 -41.06 86.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -35.03 73.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.536 -0.728 . . . . 0.0 109.289 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.503 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -62.22 -50.64 70.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.485 -0.759 . . . . 0.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.501 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 12.8 t -70.74 -30.44 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.84 -55.26 36.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.461 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -74.68 -23.8 58.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.575 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.763 ' CD1' ' CE1' ' A' ' 154' ' ' HIS . 45.0 t80 -58.89 -62.2 2.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.799 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.457 HD13 HG22 ' A' ' 13' ' ' ILE . 34.3 mt -44.42 -26.61 0.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.079 . . . . 0.0 110.414 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.471 ' N ' HD11 ' A' ' 152' ' ' LEU . 9.1 mp -79.22 -52.61 7.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 110.95 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.31 -27.86 69.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.763 ' CE1' ' CD1' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -122.88 104.16 9.09 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.825 -0.547 . . . . 0.0 109.926 -178.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 58.1 m -88.91 16.33 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 110.156 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -108.72 -22.18 12.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.468 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -84.6 130.26 34.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.462 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.576 ' CE1' ' HA ' ' A' ' 21' ' ' ALA . 37.1 m-85 59.93 48.64 8.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.637 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.226 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.532 HG11 ' N ' ' A' ' 3' ' ' PHE . 95.6 t -54.6 151.99 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.579 ' CE1' HG21 ' A' ' 128' ' ' VAL . 80.3 m-85 -114.15 149.14 36.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 110.066 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.98 84.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.586 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 45.5 m-85 -88.43 78.62 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.02 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 7' ' ' THR . 98.7 mt-10 -90.02 165.93 13.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.353 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 12.3 t -179.8 172.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.835 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.458 ' OE1' ' HD2' ' A' ' 115' ' ' LYS . 23.5 tt0 -155.89 147.08 22.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.13 -0.981 . . . . 0.0 110.336 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.55 HG21 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.92 172.31 11.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.887 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.79 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.965 -1.084 . . . . 0.0 110.132 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.54 ' OG ' ' CD1' ' A' ' 18' ' ' LEU . 63.9 p -129.1 150.83 50.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.26 -22.88 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 109.774 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 19.3 mm -80.25 142.87 55.37 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 35.5 Cg_endo -58.02 148.58 76.18 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.749 1.394 . . . . 0.0 110.732 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' CA ' HG23 ' A' ' 104' ' ' ILE . . . -55.07 -36.69 65.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.03 70.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -62.88 -50.84 69.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 110.61 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.557 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 14.4 mt -57.23 -39.22 75.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.946 -1.096 . . . . 0.0 109.766 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CE1' HG23 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -61.36 -63.99 1.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.098 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.27 -30.29 50.11 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.552 -0.718 . . . . 0.0 112.223 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.591 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -105.69 -64.61 1.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.758 -1.214 . . . . 0.0 111.44 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.574 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 63.3 t80 -70.29 5.47 1.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 112.449 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.584 HG23 ' CE1' ' A' ' 19' ' ' PHE . 28.7 mm -142.81 -26.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.307 -1.495 . . . . 0.0 111.882 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 19' ' ' PHE . 4.2 mt -102.31 -34.44 9.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.62 -1.3 . . . . 0.0 109.833 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.484 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 5.9 t0 -119.64 31.96 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -71.31 -25.14 76.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.498 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 20.6 m-20 -76.6 3.52 11.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 5.5 t30 -140.16 52.73 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.61 HD12 ' CZ ' ' A' ' 150' ' ' TYR . 1.5 tp 170.62 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.516 -0.74 . . . . 0.0 109.26 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.4 m-30 -42.97 -59.82 2.79 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.874 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.1 Cg_endo -66.22 -29.45 47.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.915 1.482 . . . . 0.0 111.189 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -36.3 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.9 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 150' ' ' TYR . 15.9 m -104.12 -9.21 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.062 -1.024 . . . . 0.0 110.409 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.41 63.89 56.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.965 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.53 -7.82 20.39 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.97 1.51 . . . . 0.0 110.139 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -92.11 -18.33 23.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.424 -0.798 . . . . 0.0 109.167 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.1 -58.41 2.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.514 HD12 ' CE ' ' A' ' 139' ' ' MET . 10.0 mm -95.68 179.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.384 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.47 -49.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.959 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.27 142.61 30.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 27' ' ' ASP . 7.6 p -120.99 121.55 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 110.419 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 tt0 -92.02 102.51 15.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 109.929 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' ILE . 89.2 m-20 -90.88 72.97 6.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.498 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.503 HG22 HD11 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -44.84 -26.48 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.408 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 44' ' ' ILE . 2.1 tt0 40.55 79.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.485 -0.759 . . . . 0.0 110.754 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.5 -55.15 6.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 64.2 t-20 -128.86 -14.8 4.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.471 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.42 4.85 83.03 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.56 -103.18 0.32 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.31 78.96 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.959 1.505 . . . . 0.0 110.461 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.08 32.96 0.29 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m -95.23 104.95 16.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -1.223 . . . . 0.0 109.739 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.437 HG21 ' N ' ' A' ' 54' ' ' LYS . 3.6 mp -102.56 143.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.616 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 2.4 mttt -130.76 150.13 52.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -117.9 97.97 6.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.412 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.558 HG23 ' CE1' ' A' ' 58' ' ' PHE . 1.5 mp -78.58 131.81 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -115.28 141.14 48.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CD2' HD22 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -107.69 135.19 19.8 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 110.538 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 38' ' ' ILE . 50.9 Cg_endo -84.34 47.93 2.33 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.952 1.501 . . . . 0.0 109.965 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.71 -171.48 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 0.0 110.627 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.36 35.44 4.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -54.19 -176.49 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -1.052 . . . . 0.0 110.324 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.635 ' HD2' ' HB2' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -82.46 -20.95 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.04 1.021 . . . . 0.0 110.462 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 2.4 m-85 -97.08 -154.92 0.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -131.27 -33.95 1.45 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.448 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 36.6 p90 -169.04 -153.53 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.521 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 8.9 p -168.37 111.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 111.149 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.7 ttpp -99.7 149.15 23.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.19 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 29.8 p30 -154.26 148.18 25.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.984 -1.072 . . . . 0.0 110.964 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 83' ' ' TYR . 4.6 ttp180 -103.6 154.27 19.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 109.584 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 15.6 t -99.39 -44.53 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.113 -0.992 . . . . 0.0 110.359 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER 76.94 -38.13 0.3 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.848 -0.532 . . . . 0.0 111.721 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 1.2 pt-20 178.28 155.95 0.4 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.686 -1.259 . . . . 0.0 110.505 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -146.05 153.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.818 . . . . 0.0 109.901 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.65 164.46 15.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.723 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.478 ' NE2' HD13 ' A' ' 24' ' ' LEU . 3.8 m80 -134.4 -40.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.51 -0.744 . . . . 0.0 109.856 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -55.42 -38.55 69.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.253 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -108.25 12.8 26.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.511 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 52.11 60.59 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' A' ' 81' ' ' TYR . 1.4 tppt? -123.35 155.51 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.39 -0.819 . . . . 0.0 110.586 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.507 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 64.6 t80 -144.06 162.2 36.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.58 -0.7 . . . . 0.0 109.162 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 71' ' ' VAL . 28.0 t30 -167.52 128.63 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.913 -1.117 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 32.7 p90 -143.23 142.44 31.4 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.383 -0.823 . . . . 0.0 109.941 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.45 126.25 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.775 . . . . 0.0 110.173 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.05 128.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.465 ' N ' HD11 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -124.7 10.64 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.962 . . . . 0.0 109.865 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 2.2 mm-40 -176.65 170.72 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.492 ' O ' HG13 ' A' ' 91' ' ' ILE . . . 73.12 173.33 25.03 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.467 ' O ' HD13 ' A' ' 91' ' ' ILE . . . 78.82 -144.19 27.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.4 Cg_endo -84.8 34.27 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.067 1.561 . . . . 0.0 110.735 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.515 ' N ' HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -50.25 172.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.985 . . . . 0.0 110.437 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 45.7 63.48 2.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD1' ' NZ ' ' A' ' 129' ' ' LYS . 7.5 t0 -177.83 82.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -1.164 . . . . 0.0 110.422 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' ASP . 18.8 p 43.65 29.0 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.278 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.507 ' CD1' ' CD2' ' A' ' 120' ' ' TYR . 1.9 tp -150.61 95.77 2.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.171 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.5 -49.83 44.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.643 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -152.62 165.54 34.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.321 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.554 HD13 ' CD2' ' A' ' 120' ' ' TYR . 24.2 mm -140.76 116.78 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.833 . . . . 0.0 110.442 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -96.33 143.2 27.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 108.946 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 36.0 t-20 -143.04 149.53 38.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.259 -1.376 . . . . 0.0 112.126 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 25.3 mt-10 -129.03 152.47 48.6 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 12.1 mt -142.0 124.03 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 0.0 110.635 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -115.41 130.96 57.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 0.0 109.738 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.571 HD12 ' CD2' ' A' ' 19' ' ' PHE . 1.3 mp -99.43 118.95 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.036 -1.04 . . . . 0.0 109.782 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 112' ' ' SER . 6.6 t -107.34 129.56 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.24 140.92 29.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.757 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -104.47 148.96 36.85 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 110.397 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.0 -8.62 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.09 1.574 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -165.01 83.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.43 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.14 -85.83 0.1 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.91 -113.29 0.3 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.528 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 4.5 p -138.9 176.82 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -1.192 . . . . 0.0 109.972 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.472 HG21 ' O ' ' A' ' 9' ' ' THR . 15.9 mt -139.28 123.35 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.271 -0.893 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.55 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.19 90.72 8.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.458 ' HD2' ' OE1' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -85.22 99.51 11.15 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.436 HG13 HG12 ' A' ' 102' ' ' ILE . 1.2 mp -99.84 155.02 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.061 -1.024 . . . . 0.0 111.679 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 m -140.14 107.71 5.6 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 100' ' ' ASN . 3.3 t-20 -105.85 105.77 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 112.034 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HG3' ' CG1' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -88.47 107.64 18.97 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.554 ' CD2' HD13 ' A' ' 98' ' ' ILE . 2.7 m-85 -82.52 142.94 31.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.924 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.483 ' ND1' HG23 ' A' ' 2' ' ' VAL . 83.6 m-70 -126.31 100.37 6.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.766 -0.584 . . . . 0.0 109.566 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 4.9 p -110.53 -166.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 110.35 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 122' ' ' THR . 0.0 OUTLIER 174.69 67.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 -149.67 5.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -68.98 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.448 -1.031 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -75.67 -174.49 2.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 12.2 mp0 -115.46 -171.7 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 110.284 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.579 HG21 ' CE1' ' A' ' 3' ' ' PHE . 88.6 t -54.13 152.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.472 ' NZ ' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -98.85 108.21 20.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.434 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -41.91 -59.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 110.422 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 2.5 tt0 -43.17 -45.25 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.782 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -45.23 94.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.586 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 76.4 t -58.04 -24.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -76.82 -51.42 11.36 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.751 -0.593 . . . . 0.0 110.108 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -43.8 -43.82 6.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.872 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.1 t -60.45 -54.82 40.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.569 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -53.45 -27.87 27.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.745 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.474 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.72 -46.87 43.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.527 -0.733 . . . . 0.0 110.392 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.514 ' CE ' HD12 ' A' ' 38' ' ' ILE . 4.6 mtp -63.19 -30.46 71.6 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.846 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.6 -45.43 53.34 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -72.32 -30.07 64.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.359 . . . . 0.0 110.614 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 1.2 p -72.99 -40.35 65.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.794 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 143' ' ' LEU . 1.1 mm? -80.03 -25.84 40.02 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.354 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.437 HD13 HD12 ' A' ' 18' ' ' LEU . 16.4 tp -70.75 -39.95 72.98 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -44.36 59.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.52 -55.51 31.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.507 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 69.3 t -66.02 -32.31 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.466 ' HG2' HG12 ' A' ' 13' ' ' ILE . 1.2 tm-20 -58.48 -52.13 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.3 p -75.99 -26.67 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.61 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 8.5 t80 -57.71 -45.75 85.33 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.724 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.7 mt -58.05 -24.81 59.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 6.0 mp -93.01 -19.68 21.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 110.516 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.5 -34.03 23.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 155' ' ' SER . 10.0 m-70 -91.86 166.2 12.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 110.6 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.48 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 22.9 m -43.48 -56.81 3.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 110.608 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 155' ' ' SER . 2.4 m-20 -177.94 65.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -67.76 133.58 49.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.354 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.591 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 56.5 m-85 60.59 19.9 9.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 110.587 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.065 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.547 ' CG2' ' HG3' ' A' ' 119' ' ' LYS . 11.7 p -55.36 154.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.16 . . . . 0.0 110.456 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 1' ' ' GLY . 53.9 m-85 -115.88 158.75 22.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -117.37 118.69 32.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.586 ' CE2' HG23 ' A' ' 133' ' ' VAL . 37.2 m-85 -122.63 89.51 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -99.82 155.13 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.467 HG21 ' HB ' ' A' ' 116' ' ' ILE . 11.8 t -171.24 170.21 6.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.171 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.441 ' CG ' ' C ' ' A' ' 7' ' ' THR . 27.6 mt-10 -148.04 118.97 7.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.526 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -100.58 -177.73 3.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 109.815 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.532 HG21 ' CD1' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -124.0 137.93 54.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.0 110.424 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.484 ' HB2' HD22 ' A' ' 114' ' ' LEU . 36.4 t -125.01 139.44 53.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.5 -2.66 4.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.457 -0.777 . . . . 0.0 110.161 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.561 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 7.9 mm -96.11 149.31 35.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.253 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -56.68 155.66 25.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.019 1.536 . . . . 0.0 110.518 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.553 ' CB ' HG23 ' A' ' 104' ' ' ILE . . . -64.17 -71.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 111.268 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -39.3 -51.43 2.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.686 . . . . 0.0 110.951 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.556 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 6.7 ttm180 -57.33 -54.97 40.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.812 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.561 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 8.7 mt -50.43 -29.2 9.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.184 -1.006 . . . . 0.0 108.822 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.612 ' CE1' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -69.76 -67.35 0.49 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.545 -0.722 . . . . 0.0 110.678 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 25.5 mtpt -57.34 -21.36 34.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.377 -0.827 . . . . 0.0 112.717 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.576 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -110.58 -58.98 2.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.46 -1.4 . . . . 0.0 112.512 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.53 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 34.1 t80 -73.24 -11.51 60.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.893 -1.129 . . . . 0.0 112.353 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.565 ' CG2' HD22 ' A' ' 24' ' ' LEU . 23.0 mt -121.77 -80.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.674 -1.267 . . . . 0.0 110.393 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.612 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 2.3 mt -45.44 -56.72 4.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.865 -1.147 . . . . 0.0 110.032 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.48 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -100.21 66.54 1.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -101.96 -30.95 5.56 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' HB3' HG13 ' A' ' 41' ' ' VAL . 99.4 m-20 -81.39 13.49 2.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 110.456 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.5 t30 -138.68 45.06 2.05 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.578 HD12 ' CE2' ' A' ' 150' ' ' TYR . 1.2 tp 173.55 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 109.441 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.562 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.9 m-30 -48.41 -61.01 3.57 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.367 -0.833 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.3 Cg_endo -65.95 -22.96 54.94 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.8 1.421 . . . . 0.0 111.464 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -71.73 -50.91 25.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 150' ' ' TYR . 19.5 m -89.54 -8.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 110.243 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.96 62.43 52.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.505 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.98 -15.7 43.95 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 109.358 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -83.88 -16.74 43.24 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.543 0.687 . . . . 0.0 109.192 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.472 ' O ' HD13 ' A' ' 62' ' ' LEU . . . -111.51 -64.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 110.595 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 31' ' ' PRO . 10.5 mm -93.73 169.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.456 ' HB2' ' HD3' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -136.16 -36.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 109.986 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.39 160.77 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.522 ' CG2' HD13 ' A' ' 56' ' ' ILE . 3.7 p -140.57 154.25 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.028 -1.045 . . . . 0.0 110.647 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -107.29 138.77 42.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.459 -0.776 . . . . 0.0 109.603 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 54' ' ' LYS . 4.9 m-20 -121.91 106.94 11.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 0.0 110.748 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.55 HG21 ' CG2' ' A' ' 53' ' ' ILE . 0.4 OUTLIER -127.1 -41.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.104 -0.998 . . . . 0.0 109.589 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' N ' HG21 ' A' ' 44' ' ' ILE . 4.1 tt0 56.29 155.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.937 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' C ' ' OD1' ' A' ' 47' ' ' ASN . . . -120.94 -69.82 0.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 46' ' ' GLY . 4.5 m120 -148.61 22.51 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -1.092 . . . . 0.0 109.755 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.61 -152.65 12.23 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' O ' ' OE2' ' A' ' 45' ' ' GLU . . . -54.35 -179.6 0.17 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -82.27 43.33 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.089 1.573 . . . . 0.0 110.99 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -171.08 24.11 0.09 OUTLIER Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.007 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 53' ' ' ILE . 1.2 m -76.38 175.08 9.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -1.19 . . . . 0.0 110.31 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.571 ' N ' ' CG2' ' A' ' 52' ' ' THR . 1.0 OUTLIER 30.55 31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.587 0.708 . . . . 0.0 112.477 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' A' ' 52' ' ' THR . 14.5 mttt -75.53 152.41 37.8 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -124.7 91.5 3.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.892 -1.13 . . . . 0.0 111.053 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.522 HD13 ' CG2' ' A' ' 41' ' ' VAL . 1.2 mp -77.51 158.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.586 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.459 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -144.63 171.3 14.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 15.9 m-85 -134.72 157.09 77.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 47.3 Cg_endo -77.19 177.62 8.65 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.907 1.477 . . . . 0.0 109.835 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.07 175.43 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.0 110.142 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.34 -47.37 3.29 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' CD1' ' HB3' ' A' ' 58' ' ' PHE . 13.5 mt -78.38 139.52 59.81 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.71 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.75 -7.09 19.01 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.009 1.531 . . . . 0.0 110.217 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.462 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 3.6 m-30 -97.32 135.07 39.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 110.155 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -87.94 -42.63 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 0.0 110.365 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 30.3 p90 -167.55 -173.76 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.003 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -166.07 124.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -0.786 . . . . 0.0 110.693 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -81.12 92.85 6.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.464 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -84.35 96.19 8.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.477 ' HG3' ' HA ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.67 83.64 7.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.872 . . . . 0.0 110.043 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -45.44 -60.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 109.54 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.558 ' N ' ' CG1' ' A' ' 71' ' ' VAL . 0.1 OUTLIER 73.07 -28.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -167.5 171.84 10.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.211 -1.555 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.57 HG22 ' CD1' ' A' ' 81' ' ' TYR . 3.2 p -165.56 146.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.671 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.444 ' N ' HG21 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -101.02 -171.53 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 0.0 110.146 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 -56.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 110.376 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 m -59.46 -20.14 52.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.835 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -118.27 8.38 12.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 110.564 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.595 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.6 m-30 54.49 54.21 9.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.994 . . . . 0.0 109.863 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.64 147.3 47.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CD1' HG22 ' A' ' 74' ' ' VAL . 14.4 t80 -133.2 105.0 6.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -1.0 . . . . 0.0 110.693 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -101.59 115.55 30.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 7.4 p90 -138.91 155.3 48.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.101 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -109.29 136.36 48.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 110.856 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.459 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 73.0 t -111.53 121.12 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.459 ' CG2' ' C ' ' A' ' 85' ' ' VAL . 8.4 pt -147.16 164.43 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.962 -1.086 . . . . 0.0 111.281 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER 64.76 133.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 110.847 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 66' ' ' TYR . . . 56.29 178.08 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.545 ' HA3' ' CG1' ' A' ' 67' ' ' VAL . . . 80.89 -133.25 11.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.511 ' HG2' ' CD1' ' A' ' 98' ' ' ILE . 48.7 Cg_endo -78.91 1.6 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.054 1.555 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 96' ' ' GLU 0.293 1.3 mm -61.27 140.92 18.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.223 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 159.15 -92.97 0.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.466 ' O ' ' OG1' ' A' ' 94' ' ' THR . 5.8 m-20 -117.68 145.0 44.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -1.15 . . . . 0.0 110.315 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 6.5 p 50.79 50.39 19.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.524 ' CB ' ' O ' ' A' ' 94' ' ' THR . 0.5 OUTLIER 167.14 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.341 -0.85 . . . . 0.0 110.379 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.456 ' O ' HD13 ' A' ' 91' ' ' ILE . 8.2 tt0 -96.13 -39.59 9.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.27 136.81 50.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.56 HG22 ' CE1' ' A' ' 120' ' ' TYR . 29.8 mt -131.94 113.06 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.861 . . . . 0.0 110.361 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 135.85 33.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 0.0 109.205 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.492 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 4.9 m120 -132.14 139.23 48.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.786 -1.196 . . . . 0.0 110.88 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' TYR . 2.0 mt-10 -137.05 130.93 32.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.105 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.56 HD13 ' CE1' ' A' ' 83' ' ' TYR . 7.4 mt -118.93 127.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 tmtt? -115.14 118.13 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.746 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.574 ' CD1' ' CD1' ' A' ' 114' ' ' LEU . 38.7 mm -79.36 115.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 110.283 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.404 HG22 ' HG3' ' A' ' 115' ' ' LYS . 63.0 t -108.93 123.72 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 110.117 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.69 135.99 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.235 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.6 p -106.76 150.19 39.38 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 48.4 Cg_endo -66.84 81.13 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.181 1.622 . . . . 0.0 110.698 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 18.9 t0 -179.93 -62.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 0.0 110.284 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.19 38.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.33 28.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.551 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -127.95 130.38 48.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -1.217 . . . . 0.0 110.464 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.698 ' CD1' ' N ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -85.47 143.99 10.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 109.548 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 114' ' ' LEU . 3.8 mm? -97.66 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -85.43 99.77 11.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.094 -1.004 . . . . 0.0 109.425 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.467 ' HB ' HG21 ' A' ' 7' ' ' THR . 7.6 mt -98.37 131.19 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.839 -1.163 . . . . 0.0 111.678 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 m -123.56 129.89 51.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 9.9 m-20 -131.25 105.85 7.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.993 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.572 ' HG2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -90.79 107.92 19.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.56 ' CE1' HG22 ' A' ' 98' ' ' ILE . 2.8 m-85 -88.19 95.02 10.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 111.864 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.572 ' CE1' ' HG2' ' A' ' 119' ' ' LYS . 72.4 m-70 -79.95 95.95 6.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 108.882 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 5.6 p -102.67 -56.22 2.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.17 -0.956 . . . . 0.0 111.017 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 122' ' ' THR . 18.1 pttm 35.29 72.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.624 -0.673 . . . . 0.0 111.246 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.65 -72.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.48 ' O ' ' CG2' ' A' ' 94' ' ' THR . 14.8 t70 -153.99 150.62 28.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 51.83 -167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.08 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -121.49 170.09 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.883 . . . . 0.0 110.486 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.555 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 64.8 t -61.95 135.31 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.224 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.3 mtmt -82.33 115.57 21.44 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -45.34 -42.01 9.51 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 10.2 tm-20 -54.79 -47.28 74.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.41 -39.39 83.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.278 -0.889 . . . . 0.0 108.921 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.586 HG23 ' CE2' ' A' ' 5' ' ' TYR . 84.2 t -66.7 -23.46 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 135' ' ' ALA . 14.5 tttt -79.06 -63.04 1.51 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.684 -0.635 . . . . 0.0 110.499 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.22 -46.06 1.03 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -0.817 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m -60.61 -47.84 84.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.466 ' HE2' HG23 ' A' ' 7' ' ' THR . 36.0 mttt -59.96 -28.55 67.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.43 -39.76 64.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.464 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.0 OUTLIER -65.3 -37.3 86.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 108.783 178.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.47 -42.64 93.6 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -32.19 72.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.214 -1.168 . . . . 0.0 110.182 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 1.7 p -70.6 -39.18 73.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.324 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -75.14 -28.13 60.04 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.6 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 23.9 tp -71.18 -39.94 71.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 0.0 108.594 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.542 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 1.3 ptm85 -73.76 -32.68 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 109.472 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 145' ' ' ARG . . . -65.83 -58.12 6.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.1 -1.0 . . . . 0.0 109.059 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 22' ' ' PHE . 47.7 t -64.95 -28.12 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.554 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -63.64 -49.45 73.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.814 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.413 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 1.3 t -78.69 -20.89 49.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 110.044 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.578 ' CE2' HD12 ' A' ' 29' ' ' LEU . 12.0 t80 -62.55 -41.07 98.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.525 HD22 ' CD2' ' A' ' 150' ' ' TYR . 65.9 mt -67.45 -22.29 65.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 109.917 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 mp -82.72 -38.35 23.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.04 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.0 -46.18 62.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 154' ' ' HIS . 19.0 m-70 -81.63 -39.03 25.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.887 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.9 m 58.06 19.54 6.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 2.6 p30 -138.51 -33.45 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 156' ' ' ASP . . . -60.36 131.92 52.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 41.5 m-85 55.69 49.3 16.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 110.868 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.22 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.555 HG22 ' CE1' ' A' ' 121' ' ' HIS . 8.1 p -132.46 165.41 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.189 . . . . 0.0 110.259 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.552 ' CD1' HG21 ' A' ' 128' ' ' VAL . 45.6 m-85 -129.02 148.57 50.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.11 86.8 2.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 0.0 111.004 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.633 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 18.3 m-85 -84.82 73.45 10.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.464 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.24 118.17 21.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.917 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -132.13 -168.9 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.88 163.44 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 0.0 110.177 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.556 HG21 ' HB2' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -141.51 173.39 11.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.4 141.58 50.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.957 . . . . 0.0 110.662 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' HD12 ' A' ' 18' ' ' LEU . 2.8 t -136.71 147.1 46.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 109.929 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.76 -20.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.504 ' O ' HD13 ' A' ' 18' ' ' LEU . 5.4 mm -79.03 140.91 57.93 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 110.705 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -57.53 151.91 51.09 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.659 1.573 . . . . 0.0 111.173 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' N ' ' HB3' ' A' ' 112' ' ' SER . . . -56.67 -48.59 77.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 111.455 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -52.31 -61.78 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.037 -1.039 . . . . 0.0 111.045 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.539 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.6 ttp180 -54.07 -57.73 10.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.022 . . . . 0.0 109.944 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -48.08 -29.25 3.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CE1' ' CD2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.09 -63.12 1.12 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 109.326 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.68 -46.05 19.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 110.481 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.638 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . . . -83.94 -70.82 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.698 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 22.0 t80 -76.0 142.61 41.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 108.941 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.698 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 14.7 mt 81.29 -46.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 CA-C-O 120.914 0.387 . . . . 0.0 110.922 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.639 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -86.71 -77.15 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.957 -1.089 . . . . 0.0 109.484 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 29' ' ' LEU . 9.5 t70 -57.5 -96.35 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.05 -1.031 . . . . 0.0 109.193 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.583 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . 79.11 -74.0 2.26 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.837 -1.164 . . . . 0.0 110.936 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' OD1' HG11 ' A' ' 41' ' ' VAL . 6.5 t70 -65.54 -4.47 6.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.977 -1.308 . . . . 0.0 111.106 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 12.3 t30 -135.96 51.71 2.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.645 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.62 HD22 ' CE2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER 171.15 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.89 . . . . 0.0 109.554 -179.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CD1' ' HA2' ' A' ' 26' ' ' GLY . 5.3 m-30 -65.14 -58.09 13.5 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.95 . . . . 0.0 110.229 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.558 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 44.0 Cg_endo -65.1 -35.3 42.89 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.808 1.425 . . . . 0.0 110.604 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.55 -37.87 76.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 146' ' ' ALA . 6.0 m -106.71 2.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.83 66.15 6.04 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 59' ' ' PRO . 42.0 Cg_endo -67.91 -24.22 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.903 1.475 . . . . 0.0 109.439 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -81.21 -9.46 59.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.438 ' HB2' HD22 ' A' ' 143' ' ' LEU . . . -104.0 -57.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -124.79 168.05 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.168 -0.957 . . . . 0.0 110.984 -179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.503 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 1.4 t -131.48 -37.45 1.21 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.653 -0.654 . . . . 0.0 109.398 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 39' ' ' SER . 7.5 t -177.42 142.79 0.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 0.0 109.862 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 2.5 p -132.95 116.04 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.028 -1.045 . . . . 0.0 110.753 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.6 tt0 178.82 156.12 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.834 . . . . 0.0 110.504 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.581 ' HB2' ' HA ' ' A' ' 54' ' ' LYS . 1.3 m-20 -143.69 -63.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 109.365 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.444 ' O ' HD11 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -119.16 -26.54 2.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.976 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 1.8 tt0 48.12 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.813 . . . . 0.0 110.15 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' ASN . . . 177.57 35.3 0.05 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 46' ' ' GLY . 4.7 m120 42.03 66.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -1.126 . . . . 0.0 110.271 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -46.56 -42.76 14.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 72' ' ' ASP . . . 115.27 -63.12 0.33 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 51.7 Cg_endo -96.4 53.45 0.14 Allowed 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 121.368 1.379 . . . . 0.0 109.495 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.526 ' CA ' ' C ' ' A' ' 70' ' ' ARG . . . 105.47 77.92 1.16 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 64.5 m -41.12 109.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.518 -0.989 . . . . 0.0 108.974 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.494 HG21 ' CB ' ' A' ' 43' ' ' ASN . 44.4 mm -53.59 119.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 111.123 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 21.6 mtmt -144.39 144.27 31.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.567 -0.708 . . . . 0.0 109.327 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 4.2 ttpp -115.01 116.97 29.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.915 . . . . 0.0 110.255 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 2.0 mp -90.52 115.94 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 110.03 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 t -113.84 126.89 55.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 110.561 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.591 ' CE2' HG23 ' A' ' 67' ' ' VAL . 42.5 m-85 -94.5 143.1 25.71 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 49.1 Cg_endo -88.53 37.88 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.81 1.426 . . . . 0.0 110.638 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -150.41 -177.29 5.87 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.578 0.704 . . . . 0.0 110.084 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.608 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -70.07 -59.01 5.72 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 58' ' ' PHE . 10.7 mt 53.42 168.25 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.366 -1.079 . . . . 0.0 110.115 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -72.61 -21.68 21.82 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.789 1.415 . . . . 0.0 109.897 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.516 ' CE2' ' HD3' ' A' ' 90' ' ' PRO . 11.0 m-85 -129.53 160.9 31.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.503 -0.748 . . . . 0.0 109.66 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -20.06 30.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.318 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 27.6 p90 -173.8 -171.7 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.591 HG23 ' CE2' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -161.08 108.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.765 . . . . 0.0 110.602 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -76.81 155.22 33.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.303 -0.873 . . . . 0.0 109.012 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.74 131.11 12.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.671 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.526 ' C ' ' CA ' ' A' ' 51' ' ' GLY . 0.7 OUTLIER -104.43 87.76 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.551 ' HA ' ' HB2' ' A' ' 83' ' ' TYR . 45.1 t -82.05 -104.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.22 162.96 0.24 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.552 -0.717 . . . . 0.0 110.811 -178.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER 73.75 136.56 0.05 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.578 HG22 ' CD2' ' A' ' 81' ' ' TYR . 6.3 p -173.2 103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.31 161.67 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.34 -48.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.234 -0.916 . . . . 0.0 110.564 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 m -59.35 -24.13 63.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.753 -1.217 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -118.38 14.96 13.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.962 . . . . 0.0 110.348 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.574 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 8.2 m-30 44.25 63.38 1.66 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.278 -0.888 . . . . 0.0 110.585 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 13.3 tttt -122.05 141.82 50.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.698 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.578 ' CD2' HG22 ' A' ' 74' ' ' VAL . 22.5 t80 -148.59 98.36 2.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.087 -1.008 . . . . 0.0 110.82 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.51 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -111.76 143.14 43.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.603 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 15.8 p90 -134.75 163.53 29.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -104.54 112.08 25.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.535 -0.728 . . . . 0.0 111.143 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.422 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.4 t -94.64 104.11 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 87' ' ' GLU . 49.0 pt -93.81 -34.58 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.8 mt-10 -146.81 169.41 19.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.003 -1.06 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.563 ' CA ' ' HA ' ' A' ' 67' ' ' VAL . . . 112.41 115.9 3.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.492 ' HA2' ' CD2' ' A' ' 64' ' ' PHE . . . 124.48 -143.93 15.0 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.516 ' HD3' ' CE2' ' A' ' 64' ' ' PHE . 53.1 Cg_endo -83.51 26.87 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.092 1.575 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -27.69 145.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.436 0.636 . . . . 0.0 111.358 -179.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.36 -100.45 0.16 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.475 ' O ' ' OG1' ' A' ' 94' ' ' THR . 29.5 m-20 -125.86 -176.28 3.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -1.098 . . . . 0.0 110.395 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 46.1 p 46.23 22.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.581 HD22 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -172.16 96.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.419 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -114.02 -21.46 10.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.0 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -142.18 147.96 37.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 110.083 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.525 ' CD1' HD22 ' A' ' 95' ' ' LEU . 35.5 mm -145.43 131.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.0 m -116.34 131.37 56.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 109.144 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 1.3 m-20 -126.3 147.63 49.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.043 -1.035 . . . . 0.0 111.267 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 3.8 tt0 -138.02 132.33 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.693 -0.629 . . . . 0.0 109.573 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.463 HG21 ' N ' ' A' ' 103' ' ' LYS . 77.2 mt -118.66 165.7 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.463 ' N ' HG21 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -157.69 111.86 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 110.551 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.539 HG12 ' CD1' ' A' ' 23' ' ' ILE . 2.8 mp -87.93 112.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 0.0 109.944 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.491 HG22 ' CE ' ' A' ' 115' ' ' LYS . 90.4 t -103.58 139.09 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.078 -1.014 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.72 132.01 41.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.0 109.961 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.4 p -105.57 154.22 39.31 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.435 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 48.3 Cg_endo -66.59 -33.2 36.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.016 1.535 . . . . 0.0 110.509 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 108' ' ' PRO . 5.3 m-20 -151.75 67.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.75 35.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.12 -140.3 46.68 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.528 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 80.0 p -128.06 155.18 44.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -1.14 . . . . 0.0 110.052 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 9' ' ' THR . 18.4 mt -112.53 126.83 69.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 110.43 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.556 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.2 tp -88.53 89.2 7.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.795 -0.566 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.491 ' CE ' HG22 ' A' ' 105' ' ' VAL . 9.1 mttt -73.77 128.77 36.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.404 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.7 mt -128.23 150.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 111.18 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 t -138.89 120.36 14.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.176 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.506 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 2.5 m-20 -112.79 94.7 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 0.0 111.53 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.521 ' HG3' ' CG2' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -82.42 106.18 14.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.001 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.581 ' CD2' HD22 ' A' ' 95' ' ' LEU . 1.5 m-85 -85.15 111.14 19.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.962 -1.086 . . . . 0.0 111.461 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.555 ' CE1' HG22 ' A' ' 2' ' ' VAL . 97.1 m-70 -90.25 102.05 14.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.335 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 94' ' ' THR . 7.5 p -103.23 162.33 13.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -145.97 37.65 1.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.46 -147.44 7.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.88 -65.05 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -56.1 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.348 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.484 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 17.3 pt-20 -111.23 -169.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.552 HG21 ' CD1' ' A' ' 3' ' ' PHE . 24.9 t -68.64 163.72 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.1 101.49 10.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 110.004 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.2 -32.25 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 4.3 tt0 -59.96 -50.48 73.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.404 ' OE1' HD12 ' A' ' 95' ' ' LEU . 48.4 tt0 -61.04 -40.79 94.94 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.633 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 61.4 t -62.4 -23.66 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 135' ' ' ALA . 1.8 tptt -78.72 -59.23 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.837 -0.539 . . . . 0.0 110.898 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.37 -45.93 1.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.394 -0.816 . . . . 0.0 110.842 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -59.99 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.095 -1.003 . . . . 0.0 109.652 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 133' ' ' VAL . 16.9 mtmt -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.838 . . . . 0.0 110.318 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.36 -54.3 15.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -0.915 . . . . 0.0 110.135 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.467 ' SD ' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -57.32 -37.77 73.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.061 -1.024 . . . . 0.0 109.287 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.31 -39.8 97.32 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -72.16 -38.72 69.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.999 -1.295 . . . . 0.0 111.003 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.234 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.473 HD22 HD11 ' A' ' 38' ' ' ILE . 1.3 mm? -77.41 -31.15 53.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.112 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.544 ' CD2' HG22 ' A' ' 9' ' ' THR . 20.4 tp -68.64 -32.54 72.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 108.696 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -77.62 -41.21 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.527 -0.733 . . . . 0.0 109.517 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.498 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -61.09 -43.88 98.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.506 -0.746 . . . . 0.0 110.012 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.521 HG23 ' CD1' ' A' ' 29' ' ' LEU . 21.2 t -75.33 -43.16 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.954 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.463 ' HG2' HG12 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -53.86 -41.89 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -0.825 . . . . 0.0 110.221 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.6 p -85.19 -29.68 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 0.0 110.173 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.676 ' CD1' ' CD2' ' A' ' 154' ' ' HIS . 4.5 t80 -58.17 -35.99 72.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.024 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 11.5 mt -71.11 -22.1 62.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 0.0 110.025 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.504 ' N ' HD11 ' A' ' 152' ' ' LEU . 0.1 OUTLIER -91.62 -23.65 19.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.861 . . . . 0.0 110.303 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.93 -49.12 7.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.629 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.676 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 30.1 m-70 -63.25 -97.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.085 -1.01 . . . . 0.0 110.528 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.404 ' OG ' ' C ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -160.51 -70.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 110.385 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.508 ' HB2' ' ND2' ' A' ' 159' ' ' ASN . 3.4 p-10 -142.41 31.49 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.223 -0.923 . . . . 0.0 110.556 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.542 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -52.53 131.08 33.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 0.0 109.767 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.638 ' CD2' ' CB ' ' A' ' 21' ' ' ALA . 51.3 m-85 59.25 66.32 1.05 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 156' ' ' ASP . 1.1 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.204 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 3' ' ' PHE . 45.4 t -79.75 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.343 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.579 ' CD2' HG22 ' A' ' 128' ' ' VAL . 90.8 m-85 -137.74 144.46 41.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.28 110.0 20.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.421 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 3' ' ' PHE . 19.2 m-30 -112.3 88.23 2.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.739 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.01 128.3 38.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.481 HG23 ' CE ' ' A' ' 137' ' ' LYS . 2.9 t -147.16 -172.28 3.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 110.765 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -165.68 173.87 10.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.85 . . . . 0.0 110.782 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.582 HG21 ' CB ' ' A' ' 114' ' ' LEU . 13.1 t -151.58 168.46 24.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.45 139.82 52.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.794 -1.191 . . . . 0.0 111.08 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.441 ' OG ' HD12 ' A' ' 18' ' ' LEU . 43.3 t -134.99 153.89 51.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 110.257 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.85 -22.12 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.213 -0.929 . . . . 0.0 110.04 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.481 HG21 ' HD2' ' A' ' 14' ' ' PRO . 4.3 mm -75.84 140.98 71.24 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.636 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.503 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 33.1 Cg_endo -57.73 154.53 36.88 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.024 1.539 . . . . 0.0 111.196 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -54.65 -64.46 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 111.172 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -40.87 -62.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 0.0 111.113 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.503 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -50.36 -58.56 5.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.083 -1.011 . . . . 0.0 110.761 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -49.39 -31.3 9.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 110.924 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.665 ' CE2' HD23 ' A' ' 24' ' ' LEU . 24.9 t80 -74.21 -55.86 5.57 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.415 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 4.3 mtmm -52.09 -42.98 63.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.07 -1.019 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -83.78 -71.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 108.398 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.632 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 27.2 t80 -79.49 147.24 32.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.315 -0.865 . . . . 0.0 108.696 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.632 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 38.0 mt 81.93 -44.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.665 HD23 ' CE2' ' A' ' 19' ' ' PHE . 1.2 mt -97.97 -56.44 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.982 . . . . 0.0 109.933 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -102.91 80.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.199 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.76 -23.02 10.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' OD2' ' OD1' ' A' ' 28' ' ' ASN . 7.8 p-10 -78.24 -22.12 48.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' OD1' ' OD2' ' A' ' 27' ' ' ASP . 30.5 m-20 -105.75 4.68 30.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.561 HD13 ' CD1' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -128.27 -42.23 1.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.574 ' HB2' ' CD ' ' A' ' 31' ' ' PRO . 8.1 m-30 -54.35 -58.24 14.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.774 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.574 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 52.5 Cg_endo -68.45 -5.54 15.38 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.249 1.131 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 1.1 mmpt? -106.14 -14.01 15.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 111.308 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.538 HG22 ' CB ' ' A' ' 146' ' ' ALA . 15.8 m -134.41 6.27 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.008 -1.058 . . . . 0.0 110.051 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.11 62.63 2.45 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.26 -20.67 55.55 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.893 1.47 . . . . 0.0 109.623 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -75.43 -19.14 59.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' CB ' ' SD ' ' A' ' 139' ' ' MET . . . -101.67 -52.45 3.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.547 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 39' ' ' SER . 1.4 mp -109.74 166.0 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.968 . . . . 0.0 110.675 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.472 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -124.51 -46.16 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 109.891 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -165.45 159.06 16.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.438 HG11 ' N ' ' A' ' 42' ' ' GLU . 73.1 t -111.41 160.87 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.922 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 10.0 mt-10 -143.33 -179.75 6.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.964 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 44' ' ' ILE . 0.8 OUTLIER 67.51 -87.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.527 -0.733 . . . . 0.0 109.421 -179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.562 ' O ' ' CD1' ' A' ' 44' ' ' ILE . 0.1 OUTLIER 25.68 58.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-O 121.954 0.883 . . . . 0.0 111.433 179.03 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 5.7 pt-20 -115.16 123.18 48.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.902 -1.124 . . . . 0.0 110.398 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.92 -61.52 0.3 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 51.53 87.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 110.129 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.94 7.26 8.71 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.13 165.93 19.83 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.45 82.3 1.9 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.141 1.601 . . . . 0.0 110.524 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 53' ' ' ILE . . . 122.17 29.98 1.27 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 51' ' ' GLY . 64.0 m -43.93 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -1.183 . . . . 0.0 109.693 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 51' ' ' GLY . 28.2 mm -79.65 125.94 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 111.125 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 14.3 mtpt -133.06 148.8 52.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.46 -0.775 . . . . 0.0 109.288 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 4.7 tttp -124.58 117.1 23.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.902 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.4 mp -94.92 130.62 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.723 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -117.61 124.25 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.1 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CB ' ' CD1' ' A' ' 62' ' ' LEU . 12.7 m-85 -91.11 166.75 17.72 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.15 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -72.83 178.1 6.82 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.854 1.45 . . . . 0.0 110.177 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.77 173.58 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.497 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.23 52.61 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.593 ' CD1' ' CB ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -76.72 152.68 83.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.213 -1.169 . . . . 0.0 110.366 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.07 -22.58 19.24 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.136 1.598 . . . . 0.0 109.889 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 18.6 m-85 -123.28 -159.81 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.47 -0.769 . . . . 0.0 109.655 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -122.26 -26.85 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 110.423 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 16.0 p90 -176.98 -175.73 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.314 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.485 HG21 ' HB ' ' A' ' 56' ' ' ILE . 7.5 m -153.81 122.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.445 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 18.9 mtmt -93.82 133.61 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -114.93 144.69 43.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.848 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.52 ' NH2' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -113.52 103.9 11.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 110.03 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.01 125.9 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 110.19 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 70' ' ' ARG . 1.2 m-20 -97.34 52.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.85 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.5 OUTLIER 63.54 77.68 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.081 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.1 m -56.71 -177.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.375 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 1.8 t0 -123.06 -168.01 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.837 . . . . 0.0 109.748 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.487 ' CE1' HD12 ' A' ' 24' ' ' LEU . 5.0 m80 -144.83 -53.95 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.2 m -51.95 -57.35 9.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.54 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 19.2 m-80 -91.16 17.69 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.538 ' CD2' ' HB2' ' A' ' 15' ' ' ALA . 16.2 m-85 42.47 48.72 4.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 109.997 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.0 tppt? -93.44 123.79 36.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 110.805 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -120.53 112.55 19.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 31.4 t-20 -127.3 108.34 10.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.8 p90 -136.81 165.51 25.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 109.982 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -117.16 141.11 48.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.536 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 86' ' ' ILE . 40.2 t -86.39 78.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.734 . . . . 0.0 109.266 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.526 HG13 ' N ' ' A' ' 87' ' ' GLU . 43.1 pt -59.61 -131.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.503 -0.748 . . . . 0.0 110.751 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' N ' HG13 ' A' ' 86' ' ' ILE . 28.3 mm-40 -67.64 160.95 26.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 102.8 152.29 23.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.474 ' O ' HD13 ' A' ' 91' ' ' ILE . . . 96.04 -147.0 18.49 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.8 Cg_endo -84.23 29.08 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.984 1.518 . . . . 0.0 110.84 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.553 ' N ' HD11 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -41.24 163.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.119 -0.988 . . . . 0.0 109.95 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.4 -170.55 14.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' O ' ' OG1' ' A' ' 94' ' ' THR . 36.7 p-10 -55.12 173.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -1.075 . . . . 0.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 5.4 p 54.23 15.13 0.86 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 94' ' ' THR . 1.2 mt 167.56 92.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.022 -1.049 . . . . 0.0 110.089 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 2.6 tp10 -91.08 -34.14 15.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 110.332 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 96' ' ' GLU . 13.2 mttp -149.69 153.25 36.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.423 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.575 HD12 ' CE2' ' A' ' 120' ' ' TYR . 75.5 mt -137.47 150.71 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.85 . . . . 0.0 109.731 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.511 ' N ' HG21 ' A' ' 98' ' ' ILE . 1.3 m -134.35 143.91 47.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' TYR . 37.8 t-20 -136.47 133.17 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 0.0 110.244 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.776 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 3.1 pt-20 -151.69 149.72 29.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.128 -0.982 . . . . 0.0 109.794 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.776 ' HB ' ' O ' ' A' ' 101' ' ' GLU . 8.0 tp 168.46 -138.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.619 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.588 ' N ' ' CG2' ' A' ' 102' ' ' ILE . 20.5 ptmt -179.82 -171.07 0.17 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.907 -1.121 . . . . 0.0 111.506 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.534 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 66.1 mt -120.0 163.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.231 -0.918 . . . . 0.0 109.685 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.454 HG22 ' HD2' ' A' ' 115' ' ' LYS . 3.9 t -132.0 124.4 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.911 -1.118 . . . . 0.0 110.425 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.19 131.9 35.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.6 p -108.92 155.55 40.6 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.668 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 47.1 Cg_endo -66.28 82.2 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.251 1.658 . . . . 0.0 110.817 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 1.4 m-20 70.71 25.97 3.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.524 -0.735 . . . . 0.0 110.346 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.73 -2.68 18.96 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.89 -170.74 22.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 12.6 m -120.94 130.09 53.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.299 -1.118 . . . . 0.0 109.918 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.3 mt -99.86 121.48 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 109.854 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.582 ' CB ' HG21 ' A' ' 9' ' ' THR . 1.0 OUTLIER -86.89 108.48 18.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.651 -0.655 . . . . 0.0 109.672 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.729 ' O ' HG22 ' A' ' 102' ' ' ILE . 1.3 ptmt -102.44 133.87 46.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.565 -1.335 . . . . 0.0 108.533 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.707 ' HA ' ' CG2' ' A' ' 102' ' ' ILE . 6.7 mt -135.8 139.42 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.46 ' H ' ' HB ' ' A' ' 102' ' ' ILE . 8.7 t -112.6 107.79 16.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 6.9 m-80 -107.04 108.3 19.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.836 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.519 ' HD2' ' CG1' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.99 132.51 46.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.826 179.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.575 ' CE2' HD12 ' A' ' 98' ' ' ILE . 3.6 m-85 -101.73 129.37 47.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.4 m-70 -110.41 101.68 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.771 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.417 HG21 ' HG ' ' A' ' 95' ' ' LEU . 16.2 p -101.82 -165.19 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.366 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -160.39 126.08 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 128.63 -129.4 6.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -124.11 -53.7 1.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.146 -1.208 . . . . 0.0 110.129 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 125' ' ' ASP . 90.4 m-70 -44.22 168.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 109.929 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.93 163.31 21.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 0.0 110.596 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.579 HG22 ' CD2' ' A' ' 3' ' ' PHE . 24.4 t -53.41 157.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -102.5 108.29 19.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.04 -47.32 8.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -0.981 . . . . 0.0 109.953 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.79 -46.62 59.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -35.55 80.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.863 . . . . 0.0 109.648 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.465 HG12 ' CD2' ' A' ' 5' ' ' TYR . 21.8 t -76.99 -12.22 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.459 -0.775 . . . . 0.0 109.775 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -46.74 7.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.447 -0.783 . . . . 0.0 110.808 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -54.38 -49.47 69.79 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.066 -1.021 . . . . 0.0 109.572 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -57.99 -43.94 86.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.925 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.481 ' CE ' HG23 ' A' ' 7' ' ' THR . 4.9 mmtp -66.1 -23.66 66.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.166 -0.959 . . . . 0.0 109.361 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 3.1 tt0 -73.07 -43.71 61.51 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.46 ' SD ' ' CB ' ' A' ' 37' ' ' ALA . 5.3 mmm -64.27 -35.94 82.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.41 -44.2 97.97 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.27 -45.97 75.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.053 -1.263 . . . . 0.0 110.262 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -37.65 68.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 108.897 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.17 -52.98 28.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.434 -0.791 . . . . 0.0 109.578 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.4 tp -47.6 -36.8 11.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.877 -1.14 . . . . 0.0 108.519 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 15.2 mtt180 -71.76 -38.77 70.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 0.0 109.367 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.538 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -58.51 -57.93 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.521 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.484 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 17.7 t -66.92 -27.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.473 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' OE2' HG12 ' A' ' 13' ' ' ILE . 16.3 tp10 -59.43 -54.98 40.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 109.976 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.406 ' HA ' HD21 ' A' ' 152' ' ' LEU . 22.5 p -75.71 -27.24 58.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.045 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.561 ' CD1' HD13 ' A' ' 29' ' ' LEU . 7.1 t80 -53.8 -45.92 70.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 79.7 mt -61.1 -29.93 70.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.763 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -89.0 -18.78 26.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 110.703 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.58 -52.75 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.477 ' O ' ' HB3' ' A' ' 155' ' ' SER . 9.2 m-70 -63.97 -111.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 156' ' ' ASP . 92.0 p -178.11 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.851 -1.155 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 155' ' ' SER . 0.0 OUTLIER 71.94 20.65 4.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 111.457 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -52.45 137.28 30.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.619 -1.301 . . . . 0.0 109.462 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.541 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 72.2 m-85 58.72 81.8 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.403 ' O ' ' HE3' ' A' ' 20' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.222 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.501 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 10.9 p -117.71 167.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.605 ' CD1' ' CG2' ' A' ' 128' ' ' VAL . 29.0 m-85 -132.44 108.64 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.414 -0.803 . . . . 0.0 110.098 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -62.84 142.69 58.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.522 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CD1' HG13 ' A' ' 133' ' ' VAL . 23.9 m-85 -150.05 69.05 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.0 109.657 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 72.3 mt-10 -94.72 141.89 28.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.594 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.441 HG21 ' HB ' ' A' ' 116' ' ' ILE . 15.1 t -159.9 -178.22 6.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.45 -0.781 . . . . 0.0 109.59 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 7' ' ' THR . 1.8 pm0 -155.42 154.75 32.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.057 -1.027 . . . . 0.0 110.425 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.518 HG22 ' CD1' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -129.34 158.58 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.664 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.472 HG21 HG12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -120.41 139.69 52.45 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.05 -1.032 . . . . 0.0 110.48 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.423 ' HB2' HD23 ' A' ' 144' ' ' LEU . 30.1 t -135.05 141.22 46.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.549 -0.719 . . . . 0.0 109.872 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.12 -15.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.578 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 15.0 mm -75.72 147.14 80.97 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 110.018 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 32.0 Cg_endo -56.38 155.23 26.05 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.902 1.475 . . . . 0.0 110.683 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . . . -63.47 -69.29 0.28 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 111.311 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -39.26 -46.43 1.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.29 -0.881 . . . . 0.0 111.538 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 41.7 mtt180 -64.95 -50.5 66.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.115 . . . . 0.0 110.052 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 9.8 mt -56.1 -25.89 47.6 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.939 0.876 . . . . 0.0 109.547 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.654 ' CE2' HD23 ' A' ' 24' ' ' LEU . 21.4 t80 -79.46 -48.62 13.62 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.2 -0.937 . . . . 0.0 110.902 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -67.46 -27.47 67.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.501 -0.749 . . . . 0.0 112.117 -178.422 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.593 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -110.11 -29.84 8.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.553 -1.342 . . . . 0.0 112.165 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.584 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 88.2 t80 -109.14 5.0 23.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.785 -1.197 . . . . 0.0 111.582 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.58 HG22 ' CE1' ' A' ' 19' ' ' PHE . 41.2 mt -141.77 -19.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.942 -1.099 . . . . 0.0 111.23 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.654 HD23 ' CE2' ' A' ' 19' ' ' PHE . 1.8 mt -110.68 -37.09 5.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.966 -1.084 . . . . 0.0 109.904 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.6 42.43 2.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -40.4 71.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.528 ' HB2' ' CG1' ' A' ' 41' ' ' VAL . 2.2 p30 -70.45 -0.8 9.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -1.127 . . . . 0.0 110.929 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 13.9 t30 -138.93 47.98 1.91 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.588 HD22 ' CE2' ' A' ' 150' ' ' TYR . 0.1 OUTLIER 177.37 -30.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.511 -0.743 . . . . 0.0 109.077 -178.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.566 ' HB2' ' CD ' ' A' ' 31' ' ' PRO . 5.9 m-30 -56.24 -59.14 12.78 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.566 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -67.58 -11.28 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.741 1.39 . . . . 0.0 110.635 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -16.33 38.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.605 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.545 HG13 ' CD1' ' A' ' 150' ' ' TYR . 25.7 m -127.19 -3.09 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.328 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.77 65.19 8.18 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.055 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.85 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.054 1.555 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -90.13 -14.47 33.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.559 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB2' ' HE2' ' A' ' 139' ' ' MET . . . -115.29 -29.79 6.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.018 -1.051 . . . . 0.0 110.576 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.5 mm -120.82 161.11 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.49 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.3 OUTLIER -127.6 -49.29 1.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 109.254 179.057 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' SER . 12.5 t 174.19 138.54 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.566 -0.709 . . . . 0.0 110.276 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 27' ' ' ASP . 8.6 p -109.13 162.54 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 108.979 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.597 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 9.8 tt0 -175.62 144.69 0.67 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.795 -1.191 . . . . 0.0 111.377 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.655 ' HB2' ' HA ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER 148.74 -79.76 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 43' ' ' ASN . 3.7 tp 36.68 46.12 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.723 -0.611 . . . . 0.0 111.261 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 44' ' ' ILE . 7.2 tp10 -44.99 140.14 2.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.109 -0.994 . . . . 0.0 109.739 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.73 99.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.21 -67.08 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 0.0 110.317 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.93 -9.24 4.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.521 ' O ' ' CG1' ' A' ' 71' ' ' VAL . . . 145.31 -85.21 0.18 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HG3' ' OE2' ' A' ' 73' ' ' GLU . 50.1 Cg_endo -73.33 99.28 1.1 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.924 1.486 . . . . 0.0 110.648 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.37 -9.06 7.83 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 44' ' ' ILE . 2.5 m -65.47 122.39 17.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -1.163 . . . . 0.0 110.078 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.476 HD11 ' CG ' ' A' ' 70' ' ' ARG . 18.3 mm -82.73 148.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 14.0 mtmt -148.17 141.26 24.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 110.421 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.55 ' CG ' ' O ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -114.23 132.22 56.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 110.251 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.577 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 1.8 mp -107.22 112.33 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.351 -0.843 . . . . 0.0 110.097 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 39' ' ' SER . 9.2 t -103.57 136.42 43.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.952 -1.093 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CZ ' HG23 ' A' ' 56' ' ' ILE . 17.9 m-85 -103.26 166.02 12.54 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.86 . . . . 0.0 109.763 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -73.14 175.14 10.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.873 1.459 . . . . 0.0 110.413 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.18 178.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 110.374 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.72 -38.29 3.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -62.09 133.13 94.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.139 -1.213 . . . . 0.0 110.29 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.3 -13.76 16.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.175 1.618 . . . . 0.0 110.346 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -101.01 -163.88 1.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -117.88 -39.12 3.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.121 -0.987 . . . . 0.0 110.686 -179.543 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 21.2 p90 -177.31 -171.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.705 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 66' ' ' TYR . 12.2 t -147.08 99.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.485 -0.76 . . . . 0.0 111.043 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -89.99 139.77 30.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.016 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -157.42 162.05 38.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.476 ' CG ' HD11 ' A' ' 53' ' ' ILE . 4.3 mtm105 -112.47 155.97 23.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.204 -0.935 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 49' ' ' GLY . 2.6 p -98.35 161.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 110.388 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 5.4 m-20 -124.1 54.03 1.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.6 mt-10 65.88 115.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.519 HG22 ' CD2' ' A' ' 24' ' ' LEU . 4.4 p -90.68 145.6 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -92.47 -151.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.083 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.495 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -168.1 -62.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 m -50.63 -56.11 13.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.825 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 79' ' ' PHE . 2.1 m-80 -95.84 18.37 13.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 0.0 110.672 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.645 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 6.2 m-85 42.47 72.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 0.0 109.924 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.1 tttp -123.92 115.41 21.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.023 -1.048 . . . . 0.0 110.707 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -113.4 173.21 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 54.5 t-20 -176.35 123.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 36.7 p90 -135.28 157.58 46.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.2 135.37 55.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 73.3 t -108.01 110.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.253 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.81 -14.06 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 68' ' ' LYS . 5.4 mt-10 -139.68 140.92 36.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.179 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.439 ' C ' HG12 ' A' ' 91' ' ' ILE . . . 103.2 177.23 26.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.18 -135.01 20.64 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.512 ' HG3' ' NE2' ' A' ' 132' ' ' GLN . 51.6 Cg_endo -86.48 29.84 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 111.46 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.474 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -37.66 157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.28 -132.38 4.63 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.428 ' O ' HG21 ' A' ' 94' ' ' THR . 5.4 p-10 -114.66 55.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 0.0 110.625 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 93' ' ' ASP . 0.8 OUTLIER -150.57 -70.26 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.56 HD23 ' CD2' ' A' ' 120' ' ' TYR . 2.6 mt -98.7 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 109.873 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -93.19 -39.8 10.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 110.517 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.533 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.9 tttm -134.47 164.56 27.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 0.0 110.868 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 97' ' ' LYS . 13.0 mt -158.82 132.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.28 116.34 27.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.898 -1.127 . . . . 0.0 110.523 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 11.1 t-20 -116.35 126.67 53.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -116.38 149.24 39.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.461 -0.775 . . . . 0.0 109.673 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.5 mt -136.29 134.16 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.469 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -131.62 99.85 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.445 -0.785 . . . . 0.0 109.829 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 1.7 mp -77.29 113.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.269 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.6 t -102.28 122.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.288 -0.882 . . . . 0.0 109.725 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.472 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . . . -78.61 134.49 37.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.601 -0.687 . . . . 0.0 110.102 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 110' ' ' GLY . 71.2 p -104.85 156.1 36.52 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.845 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.36 -2.87 8.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -173.07 -25.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 111.269 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.431 ' C ' ' OG1' ' A' ' 107' ' ' THR . . . -83.55 45.54 3.48 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 52.21 -114.91 3.64 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 3.1 m -150.57 158.52 44.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.409 -1.054 . . . . 0.0 109.557 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.472 HG12 HG21 ' A' ' 10' ' ' THR . 20.7 mt -126.02 122.32 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.873 -1.142 . . . . 0.0 110.832 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 7.1 mp -84.63 105.11 15.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.708 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -84.32 100.65 11.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.778 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.441 ' HB ' HG21 ' A' ' 7' ' ' THR . 3.8 mt -92.76 155.03 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.868 . . . . 0.0 110.864 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 36.3 t -151.34 91.21 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.488 -0.758 . . . . 0.0 109.297 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 100' ' ' ASN . 36.3 t-20 -101.82 145.83 28.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 111.444 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.45 ' CG ' HG22 ' A' ' 2' ' ' VAL . 2.1 ttmt -131.96 118.94 20.42 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CD2' HG12 ' A' ' 128' ' ' VAL . 2.7 m-85 -86.14 107.92 18.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.934 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -92.22 96.8 10.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.457 HG22 HG21 ' A' ' 128' ' ' VAL . 20.8 p -92.12 -136.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 110.083 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -40.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 160.68 -149.35 18.47 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 126' ' ' HIS . 5.2 t0 47.09 -92.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -1.082 . . . . 0.0 110.135 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 124' ' ' GLY . 35.9 m170 -87.52 172.0 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -124.21 179.54 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.605 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 99.3 t -78.13 153.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.123 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -106.95 110.22 22.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.316 -0.865 . . . . 0.0 109.816 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.29 -40.62 3.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.0 tt0 -55.27 -49.1 72.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.512 ' NE2' ' HG3' ' A' ' 90' ' ' PRO . 1.1 tt0 -60.32 -39.7 87.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 108.954 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.593 HG13 ' CD1' ' A' ' 5' ' ' TYR . 64.4 t -64.91 -22.82 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.754 0.787 . . . . 0.0 109.162 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -83.64 -67.63 0.78 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.628 -0.67 . . . . 0.0 110.693 -179.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -33.5 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.501 -0.749 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -67.1 -55.18 15.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 108.724 178.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 134' ' ' LYS . 8.9 mptt -53.42 -55.42 25.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.815 . . . . 0.0 109.073 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -46.69 -47.07 20.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.585 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.468 ' HE2' ' HB2' ' A' ' 37' ' ' ALA . 2.6 tpp -56.19 -44.1 79.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.116 -0.99 . . . . 0.0 108.799 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.54 92.83 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.83 -31.41 66.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.066 -1.255 . . . . 0.0 110.804 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.1 OUTLIER -68.6 -43.9 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.954 -1.091 . . . . 0.0 109.056 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 143' ' ' LEU . 1.5 mm? -70.5 -33.36 71.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.246 -0.909 . . . . 0.0 109.189 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 9' ' ' THR . 0.8 OUTLIER -61.62 -41.53 97.6 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.74 -47.05 76.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.606 -0.684 . . . . 0.0 110.063 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.68 -59.6 4.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.494 ' CG2' HD13 ' A' ' 29' ' ' LEU . 40.7 t -65.63 -19.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.492 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 22.1 tt0 -71.99 -46.21 58.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.1 -1.0 . . . . 0.0 110.072 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.73 -12.3 37.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 110.291 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.588 ' CE2' HD22 ' A' ' 29' ' ' LEU . 8.5 t80 -69.58 -36.4 76.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.075 -1.016 . . . . 0.0 109.637 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.559 HD22 ' CD2' ' A' ' 150' ' ' TYR . 38.7 mt -72.6 -19.94 61.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.173 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.2 mp -87.46 -33.26 19.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.233 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.42 -48.66 13.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.858 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.518 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 54.8 m-70 -76.71 -22.5 53.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.825 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 154' ' ' HIS . 17.0 p 41.93 51.1 4.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.333 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -168.83 -37.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.604 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.556 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -64.15 130.86 45.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.383 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 58.4 m-85 55.75 62.85 2.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.261 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.541 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 12.1 p -132.77 157.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -1.143 . . . . 0.0 110.564 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.544 ' CD1' HG21 ' A' ' 128' ' ' VAL . 68.1 m-85 -130.82 156.7 44.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -120.16 91.44 3.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.162 -0.961 . . . . 0.0 110.234 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CD2' ' CG1' ' A' ' 133' ' ' VAL . 31.3 m-85 -87.52 146.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.059 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.86 149.73 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.398 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.451 ' C ' ' CG ' ' A' ' 8' ' ' GLU . 8.6 t -169.13 167.63 10.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 109.903 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.451 ' CG ' ' C ' ' A' ' 7' ' ' THR . 32.0 mt-10 -148.8 146.97 28.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.604 HG21 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.9 178.24 5.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 109.853 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.46 149.49 51.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.678 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.41 ' OG ' HD22 ' A' ' 144' ' ' LEU . 0.5 OUTLIER -143.73 142.54 30.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.341 -0.849 . . . . 0.0 109.905 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -71.66 -6.17 7.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.573 -0.705 . . . . 0.0 110.4 -179.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.575 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 15.6 mm -89.5 143.17 30.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.104 -0.998 . . . . 0.0 109.952 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 33.0 Cg_endo -56.94 154.75 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.739 1.389 . . . . 0.0 110.06 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB3' HG21 ' A' ' 104' ' ' ILE . . . -62.02 -39.73 93.29 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.099 -1.001 . . . . 0.0 110.812 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 -60.86 3.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.615 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.5 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -55.91 -47.44 77.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.575 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 9.4 mt -53.32 -37.89 62.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.964 -1.085 . . . . 0.0 109.075 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.619 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -70.17 -69.91 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.027 -1.046 . . . . 0.0 110.227 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HA ' HD11 ' A' ' 24' ' ' LEU . 4.7 mtpt -52.37 -19.37 2.09 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.669 -1.269 . . . . 0.0 113.279 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.58 ' HA ' ' CE1' ' A' ' 158' ' ' TYR . . . -114.06 -56.36 2.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.49 -1.381 . . . . 0.0 112.176 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 19.2 t80 -73.64 -85.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.489 -1.382 . . . . 0.0 110.82 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.564 ' CG2' ' CD2' ' A' ' 81' ' ' TYR . 21.9 mm -37.42 -48.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.512 -0.742 . . . . 0.0 110.221 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.619 HD13 ' CD1' ' A' ' 19' ' ' PHE . 4.5 mt -100.53 -170.64 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 32.88 34.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.726 -0.609 . . . . 0.0 111.588 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' A' ' 30' ' ' PHE . . . -92.26 -12.95 58.08 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.482 ' HB2' HG13 ' A' ' 41' ' ' VAL . 52.2 p30 -67.33 -7.39 24.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.459 -1.024 . . . . 0.0 111.07 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -130.23 16.59 5.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.091 -1.005 . . . . 0.0 108.532 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 33' ' ' VAL . 5.9 tp -131.54 -50.33 0.99 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.452 -0.78 . . . . 0.0 110.746 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.578 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.0 m-30 -42.71 -53.74 9.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.419 -0.801 . . . . 0.0 110.315 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -67.04 -38.01 17.41 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.408 1.215 . . . . 0.0 110.957 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 2.4 mtmt -75.23 -73.3 0.26 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.977 -1.077 . . . . 0.0 110.907 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG21 ' N ' ' A' ' 34' ' ' ALA . 26.0 m -62.94 -21.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.729 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 30' ' ' PHE . . . -126.16 69.48 67.12 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.049 -1.032 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 43.7 Cg_endo -69.45 -21.92 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.891 1.469 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.489 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -83.92 -3.2 57.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.308 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB3' HD22 ' A' ' 143' ' ' LEU . . . -114.12 -51.18 2.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 111.124 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.523 ' CG2' ' CG2' ' A' ' 56' ' ' ILE . 3.9 mp -138.95 172.46 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.871 -1.143 . . . . 0.0 110.761 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.529 ' HB3' ' CG ' ' A' ' 59' ' ' PRO . 29.6 t -133.37 -31.05 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.582 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -158.89 166.7 31.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 2.2 p -133.32 140.1 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.021 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.56 102.22 10.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 110.655 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -99.3 91.14 4.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.243 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.51 HG21 ' N ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -51.17 -40.49 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.875 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.51 ' N ' HG21 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -112.95 142.12 46.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.837 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 47' ' ' ASN . . . -84.12 86.64 1.53 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 46' ' ' GLY . 19.2 p30 36.08 48.23 0.51 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.662 -0.905 . . . . 0.0 110.977 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.67 68.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.75 -137.52 6.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 45.8 Cg_endo -72.84 94.56 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.026 1.54 . . . . 0.0 110.172 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 52' ' ' THR . . . 145.82 -16.49 1.78 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 51' ' ' GLY . 46.8 m -42.28 116.59 0.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -1.1 . . . . 0.0 109.991 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.467 HD12 ' HG2' ' A' ' 70' ' ' ARG . 10.1 mm -97.15 129.72 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 1.7 ptmt -127.59 149.05 50.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.34 -0.85 . . . . 0.0 110.082 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' CG ' ' HG2' ' A' ' 68' ' ' LYS . 4.0 mttp -140.4 100.95 4.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.676 -0.64 . . . . 0.0 109.311 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.577 HG23 ' CE1' ' A' ' 58' ' ' PHE . 2.0 mp -82.74 156.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.82 -1.175 . . . . 0.0 110.206 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 85.1 p -115.55 145.22 42.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.965 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE1' HG23 ' A' ' 56' ' ' ILE . 4.8 m-85 -118.99 72.94 12.06 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.233 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.529 ' CG ' ' HB3' ' A' ' 39' ' ' SER . 45.5 Cg_endo -75.51 68.7 6.11 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.627 1.856 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.0 -163.37 1.76 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.278 -0.889 . . . . 0.0 110.288 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.75 69.62 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.4 mt -65.37 158.74 71.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.12 -1.223 . . . . 0.0 110.353 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.78 -35.13 4.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.961 1.506 . . . . 0.0 109.959 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 9.4 m-30 -79.94 150.54 30.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.848 . . . . 0.0 110.044 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -113.94 -6.22 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.843 179.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.571 ' CD1' ' HE2' ' A' ' 68' ' ' LYS . 20.7 p90 179.23 176.26 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.541 -0.724 . . . . 0.0 109.394 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.574 ' CG2' ' HB ' ' A' ' 56' ' ' ILE . 35.6 m -159.11 109.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 109.283 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.571 ' HE2' ' CD1' ' A' ' 66' ' ' TYR . 7.6 mttm -96.2 139.48 32.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 109.503 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 14.3 m-20 -156.78 132.62 9.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 0.0 111.233 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.467 ' HG2' HD12 ' A' ' 53' ' ' ILE . 47.6 mtt180 -73.21 156.46 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.072 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.4 p -94.27 -17.7 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.938 -1.101 . . . . 0.0 111.039 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 61.1 -87.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 72' ' ' ASP . 0.1 OUTLIER 179.24 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.085 -1.009 . . . . 0.0 110.351 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 75' ' ' ASP . 49.7 t -66.87 161.02 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.386 -0.821 . . . . 0.0 110.223 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 76' ' ' HIS . 6.3 t70 -103.16 -57.55 2.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.594 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER 75.58 -58.9 0.54 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.265 -0.272 . . . . 0.0 111.092 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 m -52.08 -55.08 23.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 110.011 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -95.02 16.04 17.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.37 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 52.66 52.59 13.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.182 -0.948 . . . . 0.0 109.867 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 102' ' ' ILE . 17.7 ttpt -124.44 127.24 47.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CD2' ' CG2' ' A' ' 23' ' ' ILE . 70.6 t80 -128.58 125.79 38.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.51 145.2 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.702 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.629 ' CE1' ' CB ' ' A' ' 100' ' ' ASN . 18.1 p90 -136.11 158.33 44.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.31 138.14 41.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.517 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 24.9 t -107.42 69.47 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.817 . . . . 0.0 109.823 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -66.6 -11.19 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.474 ' CA ' HD12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER 172.47 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.534 ' O ' ' CG1' ' A' ' 91' ' ' ILE . . . -106.31 -146.22 13.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . -91.57 -38.28 5.91 Favored Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.334 -1.098 . . . . 0.0 111.382 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -76.46 -9.91 18.81 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.128 1.067 . . . . 0.0 111.981 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -41.61 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.997 -1.064 . . . . 0.0 110.706 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.53 -168.07 41.15 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.6 m-20 -66.03 -175.18 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -1.182 . . . . 0.0 110.333 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 18.6 p 48.83 21.18 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 110.985 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 98' ' ' ILE . 0.9 OUTLIER -161.25 133.4 5.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.028 . . . . 0.0 110.143 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.67 -60.4 1.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.482 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HG2' ' N ' ' A' ' 98' ' ' ILE . 17.1 ttmt -127.23 160.05 32.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.056 -1.027 . . . . 0.0 110.43 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.525 ' CD1' HD23 ' A' ' 95' ' ' LEU . 24.0 mt -152.39 142.79 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.5 t -119.1 143.04 47.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -126.02 125.76 43.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 111.124 -179.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.34 135.81 53.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.454 -0.778 . . . . 0.0 109.404 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 81' ' ' TYR . 22.7 mt -130.54 157.87 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.825 -1.172 . . . . 0.0 110.916 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 13.4 ttmt -151.12 110.83 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 15' ' ' ALA . 4.7 mt -84.4 128.94 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.097 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 112' ' ' SER . 6.6 t -119.83 151.58 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.732 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.99 135.3 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 109.754 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.427 ' OG1' ' CG ' ' A' ' 109' ' ' ASP . 11.6 p -138.36 142.61 35.6 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.002 . . . . 0.0 110.768 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.38 -3.59 12.72 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.279 1.673 . . . . 0.0 110.533 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 109' ' ' ASP . 10.6 p30 -80.11 2.81 22.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.287 -0.883 . . . . 0.0 111.004 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.85 -82.28 0.15 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.41 -134.47 3.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 60.4 p -113.42 175.63 5.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.51 HD11 HG23 ' A' ' 113' ' ' ILE . 9.8 mt -130.61 132.97 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.604 ' HB2' HG21 ' A' ' 9' ' ' THR . 1.1 tp -91.59 100.44 13.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.568 -0.708 . . . . 0.0 110.419 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 102' ' ' ILE . 45.8 mttt -79.71 130.01 34.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.44 HG13 ' C ' ' A' ' 115' ' ' LYS . 3.8 mt -132.84 140.88 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 111.305 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.62 117.59 16.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 2.0 m-80 -107.93 106.41 16.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 111.423 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.541 ' HD2' ' CG2' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -88.85 122.35 32.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.51 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 4.9 m-85 -102.97 144.06 31.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.0 111.004 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -131.84 89.08 2.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.644 -0.66 . . . . 0.0 109.708 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.474 HG21 ' HA ' ' A' ' 95' ' ' LEU . 7.3 p -95.81 -159.96 0.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -83.28 -66.75 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.123 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.69 -32.37 0.62 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -69.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -1.154 . . . . 0.0 110.13 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -99.51 -170.72 1.94 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 0.0 110.114 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 mm-40 -115.81 171.15 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.538 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.572 HG13 ' CE1' ' A' ' 5' ' ' TYR . 3.4 t -67.15 156.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 4.2 mppt? -90.86 102.5 15.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.842 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -44.32 -51.17 8.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.44 -44.77 62.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.166 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 2.7 tt0 -56.52 -41.98 77.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 108.753 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.597 ' CG1' ' CD2' ' A' ' 5' ' ' TYR . 78.6 t -63.26 -30.09 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.825 0.821 . . . . 0.0 108.944 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' ALA . 4.1 tttt -68.69 -51.53 40.78 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.772 -0.58 . . . . 0.0 110.267 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.55 -56.55 3.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.04 -43.74 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.433 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 4.5 mtpp -60.5 -38.1 83.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.805 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -65.54 -54.63 25.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 110.074 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -35.61 65.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.06 -1.025 . . . . 0.0 109.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.86 -38.95 93.31 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 1.0 OUTLIER -74.22 -35.6 63.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.314 . . . . 0.0 110.934 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.3 p -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.18 -0.95 . . . . 0.0 109.785 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -73.32 -51.05 18.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 15.5 tp -50.7 -44.16 57.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -62.91 -44.48 95.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 109.511 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 143' ' ' LEU . . . -51.27 -58.98 4.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.481 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 21.9 t -66.36 -21.81 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.78 -51.05 64.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.07 -1.018 . . . . 0.0 109.736 179.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 3.1 t -75.33 -31.03 60.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.891 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.492 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 14.7 t80 -55.96 -50.85 69.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.3 mt -56.13 -29.94 61.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 109.96 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 148' ' ' GLU . 8.6 mp -72.01 -55.67 7.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 110.241 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -55.32 -41.23 72.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.466 -0.772 . . . . 0.0 110.544 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.581 ' N ' ' CD2' ' A' ' 154' ' ' HIS . 4.5 m-70 -105.55 122.52 46.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.82 30.57 2.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.855 . . . . 0.0 109.911 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -132.13 -26.9 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.809 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.477 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -69.99 128.49 36.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.964 -1.085 . . . . 0.0 110.589 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 21' ' ' ALA . 40.3 m-85 56.68 81.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.264 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.508 HG23 ' ND1' ' A' ' 121' ' ' HIS . 56.1 t -44.74 156.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -1.213 . . . . 0.0 110.162 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 97.4 m-85 -120.48 164.62 16.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 110.274 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 4' ' ' ASN . 3.4 t-20 -127.51 105.76 8.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.913 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.589 ' CG ' HG12 ' A' ' 133' ' ' VAL . 25.6 m-85 -99.01 92.75 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.983 . . . . 0.0 110.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 2.2 mp0 -53.8 141.15 27.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.85 . . . . 0.0 109.969 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.49 ' CG2' HG21 ' A' ' 102' ' ' ILE . 4.8 t -125.47 162.94 23.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.804 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 115' ' ' LYS . 4.0 tm-20 178.49 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.307 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.542 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -120.64 162.6 19.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 0.0 109.835 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.468 HG21 HG12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -122.92 145.89 48.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.753 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.426 ' OG ' HD13 ' A' ' 18' ' ' LEU . 35.4 t -142.19 149.17 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.885 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.86 -25.96 29.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.793 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.506 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 5.2 mm -72.5 142.01 83.53 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 34.5 Cg_endo -57.97 151.79 55.28 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.76 1.4 . . . . 0.0 110.521 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' N ' ' HB3' ' A' ' 112' ' ' SER . . . -58.13 -45.63 87.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.88 . . . . 0.0 110.99 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.448 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -58.43 -59.78 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 110.535 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.524 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -51.0 -59.57 4.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.496 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -46.28 -35.57 5.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.364 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CE1' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -65.67 -64.26 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 20.9 mtmt -54.39 -21.66 10.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.458 -0.776 . . . . 0.0 112.305 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -112.65 -59.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.536 ' CA ' HG12 ' A' ' 147' ' ' VAL . 64.6 t80 -69.22 -44.0 72.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.717 -1.239 . . . . 0.0 111.859 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.56 HG23 ' CE1' ' A' ' 19' ' ' PHE . 46.9 mm -82.8 -82.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 111.296 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.544 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.7 mt -40.56 -68.4 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -55.33 -67.6 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.427 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.605 ' HA2' ' CE1' ' A' ' 30' ' ' PHE . . . 49.18 -86.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.548 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 4.6 p30 -73.99 27.12 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.586 -0.95 . . . . 0.0 112.349 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 11.5 t30 -139.72 38.16 2.01 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 150' ' ' TYR . 0.8 OUTLIER 174.25 -30.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.609 -177.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' CE1' ' HA2' ' A' ' 26' ' ' GLY . 2.6 m-30 -38.92 -62.52 0.74 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.385 -0.822 . . . . 0.0 111.304 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.7 Cg_endo -65.89 -27.44 51.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.762 1.401 . . . . 0.0 110.288 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -72.75 -16.56 61.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.83 . . . . 0.0 110.484 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.593 HG13 ' CD1' ' A' ' 150' ' ' TYR . 19.1 m -124.25 -4.12 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.338 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.69 65.37 12.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 -10.16 27.71 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 123.835 1.439 . . . . 0.0 109.657 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -86.08 -20.42 28.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 109.127 179.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.422 ' HB2' ' CE ' ' A' ' 139' ' ' MET . . . -107.79 -61.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.593 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.473 HG13 ' HB3' ' A' ' 30' ' ' PHE . 7.7 mm -94.55 166.65 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.617 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -131.46 -40.17 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 p -160.16 155.9 25.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 109.944 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 27' ' ' ASP . 2.7 p -121.33 146.63 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 109.966 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 2.4 mm-40 -138.41 -174.03 3.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.642 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' GLU . 0.7 OUTLIER 65.24 -88.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.333 -179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.491 ' C ' ' O ' ' A' ' 43' ' ' ASN . 5.3 tp 32.45 36.15 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.62 -0.675 . . . . 0.0 111.246 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 18.9 tp10 -40.32 131.93 2.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.868 . . . . 0.0 110.152 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -77.33 136.08 17.84 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 17.8 t-20 61.91 65.99 0.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.183 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.437 ' HA3' ' OG1' ' A' ' 52' ' ' THR . . . -105.75 -16.08 16.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 48' ' ' GLY . . . 43.39 -131.78 5.86 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.92 81.8 1.86 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.826 1.435 . . . . 0.0 110.408 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 53' ' ' ILE . . . 150.2 -12.85 0.94 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.437 ' OG1' ' HA3' ' A' ' 48' ' ' GLY . 7.6 m -45.04 150.32 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.017 -1.284 . . . . 0.0 110.156 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 HD11 ' HG2' ' A' ' 70' ' ' ARG . 45.8 mm -131.4 154.87 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.95 . . . . 0.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.502 ' NZ ' ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -141.97 143.51 33.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.52 -0.737 . . . . 0.0 109.869 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 31.2 tttp -118.99 110.4 17.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.628 -0.67 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.501 ' HB ' ' CG2' ' A' ' 67' ' ' VAL . 9.8 mm -98.72 109.43 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.82 -1.175 . . . . 0.0 110.611 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 39' ' ' SER . 0.8 OUTLIER -103.07 124.87 49.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 110.405 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' CE2' HG12 ' A' ' 67' ' ' VAL . 32.1 m-85 -84.58 164.66 41.69 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.403 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.3 Cg_endo -74.47 -163.23 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.14 1.6 . . . . 0.0 109.726 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER 38.61 -162.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.569 -0.707 . . . . 0.0 111.133 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -99.58 -34.74 4.89 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 58' ' ' PHE . 11.0 mt 55.71 165.4 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.105 -1.232 . . . . 0.0 109.934 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 45.5 Cg_endo -72.15 -24.96 19.6 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.846 1.446 . . . . 0.0 109.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.5 ' HB3' ' CA ' ' A' ' 89' ' ' GLY . 18.0 m-30 -106.45 -140.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.814 . . . . 0.0 109.818 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 22.7 mttt -144.67 -32.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 111.16 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 176.65 177.44 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.56 HG11 ' O ' ' A' ' 66' ' ' TYR . 35.7 m -142.25 117.98 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -93.57 162.81 13.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.945 . . . . 0.0 109.342 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -144.64 154.48 42.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.844 -1.16 . . . . 0.0 111.627 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.453 ' HG2' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -122.29 134.68 54.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.675 -0.641 . . . . 0.0 109.386 179.392 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.502 ' HB ' ' NZ ' ' A' ' 54' ' ' LYS . 2.6 p -89.89 136.71 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.003 . . . . 0.0 110.671 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -113.94 55.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 109.401 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.4 mt-10 60.28 117.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 0.0 109.842 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.2 t -96.97 125.52 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 15.1 t0 -68.63 -170.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.572 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.07 -48.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 110.152 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 m -57.5 -16.1 8.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 110.089 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.524 ' CB ' ' HD2' ' A' ' 80' ' ' LYS . 97.3 m-20 -130.31 6.74 4.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 3.7 m-85 57.56 55.32 5.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 110.737 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.524 ' HD2' ' CB ' ' A' ' 78' ' ' ASN . 6.8 mttt -117.63 121.72 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.366 -0.834 . . . . 0.0 110.026 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.403 ' CD2' HG22 ' A' ' 23' ' ' ILE . 17.9 t80 -114.18 161.2 18.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.456 ' CB ' ' OE2' ' A' ' 101' ' ' GLU . 8.0 p30 -163.83 138.09 5.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.261 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 10.9 p90 -147.5 172.49 13.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 4.6 p -139.42 135.3 33.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.736 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.07 81.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.487 ' O ' ' CG ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -66.57 -10.88 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -173.4 157.34 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.782 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.508 ' O ' ' CG1' ' A' ' 91' ' ' ILE . . . 168.38 -137.57 4.66 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.239 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.607 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . -95.28 -38.16 4.88 Favored Glycine 0 N--CA 1.489 2.168 0 O-C-N 121.727 -0.866 . . . . 0.0 111.92 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -77.48 -1.59 11.77 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.0 1.0 . . . . 0.0 111.202 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.527 ' N ' HD11 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -46.82 176.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.156 -0.965 . . . . 0.0 110.221 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 94' ' ' THR . . . 157.19 74.12 0.02 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.513 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 94' ' ' THR . 2.8 m-20 40.25 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.442 -1.034 . . . . 0.0 111.188 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 92' ' ' GLY . 3.2 p -31.41 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.789 -0.569 . . . . 0.0 111.102 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.565 HD22 ' CE2' ' A' ' 120' ' ' TYR . 15.6 tp -64.49 88.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.081 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.78 -49.64 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.542 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 142.87 45.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.217 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.545 HG22 ' CD1' ' A' ' 120' ' ' TYR . 44.2 mt -136.24 114.99 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -0.948 . . . . 0.0 110.604 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 1.4 m -112.18 111.56 22.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 109.424 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.528 ' CB ' ' HA ' ' A' ' 118' ' ' ASN . 25.4 m-20 -121.27 147.3 45.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.308 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 116' ' ' ILE . 12.3 mt-10 -136.02 141.48 44.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.532 -0.73 . . . . 0.0 109.68 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.645 ' HA ' ' HB ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -136.3 177.93 5.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 113' ' ' ILE . 75.1 tttt -140.0 137.42 34.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.349 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.527 ' CD1' ' HG ' ' A' ' 114' ' ' LEU . 6.1 mm -96.82 80.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 112' ' ' SER . 90.7 t -71.39 130.97 35.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 110.702 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.411 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . . . -91.87 141.28 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.505 ' OG1' ' CA ' ' A' ' 110' ' ' GLY . 38.0 p -127.42 156.51 74.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.34 -34.74 34.11 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.071 1.564 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.45 37.49 2.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.295 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.505 ' CA ' ' OG1' ' A' ' 107' ' ' THR . . . -148.43 30.48 1.3 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 45.84 -103.94 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.535 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 2.6 p -142.99 170.25 16.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 110.355 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 9' ' ' THR . 9.7 mt -138.68 129.77 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.602 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 8.0 mp -97.55 94.45 7.01 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 116' ' ' ILE . 1.0 OUTLIER -124.1 -176.83 3.59 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.779 -1.168 . . . . 0.0 112.721 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' A' ' 102' ' ' ILE . 21.6 mm 120.63 -102.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.236 1.414 . . . . 0.0 109.853 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.519 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 4.7 m -168.79 177.22 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.725 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.528 ' HA ' ' CB ' ' A' ' 100' ' ' ASN . 4.6 m120 -139.49 96.71 3.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 99' ' ' SER . 4.9 mttt -75.66 129.08 36.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 111.271 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CE2' HD22 ' A' ' 95' ' ' LEU . 2.6 m-85 -105.75 106.23 16.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.508 ' ND1' HG23 ' A' ' 2' ' ' VAL . 60.3 m-70 -90.9 95.05 9.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.843 . . . . 0.0 110.307 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p -79.34 -170.88 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 -72.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 110.249 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.88 60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -153.24 -114.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -1.153 . . . . 0.0 109.79 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -71.13 161.22 31.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.975 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.5 mp0 -77.43 -164.36 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.906 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.554 ' CG2' ' CD1' ' A' ' 3' ' ' PHE . 55.6 t -90.7 141.42 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -81.65 119.48 23.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -0.91 . . . . 0.0 109.887 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.06 83.24 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.132 -0.98 . . . . 0.0 109.958 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.99 -29.24 59.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -1.0 . . . . 0.0 108.839 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 90' ' ' PRO . 37.3 tt0 -77.8 -40.16 41.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.589 HG12 ' CG ' ' A' ' 5' ' ' TYR . 96.7 t -69.25 -14.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.082 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.07 -49.27 6.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.655 -0.653 . . . . 0.0 109.979 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -50.71 -45.46 58.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 t -59.14 -47.58 84.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 109.349 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.412 ' HE2' ' ND2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -63.3 -22.09 66.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.643 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 74.2 tt0 -75.2 -47.6 27.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.361 -0.837 . . . . 0.0 109.416 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 42.3 mmm -65.86 -30.83 71.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.25 -0.906 . . . . 0.0 108.867 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.43 -35.5 56.06 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.66 -34.92 65.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.884 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 p -72.23 -37.94 69.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.246 -0.908 . . . . 0.0 108.807 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 139' ' ' MET . 0.6 OUTLIER -72.05 -31.4 66.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.531 ' CD2' HG22 ' A' ' 9' ' ' THR . 11.7 tp -67.57 -41.96 83.32 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -68.74 -33.1 73.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -63.84 -60.99 2.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.457 -0.777 . . . . 0.0 109.245 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.536 HG12 ' CA ' ' A' ' 22' ' ' PHE . 63.4 t -60.82 -28.62 43.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.451 -0.78 . . . . 0.0 109.697 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -50.0 72.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.945 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.49 -11.99 56.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.593 ' CD1' HG13 ' A' ' 33' ' ' VAL . 6.5 t80 -69.53 -37.24 77.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.6 -24.58 60.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.488 ' N ' HD11 ' A' ' 152' ' ' LEU . 4.7 mp -81.64 -36.27 29.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.52 -41.66 45.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.469 ' O ' ' HB3' ' A' ' 155' ' ' SER . 59.7 m-70 -86.1 -48.44 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.372 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 7.9 t 62.22 14.34 6.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.259 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -131.95 4.08 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.371 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.491 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -106.69 143.36 34.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.288 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.544 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 41.8 m-85 50.56 33.51 8.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.523 HG11 ' N ' ' A' ' 3' ' ' PHE . 95.7 t -63.63 152.14 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -1.172 . . . . 0.0 110.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.637 ' CD2' HG22 ' A' ' 128' ' ' VAL . 23.1 m-85 -113.38 164.47 13.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.494 -0.754 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.471 ' HA ' ' HG2' ' A' ' 119' ' ' LYS . 61.9 t-20 -148.99 98.79 2.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.083 -1.011 . . . . 0.0 111.37 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.69 ' CE2' HG23 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -95.59 134.34 38.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.163 -0.961 . . . . 0.0 108.944 178.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -119.01 117.45 28.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 110.779 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 116' ' ' ILE . 7.9 t -142.6 -161.19 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 109.845 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' CB ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -173.63 158.92 3.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.011 -1.056 . . . . 0.0 110.538 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -122.68 175.44 6.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.156 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.44 145.29 51.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 110.242 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.461 ' HB3' HD13 ' A' ' 18' ' ' LEU . 16.5 t -143.52 142.45 31.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.377 -0.827 . . . . 0.0 110.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -75.11 -10.28 13.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.639 -0.663 . . . . 0.0 110.256 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.57 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 15.6 mm -86.72 149.34 48.2 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.568 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 33.3 Cg_endo -56.19 156.36 21.05 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 121.555 1.503 . . . . 0.0 110.444 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -69.5 -51.05 39.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.26 -52.57 51.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.937 -1.102 . . . . 0.0 110.298 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.517 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -60.63 -55.18 36.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 7.7 mt -47.48 -34.69 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.008 . . . . 0.0 109.318 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE1' HD23 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.93 -61.9 1.6 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 110.482 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 mtpt -54.44 -25.21 23.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.376 -0.828 . . . . 0.0 112.581 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.586 ' HB1' ' CG ' ' A' ' 158' ' ' TYR . . . -110.49 -56.4 2.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.446 -1.409 . . . . 0.0 111.904 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.513 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 73.6 t80 -78.92 0.79 25.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 112.267 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.576 HG23 ' CE1' ' A' ' 19' ' ' PHE . 4.5 mt -138.81 -22.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.689 -1.257 . . . . 0.0 111.471 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.58 HD23 ' CE1' ' A' ' 19' ' ' PHE . 2.8 mt -100.54 -35.84 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.728 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.488 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.6 OUTLIER -117.02 88.76 2.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.75 -0.594 . . . . 0.0 109.613 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.52 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -113.56 -35.9 1.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB2' HG13 ' A' ' 41' ' ' VAL . 2.9 p30 -73.99 0.36 13.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.421 -1.046 . . . . 0.0 110.821 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 2.5 t30 -139.82 7.76 2.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.977 . . . . 0.0 109.935 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.611 HD22 ' CE2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -142.15 -14.66 0.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.894 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 8.4 m-30 -71.88 -57.04 4.26 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.739 -1.225 . . . . 0.0 110.435 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.21 -34.67 44.56 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.685 1.36 . . . . 0.0 110.732 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' C ' HG11 ' A' ' 33' ' ' VAL . 18.4 mttt -60.14 -15.21 21.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 0.0 109.98 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.521 ' CG1' ' HB2' ' A' ' 150' ' ' TYR . 6.4 m -130.56 -4.05 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' CB ' HD23 ' A' ' 143' ' ' LEU . . . -148.4 62.63 6.63 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.082 -1.011 . . . . 0.0 110.709 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.72 -24.19 41.33 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.844 1.444 . . . . 0.0 109.632 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -74.38 -13.04 60.67 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.573 -0.705 . . . . 0.0 109.227 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 62' ' ' LEU . . . -109.08 -63.05 1.39 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.166 -0.959 . . . . 0.0 110.396 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.426 HG21 ' N ' ' A' ' 39' ' ' SER . 0.8 OUTLIER -100.48 154.48 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.905 -1.122 . . . . 0.0 110.14 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.521 ' HB3' ' N ' ' A' ' 59' ' ' PRO . 54.4 p -108.49 -45.12 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.777 . . . . 0.0 110.187 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 p -174.59 -169.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 27' ' ' ASP . 7.6 p -147.84 162.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.953 . . . . 0.0 110.065 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 12.1 mt-10 -141.06 175.13 9.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 109.895 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.526 ' O ' ' C ' ' A' ' 44' ' ' ILE . 5.5 m-20 62.41 -87.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.601 -0.687 . . . . 0.0 110.038 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.541 ' O ' ' CD1' ' A' ' 44' ' ' ILE . 0.1 OUTLIER 24.96 50.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-O 121.761 0.791 . . . . 0.0 110.872 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 43' ' ' ASN . 2.0 mt-10 -79.52 134.95 36.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.111 -0.993 . . . . 0.0 110.157 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.06 65.67 3.42 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -147.46 -36.24 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -1.132 . . . . 0.0 110.573 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -62.56 -21.74 62.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.24 -106.73 0.22 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 48' ' ' GLY . 48.4 Cg_endo -74.97 77.72 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.86 1.452 . . . . 0.0 110.603 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 52' ' ' THR . . . 134.17 0.05 3.88 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.437 ' C ' ' O ' ' A' ' 51' ' ' GLY . 24.3 m -42.14 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -1.165 . . . . 0.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.486 ' CD1' ' HG2' ' A' ' 70' ' ' ARG . 19.3 mm -126.74 124.04 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.61 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.52 144.81 49.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 0.0 110.424 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -111.29 111.26 22.19 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.94 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.527 ' HB ' ' CG2' ' A' ' 67' ' ' VAL . 5.2 mm -89.5 127.92 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.97 -1.081 . . . . 0.0 109.782 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 m -111.19 145.72 38.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 0.0 109.786 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.551 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 79.2 m-85 -121.18 155.12 58.65 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 110.775 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.521 ' N ' ' HB3' ' A' ' 39' ' ' SER . 48.9 Cg_endo -78.47 -169.05 0.7 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.155 1.608 . . . . 0.0 109.497 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 168.42 10.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 0.0 110.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.58 -52.7 2.36 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.551 ' CD1' ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.11 142.11 86.03 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.147 . . . . 0.0 109.972 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 48.8 Cg_endo -81.84 27.92 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.082 1.569 . . . . 0.0 111.08 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 63' ' ' PRO . 82.3 m-85 -156.08 141.09 17.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.042 -1.036 . . . . 0.0 110.21 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -75.68 -34.68 60.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 23.6 p90 -173.09 -178.12 1.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 27.8 m -157.71 125.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.307 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -85.35 131.52 34.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 108.794 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -130.29 141.54 50.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.867 -1.145 . . . . 0.0 111.664 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' HG2' ' CD1' ' A' ' 53' ' ' ILE . 60.6 mtm180 -110.69 132.34 54.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.589 -0.694 . . . . 0.0 109.129 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.583 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -73.08 -37.48 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.84 -1.163 . . . . 0.0 110.052 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.6 OUTLIER 78.76 -39.76 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.115 -0.366 . . . . 0.0 111.103 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 5.4 pt-20 173.34 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.71 -1.244 . . . . 0.0 111.077 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.532 HG22 ' CG1' ' A' ' 71' ' ' VAL . 39.3 t 60.59 139.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.37 -0.831 . . . . 0.0 109.657 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.23 164.38 13.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.073 -1.017 . . . . 0.0 110.87 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -142.03 -45.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -57.45 -34.42 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 78' ' ' ASN . 1.9 m120 -109.42 12.41 24.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.51 39.16 27.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.977 . . . . 0.0 109.786 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HG2' ' HG2' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -105.19 153.47 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.392 -0.817 . . . . 0.0 110.324 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 102' ' ' ILE . 15.4 t80 -144.62 111.38 5.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.808 . . . . 0.0 109.612 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.509 ' ND2' ' CG ' ' A' ' 101' ' ' GLU . 60.6 t-20 -121.2 126.85 50.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 18.8 p90 -139.67 154.67 47.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.66 164.19 11.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.098 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 86' ' ' ILE . 97.8 t -107.94 -14.88 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 85' ' ' VAL . 25.9 pt 33.02 -120.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.744 -0.597 . . . . 0.0 111.075 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.0 mp0 -84.47 164.25 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 110.227 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.51 149.66 19.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.63 -146.3 17.85 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.0 Cg_endo -81.86 23.59 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.092 1.575 . . . . 0.0 111.238 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.06 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.448 -0.783 . . . . 0.0 111.015 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' ASP . . . 102.53 -51.28 0.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 92' ' ' GLY . 6.4 m-20 -57.59 -155.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -1.149 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.468 ' O ' ' HB ' ' A' ' 122' ' ' THR . 73.0 p -81.42 2.37 28.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.559 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.587 ' CD2' ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -106.58 107.61 18.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.988 . . . . 0.0 109.932 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.454 ' OE1' ' HE3' ' A' ' 123' ' ' LYS . 20.3 tt0 -94.29 -37.02 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.836 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -135.21 165.29 25.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.975 -1.078 . . . . 0.0 110.655 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.595 HG22 ' CD1' ' A' ' 120' ' ' TYR . 13.7 mt -155.83 122.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -104.61 131.51 51.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.476 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -123.15 135.43 54.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.973 -1.079 . . . . 0.0 111.216 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.509 ' CG ' ' ND2' ' A' ' 82' ' ' ASN . 11.5 mt-10 -120.98 152.21 38.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 58.1 mt -140.05 159.08 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.919 -1.113 . . . . 0.0 110.482 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 1.1 ttmt -149.42 101.5 3.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mp -83.28 111.14 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.371 -0.831 . . . . 0.0 110.182 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.526 HG22 ' CE ' ' A' ' 115' ' ' LYS . 15.5 t -110.52 130.78 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.46 ' HB1' ' HB1' ' A' ' 15' ' ' ALA . . . -82.46 144.54 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -119.7 158.02 50.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.029 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.15 -38.39 21.75 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.988 1.52 . . . . 0.0 110.709 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 14.3 t70 -143.88 36.14 1.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 110.327 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.11 14.6 3.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.55 -101.04 0.86 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 69.8 m -161.52 138.48 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 0.0 110.204 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.1 mt -109.09 130.13 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.605 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 6.6 mp -95.84 89.52 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.643 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.526 ' CE ' HG22 ' A' ' 105' ' ' VAL . 2.1 mttm -64.36 118.05 8.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 108.352 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.512 HG23 ' ND2' ' A' ' 118' ' ' ASN . 43.4 mt -119.65 118.32 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 111.791 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.01 106.2 18.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.512 ' ND2' HG23 ' A' ' 116' ' ' ILE . 1.5 m-80 -90.12 92.99 9.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 111.171 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -87.74 135.2 33.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.595 ' CD1' HG22 ' A' ' 98' ' ' ILE . 2.5 m-85 -111.96 167.13 10.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.915 -1.115 . . . . 0.0 110.834 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.516 ' CE1' HG23 ' A' ' 2' ' ' VAL . 16.0 m-70 -139.35 89.53 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 94' ' ' THR . 3.0 p -92.8 -170.56 2.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 110.04 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.454 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -111.9 -3.01 14.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 110.091 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 124.67 -141.55 13.3 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' GLY . 3.5 t70 42.69 -139.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.111 . . . . 0.0 110.16 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -48.58 158.86 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.033 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -89.37 -137.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.574 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.637 HG22 ' CD2' ' A' ' 3' ' ' PHE . 90.8 t -105.97 154.23 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.806 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.544 ' N ' HG11 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -102.53 117.35 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.863 . . . . 0.0 109.892 179.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.16 -42.04 63.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -49.58 -42.33 44.15 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.109 -0.995 . . . . 0.0 108.692 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 21.7 mt-30 -67.52 -44.55 78.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.571 -0.706 . . . . 0.0 109.315 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.69 HG23 ' CE2' ' A' ' 5' ' ' TYR . 21.2 t -70.24 -6.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.738 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.9 tttt -98.0 -65.98 0.93 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.286 -0.884 . . . . 0.0 110.821 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -32.52 -45.75 0.12 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -51.45 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.286 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 134' ' ' LYS . 1.7 ttmt -55.86 -32.49 63.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.961 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.2 -52.93 28.71 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.477 -0.765 . . . . 0.0 109.618 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.463 ' HE3' ' CB ' ' A' ' 37' ' ' ALA . 39.7 mmm -54.64 -39.0 67.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.29 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.49 98.03 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.76 -39.52 87.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.283 . . . . 0.0 110.522 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -34.3 76.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.079 -1.013 . . . . 0.0 109.031 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.467 HD23 ' CB ' ' A' ' 34' ' ' ALA . 1.6 mm? -77.78 -24.09 49.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.335 -0.853 . . . . 0.0 109.085 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 18.3 tp -75.58 -33.89 60.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.429 ' HA ' ' HB3' ' A' ' 148' ' ' GLU . 8.6 ttt180 -80.93 -31.25 35.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.428 ' HB3' HG21 ' A' ' 33' ' ' VAL . . . -69.17 -45.59 69.61 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.529 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 96.7 t -76.19 -30.33 20.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.507 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.88 -37.82 88.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.444 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.462 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -89.13 -22.45 22.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.632 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.611 ' CE2' HD22 ' A' ' 29' ' ' LEU . 6.9 t80 -63.6 -38.32 90.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 109.672 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 50.9 mt -73.72 -19.9 60.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 4.8 mp -92.94 -19.21 21.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.98 -31.25 13.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.145 -0.972 . . . . 0.0 110.335 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -80.87 -165.0 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.868 . . . . 0.0 110.293 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 1.2 p -86.5 -57.21 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.493 ' N ' ' OG ' ' A' ' 155' ' ' SER . 13.6 m-20 -166.02 54.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.181 -0.95 . . . . 0.0 110.665 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.477 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -68.55 136.41 53.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.168 -0.958 . . . . 0.0 109.919 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.586 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 60.5 m-85 58.81 53.95 5.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.47 ' OD1' ' HD3' ' A' ' 17' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.275 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 3' ' ' PHE . 84.0 t -85.52 171.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -1.214 . . . . 0.0 110.567 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 97.9 m-85 -141.98 171.57 13.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.492 -0.755 . . . . 0.0 110.136 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -138.87 122.04 16.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.37 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.591 ' CE2' HG23 ' A' ' 133' ' ' VAL . 36.5 m-85 -116.81 97.81 6.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 109.557 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.58 129.56 37.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.714 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.1 -174.0 4.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 3.0 pt-20 -166.43 166.3 16.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.636 ' O ' ' CB ' ' A' ' 10' ' ' THR . 10.8 t -175.1 -126.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.088 -1.008 . . . . 0.0 111.43 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.636 ' CB ' ' O ' ' A' ' 9' ' ' THR . 4.4 m 94.7 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 123.069 0.548 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 10' ' ' THR . 0.5 OUTLIER 169.43 -167.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.568 -1.333 . . . . 0.0 111.534 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.474 ' HA ' ' CA ' ' A' ' 111' ' ' GLY . 0.9 OUTLIER -72.89 -16.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.85 -0.531 . . . . 0.0 110.009 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.546 HG21 ' CD ' ' A' ' 14' ' ' PRO . 4.3 mm -63.26 145.56 96.85 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.001 -1.062 . . . . 0.0 109.058 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' CD ' HG21 ' A' ' 13' ' ' ILE . 31.6 Cg_endo -54.75 148.53 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.848 1.446 . . . . 0.0 111.266 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -62.29 -43.57 98.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.641 -0.662 . . . . 0.0 110.789 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.46 -51.76 68.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 110.814 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.67 -55.51 29.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 109.769 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.591 HD11 ' CG2' ' A' ' 10' ' ' THR . 0.3 OUTLIER -53.3 -27.04 20.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.709 179.094 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.658 ' CE1' ' CD2' ' A' ' 24' ' ' LEU . 1.1 t80 -73.45 -70.98 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.589 . . . . 0.0 110.478 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.519 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 11.1 mtpt -55.1 -22.43 16.45 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.69 -0.631 . . . . 0.0 112.636 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.569 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -102.52 -48.13 4.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.0 112.188 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.0 t80 -95.46 9.79 38.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.807 -1.183 . . . . 0.0 112.017 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.558 ' CG2' HD22 ' A' ' 24' ' ' LEU . 7.1 mt -143.39 -27.89 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.711 -1.243 . . . . 0.0 110.838 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.658 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 6.6 mt -106.22 -17.36 14.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.795 -1.19 . . . . 0.0 109.292 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 3.0 t0 -132.11 94.97 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.898 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.485 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -120.16 -35.84 0.85 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.78 6.6 10.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.97 -1.312 . . . . 0.0 110.147 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 5.7 t30 -143.15 25.06 1.77 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.572 HD22 ' CE2' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -159.33 -32.21 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.136 -178.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.57 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 12.2 m-30 -60.26 -55.36 46.1 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 0.0 110.233 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.6 Cg_endo -65.53 -35.92 36.3 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.539 1.284 . . . . 0.0 110.823 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -62.92 -15.49 55.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.507 ' CG1' ' CD1' ' A' ' 150' ' ' TYR . 17.8 m -128.66 -2.4 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 110.553 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.43 68.95 6.57 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.949 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.05 -13.59 38.58 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.879 1.463 . . . . 0.0 109.248 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -82.76 -19.77 37.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.66 -54.91 2.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.33 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.61 150.71 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.053 -1.029 . . . . 0.0 110.319 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.406 ' CB ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 t -110.59 -37.26 5.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.994 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -173.07 -179.58 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.518 HG11 ' CD1' ' A' ' 56' ' ' ILE . 91.6 t -143.65 165.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.431 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -130.75 79.79 1.91 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.935 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' ND2' HG13 ' A' ' 41' ' ' VAL . 2.1 m-80 -95.91 108.42 20.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.406 -0.809 . . . . 0.0 109.466 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.497 HG21 ' N ' ' A' ' 45' ' ' GLU . 9.7 tp -167.37 -32.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.0 111.443 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.497 ' N ' HG21 ' A' ' 44' ' ' ILE . 5.8 pt-20 -100.33 157.53 16.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.065 . . . . 0.0 110.4 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.15 -115.81 1.83 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.62 -44.82 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.128 . . . . 0.0 110.272 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.78 74.29 1.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 144.83 -117.9 1.07 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.02 74.4 5.02 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.776 1.409 . . . . 0.0 110.41 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.37 77.47 0.53 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.9 m -105.04 149.09 26.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.093 -1.239 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 45' ' ' GLU . 5.0 mm -101.86 119.04 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.955 . . . . 0.0 110.117 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.474 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 1.2 mttm -121.86 147.39 46.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 17.0 tttt -115.93 107.29 14.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.518 ' CD1' HG11 ' A' ' 41' ' ' VAL . 4.8 mm -82.58 147.23 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.479 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.09 140.45 52.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.504 -0.747 . . . . 0.0 109.518 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.495 ' HB3' HD13 ' A' ' 62' ' ' LEU . 69.3 m-85 -116.54 142.06 28.98 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 39' ' ' SER . 48.5 Cg_endo -74.6 -171.18 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.014 1.534 . . . . 0.0 110.143 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.8 160.77 13.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 110.451 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -41.01 2.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.495 HD13 ' HB3' ' A' ' 58' ' ' PHE . 3.0 mt -83.14 164.16 47.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.236 . . . . 0.0 110.321 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 46.0 Cg_endo -76.92 -82.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.238 1.651 . . . . 0.0 111.207 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 m-30 -56.51 161.12 2.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.018 . . . . 0.0 110.716 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.21 -22.74 18.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 110.445 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 16.3 p90 -173.78 -176.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.928 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 13.5 m -160.42 161.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.396 -0.815 . . . . 0.0 110.734 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -119.72 117.45 28.27 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD2' ' CD1' ' A' ' 83' ' ' TYR . 15.6 t70 -120.37 153.55 36.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.969 -1.082 . . . . 0.0 111.542 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.69 126.99 51.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.67 -0.643 . . . . 0.0 109.409 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 82' ' ' ASN . 6.1 p -61.01 -22.61 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.919 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 45.13 52.07 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.001 . . . . 0.0 109.564 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.5 mt-10 58.25 154.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 110.172 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.45 120.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -74.19 178.05 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.921 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.403 ' O ' ' HD1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -152.65 -41.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 110.773 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -52.22 -48.72 64.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.638 -1.289 . . . . 0.0 110.44 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -105.46 19.72 20.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.611 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 6.7 m-30 51.86 75.04 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.276 -0.89 . . . . 0.0 110.557 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 17.5 mtmt -131.55 124.77 30.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.428 ' HB3' ' HB ' ' A' ' 102' ' ' ILE . 2.7 t80 -117.08 113.22 22.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' VAL . 88.1 m-20 -112.0 105.33 13.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 110.719 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' OD2' ' A' ' 69' ' ' ASP . 1.4 p90 -122.46 169.55 10.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -151.46 140.92 21.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.868 -1.145 . . . . 0.0 111.708 -179.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.499 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 44.5 t -95.93 145.14 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.54 ' CD1' ' N ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -150.99 24.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.74 -1.225 . . . . 0.0 111.654 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.58 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -172.89 147.66 1.7 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.612 -1.305 . . . . 0.0 111.066 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' GLU . . . 49.79 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.541 ' CA ' HG11 ' A' ' 67' ' ' VAL . . . 78.44 -134.31 14.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.27 -17.15 31.23 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.108 1.583 . . . . 0.0 110.634 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 87' ' ' GLU 0.31 4.7 mt -66.66 114.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.13 89.7 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.1 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.1 t0 62.45 5.84 1.75 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -1.087 . . . . 0.0 111.998 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -135.32 -78.74 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.765 -1.209 . . . . 0.0 109.992 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -78.56 108.42 11.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.974 . . . . 0.0 109.691 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -90.08 -45.4 9.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.419 ' C ' HG13 ' A' ' 98' ' ' ILE . 52.4 mttt -119.84 147.4 44.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 98' ' ' ILE . 45.9 mt -152.17 110.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.727 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 1.3 t -93.04 157.05 16.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.307 -0.871 . . . . 0.0 109.228 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.65 108.43 3.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 110.407 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 102' ' ' ILE . 17.9 mt-10 -97.91 156.06 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 101' ' ' GLU . 4.5 mt -140.84 146.95 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.287 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 7.4 ttmt -139.04 115.67 10.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.446 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 1.3 mp -92.27 129.2 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.57 124.5 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 110.629 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.75 142.03 49.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 111' ' ' GLY . 61.0 p -94.18 153.19 40.7 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.82 -7.1 15.65 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -99.3 -85.85 0.38 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.235 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.41 87.36 0.09 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.474 ' CA ' ' HA ' ' A' ' 12' ' ' VAL . . . 153.98 146.91 4.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.521 ' O ' ' HB ' ' A' ' 10' ' ' THR . 77.3 p -104.08 152.53 21.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.389 -1.065 . . . . 0.0 109.186 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 2.9 mt -122.01 156.25 26.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.604 ' N ' ' OG1' ' A' ' 10' ' ' THR . 0.5 OUTLIER -115.05 137.92 51.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.115 -0.991 . . . . 0.0 109.862 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 42.7 mttm -122.68 106.97 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.2 mp -115.67 139.88 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.112 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.33 112.82 22.08 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.56 102.94 14.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 111.43 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -83.7 111.74 19.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.94 . . . . 0.0 109.059 178.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.544 ' CD2' HD23 ' A' ' 95' ' ' LEU . 3.4 m-85 -98.32 104.27 16.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 111.048 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -95.76 96.18 8.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.522 -0.736 . . . . 0.0 109.407 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 19.5 p -78.36 -149.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.496 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.97 53.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.635 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 71.48 -83.55 0.45 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 126' ' ' HIS . 10.9 t70 -39.54 115.89 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -1.018 . . . . 0.0 110.514 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.532 ' HB3' ' CG2' ' A' ' 94' ' ' THR . 0.1 OUTLIER 53.98 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.966 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 61.8 mt-10 -123.86 -144.47 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.527 ' CG1' ' OH ' ' A' ' 5' ' ' TYR . 98.9 t -95.08 133.03 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.265 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.5 mtmt -98.57 123.57 42.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.944 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.96 -46.37 8.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 110.305 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -52.17 -46.27 65.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 109.463 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.7 77.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 108.826 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.591 HG23 ' CE2' ' A' ' 5' ' ' TYR . 72.6 t -72.59 -19.36 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.794 0.807 . . . . 0.0 109.284 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.6 tttp -84.67 -60.13 2.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.507 -0.746 . . . . 0.0 111.2 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.79 -51.81 1.28 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 110.673 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.2 m -57.0 -47.37 80.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 110.162 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -64.44 -21.73 66.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 8.0 tt0 -77.23 -44.64 29.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.728 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.429 ' HE3' HD12 ' A' ' 62' ' ' LEU . 72.1 mmm -66.36 -37.88 86.3 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.69 -39.75 93.79 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -70.96 -40.55 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.814 -1.404 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -62.7 -40.61 97.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 108.971 179.398 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 147' ' ' VAL . 1.1 mm? -71.48 -33.39 69.24 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.591 ' HA ' ' CE1' ' A' ' 22' ' ' PHE . 45.0 tp -62.28 -40.63 96.9 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.096 -1.002 . . . . 0.0 109.038 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.062 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.83 -55.14 33.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.105 -0.997 . . . . 0.0 109.546 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 143' ' ' LEU . 48.5 t -63.36 -37.03 78.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.4 OUTLIER -55.99 -46.13 78.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 110.132 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -83.75 -19.25 35.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.572 ' CE2' HD22 ' A' ' 29' ' ' LEU . 9.8 t80 -66.64 -39.71 88.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.539 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.495 HD22 ' CD2' ' A' ' 150' ' ' TYR . 80.8 mt -62.33 -33.11 74.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.027 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 5.2 mp -77.65 -42.53 34.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.569 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.22 80.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.148 -0.97 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.26 -25.43 39.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.7 t 44.79 44.01 7.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 110.029 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -166.2 -41.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.525 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -59.05 133.81 56.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 48.0 m-85 56.43 68.8 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.341 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.166 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.3 t -69.21 170.88 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -1.144 . . . . 0.0 110.691 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.595 ' CG ' HG22 ' A' ' 128' ' ' VAL . 24.1 m-85 -126.07 154.34 43.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -125.63 97.13 5.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.063 -1.023 . . . . 0.0 111.205 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.575 ' CD2' HG12 ' A' ' 133' ' ' VAL . 37.4 m-85 -100.94 81.63 2.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.286 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -84.15 113.94 21.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.81 . . . . 0.0 110.96 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.426 HG22 ' HB ' ' A' ' 116' ' ' ILE . 5.1 t -132.97 -176.37 4.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.4 -0.812 . . . . 0.0 109.624 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -157.01 153.4 27.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.115 -0.99 . . . . 0.0 110.222 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.79 156.23 44.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 110.12 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.32 152.84 29.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.416 ' CB ' HD13 ' A' ' 18' ' ' LEU . 45.6 t -142.0 135.72 29.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.72 -3.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.708 -0.62 . . . . 0.0 109.977 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.58 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 8.8 mm -95.77 149.12 35.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.558 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 33.0 Cg_endo -56.7 162.72 8.11 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.952 1.501 . . . . 0.0 110.437 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -71.53 -66.43 0.63 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 111.025 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -41.65 -53.63 3.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.558 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -59.63 -51.71 68.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.979 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.58 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 5.9 mt -51.15 -27.04 7.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 108.693 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.574 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -74.1 -68.63 0.5 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.447 0.642 . . . . 0.0 109.991 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 11.6 mtmm -47.66 -36.17 10.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.855 -1.153 . . . . 0.0 111.322 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -90.35 -67.99 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.951 -1.093 . . . . 0.0 109.172 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.694 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 20.6 t80 -82.94 150.39 26.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 108.989 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 8.3 mt 82.4 -47.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 CA-C-O 121.24 0.543 . . . . 0.0 110.327 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.574 HD13 ' CD1' ' A' ' 19' ' ' PHE . 17.2 mt -97.74 -50.8 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -104.41 89.81 3.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.031 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -122.14 -33.54 0.89 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 41' ' ' VAL . 52.8 m-20 -71.82 -1.25 13.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.101 -1.235 . . . . 0.0 110.615 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -123.88 13.02 9.15 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.084 -1.01 . . . . 0.0 108.829 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.482 ' O ' ' C ' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -146.61 -51.41 0.22 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 110.971 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.542 ' HB2' ' CD ' ' A' ' 31' ' ' PRO . 5.3 m-30 -29.81 -58.71 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.542 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -67.82 -38.99 12.26 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.609 1.321 . . . . 0.0 111.414 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 12.7 mmtt -66.97 -66.61 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.102 -0.999 . . . . 0.0 111.219 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.551 ' CG1' ' HB2' ' A' ' 150' ' ' TYR . 16.5 m -70.69 -19.94 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.254 -0.904 . . . . 0.0 111.02 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -127.09 65.75 65.4 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.383 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.69 -6.44 17.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.859 1.452 . . . . 0.0 110.128 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -96.45 0.75 50.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.02 -50.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 110.778 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 30' ' ' PHE . 11.3 mm -109.15 163.17 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 110.613 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.4 OUTLIER -138.07 -43.69 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 0.0 110.138 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 39' ' ' SER . 11.3 t -178.28 133.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.343 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 54' ' ' LYS . 3.6 p -92.73 146.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 30.6 mt-10 -124.6 -153.25 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER 69.62 -149.87 0.11 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.192 -0.943 . . . . 0.0 109.728 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.487 ' CG2' HG21 ' A' ' 52' ' ' THR . 0.5 OUTLIER -61.61 -37.76 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.866 -1.146 . . . . 0.0 109.955 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 44' ' ' ILE . 2.2 pt-20 24.68 100.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.432 0.634 . . . . 0.0 112.178 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.66 67.95 1.73 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -122.1 -37.07 2.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -1.165 . . . . 0.0 109.966 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.77 -94.75 0.1 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.26 -78.25 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HB3' ' CG ' ' A' ' 73' ' ' GLU . 48.3 Cg_endo -73.9 98.3 1.06 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.038 1.546 . . . . 0.0 110.692 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 53' ' ' ILE . . . 116.06 -4.91 20.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.487 HG21 ' CG2' ' A' ' 44' ' ' ILE . 99.3 m -53.56 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -1.172 . . . . 0.0 110.356 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.49 HG22 HD11 ' A' ' 53' ' ' ILE . 21.4 mm -83.05 130.69 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.913 . . . . 0.0 109.886 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 2.5 ptpp? -132.98 152.86 51.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 6.9 ttmt -120.29 88.57 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.578 HG23 ' CE1' ' A' ' 58' ' ' PHE . 1.7 mp -64.73 123.13 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.145 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -109.44 102.53 11.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.612 ' CZ ' HG13 ' A' ' 67' ' ' VAL . 3.0 m-85 -64.08 173.81 1.31 Allowed Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.099 -1.001 . . . . 0.0 109.231 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -75.72 -172.45 1.32 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.706 1.372 . . . . 0.0 109.715 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -77.24 168.15 20.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.546 ' N ' ' HG2' ' A' ' 60' ' ' GLU . . . 104.43 -39.86 2.67 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 58' ' ' PHE . 13.2 mt -62.13 157.94 49.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.106 -1.232 . . . . 0.0 110.478 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.55 -18.63 19.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.132 1.596 . . . . 0.0 110.473 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.53 -161.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.93 . . . . 0.0 110.425 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 12.0 tptt -121.44 -24.08 5.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 53.6 p90 -179.32 -152.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 109.906 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.612 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 9.1 p -172.04 120.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 111.191 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 2.8 mttp -98.01 137.82 36.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.471 -0.768 . . . . 0.0 109.047 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 1.5 m-20 -142.18 148.84 38.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HD2' HD13 ' A' ' 53' ' ' ILE . 25.9 ttt180 -108.5 130.0 55.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.536 -0.727 . . . . 0.0 109.392 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 -24.18 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 16.3 m-20 45.96 43.79 10.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.972 . . . . 0.0 109.942 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' A' ' 50' ' ' PRO . 11.4 mt-10 58.27 151.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.464 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.594 HG13 ' CD2' ' A' ' 81' ' ' TYR . 6.4 m -138.78 148.98 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' CB ' ' HB3' ' A' ' 80' ' ' LYS . 4.2 t0 -69.08 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.054 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.35 -47.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 m -54.24 -35.91 62.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.411 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 1.9 m-80 -115.31 17.15 16.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 110.199 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.569 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 10.1 m-30 55.46 57.48 5.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HB3' ' CB ' ' A' ' 75' ' ' ASP . 30.1 tttm -118.89 98.54 6.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.833 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.606 ' CG ' ' CG2' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -91.16 177.94 6.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.122 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 81' ' ' TYR . 22.5 p-10 -178.82 142.5 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.501 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 12.4 p90 -154.39 172.87 17.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.388 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -136.1 149.99 48.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.817 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.474 ' CG2' ' HB ' ' A' ' 98' ' ' ILE . 4.2 m -110.21 94.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.461 -0.774 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.471 ' C ' ' CD1' ' A' ' 91' ' ' ILE . 1.3 pp -100.65 -2.63 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.778 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' N ' HD13 ' A' ' 91' ' ' ILE . 1.9 tt0 -155.83 140.31 16.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . 65.63 -176.02 15.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.472 ' CA ' HG21 ' A' ' 67' ' ' VAL . . . 76.51 -141.56 26.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.6 -6.69 18.6 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.092 1.575 . . . . 0.0 111.019 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.502 HG22 HD11 ' A' ' 91' ' ' ILE 0.292 1.8 mt -63.31 117.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.104 -0.998 . . . . 0.0 110.362 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 137.23 42.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' ' OG1' ' A' ' 94' ' ' THR . 0.9 OUTLIER 179.19 96.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -1.191 . . . . 0.0 110.546 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 93' ' ' ASP . 40.0 p 42.35 28.3 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 110.63 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.575 HD12 ' CD2' ' A' ' 120' ' ' TYR . 6.5 mt -144.24 74.65 1.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 95' ' ' LEU . 10.3 tp10 -42.42 -58.33 2.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 110.56 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.529 ' CG ' ' HB2' ' A' ' 121' ' ' HIS . 28.8 pttt -144.53 162.37 36.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.516 HG22 ' CE1' ' A' ' 120' ' ' TYR . 39.7 mt -145.81 138.67 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 110.513 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.9 m -117.23 152.36 34.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 109.175 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -144.08 139.89 29.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.723 -1.236 . . . . 0.0 111.37 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' O ' HG13 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -117.81 154.58 31.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.396 179.19 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 101' ' ' GLU . 1.3 mp -144.25 136.8 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -135.79 105.6 6.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.778 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.513 HD12 ' CD1' ' A' ' 23' ' ' ILE . 4.4 mp -81.12 109.94 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 110.532 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.425 HG22 ' HE3' ' A' ' 115' ' ' LYS . 86.5 t -101.49 131.19 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.17 129.93 34.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.867 . . . . 0.0 110.053 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 17.7 p -86.46 164.41 37.94 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 49.0 Cg_endo -66.76 81.06 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.114 1.586 . . . . 0.0 110.371 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 60.5 t0 58.01 65.01 1.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 110.166 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.11 27.62 0.13 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.21 -165.48 31.53 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -131.45 174.9 9.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.335 -1.097 . . . . 0.0 110.041 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CG2' ' CD ' ' A' ' 8' ' ' GLU . 26.2 mt -136.75 121.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.989 . . . . 0.0 110.686 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.529 ' HB2' ' CG2' ' A' ' 9' ' ' THR . 7.6 mt -86.17 93.42 9.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.891 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HE3' HG22 ' A' ' 105' ' ' VAL . 4.1 mttm -69.22 117.99 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.302 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.426 ' HB ' HG22 ' A' ' 7' ' ' THR . 94.3 mt -109.2 146.62 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.87 -1.144 . . . . 0.0 111.84 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.18 94.58 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -93.52 100.28 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 112.518 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -82.3 131.2 35.23 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.575 ' CD2' HD12 ' A' ' 95' ' ' LEU . 3.2 m-85 -110.88 112.85 24.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.775 -1.203 . . . . 0.0 110.715 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.529 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 63.2 m-70 -92.83 103.24 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.576 HG22 ' CD1' ' A' ' 3' ' ' PHE . 4.5 p -102.13 153.35 20.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.813 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 26.39 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.012 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.43 -162.74 14.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.33 -38.25 15.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -1.168 . . . . 0.0 110.309 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -74.34 -172.51 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.387 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 60.1 mp0 -124.0 -169.98 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 110.346 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.595 HG22 ' CG ' ' A' ' 3' ' ' PHE . 55.7 t -69.27 150.28 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 130' ' ' ALA . 3.9 mtmm -105.01 116.01 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.765 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.64 -52.79 4.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.26 -0.9 . . . . 0.0 110.366 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.6 -46.79 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 109.77 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.463 ' OE1' HD11 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -62.14 -45.03 95.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 108.996 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.575 HG12 ' CD2' ' A' ' 5' ' ' TYR . 53.0 t -62.42 -16.29 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.269 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.6 ttmt -86.42 -60.59 1.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.489 -0.757 . . . . 0.0 110.683 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -41.32 -50.16 3.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 110.092 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.6 t -56.11 -44.32 78.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 110.012 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -27.12 68.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.458 ' O ' ' OG1' ' A' ' 142' ' ' THR . 2.0 tt0 -77.25 -33.9 55.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.422 -0.799 . . . . 0.0 109.924 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.443 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.32 -39.63 65.11 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.602 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.17 85.73 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.32 -32.44 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.273 . . . . 0.0 109.743 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 1.3 p -70.4 -34.81 72.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.247 -0.908 . . . . 0.0 108.802 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.536 HD13 ' CG ' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -71.17 -53.69 13.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.188 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.462 HD12 HD13 ' A' ' 114' ' ' LEU . 9.4 tp -51.4 -39.08 56.51 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -65.09 -38.21 90.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.569 -0.707 . . . . 0.0 109.426 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 34' ' ' ALA . . . -61.48 -60.1 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 21.6 t -61.81 -24.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' HD11 ' A' ' 152' ' ' LEU . 1.5 tt0 -68.14 -48.02 66.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.05 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.9 t -81.26 -17.05 50.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.551 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 9.8 t80 -69.7 -43.93 71.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.713 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 28.1 mt -63.95 -26.05 68.41 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.784 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -80.87 -42.47 21.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.098 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.12 -50.93 66.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.107 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -76.88 -162.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.195 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 6.5 t -92.39 54.19 2.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.537 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER 60.81 53.3 3.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.883 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 156' ' ' ASP . . . -40.91 166.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.716 -0.615 . . . . 0.0 110.761 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 85.4 m-85 57.75 48.27 14.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.447 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.206 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.588 HG12 ' CE1' ' A' ' 121' ' ' HIS . 92.5 t -101.03 153.27 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.156 -1.202 . . . . 0.0 110.426 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.588 ' CD1' HG21 ' A' ' 128' ' ' VAL . 92.3 m-85 -116.07 151.41 35.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.507 -0.745 . . . . 0.0 109.895 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -117.33 99.47 7.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 110.246 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.611 ' CD1' ' CG1' ' A' ' 133' ' ' VAL . 45.6 m-85 -97.18 99.93 11.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' OE1' ' HB3' ' A' ' 117' ' ' SER . 3.3 mt-10 -109.42 136.3 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.97 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 -171.51 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.386 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' OE1' ' CG2' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -165.21 156.31 14.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 110.705 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.553 HG22 ' CD2' ' A' ' 144' ' ' LEU . 0.9 OUTLIER -129.12 173.59 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.329 -0.857 . . . . 0.0 110.155 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.05 143.28 51.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.155 -0.966 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -140.25 147.48 40.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.101 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -21.35 15.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.601 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 36.7 mm -77.16 145.92 73.98 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.035 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 32.7 Cg_endo -56.72 157.93 18.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.91 1.479 . . . . 0.0 110.313 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.577 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -69.48 -47.93 62.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.471 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.574 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -56.33 -44.92 80.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.942 -1.099 . . . . 0.0 110.782 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 1.3 mtt85 -68.78 -49.95 54.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.936 -1.103 . . . . 0.0 109.777 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.601 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 mt -52.08 -30.86 27.88 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.28 1.038 . . . . 0.0 108.518 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.691 ' CE1' ' CD2' ' A' ' 24' ' ' LEU . 8.9 t80 -72.44 -72.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.554 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 11.2 mtpt -45.1 -20.56 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 112.102 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.583 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . . . -115.98 -61.83 1.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.537 -1.352 . . . . 0.0 112.11 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 9.8 t80 -65.51 -80.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.341 -1.475 . . . . 0.0 110.211 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.581 ' CG2' HD22 ' A' ' 24' ' ' LEU . 2.7 mt -43.98 -71.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.858 -1.151 . . . . 0.0 108.495 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.691 ' CD2' ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -61.68 -179.47 0.19 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER 66.11 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.126 -0.984 . . . . 0.0 108.95 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' CG ' ' A' ' 25' ' ' ASP . . . 52.4 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 O-C-N 120.723 -1.235 . . . . 0.0 111.08 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.5 p30 -47.46 -20.37 0.23 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -1.092 . . . . 0.0 111.524 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.542 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 53.5 t30 -110.38 38.89 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 109.779 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -161.07 -49.34 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.465 -0.772 . . . . 0.0 110.56 -179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CD1' HD11 ' A' ' 143' ' ' LEU . 8.0 m-30 -56.39 -53.64 61.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 0.0 111.531 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.1 -4.38 8.93 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 O-C-N 123.293 1.154 . . . . 0.0 111.83 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 13.6 mmtt -109.33 -66.24 1.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.801 -1.187 . . . . 0.0 110.692 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 150' ' ' TYR . 13.7 m -75.72 -14.19 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -139.87 64.3 27.82 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.04 -1.038 . . . . 0.0 110.849 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.1 -8.5 22.92 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 109.764 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.4 tt0 -86.28 -17.4 34.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.564 -0.71 . . . . 0.0 109.432 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' HB2' ' CE ' ' A' ' 139' ' ' MET . . . -108.65 -37.99 5.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.451 HG21 ' N ' ' A' ' 39' ' ' SER . 2.2 mp -127.7 164.87 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.451 ' N ' HG21 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -138.14 -47.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 110.284 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.9 t -161.9 130.17 4.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.118 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 55' ' ' LYS . 54.2 t -95.84 129.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.138 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 14.8 tt0 -117.43 139.08 51.36 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.227 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.6 OUTLIER 71.05 147.23 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.188 -0.945 . . . . 0.0 110.141 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 1.2 tp 176.73 47.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER 172.74 48.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.809 0.814 . . . . 0.0 109.175 -179.226 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' N ' HG21 ' A' ' 52' ' ' THR . . . -52.58 -19.63 6.63 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.495 ' CB ' HG23 ' A' ' 52' ' ' THR . 9.7 t-20 -106.62 -59.73 1.76 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -1.13 . . . . 0.0 109.521 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.85 33.53 0.33 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.283 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.77 -95.21 0.29 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.471 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 42.2 Cg_endo -71.43 -156.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.301 -1.936 0 O-C-N 124.063 1.56 . . . . 0.0 109.978 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 52' ' ' THR . . . -84.95 17.61 31.03 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.537 HG21 ' N ' ' A' ' 46' ' ' GLY . 1.1 m -32.48 148.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.745 -0.856 . . . . 0.0 111.641 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 52' ' ' THR . 20.5 mm 33.36 101.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.948 0.88 . . . . 0.0 111.932 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -134.43 158.07 44.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -129.39 142.27 50.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.472 -1.393 . . . . 0.0 111.839 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.53 ' HB ' ' CG1' ' A' ' 67' ' ' VAL . 1.2 mp -121.64 115.85 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 101.03 10.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.831 . . . . 0.0 110.817 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.598 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . 8.6 m-85 -56.46 177.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.229 -0.919 . . . . 0.0 108.933 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -75.85 145.84 29.06 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.387 1.204 . . . . 0.0 109.962 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' PRO . 1.1 tt0 -41.88 165.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.62 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.27 36.13 15.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.561 ' CD1' ' HB2' ' A' ' 58' ' ' PHE . 3.4 mt -106.31 156.03 37.63 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.127 -1.219 . . . . 0.0 110.561 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.74 -30.77 9.17 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.081 1.569 . . . . 0.0 109.199 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 20.0 m-30 -101.23 -96.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.632 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 179.92 -35.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.806 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 51.5 p90 -179.54 -158.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.375 -0.828 . . . . 0.0 109.687 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.578 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 7.0 p -163.16 108.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.565 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -99.05 160.91 13.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 2.6 p-10 -173.15 139.3 0.79 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.841 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -87.38 146.71 25.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.043 -1.036 . . . . 0.0 110.341 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG11 ' N ' ' A' ' 72' ' ' ASP . 1.2 t -102.22 167.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.307 -0.87 . . . . 0.0 109.706 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.559 ' N ' HG11 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -140.55 56.68 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 110.235 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 74' ' ' VAL . 1.9 mt-10 63.19 177.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.927 . . . . 0.0 109.918 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 73' ' ' GLU . 5.2 t -151.06 137.85 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 111.063 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.453 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -80.43 179.98 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.141 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.489 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 4.1 m-70 -136.08 -49.86 0.69 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.786 -1.196 . . . . 0.0 111.114 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -49.91 -57.6 7.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.908 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -96.0 21.28 8.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.087 -1.008 . . . . 0.0 110.843 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 15' ' ' ALA . 11.4 m-85 41.24 73.74 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 0.0 109.912 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 2.6 tttt -117.76 106.74 13.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 110.746 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.48 ' CD2' HG22 ' A' ' 23' ' ' ILE . 11.0 t80 -111.42 105.47 14.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -113.46 153.88 27.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.861 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.536 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 33.7 p90 -165.29 173.4 11.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 109.924 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.97 121.94 26.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.187 -0.946 . . . . 0.0 111.086 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 85' ' ' VAL . 15.5 m -95.51 122.52 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.487 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.1 pp -123.19 -0.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 8.2 mt-10 -158.33 150.85 22.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.493 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.475 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 90.6 -179.45 43.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.65 -145.74 31.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 51.0 Cg_endo -85.93 31.49 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.55 . . . . 0.0 110.834 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -33.21 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.468 0.652 . . . . 0.0 110.905 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.02 -168.38 40.22 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 11.2 m-20 -87.68 -9.75 53.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -1.142 . . . . 0.0 110.47 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 58.8 p -101.64 41.68 1.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.509 HD23 ' CG1' ' A' ' 98' ' ' ILE . 1.5 mt 169.16 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.13 -45.94 3.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 110.764 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 14.3 mtpp -131.47 143.13 50.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 110.514 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.509 ' CG1' HD23 ' A' ' 95' ' ' LEU . 81.3 mt -140.21 118.4 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.998 -1.064 . . . . 0.0 110.564 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.51 160.43 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 109.793 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.536 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 20.8 t-20 -149.35 145.3 26.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.027 -1.045 . . . . 0.0 111.257 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -132.46 129.2 38.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.522 -0.736 . . . . 0.0 109.078 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 26.8 mm -113.38 135.92 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 0.0 110.396 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.465 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 2.4 mtpm? -139.0 105.39 5.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 110.301 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.516 HD13 ' CD1' ' A' ' 23' ' ' ILE . 72.1 mt -83.84 148.89 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 110.05 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.95 128.71 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.03 132.93 34.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.128 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -107.43 152.44 41.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.414 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.75 -21.79 44.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.291 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.15 -50.77 69.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 142.35 54.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.46 -167.99 34.65 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -148.69 145.43 27.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -1.124 . . . . 0.0 109.856 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.515 ' CG2' ' OE1' ' A' ' 8' ' ' GLU . 8.9 mt -109.14 135.19 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 114' ' ' LEU . 5.5 mp -99.18 108.47 21.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -0.906 . . . . 0.0 110.022 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.79 118.76 26.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 109.749 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.3 mt -110.04 121.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.419 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -118.66 100.86 7.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 109.35 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -103.31 115.6 30.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.168 -0.957 . . . . 0.0 111.078 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.443 ' CG ' ' NE2' ' A' ' 121' ' ' HIS . 1.9 tptt -95.7 115.65 27.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.408 -0.808 . . . . 0.0 108.951 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.539 ' HB3' ' CG2' ' A' ' 128' ' ' VAL . 5.4 m-85 -90.41 147.2 23.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.117 -0.989 . . . . 0.0 111.012 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.588 ' CE1' HG12 ' A' ' 2' ' ' VAL . 73.4 m-70 -133.71 91.48 2.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.604 -0.685 . . . . 0.0 109.21 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.431 ' CG2' HG21 ' A' ' 128' ' ' VAL . 9.7 p -83.03 -179.49 7.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.638 -0.664 . . . . 0.0 110.465 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -84.87 6.1 26.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.094 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 101.72 -166.23 18.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 t0 50.15 -91.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 110.29 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' GLY . 62.7 m-70 -66.24 156.63 33.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 110.145 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 27.0 mt-10 -107.99 169.45 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 3' ' ' PHE . 55.7 t -59.09 151.27 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.054 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 130' ' ' ALA . 46.0 mtmt -96.06 117.22 30.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 0.0 110.419 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -46.13 -38.24 7.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -56.4 -47.59 78.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.838 . . . . 0.0 109.38 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.455 ' OE1' ' HB2' ' A' ' 90' ' ' PRO . 21.5 mt-30 -61.78 -38.31 87.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.611 ' CG1' ' CD1' ' A' ' 5' ' ' TYR . 96.1 t -68.78 -19.5 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.768 0.794 . . . . 0.0 109.421 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -85.99 -66.89 0.85 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.463 -0.773 . . . . 0.0 110.921 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -34.47 -40.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.482 -0.761 . . . . 0.0 110.88 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 t -64.36 -52.79 56.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -54.86 -45.88 74.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.128 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 139' ' ' MET . 3.2 mt-10 -56.72 -59.58 4.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.196 -0.94 . . . . 0.0 109.743 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.497 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -44.99 -49.19 11.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.058 -1.027 . . . . 0.0 109.651 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.2 92.84 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 142' ' ' THR . 35.2 tt0 -74.78 -65.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.313 . . . . 0.0 110.501 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -42.28 -46.45 4.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.587 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 30' ' ' PHE . 3.5 mm? -63.88 -55.23 24.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 109.84 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.553 ' CD2' HG22 ' A' ' 9' ' ' THR . 22.5 tp -40.45 -46.17 2.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.432 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -43.33 92.07 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.804 . . . . 0.0 109.55 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.496 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -56.2 -61.75 2.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 110.085 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.474 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 24.7 t -67.49 -18.26 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.815 . . . . 0.0 110.644 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 18.1 tt0 -70.98 -47.1 60.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 0.0 109.557 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 -21.77 31.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.547 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 10.6 t80 -57.6 -49.52 76.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.475 -0.765 . . . . 0.0 109.699 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 150' ' ' TYR . 65.3 mt -54.98 -25.71 31.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.582 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -84.64 -33.16 23.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.892 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.32 -46.82 69.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.22 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 154' ' ' HIS . 19.2 m-70 -90.27 -24.75 20.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' HIS . 1.4 p 44.24 30.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.312 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -152.34 15.32 0.61 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.598 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -110.5 131.53 54.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.076 -1.015 . . . . 0.0 110.112 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.583 ' CD2' ' HB3' ' A' ' 21' ' ' ALA . 37.7 m-85 63.88 9.33 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.397 -0.814 . . . . 0.0 110.458 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.189 -179.803 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.528 HG11 ' N ' ' A' ' 3' ' ' PHE . 97.2 t -72.62 151.14 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -1.083 . . . . 0.0 110.347 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 56.9 m-85 -109.74 131.7 54.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 109.607 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -95.25 95.53 8.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.886 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 3' ' ' PHE . 23.2 m-30 -101.6 95.75 6.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.83 . . . . 0.0 110.24 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -88.01 126.37 35.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.303 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 t -145.4 178.33 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.18 . . . . 0.0 111.191 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -168.43 159.19 10.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.543 -0.723 . . . . 0.0 109.688 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 HD23 ' A' ' 144' ' ' LEU . 1.9 t -132.16 162.63 30.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.458 HG21 HG12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -113.48 142.57 45.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.435 ' HB3' HD13 ' A' ' 18' ' ' LEU . 48.0 t -140.73 143.36 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.983 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -72.47 -2.04 2.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 109.968 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.577 ' CG2' ' NE ' ' A' ' 17' ' ' ARG . 19.2 mm -91.95 146.42 32.84 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 110.243 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 32.8 Cg_endo -57.39 153.82 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 0.0 110.162 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' CB ' HG23 ' A' ' 104' ' ' ILE . . . -62.81 -59.47 4.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -0.996 . . . . 0.0 110.479 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -42.96 -59.92 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 151' ' ' LEU . 6.7 ttp180 -53.03 -57.71 9.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.554 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 10.7 mt -45.6 -32.71 2.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CE1' HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -72.41 -55.54 6.88 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 110.687 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -60.1 -33.41 72.07 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB1' ' CG ' ' A' ' 158' ' ' TYR . . . -107.74 -34.78 6.87 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.264 -1.523 . . . . 0.0 112.551 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 81.3 t80 -102.53 9.45 39.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.731 -1.231 . . . . 0.0 111.873 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.567 HG23 ' CE1' ' A' ' 19' ' ' PHE . 29.2 mm -142.98 -26.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.823 -1.173 . . . . 0.0 110.968 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 19' ' ' PHE . 4.1 mt -103.8 -35.89 8.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.713 -1.242 . . . . 0.0 109.16 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.487 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -112.97 41.08 2.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.585 -0.697 . . . . 0.0 110.535 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.24 -30.36 62.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD1' ' CG1' ' A' ' 41' ' ' VAL . 3.2 t70 -69.1 -6.41 28.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 2.5 t30 -126.01 13.91 7.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.571 HD12 ' CD2' ' A' ' 150' ' ' TYR . 0.2 OUTLIER -130.98 -43.91 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.573 ' CD1' HD11 ' A' ' 143' ' ' LEU . 7.6 m-30 -57.58 -54.41 55.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 111.197 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -66.97 -15.21 46.34 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.34 1.179 . . . . 0.0 111.293 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 4.8 mptt -91.08 -71.81 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 110.736 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.579 ' CG1' ' CD1' ' A' ' 150' ' ' TYR . 17.4 m -75.52 -18.25 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.839 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.463 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -118.59 60.6 4.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.624 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.9 Cg_endo -67.61 -19.91 47.63 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.934 1.492 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 2.2 tt0 -82.62 -16.42 48.41 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.662 0.744 . . . . 0.0 109.073 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' CB ' ' CD2' ' A' ' 143' ' ' LEU . . . -100.18 -63.15 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.286 -0.884 . . . . 0.0 110.574 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.473 HD11 ' HB2' ' A' ' 37' ' ' ALA . 3.7 mp -115.63 153.94 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.693 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 -38.15 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 109.631 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 57' ' ' SER . 47.7 p -177.64 151.91 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.533 -0.729 . . . . 0.0 109.681 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.53 ' CG1' ' OD1' ' A' ' 27' ' ' ASP . 3.7 p -141.46 129.15 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.972 . . . . 0.0 110.571 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.8 OUTLIER 177.23 -176.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.915 . . . . 0.0 110.991 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER 169.47 -60.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.462 ' O ' HD11 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -120.17 -22.81 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.549 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.08 77.2 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 110.365 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.15 -121.31 0.02 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.83 12.57 4.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -1.225 . . . . 0.0 110.475 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.46 133.68 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 71' ' ' VAL . . . 106.36 -135.83 12.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.12 83.76 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.919 1.483 . . . . 0.0 110.91 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.66 32.87 0.54 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.101 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m -84.74 115.09 22.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.254 . . . . 0.0 110.264 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 44' ' ' ILE . 38.6 mm -113.33 108.96 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.271 -0.893 . . . . 0.0 110.251 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -150.17 168.55 23.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 20.5 ttpt -121.4 113.51 19.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.584 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 2.1 mp -72.75 144.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -131.7 165.52 23.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.58 -0.7 . . . . 0.0 109.697 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CZ ' HG21 ' A' ' 56' ' ' ILE . 30.7 m-85 -137.9 157.04 73.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.042 -1.037 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 60' ' ' GLU . 50.4 Cg_endo -75.48 154.74 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.159 1.61 . . . . 0.0 109.901 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 59' ' ' PRO . 4.7 pt-20 -42.78 157.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.283 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.13 -58.8 0.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.478 HD13 ' HB3' ' A' ' 58' ' ' PHE . 11.6 mt -62.18 161.17 26.03 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.161 -1.199 . . . . 0.0 110.35 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.16 -38.6 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.152 1.606 . . . . 0.0 110.4 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 9.2 m-30 -92.91 153.39 18.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -104.19 -17.36 14.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.484 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 29.1 p90 -174.14 -173.34 0.79 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.718 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -177.66 115.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 109.947 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -68.98 134.16 49.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -128.5 127.27 42.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 110.951 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -127.94 103.32 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.414 -0.804 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 32.2 m -57.01 -32.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.287 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 64.08 5.75 2.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -0.917 . . . . 0.0 110.729 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 167.36 177.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -179.23 125.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 109.658 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -104.58 -176.74 3.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.24 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.73 -67.28 0.32 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.3 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.8 m -58.12 -36.32 72.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 0.0 110.532 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 5.5 m-80 -93.73 0.77 56.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.006 . . . . 0.0 110.694 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 19.8 m-30 57.06 14.92 2.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 110.552 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HA ' ' CB ' ' A' ' 103' ' ' LYS . 16.5 mttm -71.61 136.53 47.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.086 . . . . 0.0 109.744 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 67.8 t80 -149.72 121.82 8.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 110.462 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.572 ' HA ' ' CB ' ' A' ' 101' ' ' GLU . 4.6 m-20 -125.29 142.94 51.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.88 . . . . 0.0 110.558 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -152.34 149.49 28.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.105 -0.997 . . . . 0.0 111.102 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.58 135.78 54.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.553 -0.717 . . . . 0.0 109.691 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.571 ' CG1' ' HB ' ' A' ' 98' ' ' ILE . 2.2 p -103.62 123.91 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.545 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 1.5 pp -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 1.8 tt0 73.91 138.49 0.06 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 0.0 110.603 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.435 ' C ' HG11 ' A' ' 67' ' ' VAL . . . 81.08 162.85 29.32 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.83 -144.65 17.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.9 Cg_endo -81.9 22.57 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.98 1.516 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -38.83 164.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.359 -0.838 . . . . 0.0 111.116 -179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.6 38.14 7.16 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.469 ' O ' ' OG1' ' A' ' 94' ' ' THR . 9.7 t0 -155.37 68.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.48 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 13.9 p 48.28 38.18 9.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -159.92 60.38 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -49.09 -72.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -128.35 159.98 33.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.585 HG22 ' CD1' ' A' ' 120' ' ' TYR . 71.3 mt -137.39 117.27 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.85 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.45 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 28.8 t -103.92 128.19 51.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 0.0 110.607 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.575 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 19.0 m-20 -129.19 134.07 47.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.594 ' O ' HG12 ' A' ' 102' ' ' ILE . 6.6 pt-20 -175.56 149.09 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 117.881 -1.528 . . . . 0.0 113.312 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -178.58 -95.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.591 ' N ' ' CG2' ' A' ' 102' ' ' ILE . 0.7 OUTLIER 176.0 -176.49 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 0.0 110.625 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.531 ' CG2' HD21 ' A' ' 114' ' ' LEU . 36.2 mt -113.76 124.79 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 108.915 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.515 ' CG2' ' HD2' ' A' ' 115' ' ' LYS . 64.6 t -96.92 125.72 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.3 131.78 37.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.668 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' A' ' 111' ' ' GLY . 67.6 p -78.67 162.51 65.23 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 47.7 Cg_endo -66.92 -18.16 52.11 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.066 1.561 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -171.04 -30.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 111.239 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.26 -88.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.533 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . -151.09 -95.45 0.12 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 11.9 m -171.12 137.0 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.323 -1.104 . . . . 0.0 109.83 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 10' ' ' THR . 2.2 mt -100.95 114.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.095 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.531 HD21 ' CG2' ' A' ' 104' ' ' ILE . 45.8 mt -71.71 103.01 2.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.58 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HD2' ' CG2' ' A' ' 105' ' ' VAL . 78.6 mttt -86.64 126.16 34.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.853 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.531 HG23 ' ND2' ' A' ' 118' ' ' ASN . 16.4 mt -137.25 130.27 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.518 ' N ' HG12 ' A' ' 102' ' ' ILE . 36.6 m -96.28 102.48 14.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.082 -1.011 . . . . 0.0 108.963 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.531 ' ND2' HG23 ' A' ' 116' ' ' ILE . 1.5 m-80 -83.63 143.74 29.9 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.435 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 117.8 9.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.585 ' CD1' HG22 ' A' ' 98' ' ' ILE . 2.7 m-85 -92.98 99.86 12.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.018 -1.051 . . . . 0.0 111.115 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.462 ' HA ' HG23 ' A' ' 2' ' ' VAL . 73.5 m-70 -82.04 83.88 7.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.409 -0.807 . . . . 0.0 109.192 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.508 HG23 ' CG2' ' A' ' 128' ' ' VAL . 11.7 p -82.21 -146.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.843 . . . . 0.0 110.571 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.79 18.98 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 0.0 110.708 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.67 -143.55 16.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.3 t0 48.53 -144.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -1.148 . . . . 0.0 110.116 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -50.04 149.71 2.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.833 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.53 170.9 13.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 110.492 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.597 HG22 ' CE1' ' A' ' 3' ' ' PHE . 35.4 t -62.27 143.27 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.426 ' HE3' ' OE1' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -85.91 110.01 19.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.52 -49.03 10.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.154 -0.966 . . . . 0.0 109.795 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.15 -43.25 74.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.011 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.432 ' NE2' ' HB2' ' A' ' 90' ' ' PRO . 42.6 tt0 -58.34 -38.55 77.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -0.753 . . . . 0.0 109.478 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.569 HG12 ' CD2' ' A' ' 5' ' ' TYR . 4.0 t -77.5 -17.6 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 109.798 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.1 tptt -81.35 -61.9 1.81 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -0.791 . . . . 0.0 110.369 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -39.23 -50.49 1.95 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.338 -0.851 . . . . 0.0 110.163 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -48.18 74.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.355 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -36.39 69.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -61.89 -59.95 4.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.144 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.456 ' CE ' HD13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -46.13 -42.83 14.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.158 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.53 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.01 -47.53 71.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -1.224 . . . . 0.0 110.907 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.5 -38.34 63.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.021 -1.05 . . . . 0.0 109.186 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.588 ' CD2' ' CB ' ' A' ' 37' ' ' ALA . 1.5 mm? -69.99 -50.21 43.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.836 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.549 ' HA ' ' CE1' ' A' ' 22' ' ' PHE . 14.5 tp -51.14 -30.87 17.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 108.792 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -43.73 34.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 110.075 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.51 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -56.91 -48.32 78.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 109.896 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.457 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 27.7 t -74.03 -36.5 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.41 -0.806 . . . . 0.0 110.111 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.457 ' HG3' ' CG1' ' A' ' 13' ' ' ILE . 19.6 tt0 -57.19 -41.03 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.52 -25.52 21.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.93 . . . . 0.0 110.083 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.614 ' CD2' HD21 ' A' ' 151' ' ' LEU . 7.3 t80 -57.39 -33.71 68.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.746 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.614 HD21 ' CD2' ' A' ' 150' ' ' TYR . 20.1 mt -79.07 -26.19 43.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.201 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 8.1 mp -78.53 -22.38 47.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.22 -45.43 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -72.37 171.9 11.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 110.697 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.6 t -54.01 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 3.8 p-10 -155.53 54.34 0.61 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 110.756 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.571 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -59.08 133.95 56.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.875 -1.14 . . . . 0.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.589 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 53.2 m-85 62.37 62.3 1.17 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.679 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.175 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.534 HG11 ' N ' ' A' ' 3' ' ' PHE . 78.2 t -76.69 151.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -1.195 . . . . 0.0 110.046 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 127' ' ' GLU . 87.1 m-85 -115.28 129.46 56.63 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 110.206 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.25 105.1 16.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.578 ' CD1' HG13 ' A' ' 133' ' ' VAL . 23.5 m-85 -106.58 82.11 1.68 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -88.04 157.41 18.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 0.0 110.937 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.541 ' CG2' ' HB ' ' A' ' 116' ' ' ILE . 11.5 t -173.39 -174.02 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 0.0 109.693 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 7' ' ' THR . 6.9 mt-10 -140.19 149.9 43.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.107 -0.996 . . . . 0.0 110.335 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.795 ' O ' ' HB2' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -158.5 136.5 10.59 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.239 -0.913 . . . . 0.0 109.21 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.66 ' CB ' ' HA ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER 175.88 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 119.778 -1.826 . . . . 0.0 113.967 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.481 ' OG ' ' C ' ' A' ' 10' ' ' THR . 0.5 OUTLIER -169.38 -175.52 2.24 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.935 -178.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -72.79 -15.76 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.21 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.564 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 4.6 mm -61.51 140.87 94.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 110.045 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -56.08 158.54 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.029 1.542 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.563 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -70.24 -32.84 70.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.685 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.32 90.83 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 110.686 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.488 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 19.2 mtm180 -79.25 -50.33 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.078 . . . . 0.0 109.893 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.564 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -57.69 -30.94 65.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.66 ' CE2' HD23 ' A' ' 24' ' ' LEU . 61.8 t80 -79.11 -46.3 18.31 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.624 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -68.19 -20.95 64.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.773 . . . . 0.0 112.155 -178.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.631 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . . . -111.71 -31.66 6.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.678 -1.264 . . . . 0.0 112.15 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 86.0 t80 -107.16 -13.25 15.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.682 -1.261 . . . . 0.0 111.934 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.593 HG22 ' CE1' ' A' ' 19' ' ' PHE . 39.4 mm -122.46 -16.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.794 -1.192 . . . . 0.0 110.486 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.66 HD23 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -112.38 -29.48 7.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.231 -0.918 . . . . 0.0 110.173 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.483 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -137.15 66.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.886 -179.54 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -83.56 -25.48 46.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -80.18 13.73 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.515 -0.991 . . . . 0.0 110.834 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 89.7 m-20 -135.97 37.77 2.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.826 -1.171 . . . . 0.0 108.15 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.653 ' CD1' ' CG ' ' A' ' 150' ' ' TYR . 0.3 OUTLIER 174.68 -36.42 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.188 -177.033 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 3.2 m-30 -38.79 -62.09 0.79 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.62 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 55.6 Cg_endo -69.83 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.902 1.475 . . . . 0.0 110.725 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.8 mmtt -49.74 -25.9 3.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 111.14 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 150' ' ' TYR . 3.6 m -120.16 -10.13 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.049 . . . . 0.0 110.789 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.05 65.51 36.83 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.045 -1.034 . . . . 0.0 110.459 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.67 -13.63 37.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.05 1.553 . . . . 0.0 109.542 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.466 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -82.98 -14.96 53.03 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HB2' HD22 ' A' ' 143' ' ' LEU . . . -110.48 -58.53 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.23 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.466 HD11 HD22 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -115.35 125.82 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.008 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.484 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 8.1 t -82.9 -38.74 22.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.826 . . . . 0.0 110.354 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 p -172.45 151.22 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.328 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' HB ' ' A' ' 44' ' ' ILE . 7.3 p -99.61 129.49 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.644 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HB3' ' CB ' ' A' ' 55' ' ' LYS . 13.4 tp10 -104.28 170.13 8.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.581 -0.699 . . . . 0.0 109.647 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.541 ' O ' ' C ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER 60.86 -92.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.086 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.541 ' C ' ' O ' ' A' ' 43' ' ' ASN . 4.8 tp 25.35 59.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-O 121.331 0.586 . . . . 0.0 111.271 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 57.23 4.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.632 -0.668 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.93 -108.6 0.36 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.48 82.46 2.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -1.098 . . . . 0.0 110.135 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.41 -14.33 41.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.73 -161.51 29.56 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.3 83.37 1.49 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.036 1.545 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 53' ' ' ILE . . . 127.73 51.49 0.14 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.2 m -67.81 151.52 47.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.178 -1.189 . . . . 0.0 110.068 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.547 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.8 mp -114.93 134.66 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 110.676 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HE3' ' CD1' ' A' ' 44' ' ' ILE . 26.5 mtpt -123.32 148.06 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.885 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 42' ' ' GLU . 28.7 mttp -121.76 84.72 2.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.869 . . . . 0.0 110.223 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.491 ' CG2' ' HE1' ' A' ' 58' ' ' PHE . 1.6 mp -66.42 125.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.867 -1.146 . . . . 0.0 109.141 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -105.78 126.31 52.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.631 -1.293 . . . . 0.0 111.318 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.595 ' CZ ' ' CG2' ' A' ' 67' ' ' VAL . 10.8 m-30 -84.82 141.93 38.72 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.458 -0.777 . . . . 0.0 110.59 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 39' ' ' SER . 43.7 Cg_endo -70.48 -179.23 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.936 1.493 . . . . 0.0 108.77 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.24 163.82 12.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.723 -1.236 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.61 -47.92 3.9 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -49.83 159.07 0.79 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 111.041 -179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HD2' ' CD1' ' A' ' 62' ' ' LEU . 45.0 Cg_endo -72.1 152.37 56.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.187 1.625 . . . . 0.0 108.586 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.403 ' CD2' ' HB2' ' A' ' 63' ' ' PRO . 21.9 m-85 52.84 -136.19 1.41 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.158 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -152.25 -3.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.901 -1.124 . . . . 0.0 112.093 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.586 ' CE2' ' CA ' ' A' ' 88' ' ' GLY . 43.9 p90 178.02 -158.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.837 -1.165 . . . . 0.0 110.442 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.595 ' CG2' ' CZ ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -173.07 130.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.53 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -95.85 154.12 17.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.566 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.85 127.16 12.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.01 -1.056 . . . . 0.0 111.241 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.68 142.02 31.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 109.127 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.21 137.97 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 111.157 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -110.98 47.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.379 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.6 mt-10 63.69 110.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 109.863 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.554 HG13 ' CD1' ' A' ' 81' ' ' TYR . 3.8 m -82.72 168.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.329 -0.857 . . . . 0.0 110.499 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -102.89 139.51 38.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.829 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -102.42 -48.8 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.36 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.7 m -53.59 -42.31 67.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.909 -1.119 . . . . 0.0 110.928 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 79' ' ' PHE . 17.9 m120 -105.73 15.2 27.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.053 . . . . 0.0 110.811 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 76' ' ' HIS . 12.3 m-30 41.58 59.23 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 110.291 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -115.53 164.85 13.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 0.0 109.942 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.554 ' CD1' HG13 ' A' ' 74' ' ' VAL . 10.1 t80 -147.69 143.0 27.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.913 . . . . 0.0 110.5 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -145.56 100.41 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.824 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.538 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 38.2 p90 -128.59 168.97 14.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.51 135.39 53.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.473 HG22 ' OD1' ' A' ' 100' ' ' ASN . 21.4 t -94.92 112.34 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.529 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 18.6 pt -132.32 150.67 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' OE1' ' CG1' ' A' ' 86' ' ' ILE . 27.7 mp0 58.65 156.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 110.722 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.586 ' CA ' ' CE2' ' A' ' 66' ' ' TYR . . . 61.04 149.06 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.11 -141.45 15.6 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ILE . 50.1 Cg_endo -84.2 26.62 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.022 1.538 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.35 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.531 -0.73 . . . . 0.0 110.517 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.45 -160.23 28.23 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -93.83 -30.74 14.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.452 ' O ' ' HB ' ' A' ' 122' ' ' THR . 71.0 p -59.75 -24.45 64.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.485 HD21 ' CG1' ' A' ' 98' ' ' ILE . 1.7 mt -146.18 86.74 1.71 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -81.42 -41.66 21.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.902 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.7 mmtt -123.0 158.49 30.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.997 -1.064 . . . . 0.0 110.527 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 97' ' ' LYS . 12.9 mt -158.27 115.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.485 -0.759 . . . . 0.0 109.996 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 t -103.69 114.28 28.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 109.96 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.473 ' OD1' HG22 ' A' ' 85' ' ' VAL . 7.1 m120 -116.67 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.051 -1.03 . . . . 0.0 110.964 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.446 ' O ' HD13 ' A' ' 102' ' ' ILE . 3.9 pt-20 -141.98 145.48 34.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.492 -0.755 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.462 ' CG2' ' HG ' ' A' ' 114' ' ' LEU . 1.3 mp -126.14 135.25 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.832 -1.168 . . . . 0.0 110.193 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 ttpt -115.89 101.33 8.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.375 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.539 ' CG1' HD13 ' A' ' 114' ' ' LEU . 4.7 mp -78.81 135.67 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.964 -1.085 . . . . 0.0 109.785 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 104' ' ' ILE . 44.5 t -140.85 125.94 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.442 ' HB1' ' HB1' ' A' ' 15' ' ' ALA . . . -81.25 140.04 35.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.336 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.6 p -100.35 157.43 33.81 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.968 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.07 -16.87 50.33 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.034 1.544 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -161.64 83.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.026 -1.046 . . . . 0.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 168.98 -87.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -173.68 -153.17 9.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.646 ' O ' ' HB ' ' A' ' 10' ' ' THR . 0.4 OUTLIER -108.26 143.78 36.64 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.174 -1.192 . . . . 0.0 109.344 179.06 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.66 ' HA ' ' CB ' ' A' ' 10' ' ' THR . 1.8 mt -119.68 137.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.401 0.62 . . . . 0.0 111.373 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.795 ' HB2' ' O ' ' A' ' 9' ' ' THR . 2.5 mp -101.27 110.33 22.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.447 -0.783 . . . . 0.0 109.513 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 1.8 mptp? -81.14 104.98 11.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 77.5 mt -93.47 112.83 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.661 0.743 . . . . 0.0 112.23 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.1 111.66 23.41 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.45 ' OD1' HG23 ' A' ' 116' ' ' ILE . 16.5 m120 -110.42 96.58 6.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 111.216 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -84.56 99.69 10.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.478 ' O ' HG11 ' A' ' 2' ' ' VAL . 3.2 m-85 -75.83 132.8 40.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.772 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.53 ' CE1' HG22 ' A' ' 2' ' ' VAL . 55.4 m-70 -114.49 100.07 8.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.535 ' CG2' HG21 ' A' ' 128' ' ' VAL . 6.3 p -104.6 179.48 4.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 110.332 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 122' ' ' THR . 1.1 ptpm? 175.21 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 159.62 126.47 0.85 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.18 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 47.89 -150.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -1.075 . . . . 0.0 110.824 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 125' ' ' ASP . 4.3 m-70 -42.13 166.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.359 -0.838 . . . . 0.0 110.533 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -107.44 -121.21 0.24 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 110.141 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.535 HG21 ' CG2' ' A' ' 122' ' ' THR . 97.7 t -103.2 141.8 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.822 -1.174 . . . . 0.0 110.492 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 130' ' ' ALA . 37.5 mtmt -107.29 124.22 49.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.699 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.32 -41.31 5.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.173 -0.955 . . . . 0.0 109.786 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 tm-20 -52.03 -49.53 63.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.209 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.422 ' OE1' ' HE3' ' A' ' 129' ' ' LYS . 7.6 mt-30 -61.87 -43.29 99.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.195 -0.94 . . . . 0.0 109.007 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.578 HG13 ' CD1' ' A' ' 5' ' ' TYR . 96.9 t -62.0 -18.33 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.137 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 23.3 ttpt -87.72 -63.61 1.28 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 110.694 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.12 -47.98 0.79 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.697 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -47.22 87.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -64.77 -19.37 65.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 24.4 tt0 -78.7 -45.47 21.21 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.454 ' HE2' HD13 ' A' ' 38' ' ' ILE . 44.0 mmm -64.0 -35.18 79.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.532 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.43 -42.62 73.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.17 -33.35 74.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.999 -1.295 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.25 70.4 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.164 -0.96 . . . . 0.0 109.045 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.466 HD22 HD11 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -69.96 -29.31 66.4 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.485 ' CD2' HG21 ' A' ' 9' ' ' THR . 15.9 tp -69.13 -46.07 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -33.4 75.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.39 -0.819 . . . . 0.0 108.945 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -62.52 -54.65 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.822 . . . . 0.0 109.273 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.539 ' CG1' HD22 ' A' ' 29' ' ' LEU . 39.2 t -70.99 -16.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -0.768 . . . . 0.0 109.968 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.456 ' HG3' ' HB3' ' A' ' 11' ' ' SER . 5.5 tm-20 -75.17 -44.33 47.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.635 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -15.29 32.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.404 -0.81 . . . . 0.0 109.707 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.653 ' CG ' ' CD1' ' A' ' 29' ' ' LEU . 4.1 t80 -64.69 -52.12 58.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.352 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.575 HD22 ' CE2' ' A' ' 150' ' ' TYR . 84.8 mt -53.46 -30.71 42.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.706 -0.621 . . . . 0.0 110.167 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.26 -51.76 10.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.701 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 154' ' ' HIS . . . -55.24 -53.76 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.451 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 153' ' ' ALA . 46.2 m-70 -60.01 -122.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.038 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 9.6 t -175.02 -31.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.59 -1.319 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -144.54 39.94 1.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 110.938 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.5 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -85.0 128.4 34.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.776 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.631 ' CD2' ' CB ' ' A' ' 21' ' ' ALA . 44.4 m-85 56.16 49.26 15.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.286 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 120' ' ' TYR . 9.2 p -144.66 161.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -1.12 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 76.5 m-85 -132.82 161.4 34.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.382 -0.824 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.59 106.82 10.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -0.963 . . . . 0.0 110.437 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CD1' HG13 ' A' ' 133' ' ' VAL . 44.7 m-85 -108.14 86.8 2.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.398 -0.814 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -101.76 156.34 17.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.666 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.451 HG21 ' HB ' ' A' ' 116' ' ' ILE . 5.5 t -166.15 176.63 7.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.972 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.2 mp0 -146.35 137.05 24.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 1.5 t -118.26 166.43 12.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.87 142.31 51.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.698 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.529 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -141.19 147.95 39.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.448 HG11 ' N ' ' A' ' 13' ' ' ILE . 0.8 OUTLIER -72.49 -39.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.433 -0.792 . . . . 0.0 110.174 -179.364 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.542 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 3.4 mm -58.88 141.91 85.17 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' ' 13' ' ' ILE . 35.7 Cg_endo -57.89 155.27 33.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.912 1.48 . . . . 0.0 110.804 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -60.68 -36.68 79.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 110.103 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . . . -62.68 -56.24 19.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 110.735 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.458 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 51.7 mtt180 -61.3 -55.17 34.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.151 -0.968 . . . . 0.0 110.245 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.542 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -52.27 -33.72 43.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.221 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.637 ' CE2' HD23 ' A' ' 24' ' ' LEU . 75.7 t80 -69.88 -52.6 23.43 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 11.5 mtmm -61.26 -25.34 67.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 0.0 111.552 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.646 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.66 -61.12 1.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 111.522 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 80.7 t80 -76.28 -4.9 44.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.304 -0.872 . . . . 0.0 112.253 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 34.9 mm -132.95 -20.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.642 -1.286 . . . . 0.0 111.123 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.637 HD23 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -111.19 -5.69 14.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -154.75 53.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 110.557 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.36 -21.78 55.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 49.8 p30 -68.21 -15.44 63.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -1.086 . . . . 0.0 110.449 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -122.77 10.75 9.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.77 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.594 HD13 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -122.27 -42.68 2.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.339 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 7.3 m-30 -60.7 -51.8 77.12 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.87 . . . . 0.0 111.684 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.9 Cg_endo -65.42 -4.82 10.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.224 1.118 . . . . 0.0 111.741 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -107.93 -64.11 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.898 -1.126 . . . . 0.0 110.5 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.499 HG22 ' CB ' ' A' ' 146' ' ' ALA . 18.5 m -71.95 -17.71 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.472 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -132.97 66.3 75.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.101 -0.999 . . . . 0.0 110.872 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.0 Cg_endo -68.39 -19.96 42.78 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 109.466 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -83.9 -9.57 58.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.558 -0.714 . . . . 0.0 109.548 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' HB2' HD13 ' A' ' 38' ' ' ILE . . . -105.56 -59.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.968 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.456 HD12 ' HE3' ' A' ' 139' ' ' MET . 1.4 mp -119.16 161.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.489 ' HB2' ' N ' ' A' ' 59' ' ' PRO . 42.8 t -111.15 -57.44 2.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.055 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.38 144.48 3.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.914 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.481 HG13 ' HB2' ' A' ' 27' ' ' ASP . 12.8 p -109.29 139.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.163 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 5.1 mt-10 -102.65 106.05 16.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.129 -0.982 . . . . 0.0 109.87 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -102.18 97.86 8.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.321 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.416 HG21 ' O ' ' A' ' 53' ' ' ILE . 5.8 tp -58.45 -25.32 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 110.013 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.59 108.11 15.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.097 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.33 -3.02 88.39 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.502 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 26.9 p-10 -163.08 56.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -1.23 . . . . 0.0 110.312 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.05 1.21 57.62 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.48 -112.9 0.97 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.13 85.62 1.64 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.873 1.459 . . . . 0.0 110.622 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 52' ' ' THR . . . 142.77 -15.23 2.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.417 ' C ' ' O ' ' A' ' 51' ' ' GLY . 62.2 m -43.91 101.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -1.201 . . . . 0.0 110.178 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.523 ' CD1' ' HG3' ' A' ' 70' ' ' ARG . 22.8 mm -85.68 121.7 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.099 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -137.76 154.31 49.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.495 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' CG ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -125.38 107.24 10.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.392 -0.817 . . . . 0.0 110.173 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.534 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 1.7 mp -73.44 136.34 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 109.664 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -119.04 162.16 19.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 110.356 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 19.5 m-85 -128.05 161.57 55.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.489 ' N ' ' HB2' ' A' ' 39' ' ' SER . 43.0 Cg_endo -71.21 159.92 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.981 1.516 . . . . 0.0 110.017 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.69 164.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 110.627 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.61 -45.47 3.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.454 HD21 ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -66.16 145.23 98.98 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.195 -1.179 . . . . 0.0 110.797 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 64' ' ' PHE . 47.5 Cg_endo -75.57 -163.65 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 110.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 5.2 m-30 51.83 103.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.376 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.6 tppt? -56.78 -17.62 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.604 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 175.6 -175.05 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG21 ' C ' ' A' ' 66' ' ' TYR . 53.8 t -147.64 80.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -79.44 133.59 36.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 84' ' ' SER . 4.8 p-10 -163.39 -177.77 5.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG3' ' CD1' ' A' ' 53' ' ' ILE . 6.4 mtp180 -121.8 159.73 26.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 4.6 p -85.93 -25.44 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.933 . . . . 0.0 111.042 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 72.14 -80.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -168.73 157.77 8.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 178.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 81' ' ' TYR . 14.6 p -128.45 109.79 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.96 154.86 41.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 109.464 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.41 -59.06 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 110.61 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.9 m -63.0 -8.23 6.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 0.0 110.993 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.475 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 73.3 m-20 -121.29 6.87 10.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.91 -1.119 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 8.6 m-30 44.66 67.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.475 ' HE2' ' HB3' ' A' ' 78' ' ' ASN . 3.0 mtmt -137.1 122.29 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.883 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.532 ' CD1' HG22 ' A' ' 74' ' ' VAL . 4.3 t80 -111.05 128.98 56.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.556 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -101.0 143.85 30.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.607 ' CZ ' ' CG2' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -149.3 115.96 5.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.417 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -103.27 127.47 50.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.607 ' CG2' ' CZ ' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -102.45 95.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.435 -0.791 . . . . 0.0 109.783 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 87' ' ' GLU . 25.0 pt -87.44 -29.6 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 0.0 110.414 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -156.48 102.58 2.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.898 . . . . 0.0 110.363 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 143.79 166.3 11.25 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 91' ' ' ILE . . . 86.1 -121.43 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 91' ' ' ILE . 47.4 Cg_endo -74.24 -52.26 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.788 1.415 . . . . 0.0 110.584 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.2 OUTLIER 30.03 -156.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.875 0.845 . . . . 0.0 111.862 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.83 -161.67 2.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 94' ' ' THR . 3.4 m-20 51.68 -95.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -1.142 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 126' ' ' HIS . 18.3 p -156.23 22.25 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 110.516 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.464 HD12 ' CE2' ' A' ' 120' ' ' TYR . 9.9 mt -94.93 95.49 8.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.205 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 4.6 mt-10 -76.6 -43.34 38.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 98' ' ' ILE . 9.1 tttp -129.43 152.13 49.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.005 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 97' ' ' LYS . 13.3 mt -153.74 122.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 110.635 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.53 127.34 48.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 109.872 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 2.3 m-80 -121.54 114.65 21.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.621 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.01 159.0 16.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 109.703 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.452 ' C ' ' HG3' ' A' ' 103' ' ' LYS . 13.7 mt -141.89 142.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HE3' ' HD3' ' A' ' 80' ' ' LYS . 1.8 mtpp -138.09 151.86 48.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.147 -0.971 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.509 HG22 ' CD2' ' A' ' 114' ' ' LEU . 4.9 mp -130.84 125.85 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.002 . . . . 0.0 109.927 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.425 HG22 ' HD2' ' A' ' 115' ' ' LYS . 13.0 t -116.41 133.23 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.02 21.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 p -128.96 152.85 79.89 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.843 . . . . 0.0 110.115 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.99 -32.38 28.55 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.024 1.539 . . . . 0.0 110.706 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 p30 -149.99 43.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.81 14.21 0.89 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.47 -138.07 29.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -128.58 136.56 50.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -1.157 . . . . 0.0 110.571 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.11 125.79 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.803 . . . . 0.0 109.211 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.513 ' HB2' ' CG2' ' A' ' 9' ' ' THR . 20.1 mt -89.72 108.19 19.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.001 . . . . 0.0 111.134 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 10.2 mttp -81.65 106.47 13.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.451 ' HB ' HG21 ' A' ' 7' ' ' THR . 43.4 mm -101.38 151.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.08 132.08 35.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 4.9 m120 -129.53 88.17 2.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.125 -0.984 . . . . 0.0 110.725 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HD2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -81.29 124.27 29.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.571 ' CD2' HG12 ' A' ' 128' ' ' VAL . 3.3 m-85 -103.67 149.38 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.911 -1.118 . . . . 0.0 110.401 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.467 ' ND1' HG22 ' A' ' 2' ' ' VAL . 87.0 m-70 -134.33 93.48 3.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 2.0 p -86.14 -162.9 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.87 . . . . 0.0 109.717 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 122' ' ' THR . 5.2 ttpp -177.26 97.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.041 . . . . 0.0 110.854 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.42 160.59 12.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 56.08 -161.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -1.021 . . . . 0.0 110.635 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.475 ' N ' HG23 ' A' ' 94' ' ' THR . 81.1 m-70 -48.96 -179.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 110.436 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 5.5 mm-40 -127.32 -112.98 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.931 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.571 HG12 ' CD2' ' A' ' 120' ' ' TYR . 60.5 t -118.23 138.03 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.805 -1.185 . . . . 0.0 110.256 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 130' ' ' ALA . 5.5 mtmt -101.66 111.4 23.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -41.36 -50.31 3.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.696 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -46.44 -48.27 18.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.902 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.521 ' NE2' ' HB2' ' A' ' 90' ' ' PRO . 2.9 tt0 -63.36 -39.44 94.54 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.597 HG13 ' CD1' ' A' ' 5' ' ' TYR . 79.5 t -65.92 -17.22 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.757 0.789 . . . . 0.0 109.169 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 135' ' ' ALA . 2.0 ttmt -85.54 -58.13 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.499 -0.75 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.38 -50.64 5.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 109.916 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.43 -45.86 69.58 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.13 -31.68 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.701 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.77 -39.68 80.09 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.332 -0.855 . . . . 0.0 109.369 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.456 ' HE3' HD12 ' A' ' 38' ' ' ILE . 1.3 mtp -66.18 -38.43 88.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.21 -0.931 . . . . 0.0 109.05 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.21 -38.18 93.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -74.77 -35.02 62.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.896 -1.355 . . . . 0.0 110.158 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -39.77 90.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 108.743 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.559 HD11 ' CD1' ' A' ' 30' ' ' PHE . 1.1 mm? -68.66 -48.97 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.165 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.48 HD23 HG22 ' A' ' 9' ' ' THR . 13.3 tp -49.58 -42.89 45.62 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.204 -0.935 . . . . 0.0 108.849 178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -65.79 -42.64 90.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.83 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.499 ' CB ' HG22 ' A' ' 33' ' ' VAL . . . -56.5 -62.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.358 -0.838 . . . . 0.0 109.734 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 84.6 t -59.01 -28.61 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.555 -0.715 . . . . 0.0 110.09 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -61.95 -53.06 60.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 0.0 109.958 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.4 p -76.7 -18.59 58.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 109.9 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CD2' HD13 ' A' ' 29' ' ' LEU . 5.7 t80 -64.44 -47.95 77.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.627 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.56 HD21 ' CD2' ' A' ' 150' ' ' TYR . 68.4 mt -61.38 -24.97 66.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.469 ' CD1' HD13 ' A' ' 13' ' ' ILE . 5.9 mp -81.76 -35.21 29.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.244 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.12 -55.14 6.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.461 ' O ' ' CB ' ' A' ' 155' ' ' SER . 35.9 m-70 -66.14 -44.42 84.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.873 . . . . 0.0 109.808 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER 66.74 20.55 10.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.459 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -159.11 19.9 0.19 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.568 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.464 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.63 130.65 48.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.077 -1.014 . . . . 0.0 110.336 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.646 ' CD2' ' CB ' ' A' ' 21' ' ' ALA . 48.4 m-85 58.24 53.13 6.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.116 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.528 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 120' ' ' TYR . 78.9 t -79.08 156.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.558 ' CD1' HG23 ' A' ' 128' ' ' VAL . 75.9 m-85 -119.61 137.38 53.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.529 -0.732 . . . . 0.0 109.965 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.432 ' OD1' ' HE2' ' A' ' 119' ' ' LYS . 3.6 t30 -101.19 91.53 4.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 0.0 110.358 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.963 ' CE2' HG21 ' A' ' 133' ' ' VAL . 29.3 m-85 -86.97 74.12 9.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -0.92 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 91.54 3.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.549 HG21 ' CE ' ' A' ' 137' ' ' LYS . 14.4 t -112.85 -169.75 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -168.03 167.16 12.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.451 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.922 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -137.16 179.13 6.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 109.911 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.14 141.13 51.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.527 ' OG ' HD11 ' A' ' 18' ' ' LEU . 5.7 t -142.57 143.36 32.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 110.162 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -31.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.755 HG13 HD12 ' A' ' 151' ' ' LEU . 3.3 mm -66.08 140.82 97.16 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 36.2 Cg_endo -60.32 158.34 31.54 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.795 1.419 . . . . 0.0 110.617 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -53.91 -70.08 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 0.0 111.732 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.772 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -37.97 -62.07 0.59 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.309 -0.869 . . . . 0.0 111.808 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.2 mpt_? -52.73 -57.45 10.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.866 -1.146 . . . . 0.0 110.673 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.45 -30.66 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.183 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.738 ' CE2' HD21 ' A' ' 24' ' ' LEU . 68.3 t80 -74.01 -57.09 4.2 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.038 -1.039 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.0 mtmt -59.73 -23.02 62.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.73 . . . . 0.0 111.883 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -107.96 -53.25 2.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.578 -1.327 . . . . 0.0 112.226 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.703 ' CA ' HG11 ' A' ' 147' ' ' VAL . 27.4 t80 -83.89 -14.07 52.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.059 . . . . 0.0 112.38 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.951 HD12 HD11 ' A' ' 104' ' ' ILE . 28.2 mt -124.5 -14.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.573 -1.33 . . . . 0.0 110.868 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.738 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -111.74 -17.01 13.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.032 . . . . 0.0 109.967 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.485 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 4.7 t0 -137.16 43.83 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 110.151 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.36 -23.16 71.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.574 ' CB ' HG11 ' A' ' 41' ' ' VAL . 74.1 m-20 -68.52 -30.53 69.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -1.166 . . . . 0.0 110.365 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 28' ' ' ASN . 10.7 p-10 -105.04 25.15 10.89 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.903 HD23 HG13 ' A' ' 147' ' ' VAL . 3.1 tp -141.56 -63.23 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.668 -0.645 . . . . 0.0 110.354 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.751 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 6.1 m-30 -34.24 -52.96 0.94 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.782 -0.574 . . . . 0.0 110.746 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 50.9 Cg_endo -68.03 -50.25 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.468 1.246 . . . . 0.0 110.742 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -65.82 -69.52 0.29 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.286 -0.884 . . . . 0.0 110.615 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 29' ' ' LEU . 12.2 m -68.05 -11.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 111.409 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -146.73 66.17 10.52 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.3 Cg_endo -69.81 -11.86 31.64 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.846 1.445 . . . . 0.0 109.45 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -83.21 -14.63 52.92 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.332 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.631 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -112.36 -48.04 3.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.044 -1.035 . . . . 0.0 111.126 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.659 ' CD1' HD21 ' A' ' 143' ' ' LEU . 2.2 mp -116.94 163.56 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.985 -1.072 . . . . 0.0 110.596 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -124.07 -33.79 3.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.94 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER 169.95 141.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.536 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG11 ' CB ' ' A' ' 27' ' ' ASP . 3.2 p -103.37 148.03 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.159 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.495 1.795 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.056 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 53' ' ' ILE . 1.3 m . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.215 0.531 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.623 ' H ' HG22 ' A' ' 52' ' ' THR . 1.1 mp -125.27 168.43 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' CG ' ' HB2' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -149.11 147.56 28.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.397 -0.815 . . . . 0.0 109.914 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 2.4 tttp -111.53 92.04 3.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.91 -1.119 . . . . 0.0 110.537 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.691 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.8 mp -79.52 133.03 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.069 -1.019 . . . . 0.0 109.576 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.33 120.25 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 0.0 110.635 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.642 ' HZ ' HG21 ' A' ' 67' ' ' VAL . 16.6 m-85 -83.08 169.62 17.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.588 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 44.7 Cg_endo -71.15 173.96 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.628 1.33 . . . . 0.0 110.023 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' O ' HD23 ' A' ' 62' ' ' LEU . 6.3 tt0 -58.74 179.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.26 2.09 86.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -84.62 138.61 38.14 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -1.219 . . . . 0.0 110.599 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.67 -12.84 26.97 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.023 1.539 . . . . 0.0 109.81 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.542 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 18.8 m-30 -110.77 -139.54 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.96 -37.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.753 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 178.44 -166.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 66' ' ' TYR . 3.5 m -159.92 123.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.562 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -92.36 130.72 37.97 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.528 ' HB2' ' CG ' ' A' ' 54' ' ' LYS . 3.6 m-20 -118.0 151.08 38.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.907 -1.121 . . . . 0.0 111.449 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.56 114.34 27.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.607 HG22 HG23 ' A' ' 74' ' ' VAL . 8.9 p -58.49 -27.74 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 0.3 OUTLIER 42.04 51.28 4.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.0 mt-10 65.14 158.97 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.339 -0.85 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.607 HG23 HG22 ' A' ' 71' ' ' VAL . 90.0 t -144.07 159.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -109.41 -150.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.215 -0.928 . . . . 0.0 110.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.498 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 2.5 t-80 179.98 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 0.0 110.18 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -55.54 -52.72 62.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.231 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -90.28 15.59 10.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.223 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.772 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 11.6 m-85 47.09 69.32 0.51 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.507 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -126.57 143.83 51.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.929 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.447 ' CE1' HG22 ' A' ' 74' ' ' VAL . 27.1 t80 -141.7 100.77 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 71' ' ' VAL . 9.8 t-20 -96.72 104.17 16.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 109.563 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 8.4 p90 -132.02 -169.5 2.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 109.983 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 t -149.09 165.8 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.218 -0.926 . . . . 0.0 110.772 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 55.3 t -105.03 -26.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.382 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 85' ' ' VAL . 41.8 pt 37.05 -139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.162 0.506 . . . . 0.0 110.81 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.445 ' N ' HG13 ' A' ' 86' ' ' ILE . 1.4 mm-40 -60.61 135.43 57.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.996 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 136.66 142.72 4.49 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.358 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.542 ' HA2' ' CD2' ' A' ' 64' ' ' PHE . . . 88.18 -142.79 17.69 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 91' ' ' ILE . 52.2 Cg_endo -83.16 27.85 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.127 1.593 . . . . 0.0 110.993 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.15 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.474 -0.766 . . . . 0.0 110.581 -179.429 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 89.84 -163.77 30.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 1.3 m-20 56.44 -91.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -1.077 . . . . 0.0 110.484 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.476 HG21 ' HB2' ' A' ' 126' ' ' HIS . 76.3 p -142.12 47.37 1.62 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.438 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.981 HD22 HD11 ' A' ' 98' ' ' ILE . 1.4 mt -170.2 90.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.49 -49.97 6.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.573 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 1.9 ttpp -113.69 161.2 17.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.981 HD11 HD22 ' A' ' 95' ' ' LEU . 15.5 mt -158.39 113.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.473 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 4.3 m -104.32 122.2 44.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.166 -0.959 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.457 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 50.4 m-20 -116.29 133.5 55.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 111.601 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 82' ' ' ASN . 3.2 tp10 -118.57 129.49 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.438 ' C ' ' HG3' ' A' ' 103' ' ' LYS . 19.6 mt -116.91 146.96 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 0.0 110.783 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 49.4 mtpt -142.69 106.53 4.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.769 . . . . 0.0 109.784 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.951 HD11 HD12 ' A' ' 23' ' ' ILE . 14.5 mt -79.39 144.32 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.645 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 115' ' ' LYS . 22.1 t -130.07 127.52 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 110.157 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.6 132.83 34.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.116 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -111.13 153.03 44.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.386 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.33 -19.96 49.24 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.06 1.558 . . . . 0.0 110.703 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.414 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 3.0 p-10 -158.43 44.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.92 21.59 0.78 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.85 -113.65 5.94 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 72.3 m -152.41 137.21 17.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.449 -1.03 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.4 mt -104.09 133.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.737 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.922 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.2 mp -95.25 99.91 11.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 110.002 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HD2' ' CG2' ' A' ' 105' ' ' VAL . 14.1 mttm -75.29 103.17 5.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.716 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.545 ' HB ' HG23 ' A' ' 7' ' ' THR . 25.8 mt -94.51 137.95 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 110.875 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.84 91.06 3.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.458 -0.776 . . . . 0.0 109.028 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 m-80 -84.48 92.24 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 111.387 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.503 ' HD2' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -84.73 103.37 13.76 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.409 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.71 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.2 m-85 -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.007 . . . . 0.0 111.468 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 32.7 m-70 -121.36 84.09 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 109.443 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.658 HG22 ' HG ' ' A' ' 95' ' ' LEU . 11.3 p -84.25 -164.74 0.99 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.357 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.415 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -137.42 88.02 2.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.34 -135.04 45.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.417 ' HB3' HG22 ' A' ' 94' ' ' THR . 17.6 t0 50.87 -141.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -1.125 . . . . 0.0 110.142 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.476 ' HB2' HG21 ' A' ' 94' ' ' THR . 43.8 m-70 -83.29 179.48 7.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -95.96 161.03 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.266 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 3' ' ' PHE . 39.6 t -50.4 139.56 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.036 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 31.4 mtmt -94.32 117.63 30.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -46.68 -43.79 18.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.153 -0.967 . . . . 0.0 109.853 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -46.04 64.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.062 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -59.99 -44.93 94.2 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.621 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.963 HG21 ' CE2' ' A' ' 5' ' ' TYR . 54.4 t -59.66 -23.64 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.67 0.747 . . . . 0.0 109.163 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -79.35 -43.64 23.11 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.81 -0.557 . . . . 0.0 110.542 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -53.6 -53.79 46.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 t -61.15 -45.15 95.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.549 ' CE ' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -62.76 -18.42 62.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.865 . . . . 0.0 108.722 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 1.4 tt0 -77.82 -51.21 10.84 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 40.0 mmm -60.22 -33.38 72.19 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.193 -1.003 . . . . 0.0 108.78 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.58 -44.87 69.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -67.08 -39.88 86.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.808 -1.407 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -45.93 90.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.339 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.659 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.1 mm? -60.97 -52.62 64.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.337 -0.852 . . . . 0.0 109.324 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 9' ' ' THR . 10.3 tp -46.81 -43.27 18.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -63.37 -40.46 97.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 0.0 109.657 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -59.4 -61.33 2.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.903 HG13 HD23 ' A' ' 29' ' ' LEU . 9.6 t -62.75 -18.38 20.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.463 -0.773 . . . . 0.0 109.89 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.508 ' O ' HD22 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -72.61 -46.1 55.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 81.1 p -87.18 -15.0 39.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.54 ' CZ ' HD11 ' A' ' 29' ' ' LEU . 3.7 t80 -67.01 -39.89 87.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.995 . . . . 0.0 109.6 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.755 HD12 HG13 ' A' ' 13' ' ' ILE . 42.7 mt -63.1 -36.34 83.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.402 -0.811 . . . . 0.0 110.596 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.523 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -75.96 -51.98 11.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.311 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -53.77 -54.1 43.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -67.28 -163.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 44.8 m -94.09 59.37 2.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.447 ' OD2' ' ND2' ' A' ' 159' ' ' ASN . 0.1 OUTLIER 61.6 41.21 12.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.472 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -42.41 151.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 110.244 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.789 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 81.9 m-85 57.87 57.38 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.34 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.447 ' ND2' ' OD2' ' A' ' 156' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.155 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 3' ' ' PHE . 40.4 t 50.71 170.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.56 -0.965 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.709 ' CD1' HG23 ' A' ' 128' ' ' VAL . 97.4 m-85 -150.93 150.37 30.75 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -111.7 103.8 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.021 ' CE2' HG21 ' A' ' 133' ' ' VAL . 55.3 m-85 -100.79 87.21 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.45 108.51 19.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -127.99 -172.12 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.19 -170.87 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.867 . . . . 0.0 109.943 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.602 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 5.0 t -165.95 173.66 10.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 0.0 109.75 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.76 142.69 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.011 . . . . 0.0 110.491 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.821 ' OG ' HD11 ' A' ' 18' ' ' LEU . 20.2 t -132.13 144.15 50.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.47 -7.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.337 -0.852 . . . . 0.0 110.116 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.592 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 7.2 mm -94.78 145.27 29.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 110.473 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 30.9 Cg_endo -56.25 160.69 10.35 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.789 1.415 . . . . 0.0 110.686 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -63.26 -78.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 111.415 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -32.04 -54.6 0.3 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.664 -0.648 . . . . 0.0 111.421 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.55 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -57.41 -55.7 31.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.0 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.821 HD11 ' OG ' ' A' ' 11' ' ' SER . 5.4 mt -51.01 -28.74 10.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 24' ' ' LEU . 19.0 t80 -73.07 -67.47 0.57 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.68 -25.11 9.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.225 -0.922 . . . . 0.0 112.317 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.794 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -101.33 -58.16 1.94 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.541 -1.349 . . . . 0.0 111.443 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 24.2 t80 -80.59 -83.14 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.03 -1.044 . . . . 0.0 111.47 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.619 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 2.4 mp -46.36 -21.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.18 -0.95 . . . . 0.0 111.876 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.667 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -106.67 -77.81 0.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.664 -1.273 . . . . 0.0 110.043 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.8 t0 -73.15 83.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 0.0 110.212 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.63 -27.94 4.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.14 -12.75 60.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.271 . . . . 0.0 110.278 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -118.79 7.13 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.576 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.757 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -122.36 -40.32 2.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.803 . . . . 0.0 110.228 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.797 ' CD1' HD12 ' A' ' 143' ' ' LEU . 6.1 m-30 -61.39 -54.66 50.67 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.919 . . . . 0.0 111.35 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 44.4 Cg_endo -65.66 -6.13 13.19 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.306 1.161 . . . . 0.0 111.262 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -103.82 -67.61 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 110.592 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.042 HG23 ' HB1' ' A' ' 146' ' ' ALA . 12.0 m -74.76 -20.91 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 110.82 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.4 61.65 15.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 110.675 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.1 Cg_endo -67.86 -23.29 41.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.101 1.58 . . . . 0.0 109.136 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -73.6 -15.87 61.26 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.544 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -108.67 -66.16 1.07 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 110.75 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 39' ' ' SER . 4.0 mp -114.47 172.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.605 ' N ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -163.97 -25.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 111.472 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.4 t -133.45 138.76 46.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.588 -1.32 . . . . 0.0 111.122 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.57 128.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.587 -0.696 . . . . 0.0 109.41 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.009 . . . . 0.0 110.137 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.323 0.582 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 54' ' ' LYS . 16.5 mm -117.11 165.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.4 pttp -179.66 142.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.006 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -140.58 108.84 5.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.831 -0.543 . . . . 0.0 109.601 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.7 mp -82.87 152.42 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.909 . . . . 0.0 110.59 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -127.38 139.83 52.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.99 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.742 ' HB3' HD12 ' A' ' 62' ' ' LEU . 24.1 m-85 -109.96 103.83 54.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.441 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.606 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 46.1 Cg_endo -72.82 -159.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.031 1.543 . . . . 0.0 110.198 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.565 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER 44.51 -172.53 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.094 -1.004 . . . . 0.0 111.526 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.565 ' N ' ' HG3' ' A' ' 60' ' ' GLU . . . -45.06 -18.26 0.13 Allowed Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.737 -0.602 . . . . 0.0 112.992 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.742 HD12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -42.82 125.75 3.14 Favored Pre-proline 0 N--CA 1.501 2.097 0 CA-C-N 119.672 1.736 . . . . 0.0 110.302 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 64' ' ' PHE . 50.4 Cg_endo -74.99 -156.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 109.846 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 63' ' ' PRO . 3.4 m-85 57.18 168.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.068 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -104.96 -39.82 6.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.89 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 29.1 p90 179.56 -175.11 0.25 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.74 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.554 HG23 ' HB ' ' A' ' 56' ' ' ILE . 8.2 m -150.93 106.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.961 -1.087 . . . . 0.0 110.779 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.1 tttt -107.35 139.41 41.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.93 ' HB3' HG13 ' A' ' 85' ' ' VAL . 2.7 p30 -159.71 166.13 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.907 -1.121 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.459 ' HD2' ' CD1' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -104.69 145.99 29.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.599 -0.688 . . . . 0.0 109.362 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.678 HG23 ' OH ' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -83.11 -38.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.986 -1.072 . . . . 0.0 110.154 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.05 -33.93 0.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.731 -0.606 . . . . 0.0 111.646 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' C ' HG23 ' A' ' 74' ' ' VAL . 6.0 pt-20 174.54 160.42 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.761 -1.212 . . . . 0.0 110.292 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.614 HG22 ' CE1' ' A' ' 81' ' ' TYR . 44.5 t -151.99 92.5 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.827 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -66.56 -169.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.185 -0.947 . . . . 0.0 110.541 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.414 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -153.75 -52.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.5 m -48.38 -34.81 11.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 75.3 m-20 -118.93 6.06 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.388 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 9.0 m-85 58.9 40.6 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.982 . . . . 0.0 110.059 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 1.4 tttt -89.02 117.46 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.988 . . . . 0.0 110.65 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.765 ' O ' HD12 ' A' ' 102' ' ' ILE . 25.1 t80 -118.4 132.93 56.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' VAL . 4.0 t30 -144.19 104.89 4.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 109.956 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.8 p90 -125.0 164.18 20.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.01 136.37 51.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.756 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.93 HG13 ' HB3' ' A' ' 69' ' ' ASP . 1.6 t -108.87 114.3 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.504 -0.748 . . . . 0.0 109.199 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 pt -113.94 6.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.029 -1.044 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.1 144.18 5.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.013 -1.054 . . . . 0.0 110.308 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.911 ' C ' HD11 ' A' ' 91' ' ' ILE . . . 84.0 133.48 2.43 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.476 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 124.18 -134.5 9.2 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' ILE . 45.0 Cg_endo -72.54 -6.32 18.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.919 1.484 . . . . 0.0 110.631 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.911 HD11 ' C ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -35.97 157.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.32 23.91 18.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.1 -146.36 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -1.187 . . . . 0.0 110.089 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 122' ' ' THR . 1.2 p -87.22 44.41 1.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.744 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -132.59 124.14 27.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.9 OUTLIER -105.72 -71.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.93 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -125.7 132.59 52.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.819 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.98 121.81 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.264 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.27 157.16 16.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.975 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.456 HD21 HG23 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -141.13 109.47 5.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.001 -1.062 . . . . 0.0 110.689 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 102' ' ' ILE . 33.6 tt0 -125.95 137.07 53.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.354 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.914 HD12 ' N ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER 175.71 -157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.242 -0.911 . . . . 0.0 112.837 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 80' ' ' LYS . 14.8 ptmt -172.59 179.52 2.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.26 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.815 HG23 HD12 ' A' ' 114' ' ' LEU . 14.8 mm -110.57 146.3 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.614 -0.679 . . . . 0.0 109.832 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.428 HG21 ' HD2' ' A' ' 115' ' ' LYS . 56.8 t -122.12 142.82 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HA ' ' OG ' ' A' ' 112' ' ' SER . . . -110.1 133.03 53.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.0 110.424 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 39.5 p -93.82 164.07 21.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 43.3 Cg_endo -64.91 -22.57 62.89 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.915 1.482 . . . . 0.0 111.149 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 22.4 p-10 -175.58 88.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.027 -1.045 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.82 -30.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.05 -133.77 6.2 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -147.84 140.18 24.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -1.128 . . . . 0.0 110.059 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 mt -95.72 120.48 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.863 . . . . 0.0 110.245 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.815 HD12 HG23 ' A' ' 104' ' ' ILE . 3.8 mp -83.25 108.04 16.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.773 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.747 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 18.1 mttt -94.44 121.68 36.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.683 -1.26 . . . . 0.0 109.17 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.874 ' CA ' HG21 ' A' ' 102' ' ' ILE . 34.1 mm -120.98 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.607 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.551 ' N ' HG21 ' A' ' 102' ' ' ILE . 13.0 m -119.06 126.4 51.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.495 -1.378 . . . . 0.0 109.275 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -119.7 150.32 40.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.948 . . . . 0.0 111.191 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.49 109.54 12.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.744 ' CD2' HD11 ' A' ' 95' ' ' LEU . 4.6 m-85 -86.9 135.06 33.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 111.556 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 96' ' ' GLU . 76.6 m-70 -123.08 86.49 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.49 HG21 ' CG2' ' A' ' 128' ' ' VAL . 8.9 p -86.9 -179.2 6.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -0.761 . . . . 0.0 110.902 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -60.04 -147.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.437 -0.789 . . . . 0.0 110.449 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.38 77.9 0.38 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.88 -71.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 109.918 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -85.54 173.65 10.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.896 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 52.8 mt-10 -110.25 -174.15 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 110.431 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.709 HG23 ' CD1' ' A' ' 3' ' ' PHE . 46.6 t -83.78 145.18 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.33 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -90.42 112.35 23.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.37 -41.82 14.08 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.168 -0.958 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.49 -46.82 76.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.296 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -58.83 -42.59 89.58 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.021 HG21 ' CE2' ' A' ' 5' ' ' TYR . 70.3 t -62.83 -25.81 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.748 0.785 . . . . 0.0 109.224 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.8 ttmt -73.83 -56.95 4.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.705 -0.622 . . . . 0.0 110.492 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -35.64 -52.1 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.688 -0.633 . . . . 0.0 110.952 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 t -57.49 -47.82 80.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -61.42 -28.63 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 135' ' ' ALA . 14.0 mm-40 -69.88 -57.83 4.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.281 -0.887 . . . . 0.0 109.351 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.544 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 2.7 mtp -54.81 -35.63 64.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.221 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.69 -39.04 95.12 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.79 -45.93 48.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.869 -1.371 . . . . 0.0 110.888 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 -41.01 92.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.027 -1.046 . . . . 0.0 109.49 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.797 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.5 mm? -68.35 -53.8 21.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.511 -0.743 . . . . 0.0 109.887 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 114' ' ' LEU . 16.1 tp -46.21 -43.72 15.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.145 -0.972 . . . . 0.0 108.811 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.509 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 2.2 ttp180 -66.22 -39.94 89.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.388 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.042 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -55.52 -62.36 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -0.843 . . . . 0.0 109.359 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.672 HG22 HD12 ' A' ' 29' ' ' LEU . 60.4 t -62.57 -23.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -61.79 -55.93 24.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.372 -0.83 . . . . 0.0 110.085 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -23.37 53.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.8 ' HB2' HG11 ' A' ' 33' ' ' VAL . 11.3 t80 -56.08 -37.82 69.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.117 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.5 -25.62 62.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.174 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 2.1 mp -88.89 -19.12 26.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.79 -38.41 14.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.838 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.56 156.27 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.846 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 3.3 p -44.26 -53.54 6.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 155' ' ' SER . 23.3 t70 -177.1 64.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.195 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.64 146.29 46.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 110.358 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.794 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 63.0 m-85 54.45 70.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 110.48 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.35 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.613 HG21 ' HD3' ' A' ' 119' ' ' LYS . 7.9 p -88.03 157.16 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -1.103 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.652 ' CD1' HG23 ' A' ' 128' ' ' VAL . 87.7 m-85 -123.6 122.78 39.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 110.03 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.59 98.82 10.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.815 ' CD1' HG11 ' A' ' 133' ' ' VAL . 46.7 m-85 -100.45 103.71 15.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 109.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -108.59 122.28 46.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.953 -1.092 . . . . 0.0 110.109 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 6.2 t -130.54 166.73 19.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 110.541 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 7' ' ' THR . 75.1 mt-10 -155.18 157.69 37.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.887 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -142.37 -178.51 5.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.015 . . . . 0.0 110.27 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.433 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -131.0 141.8 50.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.039 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.538 ' CB ' HD11 ' A' ' 18' ' ' LEU . 19.6 t -134.42 142.25 47.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.46 0.33 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.54 -0.725 . . . . 0.0 110.124 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.652 HD11 HD21 ' A' ' 152' ' ' LEU . 11.1 mm -96.69 147.99 33.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.9 Cg_endo -56.55 157.81 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.885 1.466 . . . . 0.0 110.033 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' ALA . . . -68.5 -64.04 0.94 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.072 -1.017 . . . . 0.0 110.886 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -43.35 -50.52 6.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.732 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.572 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.17 -52.18 65.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.607 HD12 ' OG ' ' A' ' 112' ' ' SER . 6.0 mt -52.31 -24.1 6.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 108.773 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.712 ' CE2' HD21 ' A' ' 24' ' ' LEU . 43.5 t80 -77.66 -55.66 5.17 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.466 -0.772 . . . . 0.0 110.384 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 5.0 mmmt -61.25 -21.76 64.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.569 -0.707 . . . . 0.0 111.884 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -111.39 -47.26 3.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.685 -1.259 . . . . 0.0 112.774 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' HE2' HD21 ' A' ' 114' ' ' LEU . 39.2 t80 -89.68 -22.08 22.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.718 -1.239 . . . . 0.0 112.482 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.638 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 mp -116.56 -13.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.649 -1.282 . . . . 0.0 110.378 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.712 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -111.96 -12.91 13.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.481 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 9.6 t0 -146.67 47.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.547 ' CA ' ' CE1' ' A' ' 30' ' ' PHE . . . -83.25 -31.16 28.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.775 ' HB3' HG11 ' A' ' 41' ' ' VAL . 52.4 m-20 -76.77 2.96 12.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -1.088 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 9.5 t-20 -138.62 50.47 1.86 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.994 HD21 HG13 ' A' ' 147' ' ' VAL . 1.1 tp 173.06 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.581 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' CA ' ' A' ' 26' ' ' GLY . 3.0 m-30 -52.18 -59.29 8.74 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.919 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -67.06 -11.97 34.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 111.211 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -90.06 -31.58 17.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 111.031 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HB1' ' A' ' 146' ' ' ALA . 10.5 m -103.82 -11.81 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -138.94 66.6 40.15 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.808 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.4 -5.37 14.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.967 1.509 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -94.9 -12.61 26.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.411 -0.806 . . . . 0.0 109.625 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.02 -28.93 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.668 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 39' ' ' SER . 6.7 mm -125.75 178.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.967 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.603 ' H ' HG22 ' A' ' 38' ' ' ILE . 4.1 t -136.35 -45.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 t -174.85 165.16 3.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.775 HG11 ' HB3' ' A' ' 27' ' ' ASP . 99.5 t -118.58 124.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 110.034 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 3.5 tp10 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.417 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.1 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.28 0.562 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.618 HD12 ' N ' ' A' ' 53' ' ' ILE . 3.9 mp -97.06 136.71 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 84.6 mttt -139.41 148.99 43.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 6.7 tttt -117.45 96.03 5.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.82 . . . . 0.0 110.653 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.563 HD11 ' OD1' ' A' ' 27' ' ' ASP . 1.4 mp -73.47 148.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 27.5 t -124.75 169.38 12.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.271 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 39.4 m-85 -134.33 153.68 79.47 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.601 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 62' ' ' LEU . 48.4 Cg_endo -76.36 169.72 21.39 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.185 1.624 . . . . 0.0 109.615 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 167.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 110.061 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.03 -43.41 3.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 59' ' ' PRO . 8.5 mt -79.96 155.36 75.24 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.083 -1.245 . . . . 0.0 110.65 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HG2' ' CE2' ' A' ' 64' ' ' PHE . 50.8 Cg_endo -81.88 162.36 18.48 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.193 1.628 . . . . 0.0 110.971 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' A' ' 63' ' ' PRO . 11.6 m-85 65.69 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 0.0 110.634 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -69.1 -9.5 52.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.482 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 30.1 p90 -175.75 -170.34 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 110.176 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 67' ' ' VAL . 7.3 p -170.93 109.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.3 mtmm -96.15 138.42 33.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.751 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.18 -176.06 4.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.691 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.406 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -138.75 127.91 24.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 109.902 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.533 HG13 ' CZ ' ' A' ' 81' ' ' TYR . 55.7 t -68.25 -44.38 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.323 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.4 m-20 77.98 -38.2 0.25 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.803 -0.56 . . . . 0.0 111.419 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 179.0 -167.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.696 -1.253 . . . . 0.0 111.001 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.2 p -167.91 118.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.628 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -77.26 -49.75 14.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.174 -0.953 . . . . 0.0 110.955 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.566 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 77.94 -71.16 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.634 -0.666 . . . . 0.0 110.506 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -57.77 -42.49 84.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.316 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 79' ' ' PHE . 76.2 m-20 -97.03 18.0 15.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 23.2 m-30 43.49 27.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.525 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.5 ttpt -95.29 107.62 19.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.161 -0.962 . . . . 0.0 109.874 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 102' ' ' ILE . 20.4 t80 -110.79 96.82 6.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.596 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 2.2 m-20 -84.39 161.22 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.839 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 13.4 p90 -179.33 152.42 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.44 -0.787 . . . . 0.0 109.768 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.66 146.66 48.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.206 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.6 t -104.97 73.11 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.257 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.413 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 5.4 pt -62.06 -42.51 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.345 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 2.6 mt-10 -139.66 94.91 2.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.898 -1.126 . . . . 0.0 110.709 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.97 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 167.96 120.35 0.52 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.97 -147.35 16.85 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 91' ' ' ILE . 47.7 Cg_endo -72.43 -3.41 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 124.033 1.544 . . . . 0.0 110.22 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.97 HD11 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -34.85 157.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 121.535 0.683 . . . . 0.0 110.596 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.95 -8.05 59.25 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -108.66 -85.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -1.147 . . . . 0.0 110.396 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 122' ' ' THR . 0.6 OUTLIER -130.1 -18.89 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.931 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.715 HD22 HG12 ' A' ' 98' ' ' ILE . 2.3 mt -80.9 83.35 6.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 110.195 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.88 -52.33 63.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' C ' HG13 ' A' ' 98' ' ' ILE . 3.4 tptt -137.32 165.71 25.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.199 -0.938 . . . . 0.0 110.531 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.715 HG12 HD22 ' A' ' 95' ' ' LEU . 23.1 mt -150.73 122.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.078 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -99.19 135.08 41.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.908 . . . . 0.0 109.761 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 76.8 m-20 -137.71 140.89 40.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.75 -1.218 . . . . 0.0 110.972 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 7.0 pt-20 -138.26 154.03 49.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.76 . . . . 0.0 109.546 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 81' ' ' TYR . 2.9 mt -128.13 155.13 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.469 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 22.9 mtmt -149.1 103.77 3.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 109.502 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 2.9 mm -81.53 120.19 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 109.871 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.551 HG21 ' CD ' ' A' ' 115' ' ' LYS . 61.3 t -105.14 123.08 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.99 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.22 140.31 34.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 44.3 p -113.16 162.17 23.3 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.87 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 48.9 Cg_endo -66.62 -30.62 42.27 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.961 1.506 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -162.86 44.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.31 23.39 2.05 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.96 -135.84 26.65 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.607 ' OG ' HD12 ' A' ' 18' ' ' LEU . 6.5 p -132.81 134.62 44.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -1.14 . . . . 0.0 110.326 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 10' ' ' THR . 13.2 mt -95.13 124.06 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.887 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.0 OUTLIER -81.86 96.09 7.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 110.964 -179.311 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.551 ' CD ' HG21 ' A' ' 105' ' ' VAL . 3.9 mttp -87.47 107.86 18.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.402 ' CG1' HG23 ' A' ' 102' ' ' ILE . 5.2 mt -116.78 132.54 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.22 144.06 36.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.519 -0.738 . . . . 0.0 109.589 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' TYR . 25.1 m120 -136.78 143.46 43.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 110.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.613 ' HD3' HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -132.47 108.92 9.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.679 ' CD2' HD11 ' A' ' 95' ' ' LEU . 5.4 m-85 -87.12 114.18 23.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.835 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -101.21 92.12 4.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.224 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 128' ' ' VAL . 7.6 p -85.27 -151.75 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.827 . . . . 0.0 110.748 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.42 3.07 15.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 110.566 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 96.45 -157.24 21.33 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -1.017 . . . . 0.0 110.248 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 124' ' ' GLY . 1.6 m-70 -81.1 166.21 20.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.895 -1.128 . . . . 0.0 110.009 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -109.58 167.84 9.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.431 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.652 HG23 ' CD1' ' A' ' 3' ' ' PHE . 23.4 t -63.39 150.51 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 110.248 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 132' ' ' GLN . 40.8 mtmt -83.57 102.79 12.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.87 -56.42 3.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.133 -0.98 . . . . 0.0 109.912 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.3 tt0 -44.83 -45.34 10.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.227 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.533 ' HB2' ' HB2' ' A' ' 129' ' ' LYS . 1.4 tm0? -58.11 -44.71 87.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 108.921 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.815 HG11 ' CD1' ' A' ' 5' ' ' TYR . 79.0 t -60.67 -25.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 135' ' ' ALA . 1.9 tttm -81.88 -68.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.966 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.53 -40.76 0.41 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 110.325 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -51.25 68.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.047 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 6.6 mptt -56.07 -30.65 62.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.489 -0.757 . . . . 0.0 109.557 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 109.876 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 57.0 mmm -67.62 -34.34 76.79 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.864 . . . . 0.0 108.813 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -71.01 -43.32 57.66 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -66.48 -33.76 76.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -1.157 . . . . 0.0 110.108 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.512 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 2.0 p -70.59 -43.45 69.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.271 -0.893 . . . . 0.0 109.23 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 143' ' ' LEU . 1.0 OUTLIER -70.08 -25.27 63.44 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.548 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.794 HD22 HD22 ' A' ' 114' ' ' LEU . 17.2 tp -73.3 -43.32 61.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 108.901 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -72.32 -25.64 61.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -70.84 -53.94 13.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 109.028 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.994 HG13 HD21 ' A' ' 29' ' ' LEU . 62.1 t -70.61 -21.86 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.154 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -69.55 -52.39 26.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.315 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.478 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 88.9 p -74.87 -23.13 58.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.333 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.589 ' CG ' HD11 ' A' ' 29' ' ' LEU . 9.1 t80 -59.04 -41.8 88.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.94 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.09 -27.7 69.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.652 HD21 HD11 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -86.35 -23.63 26.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.15 -55.49 5.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.227 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.469 ' O ' ' HB3' ' A' ' 155' ' ' SER . 11.4 m80 -73.8 -34.11 64.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 110.064 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 23.1 t 59.36 15.02 4.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 156' ' ' ASP . 1.7 p30 -145.48 12.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.95 . . . . 0.0 110.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.571 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.85 131.16 48.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.4 m-85 58.03 48.02 13.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.421 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.209 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 3' ' ' PHE . 47.1 t -105.72 165.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -1.21 . . . . 0.0 110.537 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 53.6 m-85 -125.29 148.4 48.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.785 . . . . 0.0 109.65 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -117.2 110.08 17.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 110.539 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.748 ' CD2' HG11 ' A' ' 133' ' ' VAL . 23.0 m-85 -108.75 76.7 1.03 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.598 -0.689 . . . . 0.0 109.527 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 85.7 mt-10 -84.05 96.72 8.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 110.879 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -106.29 163.17 13.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.836 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -135.33 144.44 46.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.146 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.807 HG22 ' HB3' ' A' ' 114' ' ' LEU . 1.1 t -134.39 161.48 34.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.86 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -123.52 143.64 50.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.99 . . . . 0.0 110.341 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -135.8 147.33 48.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 110.24 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.03 -20.93 19.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 109.772 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.543 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 6.4 mm -75.93 140.0 70.08 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.7 Cg_endo -57.22 148.95 67.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.807 1.425 . . . . 0.0 110.568 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.557 ' HA ' ' CG2' ' A' ' 104' ' ' ILE . . . -55.08 -46.09 75.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 0.0 111.275 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.0 -58.98 5.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 111.009 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.523 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 6.4 mtm180 -53.95 -57.35 11.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 109.671 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.48 -32.11 7.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.561 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 1.022 ' CE1' HD21 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -68.34 -62.77 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.525 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 26.5 mtpp -59.54 -23.06 62.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.519 -0.738 . . . . 0.0 112.842 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.632 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -106.08 -55.73 2.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.481 -1.387 . . . . 0.0 111.943 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 57.7 t80 -79.19 -9.33 59.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 0.0 112.07 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 24' ' ' LEU . 71.4 mt -130.07 -21.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.627 -1.296 . . . . 0.0 111.63 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.022 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.7 mt -106.18 -14.93 15.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.224 . . . . 0.0 109.536 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.524 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -138.39 30.67 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.441 -0.787 . . . . 0.0 110.416 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.3 -36.95 93.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' HG11 ' A' ' 41' ' ' VAL . 52.1 m-20 -60.89 -14.57 23.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -1.047 . . . . 0.0 109.815 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t30 -122.47 52.12 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.655 HD21 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -172.4 -52.26 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.493 -0.755 . . . . 0.0 110.102 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.614 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 7.1 m-30 -43.73 -53.91 11.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 111.093 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -67.02 -29.57 40.19 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.346 1.182 . . . . 0.0 111.065 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -77.42 -71.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 111.17 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 150' ' ' TYR . 22.2 m -71.99 -20.49 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 111.596 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -126.18 63.17 48.99 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.897 -1.127 . . . . 0.0 111.106 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.7 Cg_endo -69.26 -11.42 31.44 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.858 1.451 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.5 OUTLIER -87.08 -8.18 57.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.501 -0.749 . . . . 0.0 109.578 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.626 ' HB3' HD21 ' A' ' 143' ' ' LEU . . . -117.53 -48.53 2.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.974 . . . . 0.0 110.392 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' A' ' 30' ' ' PHE . 2.9 mp -117.69 156.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.077 -1.014 . . . . 0.0 110.199 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -113.55 -31.04 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER 169.53 159.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.81 . . . . 0.0 109.905 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 27' ' ' ASP . 3.4 p -126.9 129.51 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.925 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 110.589 -179.468 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.233 0.54 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.614 HD12 ' CD ' ' A' ' 70' ' ' ARG . 16.2 mm -106.37 116.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.406 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -118.47 162.4 18.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.074 . . . . 0.0 110.708 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -134.21 113.49 12.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.579 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.9 mp -81.49 144.7 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 t -125.9 101.43 6.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.622 -0.674 . . . . 0.0 109.844 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' HB2' HD12 ' A' ' 62' ' ' LEU . 38.6 m-85 -70.06 140.23 88.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 50.5 Cg_endo -82.74 48.28 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.165 1.613 . . . . 0.0 110.4 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.461 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 5.1 tt0 -135.04 -170.82 2.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.382 -0.824 . . . . 0.0 110.357 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.08 37.36 3.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 58' ' ' PHE . 79.1 mt -56.1 163.2 2.4 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.311 -1.111 . . . . 0.0 110.168 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 64' ' ' PHE . 46.6 Cg_endo -73.38 -9.47 23.06 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.021 1.538 . . . . 0.0 110.257 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 3.8 m-85 -114.88 -34.51 5.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.128 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 1.5 ttpt 74.45 -0.41 3.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.603 -0.685 . . . . 0.0 109.997 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 32.9 p90 179.88 -161.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 67' ' ' VAL . 8.7 p -179.45 118.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.308 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 55' ' ' LYS . 2.7 tttt -87.67 138.57 31.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -140.29 163.89 31.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.087 -1.008 . . . . 0.0 110.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.614 ' CD ' HD12 ' A' ' 53' ' ' ILE . 5.8 mtm180 -121.82 139.54 53.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.384 -0.822 . . . . 0.0 109.943 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' ASP . 24.6 t -73.21 -17.92 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.942 . . . . 0.0 110.262 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER 44.99 27.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.959 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.7 mt-10 65.76 148.6 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.679 HG11 ' CD1' ' A' ' 81' ' ' TYR . 27.3 m -123.23 -170.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.545 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.04 152.28 42.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.39 -52.61 2.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.021 -1.05 . . . . 0.0 110.633 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.3 m -61.4 -10.91 8.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.856 -1.152 . . . . 0.0 110.599 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -125.19 6.44 7.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.015 -1.053 . . . . 0.0 110.535 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.553 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.7 m-30 46.83 54.97 8.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 29.3 tttt -124.14 105.52 9.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 111.143 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.679 ' CD1' HG11 ' A' ' 74' ' ' VAL . 74.2 t80 -89.72 178.23 6.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 109.315 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.427 ' N ' ' CG ' ' A' ' 81' ' ' TYR . 5.9 t30 -179.2 129.81 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.788 -1.195 . . . . 0.0 110.642 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 3.8 p90 -137.77 152.46 49.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.802 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.18 132.4 44.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.643 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.0 HG12 HD11 ' A' ' 91' ' ' ILE . 25.4 t -89.55 133.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 109.331 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.3 -14.96 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 111.328 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.625 ' C ' HD12 ' A' ' 91' ' ' ILE . 1.4 mm-40 -150.67 107.57 3.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.93 -1.106 . . . . 0.0 110.917 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 1.127 ' N ' HD12 ' A' ' 91' ' ' ILE . . . 127.04 -137.75 10.12 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 64' ' ' PHE . . . 26.69 -128.22 0.05 OUTLIER Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.567 ' O ' ' C ' ' A' ' 91' ' ' ILE . 42.8 Cg_endo -70.86 -59.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.877 1.462 . . . . 0.0 109.376 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 1.127 HD12 ' N ' ' A' ' 88' ' ' GLY . 1.8 mt 4.59 90.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 121.746 0.784 . . . . 0.0 112.893 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.95 -149.34 6.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.98 -18.82 5.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.287 . . . . 0.0 109.435 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -128.12 136.26 50.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.81 . . . . 0.0 109.964 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 120' ' ' TYR . 4.6 mt 63.38 92.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.294 -0.878 . . . . 0.0 110.063 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.78 -34.88 21.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -140.77 150.01 42.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.017 . . . . 0.0 110.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.556 HD11 ' CG ' ' A' ' 90' ' ' PRO . 58.9 mt -139.59 126.23 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.5 m -117.41 110.44 18.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 118' ' ' ASN . 1.9 m120 -106.86 119.45 39.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.905 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.468 ' O ' HD13 ' A' ' 102' ' ' ILE . 53.7 mt-10 -105.51 132.37 51.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 109.418 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.674 HD12 HG12 ' A' ' 116' ' ' ILE . 20.0 mm -124.31 155.95 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.093 -1.004 . . . . 0.0 110.915 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 2.8 ttmt -148.2 114.5 5.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.796 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.557 ' CG2' ' HA ' ' A' ' 15' ' ' ALA . 1.5 mp -77.41 121.27 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.01 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG23 ' HG2' ' A' ' 115' ' ' LYS . 61.9 t -104.45 133.4 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 110.435 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.26 132.37 44.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.0 p -106.68 157.87 34.12 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.018 . . . . 0.0 110.625 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.509 ' O ' ' HB3' ' A' ' 109' ' ' ASP . 49.6 Cg_endo -67.63 81.88 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.156 1.609 . . . . 0.0 110.218 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 7.6 t70 71.02 49.69 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.567 -0.708 . . . . 0.0 110.275 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.65 13.9 1.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.87 -159.21 34.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 3.4 p -126.38 131.09 51.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -1.129 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.59 HG23 HG23 ' A' ' 10' ' ' THR . 6.1 mt -93.79 116.89 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.807 ' HB3' HG22 ' A' ' 9' ' ' THR . 0.7 OUTLIER -77.69 106.4 9.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 110.703 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.554 ' HG2' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -82.06 115.63 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.881 -1.137 . . . . 0.0 108.952 178.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.674 HG12 HD12 ' A' ' 102' ' ' ILE . 81.7 mt -113.79 127.99 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 111.199 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -126.72 95.55 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.531 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 72.2 m-20 -93.08 108.29 19.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 111.403 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 124.94 39.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 109.322 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.921 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.6 m-85 -103.34 112.22 25.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 111.115 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -96.19 98.15 10.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.68 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.714 HG21 HG23 ' A' ' 128' ' ' VAL . 11.3 p -82.69 -173.1 4.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.334 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' THR . 0.0 OUTLIER 170.27 43.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.46 -152.14 5.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.62 -69.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -1.14 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.539 ' HB2' ' CG2' ' A' ' 94' ' ' THR . 7.1 m-70 -80.53 176.28 9.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.182 -0.949 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 11.8 mp0 -106.02 -99.98 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.548 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.714 HG23 HG21 ' A' ' 122' ' ' THR . 40.1 t -126.41 151.5 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.704 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 130' ' ' ALA . 6.4 mtmt -104.43 99.3 9.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.02 -42.8 2.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.328 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 9.4 tt0 -54.81 -49.01 72.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.043 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -58.92 -46.37 88.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 109.45 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.92 HG22 ' CE2' ' A' ' 120' ' ' TYR . 38.5 t -62.23 -20.74 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.15 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.0 tttm -81.14 -68.57 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.6 -40.57 0.41 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 110.189 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.45 -51.61 66.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.179 -0.951 . . . . 0.0 109.105 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -54.92 -52.57 62.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 109.981 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -50.27 -46.45 55.08 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -34.99 75.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.29 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.53 -34.46 89.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -71.83 -45.45 61.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -1.192 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -37.1 80.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 108.857 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.626 HD21 ' HB3' ' A' ' 37' ' ' ALA . 1.3 mm? -69.24 -37.92 78.24 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.492 HD13 HD22 ' A' ' 114' ' ' LEU . 13.6 tp -62.08 -34.62 76.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -33.91 61.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.649 -0.657 . . . . 0.0 109.728 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -65.49 -50.06 66.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.844 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 34.4 t -74.74 -27.88 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.793 . . . . 0.0 109.772 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 13' ' ' ILE . 10.7 tt0 -65.61 -44.42 86.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 34.5 m -86.79 -21.32 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 109.939 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.661 ' HB2' HG11 ' A' ' 33' ' ' VAL . 5.3 t80 -58.81 -44.42 90.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 ' CD2' ' A' ' 150' ' ' TYR . 52.6 mt -63.08 -24.41 67.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.96 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.6 mp -82.36 -36.86 26.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 110.361 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.46 -53.86 10.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.0 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.456 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 58.8 m80 -75.39 -32.35 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.993 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.5 t 46.48 23.68 0.24 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 154' ' ' HIS . 4.7 m-20 -141.51 9.18 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.463 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -113.18 128.81 56.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CE2' HD11 ' A' ' 29' ' ' LEU . 28.2 m-85 61.93 41.72 11.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.477 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.216 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 121' ' ' HIS . 54.8 t -82.63 152.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 83.2 m-85 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -108.18 116.04 31.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.995 -1.065 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.72 ' CD2' HG11 ' A' ' 133' ' ' VAL . 21.3 m-85 -114.98 86.34 2.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 0.0 110.729 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.9 mt-10 -51.25 147.15 5.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 108.917 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.5 ' HB ' ' OD1' ' A' ' 118' ' ' ASN . 12.3 t -141.06 173.52 11.4 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.51 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.603 ' OE1' HG22 ' A' ' 113' ' ' ILE . 0.2 OUTLIER 178.31 126.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.452 0.644 . . . . 0.0 110.07 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.983 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -129.95 158.23 40.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 140.21 49.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.832 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 18' ' ' LEU . 92.7 p -132.48 148.33 52.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.622 -0.674 . . . . 0.0 109.786 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -23.05 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 110.297 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.556 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 14.8 mm -81.85 143.1 49.52 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.576 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -57.17 150.51 56.95 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.04 1.547 . . . . 0.0 110.946 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.74 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -51.84 -49.07 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 110.699 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -54.42 -55.09 32.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.971 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.56 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 9.6 mmt85 -54.9 -55.75 27.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.111 -0.993 . . . . 0.0 110.657 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 11' ' ' SER . 9.9 mt -58.87 -24.49 62.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.908 -1.12 . . . . 0.0 109.483 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.762 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -67.64 -56.02 11.02 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.58 -0.7 . . . . 0.0 109.789 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.5 mtpt -68.9 -25.09 64.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.618 -0.676 . . . . 0.0 112.128 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.784 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -103.89 -55.85 2.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.658 -1.276 . . . . 0.0 111.625 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.4 t80 -84.1 -1.41 54.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 112.203 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 104' ' ' ILE . 12.8 mt -134.4 -22.95 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.555 -1.34 . . . . 0.0 111.38 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.762 HD21 ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -105.87 -22.78 12.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 108.87 178.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -131.98 70.04 1.47 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.699 -0.626 . . . . 0.0 109.899 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -97.44 -43.31 2.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.608 ' HB3' HG11 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -69.9 -9.99 56.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -1.111 . . . . 0.0 110.337 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 21.7 t-20 -130.56 52.02 2.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.78 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.964 HD22 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER 173.49 -26.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.675 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.783 ' N ' HD13 ' A' ' 29' ' ' LEU . 3.8 m-30 -56.78 -58.74 15.42 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.253 -0.904 . . . . 0.0 110.601 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.4 Cg_endo -64.67 -29.95 60.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.829 1.436 . . . . 0.0 111.205 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -16.18 63.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.092 -1.005 . . . . 0.0 110.552 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.839 HG23 ' HB1' ' A' ' 146' ' ' ALA . 9.0 m -123.63 -10.75 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.943 . . . . 0.0 110.271 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -138.11 66.66 46.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.803 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.67 -9.71 26.96 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.871 1.458 . . . . 0.0 109.821 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -88.98 -10.87 46.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -118.03 -57.42 2.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 109.946 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG12 HD21 ' A' ' 143' ' ' LEU . 13.5 mm -95.14 170.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 0.0 110.45 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.63 -41.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.2 t -169.13 171.93 7.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.608 HG11 ' HB3' ' A' ' 27' ' ' ASP . 60.1 t -136.8 149.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 55' ' ' LYS . 3.9 tt0 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.463 -0.773 . . . . 0.0 109.498 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.1 m . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.24 0.543 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.46 HD11 ' HD3' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -112.41 156.13 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -139.85 153.3 47.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.866 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' CG ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.81 87.97 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 110.6 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.824 ' HB ' HG13 ' A' ' 67' ' ' VAL . 1.9 mp -69.68 146.92 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.005 -1.06 . . . . 0.0 109.873 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.45 155.52 46.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.607 -0.683 . . . . 0.0 109.885 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 62' ' ' LEU . 30.1 m-85 -119.02 161.46 36.36 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.067 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' GLU . 47.5 Cg_endo -74.9 -164.73 0.24 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.059 1.557 . . . . 0.0 110.08 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER 40.0 -166.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.483 -0.761 . . . . 0.0 111.183 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.542 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -109.48 62.26 0.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 58' ' ' PHE . 13.3 mt -40.84 167.01 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.953 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 42.2 Cg_endo -68.97 -6.68 18.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.88 1.463 . . . . 0.0 110.277 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 18.7 m-30 -114.0 -100.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 166.09 -28.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 108.992 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 30.2 p90 -177.01 -164.55 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.824 HG13 ' HB ' ' A' ' 56' ' ' ILE . 3.6 p -166.25 128.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 0.0 110.547 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -103.03 147.35 27.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.412 ' OD1' HD13 ' A' ' 56' ' ' ILE . 6.9 p-10 -145.01 146.01 31.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HD3' HD11 ' A' ' 53' ' ' ILE . 12.0 ttp180 -117.32 134.4 54.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.3 131.1 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 110.271 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -103.31 52.03 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 16.2 mm-40 59.22 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.297 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 81' ' ' TYR . 35.1 t -105.4 147.84 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.638 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.7 OUTLIER -63.25 -51.64 65.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 73.25 -75.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.546 -0.721 . . . . 0.0 110.887 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -60.53 -11.7 7.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.839 -1.163 . . . . 0.0 110.638 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -122.3 5.06 9.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 0.0 110.474 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.475 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.2 m-30 54.92 65.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.317 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.504 ' HB2' ' CB ' ' A' ' 75' ' ' ASP . 5.1 mttp -142.66 108.82 5.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.658 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.619 ' O ' HD12 ' A' ' 102' ' ' ILE . 7.4 t80 -95.25 123.57 38.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 110.838 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -119.94 123.37 43.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.486 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 84' ' ' SER . 2.7 p90 -148.89 174.06 12.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 110.698 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.41 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 10.5 p -140.2 167.66 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.741 ' C ' HG23 ' A' ' 86' ' ' ILE . 23.5 t -92.64 -54.2 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.741 HG23 ' C ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER 69.67 -18.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 2.1 tt0 170.68 162.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.543 -1.348 . . . . 0.0 110.403 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 81.76 -173.08 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.79 -147.96 47.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 49.4 Cg_endo -81.39 32.67 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.99 1.521 . . . . 0.0 110.94 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 91' ' ' ILE 0.297 1.5 mm -67.55 138.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 142.89 -165.94 26.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 44.6 -141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.889 HG21 ' HB2' ' A' ' 126' ' ' HIS . 1.8 p -89.06 72.15 8.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.967 HD22 HD11 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -168.36 82.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.333 -0.854 . . . . 0.0 110.044 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.501 ' OE2' ' CE ' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -63.62 -59.0 5.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.434 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.532 ' HG3' ' HB2' ' A' ' 121' ' ' HIS . 1.6 pttm -135.97 162.26 33.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.969 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.967 HD11 HD22 ' A' ' 95' ' ' LEU . 95.7 mt -139.15 122.23 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 111.289 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.6 151.96 20.59 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.517 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 53.6 t30 -154.75 147.48 24.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.873 -1.142 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.754 ' HB2' HG21 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -141.25 152.63 44.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.689 -0.632 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.826 HD12 ' N ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -152.62 144.6 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.294 0.569 . . . . 0.0 110.044 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.664 ' HG3' HG23 ' A' ' 105' ' ' VAL . 4.1 ptmm? -116.13 134.6 54.76 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.901 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.74 HG22 ' CB ' ' A' ' 15' ' ' ALA . 10.9 mm -92.18 90.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.673 -0.642 . . . . 0.0 109.86 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.664 HG23 ' HG3' ' A' ' 103' ' ' LYS . 17.2 t -87.02 133.97 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.349 -0.844 . . . . 0.0 110.372 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.93 133.1 35.99 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.632 -0.668 . . . . 0.0 109.668 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.1 p -87.65 155.93 53.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.297 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.27 -11.55 32.62 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -175.43 86.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 170.48 -88.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.03 -135.18 1.77 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.54 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 5.0 p -124.93 170.42 11.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -1.156 . . . . 0.0 109.889 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.603 HG22 ' OE1' ' A' ' 8' ' ' GLU . 36.5 mt -139.22 123.55 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 111.203 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.983 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.6 mp -93.43 93.83 8.36 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.646 ' HE2' HG21 ' A' ' 105' ' ' VAL . 5.6 pttt -131.45 138.24 48.96 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.821 -1.152 . . . . 0.0 113.589 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.868 HG22 ' N ' ' A' ' 117' ' ' SER . 1.2 mm -178.71 -95.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.868 ' N ' HG22 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -175.07 177.4 1.94 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.835 -1.166 . . . . 0.0 112.686 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.1 m120 -142.44 106.56 4.74 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -92.5 122.88 35.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 111.06 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.744 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.5 m-85 -96.81 109.33 22.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.404 -0.81 . . . . 0.0 109.646 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.532 ' HB2' ' HG3' ' A' ' 97' ' ' LYS . 76.6 m-70 -89.06 104.02 16.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 95' ' ' LEU . 3.0 p -116.43 -158.04 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.491 -0.755 . . . . 0.0 109.881 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.501 ' CE ' ' OE2' ' A' ' 96' ' ' GLU . 3.5 pttp -177.12 143.77 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 129.15 -98.0 0.43 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.19 -48.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.889 ' HB2' HG21 ' A' ' 94' ' ' THR . 80.1 m-70 -56.83 144.5 32.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' VAL . 52.3 mt-10 -89.86 148.86 22.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 110.403 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.565 HG23 ' CD1' ' A' ' 3' ' ' PHE . 13.3 t -41.34 164.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.499 -0.751 . . . . 0.0 110.174 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 133' ' ' VAL . 5.0 mtmt -111.49 131.53 55.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.38 -44.88 84.84 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.033 -1.042 . . . . 0.0 109.413 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -31.51 16.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 25.9 mt-30 -79.23 -40.67 30.09 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.233 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.72 HG11 ' CD2' ' A' ' 5' ' ' TYR . 2.6 t -78.84 -0.3 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.655 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.27 -42.52 4.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.8 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -57.79 -44.91 86.58 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.72 86.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.344 -0.848 . . . . 0.0 109.533 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -64.34 -21.85 66.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 108.984 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 5.7 tm-20 -77.61 -44.92 26.74 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.657 -0.652 . . . . 0.0 109.299 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.484 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 40.2 mmm -64.5 -34.53 78.44 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.13 -42.74 75.21 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.78 -27.52 64.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.092 -1.24 . . . . 0.0 109.877 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -75.76 -35.33 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 108.965 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.663 HD21 HG12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -77.18 -28.15 53.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.136 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 9' ' ' THR . 11.4 tp -70.89 -42.51 69.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 3.1 ttt85 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.839 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -60.06 -58.27 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.053 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.837 HG22 HD11 ' A' ' 29' ' ' LEU . 87.2 t -62.53 -25.09 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.619 -0.676 . . . . 0.0 109.67 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 2.9 mt-10 -65.31 -50.55 65.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -15.74 53.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.636 ' CG ' HG11 ' A' ' 33' ' ' VAL . 10.9 t80 -67.44 -37.42 82.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 109.811 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 65.5 mt -67.87 -18.43 64.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.976 -1.078 . . . . 0.0 109.321 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 mp -89.79 -40.71 12.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.657 -0.652 . . . . 0.0 110.955 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.96 -47.86 14.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 111.03 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 156' ' ' ASP . 71.1 m80 -79.94 81.44 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.274 -0.891 . . . . 0.0 110.936 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 154' ' ' HIS . 58.4 m 38.23 -94.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 111.033 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 154' ' ' HIS . 24.9 m-20 -155.12 51.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.682 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.54 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -49.29 145.12 4.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.961 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.784 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 70.2 m-85 57.03 69.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.257 -0.902 . . . . 0.0 110.273 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 120' ' ' TYR . 61.7 t -47.15 156.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.649 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 64.8 m-85 -117.97 96.56 5.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.868 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.5 121.68 19.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.054 -1.029 . . . . 0.0 111.469 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.685 ' CD2' HG11 ' A' ' 133' ' ' VAL . 22.0 m-85 -117.01 112.06 20.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.36 132.84 52.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 111.489 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -157.69 173.32 17.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.3 pp20? -145.68 149.94 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.806 -1.184 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.957 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -124.56 172.86 8.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.88 142.22 51.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.992 -1.068 . . . . 0.0 111.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB3' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -131.81 147.6 52.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.665 -0.647 . . . . 0.0 109.622 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -18.18 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.331 -0.856 . . . . 0.0 109.921 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.498 ' O ' HD12 ' A' ' 18' ' ' LEU . 5.7 mm -83.33 140.86 42.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.479 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 35.6 Cg_endo -59.03 152.61 57.49 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.848 1.446 . . . . 0.0 111.17 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -53.06 -47.92 68.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 111.24 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.55 -59.04 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.564 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.569 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 2.6 mmt180 -47.18 -57.81 4.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 109.904 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -51.4 -37.19 47.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 109.625 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 1.15 ' CE1' HD21 ' A' ' 24' ' ' LEU . 3.8 t80 -62.13 -69.14 0.27 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.851 -1.156 . . . . 0.0 109.848 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 7.1 mtmt -50.99 -24.82 3.99 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 112.1 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.675 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -113.66 -63.53 1.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.584 -1.322 . . . . 0.0 111.459 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.685 ' HD1' HG21 ' A' ' 147' ' ' VAL . 24.7 t80 -60.55 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.742 -1.224 . . . . 0.0 110.207 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.945 HG22 HD23 ' A' ' 24' ' ' LEU . 31.2 mm -48.24 -81.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.763 -1.211 . . . . 0.0 108.129 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.15 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.5 mt -57.76 160.4 4.53 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.244 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER 44.85 54.57 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.107 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -99.74 -35.11 4.72 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HB3' HG11 ' A' ' 41' ' ' VAL . 83.0 m-20 -81.66 15.4 2.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -1.139 . . . . 0.0 110.635 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 16.6 t-20 -135.0 42.96 2.74 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.832 HD21 HG13 ' A' ' 147' ' ' VAL . 1.0 OUTLIER 175.26 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.7 m-30 -42.25 -55.55 6.43 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.763 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.7 Cg_endo -65.82 -49.28 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.708 1.373 . . . . 0.0 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -45.47 -52.56 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 111.159 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HB1' ' A' ' 146' ' ' ALA . 9.3 m -86.21 -16.76 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.93 . . . . 0.0 110.847 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -135.69 71.96 63.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.74 -19.51 41.25 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.887 1.467 . . . . 0.0 109.464 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -83.98 -9.74 58.44 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.602 -0.686 . . . . 0.0 109.149 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -105.84 -57.22 2.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 31' ' ' PRO . 2.0 mp -117.62 165.93 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 110.152 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.447 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 4.4 m -130.26 -46.98 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 169.11 24.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.888 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 27' ' ' ASP . 72.0 t -137.34 119.62 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.199 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 7.5 mt-10 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 110.139 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.208 0.528 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 1.1 mt -115.08 118.85 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.859 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 8.8 mttp -143.11 154.08 43.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 42' ' ' GLU . 76.0 mttt -120.36 140.6 51.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.592 -0.693 . . . . 0.0 110.161 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 55' ' ' LYS . 1.4 mp -113.2 123.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -104.69 115.91 31.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.463 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 1.013 ' CD2' HD13 ' A' ' 62' ' ' LEU . 13.1 m-85 -75.22 167.38 37.31 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.183 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 60' ' ' GLU . 49.6 Cg_endo -81.91 66.21 8.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.011 1.532 . . . . 0.0 109.854 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' PRO . 3.8 tt0 44.37 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.473 -0.767 . . . . 0.0 111.103 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.3 -51.98 1.85 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.013 HD13 ' CD2' ' A' ' 58' ' ' PHE . 4.0 mt -60.25 163.55 8.15 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.273 -1.133 . . . . 0.0 110.395 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.4 -25.0 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.934 1.492 . . . . 0.0 109.237 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -103.44 -148.15 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.336 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.3 tttt -137.93 -10.36 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.971 -1.081 . . . . 0.0 111.402 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 47.5 p90 -176.83 -157.93 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.656 -1.277 . . . . 0.0 111.011 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 67' ' ' VAL . 8.3 p -169.44 113.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 7.1 tttt -87.75 153.1 21.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.982 -1.074 . . . . 0.0 109.809 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.53 ' N ' ' HG2' ' A' ' 68' ' ' LYS . 4.9 p-10 -136.88 148.89 47.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.04 -1.037 . . . . 0.0 110.626 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -128.01 104.27 7.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 52.6 t -73.51 148.88 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.122 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.2 -14.0 8.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.382 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.82 170.8 3.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 74' ' ' VAL . 7.4 p -170.67 108.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 6.0 t0 -74.81 -156.19 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.928 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.437 ' CD2' ' HE2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -159.76 -57.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 0.0 110.796 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.9 m -50.57 -42.05 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.39 3.51 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.571 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 18.8 m-85 57.03 91.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.142 -0.974 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -139.66 106.19 5.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 0.0 110.289 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.664 ' HD1' HG23 ' A' ' 74' ' ' VAL . 1.1 t80 -101.07 152.6 20.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.08 -1.013 . . . . 0.0 109.68 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.74 132.75 13.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.115 -0.99 . . . . 0.0 110.722 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.3 169.26 24.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 109.719 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.458 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -134.57 157.9 45.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 110.281 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.611 HG12 HD11 ' A' ' 91' ' ' ILE . 3.5 t -104.83 136.34 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 109.039 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.488 ' CG2' ' C ' ' A' ' 85' ' ' VAL . 6.0 pt -148.61 14.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.794 -1.191 . . . . 0.0 111.432 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -169.42 89.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.82 -1.175 . . . . 0.0 110.921 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 126.05 -148.79 17.18 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 88' ' ' GLY . . . 29.85 -118.56 0.08 OUTLIER Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.628 ' HG2' HD12 ' A' ' 98' ' ' ILE . 39.3 Cg_endo -69.46 -73.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.975 1.513 . . . . 0.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.611 HD11 HG12 ' A' ' 85' ' ' VAL . 1.5 mm 9.6 59.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.687 0.756 . . . . 0.0 112.863 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' PRO . . . -158.09 152.02 23.18 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' THR . 7.4 t70 63.59 -162.29 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.243 . . . . 0.0 109.954 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.634 HG21 ' CB ' ' A' ' 126' ' ' HIS . 44.1 p -43.01 -44.07 4.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.144 -0.973 . . . . 0.0 110.108 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.797 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -52.49 119.63 4.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.79 -55.4 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.163 -0.96 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.511 ' C ' ' CG1' ' A' ' 98' ' ' ILE . 5.2 mmtt -113.44 157.12 22.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.195 -0.941 . . . . 0.0 109.829 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.628 HD12 ' HG2' ' A' ' 90' ' ' PRO . 8.5 mt -154.11 122.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.147 -0.971 . . . . 0.0 110.406 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 1.4 t -107.31 123.6 48.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 109.856 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.71 108.38 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 111.28 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.54 ' O ' ' CG1' ' A' ' 102' ' ' ILE . 43.2 mt-10 -99.05 165.15 11.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.815 . . . . 0.0 109.37 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 101' ' ' GLU . 12.4 mt -157.17 137.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -138.61 109.52 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 110.173 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.857 HD11 HG13 ' A' ' 23' ' ' ILE . 50.8 mt -75.43 151.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 112' ' ' SER . 3.6 t -131.2 131.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.068 -1.02 . . . . 0.0 110.766 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.69 136.86 36.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.611 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.5 p -121.11 144.66 40.02 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.917 . . . . 0.0 110.581 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.32 -7.96 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.137 1.599 . . . . 0.0 110.739 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 10.5 p30 -166.89 85.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.13 -23.11 0.23 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.26 -139.61 15.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 79.9 p -115.0 172.06 7.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.262 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 4.9 mt -140.47 122.76 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.807 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.957 ' HB2' HG22 ' A' ' 9' ' ' THR . 3.7 mm? -84.85 102.16 12.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.616 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 103' ' ' LYS . 7.0 mmmt -79.11 91.55 4.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.4 mm -79.08 138.32 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.344 -0.847 . . . . 0.0 111.078 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -139.35 139.5 37.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 5' ' ' TYR . 3.8 p-10 -164.58 109.33 0.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.69 -1.256 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.55 ' HD3' ' NE2' ' A' ' 121' ' ' HIS . 12.9 ptpt -98.22 132.08 44.02 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.288 -0.882 . . . . 0.0 109.207 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.903 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.2 m-85 -90.54 141.72 28.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.55 ' NE2' ' HD3' ' A' ' 119' ' ' LYS . 28.3 m-70 -117.38 92.57 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.659 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 p -102.01 -170.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -140.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.961 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.77 33.79 5.96 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 126' ' ' HIS . 1.1 t0 -160.71 163.01 32.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 110.081 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.634 ' CB ' HG21 ' A' ' 94' ' ' THR . 0.2 OUTLIER 53.2 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.109 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' VAL . 3.1 pt-20 -77.6 147.42 35.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.118 -0.989 . . . . 0.0 110.247 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.644 HG23 ' CD1' ' A' ' 3' ' ' PHE . 92.5 t -42.31 155.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 110.248 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.449 ' HB3' ' HE3' ' A' ' 129' ' ' LYS . 8.5 mtpp -101.16 106.79 18.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.87 -40.34 9.82 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.005 -1.06 . . . . 0.0 109.899 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.46 -45.42 80.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.413 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -63.76 -43.9 95.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.685 HG11 ' CD2' ' A' ' 5' ' ' TYR . 5.8 t -67.91 -16.33 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -86.17 -41.44 14.69 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 110.356 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -52.63 -47.97 66.69 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.983 . . . . 0.0 109.55 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 139' ' ' MET . 0.2 OUTLIER -60.71 -49.16 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.724 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -61.86 -20.56 63.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 11.9 tm-20 -76.27 -56.95 4.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.6 -0.687 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.519 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 2.3 ppp? -59.29 -28.66 66.97 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 108.504 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 139' ' ' MET . . . -69.53 -45.28 60.38 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.79 -32.19 73.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.263 . . . . 0.0 109.774 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 2.1 p -69.99 -38.0 75.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.173 -0.955 . . . . 0.0 108.862 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -71.84 -31.57 66.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.708 ' CD2' HG21 ' A' ' 9' ' ' THR . 11.0 tp -67.18 -41.06 86.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -35.03 73.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.536 -0.728 . . . . 0.0 109.289 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -62.22 -50.64 70.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.485 -0.759 . . . . 0.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.832 HG13 HD21 ' A' ' 29' ' ' LEU . 12.8 t -70.74 -30.44 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.84 -55.26 36.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.461 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -74.68 -23.8 58.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.575 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.763 ' CD1' ' CE1' ' A' ' 154' ' ' HIS . 45.0 t80 -58.89 -62.2 2.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.799 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.466 HD23 ' CD2' ' A' ' 150' ' ' TYR . 34.3 mt -44.42 -26.61 0.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.079 . . . . 0.0 110.414 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 149' ' ' SER . 9.1 mp -79.22 -52.61 7.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 110.95 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 154' ' ' HIS . . . -63.31 -27.86 69.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.763 ' CE1' ' CD1' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -122.88 104.16 9.09 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.825 -0.547 . . . . 0.0 109.926 -178.082 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 58.1 m -88.91 16.33 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 110.156 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -108.72 -22.18 12.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.468 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.48 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -84.6 130.26 34.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.462 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.675 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 37.1 m-85 59.93 48.64 8.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.637 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.226 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.496 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.911 HG13 ' O ' ' A' ' 120' ' ' TYR . 95.6 t -54.6 151.99 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CE1' HG23 ' A' ' 128' ' ' VAL . 80.3 m-85 -114.15 149.14 36.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 110.066 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -106.98 84.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.016 ' CD1' HG11 ' A' ' 133' ' ' VAL . 45.5 m-85 -88.43 78.62 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.02 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 7' ' ' THR . 98.7 mt-10 -90.02 165.93 13.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.353 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 12.3 t -179.8 172.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.835 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.478 ' OE1' ' HD2' ' A' ' 115' ' ' LYS . 23.5 tt0 -155.89 147.08 22.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.13 -0.981 . . . . 0.0 110.336 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.903 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.92 172.31 11.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.887 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.79 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.965 -1.084 . . . . 0.0 110.132 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.54 ' OG ' ' CD1' ' A' ' 18' ' ' LEU . 63.9 p -129.1 150.83 50.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.26 -22.88 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 109.774 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.57 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 19.3 mm -80.25 142.87 55.37 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 35.5 Cg_endo -58.02 148.58 76.18 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.749 1.394 . . . . 0.0 110.732 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.687 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -55.07 -36.69 65.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.03 70.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -62.88 -50.84 69.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 110.61 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 14.4 mt -57.23 -39.22 75.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.946 -1.096 . . . . 0.0 109.766 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.93 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -61.36 -63.99 1.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.098 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.27 -30.29 50.11 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.552 -0.718 . . . . 0.0 112.223 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -105.69 -64.61 1.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.758 -1.214 . . . . 0.0 111.44 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.844 ' HE2' HD21 ' A' ' 114' ' ' LEU . 63.3 t80 -70.29 5.47 1.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 112.449 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.518 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 28.7 mm -142.81 -26.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.307 -1.495 . . . . 0.0 111.882 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.93 HD21 ' CE1' ' A' ' 19' ' ' PHE . 4.2 mt -102.31 -34.44 9.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.62 -1.3 . . . . 0.0 109.833 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 5.9 t0 -119.64 31.96 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -71.31 -25.14 76.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.93 ' O ' HG11 ' A' ' 41' ' ' VAL . 20.6 m-20 -76.6 3.52 11.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 5.5 t30 -140.16 52.73 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.648 HD11 ' CD2' ' A' ' 150' ' ' TYR . 1.5 tp 170.62 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.516 -0.74 . . . . 0.0 109.26 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.4 m-30 -42.97 -59.82 2.79 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.874 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.1 Cg_endo -66.22 -29.45 47.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.915 1.482 . . . . 0.0 111.189 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -36.3 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.9 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.802 HG23 ' HB1' ' A' ' 146' ' ' ALA . 15.9 m -104.12 -9.21 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.062 -1.024 . . . . 0.0 110.409 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.41 63.89 56.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.965 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.53 -7.82 20.39 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.97 1.51 . . . . 0.0 110.139 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -92.11 -18.33 23.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.424 -0.798 . . . . 0.0 109.167 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.1 -58.41 2.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.654 HG12 HD21 ' A' ' 143' ' ' LEU . 10.0 mm -95.68 179.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.384 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.628 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -159.47 -49.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.959 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.27 142.61 30.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.93 HG11 ' O ' ' A' ' 27' ' ' ASP . 7.6 p -120.99 121.55 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 110.419 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 tt0 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 109.929 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.214 0.53 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.597 HD11 ' HD2' ' A' ' 70' ' ' ARG . 3.6 mp -102.56 143.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.616 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 2.4 mttt -130.76 150.13 52.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -117.9 97.97 6.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.412 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.501 HG22 ' CE1' ' A' ' 58' ' ' PHE . 1.5 mp -78.58 131.81 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -115.28 141.14 48.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.762 ' HD2' HD21 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -107.69 135.19 19.8 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 110.538 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 38' ' ' ILE . 50.9 Cg_endo -84.34 47.93 2.33 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.952 1.501 . . . . 0.0 109.965 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.71 -171.48 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 0.0 110.627 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.36 35.44 4.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.762 HD21 ' HD2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -54.19 -176.49 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -1.052 . . . . 0.0 110.324 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.686 ' HD2' ' HB2' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -82.46 -20.95 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.04 1.021 . . . . 0.0 110.462 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 2.4 m-85 -97.08 -154.92 0.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -131.27 -33.95 1.45 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.448 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 36.6 p90 -169.04 -153.53 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 67' ' ' VAL . 8.9 p -168.37 111.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 111.149 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.7 ttpp -99.7 149.15 23.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.19 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 29.8 p30 -154.26 148.18 25.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.984 -1.072 . . . . 0.0 110.964 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.597 ' HD2' HD11 ' A' ' 53' ' ' ILE . 4.6 ttp180 -103.6 154.27 19.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 109.584 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 15.6 t -99.39 -44.53 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.113 -0.992 . . . . 0.0 110.359 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER 76.94 -38.13 0.3 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.848 -0.532 . . . . 0.0 111.721 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 1.2 pt-20 178.28 155.95 0.4 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.686 -1.259 . . . . 0.0 110.505 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.451 HG13 ' HD1' ' A' ' 81' ' ' TYR . 94.3 t -146.05 153.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.818 . . . . 0.0 109.901 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.65 164.46 15.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.723 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.502 ' NE2' HD11 ' A' ' 24' ' ' LEU . 3.8 m80 -134.4 -40.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.51 -0.744 . . . . 0.0 109.856 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -55.42 -38.55 69.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.253 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -108.25 12.8 26.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.511 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.538 ' O ' HD12 ' A' ' 104' ' ' ILE . 3.8 m-85 52.11 60.59 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 81' ' ' TYR . 1.4 tppt? -123.35 155.51 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.39 -0.819 . . . . 0.0 110.586 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.5 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 64.6 t80 -144.06 162.2 36.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.58 -0.7 . . . . 0.0 109.162 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 71' ' ' VAL . 28.0 t30 -167.52 128.63 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.913 -1.117 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 32.7 p90 -143.23 142.44 31.4 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.383 -0.823 . . . . 0.0 109.941 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.45 126.25 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.775 . . . . 0.0 110.173 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.05 128.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.781 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -124.7 10.64 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.962 . . . . 0.0 109.865 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 2.2 mm-40 -176.65 170.72 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.507 ' O ' HG13 ' A' ' 91' ' ' ILE . . . 73.12 173.33 25.03 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.82 -144.19 27.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.4 Cg_endo -84.8 34.27 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.067 1.561 . . . . 0.0 110.735 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -50.25 172.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.985 . . . . 0.0 110.437 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 45.7 63.48 2.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 7.5 t0 -177.83 82.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -1.164 . . . . 0.0 110.422 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' ASP . 18.8 p 43.65 29.0 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.278 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.904 HD11 ' CD2' ' A' ' 120' ' ' TYR . 1.9 tp -150.61 95.77 2.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.171 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.5 -49.83 44.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.643 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -152.62 165.54 34.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.321 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.734 HD11 HD11 ' A' ' 95' ' ' LEU . 24.2 mm -140.76 116.78 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.833 . . . . 0.0 110.442 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -96.33 143.2 27.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 108.946 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 36.0 t-20 -143.04 149.53 38.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.259 -1.376 . . . . 0.0 112.126 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 25.3 mt-10 -129.03 152.47 48.6 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 12.1 mt -142.0 124.03 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 0.0 110.635 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -115.41 130.96 57.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 0.0 109.738 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 19' ' ' PHE . 1.3 mp -99.43 118.95 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.036 -1.04 . . . . 0.0 109.782 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 112' ' ' SER . 6.6 t -107.34 129.56 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.24 140.92 29.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.757 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -104.47 148.96 36.85 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 110.397 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.0 -8.62 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.09 1.574 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -165.01 83.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.43 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.14 -85.83 0.1 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.91 -113.29 0.3 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.546 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 4.5 p -138.9 176.82 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -1.192 . . . . 0.0 109.972 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.411 HG21 ' OE2' ' A' ' 8' ' ' GLU . 15.9 mt -139.28 123.35 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.271 -0.893 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.903 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.19 90.72 8.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HD2' ' OE1' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -85.22 99.51 11.15 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 114' ' ' LEU . 1.2 mp -99.84 155.02 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.061 -1.024 . . . . 0.0 111.679 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 m -140.14 107.71 5.6 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 100' ' ' ASN . 3.3 t-20 -105.85 105.77 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 112.034 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.486 ' HG3' ' CG1' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -88.47 107.64 18.97 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.911 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.7 m-85 -82.52 142.94 31.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.924 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 97' ' ' LYS . 83.6 m-70 -126.31 100.37 6.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.766 -0.584 . . . . 0.0 109.566 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.518 HG21 ' CG2' ' A' ' 128' ' ' VAL . 4.9 p -110.53 -166.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 110.35 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.69 67.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 -149.67 5.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -68.98 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.448 -1.031 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -75.67 -174.49 2.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 12.2 mp0 -115.46 -171.7 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 110.284 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.643 HG23 ' CE1' ' A' ' 3' ' ' PHE . 88.6 t -54.13 152.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.448 ' NZ ' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -98.85 108.21 20.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -41.91 -59.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 110.422 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 2.5 tt0 -43.17 -45.25 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.782 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -45.23 94.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.016 HG11 ' CD1' ' A' ' 5' ' ' TYR . 76.4 t -58.04 -24.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -76.82 -51.42 11.36 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.751 -0.593 . . . . 0.0 110.108 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -43.8 -43.82 6.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.872 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.1 t -60.45 -54.82 40.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.569 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -53.45 -27.87 27.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.745 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.405 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.72 -46.87 43.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.527 -0.733 . . . . 0.0 110.392 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.455 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 4.6 mtp -63.19 -30.46 71.6 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.846 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.6 -45.43 53.34 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -72.32 -30.07 64.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.359 . . . . 0.0 110.614 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 1.2 p -72.99 -40.35 65.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.794 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.654 HD21 HG12 ' A' ' 38' ' ' ILE . 1.1 mm? -80.03 -25.84 40.02 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.354 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 16.4 tp -70.75 -39.95 72.98 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -44.36 59.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.802 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -55.52 -55.51 31.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.565 HG13 HD21 ' A' ' 29' ' ' LEU . 69.3 t -66.02 -32.31 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 13' ' ' ILE . 1.2 tm-20 -58.48 -52.13 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.3 p -75.99 -26.67 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.677 ' HB2' HG11 ' A' ' 33' ' ' VAL . 8.5 t80 -57.71 -45.75 85.33 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.724 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.7 mt -58.05 -24.81 59.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 6.0 mp -93.01 -19.68 21.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 110.516 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.5 -34.03 23.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 155' ' ' SER . 4.4 m80 -91.86 166.2 12.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 110.6 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.48 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 22.9 m -43.48 -56.81 3.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 110.608 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 155' ' ' SER . 2.4 m-20 -177.94 65.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -67.76 133.58 49.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.354 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.863 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 56.5 m-85 60.59 19.9 9.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 110.587 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.065 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.56 ' CG2' ' HG3' ' A' ' 119' ' ' LYS . 11.7 p -55.36 154.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.16 . . . . 0.0 110.456 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.67 ' CD1' HG23 ' A' ' 128' ' ' VAL . 53.9 m-85 -115.88 158.75 22.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -117.37 118.69 32.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.03 ' CD1' HG11 ' A' ' 133' ' ' VAL . 37.2 m-85 -122.63 89.51 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -99.82 155.13 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.448 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 11.8 t -171.24 170.21 6.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.171 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HG3' ' C ' ' A' ' 7' ' ' THR . 27.6 mt-10 -148.04 118.97 7.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.972 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -100.58 -177.73 3.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 109.815 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.498 HG22 ' CD1' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -124.0 137.93 54.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.0 110.424 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.897 ' OG ' HD11 ' A' ' 18' ' ' LEU . 36.4 t -125.01 139.44 53.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.5 -2.66 4.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.457 -0.777 . . . . 0.0 110.161 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.687 HG23 ' HD2' ' A' ' 14' ' ' PRO . 7.9 mm -96.11 149.31 35.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.253 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.687 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.8 Cg_endo -56.68 155.66 25.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.019 1.536 . . . . 0.0 110.518 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.723 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -64.17 -71.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 111.268 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -39.3 -51.43 2.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.686 . . . . 0.0 110.951 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.572 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 6.7 ttm180 -57.33 -54.97 40.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.812 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.897 HD11 ' OG ' ' A' ' 11' ' ' SER . 8.7 mt -50.43 -29.2 9.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.184 -1.006 . . . . 0.0 108.822 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 1.121 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -69.76 -67.35 0.49 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.545 -0.722 . . . . 0.0 110.678 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 25.5 mtpt -57.34 -21.36 34.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.377 -0.827 . . . . 0.0 112.717 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.803 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.58 -58.98 2.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.46 -1.4 . . . . 0.0 112.512 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HA ' HG11 ' A' ' 147' ' ' VAL . 34.1 t80 -73.24 -11.51 60.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.893 -1.129 . . . . 0.0 112.353 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.922 HG22 HD23 ' A' ' 24' ' ' LEU . 23.0 mt -121.77 -80.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.674 -1.267 . . . . 0.0 110.393 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.121 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.3 mt -45.44 -56.72 4.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.865 -1.147 . . . . 0.0 110.032 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -100.21 66.54 1.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -101.96 -30.95 5.56 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.595 ' HB3' HG11 ' A' ' 41' ' ' VAL . 99.4 m-20 -81.39 13.49 2.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 110.456 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.5 t30 -138.68 45.06 2.05 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.898 HD21 HG13 ' A' ' 147' ' ' VAL . 1.2 tp 173.55 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 109.441 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CD1' HD12 ' A' ' 143' ' ' LEU . 2.9 m-30 -48.41 -61.01 3.57 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.367 -0.833 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.3 Cg_endo -65.95 -22.96 54.94 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.8 1.421 . . . . 0.0 111.464 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -71.73 -50.91 25.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.818 HG23 ' HB1' ' A' ' 146' ' ' ALA . 19.5 m -89.54 -8.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 110.243 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -134.96 62.43 52.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.505 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.98 -15.7 43.95 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 109.358 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -83.88 -16.74 43.24 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.543 0.687 . . . . 0.0 109.192 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.51 -64.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 110.595 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.87 HG12 HD21 ' A' ' 143' ' ' LEU . 10.5 mm -93.73 169.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.437 ' N ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -136.16 -36.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 109.986 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.39 160.77 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 27' ' ' ASP . 3.7 p -140.57 154.25 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.028 -1.045 . . . . 0.0 110.647 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.459 -0.776 . . . . 0.0 109.603 179.59 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 53' ' ' ILE . 1.2 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.138 0.494 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 53' ' ' ILE . 1.0 OUTLIER 30.55 31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.587 0.708 . . . . 0.0 112.477 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' A' ' 52' ' ' THR . 14.5 mttt -75.53 152.41 37.8 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -124.7 91.5 3.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.892 -1.13 . . . . 0.0 111.053 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.508 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.2 mp -77.51 158.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.586 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.459 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -144.63 171.3 14.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 1.01 ' HB3' HD12 ' A' ' 62' ' ' LEU . 15.9 m-85 -134.72 157.09 77.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 47.3 Cg_endo -77.19 177.62 8.65 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.907 1.477 . . . . 0.0 109.835 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.07 175.43 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.0 110.142 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.34 -47.37 3.29 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.01 HD12 ' HB3' ' A' ' 58' ' ' PHE . 13.5 mt -78.38 139.52 59.81 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.71 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.75 -7.09 19.01 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.009 1.531 . . . . 0.0 110.217 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.472 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 3.6 m-30 -97.32 135.07 39.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 110.155 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -87.94 -42.63 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 0.0 110.365 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.87 ' O ' HG13 ' A' ' 67' ' ' VAL . 30.3 p90 -167.55 -173.76 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.003 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -166.07 124.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -0.786 . . . . 0.0 110.693 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -81.12 92.85 6.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.464 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 22.3 t70 -84.35 96.19 8.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.507 ' HG3' ' HA ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.67 83.64 7.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.872 . . . . 0.0 110.043 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.685 HG12 ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -45.44 -60.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 109.54 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.685 ' N ' HG12 ' A' ' 71' ' ' VAL . 0.1 OUTLIER 73.07 -28.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.109 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -167.5 171.84 10.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.211 -1.555 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.2 p -165.56 146.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.671 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.02 -171.53 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 0.0 110.146 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 -56.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 110.376 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 m -59.46 -20.14 52.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.835 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -118.27 8.38 12.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 110.564 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.619 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.6 m-30 54.49 54.21 9.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.994 . . . . 0.0 109.863 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.64 147.3 47.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.556 ' CD1' ' CG2' ' A' ' 23' ' ' ILE . 14.4 t80 -133.2 105.0 6.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -1.0 . . . . 0.0 110.693 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -101.59 115.55 30.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 7.4 p90 -138.91 155.3 48.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.101 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -109.29 136.36 48.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 110.856 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.459 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 73.0 t -111.53 121.12 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.462 HD11 ' CD ' ' A' ' 70' ' ' ARG . 8.4 pt -147.16 164.43 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.962 -1.086 . . . . 0.0 111.281 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 64.76 133.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 110.847 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 66' ' ' TYR . . . 56.29 178.08 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.611 ' HA3' HG12 ' A' ' 67' ' ' VAL . . . 80.89 -133.25 11.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' A' ' 98' ' ' ILE . 48.7 Cg_endo -78.91 1.6 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.054 1.555 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.65 HD11 ' O ' ' A' ' 96' ' ' GLU 0.293 1.3 mm -61.27 140.92 18.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.223 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 159.15 -92.97 0.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -117.68 145.0 44.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -1.15 . . . . 0.0 110.315 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.871 HG22 ' O ' ' A' ' 125' ' ' ASP . 6.5 p 50.79 50.39 19.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.968 HD21 ' CD2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER 167.14 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.341 -0.85 . . . . 0.0 110.379 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.65 ' O ' HD11 ' A' ' 91' ' ' ILE . 8.2 tt0 -96.13 -39.59 9.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.27 136.81 50.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.584 HG23 ' CD1' ' A' ' 120' ' ' TYR . 29.8 mt -131.94 113.06 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.861 . . . . 0.0 110.361 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 135.85 33.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 0.0 109.205 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.519 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 4.9 m120 -132.14 139.23 48.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.786 -1.196 . . . . 0.0 110.88 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 81' ' ' TYR . 2.0 mt-10 -137.05 130.93 32.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.105 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 83' ' ' TYR . 7.4 mt -118.93 127.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 tmtt? -115.14 118.13 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.746 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.723 HG22 ' HB1' ' A' ' 15' ' ' ALA . 38.7 mm -79.36 115.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 110.283 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.407 ' CG2' ' HG3' ' A' ' 115' ' ' LYS . 63.0 t -108.93 123.72 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 110.117 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.69 135.99 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.235 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.6 p -106.76 150.19 39.38 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 48.4 Cg_endo -66.84 81.13 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.181 1.622 . . . . 0.0 110.698 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 18.9 t0 -179.93 -62.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 0.0 110.284 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.19 38.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.33 28.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.551 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -127.95 130.38 48.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -1.217 . . . . 0.0 110.464 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.961 HG23 ' O ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -85.47 143.99 10.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 109.548 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.972 ' HB2' HG22 ' A' ' 9' ' ' THR . 3.8 mm? -97.66 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -85.43 99.77 11.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.094 -1.004 . . . . 0.0 109.425 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.418 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 7.6 mt -98.37 131.19 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.839 -1.163 . . . . 0.0 111.678 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 m -123.56 129.89 51.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 9.9 m-20 -131.25 105.85 7.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.993 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -90.79 107.92 19.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.968 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.8 m-85 -88.19 95.02 10.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 111.864 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.594 ' CE1' ' HG2' ' A' ' 119' ' ' LYS . 72.4 m-70 -79.95 95.95 6.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 108.882 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.61 HG21 ' CG2' ' A' ' 128' ' ' VAL . 5.6 p -102.67 -56.22 2.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.17 -0.956 . . . . 0.0 111.017 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 122' ' ' THR . 18.1 pttm 35.29 72.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.624 -0.673 . . . . 0.0 111.246 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.65 -72.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.871 ' O ' HG22 ' A' ' 94' ' ' THR . 14.8 t70 -153.99 150.62 28.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 51.83 -167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.08 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -121.49 170.09 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.883 . . . . 0.0 110.486 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.67 HG23 ' CD1' ' A' ' 3' ' ' PHE . 64.8 t -61.95 135.31 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.224 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.3 mtmt -82.33 115.57 21.44 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -45.34 -42.01 9.51 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 10.2 tm-20 -54.79 -47.28 74.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -39.39 83.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.278 -0.889 . . . . 0.0 108.921 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.03 HG11 ' CD1' ' A' ' 5' ' ' TYR . 84.2 t -66.7 -23.46 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 135' ' ' ALA . 14.5 tttt -79.06 -63.04 1.51 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.684 -0.635 . . . . 0.0 110.499 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.22 -46.06 1.03 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -0.817 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m -60.61 -47.84 84.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.43 ' HE2' HG21 ' A' ' 7' ' ' THR . 36.0 mttt -59.96 -28.55 67.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.43 -39.76 64.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.464 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.0 OUTLIER -65.3 -37.3 86.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 108.783 178.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.47 -42.64 93.6 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -32.19 72.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.214 -1.168 . . . . 0.0 110.182 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.492 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 1.7 p -70.6 -39.18 73.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.324 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.87 HD21 HG12 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -75.14 -28.13 60.04 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.6 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 23.9 tp -71.18 -39.94 71.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 0.0 108.594 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.558 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 1.3 ptm85 -73.76 -32.68 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 109.472 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -65.83 -58.12 6.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.1 -1.0 . . . . 0.0 109.059 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.898 HG13 HD21 ' A' ' 29' ' ' LEU . 47.7 t -64.95 -28.12 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.554 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' HA ' HG13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -63.64 -49.45 73.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.814 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.413 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 1.3 t -78.69 -20.89 49.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 110.044 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.774 ' HB2' HG11 ' A' ' 33' ' ' VAL . 12.0 t80 -62.55 -41.07 98.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 65.9 mt -67.45 -22.29 65.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 109.917 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 mp -82.72 -38.35 23.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.04 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.0 -46.18 62.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -81.63 -39.03 25.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.887 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.9 m 58.06 19.54 6.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 2.6 p30 -138.51 -33.45 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 156' ' ' ASP . . . -60.36 131.92 52.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.803 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.5 m-85 55.69 49.3 16.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 110.868 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.22 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' A' ' 119' ' ' LYS . 8.1 p -132.46 165.41 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.189 . . . . 0.0 110.259 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.649 ' CD1' HG23 ' A' ' 128' ' ' VAL . 45.6 m-85 -129.02 148.57 50.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -111.11 86.8 2.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 0.0 111.004 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.183 ' CD1' HG11 ' A' ' 133' ' ' VAL . 18.3 m-85 -84.82 73.45 10.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.464 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.24 118.17 21.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.917 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -132.13 -168.9 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.88 163.44 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 0.0 110.177 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.785 HG22 ' CB ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -141.51 173.39 11.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.4 141.58 50.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.957 . . . . 0.0 110.662 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 t -136.71 147.1 46.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 109.929 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.76 -20.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 18' ' ' LEU . 5.4 mm -79.03 140.91 57.93 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 110.705 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -57.53 151.91 51.09 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.659 1.573 . . . . 0.0 111.173 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.678 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -56.67 -48.59 77.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 111.455 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -52.31 -61.78 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.037 -1.039 . . . . 0.0 111.045 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.6 ttp180 -54.07 -57.73 10.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.022 . . . . 0.0 109.944 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.08 -29.25 3.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.948 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.09 -63.12 1.12 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 109.326 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.68 -46.05 19.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 110.481 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.888 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -83.94 -70.82 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.725 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 22.0 t80 -76.0 142.61 41.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 108.941 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 14.7 mt 81.29 -46.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 CA-C-O 120.914 0.387 . . . . 0.0 110.922 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.948 HD21 ' CE1' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -86.71 -77.15 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.957 -1.089 . . . . 0.0 109.484 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 29' ' ' LEU . 9.5 t70 -57.5 -96.35 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.05 -1.031 . . . . 0.0 109.193 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.594 ' HA2' ' CE1' ' A' ' 30' ' ' PHE . . . 79.11 -74.0 2.26 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.837 -1.164 . . . . 0.0 110.936 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.54 -4.47 6.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.977 -1.308 . . . . 0.0 111.106 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 12.3 t30 -135.96 51.71 2.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.645 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.88 ' C ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER 171.15 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.89 . . . . 0.0 109.554 -179.029 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.648 ' N ' HD13 ' A' ' 29' ' ' LEU . 5.3 m-30 -65.14 -58.09 13.5 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.95 . . . . 0.0 110.229 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.574 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 44.0 Cg_endo -65.1 -35.3 42.89 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.808 1.425 . . . . 0.0 110.604 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.55 -37.87 76.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.844 HG23 ' HB1' ' A' ' 146' ' ' ALA . 6.0 m -106.71 2.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -152.83 66.15 6.04 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 59' ' ' PRO . 42.0 Cg_endo -67.91 -24.22 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.903 1.475 . . . . 0.0 109.439 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -81.21 -9.46 59.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.412 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -104.0 -57.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -124.79 168.05 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.168 -0.957 . . . . 0.0 110.984 -179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.503 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 1.4 t -131.48 -37.45 1.21 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.653 -0.654 . . . . 0.0 109.398 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 39' ' ' SER . 7.5 t -177.42 142.79 0.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 0.0 109.862 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.731 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.5 p -132.95 116.04 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.028 -1.045 . . . . 0.0 110.753 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.6 tt0 . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.834 . . . . 0.0 110.504 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 64.5 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.4 mm -53.59 119.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 111.123 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 52' ' ' THR . 21.6 mtmt -144.39 144.27 31.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.567 -0.708 . . . . 0.0 109.327 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 4.2 ttpp -115.01 116.97 29.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.915 . . . . 0.0 110.255 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.022 ' HB ' HG23 ' A' ' 67' ' ' VAL . 2.0 mp -90.52 115.94 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 110.03 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 t -113.84 126.89 55.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 110.561 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.754 ' CB ' HD12 ' A' ' 62' ' ' LEU . 42.5 m-85 -94.5 143.1 25.71 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.5 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 49.1 Cg_endo -88.53 37.88 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.81 1.426 . . . . 0.0 110.638 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -150.41 -177.29 5.87 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.578 0.704 . . . . 0.0 110.084 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.608 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -70.07 -59.01 5.72 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.754 HD12 ' CB ' ' A' ' 58' ' ' PHE . 10.7 mt 53.42 168.25 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.366 -1.079 . . . . 0.0 110.115 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -72.61 -21.68 21.82 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.789 1.415 . . . . 0.0 109.897 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.505 ' CE2' ' HD3' ' A' ' 90' ' ' PRO . 11.0 m-85 -129.53 160.9 31.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.503 -0.748 . . . . 0.0 109.66 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -20.06 30.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.318 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.746 ' O ' HG13 ' A' ' 67' ' ' VAL . 27.6 p90 -173.8 -171.7 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.022 HG23 ' HB ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -161.08 108.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.765 . . . . 0.0 110.602 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -76.81 155.22 33.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.303 -0.873 . . . . 0.0 109.012 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -151.74 131.11 12.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.671 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 84' ' ' SER . 0.7 OUTLIER -104.43 87.76 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.025 HG13 ' HB3' ' A' ' 83' ' ' TYR . 45.1 t -82.05 -104.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' N ' HG12 ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.22 162.96 0.24 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.552 -0.717 . . . . 0.0 110.811 -178.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER 73.75 136.56 0.05 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 74' ' ' VAL . 6.3 p -173.2 103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 3.6 t0 -80.31 161.67 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.13 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.34 -48.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.234 -0.916 . . . . 0.0 110.564 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 m -59.35 -24.13 63.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.753 -1.217 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -118.38 14.96 13.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.962 . . . . 0.0 110.348 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.576 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 8.2 m-30 44.25 63.38 1.66 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.278 -0.888 . . . . 0.0 110.585 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 13.3 tttt -122.05 141.82 50.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.698 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CD2' HG23 ' A' ' 74' ' ' VAL . 22.5 t80 -148.59 98.36 2.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.087 -1.008 . . . . 0.0 110.82 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.521 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -111.76 143.14 43.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.603 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 1.025 ' HB3' HG13 ' A' ' 71' ' ' VAL . 15.8 p90 -134.75 163.53 29.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -104.54 112.08 25.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.535 -0.728 . . . . 0.0 111.143 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.4 t -94.64 104.11 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.538 HG13 ' N ' ' A' ' 87' ' ' GLU . 49.0 pt -93.81 -34.58 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.538 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.8 mt-10 -146.81 169.41 19.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.003 -1.06 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.591 ' CA ' ' HA ' ' A' ' 67' ' ' VAL . . . 112.41 115.9 3.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.504 ' HA2' ' CD2' ' A' ' 64' ' ' PHE . . . 124.48 -143.93 15.0 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.513 ' O ' ' C ' ' A' ' 91' ' ' ILE . 53.1 Cg_endo -83.51 26.87 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.092 1.575 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -27.69 145.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.436 0.636 . . . . 0.0 111.358 -179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.36 -100.45 0.16 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.42 ' O ' ' OG1' ' A' ' 94' ' ' THR . 29.5 m-20 -125.86 -176.28 3.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -1.098 . . . . 0.0 110.395 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 122' ' ' THR . 46.1 p 46.23 22.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.891 HD23 HD11 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -172.16 96.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.419 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -114.02 -21.46 10.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.0 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.782 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -142.18 147.96 37.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 110.083 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.891 HD11 HD23 ' A' ' 95' ' ' LEU . 35.5 mm -145.43 131.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.0 m -116.34 131.37 56.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 109.144 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 1.3 m-20 -126.3 147.63 49.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.043 -1.035 . . . . 0.0 111.267 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 3.8 tt0 -138.02 132.33 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.693 -0.629 . . . . 0.0 109.573 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 103' ' ' LYS . 77.2 mt -118.66 165.7 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 0.9 OUTLIER -157.69 111.86 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 110.551 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.708 ' H ' HD12 ' A' ' 104' ' ' ILE . 2.8 mp -87.93 112.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 0.0 109.944 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.419 HG21 ' NZ ' ' A' ' 115' ' ' LYS . 90.4 t -103.58 139.09 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.078 -1.014 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.72 132.01 41.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.0 109.961 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.4 p -105.57 154.22 39.31 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.428 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 48.3 Cg_endo -66.59 -33.2 36.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.016 1.535 . . . . 0.0 110.509 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 108' ' ' PRO . 5.3 m-20 -151.75 67.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.75 35.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.12 -140.3 46.68 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.549 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 80.0 p -128.06 155.18 44.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -1.14 . . . . 0.0 110.052 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.4 mt -112.53 126.83 69.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 110.43 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.785 ' CB ' HG22 ' A' ' 9' ' ' THR . 1.2 tp -88.53 89.2 7.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.795 -0.566 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' NZ ' HG21 ' A' ' 105' ' ' VAL . 9.1 mttt -73.77 128.77 36.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.404 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 114' ' ' LEU . 2.7 mt -128.23 150.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 111.18 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 t -138.89 120.36 14.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.176 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 2.5 m-20 -112.79 94.7 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 0.0 111.53 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HG3' ' CG2' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -82.42 106.18 14.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.001 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.716 ' CD2' HD21 ' A' ' 95' ' ' LEU . 1.5 m-85 -85.15 111.14 19.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.962 -1.086 . . . . 0.0 111.461 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.1 m-70 -90.25 102.05 14.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.335 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.565 HG21 HG23 ' A' ' 128' ' ' VAL . 7.5 p -103.23 162.33 13.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -145.97 37.65 1.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.46 -147.44 7.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.88 -65.05 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -56.1 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.348 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 17.3 pt-20 -111.23 -169.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.652 HG11 ' CE2' ' A' ' 5' ' ' TYR . 24.9 t -68.64 163.72 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.1 101.49 10.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 110.004 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.2 -32.25 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 4.3 tt0 -59.96 -50.48 73.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.633 ' OE1' HD13 ' A' ' 95' ' ' LEU . 48.4 tt0 -61.04 -40.79 94.94 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.183 HG11 ' CD1' ' A' ' 5' ' ' TYR . 61.4 t -62.4 -23.66 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 1.8 tptt -78.72 -59.23 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.837 -0.539 . . . . 0.0 110.898 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.37 -45.93 1.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.394 -0.816 . . . . 0.0 110.842 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -59.99 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.095 -1.003 . . . . 0.0 109.652 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 133' ' ' VAL . 16.9 mtmt -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.838 . . . . 0.0 110.318 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.36 -54.3 15.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -0.915 . . . . 0.0 110.135 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.467 ' SD ' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -57.32 -37.77 73.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.061 -1.024 . . . . 0.0 109.287 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.31 -39.8 97.32 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -72.16 -38.72 69.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.999 -1.295 . . . . 0.0 111.003 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.234 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 147' ' ' VAL . 1.3 mm? -77.41 -31.15 53.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.112 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.749 HD22 HG21 ' A' ' 9' ' ' THR . 20.4 tp -68.64 -32.54 72.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 108.696 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -77.62 -41.21 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.527 -0.733 . . . . 0.0 109.517 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.844 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -61.09 -43.88 98.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.506 -0.746 . . . . 0.0 110.012 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 143' ' ' LEU . 21.2 t -75.33 -43.16 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.954 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.502 ' HG2' HG12 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -53.86 -41.89 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -0.825 . . . . 0.0 110.221 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.6 p -85.19 -29.68 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 0.0 110.173 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.592 ' CG ' HG11 ' A' ' 33' ' ' VAL . 4.5 t80 -58.17 -35.99 72.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.024 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 11.5 mt -71.11 -22.1 62.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 0.0 110.025 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -91.62 -23.65 19.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.861 . . . . 0.0 110.303 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.93 -49.12 7.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.629 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.59 ' CE1' ' CE1' ' A' ' 150' ' ' TYR . 46.2 m80 -63.25 -97.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.085 -1.01 . . . . 0.0 110.528 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.404 ' OG ' ' C ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -160.51 -70.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 110.385 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.521 ' HB2' ' ND2' ' A' ' 159' ' ' ASN . 3.4 p-10 -142.41 31.49 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.223 -0.923 . . . . 0.0 110.556 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.542 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -52.53 131.08 33.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 0.0 109.767 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.888 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 51.3 m-85 59.25 66.32 1.05 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 156' ' ' ASP . 1.1 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.204 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 3' ' ' PHE . 45.4 t -79.75 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.343 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.599 ' N ' HG12 ' A' ' 2' ' ' VAL . 90.8 m-85 -137.74 144.46 41.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.28 110.0 20.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.421 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.602 ' CD2' HG11 ' A' ' 133' ' ' VAL . 19.2 m-30 -112.3 88.23 2.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.739 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.01 128.3 38.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -147.16 -172.28 3.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 110.765 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -165.68 173.87 10.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.85 . . . . 0.0 110.782 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.582 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 13.1 t -151.58 168.46 24.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -128.45 139.82 52.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.794 -1.191 . . . . 0.0 111.08 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.516 ' OG ' HD11 ' A' ' 18' ' ' LEU . 43.3 t -134.99 153.89 51.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 110.257 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.85 -22.12 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.213 -0.929 . . . . 0.0 110.04 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 18' ' ' LEU . 4.3 mm -75.84 140.98 71.24 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.636 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 33.1 Cg_endo -57.73 154.53 36.88 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.024 1.539 . . . . 0.0 111.196 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -54.65 -64.46 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 111.172 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -40.87 -62.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 0.0 111.113 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.511 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -50.36 -58.56 5.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.083 -1.011 . . . . 0.0 110.761 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -49.39 -31.3 9.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 110.924 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.769 ' CE2' HD21 ' A' ' 24' ' ' LEU . 24.9 t80 -74.21 -55.86 5.57 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.415 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 4.3 mtmm -52.09 -42.98 63.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.07 -1.019 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -83.78 -71.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 108.398 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.692 ' HD1' HG21 ' A' ' 147' ' ' VAL . 27.2 t80 -79.49 147.24 32.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.315 -0.865 . . . . 0.0 108.696 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.056 ' CD1' HD11 ' A' ' 104' ' ' ILE . 38.0 mt 81.93 -44.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.769 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.2 mt -97.97 -56.44 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.982 . . . . 0.0 109.933 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -102.91 80.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.199 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.76 -23.02 10.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.526 ' HA ' HG21 ' A' ' 41' ' ' VAL . 7.8 p-10 -78.24 -22.12 48.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' OD1' ' OD2' ' A' ' 27' ' ' ASP . 30.5 m-20 -105.75 4.68 30.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -128.27 -42.23 1.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.605 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 8.1 m-30 -54.35 -58.24 14.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.774 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 52.5 Cg_endo -68.45 -5.54 15.38 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.249 1.131 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -106.14 -14.01 15.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 111.308 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.946 HG23 ' HB1' ' A' ' 146' ' ' ALA . 15.8 m -134.41 6.27 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.008 -1.058 . . . . 0.0 110.051 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.11 62.63 2.45 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.26 -20.67 55.55 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.893 1.47 . . . . 0.0 109.623 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -75.43 -19.14 59.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.697 ' HB1' ' SD ' ' A' ' 139' ' ' MET . . . -101.67 -52.45 3.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.547 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 39' ' ' SER . 1.4 mp -109.74 166.0 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.968 . . . . 0.0 110.675 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.472 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -124.51 -46.16 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 109.891 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -165.45 159.06 16.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' A' ' 27' ' ' ASP . 73.1 t -111.41 160.87 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.922 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 10.0 mt-10 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.964 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.0 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.244 0.545 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 53' ' ' ILE . 28.2 mm -79.65 125.94 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 111.125 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -133.06 148.8 52.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.46 -0.775 . . . . 0.0 109.288 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 4.7 tttp -124.58 117.1 23.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.902 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.4 mp -94.92 130.62 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.723 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -117.61 124.25 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.1 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CB ' ' CD1' ' A' ' 62' ' ' LEU . 12.7 m-85 -91.11 166.75 17.72 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.15 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -72.83 178.1 6.82 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.854 1.45 . . . . 0.0 110.177 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.77 173.58 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.497 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.23 52.61 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.593 ' CD1' ' CB ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -76.72 152.68 83.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.213 -1.169 . . . . 0.0 110.366 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.07 -22.58 19.24 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.136 1.598 . . . . 0.0 109.889 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 18.6 m-85 -123.28 -159.81 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.47 -0.769 . . . . 0.0 109.655 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -122.26 -26.85 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 110.423 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 16.0 p90 -176.98 -175.73 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.314 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 66' ' ' TYR . 7.5 m -153.81 122.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.732 ' HB3' HD11 ' A' ' 86' ' ' ILE . 18.9 mtmt -93.82 133.61 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -114.93 144.69 43.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.848 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.52 ' NH2' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -113.52 103.9 11.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 110.03 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 74' ' ' VAL . 4.5 t -83.01 125.9 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 110.19 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 70' ' ' ARG . 1.2 m-20 -97.34 52.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.85 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.5 OUTLIER 63.54 77.68 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.081 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 71' ' ' VAL . 5.1 m -56.71 -177.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.375 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 1.8 t0 -123.06 -168.01 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.837 . . . . 0.0 109.748 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.477 ' CE1' HD11 ' A' ' 24' ' ' LEU . 5.0 m80 -144.83 -53.95 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.2 m -51.95 -57.35 9.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.54 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 8.1 m120 -91.16 17.69 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.542 ' CD2' ' HB1' ' A' ' 15' ' ' ALA . 16.2 m-85 42.47 48.72 4.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 109.997 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.0 tppt? -93.44 123.79 36.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 110.805 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -120.53 112.55 19.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 31.4 t-20 -127.3 108.34 10.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.8 p90 -136.81 165.51 25.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 109.982 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -117.16 141.11 48.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.536 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.2 t -86.39 78.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.734 . . . . 0.0 109.266 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.732 HD11 ' HB3' ' A' ' 68' ' ' LYS . 43.1 pt -59.61 -131.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.503 -0.748 . . . . 0.0 110.751 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.524 ' N ' HG13 ' A' ' 86' ' ' ILE . 28.3 mm-40 -67.64 160.95 26.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 102.8 152.29 23.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.04 -147.0 18.49 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.8 Cg_endo -84.23 29.08 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.984 1.518 . . . . 0.0 110.84 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -41.24 163.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.119 -0.988 . . . . 0.0 109.95 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.4 -170.55 14.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.42 ' CG ' HG23 ' A' ' 94' ' ' THR . 36.7 p-10 -55.12 173.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -1.075 . . . . 0.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 5.4 p 54.23 15.13 0.86 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.719 ' HG ' HG22 ' A' ' 122' ' ' THR . 1.2 mt 167.56 92.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.022 -1.049 . . . . 0.0 110.089 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 2.6 tp10 -91.08 -34.14 15.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 110.332 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 96' ' ' GLU . 13.2 mttp -149.69 153.25 36.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.423 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.552 HD11 HD22 ' A' ' 95' ' ' LEU . 75.5 mt -137.47 150.71 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.85 . . . . 0.0 109.731 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m -134.35 143.91 47.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' TYR . 37.8 t-20 -136.47 133.17 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 0.0 110.244 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.744 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 3.1 pt-20 -151.69 149.72 29.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.128 -0.982 . . . . 0.0 109.794 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.903 HG23 ' N ' ' A' ' 103' ' ' LYS . 8.0 tp 168.46 -138.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.619 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.903 ' N ' HG23 ' A' ' 102' ' ' ILE . 20.5 ptmt -179.82 -171.07 0.17 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.907 -1.121 . . . . 0.0 111.506 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.056 HD11 ' CD1' ' A' ' 23' ' ' ILE . 66.1 mt -120.0 163.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.231 -0.918 . . . . 0.0 109.685 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.53 HG23 ' HD2' ' A' ' 115' ' ' LYS . 3.9 t -132.0 124.4 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.911 -1.118 . . . . 0.0 110.425 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.19 131.9 35.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.6 p -108.92 155.55 40.6 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.668 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 109' ' ' ASP . 47.1 Cg_endo -66.28 82.2 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.251 1.658 . . . . 0.0 110.817 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 1.4 m-20 70.71 25.97 3.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.524 -0.735 . . . . 0.0 110.346 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.73 -2.68 18.96 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.89 -170.74 22.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 14' ' ' PRO . 12.6 m -120.94 130.09 53.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.299 -1.118 . . . . 0.0 109.918 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 10' ' ' THR . 7.3 mt -99.86 121.48 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 109.854 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.842 HD12 HG23 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -86.89 108.48 18.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.651 -0.655 . . . . 0.0 109.672 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.598 ' O ' ' CG1' ' A' ' 102' ' ' ILE . 1.3 ptmt -102.44 133.87 46.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.565 -1.335 . . . . 0.0 108.533 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.847 ' HA ' HG21 ' A' ' 102' ' ' ILE . 6.7 mt -135.8 139.42 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.642 ' HB2' HD13 ' A' ' 102' ' ' ILE . 8.7 t -112.6 107.79 16.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 7.5 m120 -107.04 108.3 19.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.836 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.541 ' HD2' ' CG1' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.99 132.51 46.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.826 179.501 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.684 ' HD2' HD11 ' A' ' 95' ' ' LEU . 3.6 m-85 -101.73 129.37 47.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.4 m-70 -110.41 101.68 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.771 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.719 HG22 ' HG ' ' A' ' 95' ' ' LEU . 16.2 p -101.82 -165.19 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.366 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -160.39 126.08 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 128.63 -129.4 6.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -124.11 -53.7 1.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.146 -1.208 . . . . 0.0 110.129 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 125' ' ' ASP . 90.4 m-70 -44.22 168.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 109.929 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.93 163.31 21.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 0.0 110.596 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.608 HG23 HG21 ' A' ' 122' ' ' THR . 24.4 t -53.41 157.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -102.5 108.29 19.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.04 -47.32 8.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -0.981 . . . . 0.0 109.953 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.79 -46.62 59.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -35.55 80.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.863 . . . . 0.0 109.648 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.602 HG11 ' CD2' ' A' ' 5' ' ' TYR . 21.8 t -76.99 -12.22 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.459 -0.775 . . . . 0.0 109.775 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -46.74 7.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.447 -0.783 . . . . 0.0 110.808 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -54.38 -49.47 69.79 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.066 -1.021 . . . . 0.0 109.572 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -57.99 -43.94 86.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.925 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -66.1 -23.66 66.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.166 -0.959 . . . . 0.0 109.361 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 3.1 tt0 -73.07 -43.71 61.51 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.697 ' SD ' ' HB1' ' A' ' 37' ' ' ALA . 5.3 mmm -64.27 -35.94 82.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.41 -44.2 97.97 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.27 -45.97 75.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.053 -1.263 . . . . 0.0 110.262 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -37.65 68.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 108.897 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.7 mm? -68.17 -52.98 28.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.434 -0.791 . . . . 0.0 109.578 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 9' ' ' THR . 9.4 tp -47.6 -36.8 11.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.877 -1.14 . . . . 0.0 108.519 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 15.2 mtt180 -71.76 -38.77 70.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 0.0 109.367 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.946 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -58.51 -57.93 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.521 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.692 HG21 ' HD1' ' A' ' 22' ' ' PHE . 17.7 t -66.92 -27.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.473 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.558 ' O ' HD22 ' A' ' 152' ' ' LEU . 16.3 tp10 -59.43 -54.98 40.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 109.976 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.5 p -75.71 -27.24 58.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.045 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.789 ' CG ' HD11 ' A' ' 29' ' ' LEU . 7.1 t80 -53.8 -45.92 70.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.553 HD12 HG13 ' A' ' 13' ' ' ILE . 79.7 mt -61.1 -29.93 70.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.763 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.558 HD22 ' O ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -89.0 -18.78 26.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 110.703 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.58 -52.75 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 155' ' ' SER . 3.4 m80 -63.97 -111.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 156' ' ' ASP . 92.0 p -178.11 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.851 -1.155 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 155' ' ' SER . 0.0 OUTLIER 71.94 20.65 4.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 111.457 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -52.45 137.28 30.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.619 -1.301 . . . . 0.0 109.462 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.837 ' OH ' HD23 ' A' ' 29' ' ' LEU . 72.2 m-85 58.72 81.8 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.222 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.501 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 10.9 p -117.71 167.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.631 ' CD1' HG23 ' A' ' 128' ' ' VAL . 29.0 m-85 -132.44 108.64 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.414 -0.803 . . . . 0.0 110.098 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -62.84 142.69 58.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.522 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.891 ' CD1' HG11 ' A' ' 133' ' ' VAL . 23.9 m-85 -150.05 69.05 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.0 109.657 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 72.3 mt-10 -94.72 141.89 28.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.594 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.416 ' C ' ' OE1' ' A' ' 8' ' ' GLU . 15.1 t -159.9 -178.22 6.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.45 -0.781 . . . . 0.0 109.59 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 7' ' ' THR . 1.8 pm0 -155.42 154.75 32.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.057 -1.027 . . . . 0.0 110.425 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.906 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.34 158.58 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.664 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.49 HG22 HG12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -120.41 139.69 52.45 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.05 -1.032 . . . . 0.0 110.48 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.588 ' OG ' HD11 ' A' ' 18' ' ' LEU . 30.1 t -135.05 141.22 46.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.549 -0.719 . . . . 0.0 109.872 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.12 -15.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.635 HG23 ' HD2' ' A' ' 14' ' ' PRO . 15.0 mm -75.72 147.14 80.97 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 110.018 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.0 Cg_endo -56.38 155.23 26.05 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.902 1.475 . . . . 0.0 110.683 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -63.47 -69.29 0.28 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 111.311 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -39.26 -46.43 1.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.29 -0.881 . . . . 0.0 111.538 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.561 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 41.7 mtt180 -64.95 -50.5 66.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.115 . . . . 0.0 110.052 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 9.8 mt -56.1 -25.89 47.6 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.939 0.876 . . . . 0.0 109.547 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.769 ' CE2' HD21 ' A' ' 24' ' ' LEU . 21.4 t80 -79.46 -48.62 13.62 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.2 -0.937 . . . . 0.0 110.902 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -67.46 -27.47 67.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.501 -0.749 . . . . 0.0 112.117 -178.422 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.872 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.11 -29.84 8.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.553 -1.342 . . . . 0.0 112.165 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 88.2 t80 -109.14 5.0 23.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.785 -1.197 . . . . 0.0 111.582 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.648 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 41.2 mt -141.77 -19.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.942 -1.099 . . . . 0.0 111.23 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.802 HD22 HG21 ' A' ' 74' ' ' VAL . 1.8 mt -110.68 -37.09 5.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.966 -1.084 . . . . 0.0 109.904 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.6 42.43 2.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -40.4 71.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.865 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.2 p30 -70.45 -0.8 9.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -1.127 . . . . 0.0 110.929 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 13.9 t30 -138.93 47.98 1.91 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.017 HD11 HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER 177.37 -30.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.511 -0.743 . . . . 0.0 109.077 -178.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.716 ' N ' HD13 ' A' ' 29' ' ' LEU . 5.9 m-30 -56.24 -59.14 12.78 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.581 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -67.58 -11.28 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.741 1.39 . . . . 0.0 110.635 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -16.33 38.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.605 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.747 HG23 ' HB1' ' A' ' 146' ' ' ALA . 25.7 m -127.19 -3.09 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.328 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -148.77 65.19 8.18 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.055 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.85 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.054 1.555 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -90.13 -14.47 33.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.559 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.29 -29.79 6.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.018 -1.051 . . . . 0.0 110.576 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.505 HG12 HD21 ' A' ' 143' ' ' LEU . 6.5 mm -120.82 161.11 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.49 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.3 OUTLIER -127.6 -49.29 1.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 109.254 179.057 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 39' ' ' SER . 12.5 t 174.19 138.54 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.566 -0.709 . . . . 0.0 110.276 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.865 HG11 ' HB2' ' A' ' 27' ' ' ASP . 8.6 p -109.13 162.54 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 108.979 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 9.8 tt0 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 120.795 -1.191 . . . . 0.0 111.377 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.295 0.569 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.649 HD13 ' CG ' ' A' ' 70' ' ' ARG . 18.3 mm -82.73 148.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 14.0 mtmt -148.17 141.26 24.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 110.421 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -114.23 132.22 56.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 110.251 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 56' ' ' ILE . 1.8 mp -107.22 112.33 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.351 -0.843 . . . . 0.0 110.097 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 39' ' ' SER . 9.2 t -103.57 136.42 43.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.952 -1.093 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.693 ' CD2' HD12 ' A' ' 62' ' ' LEU . 17.9 m-85 -103.26 166.02 12.54 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.86 . . . . 0.0 109.763 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -73.14 175.14 10.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.873 1.459 . . . . 0.0 110.413 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.18 178.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 110.374 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.72 -38.29 3.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.693 HD12 ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -62.09 133.13 94.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.139 -1.213 . . . . 0.0 110.29 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.3 -13.76 16.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.175 1.618 . . . . 0.0 110.346 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -101.01 -163.88 1.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -117.88 -39.12 3.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.121 -0.987 . . . . 0.0 110.686 -179.543 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 21.2 p90 -177.31 -171.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.705 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 67' ' ' VAL . 12.2 t -147.08 99.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.485 -0.76 . . . . 0.0 111.043 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -89.99 139.77 30.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.016 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -157.42 162.05 38.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.649 ' CG ' HD13 ' A' ' 53' ' ' ILE . 4.3 mtm105 -112.47 155.97 23.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.204 -0.935 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.35 161.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 5.4 m-20 -124.1 54.03 1.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.6 mt-10 65.88 115.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.802 HG21 HD22 ' A' ' 24' ' ' LEU . 4.4 p -90.68 145.6 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -92.47 -151.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.083 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.495 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -168.1 -62.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 m -50.63 -56.11 13.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.825 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 79' ' ' PHE . 2.1 m-80 -95.84 18.37 13.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 0.0 110.672 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 6.2 m-85 42.47 72.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 0.0 109.924 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.1 tttp -123.92 115.41 21.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.023 -1.048 . . . . 0.0 110.707 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.543 ' HD1' HG23 ' A' ' 74' ' ' VAL . 9.9 t80 -113.4 173.21 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 54.5 t-20 -176.35 123.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 36.7 p90 -135.28 157.58 46.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.2 135.37 55.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 73.3 t -108.01 110.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.253 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.81 -14.06 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 68' ' ' LYS . 5.4 mt-10 -139.68 140.92 36.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.179 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.461 ' C ' HG12 ' A' ' 91' ' ' ILE . . . 103.2 177.23 26.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.18 -135.01 20.64 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.533 ' HG3' ' NE2' ' A' ' 132' ' ' GLN . 51.6 Cg_endo -86.48 29.84 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 111.46 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.474 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -37.66 157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.28 -132.38 4.63 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -114.66 55.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 0.0 110.625 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.824 HG22 ' HB2' ' A' ' 126' ' ' HIS . 0.8 OUTLIER -150.57 -70.26 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.677 HD11 ' CD2' ' A' ' 120' ' ' TYR . 2.6 mt -98.7 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 109.873 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -93.19 -39.8 10.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 110.517 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.533 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.9 tttm -134.47 164.56 27.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 0.0 110.868 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 97' ' ' LYS . 13.0 mt -158.82 132.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -116.28 116.34 27.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.898 -1.127 . . . . 0.0 110.523 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 11.1 t-20 -116.35 126.67 53.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 14.5 tm-20 -116.38 149.24 39.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.461 -0.775 . . . . 0.0 109.673 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.55 HG22 ' CD1' ' A' ' 104' ' ' ILE . 72.5 mt -136.29 134.16 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.469 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -131.62 99.85 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.445 -0.785 . . . . 0.0 109.829 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.58 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -77.29 113.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.269 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.428 HG21 ' HE2' ' A' ' 115' ' ' LYS . 95.6 t -102.28 122.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.288 -0.882 . . . . 0.0 109.725 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.61 134.49 37.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.601 -0.687 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 110' ' ' GLY . 71.2 p -104.85 156.1 36.52 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.845 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.36 -2.87 8.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -173.07 -25.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 111.269 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.431 ' C ' ' OG1' ' A' ' 107' ' ' THR . . . -83.55 45.54 3.48 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 52.21 -114.91 3.64 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 3.1 m -150.57 158.52 44.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.409 -1.054 . . . . 0.0 109.557 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 10' ' ' THR . 20.7 mt -126.02 122.32 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.873 -1.142 . . . . 0.0 110.832 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.906 ' HB2' HG22 ' A' ' 9' ' ' THR . 7.1 mp -84.63 105.11 15.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.708 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HE2' HG21 ' A' ' 105' ' ' VAL . 1.1 mptp? -84.32 100.65 11.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.778 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.8 mt -92.76 155.03 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.868 . . . . 0.0 110.864 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 36.3 t -151.34 91.21 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.488 -0.758 . . . . 0.0 109.297 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 99' ' ' SER . 36.3 t-20 -101.82 145.83 28.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 111.444 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.456 ' CG ' HG21 ' A' ' 2' ' ' VAL . 2.1 ttmt -131.96 118.94 20.42 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.7 m-85 -86.14 107.92 18.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.934 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -92.22 96.8 10.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.426 HG21 HG23 ' A' ' 128' ' ' VAL . 20.8 p -92.12 -136.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 110.083 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -40.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 160.68 -149.35 18.47 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 126' ' ' HIS . 5.2 t0 47.09 -92.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -1.082 . . . . 0.0 110.135 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.824 ' HB2' HG22 ' A' ' 94' ' ' THR . 1.8 m-70 -87.52 172.0 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -124.21 179.54 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG23 ' CD1' ' A' ' 3' ' ' PHE . 99.3 t -78.13 153.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.123 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -106.95 110.22 22.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.316 -0.865 . . . . 0.0 109.816 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.29 -40.62 3.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.0 tt0 -55.27 -49.1 72.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.533 ' NE2' ' HG3' ' A' ' 90' ' ' PRO . 1.1 tt0 -60.32 -39.7 87.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 108.954 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.891 HG11 ' CD1' ' A' ' 5' ' ' TYR . 64.4 t -64.91 -22.82 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.754 0.787 . . . . 0.0 109.162 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -83.64 -67.63 0.78 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.628 -0.67 . . . . 0.0 110.693 -179.239 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -33.5 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.501 -0.749 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -67.1 -55.18 15.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 108.724 178.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 134' ' ' LYS . 8.9 mptt -53.42 -55.42 25.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.815 . . . . 0.0 109.073 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -46.69 -47.07 20.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.585 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.643 ' SD ' HD23 ' A' ' 143' ' ' LEU . 2.6 tpp -56.19 -44.1 79.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.116 -0.99 . . . . 0.0 108.799 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.54 92.83 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.83 -31.41 66.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.066 -1.255 . . . . 0.0 110.804 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.511 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.1 OUTLIER -68.6 -43.9 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.954 -1.091 . . . . 0.0 109.056 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.643 HD23 ' SD ' ' A' ' 139' ' ' MET . 1.5 mm? -70.5 -33.36 71.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.246 -0.909 . . . . 0.0 109.189 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.581 HD12 HG21 ' A' ' 9' ' ' THR . 0.8 OUTLIER -61.62 -41.53 97.6 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.104 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.74 -47.05 76.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.606 -0.684 . . . . 0.0 110.063 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.747 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.68 -59.6 4.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 1.017 HG22 HD11 ' A' ' 29' ' ' LEU . 40.7 t -65.63 -19.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.492 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.53 ' HG3' HG12 ' A' ' 13' ' ' ILE . 22.1 tt0 -71.99 -46.21 58.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.1 -1.0 . . . . 0.0 110.072 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.73 -12.3 37.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 110.291 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.649 ' CG ' HG11 ' A' ' 33' ' ' VAL . 8.5 t80 -69.58 -36.4 76.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.075 -1.016 . . . . 0.0 109.637 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 38.7 mt -72.6 -19.94 61.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.173 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 152' ' ' LEU . 10.2 mp -87.46 -33.26 19.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.42 -48.66 13.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.858 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 155' ' ' SER . 69.5 m80 -76.71 -22.5 53.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.825 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 154' ' ' HIS . 17.0 p 41.93 51.1 4.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.333 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -168.83 -37.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.604 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB2' ' OH ' ' A' ' 150' ' ' TYR . . . -64.15 130.86 45.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.383 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.872 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 58.4 m-85 55.75 62.85 2.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.261 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 120' ' ' TYR . 12.1 p -132.77 157.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -1.143 . . . . 0.0 110.564 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.571 ' CD1' HG23 ' A' ' 128' ' ' VAL . 68.1 m-85 -130.82 156.7 44.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -120.16 91.44 3.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.162 -0.961 . . . . 0.0 110.234 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.072 ' CD2' HG11 ' A' ' 133' ' ' VAL . 31.3 m-85 -87.52 146.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.059 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.86 149.73 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.398 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.451 ' C ' ' CG ' ' A' ' 8' ' ' GLU . 8.6 t -169.13 167.63 10.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 109.903 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' CG ' ' C ' ' A' ' 7' ' ' THR . 32.0 mt-10 -148.8 146.97 28.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.85 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.9 178.24 5.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 109.853 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.46 149.49 51.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.678 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.694 ' HB3' HD11 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -143.73 142.54 30.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.341 -0.849 . . . . 0.0 109.905 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -6.17 7.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.573 -0.705 . . . . 0.0 110.4 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.587 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 15.6 mm -89.5 143.17 30.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.104 -0.998 . . . . 0.0 109.952 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.507 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 33.0 Cg_endo -56.94 154.75 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.739 1.389 . . . . 0.0 110.06 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -62.02 -39.73 93.29 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.099 -1.001 . . . . 0.0 110.812 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 -60.86 3.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.615 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -55.91 -47.44 77.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 11' ' ' SER . 9.4 mt -53.32 -37.89 62.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.964 -1.085 . . . . 0.0 109.075 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.816 ' HE1' HD21 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -70.17 -69.91 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.027 -1.046 . . . . 0.0 110.227 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.617 ' HA ' HD12 ' A' ' 24' ' ' LEU . 4.7 mtpt -52.37 -19.37 2.09 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.669 -1.269 . . . . 0.0 113.279 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.813 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -114.06 -56.36 2.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.49 -1.381 . . . . 0.0 112.176 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.704 ' HD1' HG21 ' A' ' 147' ' ' VAL . 19.2 t80 -73.64 -85.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.489 -1.382 . . . . 0.0 110.82 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.703 HG23 ' CD2' ' A' ' 81' ' ' TYR . 21.9 mm -37.42 -48.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.512 -0.742 . . . . 0.0 110.221 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.816 HD21 ' HE1' ' A' ' 19' ' ' PHE . 4.5 mt -100.53 -170.64 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 32.88 34.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.726 -0.609 . . . . 0.0 111.588 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA3' ' CE1' ' A' ' 30' ' ' PHE . . . -92.26 -12.95 58.08 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' HB2' HG11 ' A' ' 41' ' ' VAL . 52.2 p30 -67.33 -7.39 24.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.459 -1.024 . . . . 0.0 111.07 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -130.23 16.59 5.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.091 -1.005 . . . . 0.0 108.532 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.901 ' O ' HG22 ' A' ' 33' ' ' VAL . 5.9 tp -131.54 -50.33 0.99 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.452 -0.78 . . . . 0.0 110.746 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.887 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 4.0 m-30 -42.71 -53.74 9.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.419 -0.801 . . . . 0.0 110.315 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -67.04 -38.01 17.41 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.408 1.215 . . . . 0.0 110.957 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 2.4 mtmt -75.23 -73.3 0.26 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.977 -1.077 . . . . 0.0 110.907 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.0 m -62.94 -21.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.729 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -126.16 69.48 67.12 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.049 -1.032 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 43.7 Cg_endo -69.45 -21.92 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.891 1.469 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.496 ' O ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.92 -3.2 57.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.308 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.651 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -114.12 -51.18 2.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 111.124 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.627 HD12 ' CB ' ' A' ' 37' ' ' ALA . 3.9 mp -138.95 172.46 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.871 -1.143 . . . . 0.0 110.761 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.593 ' N ' HG22 ' A' ' 38' ' ' ILE . 29.6 t -133.37 -31.05 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.582 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -158.89 166.7 31.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 27' ' ' ASP . 2.2 p -133.32 140.1 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.021 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 110.655 -179.463 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.216 0.531 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 53' ' ' ILE . 10.1 mm -97.15 129.72 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 1.7 ptmt -127.59 149.05 50.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.34 -0.85 . . . . 0.0 110.082 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' CB ' ' HG2' ' A' ' 68' ' ' LYS . 4.0 mttp -140.4 100.95 4.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.676 -0.64 . . . . 0.0 109.311 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.667 HD12 ' N ' ' A' ' 56' ' ' ILE . 2.0 mp -82.74 156.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.82 -1.175 . . . . 0.0 110.206 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 85.1 p -115.55 145.22 42.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.965 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.79 ' HE1' HG22 ' A' ' 67' ' ' VAL . 4.8 m-85 -118.99 72.94 12.06 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.233 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.551 ' CG ' ' HB3' ' A' ' 39' ' ' SER . 45.5 Cg_endo -75.51 68.7 6.11 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.627 1.856 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.0 -163.37 1.76 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.278 -0.889 . . . . 0.0 110.288 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.75 69.62 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.496 HD11 ' O ' ' A' ' 36' ' ' GLN . 27.4 mt -65.37 158.74 71.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.12 -1.223 . . . . 0.0 110.353 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.78 -35.13 4.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.961 1.506 . . . . 0.0 109.959 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 9.4 m-30 -79.94 150.54 30.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.848 . . . . 0.0 110.044 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -113.94 -6.22 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.843 179.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.6 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 20.7 p90 179.23 176.26 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.541 -0.724 . . . . 0.0 109.394 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.79 HG22 ' HE1' ' A' ' 58' ' ' PHE . 35.6 m -159.11 109.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 109.283 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HE2' ' CE1' ' A' ' 66' ' ' TYR . 7.6 mttm -96.2 139.48 32.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 109.503 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.904 ' OD1' HG22 ' A' ' 85' ' ' VAL . 14.3 m-20 -156.78 132.62 9.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 0.0 111.233 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 47.6 mtt180 -73.21 156.46 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.072 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 3.4 p -94.27 -17.7 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.938 -1.101 . . . . 0.0 111.039 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 61.1 -87.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 72' ' ' ASP . 0.1 OUTLIER 179.24 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.085 -1.009 . . . . 0.0 110.351 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.854 HG22 ' CD1' ' A' ' 81' ' ' TYR . 49.7 t -66.87 161.02 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.386 -0.821 . . . . 0.0 110.223 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.618 ' O ' ' HB2' ' A' ' 76' ' ' HIS . 6.3 t70 -103.16 -57.55 2.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER 75.58 -58.9 0.54 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.265 -0.272 . . . . 0.0 111.092 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 m -52.08 -55.08 23.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 110.011 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -95.02 16.04 17.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.37 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.418 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.7 m-85 52.66 52.59 13.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.182 -0.948 . . . . 0.0 109.867 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 102' ' ' ILE . 17.7 ttpt -124.44 127.24 47.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.854 ' CD1' HG22 ' A' ' 74' ' ' VAL . 70.6 t80 -128.58 125.79 38.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -130.51 145.2 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.702 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.761 ' HE2' HD11 ' A' ' 102' ' ' ILE . 18.1 p90 -136.11 158.33 44.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -104.31 138.14 41.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.904 HG22 ' OD1' ' A' ' 69' ' ' ASP . 24.9 t -107.42 69.47 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.817 . . . . 0.0 109.823 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.574 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -66.6 -11.19 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER 172.47 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.751 ' O ' HD11 ' A' ' 91' ' ' ILE . . . -106.31 -146.22 13.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . -91.57 -38.28 5.91 Favored Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.334 -1.098 . . . . 0.0 111.382 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -76.46 -9.91 18.81 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.128 1.067 . . . . 0.0 111.981 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.751 HD11 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -41.61 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.997 -1.064 . . . . 0.0 110.706 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.53 -168.07 41.15 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.6 m-20 -66.03 -175.18 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -1.182 . . . . 0.0 110.333 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 122' ' ' THR . 18.6 p 48.83 21.18 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 110.985 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -161.25 133.4 5.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.028 . . . . 0.0 110.143 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.67 -60.4 1.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.482 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' C ' HG13 ' A' ' 98' ' ' ILE . 17.1 ttmt -127.23 160.05 32.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.056 -1.027 . . . . 0.0 110.43 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.909 HD11 HD22 ' A' ' 95' ' ' LEU . 24.0 mt -152.39 142.79 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.5 t -119.1 143.04 47.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 83' ' ' TYR . 1.6 t-20 -126.02 125.76 43.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 111.124 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.34 135.81 53.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.454 -0.778 . . . . 0.0 109.404 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.761 HD11 ' HE2' ' A' ' 83' ' ' TYR . 22.7 mt -130.54 157.87 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.825 -1.172 . . . . 0.0 110.916 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 13.4 ttmt -151.12 110.83 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.608 HD11 HG13 ' A' ' 23' ' ' ILE . 4.7 mt -84.4 128.94 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.097 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 112' ' ' SER . 6.6 t -119.83 151.58 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.732 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.99 135.3 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 109.754 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 109' ' ' ASP . 11.6 p -138.36 142.61 35.6 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.002 . . . . 0.0 110.768 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.38 -3.59 12.72 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.279 1.673 . . . . 0.0 110.533 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.445 ' CG ' ' HG1' ' A' ' 107' ' ' THR . 10.6 p30 -80.11 2.81 22.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.287 -0.883 . . . . 0.0 111.004 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.85 -82.28 0.15 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.41 -134.47 3.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.685 ' OG ' HD12 ' A' ' 18' ' ' LEU . 60.4 p -113.42 175.63 5.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 9' ' ' THR . 9.8 mt -130.61 132.97 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.85 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.1 tp -91.59 100.44 13.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.568 -0.708 . . . . 0.0 110.419 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 102' ' ' ILE . 45.8 mttt -79.71 130.01 34.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.434 HG13 ' C ' ' A' ' 115' ' ' LYS . 3.8 mt -132.84 140.88 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 111.305 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.62 117.59 16.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 2.0 m-80 -107.93 106.41 16.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 111.423 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.56 ' HD2' ' CG2' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -88.85 122.35 32.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.855 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.9 m-85 -102.97 144.06 31.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.0 111.004 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -131.84 89.08 2.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.644 -0.66 . . . . 0.0 109.708 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.562 HG22 ' HG ' ' A' ' 95' ' ' LEU . 7.3 p -95.81 -159.96 0.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -83.28 -66.75 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.123 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.69 -32.37 0.62 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -69.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -1.154 . . . . 0.0 110.13 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -99.51 -170.72 1.94 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 0.0 110.114 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 mm-40 -115.81 171.15 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.538 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.571 HG23 ' CD1' ' A' ' 3' ' ' PHE . 3.4 t -67.15 156.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 4.2 mppt? -90.86 102.5 15.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.842 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -44.32 -51.17 8.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.44 -44.77 62.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.166 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 1.7 tt0 -56.52 -41.98 77.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 108.753 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.072 HG11 ' CD2' ' A' ' 5' ' ' TYR . 78.6 t -63.26 -30.09 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.825 0.821 . . . . 0.0 108.944 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 4.1 tttt -68.69 -51.53 40.78 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.772 -0.58 . . . . 0.0 110.267 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.55 -56.55 3.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.04 -43.74 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.433 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 4.5 mtpp -60.5 -38.1 83.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.805 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -65.54 -54.63 25.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 110.074 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -35.61 65.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.06 -1.025 . . . . 0.0 109.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.86 -38.95 93.31 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 1.0 OUTLIER -74.22 -35.6 63.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.314 . . . . 0.0 110.934 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.3 p -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.18 -0.95 . . . . 0.0 109.785 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.651 HD21 ' CB ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -73.32 -51.05 18.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.519 HD11 ' OG ' ' A' ' 11' ' ' SER . 15.5 tp -50.7 -44.16 57.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -62.91 -44.48 95.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 109.511 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.559 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -51.27 -58.98 4.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.704 HG21 ' HD1' ' A' ' 22' ' ' PHE . 21.9 t -66.36 -21.81 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.78 -51.05 64.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.07 -1.018 . . . . 0.0 109.736 179.552 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 3.1 t -75.33 -31.03 60.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.891 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.542 ' CE1' HD11 ' A' ' 29' ' ' LEU . 14.7 t80 -55.96 -50.85 69.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.3 mt -56.13 -29.94 61.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 109.96 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 148' ' ' GLU . 8.6 mp -72.01 -55.67 7.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 110.241 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.448 ' HB3' ' ND1' ' A' ' 154' ' ' HIS . . . -55.32 -41.23 72.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.466 -0.772 . . . . 0.0 110.544 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.448 ' ND1' ' HB3' ' A' ' 153' ' ' ALA . 2.8 m80 -105.55 122.52 46.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.82 30.57 2.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.855 . . . . 0.0 109.911 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -132.13 -26.9 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.809 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.488 ' HB2' ' OH ' ' A' ' 150' ' ' TYR . . . -69.99 128.49 36.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.964 -1.085 . . . . 0.0 110.589 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.813 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 40.3 m-85 56.68 81.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.264 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 121' ' ' HIS . 56.1 t -44.74 156.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -1.213 . . . . 0.0 110.162 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.771 ' CD1' HG23 ' A' ' 128' ' ' VAL . 97.4 m-85 -120.48 164.62 16.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 110.274 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 4' ' ' ASN . 3.4 t-20 -127.51 105.76 8.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.913 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.041 ' CD1' HG11 ' A' ' 133' ' ' VAL . 25.6 m-85 -99.01 92.75 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.983 . . . . 0.0 110.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 2.2 mp0 -53.8 141.15 27.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.85 . . . . 0.0 109.969 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.737 ' CG2' HG23 ' A' ' 102' ' ' ILE . 4.8 t -125.47 162.94 23.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.804 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.0 tm-20 178.49 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.307 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.932 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -120.64 162.6 19.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 0.0 109.835 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.92 145.89 48.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.753 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.447 ' OG ' HD11 ' A' ' 18' ' ' LEU . 35.4 t -142.19 149.17 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.885 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.86 -25.96 29.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.793 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.631 HD12 ' NH2' ' A' ' 17' ' ' ARG . 5.2 mm -72.5 142.01 83.53 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 34.5 Cg_endo -57.97 151.79 55.28 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.76 1.4 . . . . 0.0 110.521 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.586 ' HA ' HG22 ' A' ' 104' ' ' ILE . . . -58.13 -45.63 87.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.88 . . . . 0.0 110.99 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.473 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -58.43 -59.78 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 110.535 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.632 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -51.0 -59.57 4.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.496 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.55 ' HG ' HG21 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -46.28 -35.57 5.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.364 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CE1' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -65.67 -64.26 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 20.9 mtmt -54.39 -21.66 10.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.458 -0.776 . . . . 0.0 112.305 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.69 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -112.65 -59.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.638 ' CA ' HG11 ' A' ' 147' ' ' VAL . 64.6 t80 -69.22 -44.0 72.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.717 -1.239 . . . . 0.0 111.859 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.594 HG21 ' CE1' ' A' ' 19' ' ' PHE . 46.9 mm -82.8 -82.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 111.296 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.656 ' N ' HD23 ' A' ' 24' ' ' LEU . 3.7 mt -40.56 -68.4 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -55.33 -67.6 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.427 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.617 ' HA2' ' CE1' ' A' ' 30' ' ' PHE . . . 49.18 -86.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.709 ' HB2' HG21 ' A' ' 41' ' ' VAL . 4.6 p30 -73.99 27.12 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.586 -0.95 . . . . 0.0 112.349 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 11.5 t30 -139.72 38.16 2.01 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 150' ' ' TYR . 0.8 OUTLIER 174.25 -30.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.609 -177.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CE1' ' HA2' ' A' ' 26' ' ' GLY . 2.6 m-30 -38.92 -62.52 0.74 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.385 -0.822 . . . . 0.0 111.304 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.7 Cg_endo -65.89 -27.44 51.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.762 1.401 . . . . 0.0 110.288 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -72.75 -16.56 61.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.83 . . . . 0.0 110.484 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.653 HG23 ' HB1' ' A' ' 146' ' ' ALA . 19.1 m -124.25 -4.12 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.338 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.69 65.37 12.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 -10.16 27.71 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 123.835 1.439 . . . . 0.0 109.657 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -86.08 -20.42 28.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 109.127 179.057 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.442 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -107.79 -61.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.593 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 143' ' ' LEU . 7.7 mm -94.55 166.65 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.617 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -131.46 -40.17 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 p -160.16 155.9 25.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 109.944 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 27' ' ' ASP . 2.7 p -121.33 146.63 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 109.966 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 2.4 mm-40 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.642 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.655 ' O ' HD13 ' A' ' 53' ' ' ILE . 7.6 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.176 0.512 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 52' ' ' THR . 45.8 mm -131.4 154.87 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.95 . . . . 0.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' NZ ' ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -141.97 143.51 33.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.52 -0.737 . . . . 0.0 109.869 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 31.2 tttp -118.99 110.4 17.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.628 -0.67 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.545 ' CD1' HG23 ' A' ' 41' ' ' VAL . 9.8 mm -98.72 109.43 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.82 -1.175 . . . . 0.0 110.611 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 39' ' ' SER . 0.8 OUTLIER -103.07 124.87 49.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 110.405 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' HB2' HD12 ' A' ' 62' ' ' LEU . 32.1 m-85 -84.58 164.66 41.69 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.403 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.3 Cg_endo -74.47 -163.23 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.14 1.6 . . . . 0.0 109.726 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER 38.61 -162.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.569 -0.707 . . . . 0.0 111.133 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -99.58 -34.74 4.89 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 58' ' ' PHE . 11.0 mt 55.71 165.4 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.105 -1.232 . . . . 0.0 109.934 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 45.5 Cg_endo -72.15 -24.96 19.6 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.846 1.446 . . . . 0.0 109.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.511 ' HB3' ' CA ' ' A' ' 89' ' ' GLY . 18.0 m-30 -106.45 -140.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.814 . . . . 0.0 109.818 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 22.7 mttt -144.67 -32.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 111.16 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 176.65 177.44 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 89' ' ' GLY . 35.7 m -142.25 117.98 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -93.57 162.81 13.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.945 . . . . 0.0 109.342 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.495 ' OD1' HG22 ' A' ' 85' ' ' VAL . 67.0 m-20 -144.64 154.48 42.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.844 -1.16 . . . . 0.0 111.627 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HG2' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -122.29 134.68 54.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.675 -0.641 . . . . 0.0 109.386 179.392 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.506 ' HB ' ' NZ ' ' A' ' 54' ' ' LYS . 2.6 p -89.89 136.71 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.003 . . . . 0.0 110.671 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -113.94 55.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 109.401 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.4 mt-10 60.28 117.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 0.0 109.842 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.672 HG13 ' HD1' ' A' ' 81' ' ' TYR . 25.2 t -96.97 125.52 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 15.1 t0 -68.63 -170.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.572 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.07 -48.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 110.152 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 m -57.5 -16.1 8.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 110.089 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.538 ' CB ' ' HD2' ' A' ' 80' ' ' LYS . 97.3 m-20 -130.31 6.74 4.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 3.7 m-85 57.56 55.32 5.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 110.737 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.538 ' HD2' ' CB ' ' A' ' 78' ' ' ASN . 6.8 mttt -117.63 121.72 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.366 -0.834 . . . . 0.0 110.026 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.672 ' HD1' HG13 ' A' ' 74' ' ' VAL . 17.9 t80 -114.18 161.2 18.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.456 ' CB ' ' OE2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -163.83 138.09 5.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.261 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.465 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 10.9 p90 -147.5 172.49 13.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 4.6 p -139.42 135.3 33.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.736 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.495 HG22 ' OD1' ' A' ' 69' ' ' ASP . 66.9 t -101.07 81.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.582 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -66.57 -10.88 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -173.4 157.34 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.782 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.564 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 168.38 -137.57 4.66 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.239 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.666 ' H ' HG12 ' A' ' 67' ' ' VAL . . . -95.28 -38.16 4.88 Favored Glycine 0 N--CA 1.489 2.168 0 O-C-N 121.727 -0.866 . . . . 0.0 111.92 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -77.48 -1.59 11.77 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.0 1.0 . . . . 0.0 111.202 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -46.82 176.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.156 -0.965 . . . . 0.0 110.221 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 94' ' ' THR . . . 157.19 74.12 0.02 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.513 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 94' ' ' THR . 2.8 m-20 40.25 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.442 -1.034 . . . . 0.0 111.188 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.569 HG21 ' HB2' ' A' ' 126' ' ' HIS . 3.2 p -31.41 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.789 -0.569 . . . . 0.0 111.102 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.597 HD11 HG12 ' A' ' 98' ' ' ILE . 15.6 tp -64.49 88.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.081 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.78 -49.64 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.542 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -114.62 142.87 45.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.217 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.597 HG12 HD11 ' A' ' 95' ' ' LEU . 44.2 mt -136.24 114.99 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -0.948 . . . . 0.0 110.604 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 1.4 m -112.18 111.56 22.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 109.424 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.549 ' CB ' ' HA ' ' A' ' 118' ' ' ASN . 25.4 m-20 -121.27 147.3 45.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.308 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.456 ' OE2' ' CB ' ' A' ' 82' ' ' ASN . 12.3 mt-10 -136.02 141.48 44.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.532 -0.73 . . . . 0.0 109.68 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.737 HG23 ' CG2' ' A' ' 7' ' ' THR . 0.2 OUTLIER -136.3 177.93 5.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 113' ' ' ILE . 75.1 tttt -140.0 137.42 34.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.349 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.586 HG22 ' HA ' ' A' ' 15' ' ' ALA . 6.1 mm -96.82 80.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 112' ' ' SER . 90.7 t -71.39 130.97 35.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 110.702 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.87 141.28 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.544 HG21 HD11 ' A' ' 113' ' ' ILE . 38.0 p -127.42 156.51 74.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.34 -34.74 34.11 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.071 1.564 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.45 37.49 2.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.295 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.505 ' CA ' ' OG1' ' A' ' 107' ' ' THR . . . -148.43 30.48 1.3 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 45.84 -103.94 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.555 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 2.6 p -142.99 170.25 16.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 110.355 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 114' ' ' LEU . 9.7 mt -138.68 129.77 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.932 ' HB2' HG22 ' A' ' 9' ' ' THR . 8.0 mp -97.55 94.45 7.01 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 116' ' ' ILE . 1.0 OUTLIER -124.1 -176.83 3.59 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.779 -1.168 . . . . 0.0 112.721 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.742 HG22 ' N ' ' A' ' 117' ' ' SER . 21.6 mm 120.63 -102.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.236 1.414 . . . . 0.0 109.853 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.742 ' N ' HG22 ' A' ' 116' ' ' ILE . 4.7 m -168.79 177.22 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.725 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 100' ' ' ASN . 4.6 m120 -139.49 96.71 3.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.505 ' HD3' HG11 ' A' ' 2' ' ' VAL . 4.9 mttt -75.66 129.08 36.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 111.271 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.593 ' CE2' HD21 ' A' ' 95' ' ' LEU . 2.6 m-85 -105.75 106.23 16.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.825 ' HA ' HG22 ' A' ' 2' ' ' VAL . 60.3 m-70 -90.9 95.05 9.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.843 . . . . 0.0 110.307 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p -79.34 -170.88 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 -72.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 110.249 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.88 60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -153.24 -114.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -1.153 . . . . 0.0 109.79 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.569 ' HB2' HG21 ' A' ' 94' ' ' THR . 15.0 m170 -71.13 161.22 31.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.975 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.5 mp0 -77.43 -164.36 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.906 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.771 HG23 ' CD1' ' A' ' 3' ' ' PHE . 55.6 t -90.7 141.42 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -81.65 119.48 23.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -0.91 . . . . 0.0 109.887 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.06 83.24 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.132 -0.98 . . . . 0.0 109.958 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.99 -29.24 59.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -1.0 . . . . 0.0 108.839 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 90' ' ' PRO . 37.3 tt0 -77.8 -40.16 41.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.041 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.7 t -69.25 -14.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.082 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.07 -49.27 6.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.655 -0.653 . . . . 0.0 109.979 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -50.71 -45.46 58.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 t -59.14 -47.58 84.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 109.349 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HE2' ' ND2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -63.3 -22.09 66.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.643 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 74.2 tt0 -75.2 -47.6 27.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.361 -0.837 . . . . 0.0 109.416 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.442 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 42.3 mmm -65.86 -30.83 71.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.25 -0.906 . . . . 0.0 108.867 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.43 -35.5 56.06 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.66 -34.92 65.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.884 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 p -72.23 -37.94 69.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.246 -0.908 . . . . 0.0 108.807 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.597 HD21 HG12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -72.05 -31.4 66.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 9' ' ' THR . 11.7 tp -67.57 -41.96 83.32 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -68.74 -33.1 73.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.653 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -63.84 -60.99 2.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.457 -0.777 . . . . 0.0 109.245 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.638 HG11 ' CA ' ' A' ' 22' ' ' PHE . 63.4 t -60.82 -28.62 43.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.451 -0.78 . . . . 0.0 109.697 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -50.0 72.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.945 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.49 -11.99 56.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.583 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 6.5 t80 -69.53 -37.24 77.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.632 HD13 ' HG2' ' A' ' 17' ' ' ARG . 11.6 mt -73.6 -24.58 60.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 13' ' ' ILE . 4.7 mp -81.64 -36.27 29.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.52 -41.66 45.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 155' ' ' SER . 71.9 m80 -86.1 -48.44 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.372 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 7.9 t 62.22 14.34 6.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.259 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -131.95 4.08 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.371 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.491 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -106.69 143.36 34.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.288 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.69 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.8 m-85 50.56 33.51 8.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 120' ' ' TYR . 95.7 t -63.63 152.14 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -1.172 . . . . 0.0 110.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.626 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 23.1 m-85 -113.38 164.47 13.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.494 -0.754 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 119' ' ' LYS . 61.9 t-20 -148.99 98.79 2.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.083 -1.011 . . . . 0.0 111.37 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.908 ' OH ' HG21 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -95.59 134.34 38.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.163 -0.961 . . . . 0.0 108.944 178.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -119.01 117.45 28.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 110.779 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.407 HG21 ' HD3' ' A' ' 137' ' ' LYS . 7.9 t -142.6 -161.19 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 109.845 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -173.63 158.92 3.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.011 -1.056 . . . . 0.0 110.538 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.972 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -122.68 175.44 6.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.156 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.44 145.29 51.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 110.242 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.587 ' CB ' HD11 ' A' ' 18' ' ' LEU . 16.5 t -143.52 142.45 31.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.377 -0.827 . . . . 0.0 110.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.11 -10.28 13.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.639 -0.663 . . . . 0.0 110.256 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.692 HG23 ' HD2' ' A' ' 14' ' ' PRO . 15.6 mm -86.72 149.34 48.2 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.568 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.3 Cg_endo -56.19 156.36 21.05 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 121.555 1.503 . . . . 0.0 110.444 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.722 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -69.5 -51.05 39.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.26 -52.57 51.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.937 -1.102 . . . . 0.0 110.298 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -60.63 -55.18 36.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.587 HD11 ' CB ' ' A' ' 11' ' ' SER . 7.7 mt -47.48 -34.69 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.008 . . . . 0.0 109.318 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.894 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.93 -61.9 1.6 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 110.482 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 mtpt -54.44 -25.21 23.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.376 -0.828 . . . . 0.0 112.581 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.826 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.49 -56.4 2.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.446 -1.409 . . . . 0.0 111.904 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 73.6 t80 -78.92 0.79 25.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 112.267 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 4.5 mt -138.81 -22.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.689 -1.257 . . . . 0.0 111.471 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.894 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.8 mt -100.54 -35.84 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.728 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -117.02 88.76 2.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.75 -0.594 . . . . 0.0 109.613 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -113.56 -35.9 1.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.994 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.9 p30 -73.99 0.36 13.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.421 -1.046 . . . . 0.0 110.821 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 2.5 t30 -139.82 7.76 2.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.977 . . . . 0.0 109.935 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.928 HD22 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -142.15 -14.66 0.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.894 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 8.4 m-30 -71.88 -57.04 4.26 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.739 -1.225 . . . . 0.0 110.435 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.21 -34.67 44.56 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.685 1.36 . . . . 0.0 110.732 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -60.14 -15.21 21.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 0.0 109.98 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 146' ' ' ALA . 6.4 m -130.56 -4.05 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.4 62.63 6.63 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.082 -1.011 . . . . 0.0 110.709 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.72 -24.19 41.33 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.844 1.444 . . . . 0.0 109.632 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -74.38 -13.04 60.67 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.573 -0.705 . . . . 0.0 109.227 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.704 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -109.08 -63.05 1.39 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.166 -0.959 . . . . 0.0 110.396 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.48 154.48 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.905 -1.122 . . . . 0.0 110.14 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.531 ' HB3' ' N ' ' A' ' 59' ' ' PRO . 54.4 p -108.49 -45.12 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.777 . . . . 0.0 110.187 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 p -174.59 -169.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.994 HG11 ' HB2' ' A' ' 27' ' ' ASP . 7.6 p -147.84 162.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.953 . . . . 0.0 110.065 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 41' ' ' VAL . 12.1 mt-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 109.895 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.143 0.497 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.567 HD13 ' HG2' ' A' ' 70' ' ' ARG . 19.3 mm -126.74 124.04 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.61 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.864 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -124.52 144.81 49.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 0.0 110.424 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -111.29 111.26 22.19 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.94 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.864 HD11 ' CD ' ' A' ' 54' ' ' LYS . 5.2 mm -89.5 127.92 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.97 -1.081 . . . . 0.0 109.782 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 m -111.19 145.72 38.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 0.0 109.786 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 1.075 ' HB3' HD13 ' A' ' 62' ' ' LEU . 79.2 m-85 -121.18 155.12 58.65 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 110.775 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.531 ' N ' ' HB3' ' A' ' 39' ' ' SER . 48.9 Cg_endo -78.47 -169.05 0.7 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.155 1.608 . . . . 0.0 109.497 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 168.42 10.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 0.0 110.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.58 -52.7 2.36 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.075 HD13 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.11 142.11 86.03 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.147 . . . . 0.0 109.972 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 48.8 Cg_endo -81.84 27.92 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.082 1.569 . . . . 0.0 111.08 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 63' ' ' PRO . 82.3 m-85 -156.08 141.09 17.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.042 -1.036 . . . . 0.0 110.21 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -75.68 -34.68 60.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.572 ' C ' HG13 ' A' ' 67' ' ' VAL . 23.6 p90 -173.09 -178.12 1.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.572 HG13 ' C ' ' A' ' 66' ' ' TYR . 27.8 m -157.71 125.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.307 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 86' ' ' ILE . 7.6 mttt -85.35 131.52 34.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 108.794 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -130.29 141.54 50.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.867 -1.145 . . . . 0.0 111.664 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.567 ' HG2' HD13 ' A' ' 53' ' ' ILE . 60.6 mtm180 -110.69 132.34 54.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.589 -0.694 . . . . 0.0 109.129 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.088 HG13 HG23 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -73.08 -37.48 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.84 -1.163 . . . . 0.0 110.052 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.6 OUTLIER 78.76 -39.76 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.115 -0.366 . . . . 0.0 111.103 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 5.4 pt-20 173.34 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.71 -1.244 . . . . 0.0 111.077 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.088 HG23 HG13 ' A' ' 71' ' ' VAL . 39.3 t 60.59 139.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.37 -0.831 . . . . 0.0 109.657 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.23 164.38 13.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.073 -1.017 . . . . 0.0 110.87 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -142.03 -45.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' OD1' ' A' ' 78' ' ' ASN . 3.0 m -57.45 -34.42 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 78' ' ' ASN . 1.9 m120 -109.42 12.41 24.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.51 39.16 27.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.977 . . . . 0.0 109.786 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HG2' ' HG2' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -105.19 153.47 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.392 -0.817 . . . . 0.0 110.324 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.632 ' HE1' HG22 ' A' ' 74' ' ' VAL . 15.4 t80 -144.62 111.38 5.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.808 . . . . 0.0 109.612 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.509 ' ND2' ' CG ' ' A' ' 101' ' ' GLU . 60.6 t-20 -121.2 126.85 50.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.48 ' CD1' ' C ' ' A' ' 83' ' ' TYR . 18.8 p90 -139.67 154.67 47.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.66 164.19 11.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.098 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 86' ' ' ILE . 97.8 t -107.94 -14.88 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.514 HG21 ' NE ' ' A' ' 70' ' ' ARG . 25.9 pt 33.02 -120.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.744 -0.597 . . . . 0.0 111.075 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.0 mp0 -84.47 164.25 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 110.227 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.51 149.66 19.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.63 -146.3 17.85 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.0 Cg_endo -81.86 23.59 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.092 1.575 . . . . 0.0 111.238 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.06 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.448 -0.783 . . . . 0.0 111.015 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' ASP . . . 102.53 -51.28 0.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 92' ' ' GLY . 6.4 m-20 -57.59 -155.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -1.149 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 122' ' ' THR . 73.0 p -81.42 2.37 28.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.559 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.942 HD21 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -106.58 107.61 18.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.988 . . . . 0.0 109.932 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' OE1' ' HE3' ' A' ' 123' ' ' LYS . 20.3 tt0 -94.29 -37.02 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.836 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -135.21 165.29 25.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.975 -1.078 . . . . 0.0 110.655 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.905 HD11 HD22 ' A' ' 95' ' ' LEU . 13.7 mt -155.83 122.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -104.61 131.51 51.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.15 135.43 54.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.973 -1.079 . . . . 0.0 111.216 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.509 ' CG ' ' ND2' ' A' ' 82' ' ' ASN . 11.5 mt-10 -120.98 152.21 38.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 58.1 mt -140.05 159.08 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.919 -1.113 . . . . 0.0 110.482 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 1.1 ttmt -149.42 101.5 3.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.722 HG22 ' HB1' ' A' ' 15' ' ' ALA . 4.1 mp -83.28 111.14 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.371 -0.831 . . . . 0.0 110.182 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.894 HG21 ' HE3' ' A' ' 115' ' ' LYS . 15.5 t -110.52 130.78 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.46 144.54 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -119.7 158.02 50.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.029 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.15 -38.39 21.75 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.988 1.52 . . . . 0.0 110.709 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 14.3 t70 -143.88 36.14 1.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 110.327 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.11 14.6 3.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.55 -101.04 0.86 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 69.8 m -161.52 138.48 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 0.0 110.204 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 114' ' ' LEU . 23.1 mt -109.09 130.13 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.972 ' HB2' HG22 ' A' ' 9' ' ' THR . 6.6 mp -95.84 89.52 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.643 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HE3' HG21 ' A' ' 105' ' ' VAL . 2.1 mttm -64.36 118.05 8.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 108.352 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.463 HG22 ' OD1' ' A' ' 118' ' ' ASN . 43.4 mt -119.65 118.32 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 111.791 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.01 106.2 18.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.463 ' OD1' HG22 ' A' ' 116' ' ' ILE . 2.5 m120 -90.12 92.99 9.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 111.171 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -87.74 135.2 33.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.942 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.5 m-85 -111.96 167.13 10.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.915 -1.115 . . . . 0.0 110.834 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 29.8 m80 -139.35 89.53 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.637 HG22 ' HG ' ' A' ' 95' ' ' LEU . 3.0 p -92.8 -170.56 2.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 110.04 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.478 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -111.9 -3.01 14.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 110.091 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 124.67 -141.55 13.3 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' GLY . 3.5 t70 42.69 -139.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.111 . . . . 0.0 110.16 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -48.58 158.86 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.033 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -89.37 -137.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.574 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.908 HG21 ' OH ' ' A' ' 5' ' ' TYR . 90.8 t -105.97 154.23 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.806 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -102.53 117.35 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.863 . . . . 0.0 109.892 179.045 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.16 -42.04 63.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -49.58 -42.33 44.15 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.109 -0.995 . . . . 0.0 108.692 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 21.7 mt-30 -67.52 -44.55 78.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.571 -0.706 . . . . 0.0 109.315 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 5' ' ' TYR . 21.2 t -70.24 -6.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.738 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.9 tttt -98.0 -65.98 0.93 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.286 -0.884 . . . . 0.0 110.821 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -32.52 -45.75 0.12 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -51.45 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.286 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 134' ' ' LYS . 1.7 ttmt -55.86 -32.49 63.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.961 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.2 -52.93 28.71 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.477 -0.765 . . . . 0.0 109.618 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.704 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 39.7 mmm -54.64 -39.0 67.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.29 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.49 98.03 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.76 -39.52 87.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.283 . . . . 0.0 110.522 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -34.3 76.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.079 -1.013 . . . . 0.0 109.031 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.6 mm? -77.78 -24.09 49.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.335 -0.853 . . . . 0.0 109.085 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 18.3 tp -75.58 -33.89 60.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.488 ' HA ' ' HB3' ' A' ' 148' ' ' GLU . 8.6 ttt180 -80.93 -31.25 35.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -69.17 -45.59 69.61 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.805 HG22 HD11 ' A' ' 29' ' ' LEU . 96.7 t -76.19 -30.33 20.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.507 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.88 -37.82 88.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.444 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.462 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -89.13 -22.45 22.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.632 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.603 ' HB2' HG11 ' A' ' 33' ' ' VAL . 6.9 t80 -63.6 -38.32 90.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 109.672 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.58 HD23 ' CD2' ' A' ' 150' ' ' TYR . 50.9 mt -73.72 -19.9 60.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 4.8 mp -92.94 -19.21 21.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.98 -31.25 13.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.145 -0.972 . . . . 0.0 110.335 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -80.87 -165.0 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.868 . . . . 0.0 110.293 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 1.2 p -86.5 -57.21 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.493 ' N ' ' OG ' ' A' ' 155' ' ' SER . 13.6 m-20 -166.02 54.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.181 -0.95 . . . . 0.0 110.665 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.477 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -68.55 136.41 53.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.168 -0.958 . . . . 0.0 109.919 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.826 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 60.5 m-85 58.81 53.95 5.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.467 ' OD1' ' HD3' ' A' ' 17' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.275 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.617 HG12 ' N ' ' A' ' 3' ' ' PHE . 84.0 t -85.52 171.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -1.214 . . . . 0.0 110.567 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.617 ' N ' HG12 ' A' ' 2' ' ' VAL . 97.9 m-85 -141.98 171.57 13.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.492 -0.755 . . . . 0.0 110.136 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -138.87 122.04 16.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.37 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.943 ' CE2' HG21 ' A' ' 133' ' ' VAL . 36.5 m-85 -116.81 97.81 6.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 109.557 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.58 129.56 37.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.714 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.1 -174.0 4.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 3.0 pt-20 -166.43 166.3 16.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.636 ' O ' ' CB ' ' A' ' 10' ' ' THR . 10.8 t -175.1 -126.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.088 -1.008 . . . . 0.0 111.43 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.857 ' HG1' ' N ' ' A' ' 114' ' ' LEU . 4.4 m 94.7 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 123.069 0.548 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 10' ' ' THR . 0.5 OUTLIER 169.43 -167.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.568 -1.333 . . . . 0.0 111.534 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 110' ' ' GLY . 0.9 OUTLIER -72.89 -16.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.85 -0.531 . . . . 0.0 110.009 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 4.3 mm -63.26 145.56 96.85 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.001 -1.062 . . . . 0.0 109.058 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.555 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 31.6 Cg_endo -54.75 148.53 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.848 1.446 . . . . 0.0 111.266 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -62.29 -43.57 98.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.641 -0.662 . . . . 0.0 110.789 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.46 -51.76 68.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 110.814 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.67 -55.51 29.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 109.769 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.82 HD13 HG22 ' A' ' 10' ' ' THR . 0.3 OUTLIER -53.3 -27.04 20.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.709 179.094 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 1.183 ' CE1' HD21 ' A' ' 24' ' ' LEU . 1.1 t80 -73.45 -70.98 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.589 . . . . 0.0 110.478 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 11.1 mtpt -55.1 -22.43 16.45 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.69 -0.631 . . . . 0.0 112.636 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -102.52 -48.13 4.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.0 112.188 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.0 t80 -95.46 9.79 38.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.807 -1.183 . . . . 0.0 112.017 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.749 HG23 ' CD2' ' A' ' 81' ' ' TYR . 7.1 mt -143.39 -27.89 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.711 -1.243 . . . . 0.0 110.838 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.183 HD21 ' CE1' ' A' ' 19' ' ' PHE . 6.6 mt -106.22 -17.36 14.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.795 -1.19 . . . . 0.0 109.292 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 3.0 t0 -132.11 94.97 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.898 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.505 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -120.16 -35.84 0.85 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.78 6.6 10.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.97 -1.312 . . . . 0.0 110.147 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 5.7 t30 -143.15 25.06 1.77 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.933 HD11 HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -159.33 -32.21 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.136 -178.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.661 ' N ' HD13 ' A' ' 29' ' ' LEU . 12.2 m-30 -60.26 -55.36 46.1 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 0.0 110.233 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.6 Cg_endo -65.53 -35.92 36.3 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.539 1.284 . . . . 0.0 110.823 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -62.92 -15.49 55.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 29' ' ' LEU . 17.8 m -128.66 -2.4 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 110.553 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.43 68.95 6.57 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.949 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.05 -13.59 38.58 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.879 1.463 . . . . 0.0 109.248 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -82.76 -19.77 37.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.474 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -99.66 -54.91 2.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.33 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.61 150.71 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.053 -1.029 . . . . 0.0 110.319 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.411 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 t -110.59 -37.26 5.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.994 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -173.07 -179.58 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 56' ' ' ILE . 91.6 t -143.65 165.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.431 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.935 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.284 0.564 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.0 mm -101.86 119.04 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.955 . . . . 0.0 110.117 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -121.86 147.39 46.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 17.0 tttt -115.93 107.29 14.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.753 ' CD1' HG13 ' A' ' 41' ' ' VAL . 4.8 mm -82.58 147.23 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.479 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.09 140.45 52.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.504 -0.747 . . . . 0.0 109.518 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.606 ' HB3' HD12 ' A' ' 62' ' ' LEU . 69.3 m-85 -116.54 142.06 28.98 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 39' ' ' SER . 48.5 Cg_endo -74.6 -171.18 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.014 1.534 . . . . 0.0 110.143 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.8 160.77 13.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 110.451 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -41.01 2.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.606 HD12 ' HB3' ' A' ' 58' ' ' PHE . 3.0 mt -83.14 164.16 47.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.236 . . . . 0.0 110.321 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 46.0 Cg_endo -76.92 -82.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.238 1.651 . . . . 0.0 111.207 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.9 m-30 -56.51 161.12 2.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.018 . . . . 0.0 110.716 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.21 -22.74 18.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 110.445 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.689 ' O ' HG13 ' A' ' 67' ' ' VAL . 16.3 p90 -173.78 -176.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.928 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 66' ' ' TYR . 13.5 m -160.42 161.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.396 -0.815 . . . . 0.0 110.734 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -119.72 117.45 28.27 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD2' ' CD1' ' A' ' 83' ' ' TYR . 15.6 t70 -120.37 153.55 36.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.969 -1.082 . . . . 0.0 111.542 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.69 126.99 51.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.67 -0.643 . . . . 0.0 109.409 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 82' ' ' ASN . 6.1 p -61.01 -22.61 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.919 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 45.13 52.07 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.001 . . . . 0.0 109.564 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.5 mt-10 58.25 154.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 110.172 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' HD1' ' A' ' 81' ' ' TYR . 2.9 p -136.45 120.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -74.19 178.05 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.921 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.414 ' O ' ' HD1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -152.65 -41.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 110.773 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -52.22 -48.72 64.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.638 -1.289 . . . . 0.0 110.44 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -105.46 19.72 20.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.623 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 6.7 m-30 51.86 75.04 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.276 -0.89 . . . . 0.0 110.557 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 17.5 mtmt -131.55 124.77 30.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.803 ' HD1' HG23 ' A' ' 74' ' ' VAL . 2.7 t80 -117.08 113.22 22.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' VAL . 88.1 m-20 -112.0 105.33 13.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 110.719 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' OD2' ' A' ' 69' ' ' ASP . 1.4 p90 -122.46 169.55 10.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -151.46 140.92 21.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.868 -1.145 . . . . 0.0 111.708 -179.416 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.499 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 44.5 t -95.93 145.14 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -150.99 24.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.74 -1.225 . . . . 0.0 111.654 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.58 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -172.89 147.66 1.7 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.612 -1.305 . . . . 0.0 111.066 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' GLU . . . 49.79 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 67' ' ' VAL . . . 78.44 -134.31 14.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.27 -17.15 31.23 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.108 1.583 . . . . 0.0 110.634 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 87' ' ' GLU 0.31 4.7 mt -66.66 114.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.13 89.7 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.1 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.1 t0 62.45 5.84 1.75 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -1.087 . . . . 0.0 111.998 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -135.32 -78.74 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.765 -1.209 . . . . 0.0 109.992 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.595 HD11 ' HD2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -78.56 108.42 11.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.974 . . . . 0.0 109.691 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -90.08 -45.4 9.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' C ' HG13 ' A' ' 98' ' ' ILE . 52.4 mttt -119.84 147.4 44.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.578 HG12 HD22 ' A' ' 95' ' ' LEU . 45.9 mt -152.17 110.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.727 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 1.3 t -93.04 157.05 16.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.307 -0.871 . . . . 0.0 109.228 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.65 108.43 3.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 110.407 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 116' ' ' ILE . 17.9 mt-10 -97.91 156.06 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.7 HG13 HG23 ' A' ' 116' ' ' ILE . 4.5 mt -140.84 146.95 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.287 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 7.4 ttmt -139.04 115.67 10.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.446 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 1.3 mp -92.27 129.2 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 ' HE3' ' A' ' 115' ' ' LYS . 25.5 t -132.57 124.5 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 110.629 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.75 142.03 49.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 111' ' ' GLY . 61.0 p -94.18 153.19 40.7 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.82 -7.1 15.65 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -99.3 -85.85 0.38 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.235 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -169.41 87.36 0.09 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 12' ' ' VAL . . . 153.98 146.91 4.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.547 ' O ' ' HB ' ' A' ' 10' ' ' THR . 77.3 p -104.08 152.53 21.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.389 -1.065 . . . . 0.0 109.186 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.527 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 2.9 mt -122.01 156.25 26.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.857 ' N ' ' HG1' ' A' ' 10' ' ' THR . 0.5 OUTLIER -115.05 137.92 51.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.115 -0.991 . . . . 0.0 109.862 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 42.7 mttm -122.68 106.97 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.7 HG23 HG13 ' A' ' 102' ' ' ILE . 3.2 mp -115.67 139.88 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.112 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.33 112.82 22.08 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.56 102.94 14.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 111.43 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.493 ' HE3' HG11 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -83.7 111.74 19.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.94 . . . . 0.0 109.059 178.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.595 ' HD2' HD11 ' A' ' 95' ' ' LEU . 3.4 m-85 -98.32 104.27 16.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 111.048 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.578 ' HA ' HG22 ' A' ' 2' ' ' VAL . 37.6 m-70 -95.76 96.18 8.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.522 -0.736 . . . . 0.0 109.407 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 19.5 p -78.36 -149.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.496 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.97 53.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.635 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 71.48 -83.55 0.45 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 126' ' ' HIS . 10.9 t70 -39.54 115.89 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -1.018 . . . . 0.0 110.514 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.556 ' HB3' ' CG2' ' A' ' 94' ' ' THR . 0.1 OUTLIER 53.98 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.966 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 61.8 mt-10 -123.86 -144.47 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.582 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 98.9 t -95.08 133.03 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.265 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.5 mtmt -98.57 123.57 42.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.944 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -43.96 -46.37 8.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 110.305 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -52.17 -46.27 65.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 109.463 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.7 77.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 108.826 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.943 HG21 ' CE2' ' A' ' 5' ' ' TYR . 72.6 t -72.59 -19.36 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.794 0.807 . . . . 0.0 109.284 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.6 tttp -84.67 -60.13 2.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.507 -0.746 . . . . 0.0 111.2 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.79 -51.81 1.28 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 110.673 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.2 m -57.0 -47.37 80.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 110.162 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -64.44 -21.73 66.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 8.0 tt0 -77.23 -44.64 29.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.728 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 72.1 mmm -66.36 -37.88 86.3 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.69 -39.75 93.79 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -70.96 -40.55 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.814 -1.404 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -62.7 -40.61 97.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 108.971 179.398 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.474 HD21 ' CB ' ' A' ' 37' ' ' ALA . 1.1 mm? -71.48 -33.39 69.24 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.587 HD21 ' H ' ' A' ' 10' ' ' THR . 45.0 tp -62.28 -40.63 96.9 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.096 -1.002 . . . . 0.0 109.038 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.062 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.454 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -54.83 -55.14 33.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.105 -0.997 . . . . 0.0 109.546 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.933 HG22 HD11 ' A' ' 29' ' ' LEU . 48.5 t -63.36 -37.03 78.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.704 ' OE1' HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -55.99 -46.13 78.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 110.132 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -83.75 -19.25 35.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.59 ' CG ' HG11 ' A' ' 33' ' ' VAL . 9.8 t80 -66.64 -39.71 88.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.539 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.538 HD13 ' HG2' ' A' ' 17' ' ' ARG . 80.8 mt -62.33 -33.11 74.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.027 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 5.2 mp -77.65 -42.53 34.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.569 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.22 80.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.148 -0.97 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -80.26 -25.43 39.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.7 t 44.79 44.01 7.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 110.029 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -166.2 -41.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.525 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -59.05 133.81 56.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.865 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 48.0 m-85 56.43 68.8 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.341 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.166 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 3' ' ' PHE . 43.3 t -69.21 170.88 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -1.144 . . . . 0.0 110.691 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.592 ' HB2' ' HB2' ' A' ' 120' ' ' TYR . 24.1 m-85 -126.07 154.34 43.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -125.63 97.13 5.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.063 -1.023 . . . . 0.0 111.205 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.003 ' CD2' HG11 ' A' ' 133' ' ' VAL . 37.4 m-85 -100.94 81.63 2.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.286 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -84.15 113.94 21.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.81 . . . . 0.0 110.96 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.536 HG23 ' HB ' ' A' ' 116' ' ' ILE . 5.1 t -132.97 -176.37 4.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.4 -0.812 . . . . 0.0 109.624 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -157.01 153.4 27.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.115 -0.99 . . . . 0.0 110.222 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.912 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.79 156.23 44.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 110.12 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.32 152.84 29.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.87 ' OG ' HD11 ' A' ' 18' ' ' LEU . 45.6 t -142.0 135.72 29.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.72 -3.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.708 -0.62 . . . . 0.0 109.977 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.72 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.8 mm -95.77 149.12 35.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.72 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.0 Cg_endo -56.7 162.72 8.11 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.952 1.501 . . . . 0.0 110.437 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -71.53 -66.43 0.63 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 111.025 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -41.65 -53.63 3.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.581 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -59.63 -51.71 68.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.979 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' OG ' ' A' ' 11' ' ' SER . 5.9 mt -51.15 -27.04 7.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 108.693 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 1.043 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -74.1 -68.63 0.5 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.447 0.642 . . . . 0.0 109.991 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.66 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.6 mtmm -47.66 -36.17 10.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.855 -1.153 . . . . 0.0 111.322 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -90.35 -67.99 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.951 -1.093 . . . . 0.0 109.172 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.723 ' HD1' HG21 ' A' ' 147' ' ' VAL . 20.6 t80 -82.94 150.39 26.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 108.989 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 8.3 mt 82.4 -47.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 CA-C-O 121.24 0.543 . . . . 0.0 110.327 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.043 HD21 ' CE1' ' A' ' 19' ' ' PHE . 17.2 mt -97.74 -50.8 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -104.41 89.81 3.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.031 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -122.14 -33.54 0.89 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.73 ' CG ' HG11 ' A' ' 41' ' ' VAL . 52.8 m-20 -71.82 -1.25 13.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.101 -1.235 . . . . 0.0 110.615 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -123.88 13.02 9.15 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.084 -1.01 . . . . 0.0 108.829 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.766 HD21 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -146.61 -51.41 0.22 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 110.971 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.814 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 5.3 m-30 -29.81 -58.71 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -67.82 -38.99 12.26 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.609 1.321 . . . . 0.0 111.414 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 12.7 mmtt -66.97 -66.61 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.102 -0.999 . . . . 0.0 111.219 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.988 HG23 ' HB1' ' A' ' 146' ' ' ALA . 16.5 m -70.69 -19.94 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.254 -0.904 . . . . 0.0 111.02 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.896 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -127.09 65.75 65.4 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.383 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.69 -6.44 17.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.859 1.452 . . . . 0.0 110.128 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.606 ' O ' ' NE2' ' A' ' 36' ' ' GLN . 1.1 tm0? -96.45 0.75 50.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.02 -50.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 110.778 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.024 HG12 HD21 ' A' ' 143' ' ' LEU . 11.3 mm -109.15 163.17 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 110.613 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.492 ' C ' ' HB3' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -138.07 -43.69 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 0.0 110.138 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 39' ' ' SER . 11.3 t -178.28 133.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.343 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.73 HG11 ' CG ' ' A' ' 27' ' ' ASP . 3.6 p -92.73 146.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 30.6 mt-10 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.112 0.482 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.541 HD11 ' HD2' ' A' ' 70' ' ' ARG . 21.4 mm -83.05 130.69 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.913 . . . . 0.0 109.886 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 2.5 ptpp? -132.98 152.86 51.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.466 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.9 ttmt -120.29 88.57 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.643 HD12 HG23 ' A' ' 41' ' ' VAL . 1.7 mp -64.73 123.13 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.145 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -109.44 102.53 11.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.743 ' HB2' HD12 ' A' ' 62' ' ' LEU . 3.0 m-85 -64.08 173.81 1.31 Allowed Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.099 -1.001 . . . . 0.0 109.231 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -75.72 -172.45 1.32 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.706 1.372 . . . . 0.0 109.715 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.527 ' HG2' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -77.24 168.15 20.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' N ' ' HG2' ' A' ' 60' ' ' GLU . . . 104.43 -39.86 2.67 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.743 HD12 ' HB2' ' A' ' 58' ' ' PHE . 13.2 mt -62.13 157.94 49.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.106 -1.232 . . . . 0.0 110.478 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.55 -18.63 19.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.132 1.596 . . . . 0.0 110.473 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.53 -161.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.93 . . . . 0.0 110.425 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 12.0 tptt -121.44 -24.08 5.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 53.6 p90 -179.32 -152.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 109.906 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.911 HG23 ' CA ' ' A' ' 89' ' ' GLY . 9.1 p -172.04 120.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 111.191 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 2.8 mttp -98.01 137.82 36.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.471 -0.768 . . . . 0.0 109.047 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 1.5 m-20 -142.18 148.84 38.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HD2' HD11 ' A' ' 53' ' ' ILE . 25.9 ttt180 -108.5 130.0 55.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.536 -0.727 . . . . 0.0 109.392 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 -24.18 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 16.3 m-20 45.96 43.79 10.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.972 . . . . 0.0 109.942 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 11.4 mt-10 58.27 151.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.464 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.828 HG11 ' CZ ' ' A' ' 81' ' ' TYR . 6.4 m -138.78 148.98 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' CB ' ' HB3' ' A' ' 80' ' ' LYS . 4.2 t0 -69.08 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.054 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.35 -47.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 m -54.24 -35.91 62.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.411 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 1.9 m-80 -115.31 17.15 16.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 110.199 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.57 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 10.1 m-30 55.46 57.48 5.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HB3' ' CB ' ' A' ' 75' ' ' ASP . 30.1 tttm -118.89 98.54 6.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.833 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.828 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -91.16 177.94 6.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.122 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 81' ' ' TYR . 22.5 p-10 -178.82 142.5 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.501 ' CD1' ' C ' ' A' ' 83' ' ' TYR . 12.4 p90 -154.39 172.87 17.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.388 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -136.1 149.99 48.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.817 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.671 ' O ' HD11 ' A' ' 91' ' ' ILE . 4.2 m -110.21 94.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.461 -0.774 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.471 ' C ' ' CD1' ' A' ' 91' ' ' ILE . 1.3 pp -100.65 -2.63 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.778 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.464 ' N ' HD12 ' A' ' 91' ' ' ILE . 1.9 tt0 -155.83 140.31 16.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . 65.63 -176.02 15.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.911 ' CA ' HG23 ' A' ' 67' ' ' VAL . . . 76.51 -141.56 26.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.6 -6.69 18.6 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.092 1.575 . . . . 0.0 111.019 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.671 HD11 ' O ' ' A' ' 85' ' ' VAL 0.292 1.8 mt -63.31 117.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.104 -0.998 . . . . 0.0 110.362 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 137.23 42.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.19 96.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -1.191 . . . . 0.0 110.546 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 40.0 p 42.35 28.3 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 110.63 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 98' ' ' ILE . 6.5 mt -144.24 74.65 1.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 95' ' ' LEU . 10.3 tp10 -42.42 -58.33 2.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 110.56 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.551 ' CG ' ' HB2' ' A' ' 121' ' ' HIS . 28.8 pttt -144.53 162.37 36.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.827 HD11 HD13 ' A' ' 95' ' ' LEU . 39.7 mt -145.81 138.67 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 110.513 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.9 m -117.23 152.36 34.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 109.175 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -144.08 139.89 29.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.723 -1.236 . . . . 0.0 111.37 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.401 ' O ' HG13 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -117.81 154.58 31.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.396 179.19 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 1.3 mp -144.25 136.8 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -135.79 105.6 6.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.778 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.675 ' H ' HD12 ' A' ' 104' ' ' ILE . 4.4 mp -81.12 109.94 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 110.532 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.447 HG23 ' HD2' ' A' ' 115' ' ' LYS . 86.5 t -101.49 131.19 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.17 129.93 34.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.867 . . . . 0.0 110.053 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 17.7 p -86.46 164.41 37.94 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 49.0 Cg_endo -66.76 81.06 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.114 1.586 . . . . 0.0 110.371 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 60.5 t0 58.01 65.01 1.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 110.166 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.11 27.62 0.13 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.21 -165.48 31.53 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -131.45 174.9 9.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.335 -1.097 . . . . 0.0 110.041 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CG2' ' CD ' ' A' ' 8' ' ' GLU . 26.2 mt -136.75 121.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.989 . . . . 0.0 110.686 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.912 ' HB2' HG22 ' A' ' 9' ' ' THR . 7.6 mt -86.17 93.42 9.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.891 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HD2' HG23 ' A' ' 105' ' ' VAL . 4.1 mttm -69.22 117.99 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.302 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 7' ' ' THR . 94.3 mt -109.2 146.62 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.87 -1.144 . . . . 0.0 111.84 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.18 94.58 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -93.52 100.28 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 112.518 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -82.3 131.2 35.23 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.592 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 3.2 m-85 -110.88 112.85 24.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.775 -1.203 . . . . 0.0 110.715 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 63.2 m-70 -92.83 103.24 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.597 HG22 HD23 ' A' ' 95' ' ' LEU . 4.5 p -102.13 153.35 20.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.813 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 26.39 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.012 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.43 -162.74 14.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.33 -38.25 15.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -1.168 . . . . 0.0 110.309 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -74.34 -172.51 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.387 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.531 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 60.1 mp0 -124.0 -169.98 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 110.346 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.488 HG23 ' CD2' ' A' ' 3' ' ' PHE . 55.7 t -69.27 150.28 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 130' ' ' ALA . 3.9 mtmm -105.01 116.01 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.765 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.64 -52.79 4.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.26 -0.9 . . . . 0.0 110.366 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.6 -46.79 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 109.77 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.401 ' OE1' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -62.14 -45.03 95.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 108.996 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.003 HG11 ' CD2' ' A' ' 5' ' ' TYR . 53.0 t -62.42 -16.29 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.269 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.6 ttmt -86.42 -60.59 1.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.489 -0.757 . . . . 0.0 110.683 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -41.32 -50.16 3.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 110.092 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.6 t -56.11 -44.32 78.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 110.012 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -27.12 68.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -77.25 -33.9 55.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.422 -0.799 . . . . 0.0 109.924 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.485 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.32 -39.63 65.11 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.602 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.17 85.73 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.32 -32.44 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.273 . . . . 0.0 109.743 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 1.3 p -70.4 -34.81 72.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.247 -0.908 . . . . 0.0 108.802 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 1.024 HD21 HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -71.17 -53.69 13.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.188 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 114' ' ' LEU . 9.4 tp -51.4 -39.08 56.51 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -65.09 -38.21 90.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.569 -0.707 . . . . 0.0 109.426 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.988 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -61.48 -60.1 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.723 HG21 ' HD1' ' A' ' 22' ' ' PHE . 21.6 t -61.81 -24.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.512 ' O ' HD13 ' A' ' 152' ' ' LEU . 1.5 tt0 -68.14 -48.02 66.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.05 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.9 t -81.26 -17.05 50.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.766 ' CD2' HD21 ' A' ' 29' ' ' LEU . 9.8 t80 -69.7 -43.93 71.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.713 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.643 HD23 ' HB3' ' A' ' 157' ' ' ALA . 28.1 mt -63.95 -26.05 68.41 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.784 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -80.87 -42.47 21.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.098 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.12 -50.93 66.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.107 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -76.88 -162.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.195 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 6.5 t -92.39 54.19 2.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.537 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER 60.81 53.3 3.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.883 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.643 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -40.91 166.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.716 -0.615 . . . . 0.0 110.761 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.642 ' CD2' ' HB2' ' A' ' 21' ' ' ALA . 85.4 m-85 57.75 48.27 14.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.447 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.206 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.957 HG13 ' O ' ' A' ' 120' ' ' TYR . 92.5 t -101.03 153.27 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.156 -1.202 . . . . 0.0 110.426 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.841 ' CD1' HG23 ' A' ' 128' ' ' VAL . 92.3 m-85 -116.07 151.41 35.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.507 -0.745 . . . . 0.0 109.895 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -117.33 99.47 7.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 110.246 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.059 ' CD1' HG11 ' A' ' 133' ' ' VAL . 45.6 m-85 -97.18 99.93 11.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 117' ' ' SER . 3.3 mt-10 -109.42 136.3 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.97 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 -171.51 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.386 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' OE1' ' CG2' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -165.21 156.31 14.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 110.705 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.961 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -129.12 173.59 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.329 -0.857 . . . . 0.0 110.155 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.05 143.28 51.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.155 -0.966 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' HD11 ' A' ' 18' ' ' LEU . 8.3 t -140.25 147.48 40.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.101 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -21.35 15.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.615 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 36.7 mm -77.16 145.92 73.98 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.035 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.7 Cg_endo -56.72 157.93 18.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.91 1.479 . . . . 0.0 110.313 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB2' ' OG ' ' A' ' 112' ' ' SER . . . -69.48 -47.93 62.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.471 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -56.33 -44.92 80.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.942 -1.099 . . . . 0.0 110.782 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.563 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 1.3 mtt85 -68.78 -49.95 54.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.936 -1.103 . . . . 0.0 109.777 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.615 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 mt -52.08 -30.86 27.88 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.28 1.038 . . . . 0.0 108.518 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 1.125 ' CE1' HD21 ' A' ' 24' ' ' LEU . 8.9 t80 -72.44 -72.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.2 mtpt -45.1 -20.56 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 112.102 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -115.98 -61.83 1.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.537 -1.352 . . . . 0.0 112.11 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.841 ' HA ' HG11 ' A' ' 147' ' ' VAL . 9.8 t80 -65.51 -80.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.341 -1.475 . . . . 0.0 110.211 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 HD23 ' A' ' 24' ' ' LEU . 2.7 mt -43.98 -71.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.858 -1.151 . . . . 0.0 108.495 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.125 HD21 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -61.68 -179.47 0.19 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.645 ' OD2' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER 66.11 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.126 -0.984 . . . . 0.0 108.95 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' CG ' ' A' ' 25' ' ' ASP . . . 52.4 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 O-C-N 120.723 -1.235 . . . . 0.0 111.08 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.5 p30 -47.46 -20.37 0.23 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -1.092 . . . . 0.0 111.524 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.787 ' O ' HD22 ' A' ' 29' ' ' LEU . 53.5 t30 -110.38 38.89 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 109.779 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.787 HD22 ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -161.07 -49.34 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.465 -0.772 . . . . 0.0 110.56 -179.469 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.79 ' CD1' HD12 ' A' ' 143' ' ' LEU . 8.0 m-30 -56.39 -53.64 61.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 0.0 111.531 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.1 -4.38 8.93 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 O-C-N 123.293 1.154 . . . . 0.0 111.83 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 13.6 mmtt -109.33 -66.24 1.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.801 -1.187 . . . . 0.0 110.692 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.014 HG23 ' HB1' ' A' ' 146' ' ' ALA . 13.7 m -75.72 -14.19 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.87 64.3 27.82 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.04 -1.038 . . . . 0.0 110.849 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.1 -8.5 22.92 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 109.764 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 1.4 tt0 -86.28 -17.4 34.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.564 -0.71 . . . . 0.0 109.432 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.482 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -108.65 -37.99 5.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.656 HD13 ' HB3' ' A' ' 30' ' ' PHE . 2.2 mp -127.7 164.87 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -138.14 -47.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 110.284 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.9 t -161.9 130.17 4.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.118 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.644 HG22 HG13 ' A' ' 56' ' ' ILE . 54.2 t -95.84 129.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.138 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 14.8 tt0 . . . . . 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.227 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 53' ' ' ILE . 1.1 m . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.69 0.757 . . . . 0.0 111.641 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 52' ' ' THR . 20.5 mm 33.36 101.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.948 0.88 . . . . 0.0 111.932 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -134.43 158.07 44.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -129.39 142.27 50.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.472 -1.393 . . . . 0.0 111.839 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.656 ' HB ' HG13 ' A' ' 67' ' ' VAL . 1.2 mp -121.64 115.85 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 101.03 10.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.831 . . . . 0.0 110.817 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.649 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . 8.6 m-85 -56.46 177.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.229 -0.919 . . . . 0.0 108.933 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -75.85 145.84 29.06 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.387 1.204 . . . . 0.0 109.962 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' PRO . 1.1 tt0 -41.88 165.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.62 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.27 36.13 15.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 58' ' ' PHE . 3.4 mt -106.31 156.03 37.63 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.127 -1.219 . . . . 0.0 110.561 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.74 -30.77 9.17 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.081 1.569 . . . . 0.0 109.199 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 20.0 m-30 -101.23 -96.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.632 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 179.92 -35.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.806 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 51.5 p90 -179.54 -158.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.375 -0.828 . . . . 0.0 109.687 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 67' ' ' VAL . 7.0 p -163.16 108.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.565 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -99.05 160.91 13.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.995 ' HB3' HG12 ' A' ' 85' ' ' VAL . 2.6 p-10 -173.15 139.3 0.79 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.841 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -87.38 146.71 25.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.043 -1.036 . . . . 0.0 110.341 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.418 ' H ' ' HA ' ' A' ' 52' ' ' THR . 1.2 t -102.22 167.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.307 -0.87 . . . . 0.0 109.706 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -140.55 56.68 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 110.235 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' C ' HG23 ' A' ' 74' ' ' VAL . 1.9 mt-10 63.19 177.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.927 . . . . 0.0 109.918 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.615 HG22 ' CD1' ' A' ' 81' ' ' TYR . 5.2 t -151.06 137.85 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 111.063 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.453 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -80.43 179.98 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.141 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 4.1 m-70 -136.08 -49.86 0.69 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.786 -1.196 . . . . 0.0 111.114 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -49.91 -57.6 7.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.908 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 79' ' ' PHE . 2.3 m-20 -96.0 21.28 8.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.087 -1.008 . . . . 0.0 110.843 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 11.4 m-85 41.24 73.74 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 0.0 109.912 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 2.6 tttt -117.76 106.74 13.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 110.746 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD1' HG22 ' A' ' 74' ' ' VAL . 11.0 t80 -111.42 105.47 14.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -113.46 153.88 27.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.861 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 33.7 p90 -165.29 173.4 11.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 109.924 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.97 121.94 26.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.187 -0.946 . . . . 0.0 111.086 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.995 HG12 ' HB3' ' A' ' 69' ' ' ASP . 15.5 m -95.51 122.52 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.503 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.1 pp -123.19 -0.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 8.2 mt-10 -158.33 150.85 22.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.493 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 90.6 -179.45 43.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.65 -145.74 31.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 51.0 Cg_endo -85.93 31.49 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.55 . . . . 0.0 110.834 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -33.21 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.468 0.652 . . . . 0.0 110.905 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.02 -168.38 40.22 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 11.2 m-20 -87.68 -9.75 53.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -1.142 . . . . 0.0 110.47 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 58.8 p -101.64 41.68 1.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.95 HD12 ' NE2' ' A' ' 132' ' ' GLN . 1.5 mt 169.16 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.13 -45.94 3.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 110.764 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 14.3 mtpp -131.47 143.13 50.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 110.514 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.73 ' HB ' HG23 ' A' ' 85' ' ' VAL . 81.3 mt -140.21 118.4 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.998 -1.064 . . . . 0.0 110.564 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.51 160.43 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 109.793 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 20.8 t-20 -149.35 145.3 26.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.027 -1.045 . . . . 0.0 111.257 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -132.46 129.2 38.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.522 -0.736 . . . . 0.0 109.078 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 26.8 mm -113.38 135.92 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 0.0 110.396 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 2.4 mtpm? -139.0 105.39 5.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 110.301 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 23' ' ' ILE . 72.1 mt -83.84 148.89 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 110.05 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.95 128.71 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.03 132.93 34.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.128 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -107.43 152.44 41.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.414 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.75 -21.79 44.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.291 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.15 -50.77 69.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 142.35 54.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.46 -167.99 34.65 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.823 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -148.69 145.43 27.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -1.124 . . . . 0.0 109.856 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.515 ' CG2' ' OE1' ' A' ' 8' ' ' GLU . 8.9 mt -109.14 135.19 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.961 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.5 mp -99.18 108.47 21.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -0.906 . . . . 0.0 110.022 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.79 118.76 26.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 109.749 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.3 mt -110.04 121.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.426 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -118.66 100.86 7.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 109.35 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -103.31 115.6 30.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.168 -0.957 . . . . 0.0 111.078 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HG2' ' NE2' ' A' ' 121' ' ' HIS . 1.9 tptt -95.7 115.65 27.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.408 -0.808 . . . . 0.0 108.951 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.957 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.4 m-85 -90.41 147.2 23.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.117 -0.989 . . . . 0.0 111.012 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 73.4 m-70 -133.71 91.48 2.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.604 -0.685 . . . . 0.0 109.21 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 9.7 p -83.03 -179.49 7.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.638 -0.664 . . . . 0.0 110.465 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -84.87 6.1 26.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.094 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 101.72 -166.23 18.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 t0 50.15 -91.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 110.29 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' GLY . 23.9 m80 -66.24 156.63 33.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 110.145 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -107.99 169.45 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 3' ' ' PHE . 55.7 t -59.09 151.27 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.054 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 130' ' ' ALA . 46.0 mtmt -96.06 117.22 30.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 0.0 110.419 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -46.13 -38.24 7.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -56.4 -47.59 78.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.838 . . . . 0.0 109.38 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.95 ' NE2' HD12 ' A' ' 95' ' ' LEU . 21.5 mt-30 -61.78 -38.31 87.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.059 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.1 t -68.78 -19.5 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.768 0.794 . . . . 0.0 109.421 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -85.99 -66.89 0.85 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.463 -0.773 . . . . 0.0 110.921 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -34.47 -40.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.482 -0.761 . . . . 0.0 110.88 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 t -64.36 -52.79 56.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -54.86 -45.88 74.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.128 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 139' ' ' MET . 3.2 mt-10 -56.72 -59.58 4.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.196 -0.94 . . . . 0.0 109.743 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -44.99 -49.19 11.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.058 -1.027 . . . . 0.0 109.651 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.2 92.84 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 142' ' ' THR . 35.2 tt0 -74.78 -65.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.313 . . . . 0.0 110.501 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -42.28 -46.45 4.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.587 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.79 HD12 ' CD1' ' A' ' 30' ' ' PHE . 3.5 mm? -63.88 -55.23 24.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 109.84 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.607 HD13 ' CD2' ' A' ' 114' ' ' LEU . 22.5 tp -40.45 -46.17 2.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.432 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -43.33 92.07 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.804 . . . . 0.0 109.55 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.014 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.2 -61.75 2.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 110.085 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.841 HG11 ' HA ' ' A' ' 22' ' ' PHE . 24.7 t -67.49 -18.26 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.815 . . . . 0.0 110.644 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 18.1 tt0 -70.98 -47.1 60.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 0.0 109.557 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 -21.77 31.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.9 ' HB2' HG11 ' A' ' 33' ' ' VAL . 10.6 t80 -57.6 -49.52 76.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.475 -0.765 . . . . 0.0 109.699 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 150' ' ' TYR . 65.3 mt -54.98 -25.71 31.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.582 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -84.64 -33.16 23.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.892 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.32 -46.82 69.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.22 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 155' ' ' SER . 20.7 m80 -90.27 -24.75 20.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' HIS . 1.4 p 44.24 30.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.312 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -152.34 15.32 0.61 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.598 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' CE2' ' A' ' 158' ' ' TYR . . . -110.5 131.53 54.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.076 -1.015 . . . . 0.0 110.112 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.73 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 37.7 m-85 63.88 9.33 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.397 -0.814 . . . . 0.0 110.458 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.189 -179.803 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.464 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.55 HG22 ' HA ' ' A' ' 121' ' ' HIS . 97.2 t -72.62 151.14 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -1.083 . . . . 0.0 110.347 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 56.9 m-85 -109.74 131.7 54.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 109.607 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -95.25 95.53 8.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.886 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.827 ' HE2' HG11 ' A' ' 128' ' ' VAL . 23.2 m-30 -101.6 95.75 6.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.83 . . . . 0.0 110.24 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -88.01 126.37 35.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.303 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 t -145.4 178.33 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.18 . . . . 0.0 111.191 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' OE1' HG21 ' A' ' 113' ' ' ILE . 7.2 pt-20 -168.43 159.19 10.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.543 -0.723 . . . . 0.0 109.688 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.771 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.9 t -132.16 162.63 30.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.417 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -113.48 142.57 45.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.621 ' HB3' HD11 ' A' ' 18' ' ' LEU . 48.0 t -140.73 143.36 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.983 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.47 -2.04 2.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 109.968 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.58 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 19.2 mm -91.95 146.42 32.84 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 110.243 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.8 Cg_endo -57.39 153.82 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 0.0 110.162 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.487 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -62.81 -59.47 4.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -0.996 . . . . 0.0 110.479 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -42.96 -59.92 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 1.066 ' CZ ' HD12 ' A' ' 151' ' ' LEU . 6.7 ttp180 -53.03 -57.71 9.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.554 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 11' ' ' SER . 10.7 mt -45.6 -32.71 2.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.811 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -72.41 -55.54 6.88 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 110.687 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -60.1 -33.41 72.07 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.821 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -107.74 -34.78 6.87 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.264 -1.523 . . . . 0.0 112.551 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 81.3 t80 -102.53 9.45 39.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.731 -1.231 . . . . 0.0 111.873 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 29.2 mm -142.98 -26.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.823 -1.173 . . . . 0.0 110.968 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.811 HD21 ' CE1' ' A' ' 19' ' ' PHE . 4.1 mt -103.8 -35.89 8.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.713 -1.242 . . . . 0.0 109.16 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.495 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -112.97 41.08 2.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.585 -0.697 . . . . 0.0 110.535 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.24 -30.36 62.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.994 ' OD1' HG13 ' A' ' 41' ' ' VAL . 3.2 t70 -69.1 -6.41 28.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 2.5 t30 -126.01 13.91 7.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -130.98 -43.91 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.773 ' CD1' HD12 ' A' ' 143' ' ' LEU . 7.6 m-30 -57.58 -54.41 55.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 111.197 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -66.97 -15.21 46.34 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.34 1.179 . . . . 0.0 111.293 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.527 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 4.8 mptt -91.08 -71.81 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 110.736 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.855 HG23 ' HB1' ' A' ' 146' ' ' ALA . 17.4 m -75.52 -18.25 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.839 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -118.59 60.6 4.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.624 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.9 Cg_endo -67.61 -19.91 47.63 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.934 1.492 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 2.2 tt0 -82.62 -16.42 48.41 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.662 0.744 . . . . 0.0 109.073 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.766 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -100.18 -63.15 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.286 -0.884 . . . . 0.0 110.574 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.676 HD13 ' HB3' ' A' ' 30' ' ' PHE . 3.7 mp -115.63 153.94 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.693 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 -38.15 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 109.631 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 57' ' ' SER . 47.7 p -177.64 151.91 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.533 -0.729 . . . . 0.0 109.681 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.994 HG13 ' OD1' ' A' ' 27' ' ' ASP . 3.7 p -141.46 129.15 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.972 . . . . 0.0 110.571 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.915 . . . . 0.0 110.991 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.179 0.514 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.6 mm -113.33 108.96 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.271 -0.893 . . . . 0.0 110.251 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -150.17 168.55 23.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 20.5 ttpt -121.4 113.51 19.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 56' ' ' ILE . 2.1 mp -72.75 144.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -131.7 165.52 23.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.58 -0.7 . . . . 0.0 109.697 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 56' ' ' ILE . 30.7 m-85 -137.9 157.04 73.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.042 -1.037 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 60' ' ' GLU . 50.4 Cg_endo -75.48 154.74 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.159 1.61 . . . . 0.0 109.901 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 59' ' ' PRO . 4.7 pt-20 -42.78 157.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.283 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.13 -58.8 0.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 58' ' ' PHE . 11.6 mt -62.18 161.17 26.03 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.161 -1.199 . . . . 0.0 110.35 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.16 -38.6 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.152 1.606 . . . . 0.0 110.4 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.2 m-30 -92.91 153.39 18.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -104.19 -17.36 14.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.839 ' O ' HG13 ' A' ' 67' ' ' VAL . 29.1 p90 -174.14 -173.34 0.79 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.718 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.839 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -177.66 115.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 109.947 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -68.98 134.16 49.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.428 ' HB2' HD13 ' A' ' 56' ' ' ILE . 24.3 t0 -128.5 127.27 42.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 110.951 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -127.94 103.32 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.414 -0.804 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 32.2 m -57.01 -32.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.287 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 64.08 5.75 2.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -0.917 . . . . 0.0 110.729 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 167.36 177.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -179.23 125.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 109.658 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -104.58 -176.74 3.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.24 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.73 -67.28 0.32 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.3 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.8 m -58.12 -36.32 72.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 0.0 110.532 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 5.5 m-80 -93.73 0.77 56.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.006 . . . . 0.0 110.694 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 19.8 m-30 57.06 14.92 2.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 110.552 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HA ' ' CB ' ' A' ' 103' ' ' LYS . 16.5 mttm -71.61 136.53 47.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.086 . . . . 0.0 109.744 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 67.8 t80 -149.72 121.82 8.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 110.462 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.569 ' HA ' ' CB ' ' A' ' 101' ' ' GLU . 4.6 m-20 -125.29 142.94 51.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.88 . . . . 0.0 110.558 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -152.34 149.49 28.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.105 -0.997 . . . . 0.0 111.102 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.58 135.78 54.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.553 -0.717 . . . . 0.0 109.691 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 98' ' ' ILE . 2.2 p -103.62 123.91 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.545 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 1.5 pp -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 1.8 tt0 73.91 138.49 0.06 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 0.0 110.603 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.414 ' CA ' ' CE2' ' A' ' 66' ' ' TYR . . . 81.08 162.85 29.32 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.83 -144.65 17.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.9 Cg_endo -81.9 22.57 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.98 1.516 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -38.83 164.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.359 -0.838 . . . . 0.0 111.116 -179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.6 38.14 7.16 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 90' ' ' PRO . 9.7 t0 -155.37 68.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.812 ' O ' HD22 ' A' ' 95' ' ' LEU . 13.9 p 48.28 38.18 9.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.88 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -159.92 60.38 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -49.09 -72.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -128.35 159.98 33.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.847 ' O ' HG12 ' A' ' 85' ' ' VAL . 71.3 mt -137.39 117.27 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.85 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.45 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 28.8 t -103.92 128.19 51.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 0.0 110.607 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.594 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 19.0 m-20 -129.19 134.07 47.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.603 ' O ' HG12 ' A' ' 102' ' ' ILE . 6.6 pt-20 -175.56 149.09 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 117.881 -1.528 . . . . 0.0 113.312 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.868 HG22 ' N ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -178.58 -95.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.868 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.7 OUTLIER 176.0 -176.49 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 0.0 110.625 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.054 HG23 HD23 ' A' ' 114' ' ' LEU . 36.2 mt -113.76 124.79 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 108.915 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.508 ' CG2' ' HD2' ' A' ' 115' ' ' LYS . 64.6 t -96.92 125.72 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.3 131.78 37.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.668 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 112' ' ' SER . 67.6 p -78.67 162.51 65.23 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 47.7 Cg_endo -66.92 -18.16 52.11 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.066 1.561 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -171.04 -30.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 111.239 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.26 -88.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.533 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . -151.09 -95.45 0.12 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.63 ' HA ' HG23 ' A' ' 107' ' ' THR . 11.9 m -171.12 137.0 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.323 -1.104 . . . . 0.0 109.83 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.472 HG21 ' OE1' ' A' ' 8' ' ' GLU . 2.2 mt -100.95 114.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.095 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 1.054 HD23 HG23 ' A' ' 104' ' ' ILE . 45.8 mt -71.71 103.01 2.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.58 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.737 ' HB3' HG21 ' A' ' 102' ' ' ILE . 78.6 mttt -86.64 126.16 34.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.853 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.469 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 16.4 mt -137.25 130.27 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 100' ' ' ASN . 36.6 m -96.28 102.48 14.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.082 -1.011 . . . . 0.0 108.963 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.526 ' OD1' ' ND2' ' A' ' 100' ' ' ASN . 1.5 m-80 -83.63 143.74 29.9 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.435 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 117.8 9.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.88 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.7 m-85 -92.98 99.86 12.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.018 -1.051 . . . . 0.0 111.115 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.55 ' HA ' HG22 ' A' ' 2' ' ' VAL . 73.5 m-70 -82.04 83.88 7.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.409 -0.807 . . . . 0.0 109.192 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.564 HG21 HG23 ' A' ' 128' ' ' VAL . 11.7 p -82.21 -146.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.843 . . . . 0.0 110.571 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.79 18.98 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 0.0 110.708 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.67 -143.55 16.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.3 t0 48.53 -144.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -1.148 . . . . 0.0 110.116 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -50.04 149.71 2.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.833 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.53 170.9 13.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 110.492 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.827 HG11 ' HE2' ' A' ' 5' ' ' TYR . 35.4 t -62.27 143.27 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HE3' ' OE1' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -85.91 110.01 19.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.52 -49.03 10.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.154 -0.966 . . . . 0.0 109.795 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.15 -43.25 74.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.011 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.463 ' OE1' ' HE3' ' A' ' 129' ' ' LYS . 42.6 tt0 -58.34 -38.55 77.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -0.753 . . . . 0.0 109.478 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.556 HG22 ' CE2' ' A' ' 120' ' ' TYR . 4.0 t -77.5 -17.6 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 109.798 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.1 tptt -81.35 -61.9 1.81 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -0.791 . . . . 0.0 110.369 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -39.23 -50.49 1.95 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.338 -0.851 . . . . 0.0 110.163 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -48.18 74.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.355 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -36.39 69.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -61.89 -59.95 4.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.144 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -46.13 -42.83 14.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.158 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.53 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.01 -47.53 71.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -1.224 . . . . 0.0 110.907 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -53.5 -38.34 63.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.021 -1.05 . . . . 0.0 109.186 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.773 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.5 mm? -69.99 -50.21 43.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.836 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 114' ' ' LEU . 14.5 tp -51.14 -30.87 17.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 108.792 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -43.73 34.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 110.075 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.855 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.91 -48.32 78.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 109.896 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 29' ' ' LEU . 27.7 t -74.03 -36.5 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.41 -0.806 . . . . 0.0 110.111 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' HD13 ' A' ' 152' ' ' LEU . 19.6 tt0 -57.19 -41.03 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.52 -25.52 21.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.93 . . . . 0.0 110.083 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.778 ' HB2' HG11 ' A' ' 33' ' ' VAL . 7.3 t80 -57.39 -33.71 68.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.746 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.066 HD12 ' CZ ' ' A' ' 17' ' ' ARG . 20.1 mt -79.07 -26.19 43.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.201 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 148' ' ' GLU . 8.1 mp -78.53 -22.38 47.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.22 -45.43 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -72.37 171.9 11.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 110.697 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.6 t -54.01 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 3.8 p-10 -155.53 54.34 0.61 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 110.756 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.618 ' HB3' ' CD2' ' A' ' 151' ' ' LEU . . . -59.08 133.95 56.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.875 -1.14 . . . . 0.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.821 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 53.2 m-85 62.37 62.3 1.17 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.679 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.175 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 120' ' ' TYR . 78.2 t -76.69 151.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -1.195 . . . . 0.0 110.046 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 127' ' ' GLU . 87.1 m-85 -115.28 129.46 56.63 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 110.206 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.25 105.1 16.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.94 ' CD1' HG11 ' A' ' 133' ' ' VAL . 23.5 m-85 -106.58 82.11 1.68 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -88.04 157.41 18.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 0.0 110.937 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.549 ' CG2' ' HB ' ' A' ' 116' ' ' ILE . 11.5 t -173.39 -174.02 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 0.0 109.693 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 7' ' ' THR . 6.9 mt-10 -140.19 149.9 43.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.107 -0.996 . . . . 0.0 110.335 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 1.042 HG23 HD22 ' A' ' 144' ' ' LEU . 0.5 OUTLIER -158.5 136.5 10.59 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.239 -0.913 . . . . 0.0 109.21 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.785 HG21 ' CA ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER 175.88 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 119.778 -1.826 . . . . 0.0 113.967 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.488 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -169.38 -175.52 2.24 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.935 -178.226 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.598 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -72.79 -15.76 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.21 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.57 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 4.6 mm -61.51 140.87 94.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 110.045 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -56.08 158.54 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.029 1.542 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.686 ' HB2' ' OG ' ' A' ' 112' ' ' SER . . . -70.24 -32.84 70.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.685 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.32 90.83 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 110.686 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.491 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 19.2 mtm180 -79.25 -50.33 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.078 . . . . 0.0 109.893 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -57.69 -30.94 65.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.782 ' CE2' HD21 ' A' ' 24' ' ' LEU . 61.8 t80 -79.11 -46.3 18.31 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.624 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -68.19 -20.95 64.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.773 . . . . 0.0 112.155 -178.507 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -111.71 -31.66 6.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.678 -1.264 . . . . 0.0 112.15 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB2' HG11 ' A' ' 147' ' ' VAL . 86.0 t80 -107.16 -13.25 15.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.682 -1.261 . . . . 0.0 111.934 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.643 HG21 ' CE1' ' A' ' 19' ' ' PHE . 39.4 mm -122.46 -16.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.794 -1.192 . . . . 0.0 110.486 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.782 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -112.38 -29.48 7.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.231 -0.918 . . . . 0.0 110.173 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.508 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -137.15 66.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.886 -179.54 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -83.56 -25.48 46.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.721 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.7 p30 -80.18 13.73 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.515 -0.991 . . . . 0.0 110.834 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 89.7 m-20 -135.97 37.77 2.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.826 -1.171 . . . . 0.0 108.15 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.016 HD21 HG13 ' A' ' 147' ' ' VAL . 0.3 OUTLIER 174.68 -36.42 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.188 -177.033 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 3.2 m-30 -38.79 -62.09 0.79 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.62 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 55.6 Cg_endo -69.83 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.902 1.475 . . . . 0.0 110.725 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.8 mmtt -49.74 -25.9 3.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 111.14 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HB1' ' A' ' 146' ' ' ALA . 3.6 m -120.16 -10.13 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.049 . . . . 0.0 110.789 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -139.05 65.51 36.83 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.045 -1.034 . . . . 0.0 110.459 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 59' ' ' PRO . 41.8 Cg_endo -68.67 -13.63 37.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.05 1.553 . . . . 0.0 109.542 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.724 ' OE1' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -82.98 -14.96 53.03 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.724 ' HB2' ' OE1' ' A' ' 36' ' ' GLN . . . -110.48 -58.53 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.23 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -115.35 125.82 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.008 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.482 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 8.1 t -82.9 -38.74 22.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.826 . . . . 0.0 110.354 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 p -172.45 151.22 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.328 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.721 HG11 ' HB2' ' A' ' 27' ' ' ASP . 7.3 p -99.61 129.49 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.644 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HB3' ' CB ' ' A' ' 55' ' ' LYS . 13.4 tp10 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.581 -0.699 . . . . 0.0 109.647 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.844 ' C ' HD12 ' A' ' 53' ' ' ILE . 95.2 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.144 0.497 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.844 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -114.93 134.66 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 110.676 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -123.32 148.06 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.885 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 28.7 mttp -121.76 84.72 2.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.869 . . . . 0.0 110.223 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.6 mp -66.42 125.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.867 -1.146 . . . . 0.0 109.141 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -105.78 126.31 52.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.631 -1.293 . . . . 0.0 111.318 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.643 ' CD2' HD12 ' A' ' 62' ' ' LEU . 10.8 m-30 -84.82 141.93 38.72 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.458 -0.777 . . . . 0.0 110.59 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 39' ' ' SER . 43.7 Cg_endo -70.48 -179.23 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.936 1.493 . . . . 0.0 108.77 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.24 163.82 12.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.723 -1.236 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.61 -47.92 3.9 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.812 HD13 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -49.83 159.07 0.79 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 111.041 -179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.812 ' HD2' HD13 ' A' ' 62' ' ' LEU . 45.0 Cg_endo -72.1 152.37 56.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.187 1.625 . . . . 0.0 108.586 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 52.84 -136.19 1.41 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.158 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -152.25 -3.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.901 -1.124 . . . . 0.0 112.093 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.926 ' O ' HG13 ' A' ' 67' ' ' VAL . 43.9 p90 178.02 -158.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.837 -1.165 . . . . 0.0 110.442 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -173.07 130.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.53 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -95.85 154.12 17.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.566 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.85 127.16 12.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.01 -1.056 . . . . 0.0 111.241 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.68 142.02 31.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 109.127 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 73' ' ' GLU . 46.1 t -110.21 137.97 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 111.157 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -110.98 47.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.379 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' H ' HG12 ' A' ' 71' ' ' VAL . 1.6 mt-10 63.69 110.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 109.863 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.741 HG12 ' CD1' ' A' ' 81' ' ' TYR . 3.8 m -82.72 168.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.329 -0.857 . . . . 0.0 110.499 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -102.89 139.51 38.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.829 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -102.42 -48.8 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.36 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.7 m -53.59 -42.31 67.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.909 -1.119 . . . . 0.0 110.928 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 79' ' ' PHE . 17.9 m120 -105.73 15.2 27.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.053 . . . . 0.0 110.811 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.563 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 12.3 m-30 41.58 59.23 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 110.291 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -115.53 164.85 13.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 0.0 109.942 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.741 ' CD1' HG12 ' A' ' 74' ' ' VAL . 10.1 t80 -147.69 143.0 27.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.913 . . . . 0.0 110.5 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -145.56 100.41 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.824 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.538 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 38.2 p90 -128.59 168.97 14.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.51 135.39 53.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.457 HG22 ' HE2' ' A' ' 83' ' ' TYR . 21.4 t -94.92 112.34 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.664 HD12 ' OE1' ' A' ' 87' ' ' GLU . 18.6 pt -132.32 150.67 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.664 ' OE1' HD12 ' A' ' 86' ' ' ILE . 27.7 mp0 58.65 156.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 110.722 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.586 ' CA ' ' CE2' ' A' ' 66' ' ' TYR . . . 61.04 149.06 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.11 -141.45 15.6 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ILE . 50.1 Cg_endo -84.2 26.62 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.022 1.538 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.35 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.531 -0.73 . . . . 0.0 110.517 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.45 -160.23 28.23 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -93.83 -30.74 14.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.463 ' O ' ' HB ' ' A' ' 122' ' ' THR . 71.0 p -59.75 -24.45 64.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 120' ' ' TYR . 1.7 mt -146.18 86.74 1.71 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -81.42 -41.66 21.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.902 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.7 mmtt -123.0 158.49 30.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.997 -1.064 . . . . 0.0 110.527 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.623 ' CG1' HD22 ' A' ' 95' ' ' LEU . 12.9 mt -158.27 115.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.485 -0.759 . . . . 0.0 109.996 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 t -103.69 114.28 28.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 109.96 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 83.3 m-20 -116.67 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.051 -1.03 . . . . 0.0 110.964 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.603 ' C ' HD12 ' A' ' 102' ' ' ILE . 3.9 pt-20 -141.98 145.48 34.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.492 -0.755 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.603 HD12 ' C ' ' A' ' 101' ' ' GLU . 1.3 mp -126.14 135.25 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.832 -1.168 . . . . 0.0 110.193 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 ttpt -115.89 101.33 8.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.375 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.738 HD13 ' CD1' ' A' ' 19' ' ' PHE . 4.7 mp -78.81 135.67 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.964 -1.085 . . . . 0.0 109.785 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.85 125.94 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.25 140.04 35.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.336 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.6 p -100.35 157.43 33.81 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.968 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.07 -16.87 50.33 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.034 1.544 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -161.64 83.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.026 -1.046 . . . . 0.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 168.98 -87.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -173.68 -153.17 9.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.686 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -108.26 143.78 36.64 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.174 -1.192 . . . . 0.0 109.344 179.06 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.785 ' CA ' HG21 ' A' ' 10' ' ' THR . 1.8 mt -119.68 137.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.401 0.62 . . . . 0.0 111.373 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.833 ' HB2' ' O ' ' A' ' 9' ' ' THR . 2.5 mp -101.27 110.33 22.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.447 -0.783 . . . . 0.0 109.513 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 1.8 mptp? -81.14 104.98 11.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.549 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 77.5 mt -93.47 112.83 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.661 0.743 . . . . 0.0 112.23 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.1 111.66 23.41 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.401 ' OD1' HG22 ' A' ' 116' ' ' ILE . 16.5 m120 -110.42 96.58 6.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 111.216 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.711 ' HD3' HG11 ' A' ' 2' ' ' VAL . 1.6 mttt -84.56 99.69 10.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.921 ' CD2' HD11 ' A' ' 95' ' ' LEU . 3.2 m-85 -75.83 132.8 40.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.772 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.679 ' CE1' HG21 ' A' ' 2' ' ' VAL . 55.4 m-70 -114.49 100.07 8.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.839 HG21 HG23 ' A' ' 128' ' ' VAL . 6.3 p -104.6 179.48 4.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 110.332 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 122' ' ' THR . 1.1 ptpm? 175.21 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 159.62 126.47 0.85 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.18 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 47.89 -150.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -1.075 . . . . 0.0 110.824 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 125' ' ' ASP . 4.3 m-70 -42.13 166.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.359 -0.838 . . . . 0.0 110.533 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -107.44 -121.21 0.24 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 110.141 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.839 HG23 HG21 ' A' ' 122' ' ' THR . 97.7 t -103.2 141.8 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.822 -1.174 . . . . 0.0 110.492 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 130' ' ' ALA . 37.5 mtmt -107.29 124.22 49.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.699 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.32 -41.31 5.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.173 -0.955 . . . . 0.0 109.786 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 tm-20 -52.03 -49.53 63.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.209 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.44 ' NE2' ' HB2' ' A' ' 90' ' ' PRO . 7.6 mt-30 -61.87 -43.29 99.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.195 -0.94 . . . . 0.0 109.007 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.94 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.9 t -62.0 -18.33 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.137 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 23.3 ttpt -87.72 -63.61 1.28 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 110.694 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.12 -47.98 0.79 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.697 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -47.22 87.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -64.77 -19.37 65.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 24.4 tt0 -78.7 -45.47 21.21 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 62' ' ' LEU . 44.0 mmm -64.0 -35.18 79.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.532 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.43 -42.62 73.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.17 -33.35 74.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.999 -1.295 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.25 70.4 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.164 -0.96 . . . . 0.0 109.045 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -69.96 -29.31 66.4 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 1.042 HD22 HG23 ' A' ' 9' ' ' THR . 15.9 tp -69.13 -46.07 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -33.4 75.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.39 -0.819 . . . . 0.0 108.945 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.037 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -62.52 -54.65 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.822 . . . . 0.0 109.273 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 1.016 HG13 HD21 ' A' ' 29' ' ' LEU . 39.2 t -70.99 -16.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -0.768 . . . . 0.0 109.968 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 11' ' ' SER . 5.5 tm-20 -75.17 -44.33 47.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.635 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -15.29 32.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.404 -0.81 . . . . 0.0 109.707 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.653 ' CG ' ' CD1' ' A' ' 29' ' ' LEU . 4.1 t80 -64.69 -52.12 58.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.352 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 150' ' ' TYR . 84.8 mt -53.46 -30.71 42.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.706 -0.621 . . . . 0.0 110.167 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.26 -51.76 10.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.701 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 154' ' ' HIS . . . -55.24 -53.76 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.451 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 153' ' ' ALA . 46.2 m-70 -60.01 -122.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.038 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 9.6 t -175.02 -31.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.59 -1.319 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -144.54 39.94 1.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 110.938 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.5 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -85.0 128.4 34.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.776 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.756 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 44.4 m-85 56.16 49.26 15.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.286 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 120' ' ' TYR . 9.2 p -144.66 161.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -1.12 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 76.5 m-85 -132.82 161.4 34.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.382 -0.824 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.59 106.82 10.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -0.963 . . . . 0.0 110.437 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.041 ' CD1' HG11 ' A' ' 133' ' ' VAL . 44.7 m-85 -108.14 86.8 2.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.398 -0.814 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -101.76 156.34 17.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.666 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -166.15 176.63 7.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.972 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 115' ' ' LYS . 29.2 mp0 -146.35 137.05 24.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.883 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.5 t -118.26 166.43 12.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.87 142.31 51.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.698 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.54 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -141.19 147.95 39.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.49 -39.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.433 -0.792 . . . . 0.0 110.174 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.598 HD11 ' CD1' ' A' ' 152' ' ' LEU . 3.4 mm -58.88 141.91 85.17 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.486 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 35.7 Cg_endo -57.89 155.27 33.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.912 1.48 . . . . 0.0 110.804 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -60.68 -36.68 79.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 110.103 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . . . -62.68 -56.24 19.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 110.735 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 51.7 mtt180 -61.3 -55.17 34.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.151 -0.968 . . . . 0.0 110.245 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -52.27 -33.72 43.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.221 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.745 ' CE2' HD21 ' A' ' 24' ' ' LEU . 75.7 t80 -69.88 -52.6 23.43 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 11.5 mtmm -61.26 -25.34 67.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 0.0 111.552 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -105.66 -61.12 1.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 111.522 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' HB2' HG11 ' A' ' 147' ' ' VAL . 80.7 t80 -76.28 -4.9 44.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.304 -0.872 . . . . 0.0 112.253 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.65 ' C ' HD23 ' A' ' 24' ' ' LEU . 34.9 mm -132.95 -20.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.642 -1.286 . . . . 0.0 111.123 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.745 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -111.19 -5.69 14.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -154.75 53.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 110.557 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.36 -21.78 55.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.5 ' HB2' HG11 ' A' ' 41' ' ' VAL . 49.8 p30 -68.21 -15.44 63.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -1.086 . . . . 0.0 110.449 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -122.77 10.75 9.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.77 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.827 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -122.27 -42.68 2.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.339 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.753 ' CD1' HD12 ' A' ' 143' ' ' LEU . 7.3 m-30 -60.7 -51.8 77.12 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.87 . . . . 0.0 111.684 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.9 Cg_endo -65.42 -4.82 10.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.224 1.118 . . . . 0.0 111.741 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -107.93 -64.11 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.898 -1.126 . . . . 0.0 110.5 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 29' ' ' LEU . 18.5 m -71.95 -17.71 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.97 66.3 75.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.101 -0.999 . . . . 0.0 110.872 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.0 Cg_endo -68.39 -19.96 42.78 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 109.466 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -83.9 -9.57 58.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.558 -0.714 . . . . 0.0 109.548 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -105.56 -59.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.968 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.16 161.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.514 ' HB2' ' N ' ' A' ' 59' ' ' PRO . 42.8 t -111.15 -57.44 2.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.055 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.38 144.48 3.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.914 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 27' ' ' ASP . 12.8 p -109.29 139.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.163 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 5.1 mt-10 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.129 -0.982 . . . . 0.0 109.87 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.2 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.277 0.561 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.545 HD13 ' HG3' ' A' ' 70' ' ' ARG . 22.8 mm -85.68 121.7 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.099 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -137.76 154.31 49.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.495 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -125.38 107.24 10.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.392 -0.817 . . . . 0.0 110.173 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' A' ' 67' ' ' VAL . 1.7 mp -73.44 136.34 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 109.664 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -119.04 162.16 19.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 110.356 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 19.5 m-85 -128.05 161.57 55.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.514 ' N ' ' HB2' ' A' ' 39' ' ' SER . 43.0 Cg_endo -71.21 159.92 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.981 1.516 . . . . 0.0 110.017 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.69 164.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 110.627 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.61 -45.47 3.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -66.16 145.23 98.98 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.195 -1.179 . . . . 0.0 110.797 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 64' ' ' PHE . 47.5 Cg_endo -75.57 -163.65 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 110.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 5.2 m-30 51.83 103.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.376 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.6 tppt? -56.78 -17.62 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.604 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 175.6 -175.05 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.53 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 53.8 t -147.64 80.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -79.44 133.59 36.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' SER . 4.8 p-10 -163.39 -177.77 5.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HG3' HD13 ' A' ' 53' ' ' ILE . 6.4 mtp180 -121.8 159.73 26.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 4.6 p -85.93 -25.44 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.933 . . . . 0.0 111.042 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 72.14 -80.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.547 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -168.73 157.77 8.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 178.11 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.824 HG23 ' HD1' ' A' ' 81' ' ' TYR . 14.6 p -128.45 109.79 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.96 154.86 41.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 109.464 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.41 -59.06 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 110.61 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.9 m -63.0 -8.23 6.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 0.0 110.993 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.51 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 73.3 m-20 -121.29 6.87 10.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.91 -1.119 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 8.6 m-30 44.66 67.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.51 ' HE2' ' HB3' ' A' ' 78' ' ' ASN . 3.0 mtmt -137.1 122.29 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.883 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.824 ' HD1' HG23 ' A' ' 74' ' ' VAL . 4.3 t80 -111.05 128.98 56.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.556 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . 3.4 t-20 -101.0 143.85 30.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 1.031 ' CZ ' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -149.3 115.96 5.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.417 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -103.27 127.47 50.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.031 HG22 ' CZ ' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -102.45 95.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.435 -0.791 . . . . 0.0 109.783 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 87' ' ' GLU . 25.0 pt -87.44 -29.6 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 0.0 110.414 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -156.48 102.58 2.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.898 . . . . 0.0 110.363 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 143.79 166.3 11.25 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.554 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 86.1 -121.43 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 91' ' ' ILE . 47.4 Cg_endo -74.24 -52.26 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.788 1.415 . . . . 0.0 110.584 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.554 HD11 ' O ' ' A' ' 89' ' ' GLY . 0.2 OUTLIER 30.03 -156.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.875 0.845 . . . . 0.0 111.862 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.83 -161.67 2.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.58 ' O ' HG23 ' A' ' 94' ' ' THR . 3.4 m-20 51.68 -95.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -1.142 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 93' ' ' ASP . 18.3 p -156.23 22.25 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 110.516 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.698 ' HB3' HD11 ' A' ' 98' ' ' ILE . 9.9 mt -94.93 95.49 8.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.205 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 4.6 mt-10 -76.6 -43.34 38.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' HG12 ' A' ' 98' ' ' ILE . 9.1 tttp -129.43 152.13 49.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.005 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 95' ' ' LEU . 13.3 mt -153.74 122.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 110.635 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.53 127.34 48.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 109.872 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 2.3 m-80 -121.54 114.65 21.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.621 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.01 159.0 16.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 109.703 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.807 HG23 ' CD1' ' A' ' 116' ' ' ILE . 13.7 mt -141.89 142.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HG3' ' C ' ' A' ' 102' ' ' ILE . 1.8 mtpp -138.09 151.86 48.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.147 -0.971 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.613 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.9 mp -130.84 125.85 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.002 . . . . 0.0 109.927 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.41 133.23 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.02 21.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 p -128.96 152.85 79.89 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.843 . . . . 0.0 110.115 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.99 -32.38 28.55 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.024 1.539 . . . . 0.0 110.706 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 p30 -149.99 43.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.81 14.21 0.89 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.47 -138.07 29.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -128.58 136.56 50.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -1.157 . . . . 0.0 110.571 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.11 125.79 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.803 . . . . 0.0 109.211 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.883 ' HB2' HG22 ' A' ' 9' ' ' THR . 20.1 mt -89.72 108.19 19.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.001 . . . . 0.0 111.134 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 10.2 mttp -81.65 106.47 13.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.807 ' CD1' HG23 ' A' ' 102' ' ' ILE . 43.4 mm -101.38 151.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.08 132.08 35.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 4.9 m120 -129.53 88.17 2.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.125 -0.984 . . . . 0.0 110.725 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -81.29 124.27 29.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.716 ' O ' HG23 ' A' ' 2' ' ' VAL . 3.3 m-85 -103.67 149.38 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.911 -1.118 . . . . 0.0 110.401 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.0 m-70 -134.33 93.48 3.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.561 HG21 HG23 ' A' ' 128' ' ' VAL . 2.0 p -86.14 -162.9 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.87 . . . . 0.0 109.717 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HD3' ' OE1' ' A' ' 96' ' ' GLU . 5.2 ttpp -177.26 97.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.041 . . . . 0.0 110.854 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.42 160.59 12.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 56.08 -161.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -1.021 . . . . 0.0 110.635 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.486 ' N ' HG21 ' A' ' 94' ' ' THR . 81.1 m-70 -48.96 -179.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 110.436 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 5.5 mm-40 -127.32 -112.98 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.931 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.795 HG11 ' HE2' ' A' ' 5' ' ' TYR . 60.5 t -118.23 138.03 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.805 -1.185 . . . . 0.0 110.256 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 130' ' ' ALA . 5.5 mtmt -101.66 111.4 23.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -41.36 -50.31 3.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.696 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -46.44 -48.27 18.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.902 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.401 ' OE1' ' HB2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -63.36 -39.44 94.54 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.041 HG11 ' CD1' ' A' ' 5' ' ' TYR . 79.5 t -65.92 -17.22 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.757 0.789 . . . . 0.0 109.169 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 135' ' ' ALA . 2.0 ttmt -85.54 -58.13 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.499 -0.75 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.38 -50.64 5.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 109.916 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.43 -45.86 69.58 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.13 -31.68 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.701 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.77 -39.68 80.09 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.332 -0.855 . . . . 0.0 109.369 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 1.3 mtp -66.18 -38.43 88.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.21 -0.931 . . . . 0.0 109.05 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.21 -38.18 93.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -74.77 -35.02 62.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.896 -1.355 . . . . 0.0 110.158 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -39.77 90.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 108.743 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.753 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.1 mm? -68.66 -48.97 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.165 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.594 HD22 HG21 ' A' ' 9' ' ' THR . 13.3 tp -49.58 -42.89 45.62 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.204 -0.935 . . . . 0.0 108.849 178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 1.5 ttt-85 -65.79 -42.64 90.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.83 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.776 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.5 -62.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.358 -0.838 . . . . 0.0 109.734 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.65 HG22 HD12 ' A' ' 29' ' ' LEU . 84.6 t -59.01 -28.61 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.555 -0.715 . . . . 0.0 110.09 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -61.95 -53.06 60.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 0.0 109.958 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.4 p -76.7 -18.59 58.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 109.9 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.714 ' CD2' HD11 ' A' ' 29' ' ' LEU . 5.7 t80 -64.44 -47.95 77.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.627 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.617 HD23 ' CD2' ' A' ' 150' ' ' TYR . 68.4 mt -61.38 -24.97 66.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.598 ' CD1' HD11 ' A' ' 13' ' ' ILE . 5.9 mp -81.76 -35.21 29.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.244 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.12 -55.14 6.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.461 ' O ' ' CB ' ' A' ' 155' ' ' SER . 35.9 m-70 -66.14 -44.42 84.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.873 . . . . 0.0 109.808 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER 66.74 20.55 10.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.459 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -159.11 19.9 0.19 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.568 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.464 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.63 130.65 48.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.077 -1.014 . . . . 0.0 110.336 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.789 ' CD2' ' HB2' ' A' ' 21' ' ' ALA . 48.4 m-85 58.24 53.13 6.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.116 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.528 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 120' ' ' TYR . 78.9 t -79.08 156.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.558 ' CD1' HG23 ' A' ' 128' ' ' VAL . 75.9 m-85 -119.61 137.38 53.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.529 -0.732 . . . . 0.0 109.965 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' OD1' ' HE2' ' A' ' 119' ' ' LYS . 3.6 t30 -101.19 91.53 4.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 0.0 110.358 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.963 ' CE2' HG21 ' A' ' 133' ' ' VAL . 29.3 m-85 -86.97 74.12 9.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -0.92 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 91.54 3.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.549 HG21 ' CE ' ' A' ' 137' ' ' LYS . 14.4 t -112.85 -169.75 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -168.03 167.16 12.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.451 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.922 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -137.16 179.13 6.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 109.911 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.14 141.13 51.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.527 ' OG ' HD11 ' A' ' 18' ' ' LEU . 5.7 t -142.57 143.36 32.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 110.162 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -31.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.755 HG13 HD12 ' A' ' 151' ' ' LEU . 3.3 mm -66.08 140.82 97.16 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 36.2 Cg_endo -60.32 158.34 31.54 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.795 1.419 . . . . 0.0 110.617 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -53.91 -70.08 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 0.0 111.732 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.772 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -37.97 -62.07 0.59 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.309 -0.869 . . . . 0.0 111.808 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.2 mpt_? -52.73 -57.45 10.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.866 -1.146 . . . . 0.0 110.673 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.45 -30.66 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.183 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.738 ' CE2' HD21 ' A' ' 24' ' ' LEU . 68.3 t80 -74.01 -57.09 4.2 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.038 -1.039 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.0 mtmt -59.73 -23.02 62.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.73 . . . . 0.0 111.883 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -107.96 -53.25 2.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.578 -1.327 . . . . 0.0 112.226 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.703 ' CA ' HG11 ' A' ' 147' ' ' VAL . 27.4 t80 -83.89 -14.07 52.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.059 . . . . 0.0 112.38 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.951 HD12 HD11 ' A' ' 104' ' ' ILE . 28.2 mt -124.5 -14.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.573 -1.33 . . . . 0.0 110.868 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.738 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -111.74 -17.01 13.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.032 . . . . 0.0 109.967 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.485 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 4.7 t0 -137.16 43.83 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 110.151 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.36 -23.16 71.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.574 ' CB ' HG11 ' A' ' 41' ' ' VAL . 74.1 m-20 -68.52 -30.53 69.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -1.166 . . . . 0.0 110.365 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 28' ' ' ASN . 10.7 p-10 -105.04 25.15 10.89 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.903 HD23 HG13 ' A' ' 147' ' ' VAL . 3.1 tp -141.56 -63.23 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.668 -0.645 . . . . 0.0 110.354 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.751 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 6.1 m-30 -34.24 -52.96 0.94 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.782 -0.574 . . . . 0.0 110.746 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 50.9 Cg_endo -68.03 -50.25 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.468 1.246 . . . . 0.0 110.742 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -65.82 -69.52 0.29 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.286 -0.884 . . . . 0.0 110.615 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 29' ' ' LEU . 12.2 m -68.05 -11.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 111.409 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -146.73 66.17 10.52 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.3 Cg_endo -69.81 -11.86 31.64 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.846 1.445 . . . . 0.0 109.45 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -83.21 -14.63 52.92 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.332 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.631 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -112.36 -48.04 3.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.044 -1.035 . . . . 0.0 111.126 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.659 ' CD1' HD21 ' A' ' 143' ' ' LEU . 2.2 mp -116.94 163.56 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.985 -1.072 . . . . 0.0 110.596 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -124.07 -33.79 3.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.94 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER 169.95 141.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.536 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG11 ' CB ' ' A' ' 27' ' ' ASP . 3.2 p -103.37 148.03 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.159 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.616 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 3.4 mt-10 -141.53 116.82 10.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.621 ' HB2' ' HA ' ' A' ' 54' ' ' LYS . 3.4 m-20 147.24 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.514 HG22 ' C ' ' A' ' 43' ' ' ASN . 1.3 tp 32.78 38.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.516 -0.74 . . . . 0.0 111.298 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 43' ' ' ASN . 13.5 pt-20 -79.34 -176.37 5.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.314 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.98 65.05 0.25 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -108.37 -27.85 9.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.21 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -131.2 1.84 5.41 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.411 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . 46.87 -104.2 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 48' ' ' GLY . 48.5 Cg_endo -73.05 87.0 1.05 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.025 1.54 . . . . 0.0 110.513 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.02 27.02 1.44 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 53' ' ' ILE . 1.3 m -75.31 -171.18 1.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -1.181 . . . . 0.0 110.119 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.623 ' H ' HG22 ' A' ' 52' ' ' THR . 1.1 mp -125.27 168.43 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.621 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -149.11 147.56 28.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.397 -0.815 . . . . 0.0 109.914 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 2.4 tttp -111.53 92.04 3.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.91 -1.119 . . . . 0.0 110.537 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.691 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.8 mp -79.52 133.03 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.069 -1.019 . . . . 0.0 109.576 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.33 120.25 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 0.0 110.635 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.642 ' HZ ' HG21 ' A' ' 67' ' ' VAL . 16.6 m-85 -83.08 169.62 17.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.588 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 44.7 Cg_endo -71.15 173.96 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.628 1.33 . . . . 0.0 110.023 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' O ' HD23 ' A' ' 62' ' ' LEU . 6.3 tt0 -58.74 179.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.26 2.09 86.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -84.62 138.61 38.14 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -1.219 . . . . 0.0 110.599 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.67 -12.84 26.97 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.023 1.539 . . . . 0.0 109.81 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.542 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 18.8 m-30 -110.77 -139.54 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.96 -37.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.753 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 178.44 -166.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 66' ' ' TYR . 3.5 m -159.92 123.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.562 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -92.36 130.72 37.97 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.528 ' HB2' ' CG ' ' A' ' 54' ' ' LYS . 3.6 m-20 -118.0 151.08 38.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.907 -1.121 . . . . 0.0 111.449 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.56 114.34 27.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.607 HG22 HG23 ' A' ' 74' ' ' VAL . 8.9 p -58.49 -27.74 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 0.3 OUTLIER 42.04 51.28 4.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.0 mt-10 65.14 158.97 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.339 -0.85 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.607 HG23 HG22 ' A' ' 71' ' ' VAL . 90.0 t -144.07 159.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -109.41 -150.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.215 -0.928 . . . . 0.0 110.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.498 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 2.5 t-80 179.98 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 0.0 110.18 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -55.54 -52.72 62.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.231 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -90.28 15.59 10.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.223 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.772 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 11.6 m-85 47.09 69.32 0.51 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.507 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -126.57 143.83 51.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.929 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.447 ' CE1' HG22 ' A' ' 74' ' ' VAL . 27.1 t80 -141.7 100.77 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 71' ' ' VAL . 9.8 t-20 -96.72 104.17 16.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 109.563 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 8.4 p90 -132.02 -169.5 2.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 109.983 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 t -149.09 165.8 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.218 -0.926 . . . . 0.0 110.772 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 55.3 t -105.03 -26.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.382 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 85' ' ' VAL . 41.8 pt 37.05 -139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.162 0.506 . . . . 0.0 110.81 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' N ' HG13 ' A' ' 86' ' ' ILE . 1.4 mm-40 -60.61 135.43 57.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.996 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 136.66 142.72 4.49 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.358 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.542 ' HA2' ' CD2' ' A' ' 64' ' ' PHE . . . 88.18 -142.79 17.69 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 91' ' ' ILE . 52.2 Cg_endo -83.16 27.85 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.127 1.593 . . . . 0.0 110.993 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.15 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.474 -0.766 . . . . 0.0 110.581 -179.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 89.84 -163.77 30.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 1.3 m-20 56.44 -91.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -1.077 . . . . 0.0 110.484 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.476 HG21 ' HB2' ' A' ' 126' ' ' HIS . 76.3 p -142.12 47.37 1.62 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.438 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.981 HD22 HD11 ' A' ' 98' ' ' ILE . 1.4 mt -170.2 90.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.49 -49.97 6.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.573 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 1.9 ttpp -113.69 161.2 17.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.981 HD11 HD22 ' A' ' 95' ' ' LEU . 15.5 mt -158.39 113.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.473 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 4.3 m -104.32 122.2 44.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.166 -0.959 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.457 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 50.4 m-20 -116.29 133.5 55.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 111.601 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 82' ' ' ASN . 3.2 tp10 -118.57 129.49 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.438 ' C ' ' HG3' ' A' ' 103' ' ' LYS . 19.6 mt -116.91 146.96 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 0.0 110.783 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 49.4 mtpt -142.69 106.53 4.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.769 . . . . 0.0 109.784 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.951 HD11 HD12 ' A' ' 23' ' ' ILE . 14.5 mt -79.39 144.32 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.645 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 115' ' ' LYS . 22.1 t -130.07 127.52 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 110.157 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.6 132.83 34.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.116 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -111.13 153.03 44.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.386 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.33 -19.96 49.24 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.06 1.558 . . . . 0.0 110.703 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.414 ' OD2' ' O ' ' A' ' 109' ' ' ASP . 3.0 p-10 -158.43 44.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.92 21.59 0.78 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.85 -113.65 5.94 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 72.3 m -152.41 137.21 17.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.449 -1.03 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.4 mt -104.09 133.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.737 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.922 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.2 mp -95.25 99.91 11.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 110.002 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HD2' ' CG2' ' A' ' 105' ' ' VAL . 14.1 mttm -75.29 103.17 5.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.716 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.545 ' HB ' HG23 ' A' ' 7' ' ' THR . 25.8 mt -94.51 137.95 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 110.875 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.84 91.06 3.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.458 -0.776 . . . . 0.0 109.028 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 m-80 -84.48 92.24 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 111.387 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.503 ' HD2' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -84.73 103.37 13.76 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.71 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.2 m-85 -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.007 . . . . 0.0 111.468 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 32.7 m-70 -121.36 84.09 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 109.443 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.658 HG22 ' HG ' ' A' ' 95' ' ' LEU . 11.3 p -84.25 -164.74 0.99 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.357 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.415 ' HA ' ' HE2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -137.42 88.02 2.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.34 -135.04 45.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.417 ' HB3' HG22 ' A' ' 94' ' ' THR . 17.6 t0 50.87 -141.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -1.125 . . . . 0.0 110.142 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.476 ' HB2' HG21 ' A' ' 94' ' ' THR . 43.8 m-70 -83.29 179.48 7.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -95.96 161.03 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.266 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 3' ' ' PHE . 39.6 t -50.4 139.56 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.036 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 31.4 mtmt -94.32 117.63 30.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -46.68 -43.79 18.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.153 -0.967 . . . . 0.0 109.853 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -46.04 64.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.062 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -59.99 -44.93 94.2 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.621 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.963 HG21 ' CE2' ' A' ' 5' ' ' TYR . 54.4 t -59.66 -23.64 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.67 0.747 . . . . 0.0 109.163 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -79.35 -43.64 23.11 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.81 -0.557 . . . . 0.0 110.542 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -53.6 -53.79 46.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 t -61.15 -45.15 95.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.549 ' CE ' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -62.76 -18.42 62.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.865 . . . . 0.0 108.722 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 1.4 tt0 -77.82 -51.21 10.84 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 40.0 mmm -60.22 -33.38 72.19 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.193 -1.003 . . . . 0.0 108.78 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.58 -44.87 69.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -67.08 -39.88 86.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.808 -1.407 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -45.93 90.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.339 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.659 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.1 mm? -60.97 -52.62 64.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.337 -0.852 . . . . 0.0 109.324 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 9' ' ' THR . 10.3 tp -46.81 -43.27 18.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -63.37 -40.46 97.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 0.0 109.657 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -59.4 -61.33 2.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.903 HG13 HD23 ' A' ' 29' ' ' LEU . 9.6 t -62.75 -18.38 20.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.463 -0.773 . . . . 0.0 109.89 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' O ' HD22 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -72.61 -46.1 55.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 81.1 p -87.18 -15.0 39.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.54 ' CZ ' HD11 ' A' ' 29' ' ' LEU . 3.7 t80 -67.01 -39.89 87.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.995 . . . . 0.0 109.6 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.755 HD12 HG13 ' A' ' 13' ' ' ILE . 42.7 mt -63.1 -36.34 83.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.402 -0.811 . . . . 0.0 110.596 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.523 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -75.96 -51.98 11.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.311 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -53.77 -54.1 43.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -67.28 -163.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 44.8 m -94.09 59.37 2.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.447 ' OD2' ' ND2' ' A' ' 159' ' ' ASN . 0.1 OUTLIER 61.6 41.21 12.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.472 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -42.41 151.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 110.244 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.789 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 81.9 m-85 57.87 57.38 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.34 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.447 ' ND2' ' OD2' ' A' ' 156' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.155 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 3' ' ' PHE . 40.4 t 50.71 170.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.56 -0.965 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.709 ' CD1' HG23 ' A' ' 128' ' ' VAL . 97.4 m-85 -150.93 150.37 30.75 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -111.7 103.8 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.021 ' CE2' HG21 ' A' ' 133' ' ' VAL . 55.3 m-85 -100.79 87.21 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.45 108.51 19.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -127.99 -172.12 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.19 -170.87 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.867 . . . . 0.0 109.943 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.602 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 5.0 t -165.95 173.66 10.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 0.0 109.75 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.76 142.69 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.011 . . . . 0.0 110.491 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.821 ' OG ' HD11 ' A' ' 18' ' ' LEU . 20.2 t -132.13 144.15 50.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.47 -7.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.337 -0.852 . . . . 0.0 110.116 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.592 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 7.2 mm -94.78 145.27 29.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 110.473 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 30.9 Cg_endo -56.25 160.69 10.35 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.789 1.415 . . . . 0.0 110.686 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -63.26 -78.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 111.415 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -32.04 -54.6 0.3 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.664 -0.648 . . . . 0.0 111.421 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.55 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -57.41 -55.7 31.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.0 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.821 HD11 ' OG ' ' A' ' 11' ' ' SER . 5.4 mt -51.01 -28.74 10.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 24' ' ' LEU . 19.0 t80 -73.07 -67.47 0.57 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.68 -25.11 9.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.225 -0.922 . . . . 0.0 112.317 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.794 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -101.33 -58.16 1.94 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.541 -1.349 . . . . 0.0 111.443 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 24.2 t80 -80.59 -83.14 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.03 -1.044 . . . . 0.0 111.47 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.619 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 2.4 mp -46.36 -21.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.18 -0.95 . . . . 0.0 111.876 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.667 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -106.67 -77.81 0.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.664 -1.273 . . . . 0.0 110.043 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.8 t0 -73.15 83.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 0.0 110.212 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.63 -27.94 4.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.14 -12.75 60.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.271 . . . . 0.0 110.278 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -118.79 7.13 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.576 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.757 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -122.36 -40.32 2.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.803 . . . . 0.0 110.228 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.797 ' CD1' HD12 ' A' ' 143' ' ' LEU . 6.1 m-30 -61.39 -54.66 50.67 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.919 . . . . 0.0 111.35 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 44.4 Cg_endo -65.66 -6.13 13.19 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.306 1.161 . . . . 0.0 111.262 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -103.82 -67.61 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 110.592 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.042 HG23 ' HB1' ' A' ' 146' ' ' ALA . 12.0 m -74.76 -20.91 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 110.82 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.4 61.65 15.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 110.675 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.1 Cg_endo -67.86 -23.29 41.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.101 1.58 . . . . 0.0 109.136 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -73.6 -15.87 61.26 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.544 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -108.67 -66.16 1.07 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 110.75 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 39' ' ' SER . 4.0 mp -114.47 172.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.605 ' N ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -163.97 -25.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 111.472 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.4 t -133.45 138.76 46.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.588 -1.32 . . . . 0.0 111.122 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.846 HG11 HD13 ' A' ' 44' ' ' ILE . 19.4 t -124.57 128.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.587 -0.696 . . . . 0.0 109.41 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -133.17 148.37 52.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.009 . . . . 0.0 110.137 -179.407 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.569 ' O ' HG22 ' A' ' 53' ' ' ILE . 0.8 OUTLIER 69.48 22.79 6.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.846 HD13 HG11 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -71.56 -26.55 26.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.221 -0.925 . . . . 0.0 111.043 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 52' ' ' THR . 2.7 mp0 48.52 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.051 -1.03 . . . . 0.0 109.611 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -86.21 52.22 4.49 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 9.6 p30 178.48 39.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.241 -1.153 . . . . 0.0 110.258 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.32 -12.84 20.77 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.26 -108.87 0.28 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.23 89.87 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.872 1.459 . . . . 0.0 110.702 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.51 5.59 7.72 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.099 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 45' ' ' GLU . 86.2 m -50.07 158.44 0.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.048 -1.266 . . . . 0.0 110.172 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 43' ' ' ASN . 16.5 mm -117.11 165.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.4 pttp -179.66 142.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.006 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -140.58 108.84 5.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.831 -0.543 . . . . 0.0 109.601 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.7 mp -82.87 152.42 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.909 . . . . 0.0 110.59 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -127.38 139.83 52.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.99 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.742 ' HB3' HD12 ' A' ' 62' ' ' LEU . 24.1 m-85 -109.96 103.83 54.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.441 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.606 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 46.1 Cg_endo -72.82 -159.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.031 1.543 . . . . 0.0 110.198 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.565 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER 44.51 -172.53 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.094 -1.004 . . . . 0.0 111.526 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.565 ' N ' ' HG3' ' A' ' 60' ' ' GLU . . . -45.06 -18.26 0.13 Allowed Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.737 -0.602 . . . . 0.0 112.992 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.742 HD12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -42.82 125.75 3.14 Favored Pre-proline 0 N--CA 1.501 2.097 0 CA-C-N 119.672 1.736 . . . . 0.0 110.302 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 64' ' ' PHE . 50.4 Cg_endo -74.99 -156.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 109.846 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 63' ' ' PRO . 3.4 m-85 57.18 168.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.068 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -104.96 -39.82 6.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.89 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 29.1 p90 179.56 -175.11 0.25 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.74 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.554 HG23 ' HB ' ' A' ' 56' ' ' ILE . 8.2 m -150.93 106.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.961 -1.087 . . . . 0.0 110.779 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.1 tttt -107.35 139.41 41.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.93 ' HB3' HG13 ' A' ' 85' ' ' VAL . 2.7 p30 -159.71 166.13 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.907 -1.121 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.459 ' HD2' ' CD1' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -104.69 145.99 29.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.599 -0.688 . . . . 0.0 109.362 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.678 HG23 ' OH ' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -83.11 -38.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.986 -1.072 . . . . 0.0 110.154 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.05 -33.93 0.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.731 -0.606 . . . . 0.0 111.646 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' C ' HG23 ' A' ' 74' ' ' VAL . 6.0 pt-20 174.54 160.42 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.761 -1.212 . . . . 0.0 110.292 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.614 HG22 ' CE1' ' A' ' 81' ' ' TYR . 44.5 t -151.99 92.5 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.827 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -66.56 -169.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.185 -0.947 . . . . 0.0 110.541 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.414 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -153.75 -52.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.5 m -48.38 -34.81 11.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 75.3 m-20 -118.93 6.06 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.388 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 9.0 m-85 58.9 40.6 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.982 . . . . 0.0 110.059 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 1.4 tttt -89.02 117.46 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.988 . . . . 0.0 110.65 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.765 ' O ' HD12 ' A' ' 102' ' ' ILE . 25.1 t80 -118.4 132.93 56.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' VAL . 4.0 t30 -144.19 104.89 4.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 109.956 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.8 p90 -125.0 164.18 20.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.01 136.37 51.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.756 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.93 HG13 ' HB3' ' A' ' 69' ' ' ASP . 1.6 t -108.87 114.3 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.504 -0.748 . . . . 0.0 109.199 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 pt -113.94 6.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.029 -1.044 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.1 144.18 5.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.013 -1.054 . . . . 0.0 110.308 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.911 ' C ' HD11 ' A' ' 91' ' ' ILE . . . 84.0 133.48 2.43 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.476 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 124.18 -134.5 9.2 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' ILE . 45.0 Cg_endo -72.54 -6.32 18.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.919 1.484 . . . . 0.0 110.631 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.911 HD11 ' C ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -35.97 157.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.32 23.91 18.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.1 -146.36 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -1.187 . . . . 0.0 110.089 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 122' ' ' THR . 1.2 p -87.22 44.41 1.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.744 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -132.59 124.14 27.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.9 OUTLIER -105.72 -71.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.93 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -125.7 132.59 52.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.819 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.98 121.81 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.264 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.27 157.16 16.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.975 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.456 HD21 HG23 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -141.13 109.47 5.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.001 -1.062 . . . . 0.0 110.689 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 102' ' ' ILE . 33.6 tt0 -125.95 137.07 53.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.354 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.914 HD12 ' N ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER 175.71 -157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.242 -0.911 . . . . 0.0 112.837 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 80' ' ' LYS . 14.8 ptmt -172.59 179.52 2.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.26 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.815 HG23 HD12 ' A' ' 114' ' ' LEU . 14.8 mm -110.57 146.3 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.614 -0.679 . . . . 0.0 109.832 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.428 HG21 ' HD2' ' A' ' 115' ' ' LYS . 56.8 t -122.12 142.82 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HA ' ' OG ' ' A' ' 112' ' ' SER . . . -110.1 133.03 53.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.0 110.424 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 39.5 p -93.82 164.07 21.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 43.3 Cg_endo -64.91 -22.57 62.89 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.915 1.482 . . . . 0.0 111.149 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 22.4 p-10 -175.58 88.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.027 -1.045 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.82 -30.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.05 -133.77 6.2 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -147.84 140.18 24.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -1.128 . . . . 0.0 110.059 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 mt -95.72 120.48 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.863 . . . . 0.0 110.245 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.815 HD12 HG23 ' A' ' 104' ' ' ILE . 3.8 mp -83.25 108.04 16.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.773 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.747 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 18.1 mttt -94.44 121.68 36.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.683 -1.26 . . . . 0.0 109.17 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.874 ' CA ' HG21 ' A' ' 102' ' ' ILE . 34.1 mm -120.98 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.607 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.551 ' N ' HG21 ' A' ' 102' ' ' ILE . 13.0 m -119.06 126.4 51.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.495 -1.378 . . . . 0.0 109.275 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -119.7 150.32 40.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.948 . . . . 0.0 111.191 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.49 109.54 12.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.744 ' CD2' HD11 ' A' ' 95' ' ' LEU . 4.6 m-85 -86.9 135.06 33.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 111.556 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 96' ' ' GLU . 76.6 m-70 -123.08 86.49 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.49 HG21 ' CG2' ' A' ' 128' ' ' VAL . 8.9 p -86.9 -179.2 6.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -0.761 . . . . 0.0 110.902 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -60.04 -147.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.437 -0.789 . . . . 0.0 110.449 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.38 77.9 0.38 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.88 -71.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 109.918 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -85.54 173.65 10.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.896 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 52.8 mt-10 -110.25 -174.15 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 110.431 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.709 HG23 ' CD1' ' A' ' 3' ' ' PHE . 46.6 t -83.78 145.18 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.33 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -90.42 112.35 23.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.37 -41.82 14.08 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.168 -0.958 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.49 -46.82 76.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.296 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -58.83 -42.59 89.58 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.021 HG21 ' CE2' ' A' ' 5' ' ' TYR . 70.3 t -62.83 -25.81 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.748 0.785 . . . . 0.0 109.224 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.8 ttmt -73.83 -56.95 4.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.705 -0.622 . . . . 0.0 110.492 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -35.64 -52.1 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.688 -0.633 . . . . 0.0 110.952 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 t -57.49 -47.82 80.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -61.42 -28.63 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 135' ' ' ALA . 14.0 mm-40 -69.88 -57.83 4.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.281 -0.887 . . . . 0.0 109.351 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.544 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 2.7 mtp -54.81 -35.63 64.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.221 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.69 -39.04 95.12 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.79 -45.93 48.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.869 -1.371 . . . . 0.0 110.888 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 -41.01 92.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.027 -1.046 . . . . 0.0 109.49 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.797 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.5 mm? -68.35 -53.8 21.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.511 -0.743 . . . . 0.0 109.887 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 114' ' ' LEU . 16.1 tp -46.21 -43.72 15.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.145 -0.972 . . . . 0.0 108.811 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.509 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 2.2 ttp180 -66.22 -39.94 89.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.388 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.042 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -55.52 -62.36 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -0.843 . . . . 0.0 109.359 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.672 HG22 HD12 ' A' ' 29' ' ' LEU . 60.4 t -62.57 -23.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -61.79 -55.93 24.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.372 -0.83 . . . . 0.0 110.085 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -23.37 53.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.8 ' HB2' HG11 ' A' ' 33' ' ' VAL . 11.3 t80 -56.08 -37.82 69.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.117 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.5 -25.62 62.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.174 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 2.1 mp -88.89 -19.12 26.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.79 -38.41 14.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.838 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.56 156.27 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.846 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 3.3 p -44.26 -53.54 6.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 155' ' ' SER . 23.3 t70 -177.1 64.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.195 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.64 146.29 46.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 110.358 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.794 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 63.0 m-85 54.45 70.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 110.48 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.35 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.613 HG21 ' HD3' ' A' ' 119' ' ' LYS . 7.9 p -88.03 157.16 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -1.103 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.652 ' CD1' HG23 ' A' ' 128' ' ' VAL . 87.7 m-85 -123.6 122.78 39.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 110.03 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.59 98.82 10.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.815 ' CD1' HG11 ' A' ' 133' ' ' VAL . 46.7 m-85 -100.45 103.71 15.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 109.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -108.59 122.28 46.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.953 -1.092 . . . . 0.0 110.109 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 6.2 t -130.54 166.73 19.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 110.541 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 7' ' ' THR . 75.1 mt-10 -155.18 157.69 37.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.887 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -142.37 -178.51 5.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.015 . . . . 0.0 110.27 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.433 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -131.0 141.8 50.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.039 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.538 ' CB ' HD11 ' A' ' 18' ' ' LEU . 19.6 t -134.42 142.25 47.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.46 0.33 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.54 -0.725 . . . . 0.0 110.124 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.652 HD11 HD21 ' A' ' 152' ' ' LEU . 11.1 mm -96.69 147.99 33.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.9 Cg_endo -56.55 157.81 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.885 1.466 . . . . 0.0 110.033 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' ALA . . . -68.5 -64.04 0.94 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.072 -1.017 . . . . 0.0 110.886 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -43.35 -50.52 6.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.732 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.572 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.17 -52.18 65.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.607 HD12 ' OG ' ' A' ' 112' ' ' SER . 6.0 mt -52.31 -24.1 6.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 108.773 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.712 ' CE2' HD21 ' A' ' 24' ' ' LEU . 43.5 t80 -77.66 -55.66 5.17 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.466 -0.772 . . . . 0.0 110.384 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 5.0 mmmt -61.25 -21.76 64.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.569 -0.707 . . . . 0.0 111.884 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -111.39 -47.26 3.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.685 -1.259 . . . . 0.0 112.774 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' HE2' HD21 ' A' ' 114' ' ' LEU . 39.2 t80 -89.68 -22.08 22.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.718 -1.239 . . . . 0.0 112.482 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.638 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 mp -116.56 -13.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.649 -1.282 . . . . 0.0 110.378 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.712 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -111.96 -12.91 13.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.481 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 9.6 t0 -146.67 47.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.547 ' CA ' ' CE1' ' A' ' 30' ' ' PHE . . . -83.25 -31.16 28.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.775 ' HB3' HG11 ' A' ' 41' ' ' VAL . 52.4 m-20 -76.77 2.96 12.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -1.088 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 9.5 t-20 -138.62 50.47 1.86 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.994 HD21 HG13 ' A' ' 147' ' ' VAL . 1.1 tp 173.06 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.581 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' CA ' ' A' ' 26' ' ' GLY . 3.0 m-30 -52.18 -59.29 8.74 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.919 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -67.06 -11.97 34.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 111.211 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -90.06 -31.58 17.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 111.031 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HB1' ' A' ' 146' ' ' ALA . 10.5 m -103.82 -11.81 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -138.94 66.6 40.15 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.808 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.4 -5.37 14.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.967 1.509 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -94.9 -12.61 26.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.411 -0.806 . . . . 0.0 109.625 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.02 -28.93 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.668 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 39' ' ' SER . 6.7 mm -125.75 178.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.967 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.603 ' H ' HG22 ' A' ' 38' ' ' ILE . 4.1 t -136.35 -45.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 t -174.85 165.16 3.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.775 HG11 ' HB3' ' A' ' 27' ' ' ASP . 99.5 t -118.58 124.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 110.034 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 3.5 tp10 -97.06 124.21 41.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.417 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.84 91.12 8.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 tp -81.52 -24.7 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 110.31 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' HB3' ' HB ' ' A' ' 53' ' ' ILE . 6.5 tp10 -159.49 75.77 0.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.171 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.78 98.78 1.32 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -81.19 -70.64 0.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -1.149 . . . . 0.0 110.196 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.07 68.14 0.09 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 129.03 -137.83 9.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.99 102.97 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.935 1.492 . . . . 0.0 110.389 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA2' ' NH2' ' A' ' 70' ' ' ARG . . . 126.51 31.39 0.78 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.1 m -103.43 117.24 34.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -1.227 . . . . 0.0 110.107 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.618 HD12 ' N ' ' A' ' 53' ' ' ILE . 3.9 mp -97.06 136.71 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 84.6 mttt -139.41 148.99 43.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 6.7 tttt -117.45 96.03 5.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.82 . . . . 0.0 110.653 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.563 HD11 ' OD1' ' A' ' 27' ' ' ASP . 1.4 mp -73.47 148.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 27.5 t -124.75 169.38 12.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.271 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 39.4 m-85 -134.33 153.68 79.47 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.601 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 62' ' ' LEU . 48.4 Cg_endo -76.36 169.72 21.39 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.185 1.624 . . . . 0.0 109.615 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 167.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 110.061 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.03 -43.41 3.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 59' ' ' PRO . 8.5 mt -79.96 155.36 75.24 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.083 -1.245 . . . . 0.0 110.65 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HG2' ' CE2' ' A' ' 64' ' ' PHE . 50.8 Cg_endo -81.88 162.36 18.48 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.193 1.628 . . . . 0.0 110.971 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' A' ' 63' ' ' PRO . 11.6 m-85 65.69 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 0.0 110.634 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -69.1 -9.5 52.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.482 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 30.1 p90 -175.75 -170.34 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 110.176 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 67' ' ' VAL . 7.3 p -170.93 109.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.3 mtmm -96.15 138.42 33.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.751 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.18 -176.06 4.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.691 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.445 ' NH2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -138.75 127.91 24.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 109.902 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.533 HG13 ' CZ ' ' A' ' 81' ' ' TYR . 55.7 t -68.25 -44.38 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.323 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.4 m-20 77.98 -38.2 0.25 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.803 -0.56 . . . . 0.0 111.419 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 179.0 -167.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.696 -1.253 . . . . 0.0 111.001 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.2 p -167.91 118.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.628 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -77.26 -49.75 14.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.174 -0.953 . . . . 0.0 110.955 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.566 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.7 OUTLIER 77.94 -71.16 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.634 -0.666 . . . . 0.0 110.506 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -57.77 -42.49 84.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.316 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 79' ' ' PHE . 76.2 m-20 -97.03 18.0 15.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 23.2 m-30 43.49 27.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.525 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.5 ttpt -95.29 107.62 19.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.161 -0.962 . . . . 0.0 109.874 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 102' ' ' ILE . 20.4 t80 -110.79 96.82 6.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.596 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 2.2 m-20 -84.39 161.22 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.839 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 13.4 p90 -179.33 152.42 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.44 -0.787 . . . . 0.0 109.768 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.66 146.66 48.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.206 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.6 t -104.97 73.11 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.257 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.413 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 5.4 pt -62.06 -42.51 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.345 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 2.6 mt-10 -139.66 94.91 2.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.898 -1.126 . . . . 0.0 110.709 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.97 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 167.96 120.35 0.52 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.97 -147.35 16.85 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 91' ' ' ILE . 47.7 Cg_endo -72.43 -3.41 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 124.033 1.544 . . . . 0.0 110.22 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.97 HD11 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -34.85 157.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 121.535 0.683 . . . . 0.0 110.596 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.95 -8.05 59.25 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -108.66 -85.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -1.147 . . . . 0.0 110.396 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 122' ' ' THR . 0.6 OUTLIER -130.1 -18.89 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.931 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.715 HD22 HG12 ' A' ' 98' ' ' ILE . 2.3 mt -80.9 83.35 6.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 110.195 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.88 -52.33 63.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' C ' HG13 ' A' ' 98' ' ' ILE . 3.4 tptt -137.32 165.71 25.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.199 -0.938 . . . . 0.0 110.531 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.715 HG12 HD22 ' A' ' 95' ' ' LEU . 23.1 mt -150.73 122.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.078 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -99.19 135.08 41.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.908 . . . . 0.0 109.761 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 76.8 m-20 -137.71 140.89 40.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.75 -1.218 . . . . 0.0 110.972 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 7.0 pt-20 -138.26 154.03 49.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.76 . . . . 0.0 109.546 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 81' ' ' TYR . 2.9 mt -128.13 155.13 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.469 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 22.9 mtmt -149.1 103.77 3.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 109.502 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 2.9 mm -81.53 120.19 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 109.871 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.551 HG21 ' CD ' ' A' ' 115' ' ' LYS . 61.3 t -105.14 123.08 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.99 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.22 140.31 34.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 44.3 p -113.16 162.17 23.3 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.87 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 48.9 Cg_endo -66.62 -30.62 42.27 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.961 1.506 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -162.86 44.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.31 23.39 2.05 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.96 -135.84 26.65 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.607 ' OG ' HD12 ' A' ' 18' ' ' LEU . 6.5 p -132.81 134.62 44.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -1.14 . . . . 0.0 110.326 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 10' ' ' THR . 13.2 mt -95.13 124.06 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.887 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.0 OUTLIER -81.86 96.09 7.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 110.964 -179.311 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.551 ' CD ' HG21 ' A' ' 105' ' ' VAL . 3.9 mttp -87.47 107.86 18.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.402 ' CG1' HG23 ' A' ' 102' ' ' ILE . 5.2 mt -116.78 132.54 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.22 144.06 36.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.519 -0.738 . . . . 0.0 109.589 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' TYR . 25.1 m120 -136.78 143.46 43.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 110.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.613 ' HD3' HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -132.47 108.92 9.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.679 ' CD2' HD11 ' A' ' 95' ' ' LEU . 5.4 m-85 -87.12 114.18 23.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.835 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -101.21 92.12 4.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.224 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 128' ' ' VAL . 7.6 p -85.27 -151.75 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.827 . . . . 0.0 110.748 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.42 3.07 15.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 110.566 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 96.45 -157.24 21.33 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -1.017 . . . . 0.0 110.248 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 124' ' ' GLY . 1.6 m-70 -81.1 166.21 20.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.895 -1.128 . . . . 0.0 110.009 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -109.58 167.84 9.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.431 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.652 HG23 ' CD1' ' A' ' 3' ' ' PHE . 23.4 t -63.39 150.51 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 110.248 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 132' ' ' GLN . 40.8 mtmt -83.57 102.79 12.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.87 -56.42 3.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.133 -0.98 . . . . 0.0 109.912 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.3 tt0 -44.83 -45.34 10.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.227 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.533 ' HB2' ' HB2' ' A' ' 129' ' ' LYS . 1.4 tm0? -58.11 -44.71 87.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 108.921 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.815 HG11 ' CD1' ' A' ' 5' ' ' TYR . 79.0 t -60.67 -25.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 135' ' ' ALA . 1.9 tttm -81.88 -68.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.966 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.53 -40.76 0.41 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 110.325 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -51.25 68.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.047 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 6.6 mptt -56.07 -30.65 62.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.489 -0.757 . . . . 0.0 109.557 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 109.876 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 57.0 mmm -67.62 -34.34 76.79 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.864 . . . . 0.0 108.813 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -71.01 -43.32 57.66 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -66.48 -33.76 76.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -1.157 . . . . 0.0 110.108 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.512 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 2.0 p -70.59 -43.45 69.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.271 -0.893 . . . . 0.0 109.23 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 143' ' ' LEU . 1.0 OUTLIER -70.08 -25.27 63.44 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.548 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.794 HD22 HD22 ' A' ' 114' ' ' LEU . 17.2 tp -73.3 -43.32 61.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 108.901 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -72.32 -25.64 61.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -70.84 -53.94 13.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 109.028 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.994 HG13 HD21 ' A' ' 29' ' ' LEU . 62.1 t -70.61 -21.86 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.154 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -69.55 -52.39 26.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.315 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.478 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 88.9 p -74.87 -23.13 58.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.333 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.589 ' CG ' HD11 ' A' ' 29' ' ' LEU . 9.1 t80 -59.04 -41.8 88.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.94 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.09 -27.7 69.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.652 HD21 HD11 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -86.35 -23.63 26.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.15 -55.49 5.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.227 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.469 ' O ' ' HB3' ' A' ' 155' ' ' SER . 11.4 m80 -73.8 -34.11 64.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 110.064 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 23.1 t 59.36 15.02 4.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 156' ' ' ASP . 1.7 p30 -145.48 12.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.95 . . . . 0.0 110.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.571 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.85 131.16 48.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.4 m-85 58.03 48.02 13.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.421 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.209 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 3' ' ' PHE . 47.1 t -105.72 165.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -1.21 . . . . 0.0 110.537 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 53.6 m-85 -125.29 148.4 48.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.785 . . . . 0.0 109.65 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -117.2 110.08 17.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 110.539 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.748 ' CD2' HG11 ' A' ' 133' ' ' VAL . 23.0 m-85 -108.75 76.7 1.03 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.598 -0.689 . . . . 0.0 109.527 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 85.7 mt-10 -84.05 96.72 8.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 110.879 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -106.29 163.17 13.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.836 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -135.33 144.44 46.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.146 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.807 HG22 ' HB3' ' A' ' 114' ' ' LEU . 1.1 t -134.39 161.48 34.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.86 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -123.52 143.64 50.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.99 . . . . 0.0 110.341 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -135.8 147.33 48.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 110.24 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.03 -20.93 19.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 109.772 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.543 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 6.4 mm -75.93 140.0 70.08 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.7 Cg_endo -57.22 148.95 67.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.807 1.425 . . . . 0.0 110.568 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.557 ' HA ' ' CG2' ' A' ' 104' ' ' ILE . . . -55.08 -46.09 75.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 0.0 111.275 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.0 -58.98 5.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 111.009 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 6.4 mtm180 -53.95 -57.35 11.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 109.671 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.48 -32.11 7.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.561 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 1.022 ' CE1' HD21 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -68.34 -62.77 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.525 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 26.5 mtpp -59.54 -23.06 62.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.519 -0.738 . . . . 0.0 112.842 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.632 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -106.08 -55.73 2.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.481 -1.387 . . . . 0.0 111.943 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 57.7 t80 -79.19 -9.33 59.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 0.0 112.07 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 24' ' ' LEU . 71.4 mt -130.07 -21.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.627 -1.296 . . . . 0.0 111.63 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.022 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.7 mt -106.18 -14.93 15.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.224 . . . . 0.0 109.536 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.524 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -138.39 30.67 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.441 -0.787 . . . . 0.0 110.416 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.3 -36.95 93.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' HG11 ' A' ' 41' ' ' VAL . 52.1 m-20 -60.89 -14.57 23.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -1.047 . . . . 0.0 109.815 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t30 -122.47 52.12 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.655 HD21 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -172.4 -52.26 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.493 -0.755 . . . . 0.0 110.102 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.614 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 7.1 m-30 -43.73 -53.91 11.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 111.093 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -67.02 -29.57 40.19 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.346 1.182 . . . . 0.0 111.065 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -77.42 -71.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 111.17 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 150' ' ' TYR . 22.2 m -71.99 -20.49 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 111.596 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -126.18 63.17 48.99 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.897 -1.127 . . . . 0.0 111.106 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.7 Cg_endo -69.26 -11.42 31.44 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.858 1.451 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.5 OUTLIER -87.08 -8.18 57.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.501 -0.749 . . . . 0.0 109.578 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.626 ' HB3' HD21 ' A' ' 143' ' ' LEU . . . -117.53 -48.53 2.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.974 . . . . 0.0 110.392 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' A' ' 30' ' ' PHE . 2.9 mp -117.69 156.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.077 -1.014 . . . . 0.0 110.199 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -113.55 -31.04 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER 169.53 159.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.81 . . . . 0.0 109.905 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 27' ' ' ASP . 3.4 p -126.9 129.51 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.925 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -105.65 141.41 37.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 110.589 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -99.9 108.7 21.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.978 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.743 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -85.08 -33.02 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.499 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -149.06 92.21 1.94 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.173 -0.954 . . . . 0.0 110.54 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.92 161.76 9.53 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -125.04 22.53 7.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.262 -1.14 . . . . 0.0 110.313 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.34 147.51 18.47 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.88 -166.39 20.28 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.471 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . 45.7 Cg_endo -72.35 126.9 12.06 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.074 1.565 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.29 7.54 55.91 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.4 m -91.09 132.39 36.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -1.17 . . . . 0.0 110.353 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.614 HD12 ' CD ' ' A' ' 70' ' ' ARG . 16.2 mm -106.37 116.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.406 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -118.47 162.4 18.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.074 . . . . 0.0 110.708 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -134.21 113.49 12.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.579 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.9 mp -81.49 144.7 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 t -125.9 101.43 6.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.622 -0.674 . . . . 0.0 109.844 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' HB2' HD12 ' A' ' 62' ' ' LEU . 38.6 m-85 -70.06 140.23 88.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 50.5 Cg_endo -82.74 48.28 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.165 1.613 . . . . 0.0 110.4 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.461 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 5.1 tt0 -135.04 -170.82 2.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.382 -0.824 . . . . 0.0 110.357 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.08 37.36 3.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 58' ' ' PHE . 79.1 mt -56.1 163.2 2.4 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.311 -1.111 . . . . 0.0 110.168 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 64' ' ' PHE . 46.6 Cg_endo -73.38 -9.47 23.06 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.021 1.538 . . . . 0.0 110.257 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 3.8 m-85 -114.88 -34.51 5.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.128 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 1.5 ttpt 74.45 -0.41 3.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.603 -0.685 . . . . 0.0 109.997 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 32.9 p90 179.88 -161.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 67' ' ' VAL . 8.7 p -179.45 118.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.308 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 55' ' ' LYS . 2.7 tttt -87.67 138.57 31.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -140.29 163.89 31.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.087 -1.008 . . . . 0.0 110.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.614 ' CD ' HD12 ' A' ' 53' ' ' ILE . 5.8 mtm180 -121.82 139.54 53.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.384 -0.822 . . . . 0.0 109.943 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' ASP . 24.6 t -73.21 -17.92 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.942 . . . . 0.0 110.262 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER 44.99 27.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.959 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' OE2' ' HB2' ' A' ' 50' ' ' PRO . 1.7 mt-10 65.76 148.6 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.679 HG11 ' CD1' ' A' ' 81' ' ' TYR . 27.3 m -123.23 -170.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.545 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.04 152.28 42.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.39 -52.61 2.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.021 -1.05 . . . . 0.0 110.633 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.3 m -61.4 -10.91 8.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.856 -1.152 . . . . 0.0 110.599 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -125.19 6.44 7.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.015 -1.053 . . . . 0.0 110.535 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.553 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.7 m-30 46.83 54.97 8.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 29.3 tttt -124.14 105.52 9.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 111.143 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.679 ' CD1' HG11 ' A' ' 74' ' ' VAL . 74.2 t80 -89.72 178.23 6.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 109.315 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.427 ' N ' ' CG ' ' A' ' 81' ' ' TYR . 5.9 t30 -179.2 129.81 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.788 -1.195 . . . . 0.0 110.642 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 3.8 p90 -137.77 152.46 49.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.802 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.18 132.4 44.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.643 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.0 HG12 HD11 ' A' ' 91' ' ' ILE . 25.4 t -89.55 133.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 109.331 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.3 -14.96 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 111.328 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.625 ' C ' HD12 ' A' ' 91' ' ' ILE . 1.4 mm-40 -150.67 107.57 3.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.93 -1.106 . . . . 0.0 110.917 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 1.127 ' N ' HD12 ' A' ' 91' ' ' ILE . . . 127.04 -137.75 10.12 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 64' ' ' PHE . . . 26.69 -128.22 0.05 OUTLIER Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.567 ' O ' ' C ' ' A' ' 91' ' ' ILE . 42.8 Cg_endo -70.86 -59.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.877 1.462 . . . . 0.0 109.376 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.127 HD12 ' N ' ' A' ' 88' ' ' GLY . 1.8 mt 4.59 90.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 121.746 0.784 . . . . 0.0 112.893 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.95 -149.34 6.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.98 -18.82 5.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.287 . . . . 0.0 109.435 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -128.12 136.26 50.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.81 . . . . 0.0 109.964 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 120' ' ' TYR . 4.6 mt 63.38 92.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.294 -0.878 . . . . 0.0 110.063 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.78 -34.88 21.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -140.77 150.01 42.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.017 . . . . 0.0 110.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.556 HD11 ' CG ' ' A' ' 90' ' ' PRO . 58.9 mt -139.59 126.23 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.5 m -117.41 110.44 18.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 118' ' ' ASN . 1.9 m120 -106.86 119.45 39.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.905 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' O ' HD13 ' A' ' 102' ' ' ILE . 53.7 mt-10 -105.51 132.37 51.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 109.418 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.674 HD12 HG12 ' A' ' 116' ' ' ILE . 20.0 mm -124.31 155.95 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.093 -1.004 . . . . 0.0 110.915 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 2.8 ttmt -148.2 114.5 5.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.796 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.557 ' CG2' ' HA ' ' A' ' 15' ' ' ALA . 1.5 mp -77.41 121.27 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.01 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG23 ' HG2' ' A' ' 115' ' ' LYS . 61.9 t -104.45 133.4 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 110.435 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.26 132.37 44.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.0 p -106.68 157.87 34.12 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.018 . . . . 0.0 110.625 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.509 ' O ' ' HB3' ' A' ' 109' ' ' ASP . 49.6 Cg_endo -67.63 81.88 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.156 1.609 . . . . 0.0 110.218 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 7.6 t70 71.02 49.69 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.567 -0.708 . . . . 0.0 110.275 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.65 13.9 1.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.87 -159.21 34.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 3.4 p -126.38 131.09 51.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -1.129 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.59 HG23 HG23 ' A' ' 10' ' ' THR . 6.1 mt -93.79 116.89 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.807 ' HB3' HG22 ' A' ' 9' ' ' THR . 0.7 OUTLIER -77.69 106.4 9.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 110.703 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.554 ' HG2' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -82.06 115.63 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.881 -1.137 . . . . 0.0 108.952 178.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.674 HG12 HD12 ' A' ' 102' ' ' ILE . 81.7 mt -113.79 127.99 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 111.199 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -126.72 95.55 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.531 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 72.2 m-20 -93.08 108.29 19.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 111.403 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 124.94 39.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 109.322 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.921 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.6 m-85 -103.34 112.22 25.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 111.115 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -96.19 98.15 10.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.68 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.714 HG21 HG23 ' A' ' 128' ' ' VAL . 11.3 p -82.69 -173.1 4.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.334 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' THR . 0.0 OUTLIER 170.27 43.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.46 -152.14 5.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.62 -69.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -1.14 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.539 ' HB2' ' CG2' ' A' ' 94' ' ' THR . 7.1 m-70 -80.53 176.28 9.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.182 -0.949 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 11.8 mp0 -106.02 -99.98 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.548 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.714 HG23 HG21 ' A' ' 122' ' ' THR . 40.1 t -126.41 151.5 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.704 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 130' ' ' ALA . 6.4 mtmt -104.43 99.3 9.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.02 -42.8 2.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.328 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 9.4 tt0 -54.81 -49.01 72.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.043 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -58.92 -46.37 88.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 109.45 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.92 HG22 ' CE2' ' A' ' 120' ' ' TYR . 38.5 t -62.23 -20.74 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.15 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.0 tttm -81.14 -68.57 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.6 -40.57 0.41 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 110.189 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.45 -51.61 66.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.179 -0.951 . . . . 0.0 109.105 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -54.92 -52.57 62.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 109.981 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -50.27 -46.45 55.08 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -34.99 75.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.29 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.53 -34.46 89.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -71.83 -45.45 61.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -1.192 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -37.1 80.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 108.857 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.626 HD21 ' HB3' ' A' ' 37' ' ' ALA . 1.3 mm? -69.24 -37.92 78.24 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.492 HD13 HD22 ' A' ' 114' ' ' LEU . 13.6 tp -62.08 -34.62 76.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -33.91 61.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.649 -0.657 . . . . 0.0 109.728 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -65.49 -50.06 66.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.844 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 34.4 t -74.74 -27.88 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.793 . . . . 0.0 109.772 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 13' ' ' ILE . 10.7 tt0 -65.61 -44.42 86.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 34.5 m -86.79 -21.32 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 109.939 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.661 ' HB2' HG11 ' A' ' 33' ' ' VAL . 5.3 t80 -58.81 -44.42 90.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 ' CD2' ' A' ' 150' ' ' TYR . 52.6 mt -63.08 -24.41 67.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.96 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.6 mp -82.36 -36.86 26.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 110.361 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.46 -53.86 10.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.0 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.456 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 58.8 m80 -75.39 -32.35 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.993 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.5 t 46.48 23.68 0.24 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 154' ' ' HIS . 4.7 m-20 -141.51 9.18 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.463 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -113.18 128.81 56.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CE2' HD11 ' A' ' 29' ' ' LEU . 28.2 m-85 61.93 41.72 11.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.477 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.216 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 121' ' ' HIS . 54.8 t -82.63 152.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 83.2 m-85 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -108.18 116.04 31.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.995 -1.065 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.72 ' CD2' HG11 ' A' ' 133' ' ' VAL . 21.3 m-85 -114.98 86.34 2.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 0.0 110.729 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.9 mt-10 -51.25 147.15 5.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 108.917 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.5 ' HB ' ' OD1' ' A' ' 118' ' ' ASN . 12.3 t -141.06 173.52 11.4 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.51 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.603 ' OE1' HG22 ' A' ' 113' ' ' ILE . 0.2 OUTLIER 178.31 126.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.452 0.644 . . . . 0.0 110.07 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.983 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -129.95 158.23 40.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 140.21 49.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.832 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 18' ' ' LEU . 92.7 p -132.48 148.33 52.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.622 -0.674 . . . . 0.0 109.786 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -23.05 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 110.297 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.556 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 14.8 mm -81.85 143.1 49.52 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.576 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -57.17 150.51 56.95 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.04 1.547 . . . . 0.0 110.946 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.74 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -51.84 -49.07 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 110.699 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -54.42 -55.09 32.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.971 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 9.6 mmt85 -54.9 -55.75 27.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.111 -0.993 . . . . 0.0 110.657 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 11' ' ' SER . 9.9 mt -58.87 -24.49 62.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.908 -1.12 . . . . 0.0 109.483 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.762 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -67.64 -56.02 11.02 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.58 -0.7 . . . . 0.0 109.789 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.5 mtpt -68.9 -25.09 64.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.618 -0.676 . . . . 0.0 112.128 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.784 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -103.89 -55.85 2.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.658 -1.276 . . . . 0.0 111.625 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.4 t80 -84.1 -1.41 54.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 112.203 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 104' ' ' ILE . 12.8 mt -134.4 -22.95 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.555 -1.34 . . . . 0.0 111.38 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.762 HD21 ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -105.87 -22.78 12.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 108.87 178.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -131.98 70.04 1.47 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.699 -0.626 . . . . 0.0 109.899 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -97.44 -43.31 2.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.608 ' HB3' HG11 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -69.9 -9.99 56.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -1.111 . . . . 0.0 110.337 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 21.7 t-20 -130.56 52.02 2.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.78 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.964 HD22 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER 173.49 -26.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.675 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.783 ' N ' HD13 ' A' ' 29' ' ' LEU . 3.8 m-30 -56.78 -58.74 15.42 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.253 -0.904 . . . . 0.0 110.601 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.4 Cg_endo -64.67 -29.95 60.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.829 1.436 . . . . 0.0 111.205 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -16.18 63.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.092 -1.005 . . . . 0.0 110.552 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.839 HG23 ' HB1' ' A' ' 146' ' ' ALA . 9.0 m -123.63 -10.75 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.943 . . . . 0.0 110.271 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -138.11 66.66 46.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.803 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.67 -9.71 26.96 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.871 1.458 . . . . 0.0 109.821 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -88.98 -10.87 46.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -118.03 -57.42 2.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 109.946 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG12 HD21 ' A' ' 143' ' ' LEU . 13.5 mm -95.14 170.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 0.0 110.45 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.63 -41.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.2 t -169.13 171.93 7.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.608 HG11 ' HB3' ' A' ' 27' ' ' ASP . 60.1 t -136.8 149.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 55' ' ' LYS . 3.9 tt0 -119.1 104.14 10.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.463 -0.773 . . . . 0.0 109.498 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 1.6 m-20 -90.16 104.77 17.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.333 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.4 HG23 ' OE1' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -65.89 -21.52 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 110.058 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 6.4 pt-20 -172.92 129.24 0.49 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 0.0 109.916 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.58 58.44 0.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -144.72 11.97 1.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -1.181 . . . . 0.0 110.231 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.79 -154.49 18.43 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.27 -80.75 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.79 60.07 7.42 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.24 1.653 . . . . 0.0 110.44 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.893 ' O ' HD12 ' A' ' 53' ' ' ILE . . . 168.79 -25.61 0.11 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.125 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 51' ' ' GLY . 77.1 m -39.39 128.3 1.84 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.273 -1.133 . . . . 0.0 110.752 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -112.41 156.13 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -139.85 153.3 47.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.866 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' CG ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.81 87.97 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 110.6 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.824 ' HB ' HG13 ' A' ' 67' ' ' VAL . 1.9 mp -69.68 146.92 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.005 -1.06 . . . . 0.0 109.873 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.45 155.52 46.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.607 -0.683 . . . . 0.0 109.885 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 62' ' ' LEU . 30.1 m-85 -119.02 161.46 36.36 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.067 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' GLU . 47.5 Cg_endo -74.9 -164.73 0.24 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.059 1.557 . . . . 0.0 110.08 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER 40.0 -166.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.483 -0.761 . . . . 0.0 111.183 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.542 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -109.48 62.26 0.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 58' ' ' PHE . 13.3 mt -40.84 167.01 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.953 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 42.2 Cg_endo -68.97 -6.68 18.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.88 1.463 . . . . 0.0 110.277 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 18.7 m-30 -114.0 -100.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 166.09 -28.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 108.992 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 30.2 p90 -177.01 -164.55 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.824 HG13 ' HB ' ' A' ' 56' ' ' ILE . 3.6 p -166.25 128.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 0.0 110.547 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -103.03 147.35 27.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.412 ' OD1' HD13 ' A' ' 56' ' ' ILE . 6.9 p-10 -145.01 146.01 31.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HD3' HD11 ' A' ' 53' ' ' ILE . 12.0 ttp180 -117.32 134.4 54.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.3 131.1 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 110.271 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -103.31 52.03 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 16.2 mm-40 59.22 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.297 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 81' ' ' TYR . 35.1 t -105.4 147.84 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.638 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.7 OUTLIER -63.25 -51.64 65.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 73.25 -75.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.546 -0.721 . . . . 0.0 110.887 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -60.53 -11.7 7.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.839 -1.163 . . . . 0.0 110.638 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -122.3 5.06 9.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 0.0 110.474 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.475 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.2 m-30 54.92 65.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.317 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.504 ' HB2' ' CB ' ' A' ' 75' ' ' ASP . 5.1 mttp -142.66 108.82 5.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.658 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.619 ' O ' HD12 ' A' ' 102' ' ' ILE . 7.4 t80 -95.25 123.57 38.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 110.838 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -119.94 123.37 43.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.486 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 84' ' ' SER . 2.7 p90 -148.89 174.06 12.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 110.698 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.41 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 10.5 p -140.2 167.66 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.741 ' C ' HG23 ' A' ' 86' ' ' ILE . 23.5 t -92.64 -54.2 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.741 HG23 ' C ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER 69.67 -18.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 2.1 tt0 170.68 162.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.543 -1.348 . . . . 0.0 110.403 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 81.76 -173.08 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.79 -147.96 47.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 49.4 Cg_endo -81.39 32.67 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.99 1.521 . . . . 0.0 110.94 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 91' ' ' ILE 0.297 1.5 mm -67.55 138.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 142.89 -165.94 26.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 44.6 -141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.889 HG21 ' HB2' ' A' ' 126' ' ' HIS . 1.8 p -89.06 72.15 8.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.967 HD22 HD11 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -168.36 82.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.333 -0.854 . . . . 0.0 110.044 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.501 ' OE2' ' CE ' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -63.62 -59.0 5.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.434 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.532 ' HG3' ' HB2' ' A' ' 121' ' ' HIS . 1.6 pttm -135.97 162.26 33.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.969 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.967 HD11 HD22 ' A' ' 95' ' ' LEU . 95.7 mt -139.15 122.23 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 111.289 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.6 151.96 20.59 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.517 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 53.6 t30 -154.75 147.48 24.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.873 -1.142 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.754 ' HB2' HG21 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -141.25 152.63 44.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.689 -0.632 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.826 HD12 ' N ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -152.62 144.6 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.294 0.569 . . . . 0.0 110.044 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.664 ' HG3' HG23 ' A' ' 105' ' ' VAL . 4.1 ptmm? -116.13 134.6 54.76 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.901 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.74 HG22 ' CB ' ' A' ' 15' ' ' ALA . 10.9 mm -92.18 90.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.673 -0.642 . . . . 0.0 109.86 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.664 HG23 ' HG3' ' A' ' 103' ' ' LYS . 17.2 t -87.02 133.97 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.349 -0.844 . . . . 0.0 110.372 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.93 133.1 35.99 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.632 -0.668 . . . . 0.0 109.668 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.1 p -87.65 155.93 53.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.297 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.27 -11.55 32.62 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -175.43 86.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 170.48 -88.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.03 -135.18 1.77 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.54 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 5.0 p -124.93 170.42 11.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -1.156 . . . . 0.0 109.889 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.603 HG22 ' OE1' ' A' ' 8' ' ' GLU . 36.5 mt -139.22 123.55 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 111.203 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.983 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.6 mp -93.43 93.83 8.36 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.646 ' HE2' HG21 ' A' ' 105' ' ' VAL . 5.6 pttt -131.45 138.24 48.96 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.821 -1.152 . . . . 0.0 113.589 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.868 HG22 ' N ' ' A' ' 117' ' ' SER . 1.2 mm -178.71 -95.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.868 ' N ' HG22 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -175.07 177.4 1.94 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.835 -1.166 . . . . 0.0 112.686 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.1 m120 -142.44 106.56 4.74 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -92.5 122.88 35.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 111.06 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.744 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.5 m-85 -96.81 109.33 22.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.404 -0.81 . . . . 0.0 109.646 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.532 ' HB2' ' HG3' ' A' ' 97' ' ' LYS . 76.6 m-70 -89.06 104.02 16.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 95' ' ' LEU . 3.0 p -116.43 -158.04 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.491 -0.755 . . . . 0.0 109.881 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.501 ' CE ' ' OE2' ' A' ' 96' ' ' GLU . 3.5 pttp -177.12 143.77 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 129.15 -98.0 0.43 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.19 -48.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.889 ' HB2' HG21 ' A' ' 94' ' ' THR . 80.1 m-70 -56.83 144.5 32.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' VAL . 52.3 mt-10 -89.86 148.86 22.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 110.403 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.565 HG23 ' CD1' ' A' ' 3' ' ' PHE . 13.3 t -41.34 164.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.499 -0.751 . . . . 0.0 110.174 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 133' ' ' VAL . 5.0 mtmt -111.49 131.53 55.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.38 -44.88 84.84 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.033 -1.042 . . . . 0.0 109.413 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -31.51 16.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 25.9 mt-30 -79.23 -40.67 30.09 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.233 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.72 HG11 ' CD2' ' A' ' 5' ' ' TYR . 2.6 t -78.84 -0.3 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.655 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.27 -42.52 4.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.8 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -57.79 -44.91 86.58 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.72 86.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.344 -0.848 . . . . 0.0 109.533 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -64.34 -21.85 66.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 108.984 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 5.7 tm-20 -77.61 -44.92 26.74 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.657 -0.652 . . . . 0.0 109.299 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.484 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 40.2 mmm -64.5 -34.53 78.44 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.13 -42.74 75.21 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.78 -27.52 64.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.092 -1.24 . . . . 0.0 109.877 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -75.76 -35.33 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 108.965 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.663 HD21 HG12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -77.18 -28.15 53.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.136 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 9' ' ' THR . 11.4 tp -70.89 -42.51 69.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 3.1 ttt85 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.839 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -60.06 -58.27 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.053 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.837 HG22 HD11 ' A' ' 29' ' ' LEU . 87.2 t -62.53 -25.09 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.619 -0.676 . . . . 0.0 109.67 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 2.9 mt-10 -65.31 -50.55 65.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -15.74 53.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.636 ' CG ' HG11 ' A' ' 33' ' ' VAL . 10.9 t80 -67.44 -37.42 82.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 109.811 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 65.5 mt -67.87 -18.43 64.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.976 -1.078 . . . . 0.0 109.321 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 mp -89.79 -40.71 12.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.657 -0.652 . . . . 0.0 110.955 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.96 -47.86 14.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 111.03 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.485 ' O ' ' N ' ' A' ' 156' ' ' ASP . 71.1 m80 -79.94 81.44 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.274 -0.891 . . . . 0.0 110.936 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 154' ' ' HIS . 58.4 m 38.23 -94.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 111.033 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 154' ' ' HIS . 24.9 m-20 -155.12 51.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.682 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.54 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -49.29 145.12 4.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.961 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.784 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 70.2 m-85 57.03 69.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.257 -0.902 . . . . 0.0 110.273 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 120' ' ' TYR . 61.7 t -47.15 156.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.649 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 64.8 m-85 -117.97 96.56 5.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.868 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.5 121.68 19.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.054 -1.029 . . . . 0.0 111.469 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.685 ' CD2' HG11 ' A' ' 133' ' ' VAL . 22.0 m-85 -117.01 112.06 20.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.36 132.84 52.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 111.489 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -157.69 173.32 17.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.3 pp20? -145.68 149.94 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.806 -1.184 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.957 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -124.56 172.86 8.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.88 142.22 51.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.992 -1.068 . . . . 0.0 111.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB3' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -131.81 147.6 52.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.665 -0.647 . . . . 0.0 109.622 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -18.18 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.331 -0.856 . . . . 0.0 109.921 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.498 ' O ' HD12 ' A' ' 18' ' ' LEU . 5.7 mm -83.33 140.86 42.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.479 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 35.6 Cg_endo -59.03 152.61 57.49 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.848 1.446 . . . . 0.0 111.17 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -53.06 -47.92 68.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 111.24 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.55 -59.04 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.564 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.569 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 2.6 mmt180 -47.18 -57.81 4.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 109.904 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -51.4 -37.19 47.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 109.625 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 1.15 ' CE1' HD21 ' A' ' 24' ' ' LEU . 3.8 t80 -62.13 -69.14 0.27 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.851 -1.156 . . . . 0.0 109.848 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 7.1 mtmt -50.99 -24.82 3.99 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 112.1 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.675 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -113.66 -63.53 1.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.584 -1.322 . . . . 0.0 111.459 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.685 ' HD1' HG21 ' A' ' 147' ' ' VAL . 24.7 t80 -60.55 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.742 -1.224 . . . . 0.0 110.207 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.945 HG22 HD23 ' A' ' 24' ' ' LEU . 31.2 mm -48.24 -81.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.763 -1.211 . . . . 0.0 108.129 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.15 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.5 mt -57.76 160.4 4.53 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.244 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER 44.85 54.57 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.107 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -99.74 -35.11 4.72 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HB3' HG11 ' A' ' 41' ' ' VAL . 83.0 m-20 -81.66 15.4 2.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -1.139 . . . . 0.0 110.635 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 16.6 t-20 -135.0 42.96 2.74 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.832 HD21 HG13 ' A' ' 147' ' ' VAL . 1.0 OUTLIER 175.26 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.7 m-30 -42.25 -55.55 6.43 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.763 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.7 Cg_endo -65.82 -49.28 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.708 1.373 . . . . 0.0 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -45.47 -52.56 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 111.159 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HB1' ' A' ' 146' ' ' ALA . 9.3 m -86.21 -16.76 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.93 . . . . 0.0 110.847 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -135.69 71.96 63.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.74 -19.51 41.25 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.887 1.467 . . . . 0.0 109.464 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -83.98 -9.74 58.44 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.602 -0.686 . . . . 0.0 109.149 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -105.84 -57.22 2.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 31' ' ' PRO . 2.0 mp -117.62 165.93 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 110.152 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.447 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 4.4 m -130.26 -46.98 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 169.11 24.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.888 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 27' ' ' ASP . 72.0 t -137.34 119.62 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.199 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 7.5 mt-10 -86.91 116.07 24.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 110.139 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -94.32 99.44 11.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.409 -0.807 . . . . 0.0 110.212 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 45' ' ' GLU . 1.5 tp -71.47 -3.96 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 0.0 110.019 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER 68.81 111.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 110.286 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.97 -117.59 1.7 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -81.04 -38.22 27.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 0.0 110.084 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.17 -26.34 11.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.46 -81.25 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.27 88.81 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.164 1.612 . . . . 0.0 110.257 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 71' ' ' VAL . . . 102.77 38.36 2.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -81.42 146.37 30.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -1.063 . . . . 0.0 110.455 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 1.1 mt -115.08 118.85 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.859 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 8.8 mttp -143.11 154.08 43.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 42' ' ' GLU . 76.0 mttt -120.36 140.6 51.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.592 -0.693 . . . . 0.0 110.161 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 55' ' ' LYS . 1.4 mp -113.2 123.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -104.69 115.91 31.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.463 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 1.013 ' CD2' HD13 ' A' ' 62' ' ' LEU . 13.1 m-85 -75.22 167.38 37.31 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.183 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 60' ' ' GLU . 49.6 Cg_endo -81.91 66.21 8.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.011 1.532 . . . . 0.0 109.854 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' PRO . 3.8 tt0 44.37 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.473 -0.767 . . . . 0.0 111.103 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.3 -51.98 1.85 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.013 HD13 ' CD2' ' A' ' 58' ' ' PHE . 4.0 mt -60.25 163.55 8.15 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.273 -1.133 . . . . 0.0 110.395 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.4 -25.0 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.934 1.492 . . . . 0.0 109.237 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -103.44 -148.15 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.336 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.3 tttt -137.93 -10.36 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.971 -1.081 . . . . 0.0 111.402 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 47.5 p90 -176.83 -157.93 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.656 -1.277 . . . . 0.0 111.011 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 67' ' ' VAL . 8.3 p -169.44 113.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 7.1 tttt -87.75 153.1 21.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.982 -1.074 . . . . 0.0 109.809 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.53 ' N ' ' HG2' ' A' ' 68' ' ' LYS . 4.9 p-10 -136.88 148.89 47.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.04 -1.037 . . . . 0.0 110.626 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -128.01 104.27 7.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.425 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 52.6 t -73.51 148.88 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.122 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.2 -14.0 8.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.382 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.82 170.8 3.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 74' ' ' VAL . 7.4 p -170.67 108.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 6.0 t0 -74.81 -156.19 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.928 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.437 ' CD2' ' HE2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -159.76 -57.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 0.0 110.796 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.9 m -50.57 -42.05 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.39 3.51 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.571 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 18.8 m-85 57.03 91.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.142 -0.974 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -139.66 106.19 5.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 0.0 110.289 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.664 ' HD1' HG23 ' A' ' 74' ' ' VAL . 1.1 t80 -101.07 152.6 20.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.08 -1.013 . . . . 0.0 109.68 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.74 132.75 13.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.115 -0.99 . . . . 0.0 110.722 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.3 169.26 24.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 109.719 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.458 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -134.57 157.9 45.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 110.281 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.611 HG12 HD11 ' A' ' 91' ' ' ILE . 3.5 t -104.83 136.34 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 109.039 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.488 ' CG2' ' C ' ' A' ' 85' ' ' VAL . 6.0 pt -148.61 14.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.794 -1.191 . . . . 0.0 111.432 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -169.42 89.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.82 -1.175 . . . . 0.0 110.921 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 126.05 -148.79 17.18 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 88' ' ' GLY . . . 29.85 -118.56 0.08 OUTLIER Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.628 ' HG2' HD12 ' A' ' 98' ' ' ILE . 39.3 Cg_endo -69.46 -73.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.975 1.513 . . . . 0.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.611 HD11 HG12 ' A' ' 85' ' ' VAL . 1.5 mm 9.6 59.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.687 0.756 . . . . 0.0 112.863 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' PRO . . . -158.09 152.02 23.18 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' THR . 7.4 t70 63.59 -162.29 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.243 . . . . 0.0 109.954 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.634 HG21 ' CB ' ' A' ' 126' ' ' HIS . 44.1 p -43.01 -44.07 4.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.144 -0.973 . . . . 0.0 110.108 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.797 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -52.49 119.63 4.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.79 -55.4 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.163 -0.96 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.511 ' C ' ' CG1' ' A' ' 98' ' ' ILE . 5.2 mmtt -113.44 157.12 22.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.195 -0.941 . . . . 0.0 109.829 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.628 HD12 ' HG2' ' A' ' 90' ' ' PRO . 8.5 mt -154.11 122.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.147 -0.971 . . . . 0.0 110.406 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 1.4 t -107.31 123.6 48.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 109.856 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.71 108.38 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 111.28 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.54 ' O ' ' CG1' ' A' ' 102' ' ' ILE . 43.2 mt-10 -99.05 165.15 11.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.815 . . . . 0.0 109.37 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 101' ' ' GLU . 12.4 mt -157.17 137.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -138.61 109.52 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 110.173 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.857 HD11 HG13 ' A' ' 23' ' ' ILE . 50.8 mt -75.43 151.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 112' ' ' SER . 3.6 t -131.2 131.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.068 -1.02 . . . . 0.0 110.766 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.69 136.86 36.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.611 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.5 p -121.11 144.66 40.02 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.917 . . . . 0.0 110.581 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.32 -7.96 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.137 1.599 . . . . 0.0 110.739 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 10.5 p30 -166.89 85.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.13 -23.11 0.23 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.26 -139.61 15.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 79.9 p -115.0 172.06 7.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.262 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 4.9 mt -140.47 122.76 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.807 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.957 ' HB2' HG22 ' A' ' 9' ' ' THR . 3.7 mm? -84.85 102.16 12.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.616 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 103' ' ' LYS . 7.0 mmmt -79.11 91.55 4.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.4 mm -79.08 138.32 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.344 -0.847 . . . . 0.0 111.078 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -139.35 139.5 37.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 5' ' ' TYR . 3.8 p-10 -164.58 109.33 0.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.69 -1.256 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.55 ' HD3' ' NE2' ' A' ' 121' ' ' HIS . 12.9 ptpt -98.22 132.08 44.02 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.288 -0.882 . . . . 0.0 109.207 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.903 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.2 m-85 -90.54 141.72 28.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.55 ' NE2' ' HD3' ' A' ' 119' ' ' LYS . 28.3 m-70 -117.38 92.57 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.659 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 p -102.01 -170.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -140.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.961 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.77 33.79 5.96 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 126' ' ' HIS . 1.1 t0 -160.71 163.01 32.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 110.081 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.634 ' CB ' HG21 ' A' ' 94' ' ' THR . 0.2 OUTLIER 53.2 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.109 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' VAL . 3.1 pt-20 -77.6 147.42 35.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.118 -0.989 . . . . 0.0 110.247 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.644 HG23 ' CD1' ' A' ' 3' ' ' PHE . 92.5 t -42.31 155.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 110.248 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.449 ' HB3' ' HE3' ' A' ' 129' ' ' LYS . 8.5 mtpp -101.16 106.79 18.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.87 -40.34 9.82 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.005 -1.06 . . . . 0.0 109.899 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.46 -45.42 80.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.413 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -63.76 -43.9 95.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.685 HG11 ' CD2' ' A' ' 5' ' ' TYR . 5.8 t -67.91 -16.33 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -86.17 -41.44 14.69 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 110.356 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -52.63 -47.97 66.69 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.983 . . . . 0.0 109.55 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 139' ' ' MET . 0.2 OUTLIER -60.71 -49.16 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.724 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -61.86 -20.56 63.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 11.9 tm-20 -76.27 -56.95 4.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.6 -0.687 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.519 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 2.3 ppp? -59.29 -28.66 66.97 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 108.504 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 139' ' ' MET . . . -69.53 -45.28 60.38 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.79 -32.19 73.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.263 . . . . 0.0 109.774 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 2.1 p -69.99 -38.0 75.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.173 -0.955 . . . . 0.0 108.862 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -71.84 -31.57 66.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.708 ' CD2' HG21 ' A' ' 9' ' ' THR . 11.0 tp -67.18 -41.06 86.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -35.03 73.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.536 -0.728 . . . . 0.0 109.289 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -62.22 -50.64 70.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.485 -0.759 . . . . 0.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.832 HG13 HD21 ' A' ' 29' ' ' LEU . 12.8 t -70.74 -30.44 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.84 -55.26 36.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.461 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -74.68 -23.8 58.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.575 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.763 ' CD1' ' CE1' ' A' ' 154' ' ' HIS . 45.0 t80 -58.89 -62.2 2.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.799 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.466 HD23 ' CD2' ' A' ' 150' ' ' TYR . 34.3 mt -44.42 -26.61 0.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.079 . . . . 0.0 110.414 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 149' ' ' SER . 9.1 mp -79.22 -52.61 7.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 110.95 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 154' ' ' HIS . . . -63.31 -27.86 69.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.763 ' CE1' ' CD1' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -122.88 104.16 9.09 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.825 -0.547 . . . . 0.0 109.926 -178.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 58.1 m -88.91 16.33 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 110.156 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -108.72 -22.18 12.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.468 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.48 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -84.6 130.26 34.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.462 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.675 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 37.1 m-85 59.93 48.64 8.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.637 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.226 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.911 HG13 ' O ' ' A' ' 120' ' ' TYR . 95.6 t -54.6 151.99 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CE1' HG23 ' A' ' 128' ' ' VAL . 80.3 m-85 -114.15 149.14 36.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 110.066 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -106.98 84.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.016 ' CD1' HG11 ' A' ' 133' ' ' VAL . 45.5 m-85 -88.43 78.62 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.02 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 7' ' ' THR . 98.7 mt-10 -90.02 165.93 13.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.353 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 12.3 t -179.8 172.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.835 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.478 ' OE1' ' HD2' ' A' ' 115' ' ' LYS . 23.5 tt0 -155.89 147.08 22.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.13 -0.981 . . . . 0.0 110.336 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.903 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.92 172.31 11.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.887 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.79 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.965 -1.084 . . . . 0.0 110.132 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.54 ' OG ' ' CD1' ' A' ' 18' ' ' LEU . 63.9 p -129.1 150.83 50.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.26 -22.88 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 109.774 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.57 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 19.3 mm -80.25 142.87 55.37 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 35.5 Cg_endo -58.02 148.58 76.18 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.749 1.394 . . . . 0.0 110.732 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.687 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -55.07 -36.69 65.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.03 70.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -62.88 -50.84 69.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 110.61 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 14.4 mt -57.23 -39.22 75.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.946 -1.096 . . . . 0.0 109.766 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.93 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -61.36 -63.99 1.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.098 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.27 -30.29 50.11 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.552 -0.718 . . . . 0.0 112.223 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -105.69 -64.61 1.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.758 -1.214 . . . . 0.0 111.44 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.844 ' HE2' HD21 ' A' ' 114' ' ' LEU . 63.3 t80 -70.29 5.47 1.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 112.449 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.518 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 28.7 mm -142.81 -26.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.307 -1.495 . . . . 0.0 111.882 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.93 HD21 ' CE1' ' A' ' 19' ' ' PHE . 4.2 mt -102.31 -34.44 9.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.62 -1.3 . . . . 0.0 109.833 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 5.9 t0 -119.64 31.96 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -71.31 -25.14 76.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.93 ' O ' HG11 ' A' ' 41' ' ' VAL . 20.6 m-20 -76.6 3.52 11.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 5.5 t30 -140.16 52.73 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.648 HD11 ' CD2' ' A' ' 150' ' ' TYR . 1.5 tp 170.62 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.516 -0.74 . . . . 0.0 109.26 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.4 m-30 -42.97 -59.82 2.79 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.874 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.1 Cg_endo -66.22 -29.45 47.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.915 1.482 . . . . 0.0 111.189 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -36.3 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.9 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.802 HG23 ' HB1' ' A' ' 146' ' ' ALA . 15.9 m -104.12 -9.21 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.062 -1.024 . . . . 0.0 110.409 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.41 63.89 56.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.965 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.53 -7.82 20.39 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.97 1.51 . . . . 0.0 110.139 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.8 OUTLIER -92.11 -18.33 23.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.424 -0.798 . . . . 0.0 109.167 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.1 -58.41 2.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.654 HG12 HD21 ' A' ' 143' ' ' LEU . 10.0 mm -95.68 179.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.384 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.628 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -159.47 -49.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.959 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.27 142.61 30.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.93 HG11 ' O ' ' A' ' 27' ' ' ASP . 7.6 p -120.99 121.55 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 110.419 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 tt0 -92.02 102.51 15.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 109.929 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' ILE . 89.2 m-20 -90.88 72.97 6.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.498 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.691 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -44.84 -26.48 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.408 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 44' ' ' ILE . 2.1 tt0 40.55 79.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.485 -0.759 . . . . 0.0 110.754 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.5 -55.15 6.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 47' ' ' ASN . 64.2 t-20 -128.86 -14.8 4.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.471 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.42 4.85 83.03 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.56 -103.18 0.32 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.31 78.96 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.959 1.505 . . . . 0.0 110.461 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.08 32.96 0.29 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m -95.23 104.95 16.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -1.223 . . . . 0.0 109.739 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.597 HD11 ' HD2' ' A' ' 70' ' ' ARG . 3.6 mp -102.56 143.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.616 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 2.4 mttt -130.76 150.13 52.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -117.9 97.97 6.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.412 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.501 HG22 ' CE1' ' A' ' 58' ' ' PHE . 1.5 mp -78.58 131.81 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -115.28 141.14 48.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.762 ' HD2' HD21 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -107.69 135.19 19.8 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 110.538 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 38' ' ' ILE . 50.9 Cg_endo -84.34 47.93 2.33 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.952 1.501 . . . . 0.0 109.965 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.71 -171.48 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 0.0 110.627 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.36 35.44 4.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.762 HD21 ' HD2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -54.19 -176.49 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -1.052 . . . . 0.0 110.324 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.686 ' HD2' ' HB2' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -82.46 -20.95 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.04 1.021 . . . . 0.0 110.462 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 2.4 m-85 -97.08 -154.92 0.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -131.27 -33.95 1.45 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.448 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 36.6 p90 -169.04 -153.53 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 67' ' ' VAL . 8.9 p -168.37 111.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 111.149 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.7 ttpp -99.7 149.15 23.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.19 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 29.8 p30 -154.26 148.18 25.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.984 -1.072 . . . . 0.0 110.964 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.597 ' HD2' HD11 ' A' ' 53' ' ' ILE . 4.6 ttp180 -103.6 154.27 19.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 109.584 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 15.6 t -99.39 -44.53 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.113 -0.992 . . . . 0.0 110.359 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER 76.94 -38.13 0.3 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.848 -0.532 . . . . 0.0 111.721 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 1.2 pt-20 178.28 155.95 0.4 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.686 -1.259 . . . . 0.0 110.505 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.451 HG13 ' HD1' ' A' ' 81' ' ' TYR . 94.3 t -146.05 153.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.818 . . . . 0.0 109.901 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.65 164.46 15.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.723 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.502 ' NE2' HD11 ' A' ' 24' ' ' LEU . 3.8 m80 -134.4 -40.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.51 -0.744 . . . . 0.0 109.856 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -55.42 -38.55 69.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.253 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -108.25 12.8 26.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.511 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.538 ' O ' HD12 ' A' ' 104' ' ' ILE . 3.8 m-85 52.11 60.59 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 81' ' ' TYR . 1.4 tppt? -123.35 155.51 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.39 -0.819 . . . . 0.0 110.586 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.5 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 64.6 t80 -144.06 162.2 36.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.58 -0.7 . . . . 0.0 109.162 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 71' ' ' VAL . 28.0 t30 -167.52 128.63 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.913 -1.117 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 32.7 p90 -143.23 142.44 31.4 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.383 -0.823 . . . . 0.0 109.941 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.45 126.25 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.775 . . . . 0.0 110.173 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.05 128.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.781 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -124.7 10.64 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.962 . . . . 0.0 109.865 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 2.2 mm-40 -176.65 170.72 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.507 ' O ' HG13 ' A' ' 91' ' ' ILE . . . 73.12 173.33 25.03 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.82 -144.19 27.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.4 Cg_endo -84.8 34.27 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.067 1.561 . . . . 0.0 110.735 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -50.25 172.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.985 . . . . 0.0 110.437 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 45.7 63.48 2.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 7.5 t0 -177.83 82.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -1.164 . . . . 0.0 110.422 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' ASP . 18.8 p 43.65 29.0 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.278 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.904 HD11 ' CD2' ' A' ' 120' ' ' TYR . 1.9 tp -150.61 95.77 2.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.171 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.5 -49.83 44.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.643 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -152.62 165.54 34.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.321 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.734 HD11 HD11 ' A' ' 95' ' ' LEU . 24.2 mm -140.76 116.78 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.833 . . . . 0.0 110.442 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -96.33 143.2 27.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 108.946 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 36.0 t-20 -143.04 149.53 38.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.259 -1.376 . . . . 0.0 112.126 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 25.3 mt-10 -129.03 152.47 48.6 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 12.1 mt -142.0 124.03 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 0.0 110.635 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -115.41 130.96 57.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 0.0 109.738 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 19' ' ' PHE . 1.3 mp -99.43 118.95 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.036 -1.04 . . . . 0.0 109.782 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 112' ' ' SER . 6.6 t -107.34 129.56 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.24 140.92 29.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.757 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -104.47 148.96 36.85 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 110.397 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.0 -8.62 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.09 1.574 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -165.01 83.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.43 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.14 -85.83 0.1 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.91 -113.29 0.3 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.546 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 4.5 p -138.9 176.82 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -1.192 . . . . 0.0 109.972 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.411 HG21 ' OE2' ' A' ' 8' ' ' GLU . 15.9 mt -139.28 123.35 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.271 -0.893 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.903 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.19 90.72 8.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HD2' ' OE1' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -85.22 99.51 11.15 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 114' ' ' LEU . 1.2 mp -99.84 155.02 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.061 -1.024 . . . . 0.0 111.679 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 m -140.14 107.71 5.6 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 100' ' ' ASN . 3.3 t-20 -105.85 105.77 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 112.034 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.486 ' HG3' ' CG1' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -88.47 107.64 18.97 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.911 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.7 m-85 -82.52 142.94 31.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.924 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 97' ' ' LYS . 83.6 m-70 -126.31 100.37 6.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.766 -0.584 . . . . 0.0 109.566 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.518 HG21 ' CG2' ' A' ' 128' ' ' VAL . 4.9 p -110.53 -166.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 110.35 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.69 67.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 -149.67 5.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -68.98 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.448 -1.031 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -75.67 -174.49 2.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 12.2 mp0 -115.46 -171.7 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 110.284 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.643 HG23 ' CE1' ' A' ' 3' ' ' PHE . 88.6 t -54.13 152.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.448 ' NZ ' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -98.85 108.21 20.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -41.91 -59.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 110.422 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 2.5 tt0 -43.17 -45.25 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.782 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -45.23 94.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.016 HG11 ' CD1' ' A' ' 5' ' ' TYR . 76.4 t -58.04 -24.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -76.82 -51.42 11.36 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.751 -0.593 . . . . 0.0 110.108 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -43.8 -43.82 6.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.872 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.1 t -60.45 -54.82 40.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.569 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -53.45 -27.87 27.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.745 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.405 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.72 -46.87 43.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.527 -0.733 . . . . 0.0 110.392 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.455 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 4.6 mtp -63.19 -30.46 71.6 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.846 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.6 -45.43 53.34 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -72.32 -30.07 64.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.359 . . . . 0.0 110.614 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 1.2 p -72.99 -40.35 65.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.794 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.654 HD21 HG12 ' A' ' 38' ' ' ILE . 1.1 mm? -80.03 -25.84 40.02 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.354 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 16.4 tp -70.75 -39.95 72.98 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -44.36 59.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.802 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -55.52 -55.51 31.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.565 HG13 HD21 ' A' ' 29' ' ' LEU . 69.3 t -66.02 -32.31 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 13' ' ' ILE . 1.2 tm-20 -58.48 -52.13 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.3 p -75.99 -26.67 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.677 ' HB2' HG11 ' A' ' 33' ' ' VAL . 8.5 t80 -57.71 -45.75 85.33 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.724 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.7 mt -58.05 -24.81 59.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 6.0 mp -93.01 -19.68 21.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 110.516 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.5 -34.03 23.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 155' ' ' SER . 4.4 m80 -91.86 166.2 12.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 110.6 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.48 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 22.9 m -43.48 -56.81 3.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 110.608 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 155' ' ' SER . 2.4 m-20 -177.94 65.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -67.76 133.58 49.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.354 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.863 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 56.5 m-85 60.59 19.9 9.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 110.587 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.065 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.56 ' CG2' ' HG3' ' A' ' 119' ' ' LYS . 11.7 p -55.36 154.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.16 . . . . 0.0 110.456 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.67 ' CD1' HG23 ' A' ' 128' ' ' VAL . 53.9 m-85 -115.88 158.75 22.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -117.37 118.69 32.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.03 ' CD1' HG11 ' A' ' 133' ' ' VAL . 37.2 m-85 -122.63 89.51 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -99.82 155.13 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.448 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 11.8 t -171.24 170.21 6.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.171 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HG3' ' C ' ' A' ' 7' ' ' THR . 27.6 mt-10 -148.04 118.97 7.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.972 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -100.58 -177.73 3.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 109.815 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.498 HG22 ' CD1' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -124.0 137.93 54.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.0 110.424 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.897 ' OG ' HD11 ' A' ' 18' ' ' LEU . 36.4 t -125.01 139.44 53.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.5 -2.66 4.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.457 -0.777 . . . . 0.0 110.161 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.687 HG23 ' HD2' ' A' ' 14' ' ' PRO . 7.9 mm -96.11 149.31 35.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.253 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.687 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.8 Cg_endo -56.68 155.66 25.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.019 1.536 . . . . 0.0 110.518 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.723 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -64.17 -71.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 111.268 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -39.3 -51.43 2.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.686 . . . . 0.0 110.951 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.572 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 6.7 ttm180 -57.33 -54.97 40.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.812 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.897 HD11 ' OG ' ' A' ' 11' ' ' SER . 8.7 mt -50.43 -29.2 9.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.184 -1.006 . . . . 0.0 108.822 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 1.121 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -69.76 -67.35 0.49 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.545 -0.722 . . . . 0.0 110.678 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 25.5 mtpt -57.34 -21.36 34.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.377 -0.827 . . . . 0.0 112.717 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.803 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.58 -58.98 2.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.46 -1.4 . . . . 0.0 112.512 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HA ' HG11 ' A' ' 147' ' ' VAL . 34.1 t80 -73.24 -11.51 60.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.893 -1.129 . . . . 0.0 112.353 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.922 HG22 HD23 ' A' ' 24' ' ' LEU . 23.0 mt -121.77 -80.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.674 -1.267 . . . . 0.0 110.393 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.121 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.3 mt -45.44 -56.72 4.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.865 -1.147 . . . . 0.0 110.032 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -100.21 66.54 1.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -101.96 -30.95 5.56 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.595 ' HB3' HG11 ' A' ' 41' ' ' VAL . 99.4 m-20 -81.39 13.49 2.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 110.456 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.5 t30 -138.68 45.06 2.05 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.898 HD21 HG13 ' A' ' 147' ' ' VAL . 1.2 tp 173.55 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 109.441 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CD1' HD12 ' A' ' 143' ' ' LEU . 2.9 m-30 -48.41 -61.01 3.57 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.367 -0.833 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.3 Cg_endo -65.95 -22.96 54.94 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.8 1.421 . . . . 0.0 111.464 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -71.73 -50.91 25.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.818 HG23 ' HB1' ' A' ' 146' ' ' ALA . 19.5 m -89.54 -8.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 110.243 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -134.96 62.43 52.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.505 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.98 -15.7 43.95 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 109.358 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -83.88 -16.74 43.24 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.543 0.687 . . . . 0.0 109.192 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.51 -64.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 110.595 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.87 HG12 HD21 ' A' ' 143' ' ' LEU . 10.5 mm -93.73 169.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.437 ' N ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -136.16 -36.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 109.986 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.39 160.77 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 27' ' ' ASP . 3.7 p -140.57 154.25 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.028 -1.045 . . . . 0.0 110.647 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -107.29 138.77 42.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.459 -0.776 . . . . 0.0 109.603 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' HA ' ' HG2' ' A' ' 54' ' ' LYS . 4.9 m-20 -121.91 106.94 11.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 0.0 110.748 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.71 HG22 ' CG2' ' A' ' 53' ' ' ILE . 0.4 OUTLIER -127.1 -41.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.104 -0.998 . . . . 0.0 109.589 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.541 ' HA ' HG22 ' A' ' 53' ' ' ILE . 4.1 tt0 56.29 155.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.937 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' C ' ' OD1' ' A' ' 47' ' ' ASN . . . -120.94 -69.82 0.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 46' ' ' GLY . 4.5 m120 -148.61 22.51 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -1.092 . . . . 0.0 109.755 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.61 -152.65 12.23 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' O ' ' OE2' ' A' ' 45' ' ' GLU . . . -54.35 -179.6 0.17 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -82.27 43.33 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.089 1.573 . . . . 0.0 110.99 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -171.08 24.11 0.09 OUTLIER Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.007 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 53' ' ' ILE . 1.2 m -76.38 175.08 9.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -1.19 . . . . 0.0 110.31 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.71 ' CG2' HG22 ' A' ' 44' ' ' ILE . 1.0 OUTLIER 30.55 31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.587 0.708 . . . . 0.0 112.477 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' A' ' 52' ' ' THR . 14.5 mttt -75.53 152.41 37.8 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -124.7 91.5 3.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.892 -1.13 . . . . 0.0 111.053 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.508 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.2 mp -77.51 158.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.586 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.459 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -144.63 171.3 14.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 1.01 ' HB3' HD12 ' A' ' 62' ' ' LEU . 15.9 m-85 -134.72 157.09 77.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 47.3 Cg_endo -77.19 177.62 8.65 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.907 1.477 . . . . 0.0 109.835 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.07 175.43 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.0 110.142 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.34 -47.37 3.29 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.01 HD12 ' HB3' ' A' ' 58' ' ' PHE . 13.5 mt -78.38 139.52 59.81 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.71 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.75 -7.09 19.01 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.009 1.531 . . . . 0.0 110.217 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.472 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 3.6 m-30 -97.32 135.07 39.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 110.155 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -87.94 -42.63 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 0.0 110.365 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.87 ' O ' HG13 ' A' ' 67' ' ' VAL . 30.3 p90 -167.55 -173.76 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.003 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -166.07 124.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -0.786 . . . . 0.0 110.693 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -81.12 92.85 6.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.464 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 22.3 t70 -84.35 96.19 8.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.507 ' HG3' ' HA ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.67 83.64 7.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.872 . . . . 0.0 110.043 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.685 HG12 ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -45.44 -60.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 109.54 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.685 ' N ' HG12 ' A' ' 71' ' ' VAL . 0.1 OUTLIER 73.07 -28.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.109 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -167.5 171.84 10.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.211 -1.555 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.2 p -165.56 146.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.671 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.02 -171.53 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 0.0 110.146 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 -56.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 110.376 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 m -59.46 -20.14 52.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.835 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -118.27 8.38 12.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 110.564 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.619 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.6 m-30 54.49 54.21 9.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.994 . . . . 0.0 109.863 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.64 147.3 47.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.556 ' CD1' ' CG2' ' A' ' 23' ' ' ILE . 14.4 t80 -133.2 105.0 6.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -1.0 . . . . 0.0 110.693 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -101.59 115.55 30.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 7.4 p90 -138.91 155.3 48.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.101 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -109.29 136.36 48.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 110.856 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.459 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 73.0 t -111.53 121.12 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.462 HD11 ' CD ' ' A' ' 70' ' ' ARG . 8.4 pt -147.16 164.43 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.962 -1.086 . . . . 0.0 111.281 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 64.76 133.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 110.847 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 66' ' ' TYR . . . 56.29 178.08 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.611 ' HA3' HG12 ' A' ' 67' ' ' VAL . . . 80.89 -133.25 11.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' A' ' 98' ' ' ILE . 48.7 Cg_endo -78.91 1.6 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.054 1.555 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.65 HD11 ' O ' ' A' ' 96' ' ' GLU 0.293 1.3 mm -61.27 140.92 18.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.223 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 159.15 -92.97 0.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -117.68 145.0 44.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -1.15 . . . . 0.0 110.315 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.871 HG22 ' O ' ' A' ' 125' ' ' ASP . 6.5 p 50.79 50.39 19.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.968 HD21 ' CD2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER 167.14 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.341 -0.85 . . . . 0.0 110.379 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.65 ' O ' HD11 ' A' ' 91' ' ' ILE . 8.2 tt0 -96.13 -39.59 9.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.27 136.81 50.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.584 HG23 ' CD1' ' A' ' 120' ' ' TYR . 29.8 mt -131.94 113.06 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.861 . . . . 0.0 110.361 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 135.85 33.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 0.0 109.205 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.519 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 4.9 m120 -132.14 139.23 48.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.786 -1.196 . . . . 0.0 110.88 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 81' ' ' TYR . 2.0 mt-10 -137.05 130.93 32.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.105 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 83' ' ' TYR . 7.4 mt -118.93 127.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 tmtt? -115.14 118.13 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.746 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.723 HG22 ' HB1' ' A' ' 15' ' ' ALA . 38.7 mm -79.36 115.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 110.283 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.407 ' CG2' ' HG3' ' A' ' 115' ' ' LYS . 63.0 t -108.93 123.72 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 110.117 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.69 135.99 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.235 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.6 p -106.76 150.19 39.38 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 48.4 Cg_endo -66.84 81.13 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.181 1.622 . . . . 0.0 110.698 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 18.9 t0 -179.93 -62.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 0.0 110.284 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.19 38.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.33 28.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.551 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -127.95 130.38 48.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -1.217 . . . . 0.0 110.464 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.961 HG23 ' O ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -85.47 143.99 10.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 109.548 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.972 ' HB2' HG22 ' A' ' 9' ' ' THR . 3.8 mm? -97.66 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -85.43 99.77 11.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.094 -1.004 . . . . 0.0 109.425 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.418 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 7.6 mt -98.37 131.19 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.839 -1.163 . . . . 0.0 111.678 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 m -123.56 129.89 51.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 9.9 m-20 -131.25 105.85 7.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.993 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -90.79 107.92 19.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.968 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.8 m-85 -88.19 95.02 10.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 111.864 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.594 ' CE1' ' HG2' ' A' ' 119' ' ' LYS . 72.4 m-70 -79.95 95.95 6.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 108.882 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.61 HG21 ' CG2' ' A' ' 128' ' ' VAL . 5.6 p -102.67 -56.22 2.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.17 -0.956 . . . . 0.0 111.017 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 122' ' ' THR . 18.1 pttm 35.29 72.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.624 -0.673 . . . . 0.0 111.246 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.65 -72.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.871 ' O ' HG22 ' A' ' 94' ' ' THR . 14.8 t70 -153.99 150.62 28.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 51.83 -167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.08 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -121.49 170.09 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.883 . . . . 0.0 110.486 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.67 HG23 ' CD1' ' A' ' 3' ' ' PHE . 64.8 t -61.95 135.31 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.224 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.3 mtmt -82.33 115.57 21.44 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -45.34 -42.01 9.51 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 10.2 tm-20 -54.79 -47.28 74.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -39.39 83.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.278 -0.889 . . . . 0.0 108.921 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.03 HG11 ' CD1' ' A' ' 5' ' ' TYR . 84.2 t -66.7 -23.46 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 135' ' ' ALA . 14.5 tttt -79.06 -63.04 1.51 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.684 -0.635 . . . . 0.0 110.499 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.22 -46.06 1.03 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -0.817 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m -60.61 -47.84 84.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.43 ' HE2' HG21 ' A' ' 7' ' ' THR . 36.0 mttt -59.96 -28.55 67.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.43 -39.76 64.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.464 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.0 OUTLIER -65.3 -37.3 86.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 108.783 178.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.47 -42.64 93.6 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -32.19 72.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.214 -1.168 . . . . 0.0 110.182 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.492 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 1.7 p -70.6 -39.18 73.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.324 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.87 HD21 HG12 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -75.14 -28.13 60.04 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.6 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 23.9 tp -71.18 -39.94 71.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 0.0 108.594 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.558 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 1.3 ptm85 -73.76 -32.68 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 109.472 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -65.83 -58.12 6.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.1 -1.0 . . . . 0.0 109.059 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.898 HG13 HD21 ' A' ' 29' ' ' LEU . 47.7 t -64.95 -28.12 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.554 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' HA ' HG13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -63.64 -49.45 73.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.814 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.413 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 1.3 t -78.69 -20.89 49.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 110.044 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.774 ' HB2' HG11 ' A' ' 33' ' ' VAL . 12.0 t80 -62.55 -41.07 98.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 65.9 mt -67.45 -22.29 65.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 109.917 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 mp -82.72 -38.35 23.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.04 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.0 -46.18 62.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -81.63 -39.03 25.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.887 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.9 m 58.06 19.54 6.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 2.6 p30 -138.51 -33.45 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 156' ' ' ASP . . . -60.36 131.92 52.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.803 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.5 m-85 55.69 49.3 16.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 110.868 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.22 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' A' ' 119' ' ' LYS . 8.1 p -132.46 165.41 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.189 . . . . 0.0 110.259 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.649 ' CD1' HG23 ' A' ' 128' ' ' VAL . 45.6 m-85 -129.02 148.57 50.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -111.11 86.8 2.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 0.0 111.004 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.183 ' CD1' HG11 ' A' ' 133' ' ' VAL . 18.3 m-85 -84.82 73.45 10.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.464 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.24 118.17 21.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.917 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -132.13 -168.9 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.88 163.44 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 0.0 110.177 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.785 HG22 ' CB ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -141.51 173.39 11.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.4 141.58 50.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.957 . . . . 0.0 110.662 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 t -136.71 147.1 46.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 109.929 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.76 -20.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 18' ' ' LEU . 5.4 mm -79.03 140.91 57.93 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 110.705 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -57.53 151.91 51.09 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.659 1.573 . . . . 0.0 111.173 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.678 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -56.67 -48.59 77.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 111.455 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -52.31 -61.78 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.037 -1.039 . . . . 0.0 111.045 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.6 ttp180 -54.07 -57.73 10.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.022 . . . . 0.0 109.944 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.08 -29.25 3.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.948 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.09 -63.12 1.12 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 109.326 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.68 -46.05 19.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 110.481 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.888 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -83.94 -70.82 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.725 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 22.0 t80 -76.0 142.61 41.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 108.941 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 14.7 mt 81.29 -46.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 CA-C-O 120.914 0.387 . . . . 0.0 110.922 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.948 HD21 ' CE1' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -86.71 -77.15 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.957 -1.089 . . . . 0.0 109.484 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 29' ' ' LEU . 9.5 t70 -57.5 -96.35 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.05 -1.031 . . . . 0.0 109.193 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.594 ' HA2' ' CE1' ' A' ' 30' ' ' PHE . . . 79.11 -74.0 2.26 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.837 -1.164 . . . . 0.0 110.936 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.54 -4.47 6.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.977 -1.308 . . . . 0.0 111.106 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 12.3 t30 -135.96 51.71 2.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.645 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.88 ' C ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER 171.15 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.89 . . . . 0.0 109.554 -179.029 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.648 ' N ' HD13 ' A' ' 29' ' ' LEU . 5.3 m-30 -65.14 -58.09 13.5 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.95 . . . . 0.0 110.229 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.574 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 44.0 Cg_endo -65.1 -35.3 42.89 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.808 1.425 . . . . 0.0 110.604 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.55 -37.87 76.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.844 HG23 ' HB1' ' A' ' 146' ' ' ALA . 6.0 m -106.71 2.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -152.83 66.15 6.04 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 59' ' ' PRO . 42.0 Cg_endo -67.91 -24.22 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.903 1.475 . . . . 0.0 109.439 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -81.21 -9.46 59.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.412 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -104.0 -57.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -124.79 168.05 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.168 -0.957 . . . . 0.0 110.984 -179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.503 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 1.4 t -131.48 -37.45 1.21 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.653 -0.654 . . . . 0.0 109.398 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 39' ' ' SER . 7.5 t -177.42 142.79 0.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 0.0 109.862 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.731 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.5 p -132.95 116.04 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.028 -1.045 . . . . 0.0 110.753 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.6 tt0 178.82 156.12 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.834 . . . . 0.0 110.504 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.895 ' HB3' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -143.69 -63.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 109.365 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.658 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -119.16 -26.54 2.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.976 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 1.8 tt0 48.12 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.813 . . . . 0.0 110.15 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' ASN . . . 177.57 35.3 0.05 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 46' ' ' GLY . 4.7 m120 42.03 66.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -1.126 . . . . 0.0 110.271 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.497 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -46.56 -42.76 14.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 72' ' ' ASP . . . 115.27 -63.12 0.33 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 51.7 Cg_endo -96.4 53.45 0.14 Allowed 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 121.368 1.379 . . . . 0.0 109.495 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.526 ' CA ' ' C ' ' A' ' 70' ' ' ARG . . . 105.47 77.92 1.16 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 64.5 m -41.12 109.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.518 -0.989 . . . . 0.0 108.974 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.895 HG22 ' HB3' ' A' ' 43' ' ' ASN . 44.4 mm -53.59 119.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 111.123 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 21.6 mtmt -144.39 144.27 31.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.567 -0.708 . . . . 0.0 109.327 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 4.2 ttpp -115.01 116.97 29.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.915 . . . . 0.0 110.255 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.022 ' HB ' HG23 ' A' ' 67' ' ' VAL . 2.0 mp -90.52 115.94 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 110.03 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 t -113.84 126.89 55.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 110.561 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.754 ' CB ' HD12 ' A' ' 62' ' ' LEU . 42.5 m-85 -94.5 143.1 25.71 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.5 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 49.1 Cg_endo -88.53 37.88 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.81 1.426 . . . . 0.0 110.638 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -150.41 -177.29 5.87 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.578 0.704 . . . . 0.0 110.084 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.608 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -70.07 -59.01 5.72 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.754 HD12 ' CB ' ' A' ' 58' ' ' PHE . 10.7 mt 53.42 168.25 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.366 -1.079 . . . . 0.0 110.115 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -72.61 -21.68 21.82 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.789 1.415 . . . . 0.0 109.897 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.505 ' CE2' ' HD3' ' A' ' 90' ' ' PRO . 11.0 m-85 -129.53 160.9 31.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.503 -0.748 . . . . 0.0 109.66 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -20.06 30.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.318 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.746 ' O ' HG13 ' A' ' 67' ' ' VAL . 27.6 p90 -173.8 -171.7 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.022 HG23 ' HB ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -161.08 108.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.765 . . . . 0.0 110.602 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -76.81 155.22 33.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.303 -0.873 . . . . 0.0 109.012 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -151.74 131.11 12.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.671 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.526 ' C ' ' CA ' ' A' ' 51' ' ' GLY . 0.7 OUTLIER -104.43 87.76 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.025 HG13 ' HB3' ' A' ' 83' ' ' TYR . 45.1 t -82.05 -104.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' N ' HG12 ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.22 162.96 0.24 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.552 -0.717 . . . . 0.0 110.811 -178.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER 73.75 136.56 0.05 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 74' ' ' VAL . 6.3 p -173.2 103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 3.6 t0 -80.31 161.67 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.13 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.34 -48.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.234 -0.916 . . . . 0.0 110.564 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 m -59.35 -24.13 63.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.753 -1.217 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -118.38 14.96 13.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.962 . . . . 0.0 110.348 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.576 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 8.2 m-30 44.25 63.38 1.66 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.278 -0.888 . . . . 0.0 110.585 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 13.3 tttt -122.05 141.82 50.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.698 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CD2' HG23 ' A' ' 74' ' ' VAL . 22.5 t80 -148.59 98.36 2.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.087 -1.008 . . . . 0.0 110.82 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.521 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -111.76 143.14 43.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.603 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 1.025 ' HB3' HG13 ' A' ' 71' ' ' VAL . 15.8 p90 -134.75 163.53 29.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -104.54 112.08 25.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.535 -0.728 . . . . 0.0 111.143 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.4 t -94.64 104.11 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.538 HG13 ' N ' ' A' ' 87' ' ' GLU . 49.0 pt -93.81 -34.58 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.538 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.8 mt-10 -146.81 169.41 19.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.003 -1.06 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.591 ' CA ' ' HA ' ' A' ' 67' ' ' VAL . . . 112.41 115.9 3.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.504 ' HA2' ' CD2' ' A' ' 64' ' ' PHE . . . 124.48 -143.93 15.0 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.513 ' O ' ' C ' ' A' ' 91' ' ' ILE . 53.1 Cg_endo -83.51 26.87 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.092 1.575 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -27.69 145.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.436 0.636 . . . . 0.0 111.358 -179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.36 -100.45 0.16 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.42 ' O ' ' OG1' ' A' ' 94' ' ' THR . 29.5 m-20 -125.86 -176.28 3.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -1.098 . . . . 0.0 110.395 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 122' ' ' THR . 46.1 p 46.23 22.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.891 HD23 HD11 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -172.16 96.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.419 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -114.02 -21.46 10.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.0 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.782 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -142.18 147.96 37.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 110.083 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.891 HD11 HD23 ' A' ' 95' ' ' LEU . 35.5 mm -145.43 131.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.0 m -116.34 131.37 56.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 109.144 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 1.3 m-20 -126.3 147.63 49.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.043 -1.035 . . . . 0.0 111.267 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 3.8 tt0 -138.02 132.33 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.693 -0.629 . . . . 0.0 109.573 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 103' ' ' LYS . 77.2 mt -118.66 165.7 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 0.9 OUTLIER -157.69 111.86 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 110.551 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.708 ' H ' HD12 ' A' ' 104' ' ' ILE . 2.8 mp -87.93 112.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 0.0 109.944 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.419 HG21 ' NZ ' ' A' ' 115' ' ' LYS . 90.4 t -103.58 139.09 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.078 -1.014 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.72 132.01 41.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.0 109.961 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.4 p -105.57 154.22 39.31 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.428 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 48.3 Cg_endo -66.59 -33.2 36.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.016 1.535 . . . . 0.0 110.509 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 108' ' ' PRO . 5.3 m-20 -151.75 67.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.75 35.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.12 -140.3 46.68 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.549 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 80.0 p -128.06 155.18 44.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -1.14 . . . . 0.0 110.052 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.4 mt -112.53 126.83 69.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 110.43 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.785 ' CB ' HG22 ' A' ' 9' ' ' THR . 1.2 tp -88.53 89.2 7.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.795 -0.566 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' NZ ' HG21 ' A' ' 105' ' ' VAL . 9.1 mttt -73.77 128.77 36.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.404 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 114' ' ' LEU . 2.7 mt -128.23 150.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 111.18 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 t -138.89 120.36 14.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.176 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 2.5 m-20 -112.79 94.7 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 0.0 111.53 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HG3' ' CG2' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -82.42 106.18 14.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.001 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.716 ' CD2' HD21 ' A' ' 95' ' ' LEU . 1.5 m-85 -85.15 111.14 19.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.962 -1.086 . . . . 0.0 111.461 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.1 m-70 -90.25 102.05 14.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.335 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.565 HG21 HG23 ' A' ' 128' ' ' VAL . 7.5 p -103.23 162.33 13.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -145.97 37.65 1.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.46 -147.44 7.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.88 -65.05 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -56.1 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.348 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 17.3 pt-20 -111.23 -169.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.652 HG11 ' CE2' ' A' ' 5' ' ' TYR . 24.9 t -68.64 163.72 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.1 101.49 10.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 110.004 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.2 -32.25 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 4.3 tt0 -59.96 -50.48 73.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.633 ' OE1' HD13 ' A' ' 95' ' ' LEU . 48.4 tt0 -61.04 -40.79 94.94 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.183 HG11 ' CD1' ' A' ' 5' ' ' TYR . 61.4 t -62.4 -23.66 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 1.8 tptt -78.72 -59.23 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.837 -0.539 . . . . 0.0 110.898 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.37 -45.93 1.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.394 -0.816 . . . . 0.0 110.842 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -59.99 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.095 -1.003 . . . . 0.0 109.652 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 133' ' ' VAL . 16.9 mtmt -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.838 . . . . 0.0 110.318 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.36 -54.3 15.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -0.915 . . . . 0.0 110.135 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.467 ' SD ' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -57.32 -37.77 73.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.061 -1.024 . . . . 0.0 109.287 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.31 -39.8 97.32 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -72.16 -38.72 69.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.999 -1.295 . . . . 0.0 111.003 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.234 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 147' ' ' VAL . 1.3 mm? -77.41 -31.15 53.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.112 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.749 HD22 HG21 ' A' ' 9' ' ' THR . 20.4 tp -68.64 -32.54 72.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 108.696 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -77.62 -41.21 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.527 -0.733 . . . . 0.0 109.517 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.844 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -61.09 -43.88 98.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.506 -0.746 . . . . 0.0 110.012 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 143' ' ' LEU . 21.2 t -75.33 -43.16 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.954 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' HG2' HG12 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -53.86 -41.89 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -0.825 . . . . 0.0 110.221 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.6 p -85.19 -29.68 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 0.0 110.173 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.592 ' CG ' HG11 ' A' ' 33' ' ' VAL . 4.5 t80 -58.17 -35.99 72.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.024 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 11.5 mt -71.11 -22.1 62.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 0.0 110.025 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -91.62 -23.65 19.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.861 . . . . 0.0 110.303 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.93 -49.12 7.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.629 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.59 ' CE1' ' CE1' ' A' ' 150' ' ' TYR . 46.2 m80 -63.25 -97.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.085 -1.01 . . . . 0.0 110.528 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.404 ' OG ' ' C ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -160.51 -70.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 110.385 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.521 ' HB2' ' ND2' ' A' ' 159' ' ' ASN . 3.4 p-10 -142.41 31.49 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.223 -0.923 . . . . 0.0 110.556 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.542 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -52.53 131.08 33.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 0.0 109.767 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.888 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 51.3 m-85 59.25 66.32 1.05 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 156' ' ' ASP . 1.1 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.204 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 3' ' ' PHE . 45.4 t -79.75 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.343 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.599 ' N ' HG12 ' A' ' 2' ' ' VAL . 90.8 m-85 -137.74 144.46 41.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.28 110.0 20.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.421 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.602 ' CD2' HG11 ' A' ' 133' ' ' VAL . 19.2 m-30 -112.3 88.23 2.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.739 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.01 128.3 38.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -147.16 -172.28 3.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 110.765 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -165.68 173.87 10.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.85 . . . . 0.0 110.782 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.582 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 13.1 t -151.58 168.46 24.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -128.45 139.82 52.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.794 -1.191 . . . . 0.0 111.08 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.516 ' OG ' HD11 ' A' ' 18' ' ' LEU . 43.3 t -134.99 153.89 51.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 110.257 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.85 -22.12 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.213 -0.929 . . . . 0.0 110.04 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 18' ' ' LEU . 4.3 mm -75.84 140.98 71.24 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.636 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 33.1 Cg_endo -57.73 154.53 36.88 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.024 1.539 . . . . 0.0 111.196 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -54.65 -64.46 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 111.172 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -40.87 -62.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 0.0 111.113 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.511 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -50.36 -58.56 5.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.083 -1.011 . . . . 0.0 110.761 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -49.39 -31.3 9.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 110.924 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.769 ' CE2' HD21 ' A' ' 24' ' ' LEU . 24.9 t80 -74.21 -55.86 5.57 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.415 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 4.3 mtmm -52.09 -42.98 63.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.07 -1.019 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -83.78 -71.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 108.398 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.692 ' HD1' HG21 ' A' ' 147' ' ' VAL . 27.2 t80 -79.49 147.24 32.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.315 -0.865 . . . . 0.0 108.696 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.056 ' CD1' HD11 ' A' ' 104' ' ' ILE . 38.0 mt 81.93 -44.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.769 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.2 mt -97.97 -56.44 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.982 . . . . 0.0 109.933 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -102.91 80.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.199 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.76 -23.02 10.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.526 ' HA ' HG21 ' A' ' 41' ' ' VAL . 7.8 p-10 -78.24 -22.12 48.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' OD1' ' OD2' ' A' ' 27' ' ' ASP . 30.5 m-20 -105.75 4.68 30.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -128.27 -42.23 1.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 8.1 m-30 -54.35 -58.24 14.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.774 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 52.5 Cg_endo -68.45 -5.54 15.38 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.249 1.131 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -106.14 -14.01 15.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 111.308 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.946 HG23 ' HB1' ' A' ' 146' ' ' ALA . 15.8 m -134.41 6.27 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.008 -1.058 . . . . 0.0 110.051 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.11 62.63 2.45 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.26 -20.67 55.55 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.893 1.47 . . . . 0.0 109.623 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -75.43 -19.14 59.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.697 ' HB1' ' SD ' ' A' ' 139' ' ' MET . . . -101.67 -52.45 3.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.547 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 39' ' ' SER . 1.4 mp -109.74 166.0 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.968 . . . . 0.0 110.675 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.472 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -124.51 -46.16 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 109.891 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -165.45 159.06 16.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' A' ' 27' ' ' ASP . 73.1 t -111.41 160.87 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.922 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 10.0 mt-10 -143.33 -179.75 6.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.964 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 44' ' ' ILE . 0.8 OUTLIER 67.51 -87.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.527 -0.733 . . . . 0.0 109.421 -179.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.811 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER 25.68 58.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-O 121.954 0.883 . . . . 0.0 111.433 179.03 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 5.7 pt-20 -115.16 123.18 48.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.902 -1.124 . . . . 0.0 110.398 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.92 -61.52 0.3 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 51.53 87.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 110.129 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.94 7.26 8.71 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.13 165.93 19.83 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.45 82.3 1.9 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.141 1.601 . . . . 0.0 110.524 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' O ' HG12 ' A' ' 53' ' ' ILE . . . 122.17 29.98 1.27 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 51' ' ' GLY . 64.0 m -43.93 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -1.183 . . . . 0.0 109.693 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 51' ' ' GLY . 28.2 mm -79.65 125.94 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 111.125 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 14.3 mtpt -133.06 148.8 52.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.46 -0.775 . . . . 0.0 109.288 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 4.7 tttp -124.58 117.1 23.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.902 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.4 mp -94.92 130.62 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.723 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -117.61 124.25 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.1 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CB ' ' CD1' ' A' ' 62' ' ' LEU . 12.7 m-85 -91.11 166.75 17.72 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.15 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -72.83 178.1 6.82 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.854 1.45 . . . . 0.0 110.177 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.77 173.58 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.497 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.23 52.61 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.593 ' CD1' ' CB ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -76.72 152.68 83.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.213 -1.169 . . . . 0.0 110.366 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.07 -22.58 19.24 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.136 1.598 . . . . 0.0 109.889 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 18.6 m-85 -123.28 -159.81 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.47 -0.769 . . . . 0.0 109.655 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -122.26 -26.85 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 110.423 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 16.0 p90 -176.98 -175.73 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.314 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 66' ' ' TYR . 7.5 m -153.81 122.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.732 ' HB3' HD11 ' A' ' 86' ' ' ILE . 18.9 mtmt -93.82 133.61 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -114.93 144.69 43.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.848 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.52 ' NH2' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -113.52 103.9 11.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 110.03 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 74' ' ' VAL . 4.5 t -83.01 125.9 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 110.19 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 70' ' ' ARG . 1.2 m-20 -97.34 52.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.85 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.5 OUTLIER 63.54 77.68 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.081 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 71' ' ' VAL . 5.1 m -56.71 -177.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.375 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 1.8 t0 -123.06 -168.01 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.837 . . . . 0.0 109.748 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.477 ' CE1' HD11 ' A' ' 24' ' ' LEU . 5.0 m80 -144.83 -53.95 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.2 m -51.95 -57.35 9.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.54 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 8.1 m120 -91.16 17.69 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.542 ' CD2' ' HB1' ' A' ' 15' ' ' ALA . 16.2 m-85 42.47 48.72 4.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 109.997 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.0 tppt? -93.44 123.79 36.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 110.805 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -120.53 112.55 19.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 31.4 t-20 -127.3 108.34 10.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.8 p90 -136.81 165.51 25.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 109.982 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -117.16 141.11 48.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.536 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.2 t -86.39 78.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.734 . . . . 0.0 109.266 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.732 HD11 ' HB3' ' A' ' 68' ' ' LYS . 43.1 pt -59.61 -131.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.503 -0.748 . . . . 0.0 110.751 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.524 ' N ' HG13 ' A' ' 86' ' ' ILE . 28.3 mm-40 -67.64 160.95 26.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 102.8 152.29 23.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.04 -147.0 18.49 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.8 Cg_endo -84.23 29.08 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.984 1.518 . . . . 0.0 110.84 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -41.24 163.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.119 -0.988 . . . . 0.0 109.95 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.4 -170.55 14.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.42 ' CG ' HG23 ' A' ' 94' ' ' THR . 36.7 p-10 -55.12 173.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -1.075 . . . . 0.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 5.4 p 54.23 15.13 0.86 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.719 ' HG ' HG22 ' A' ' 122' ' ' THR . 1.2 mt 167.56 92.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.022 -1.049 . . . . 0.0 110.089 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 2.6 tp10 -91.08 -34.14 15.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 110.332 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 96' ' ' GLU . 13.2 mttp -149.69 153.25 36.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.423 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.552 HD11 HD22 ' A' ' 95' ' ' LEU . 75.5 mt -137.47 150.71 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.85 . . . . 0.0 109.731 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m -134.35 143.91 47.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' TYR . 37.8 t-20 -136.47 133.17 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 0.0 110.244 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.744 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 3.1 pt-20 -151.69 149.72 29.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.128 -0.982 . . . . 0.0 109.794 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.903 HG23 ' N ' ' A' ' 103' ' ' LYS . 8.0 tp 168.46 -138.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.619 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.903 ' N ' HG23 ' A' ' 102' ' ' ILE . 20.5 ptmt -179.82 -171.07 0.17 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.907 -1.121 . . . . 0.0 111.506 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.056 HD11 ' CD1' ' A' ' 23' ' ' ILE . 66.1 mt -120.0 163.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.231 -0.918 . . . . 0.0 109.685 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.53 HG23 ' HD2' ' A' ' 115' ' ' LYS . 3.9 t -132.0 124.4 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.911 -1.118 . . . . 0.0 110.425 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.19 131.9 35.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.6 p -108.92 155.55 40.6 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.668 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 109' ' ' ASP . 47.1 Cg_endo -66.28 82.2 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.251 1.658 . . . . 0.0 110.817 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 1.4 m-20 70.71 25.97 3.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.524 -0.735 . . . . 0.0 110.346 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.73 -2.68 18.96 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.89 -170.74 22.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 14' ' ' PRO . 12.6 m -120.94 130.09 53.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.299 -1.118 . . . . 0.0 109.918 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 10' ' ' THR . 7.3 mt -99.86 121.48 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 109.854 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.842 HD12 HG23 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -86.89 108.48 18.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.651 -0.655 . . . . 0.0 109.672 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.598 ' O ' ' CG1' ' A' ' 102' ' ' ILE . 1.3 ptmt -102.44 133.87 46.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.565 -1.335 . . . . 0.0 108.533 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.847 ' HA ' HG21 ' A' ' 102' ' ' ILE . 6.7 mt -135.8 139.42 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.642 ' HB2' HD13 ' A' ' 102' ' ' ILE . 8.7 t -112.6 107.79 16.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 7.5 m120 -107.04 108.3 19.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.836 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.541 ' HD2' ' CG1' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.99 132.51 46.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.826 179.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.684 ' HD2' HD11 ' A' ' 95' ' ' LEU . 3.6 m-85 -101.73 129.37 47.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.4 m-70 -110.41 101.68 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.771 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.719 HG22 ' HG ' ' A' ' 95' ' ' LEU . 16.2 p -101.82 -165.19 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.366 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -160.39 126.08 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 128.63 -129.4 6.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -124.11 -53.7 1.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.146 -1.208 . . . . 0.0 110.129 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 125' ' ' ASP . 90.4 m-70 -44.22 168.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 109.929 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.93 163.31 21.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 0.0 110.596 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.608 HG23 HG21 ' A' ' 122' ' ' THR . 24.4 t -53.41 157.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -102.5 108.29 19.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.04 -47.32 8.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -0.981 . . . . 0.0 109.953 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.79 -46.62 59.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -35.55 80.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.863 . . . . 0.0 109.648 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.602 HG11 ' CD2' ' A' ' 5' ' ' TYR . 21.8 t -76.99 -12.22 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.459 -0.775 . . . . 0.0 109.775 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -46.74 7.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.447 -0.783 . . . . 0.0 110.808 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -54.38 -49.47 69.79 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.066 -1.021 . . . . 0.0 109.572 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -57.99 -43.94 86.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.925 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -66.1 -23.66 66.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.166 -0.959 . . . . 0.0 109.361 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 3.1 tt0 -73.07 -43.71 61.51 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.697 ' SD ' ' HB1' ' A' ' 37' ' ' ALA . 5.3 mmm -64.27 -35.94 82.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.41 -44.2 97.97 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.27 -45.97 75.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.053 -1.263 . . . . 0.0 110.262 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -37.65 68.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 108.897 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.7 mm? -68.17 -52.98 28.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.434 -0.791 . . . . 0.0 109.578 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 9' ' ' THR . 9.4 tp -47.6 -36.8 11.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.877 -1.14 . . . . 0.0 108.519 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 15.2 mtt180 -71.76 -38.77 70.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 0.0 109.367 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.946 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -58.51 -57.93 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.521 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.692 HG21 ' HD1' ' A' ' 22' ' ' PHE . 17.7 t -66.92 -27.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.473 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.558 ' O ' HD22 ' A' ' 152' ' ' LEU . 16.3 tp10 -59.43 -54.98 40.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 109.976 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.5 p -75.71 -27.24 58.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.045 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.789 ' CG ' HD11 ' A' ' 29' ' ' LEU . 7.1 t80 -53.8 -45.92 70.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.553 HD12 HG13 ' A' ' 13' ' ' ILE . 79.7 mt -61.1 -29.93 70.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.763 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.558 HD22 ' O ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -89.0 -18.78 26.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 110.703 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.58 -52.75 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 155' ' ' SER . 3.4 m80 -63.97 -111.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 156' ' ' ASP . 92.0 p -178.11 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.851 -1.155 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 155' ' ' SER . 0.0 OUTLIER 71.94 20.65 4.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 111.457 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -52.45 137.28 30.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.619 -1.301 . . . . 0.0 109.462 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.837 ' OH ' HD23 ' A' ' 29' ' ' LEU . 72.2 m-85 58.72 81.8 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.222 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.501 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 10.9 p -117.71 167.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.631 ' CD1' HG23 ' A' ' 128' ' ' VAL . 29.0 m-85 -132.44 108.64 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.414 -0.803 . . . . 0.0 110.098 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -62.84 142.69 58.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.522 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.891 ' CD1' HG11 ' A' ' 133' ' ' VAL . 23.9 m-85 -150.05 69.05 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.0 109.657 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 72.3 mt-10 -94.72 141.89 28.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.594 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.416 ' C ' ' OE1' ' A' ' 8' ' ' GLU . 15.1 t -159.9 -178.22 6.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.45 -0.781 . . . . 0.0 109.59 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 7' ' ' THR . 1.8 pm0 -155.42 154.75 32.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.057 -1.027 . . . . 0.0 110.425 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.906 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.34 158.58 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.664 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.49 HG22 HG12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -120.41 139.69 52.45 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.05 -1.032 . . . . 0.0 110.48 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.588 ' OG ' HD11 ' A' ' 18' ' ' LEU . 30.1 t -135.05 141.22 46.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.549 -0.719 . . . . 0.0 109.872 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.12 -15.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.635 HG23 ' HD2' ' A' ' 14' ' ' PRO . 15.0 mm -75.72 147.14 80.97 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 110.018 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.0 Cg_endo -56.38 155.23 26.05 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.902 1.475 . . . . 0.0 110.683 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -63.47 -69.29 0.28 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 111.311 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -39.26 -46.43 1.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.29 -0.881 . . . . 0.0 111.538 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.561 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 41.7 mtt180 -64.95 -50.5 66.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.115 . . . . 0.0 110.052 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 9.8 mt -56.1 -25.89 47.6 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.939 0.876 . . . . 0.0 109.547 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.769 ' CE2' HD21 ' A' ' 24' ' ' LEU . 21.4 t80 -79.46 -48.62 13.62 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.2 -0.937 . . . . 0.0 110.902 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -67.46 -27.47 67.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.501 -0.749 . . . . 0.0 112.117 -178.422 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.872 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.11 -29.84 8.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.553 -1.342 . . . . 0.0 112.165 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 88.2 t80 -109.14 5.0 23.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.785 -1.197 . . . . 0.0 111.582 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.648 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 41.2 mt -141.77 -19.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.942 -1.099 . . . . 0.0 111.23 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.802 HD22 HG21 ' A' ' 74' ' ' VAL . 1.8 mt -110.68 -37.09 5.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.966 -1.084 . . . . 0.0 109.904 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.6 42.43 2.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -40.4 71.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.865 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.2 p30 -70.45 -0.8 9.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -1.127 . . . . 0.0 110.929 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 13.9 t30 -138.93 47.98 1.91 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.017 HD11 HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER 177.37 -30.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.511 -0.743 . . . . 0.0 109.077 -178.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.716 ' N ' HD13 ' A' ' 29' ' ' LEU . 5.9 m-30 -56.24 -59.14 12.78 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.581 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -67.58 -11.28 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.741 1.39 . . . . 0.0 110.635 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -16.33 38.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.605 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.747 HG23 ' HB1' ' A' ' 146' ' ' ALA . 25.7 m -127.19 -3.09 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.328 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -148.77 65.19 8.18 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.055 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.85 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.054 1.555 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -90.13 -14.47 33.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.559 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.29 -29.79 6.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.018 -1.051 . . . . 0.0 110.576 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.505 HG12 HD21 ' A' ' 143' ' ' LEU . 6.5 mm -120.82 161.11 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.49 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.3 OUTLIER -127.6 -49.29 1.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 109.254 179.057 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 39' ' ' SER . 12.5 t 174.19 138.54 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.566 -0.709 . . . . 0.0 110.276 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.865 HG11 ' HB2' ' A' ' 27' ' ' ASP . 8.6 p -109.13 162.54 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 108.979 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.597 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 9.8 tt0 -175.62 144.69 0.67 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.795 -1.191 . . . . 0.0 111.377 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.738 ' HB2' ' HA ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER 148.74 -79.76 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.627 ' HA ' HG22 ' A' ' 52' ' ' THR . 3.7 tp 36.68 46.12 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.723 -0.611 . . . . 0.0 111.261 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 44' ' ' ILE . 7.2 tp10 -44.99 140.14 2.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.109 -0.994 . . . . 0.0 109.739 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.73 99.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.21 -67.08 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 0.0 110.317 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.93 -9.24 4.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.521 ' O ' ' CG1' ' A' ' 71' ' ' VAL . . . 145.31 -85.21 0.18 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HG3' ' OE2' ' A' ' 73' ' ' GLU . 50.1 Cg_endo -73.33 99.28 1.1 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.924 1.486 . . . . 0.0 110.648 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.37 -9.06 7.83 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 44' ' ' ILE . 2.5 m -65.47 122.39 17.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -1.163 . . . . 0.0 110.078 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.649 HD13 ' CG ' ' A' ' 70' ' ' ARG . 18.3 mm -82.73 148.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 14.0 mtmt -148.17 141.26 24.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 110.421 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -114.23 132.22 56.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 110.251 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 56' ' ' ILE . 1.8 mp -107.22 112.33 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.351 -0.843 . . . . 0.0 110.097 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 39' ' ' SER . 9.2 t -103.57 136.42 43.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.952 -1.093 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.693 ' CD2' HD12 ' A' ' 62' ' ' LEU . 17.9 m-85 -103.26 166.02 12.54 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.86 . . . . 0.0 109.763 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -73.14 175.14 10.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.873 1.459 . . . . 0.0 110.413 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.18 178.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 110.374 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.72 -38.29 3.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.693 HD12 ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -62.09 133.13 94.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.139 -1.213 . . . . 0.0 110.29 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.3 -13.76 16.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.175 1.618 . . . . 0.0 110.346 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -101.01 -163.88 1.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -117.88 -39.12 3.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.121 -0.987 . . . . 0.0 110.686 -179.543 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 21.2 p90 -177.31 -171.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.705 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 67' ' ' VAL . 12.2 t -147.08 99.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.485 -0.76 . . . . 0.0 111.043 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -89.99 139.77 30.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.016 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -157.42 162.05 38.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.649 ' CG ' HD13 ' A' ' 53' ' ' ILE . 4.3 mtm105 -112.47 155.97 23.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.204 -0.935 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 49' ' ' GLY . 2.6 p -98.35 161.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 110.388 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 5.4 m-20 -124.1 54.03 1.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.6 mt-10 65.88 115.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.802 HG21 HD22 ' A' ' 24' ' ' LEU . 4.4 p -90.68 145.6 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -92.47 -151.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.083 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.495 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -168.1 -62.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 m -50.63 -56.11 13.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.825 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 79' ' ' PHE . 2.1 m-80 -95.84 18.37 13.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 0.0 110.672 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 6.2 m-85 42.47 72.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 0.0 109.924 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.1 tttp -123.92 115.41 21.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.023 -1.048 . . . . 0.0 110.707 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.543 ' HD1' HG23 ' A' ' 74' ' ' VAL . 9.9 t80 -113.4 173.21 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 54.5 t-20 -176.35 123.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 36.7 p90 -135.28 157.58 46.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.2 135.37 55.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 73.3 t -108.01 110.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.253 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.81 -14.06 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 68' ' ' LYS . 5.4 mt-10 -139.68 140.92 36.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.179 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.461 ' C ' HG12 ' A' ' 91' ' ' ILE . . . 103.2 177.23 26.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.18 -135.01 20.64 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.533 ' HG3' ' NE2' ' A' ' 132' ' ' GLN . 51.6 Cg_endo -86.48 29.84 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 111.46 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.474 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -37.66 157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.28 -132.38 4.63 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -114.66 55.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 0.0 110.625 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.824 HG22 ' HB2' ' A' ' 126' ' ' HIS . 0.8 OUTLIER -150.57 -70.26 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.677 HD11 ' CD2' ' A' ' 120' ' ' TYR . 2.6 mt -98.7 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 109.873 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -93.19 -39.8 10.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 110.517 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.533 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.9 tttm -134.47 164.56 27.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 0.0 110.868 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 97' ' ' LYS . 13.0 mt -158.82 132.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -116.28 116.34 27.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.898 -1.127 . . . . 0.0 110.523 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 11.1 t-20 -116.35 126.67 53.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 14.5 tm-20 -116.38 149.24 39.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.461 -0.775 . . . . 0.0 109.673 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.55 HG22 ' CD1' ' A' ' 104' ' ' ILE . 72.5 mt -136.29 134.16 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.469 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -131.62 99.85 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.445 -0.785 . . . . 0.0 109.829 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.58 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -77.29 113.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.269 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.428 HG21 ' HE2' ' A' ' 115' ' ' LYS . 95.6 t -102.28 122.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.288 -0.882 . . . . 0.0 109.725 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.61 134.49 37.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.601 -0.687 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 110' ' ' GLY . 71.2 p -104.85 156.1 36.52 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.845 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.36 -2.87 8.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -173.07 -25.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 111.269 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.431 ' C ' ' OG1' ' A' ' 107' ' ' THR . . . -83.55 45.54 3.48 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 52.21 -114.91 3.64 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 3.1 m -150.57 158.52 44.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.409 -1.054 . . . . 0.0 109.557 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 10' ' ' THR . 20.7 mt -126.02 122.32 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.873 -1.142 . . . . 0.0 110.832 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.906 ' HB2' HG22 ' A' ' 9' ' ' THR . 7.1 mp -84.63 105.11 15.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.708 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HE2' HG21 ' A' ' 105' ' ' VAL . 1.1 mptp? -84.32 100.65 11.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.778 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.8 mt -92.76 155.03 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.868 . . . . 0.0 110.864 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 36.3 t -151.34 91.21 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.488 -0.758 . . . . 0.0 109.297 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 99' ' ' SER . 36.3 t-20 -101.82 145.83 28.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 111.444 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.456 ' CG ' HG21 ' A' ' 2' ' ' VAL . 2.1 ttmt -131.96 118.94 20.42 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.7 m-85 -86.14 107.92 18.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.934 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -92.22 96.8 10.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.426 HG21 HG23 ' A' ' 128' ' ' VAL . 20.8 p -92.12 -136.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 110.083 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -40.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 160.68 -149.35 18.47 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 126' ' ' HIS . 5.2 t0 47.09 -92.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -1.082 . . . . 0.0 110.135 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.824 ' HB2' HG22 ' A' ' 94' ' ' THR . 1.8 m-70 -87.52 172.0 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -124.21 179.54 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG23 ' CD1' ' A' ' 3' ' ' PHE . 99.3 t -78.13 153.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.123 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -106.95 110.22 22.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.316 -0.865 . . . . 0.0 109.816 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.29 -40.62 3.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.0 tt0 -55.27 -49.1 72.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.533 ' NE2' ' HG3' ' A' ' 90' ' ' PRO . 1.1 tt0 -60.32 -39.7 87.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 108.954 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.891 HG11 ' CD1' ' A' ' 5' ' ' TYR . 64.4 t -64.91 -22.82 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.754 0.787 . . . . 0.0 109.162 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -83.64 -67.63 0.78 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.628 -0.67 . . . . 0.0 110.693 -179.239 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -33.5 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.501 -0.749 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -67.1 -55.18 15.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 108.724 178.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 134' ' ' LYS . 8.9 mptt -53.42 -55.42 25.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.815 . . . . 0.0 109.073 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -46.69 -47.07 20.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.585 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.643 ' SD ' HD23 ' A' ' 143' ' ' LEU . 2.6 tpp -56.19 -44.1 79.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.116 -0.99 . . . . 0.0 108.799 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.54 92.83 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.83 -31.41 66.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.066 -1.255 . . . . 0.0 110.804 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.511 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.1 OUTLIER -68.6 -43.9 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.954 -1.091 . . . . 0.0 109.056 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.643 HD23 ' SD ' ' A' ' 139' ' ' MET . 1.5 mm? -70.5 -33.36 71.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.246 -0.909 . . . . 0.0 109.189 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.581 HD12 HG21 ' A' ' 9' ' ' THR . 0.8 OUTLIER -61.62 -41.53 97.6 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.74 -47.05 76.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.606 -0.684 . . . . 0.0 110.063 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.747 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.68 -59.6 4.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 1.017 HG22 HD11 ' A' ' 29' ' ' LEU . 40.7 t -65.63 -19.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.492 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.53 ' HG3' HG12 ' A' ' 13' ' ' ILE . 22.1 tt0 -71.99 -46.21 58.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.1 -1.0 . . . . 0.0 110.072 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.73 -12.3 37.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 110.291 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.649 ' CG ' HG11 ' A' ' 33' ' ' VAL . 8.5 t80 -69.58 -36.4 76.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.075 -1.016 . . . . 0.0 109.637 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 38.7 mt -72.6 -19.94 61.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.173 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 152' ' ' LEU . 10.2 mp -87.46 -33.26 19.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.42 -48.66 13.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.858 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.428 ' O ' ' C ' ' A' ' 155' ' ' SER . 69.5 m80 -76.71 -22.5 53.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.825 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 154' ' ' HIS . 17.0 p 41.93 51.1 4.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.333 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -168.83 -37.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.604 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB2' ' OH ' ' A' ' 150' ' ' TYR . . . -64.15 130.86 45.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.383 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.872 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 58.4 m-85 55.75 62.85 2.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.261 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 120' ' ' TYR . 12.1 p -132.77 157.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -1.143 . . . . 0.0 110.564 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.571 ' CD1' HG23 ' A' ' 128' ' ' VAL . 68.1 m-85 -130.82 156.7 44.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -120.16 91.44 3.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.162 -0.961 . . . . 0.0 110.234 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.072 ' CD2' HG11 ' A' ' 133' ' ' VAL . 31.3 m-85 -87.52 146.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.059 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.86 149.73 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.398 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.451 ' C ' ' CG ' ' A' ' 8' ' ' GLU . 8.6 t -169.13 167.63 10.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 109.903 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.451 ' CG ' ' C ' ' A' ' 7' ' ' THR . 32.0 mt-10 -148.8 146.97 28.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.85 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.9 178.24 5.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 109.853 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.46 149.49 51.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.678 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.694 ' HB3' HD11 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -143.73 142.54 30.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.341 -0.849 . . . . 0.0 109.905 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -6.17 7.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.573 -0.705 . . . . 0.0 110.4 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.587 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 15.6 mm -89.5 143.17 30.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.104 -0.998 . . . . 0.0 109.952 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.507 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 33.0 Cg_endo -56.94 154.75 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.739 1.389 . . . . 0.0 110.06 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -62.02 -39.73 93.29 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.099 -1.001 . . . . 0.0 110.812 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 -60.86 3.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.615 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -55.91 -47.44 77.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 11' ' ' SER . 9.4 mt -53.32 -37.89 62.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.964 -1.085 . . . . 0.0 109.075 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.816 ' HE1' HD21 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -70.17 -69.91 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.027 -1.046 . . . . 0.0 110.227 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.617 ' HA ' HD12 ' A' ' 24' ' ' LEU . 4.7 mtpt -52.37 -19.37 2.09 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.669 -1.269 . . . . 0.0 113.279 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.813 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -114.06 -56.36 2.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.49 -1.381 . . . . 0.0 112.176 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.704 ' HD1' HG21 ' A' ' 147' ' ' VAL . 19.2 t80 -73.64 -85.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.489 -1.382 . . . . 0.0 110.82 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.703 HG23 ' CD2' ' A' ' 81' ' ' TYR . 21.9 mm -37.42 -48.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.512 -0.742 . . . . 0.0 110.221 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.816 HD21 ' HE1' ' A' ' 19' ' ' PHE . 4.5 mt -100.53 -170.64 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 32.88 34.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.726 -0.609 . . . . 0.0 111.588 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA3' ' CE1' ' A' ' 30' ' ' PHE . . . -92.26 -12.95 58.08 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' HB2' HG11 ' A' ' 41' ' ' VAL . 52.2 p30 -67.33 -7.39 24.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.459 -1.024 . . . . 0.0 111.07 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -130.23 16.59 5.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.091 -1.005 . . . . 0.0 108.532 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.901 ' O ' HG22 ' A' ' 33' ' ' VAL . 5.9 tp -131.54 -50.33 0.99 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.452 -0.78 . . . . 0.0 110.746 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.887 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 4.0 m-30 -42.71 -53.74 9.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.419 -0.801 . . . . 0.0 110.315 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -67.04 -38.01 17.41 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.408 1.215 . . . . 0.0 110.957 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 2.4 mtmt -75.23 -73.3 0.26 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.977 -1.077 . . . . 0.0 110.907 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.0 m -62.94 -21.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.729 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -126.16 69.48 67.12 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.049 -1.032 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 43.7 Cg_endo -69.45 -21.92 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.891 1.469 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.496 ' O ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.92 -3.2 57.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.308 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.651 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -114.12 -51.18 2.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 111.124 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.627 HD12 ' CB ' ' A' ' 37' ' ' ALA . 3.9 mp -138.95 172.46 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.871 -1.143 . . . . 0.0 110.761 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.593 ' N ' HG22 ' A' ' 38' ' ' ILE . 29.6 t -133.37 -31.05 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.582 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -158.89 166.7 31.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 27' ' ' ASP . 2.2 p -133.32 140.1 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.021 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.56 102.22 10.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 110.655 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -99.3 91.14 4.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.243 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -51.17 -40.49 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.875 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.499 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -112.95 142.12 46.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.837 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 47' ' ' ASN . . . -84.12 86.64 1.53 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 46' ' ' GLY . 19.2 p30 36.08 48.23 0.51 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.662 -0.905 . . . . 0.0 110.977 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.67 68.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.75 -137.52 6.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 45.8 Cg_endo -72.84 94.56 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.026 1.54 . . . . 0.0 110.172 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 52' ' ' THR . . . 145.82 -16.49 1.78 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 51' ' ' GLY . 46.8 m -42.28 116.59 0.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -1.1 . . . . 0.0 109.991 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 53' ' ' ILE . 10.1 mm -97.15 129.72 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 1.7 ptmt -127.59 149.05 50.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.34 -0.85 . . . . 0.0 110.082 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' CB ' ' HG2' ' A' ' 68' ' ' LYS . 4.0 mttp -140.4 100.95 4.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.676 -0.64 . . . . 0.0 109.311 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.667 HD12 ' N ' ' A' ' 56' ' ' ILE . 2.0 mp -82.74 156.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.82 -1.175 . . . . 0.0 110.206 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 85.1 p -115.55 145.22 42.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.965 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.79 ' HE1' HG22 ' A' ' 67' ' ' VAL . 4.8 m-85 -118.99 72.94 12.06 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.233 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.551 ' CG ' ' HB3' ' A' ' 39' ' ' SER . 45.5 Cg_endo -75.51 68.7 6.11 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.627 1.856 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.0 -163.37 1.76 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.278 -0.889 . . . . 0.0 110.288 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.75 69.62 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.496 HD11 ' O ' ' A' ' 36' ' ' GLN . 27.4 mt -65.37 158.74 71.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.12 -1.223 . . . . 0.0 110.353 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.78 -35.13 4.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.961 1.506 . . . . 0.0 109.959 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 9.4 m-30 -79.94 150.54 30.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.848 . . . . 0.0 110.044 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -113.94 -6.22 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.843 179.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.6 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 20.7 p90 179.23 176.26 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.541 -0.724 . . . . 0.0 109.394 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.79 HG22 ' HE1' ' A' ' 58' ' ' PHE . 35.6 m -159.11 109.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 109.283 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HE2' ' CE1' ' A' ' 66' ' ' TYR . 7.6 mttm -96.2 139.48 32.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 109.503 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.904 ' OD1' HG22 ' A' ' 85' ' ' VAL . 14.3 m-20 -156.78 132.62 9.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 0.0 111.233 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 47.6 mtt180 -73.21 156.46 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.072 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 3.4 p -94.27 -17.7 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.938 -1.101 . . . . 0.0 111.039 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 61.1 -87.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 72' ' ' ASP . 0.1 OUTLIER 179.24 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.085 -1.009 . . . . 0.0 110.351 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.854 HG22 ' CD1' ' A' ' 81' ' ' TYR . 49.7 t -66.87 161.02 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.386 -0.821 . . . . 0.0 110.223 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.618 ' O ' ' HB2' ' A' ' 76' ' ' HIS . 6.3 t70 -103.16 -57.55 2.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER 75.58 -58.9 0.54 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.265 -0.272 . . . . 0.0 111.092 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 m -52.08 -55.08 23.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 110.011 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -95.02 16.04 17.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.37 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.418 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.7 m-85 52.66 52.59 13.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.182 -0.948 . . . . 0.0 109.867 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 102' ' ' ILE . 17.7 ttpt -124.44 127.24 47.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.854 ' CD1' HG22 ' A' ' 74' ' ' VAL . 70.6 t80 -128.58 125.79 38.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -130.51 145.2 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.702 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.761 ' HE2' HD11 ' A' ' 102' ' ' ILE . 18.1 p90 -136.11 158.33 44.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -104.31 138.14 41.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.904 HG22 ' OD1' ' A' ' 69' ' ' ASP . 24.9 t -107.42 69.47 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.817 . . . . 0.0 109.823 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.574 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -66.6 -11.19 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER 172.47 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.751 ' O ' HD11 ' A' ' 91' ' ' ILE . . . -106.31 -146.22 13.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . -91.57 -38.28 5.91 Favored Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.334 -1.098 . . . . 0.0 111.382 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -76.46 -9.91 18.81 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.128 1.067 . . . . 0.0 111.981 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.751 HD11 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -41.61 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.997 -1.064 . . . . 0.0 110.706 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.53 -168.07 41.15 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.6 m-20 -66.03 -175.18 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -1.182 . . . . 0.0 110.333 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 122' ' ' THR . 18.6 p 48.83 21.18 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 110.985 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -161.25 133.4 5.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.028 . . . . 0.0 110.143 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.67 -60.4 1.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.482 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' C ' HG13 ' A' ' 98' ' ' ILE . 17.1 ttmt -127.23 160.05 32.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.056 -1.027 . . . . 0.0 110.43 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.909 HD11 HD22 ' A' ' 95' ' ' LEU . 24.0 mt -152.39 142.79 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.5 t -119.1 143.04 47.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 83' ' ' TYR . 1.6 t-20 -126.02 125.76 43.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 111.124 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.34 135.81 53.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.454 -0.778 . . . . 0.0 109.404 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.761 HD11 ' HE2' ' A' ' 83' ' ' TYR . 22.7 mt -130.54 157.87 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.825 -1.172 . . . . 0.0 110.916 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 13.4 ttmt -151.12 110.83 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.608 HD11 HG13 ' A' ' 23' ' ' ILE . 4.7 mt -84.4 128.94 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.097 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 112' ' ' SER . 6.6 t -119.83 151.58 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.732 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.99 135.3 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 109.754 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 109' ' ' ASP . 11.6 p -138.36 142.61 35.6 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.002 . . . . 0.0 110.768 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.38 -3.59 12.72 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.279 1.673 . . . . 0.0 110.533 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.445 ' CG ' ' HG1' ' A' ' 107' ' ' THR . 10.6 p30 -80.11 2.81 22.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.287 -0.883 . . . . 0.0 111.004 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.85 -82.28 0.15 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.41 -134.47 3.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.685 ' OG ' HD12 ' A' ' 18' ' ' LEU . 60.4 p -113.42 175.63 5.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 9' ' ' THR . 9.8 mt -130.61 132.97 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.85 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.1 tp -91.59 100.44 13.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.568 -0.708 . . . . 0.0 110.419 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 102' ' ' ILE . 45.8 mttt -79.71 130.01 34.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.434 HG13 ' C ' ' A' ' 115' ' ' LYS . 3.8 mt -132.84 140.88 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 111.305 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.62 117.59 16.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 2.0 m-80 -107.93 106.41 16.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 111.423 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.56 ' HD2' ' CG2' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -88.85 122.35 32.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.855 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.9 m-85 -102.97 144.06 31.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.0 111.004 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -131.84 89.08 2.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.644 -0.66 . . . . 0.0 109.708 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.562 HG22 ' HG ' ' A' ' 95' ' ' LEU . 7.3 p -95.81 -159.96 0.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -83.28 -66.75 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.123 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.69 -32.37 0.62 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -69.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -1.154 . . . . 0.0 110.13 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -99.51 -170.72 1.94 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 0.0 110.114 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 mm-40 -115.81 171.15 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.538 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.571 HG23 ' CD1' ' A' ' 3' ' ' PHE . 3.4 t -67.15 156.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 4.2 mppt? -90.86 102.5 15.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.842 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -44.32 -51.17 8.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.44 -44.77 62.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.166 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 1.7 tt0 -56.52 -41.98 77.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 108.753 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.072 HG11 ' CD2' ' A' ' 5' ' ' TYR . 78.6 t -63.26 -30.09 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.825 0.821 . . . . 0.0 108.944 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 4.1 tttt -68.69 -51.53 40.78 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.772 -0.58 . . . . 0.0 110.267 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.55 -56.55 3.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.04 -43.74 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.433 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 4.5 mtpp -60.5 -38.1 83.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.805 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -65.54 -54.63 25.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 110.074 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -35.61 65.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.06 -1.025 . . . . 0.0 109.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.86 -38.95 93.31 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 1.0 OUTLIER -74.22 -35.6 63.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.314 . . . . 0.0 110.934 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.3 p -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.18 -0.95 . . . . 0.0 109.785 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.651 HD21 ' CB ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -73.32 -51.05 18.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.519 HD11 ' OG ' ' A' ' 11' ' ' SER . 15.5 tp -50.7 -44.16 57.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -62.91 -44.48 95.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 109.511 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.559 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -51.27 -58.98 4.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.704 HG21 ' HD1' ' A' ' 22' ' ' PHE . 21.9 t -66.36 -21.81 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.78 -51.05 64.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.07 -1.018 . . . . 0.0 109.736 179.552 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 3.1 t -75.33 -31.03 60.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.891 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.542 ' CE1' HD11 ' A' ' 29' ' ' LEU . 14.7 t80 -55.96 -50.85 69.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.3 mt -56.13 -29.94 61.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 109.96 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 148' ' ' GLU . 8.6 mp -72.01 -55.67 7.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 110.241 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.448 ' HB3' ' ND1' ' A' ' 154' ' ' HIS . . . -55.32 -41.23 72.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.466 -0.772 . . . . 0.0 110.544 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.448 ' ND1' ' HB3' ' A' ' 153' ' ' ALA . 2.8 m80 -105.55 122.52 46.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.82 30.57 2.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.855 . . . . 0.0 109.911 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -132.13 -26.9 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.809 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.488 ' HB2' ' OH ' ' A' ' 150' ' ' TYR . . . -69.99 128.49 36.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.964 -1.085 . . . . 0.0 110.589 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.813 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 40.3 m-85 56.68 81.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.264 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 121' ' ' HIS . 56.1 t -44.74 156.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -1.213 . . . . 0.0 110.162 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.771 ' CD1' HG23 ' A' ' 128' ' ' VAL . 97.4 m-85 -120.48 164.62 16.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 110.274 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 4' ' ' ASN . 3.4 t-20 -127.51 105.76 8.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.913 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.041 ' CD1' HG11 ' A' ' 133' ' ' VAL . 25.6 m-85 -99.01 92.75 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.983 . . . . 0.0 110.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 2.2 mp0 -53.8 141.15 27.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.85 . . . . 0.0 109.969 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.737 ' CG2' HG23 ' A' ' 102' ' ' ILE . 4.8 t -125.47 162.94 23.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.804 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.0 tm-20 178.49 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.307 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.932 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -120.64 162.6 19.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 0.0 109.835 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.92 145.89 48.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.753 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.447 ' OG ' HD11 ' A' ' 18' ' ' LEU . 35.4 t -142.19 149.17 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.885 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.86 -25.96 29.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.793 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.631 HD12 ' NH2' ' A' ' 17' ' ' ARG . 5.2 mm -72.5 142.01 83.53 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 34.5 Cg_endo -57.97 151.79 55.28 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.76 1.4 . . . . 0.0 110.521 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.586 ' HA ' HG22 ' A' ' 104' ' ' ILE . . . -58.13 -45.63 87.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.88 . . . . 0.0 110.99 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.473 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -58.43 -59.78 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 110.535 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.632 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -51.0 -59.57 4.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.496 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.55 ' HG ' HG21 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -46.28 -35.57 5.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.364 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CE1' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -65.67 -64.26 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 20.9 mtmt -54.39 -21.66 10.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.458 -0.776 . . . . 0.0 112.305 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.69 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -112.65 -59.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.638 ' CA ' HG11 ' A' ' 147' ' ' VAL . 64.6 t80 -69.22 -44.0 72.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.717 -1.239 . . . . 0.0 111.859 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.594 HG21 ' CE1' ' A' ' 19' ' ' PHE . 46.9 mm -82.8 -82.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 111.296 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.656 ' N ' HD23 ' A' ' 24' ' ' LEU . 3.7 mt -40.56 -68.4 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -55.33 -67.6 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.427 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.617 ' HA2' ' CE1' ' A' ' 30' ' ' PHE . . . 49.18 -86.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.709 ' HB2' HG21 ' A' ' 41' ' ' VAL . 4.6 p30 -73.99 27.12 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.586 -0.95 . . . . 0.0 112.349 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 11.5 t30 -139.72 38.16 2.01 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 150' ' ' TYR . 0.8 OUTLIER 174.25 -30.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.609 -177.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CE1' ' HA2' ' A' ' 26' ' ' GLY . 2.6 m-30 -38.92 -62.52 0.74 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.385 -0.822 . . . . 0.0 111.304 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.7 Cg_endo -65.89 -27.44 51.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.762 1.401 . . . . 0.0 110.288 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -72.75 -16.56 61.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.83 . . . . 0.0 110.484 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.653 HG23 ' HB1' ' A' ' 146' ' ' ALA . 19.1 m -124.25 -4.12 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.338 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.69 65.37 12.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 -10.16 27.71 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 123.835 1.439 . . . . 0.0 109.657 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -86.08 -20.42 28.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 109.127 179.057 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.442 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -107.79 -61.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.593 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 143' ' ' LEU . 7.7 mm -94.55 166.65 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.617 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -131.46 -40.17 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 p -160.16 155.9 25.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 109.944 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 27' ' ' ASP . 2.7 p -121.33 146.63 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 109.966 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 2.4 mm-40 -138.41 -174.03 3.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.642 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' C ' HG22 ' A' ' 44' ' ' ILE . 0.7 OUTLIER 65.24 -88.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.333 -179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.504 HD13 ' OD1' ' A' ' 27' ' ' ASP . 5.3 tp 32.45 36.15 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.62 -0.675 . . . . 0.0 111.246 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 18.9 tp10 -40.32 131.93 2.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.868 . . . . 0.0 110.152 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -77.33 136.08 17.84 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 17.8 t-20 61.91 65.99 0.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.183 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 49' ' ' GLY . . . -105.75 -16.08 16.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 48' ' ' GLY . . . 43.39 -131.78 5.86 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.92 81.8 1.86 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.826 1.435 . . . . 0.0 110.408 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.2 -12.85 0.94 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.655 ' O ' HD13 ' A' ' 53' ' ' ILE . 7.6 m -45.04 150.32 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.017 -1.284 . . . . 0.0 110.156 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 52' ' ' THR . 45.8 mm -131.4 154.87 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.95 . . . . 0.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' NZ ' ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -141.97 143.51 33.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.52 -0.737 . . . . 0.0 109.869 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 31.2 tttp -118.99 110.4 17.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.628 -0.67 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.545 ' CD1' HG23 ' A' ' 41' ' ' VAL . 9.8 mm -98.72 109.43 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.82 -1.175 . . . . 0.0 110.611 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 39' ' ' SER . 0.8 OUTLIER -103.07 124.87 49.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 110.405 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' HB2' HD12 ' A' ' 62' ' ' LEU . 32.1 m-85 -84.58 164.66 41.69 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.403 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.3 Cg_endo -74.47 -163.23 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.14 1.6 . . . . 0.0 109.726 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER 38.61 -162.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.569 -0.707 . . . . 0.0 111.133 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -99.58 -34.74 4.89 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 58' ' ' PHE . 11.0 mt 55.71 165.4 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.105 -1.232 . . . . 0.0 109.934 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 45.5 Cg_endo -72.15 -24.96 19.6 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.846 1.446 . . . . 0.0 109.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.511 ' HB3' ' CA ' ' A' ' 89' ' ' GLY . 18.0 m-30 -106.45 -140.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.814 . . . . 0.0 109.818 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 22.7 mttt -144.67 -32.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 111.16 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 176.65 177.44 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 89' ' ' GLY . 35.7 m -142.25 117.98 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -93.57 162.81 13.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.945 . . . . 0.0 109.342 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.495 ' OD1' HG22 ' A' ' 85' ' ' VAL . 67.0 m-20 -144.64 154.48 42.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.844 -1.16 . . . . 0.0 111.627 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HG2' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -122.29 134.68 54.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.675 -0.641 . . . . 0.0 109.386 179.392 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.506 ' HB ' ' NZ ' ' A' ' 54' ' ' LYS . 2.6 p -89.89 136.71 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.003 . . . . 0.0 110.671 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -113.94 55.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 109.401 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.4 mt-10 60.28 117.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 0.0 109.842 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.672 HG13 ' HD1' ' A' ' 81' ' ' TYR . 25.2 t -96.97 125.52 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 15.1 t0 -68.63 -170.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.572 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.07 -48.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 110.152 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 m -57.5 -16.1 8.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 110.089 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.538 ' CB ' ' HD2' ' A' ' 80' ' ' LYS . 97.3 m-20 -130.31 6.74 4.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 3.7 m-85 57.56 55.32 5.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 110.737 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.538 ' HD2' ' CB ' ' A' ' 78' ' ' ASN . 6.8 mttt -117.63 121.72 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.366 -0.834 . . . . 0.0 110.026 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.672 ' HD1' HG13 ' A' ' 74' ' ' VAL . 17.9 t80 -114.18 161.2 18.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.456 ' CB ' ' OE2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -163.83 138.09 5.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.261 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.465 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 10.9 p90 -147.5 172.49 13.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 4.6 p -139.42 135.3 33.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.736 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.495 HG22 ' OD1' ' A' ' 69' ' ' ASP . 66.9 t -101.07 81.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.582 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -66.57 -10.88 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -173.4 157.34 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.782 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.564 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 168.38 -137.57 4.66 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.239 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.666 ' H ' HG12 ' A' ' 67' ' ' VAL . . . -95.28 -38.16 4.88 Favored Glycine 0 N--CA 1.489 2.168 0 O-C-N 121.727 -0.866 . . . . 0.0 111.92 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -77.48 -1.59 11.77 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.0 1.0 . . . . 0.0 111.202 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -46.82 176.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.156 -0.965 . . . . 0.0 110.221 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 94' ' ' THR . . . 157.19 74.12 0.02 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.513 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 94' ' ' THR . 2.8 m-20 40.25 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.442 -1.034 . . . . 0.0 111.188 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.569 HG21 ' HB2' ' A' ' 126' ' ' HIS . 3.2 p -31.41 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.789 -0.569 . . . . 0.0 111.102 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.597 HD11 HG12 ' A' ' 98' ' ' ILE . 15.6 tp -64.49 88.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.081 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.78 -49.64 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.542 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -114.62 142.87 45.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.217 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.597 HG12 HD11 ' A' ' 95' ' ' LEU . 44.2 mt -136.24 114.99 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -0.948 . . . . 0.0 110.604 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 1.4 m -112.18 111.56 22.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 109.424 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.549 ' CB ' ' HA ' ' A' ' 118' ' ' ASN . 25.4 m-20 -121.27 147.3 45.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.308 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.456 ' OE2' ' CB ' ' A' ' 82' ' ' ASN . 12.3 mt-10 -136.02 141.48 44.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.532 -0.73 . . . . 0.0 109.68 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.737 HG23 ' CG2' ' A' ' 7' ' ' THR . 0.2 OUTLIER -136.3 177.93 5.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 113' ' ' ILE . 75.1 tttt -140.0 137.42 34.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.349 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.586 HG22 ' HA ' ' A' ' 15' ' ' ALA . 6.1 mm -96.82 80.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 112' ' ' SER . 90.7 t -71.39 130.97 35.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 110.702 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.87 141.28 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.544 HG21 HD11 ' A' ' 113' ' ' ILE . 38.0 p -127.42 156.51 74.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.34 -34.74 34.11 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.071 1.564 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.45 37.49 2.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.295 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.505 ' CA ' ' OG1' ' A' ' 107' ' ' THR . . . -148.43 30.48 1.3 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 45.84 -103.94 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.555 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 2.6 p -142.99 170.25 16.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 110.355 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 114' ' ' LEU . 9.7 mt -138.68 129.77 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.932 ' HB2' HG22 ' A' ' 9' ' ' THR . 8.0 mp -97.55 94.45 7.01 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 116' ' ' ILE . 1.0 OUTLIER -124.1 -176.83 3.59 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.779 -1.168 . . . . 0.0 112.721 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.742 HG22 ' N ' ' A' ' 117' ' ' SER . 21.6 mm 120.63 -102.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.236 1.414 . . . . 0.0 109.853 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.742 ' N ' HG22 ' A' ' 116' ' ' ILE . 4.7 m -168.79 177.22 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.725 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 100' ' ' ASN . 4.6 m120 -139.49 96.71 3.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.505 ' HD3' HG11 ' A' ' 2' ' ' VAL . 4.9 mttt -75.66 129.08 36.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 111.271 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.593 ' CE2' HD21 ' A' ' 95' ' ' LEU . 2.6 m-85 -105.75 106.23 16.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.825 ' HA ' HG22 ' A' ' 2' ' ' VAL . 60.3 m-70 -90.9 95.05 9.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.843 . . . . 0.0 110.307 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p -79.34 -170.88 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 -72.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 110.249 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.88 60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -153.24 -114.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -1.153 . . . . 0.0 109.79 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.569 ' HB2' HG21 ' A' ' 94' ' ' THR . 15.0 m170 -71.13 161.22 31.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.975 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.5 mp0 -77.43 -164.36 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.906 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.771 HG23 ' CD1' ' A' ' 3' ' ' PHE . 55.6 t -90.7 141.42 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -81.65 119.48 23.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -0.91 . . . . 0.0 109.887 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.06 83.24 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.132 -0.98 . . . . 0.0 109.958 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.99 -29.24 59.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -1.0 . . . . 0.0 108.839 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 90' ' ' PRO . 37.3 tt0 -77.8 -40.16 41.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.041 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.7 t -69.25 -14.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.082 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.07 -49.27 6.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.655 -0.653 . . . . 0.0 109.979 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -50.71 -45.46 58.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 t -59.14 -47.58 84.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 109.349 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HE2' ' ND2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -63.3 -22.09 66.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.643 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 74.2 tt0 -75.2 -47.6 27.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.361 -0.837 . . . . 0.0 109.416 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.442 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 42.3 mmm -65.86 -30.83 71.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.25 -0.906 . . . . 0.0 108.867 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.43 -35.5 56.06 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.66 -34.92 65.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.884 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 p -72.23 -37.94 69.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.246 -0.908 . . . . 0.0 108.807 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.597 HD21 HG12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -72.05 -31.4 66.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 9' ' ' THR . 11.7 tp -67.57 -41.96 83.32 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -68.74 -33.1 73.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.653 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -63.84 -60.99 2.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.457 -0.777 . . . . 0.0 109.245 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.638 HG11 ' CA ' ' A' ' 22' ' ' PHE . 63.4 t -60.82 -28.62 43.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.451 -0.78 . . . . 0.0 109.697 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -50.0 72.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.945 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.49 -11.99 56.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.583 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 6.5 t80 -69.53 -37.24 77.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.632 HD13 ' HG2' ' A' ' 17' ' ' ARG . 11.6 mt -73.6 -24.58 60.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 13' ' ' ILE . 4.7 mp -81.64 -36.27 29.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.52 -41.66 45.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 155' ' ' SER . 71.9 m80 -86.1 -48.44 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.372 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 7.9 t 62.22 14.34 6.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.259 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -131.95 4.08 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.371 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.491 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -106.69 143.36 34.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.288 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.69 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.8 m-85 50.56 33.51 8.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 120' ' ' TYR . 95.7 t -63.63 152.14 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -1.172 . . . . 0.0 110.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.626 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 23.1 m-85 -113.38 164.47 13.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.494 -0.754 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 119' ' ' LYS . 61.9 t-20 -148.99 98.79 2.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.083 -1.011 . . . . 0.0 111.37 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.908 ' OH ' HG21 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -95.59 134.34 38.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.163 -0.961 . . . . 0.0 108.944 178.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -119.01 117.45 28.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 110.779 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.407 HG21 ' HD3' ' A' ' 137' ' ' LYS . 7.9 t -142.6 -161.19 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 109.845 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -173.63 158.92 3.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.011 -1.056 . . . . 0.0 110.538 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.972 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -122.68 175.44 6.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.156 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.44 145.29 51.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 110.242 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.587 ' CB ' HD11 ' A' ' 18' ' ' LEU . 16.5 t -143.52 142.45 31.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.377 -0.827 . . . . 0.0 110.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.11 -10.28 13.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.639 -0.663 . . . . 0.0 110.256 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.692 HG23 ' HD2' ' A' ' 14' ' ' PRO . 15.6 mm -86.72 149.34 48.2 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.568 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.3 Cg_endo -56.19 156.36 21.05 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 121.555 1.503 . . . . 0.0 110.444 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.722 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -69.5 -51.05 39.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.26 -52.57 51.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.937 -1.102 . . . . 0.0 110.298 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -60.63 -55.18 36.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.587 HD11 ' CB ' ' A' ' 11' ' ' SER . 7.7 mt -47.48 -34.69 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.008 . . . . 0.0 109.318 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.894 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.93 -61.9 1.6 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 110.482 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 mtpt -54.44 -25.21 23.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.376 -0.828 . . . . 0.0 112.581 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.826 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.49 -56.4 2.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.446 -1.409 . . . . 0.0 111.904 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 73.6 t80 -78.92 0.79 25.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 112.267 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 4.5 mt -138.81 -22.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.689 -1.257 . . . . 0.0 111.471 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.894 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.8 mt -100.54 -35.84 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.728 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -117.02 88.76 2.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.75 -0.594 . . . . 0.0 109.613 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -113.56 -35.9 1.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.994 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.9 p30 -73.99 0.36 13.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.421 -1.046 . . . . 0.0 110.821 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 2.5 t30 -139.82 7.76 2.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.977 . . . . 0.0 109.935 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.928 HD22 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -142.15 -14.66 0.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.894 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 8.4 m-30 -71.88 -57.04 4.26 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.739 -1.225 . . . . 0.0 110.435 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.21 -34.67 44.56 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.685 1.36 . . . . 0.0 110.732 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -60.14 -15.21 21.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 0.0 109.98 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 146' ' ' ALA . 6.4 m -130.56 -4.05 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.4 62.63 6.63 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.082 -1.011 . . . . 0.0 110.709 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.72 -24.19 41.33 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.844 1.444 . . . . 0.0 109.632 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -74.38 -13.04 60.67 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.573 -0.705 . . . . 0.0 109.227 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.704 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -109.08 -63.05 1.39 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.166 -0.959 . . . . 0.0 110.396 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.48 154.48 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.905 -1.122 . . . . 0.0 110.14 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.531 ' HB3' ' N ' ' A' ' 59' ' ' PRO . 54.4 p -108.49 -45.12 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.777 . . . . 0.0 110.187 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 p -174.59 -169.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.994 HG11 ' HB2' ' A' ' 27' ' ' ASP . 7.6 p -147.84 162.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.953 . . . . 0.0 110.065 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 12.1 mt-10 -141.06 175.13 9.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 109.895 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.526 ' O ' ' C ' ' A' ' 44' ' ' ILE . 5.5 m-20 62.41 -87.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.601 -0.687 . . . . 0.0 110.038 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.778 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER 24.96 50.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-O 121.761 0.791 . . . . 0.0 110.872 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 43' ' ' ASN . 2.0 mt-10 -79.52 134.95 36.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.111 -0.993 . . . . 0.0 110.157 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.06 65.67 3.42 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -147.46 -36.24 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -1.132 . . . . 0.0 110.573 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -62.56 -21.74 62.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.24 -106.73 0.22 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 48' ' ' GLY . 48.4 Cg_endo -74.97 77.72 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.86 1.452 . . . . 0.0 110.603 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 52' ' ' THR . . . 134.17 0.05 3.88 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.437 ' C ' ' O ' ' A' ' 51' ' ' GLY . 24.3 m -42.14 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -1.165 . . . . 0.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.567 HD13 ' HG2' ' A' ' 70' ' ' ARG . 19.3 mm -126.74 124.04 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.61 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.864 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -124.52 144.81 49.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 0.0 110.424 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -111.29 111.26 22.19 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.94 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.864 HD11 ' CD ' ' A' ' 54' ' ' LYS . 5.2 mm -89.5 127.92 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.97 -1.081 . . . . 0.0 109.782 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 m -111.19 145.72 38.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 0.0 109.786 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 1.075 ' HB3' HD13 ' A' ' 62' ' ' LEU . 79.2 m-85 -121.18 155.12 58.65 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 110.775 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.531 ' N ' ' HB3' ' A' ' 39' ' ' SER . 48.9 Cg_endo -78.47 -169.05 0.7 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.155 1.608 . . . . 0.0 109.497 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 168.42 10.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 0.0 110.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.58 -52.7 2.36 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.075 HD13 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.11 142.11 86.03 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.147 . . . . 0.0 109.972 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 48.8 Cg_endo -81.84 27.92 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.082 1.569 . . . . 0.0 111.08 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 63' ' ' PRO . 82.3 m-85 -156.08 141.09 17.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.042 -1.036 . . . . 0.0 110.21 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -75.68 -34.68 60.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.572 ' C ' HG13 ' A' ' 67' ' ' VAL . 23.6 p90 -173.09 -178.12 1.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.572 HG13 ' C ' ' A' ' 66' ' ' TYR . 27.8 m -157.71 125.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.307 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 86' ' ' ILE . 7.6 mttt -85.35 131.52 34.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 108.794 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -130.29 141.54 50.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.867 -1.145 . . . . 0.0 111.664 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.567 ' HG2' HD13 ' A' ' 53' ' ' ILE . 60.6 mtm180 -110.69 132.34 54.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.589 -0.694 . . . . 0.0 109.129 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.088 HG13 HG23 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -73.08 -37.48 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.84 -1.163 . . . . 0.0 110.052 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.6 OUTLIER 78.76 -39.76 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.115 -0.366 . . . . 0.0 111.103 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 5.4 pt-20 173.34 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.71 -1.244 . . . . 0.0 111.077 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.088 HG23 HG13 ' A' ' 71' ' ' VAL . 39.3 t 60.59 139.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.37 -0.831 . . . . 0.0 109.657 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.23 164.38 13.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.073 -1.017 . . . . 0.0 110.87 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -142.03 -45.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' OD1' ' A' ' 78' ' ' ASN . 3.0 m -57.45 -34.42 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 78' ' ' ASN . 1.9 m120 -109.42 12.41 24.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.51 39.16 27.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.977 . . . . 0.0 109.786 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HG2' ' HG2' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -105.19 153.47 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.392 -0.817 . . . . 0.0 110.324 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.632 ' HE1' HG22 ' A' ' 74' ' ' VAL . 15.4 t80 -144.62 111.38 5.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.808 . . . . 0.0 109.612 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.509 ' ND2' ' CG ' ' A' ' 101' ' ' GLU . 60.6 t-20 -121.2 126.85 50.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.48 ' CD1' ' C ' ' A' ' 83' ' ' TYR . 18.8 p90 -139.67 154.67 47.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.66 164.19 11.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.098 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 86' ' ' ILE . 97.8 t -107.94 -14.88 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.514 HG21 ' NE ' ' A' ' 70' ' ' ARG . 25.9 pt 33.02 -120.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.744 -0.597 . . . . 0.0 111.075 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.0 mp0 -84.47 164.25 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 110.227 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.51 149.66 19.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.63 -146.3 17.85 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.0 Cg_endo -81.86 23.59 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.092 1.575 . . . . 0.0 111.238 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.06 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.448 -0.783 . . . . 0.0 111.015 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' ASP . . . 102.53 -51.28 0.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 92' ' ' GLY . 6.4 m-20 -57.59 -155.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -1.149 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 122' ' ' THR . 73.0 p -81.42 2.37 28.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.559 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.942 HD21 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -106.58 107.61 18.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.988 . . . . 0.0 109.932 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' OE1' ' HE3' ' A' ' 123' ' ' LYS . 20.3 tt0 -94.29 -37.02 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.836 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -135.21 165.29 25.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.975 -1.078 . . . . 0.0 110.655 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.905 HD11 HD22 ' A' ' 95' ' ' LEU . 13.7 mt -155.83 122.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -104.61 131.51 51.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.15 135.43 54.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.973 -1.079 . . . . 0.0 111.216 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.509 ' CG ' ' ND2' ' A' ' 82' ' ' ASN . 11.5 mt-10 -120.98 152.21 38.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 58.1 mt -140.05 159.08 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.919 -1.113 . . . . 0.0 110.482 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 1.1 ttmt -149.42 101.5 3.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.722 HG22 ' HB1' ' A' ' 15' ' ' ALA . 4.1 mp -83.28 111.14 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.371 -0.831 . . . . 0.0 110.182 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.894 HG21 ' HE3' ' A' ' 115' ' ' LYS . 15.5 t -110.52 130.78 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.46 144.54 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -119.7 158.02 50.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.029 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.15 -38.39 21.75 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.988 1.52 . . . . 0.0 110.709 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 14.3 t70 -143.88 36.14 1.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 110.327 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.11 14.6 3.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.55 -101.04 0.86 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 69.8 m -161.52 138.48 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 0.0 110.204 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 114' ' ' LEU . 23.1 mt -109.09 130.13 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.972 ' HB2' HG22 ' A' ' 9' ' ' THR . 6.6 mp -95.84 89.52 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.643 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HE3' HG21 ' A' ' 105' ' ' VAL . 2.1 mttm -64.36 118.05 8.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 108.352 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.463 HG22 ' OD1' ' A' ' 118' ' ' ASN . 43.4 mt -119.65 118.32 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 111.791 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.01 106.2 18.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.463 ' OD1' HG22 ' A' ' 116' ' ' ILE . 2.5 m120 -90.12 92.99 9.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 111.171 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -87.74 135.2 33.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.942 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.5 m-85 -111.96 167.13 10.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.915 -1.115 . . . . 0.0 110.834 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 29.8 m80 -139.35 89.53 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.637 HG22 ' HG ' ' A' ' 95' ' ' LEU . 3.0 p -92.8 -170.56 2.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 110.04 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.478 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -111.9 -3.01 14.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 110.091 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 124.67 -141.55 13.3 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' GLY . 3.5 t70 42.69 -139.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.111 . . . . 0.0 110.16 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -48.58 158.86 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.033 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -89.37 -137.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.574 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.908 HG21 ' OH ' ' A' ' 5' ' ' TYR . 90.8 t -105.97 154.23 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.806 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -102.53 117.35 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.863 . . . . 0.0 109.892 179.045 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.16 -42.04 63.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -49.58 -42.33 44.15 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.109 -0.995 . . . . 0.0 108.692 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 21.7 mt-30 -67.52 -44.55 78.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.571 -0.706 . . . . 0.0 109.315 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 5' ' ' TYR . 21.2 t -70.24 -6.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.738 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.9 tttt -98.0 -65.98 0.93 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.286 -0.884 . . . . 0.0 110.821 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -32.52 -45.75 0.12 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -51.45 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.286 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 134' ' ' LYS . 1.7 ttmt -55.86 -32.49 63.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.961 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.2 -52.93 28.71 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.477 -0.765 . . . . 0.0 109.618 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.704 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 39.7 mmm -54.64 -39.0 67.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.29 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.49 98.03 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.76 -39.52 87.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.283 . . . . 0.0 110.522 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -34.3 76.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.079 -1.013 . . . . 0.0 109.031 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.6 mm? -77.78 -24.09 49.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.335 -0.853 . . . . 0.0 109.085 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 18.3 tp -75.58 -33.89 60.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.488 ' HA ' ' HB3' ' A' ' 148' ' ' GLU . 8.6 ttt180 -80.93 -31.25 35.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -69.17 -45.59 69.61 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.805 HG22 HD11 ' A' ' 29' ' ' LEU . 96.7 t -76.19 -30.33 20.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.507 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.88 -37.82 88.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.444 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.462 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -89.13 -22.45 22.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.632 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.603 ' HB2' HG11 ' A' ' 33' ' ' VAL . 6.9 t80 -63.6 -38.32 90.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 109.672 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.58 HD23 ' CD2' ' A' ' 150' ' ' TYR . 50.9 mt -73.72 -19.9 60.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 4.8 mp -92.94 -19.21 21.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.98 -31.25 13.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.145 -0.972 . . . . 0.0 110.335 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -80.87 -165.0 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.868 . . . . 0.0 110.293 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 1.2 p -86.5 -57.21 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.493 ' N ' ' OG ' ' A' ' 155' ' ' SER . 13.6 m-20 -166.02 54.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.181 -0.95 . . . . 0.0 110.665 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.477 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -68.55 136.41 53.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.168 -0.958 . . . . 0.0 109.919 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.826 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 60.5 m-85 58.81 53.95 5.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.467 ' OD1' ' HD3' ' A' ' 17' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.275 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.617 HG12 ' N ' ' A' ' 3' ' ' PHE . 84.0 t -85.52 171.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -1.214 . . . . 0.0 110.567 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.617 ' N ' HG12 ' A' ' 2' ' ' VAL . 97.9 m-85 -141.98 171.57 13.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.492 -0.755 . . . . 0.0 110.136 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -138.87 122.04 16.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.37 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.943 ' CE2' HG21 ' A' ' 133' ' ' VAL . 36.5 m-85 -116.81 97.81 6.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 109.557 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.58 129.56 37.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.714 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.1 -174.0 4.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 3.0 pt-20 -166.43 166.3 16.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.636 ' O ' ' CB ' ' A' ' 10' ' ' THR . 10.8 t -175.1 -126.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.088 -1.008 . . . . 0.0 111.43 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.857 ' HG1' ' N ' ' A' ' 114' ' ' LEU . 4.4 m 94.7 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 123.069 0.548 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 10' ' ' THR . 0.5 OUTLIER 169.43 -167.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.568 -1.333 . . . . 0.0 111.534 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 110' ' ' GLY . 0.9 OUTLIER -72.89 -16.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.85 -0.531 . . . . 0.0 110.009 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 4.3 mm -63.26 145.56 96.85 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.001 -1.062 . . . . 0.0 109.058 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.555 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 31.6 Cg_endo -54.75 148.53 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.848 1.446 . . . . 0.0 111.266 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -62.29 -43.57 98.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.641 -0.662 . . . . 0.0 110.789 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.46 -51.76 68.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 110.814 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.67 -55.51 29.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 109.769 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.82 HD13 HG22 ' A' ' 10' ' ' THR . 0.3 OUTLIER -53.3 -27.04 20.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.709 179.094 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 1.183 ' CE1' HD21 ' A' ' 24' ' ' LEU . 1.1 t80 -73.45 -70.98 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.589 . . . . 0.0 110.478 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 11.1 mtpt -55.1 -22.43 16.45 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.69 -0.631 . . . . 0.0 112.636 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -102.52 -48.13 4.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.0 112.188 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.0 t80 -95.46 9.79 38.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.807 -1.183 . . . . 0.0 112.017 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.749 HG23 ' CD2' ' A' ' 81' ' ' TYR . 7.1 mt -143.39 -27.89 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.711 -1.243 . . . . 0.0 110.838 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.183 HD21 ' CE1' ' A' ' 19' ' ' PHE . 6.6 mt -106.22 -17.36 14.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.795 -1.19 . . . . 0.0 109.292 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 3.0 t0 -132.11 94.97 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.898 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.505 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -120.16 -35.84 0.85 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.78 6.6 10.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.97 -1.312 . . . . 0.0 110.147 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 5.7 t30 -143.15 25.06 1.77 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.933 HD11 HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -159.33 -32.21 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.136 -178.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.661 ' N ' HD13 ' A' ' 29' ' ' LEU . 12.2 m-30 -60.26 -55.36 46.1 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 0.0 110.233 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.6 Cg_endo -65.53 -35.92 36.3 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.539 1.284 . . . . 0.0 110.823 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -62.92 -15.49 55.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 29' ' ' LEU . 17.8 m -128.66 -2.4 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 110.553 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.43 68.95 6.57 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.949 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.05 -13.59 38.58 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.879 1.463 . . . . 0.0 109.248 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -82.76 -19.77 37.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.474 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -99.66 -54.91 2.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.33 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.61 150.71 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.053 -1.029 . . . . 0.0 110.319 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.411 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 t -110.59 -37.26 5.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.994 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -173.07 -179.58 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 56' ' ' ILE . 91.6 t -143.65 165.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.431 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -130.75 79.79 1.91 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.935 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.475 ' OD1' ' HB3' ' A' ' 54' ' ' LYS . 2.1 m-80 -95.91 108.42 20.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.406 -0.809 . . . . 0.0 109.466 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 45' ' ' GLU . 9.7 tp -167.37 -32.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.0 111.443 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.475 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 5.8 pt-20 -100.33 157.53 16.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.065 . . . . 0.0 110.4 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.15 -115.81 1.83 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -124.62 -44.82 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.128 . . . . 0.0 110.272 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.78 74.29 1.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 144.83 -117.9 1.07 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.02 74.4 5.02 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.776 1.409 . . . . 0.0 110.41 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.37 77.47 0.53 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.481 ' H ' HG12 ' A' ' 71' ' ' VAL . 54.9 m -105.04 149.09 26.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.093 -1.239 . . . . 0.0 110.104 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 45' ' ' GLU . 5.0 mm -101.86 119.04 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.955 . . . . 0.0 110.117 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 1.2 mttm -121.86 147.39 46.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 17.0 tttt -115.93 107.29 14.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.753 ' CD1' HG13 ' A' ' 41' ' ' VAL . 4.8 mm -82.58 147.23 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.479 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.09 140.45 52.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.504 -0.747 . . . . 0.0 109.518 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.606 ' HB3' HD12 ' A' ' 62' ' ' LEU . 69.3 m-85 -116.54 142.06 28.98 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 39' ' ' SER . 48.5 Cg_endo -74.6 -171.18 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.014 1.534 . . . . 0.0 110.143 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.8 160.77 13.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 110.451 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -41.01 2.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.606 HD12 ' HB3' ' A' ' 58' ' ' PHE . 3.0 mt -83.14 164.16 47.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.236 . . . . 0.0 110.321 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 46.0 Cg_endo -76.92 -82.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.238 1.651 . . . . 0.0 111.207 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.9 m-30 -56.51 161.12 2.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.018 . . . . 0.0 110.716 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.21 -22.74 18.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 110.445 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.689 ' O ' HG13 ' A' ' 67' ' ' VAL . 16.3 p90 -173.78 -176.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.928 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 66' ' ' TYR . 13.5 m -160.42 161.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.396 -0.815 . . . . 0.0 110.734 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -119.72 117.45 28.27 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD2' ' CD1' ' A' ' 83' ' ' TYR . 15.6 t70 -120.37 153.55 36.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.969 -1.082 . . . . 0.0 111.542 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.69 126.99 51.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.67 -0.643 . . . . 0.0 109.409 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 52' ' ' THR . 6.1 p -61.01 -22.61 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.919 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 45.13 52.07 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.001 . . . . 0.0 109.564 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.5 mt-10 58.25 154.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 110.172 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' HD1' ' A' ' 81' ' ' TYR . 2.9 p -136.45 120.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -74.19 178.05 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.921 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.414 ' O ' ' HD1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -152.65 -41.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 110.773 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -52.22 -48.72 64.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.638 -1.289 . . . . 0.0 110.44 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -105.46 19.72 20.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.623 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 6.7 m-30 51.86 75.04 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.276 -0.89 . . . . 0.0 110.557 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 17.5 mtmt -131.55 124.77 30.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.803 ' HD1' HG23 ' A' ' 74' ' ' VAL . 2.7 t80 -117.08 113.22 22.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' VAL . 88.1 m-20 -112.0 105.33 13.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 110.719 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' OD2' ' A' ' 69' ' ' ASP . 1.4 p90 -122.46 169.55 10.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -151.46 140.92 21.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.868 -1.145 . . . . 0.0 111.708 -179.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.499 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 44.5 t -95.93 145.14 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -150.99 24.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.74 -1.225 . . . . 0.0 111.654 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.58 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -172.89 147.66 1.7 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.612 -1.305 . . . . 0.0 111.066 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' GLU . . . 49.79 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 67' ' ' VAL . . . 78.44 -134.31 14.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.27 -17.15 31.23 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.108 1.583 . . . . 0.0 110.634 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 87' ' ' GLU 0.31 4.7 mt -66.66 114.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.13 89.7 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.1 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.1 t0 62.45 5.84 1.75 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -1.087 . . . . 0.0 111.998 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -135.32 -78.74 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.765 -1.209 . . . . 0.0 109.992 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.595 HD11 ' HD2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -78.56 108.42 11.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.974 . . . . 0.0 109.691 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -90.08 -45.4 9.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' C ' HG13 ' A' ' 98' ' ' ILE . 52.4 mttt -119.84 147.4 44.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.578 HG12 HD22 ' A' ' 95' ' ' LEU . 45.9 mt -152.17 110.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.727 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 1.3 t -93.04 157.05 16.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.307 -0.871 . . . . 0.0 109.228 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.65 108.43 3.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 110.407 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 116' ' ' ILE . 17.9 mt-10 -97.91 156.06 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.7 HG13 HG23 ' A' ' 116' ' ' ILE . 4.5 mt -140.84 146.95 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.287 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 7.4 ttmt -139.04 115.67 10.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.446 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 1.3 mp -92.27 129.2 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 ' HE3' ' A' ' 115' ' ' LYS . 25.5 t -132.57 124.5 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 110.629 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.75 142.03 49.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 111' ' ' GLY . 61.0 p -94.18 153.19 40.7 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.82 -7.1 15.65 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -99.3 -85.85 0.38 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.235 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -169.41 87.36 0.09 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 12' ' ' VAL . . . 153.98 146.91 4.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.547 ' O ' ' HB ' ' A' ' 10' ' ' THR . 77.3 p -104.08 152.53 21.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.389 -1.065 . . . . 0.0 109.186 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.527 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 2.9 mt -122.01 156.25 26.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.857 ' N ' ' HG1' ' A' ' 10' ' ' THR . 0.5 OUTLIER -115.05 137.92 51.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.115 -0.991 . . . . 0.0 109.862 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 42.7 mttm -122.68 106.97 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.7 HG23 HG13 ' A' ' 102' ' ' ILE . 3.2 mp -115.67 139.88 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.112 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.33 112.82 22.08 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.56 102.94 14.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 111.43 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.493 ' HE3' HG11 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -83.7 111.74 19.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.94 . . . . 0.0 109.059 178.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.595 ' HD2' HD11 ' A' ' 95' ' ' LEU . 3.4 m-85 -98.32 104.27 16.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 111.048 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.578 ' HA ' HG22 ' A' ' 2' ' ' VAL . 37.6 m-70 -95.76 96.18 8.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.522 -0.736 . . . . 0.0 109.407 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 19.5 p -78.36 -149.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.496 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.97 53.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.635 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 71.48 -83.55 0.45 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 126' ' ' HIS . 10.9 t70 -39.54 115.89 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -1.018 . . . . 0.0 110.514 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.556 ' HB3' ' CG2' ' A' ' 94' ' ' THR . 0.1 OUTLIER 53.98 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.966 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 61.8 mt-10 -123.86 -144.47 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.582 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 98.9 t -95.08 133.03 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.265 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.5 mtmt -98.57 123.57 42.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.944 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.431 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -43.96 -46.37 8.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 110.305 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -52.17 -46.27 65.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 109.463 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.7 77.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 108.826 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.943 HG21 ' CE2' ' A' ' 5' ' ' TYR . 72.6 t -72.59 -19.36 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.794 0.807 . . . . 0.0 109.284 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.6 tttp -84.67 -60.13 2.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.507 -0.746 . . . . 0.0 111.2 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.79 -51.81 1.28 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 110.673 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.2 m -57.0 -47.37 80.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 110.162 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -64.44 -21.73 66.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 8.0 tt0 -77.23 -44.64 29.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.728 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 72.1 mmm -66.36 -37.88 86.3 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.69 -39.75 93.79 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -70.96 -40.55 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.814 -1.404 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -62.7 -40.61 97.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 108.971 179.398 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.474 HD21 ' CB ' ' A' ' 37' ' ' ALA . 1.1 mm? -71.48 -33.39 69.24 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.587 HD21 ' H ' ' A' ' 10' ' ' THR . 45.0 tp -62.28 -40.63 96.9 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.096 -1.002 . . . . 0.0 109.038 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.062 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.454 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -54.83 -55.14 33.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.105 -0.997 . . . . 0.0 109.546 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.933 HG22 HD11 ' A' ' 29' ' ' LEU . 48.5 t -63.36 -37.03 78.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.704 ' OE1' HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -55.99 -46.13 78.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 110.132 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -83.75 -19.25 35.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.59 ' CG ' HG11 ' A' ' 33' ' ' VAL . 9.8 t80 -66.64 -39.71 88.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.539 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.538 HD13 ' HG2' ' A' ' 17' ' ' ARG . 80.8 mt -62.33 -33.11 74.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.027 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 5.2 mp -77.65 -42.53 34.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.569 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.22 80.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.148 -0.97 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -80.26 -25.43 39.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.7 t 44.79 44.01 7.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 110.029 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -166.2 -41.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.525 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -59.05 133.81 56.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.865 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 48.0 m-85 56.43 68.8 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.341 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.166 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 3' ' ' PHE . 43.3 t -69.21 170.88 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -1.144 . . . . 0.0 110.691 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.592 ' HB2' ' HB2' ' A' ' 120' ' ' TYR . 24.1 m-85 -126.07 154.34 43.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -125.63 97.13 5.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.063 -1.023 . . . . 0.0 111.205 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.003 ' CD2' HG11 ' A' ' 133' ' ' VAL . 37.4 m-85 -100.94 81.63 2.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.286 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -84.15 113.94 21.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.81 . . . . 0.0 110.96 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.536 HG23 ' HB ' ' A' ' 116' ' ' ILE . 5.1 t -132.97 -176.37 4.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.4 -0.812 . . . . 0.0 109.624 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -157.01 153.4 27.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.115 -0.99 . . . . 0.0 110.222 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.912 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.79 156.23 44.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 110.12 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.32 152.84 29.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.87 ' OG ' HD11 ' A' ' 18' ' ' LEU . 45.6 t -142.0 135.72 29.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.72 -3.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.708 -0.62 . . . . 0.0 109.977 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.72 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.8 mm -95.77 149.12 35.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.72 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.0 Cg_endo -56.7 162.72 8.11 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.952 1.501 . . . . 0.0 110.437 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -71.53 -66.43 0.63 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 111.025 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -41.65 -53.63 3.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.581 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -59.63 -51.71 68.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.979 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' OG ' ' A' ' 11' ' ' SER . 5.9 mt -51.15 -27.04 7.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 108.693 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 1.043 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -74.1 -68.63 0.5 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.447 0.642 . . . . 0.0 109.991 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.66 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.6 mtmm -47.66 -36.17 10.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.855 -1.153 . . . . 0.0 111.322 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -90.35 -67.99 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.951 -1.093 . . . . 0.0 109.172 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.723 ' HD1' HG21 ' A' ' 147' ' ' VAL . 20.6 t80 -82.94 150.39 26.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 108.989 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 8.3 mt 82.4 -47.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 CA-C-O 121.24 0.543 . . . . 0.0 110.327 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.043 HD21 ' CE1' ' A' ' 19' ' ' PHE . 17.2 mt -97.74 -50.8 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -104.41 89.81 3.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.031 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -122.14 -33.54 0.89 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.73 ' CG ' HG11 ' A' ' 41' ' ' VAL . 52.8 m-20 -71.82 -1.25 13.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.101 -1.235 . . . . 0.0 110.615 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -123.88 13.02 9.15 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.084 -1.01 . . . . 0.0 108.829 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.766 HD21 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -146.61 -51.41 0.22 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 110.971 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.814 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 5.3 m-30 -29.81 -58.71 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -67.82 -38.99 12.26 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.609 1.321 . . . . 0.0 111.414 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 12.7 mmtt -66.97 -66.61 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.102 -0.999 . . . . 0.0 111.219 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.988 HG23 ' HB1' ' A' ' 146' ' ' ALA . 16.5 m -70.69 -19.94 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.254 -0.904 . . . . 0.0 111.02 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.896 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -127.09 65.75 65.4 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.383 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.69 -6.44 17.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.859 1.452 . . . . 0.0 110.128 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.606 ' O ' ' NE2' ' A' ' 36' ' ' GLN . 1.1 tm0? -96.45 0.75 50.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.02 -50.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 110.778 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.024 HG12 HD21 ' A' ' 143' ' ' LEU . 11.3 mm -109.15 163.17 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 110.613 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.492 ' C ' ' HB3' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -138.07 -43.69 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 0.0 110.138 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 39' ' ' SER . 11.3 t -178.28 133.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.343 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.73 HG11 ' CG ' ' A' ' 27' ' ' ASP . 3.6 p -92.73 146.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 30.6 mt-10 -124.6 -153.25 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.651 ' OD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER 69.62 -149.87 0.11 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.192 -0.943 . . . . 0.0 109.728 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.5 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -61.61 -37.76 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.866 -1.146 . . . . 0.0 109.955 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 43' ' ' ASN . 2.2 pt-20 24.68 100.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.432 0.634 . . . . 0.0 112.178 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.66 67.95 1.73 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -122.1 -37.07 2.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -1.165 . . . . 0.0 109.966 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.77 -94.75 0.1 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.26 -78.25 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.543 ' HB3' ' CG ' ' A' ' 73' ' ' GLU . 48.3 Cg_endo -73.9 98.3 1.06 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.038 1.546 . . . . 0.0 110.692 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' HG12 ' A' ' 53' ' ' ILE . . . 116.06 -4.91 20.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.472 ' HA ' HG21 ' A' ' 44' ' ' ILE . 99.3 m -53.56 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -1.172 . . . . 0.0 110.356 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.651 HG22 ' OD1' ' A' ' 43' ' ' ASN . 21.4 mm -83.05 130.69 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.913 . . . . 0.0 109.886 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 2.5 ptpp? -132.98 152.86 51.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.466 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.9 ttmt -120.29 88.57 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.643 HD12 HG23 ' A' ' 41' ' ' VAL . 1.7 mp -64.73 123.13 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.145 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -109.44 102.53 11.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.743 ' HB2' HD12 ' A' ' 62' ' ' LEU . 3.0 m-85 -64.08 173.81 1.31 Allowed Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.099 -1.001 . . . . 0.0 109.231 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -75.72 -172.45 1.32 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.706 1.372 . . . . 0.0 109.715 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.527 ' HG2' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -77.24 168.15 20.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' N ' ' HG2' ' A' ' 60' ' ' GLU . . . 104.43 -39.86 2.67 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.743 HD12 ' HB2' ' A' ' 58' ' ' PHE . 13.2 mt -62.13 157.94 49.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.106 -1.232 . . . . 0.0 110.478 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.55 -18.63 19.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.132 1.596 . . . . 0.0 110.473 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.53 -161.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.93 . . . . 0.0 110.425 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 12.0 tptt -121.44 -24.08 5.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 53.6 p90 -179.32 -152.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 109.906 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.911 HG23 ' CA ' ' A' ' 89' ' ' GLY . 9.1 p -172.04 120.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 111.191 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 2.8 mttp -98.01 137.82 36.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.471 -0.768 . . . . 0.0 109.047 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 1.5 m-20 -142.18 148.84 38.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HD2' HD11 ' A' ' 53' ' ' ILE . 25.9 ttt180 -108.5 130.0 55.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.536 -0.727 . . . . 0.0 109.392 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 -24.18 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 16.3 m-20 45.96 43.79 10.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.972 . . . . 0.0 109.942 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' CG ' ' HB3' ' A' ' 50' ' ' PRO . 11.4 mt-10 58.27 151.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.464 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.828 HG11 ' CZ ' ' A' ' 81' ' ' TYR . 6.4 m -138.78 148.98 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' CB ' ' HB3' ' A' ' 80' ' ' LYS . 4.2 t0 -69.08 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.054 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.35 -47.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 m -54.24 -35.91 62.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.411 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 1.9 m-80 -115.31 17.15 16.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 110.199 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.57 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 10.1 m-30 55.46 57.48 5.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HB3' ' CB ' ' A' ' 75' ' ' ASP . 30.1 tttm -118.89 98.54 6.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.833 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.828 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -91.16 177.94 6.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.122 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 81' ' ' TYR . 22.5 p-10 -178.82 142.5 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.501 ' CD1' ' C ' ' A' ' 83' ' ' TYR . 12.4 p90 -154.39 172.87 17.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.388 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -136.1 149.99 48.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.817 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.671 ' O ' HD11 ' A' ' 91' ' ' ILE . 4.2 m -110.21 94.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.461 -0.774 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.471 ' C ' ' CD1' ' A' ' 91' ' ' ILE . 1.3 pp -100.65 -2.63 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.778 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.464 ' N ' HD12 ' A' ' 91' ' ' ILE . 1.9 tt0 -155.83 140.31 16.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . 65.63 -176.02 15.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.911 ' CA ' HG23 ' A' ' 67' ' ' VAL . . . 76.51 -141.56 26.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.6 -6.69 18.6 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.092 1.575 . . . . 0.0 111.019 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.671 HD11 ' O ' ' A' ' 85' ' ' VAL 0.292 1.8 mt -63.31 117.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.104 -0.998 . . . . 0.0 110.362 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 137.23 42.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.19 96.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -1.191 . . . . 0.0 110.546 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 40.0 p 42.35 28.3 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 110.63 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 98' ' ' ILE . 6.5 mt -144.24 74.65 1.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 95' ' ' LEU . 10.3 tp10 -42.42 -58.33 2.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 110.56 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.551 ' CG ' ' HB2' ' A' ' 121' ' ' HIS . 28.8 pttt -144.53 162.37 36.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.827 HD11 HD13 ' A' ' 95' ' ' LEU . 39.7 mt -145.81 138.67 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 110.513 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.9 m -117.23 152.36 34.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 109.175 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -144.08 139.89 29.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.723 -1.236 . . . . 0.0 111.37 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.401 ' O ' HG13 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -117.81 154.58 31.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.396 179.19 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 1.3 mp -144.25 136.8 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -135.79 105.6 6.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.778 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.675 ' H ' HD12 ' A' ' 104' ' ' ILE . 4.4 mp -81.12 109.94 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 110.532 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.447 HG23 ' HD2' ' A' ' 115' ' ' LYS . 86.5 t -101.49 131.19 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.17 129.93 34.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.867 . . . . 0.0 110.053 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 17.7 p -86.46 164.41 37.94 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 49.0 Cg_endo -66.76 81.06 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.114 1.586 . . . . 0.0 110.371 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 60.5 t0 58.01 65.01 1.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 110.166 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.11 27.62 0.13 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.21 -165.48 31.53 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -131.45 174.9 9.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.335 -1.097 . . . . 0.0 110.041 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CG2' ' CD ' ' A' ' 8' ' ' GLU . 26.2 mt -136.75 121.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.989 . . . . 0.0 110.686 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.912 ' HB2' HG22 ' A' ' 9' ' ' THR . 7.6 mt -86.17 93.42 9.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.891 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HD2' HG23 ' A' ' 105' ' ' VAL . 4.1 mttm -69.22 117.99 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.302 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 7' ' ' THR . 94.3 mt -109.2 146.62 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.87 -1.144 . . . . 0.0 111.84 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.18 94.58 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -93.52 100.28 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 112.518 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -82.3 131.2 35.23 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.592 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 3.2 m-85 -110.88 112.85 24.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.775 -1.203 . . . . 0.0 110.715 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 63.2 m-70 -92.83 103.24 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.597 HG22 HD23 ' A' ' 95' ' ' LEU . 4.5 p -102.13 153.35 20.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.813 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 26.39 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.012 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.43 -162.74 14.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.33 -38.25 15.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -1.168 . . . . 0.0 110.309 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -74.34 -172.51 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.387 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.531 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 60.1 mp0 -124.0 -169.98 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 110.346 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.488 HG23 ' CD2' ' A' ' 3' ' ' PHE . 55.7 t -69.27 150.28 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 130' ' ' ALA . 3.9 mtmm -105.01 116.01 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.765 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.64 -52.79 4.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.26 -0.9 . . . . 0.0 110.366 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.6 -46.79 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 109.77 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.401 ' OE1' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -62.14 -45.03 95.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 108.996 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.003 HG11 ' CD2' ' A' ' 5' ' ' TYR . 53.0 t -62.42 -16.29 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.269 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.6 ttmt -86.42 -60.59 1.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.489 -0.757 . . . . 0.0 110.683 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -41.32 -50.16 3.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 110.092 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.6 t -56.11 -44.32 78.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 110.012 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -27.12 68.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -77.25 -33.9 55.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.422 -0.799 . . . . 0.0 109.924 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.485 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.32 -39.63 65.11 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.602 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.17 85.73 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.32 -32.44 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.273 . . . . 0.0 109.743 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 1.3 p -70.4 -34.81 72.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.247 -0.908 . . . . 0.0 108.802 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 1.024 HD21 HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -71.17 -53.69 13.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.188 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 114' ' ' LEU . 9.4 tp -51.4 -39.08 56.51 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -65.09 -38.21 90.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.569 -0.707 . . . . 0.0 109.426 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.988 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -61.48 -60.1 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.723 HG21 ' HD1' ' A' ' 22' ' ' PHE . 21.6 t -61.81 -24.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' O ' HD13 ' A' ' 152' ' ' LEU . 1.5 tt0 -68.14 -48.02 66.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.05 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.9 t -81.26 -17.05 50.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.766 ' CD2' HD21 ' A' ' 29' ' ' LEU . 9.8 t80 -69.7 -43.93 71.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.713 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.643 HD23 ' HB3' ' A' ' 157' ' ' ALA . 28.1 mt -63.95 -26.05 68.41 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.784 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -80.87 -42.47 21.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.098 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.12 -50.93 66.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.107 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -76.88 -162.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.195 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 6.5 t -92.39 54.19 2.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.537 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER 60.81 53.3 3.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.883 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.643 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -40.91 166.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.716 -0.615 . . . . 0.0 110.761 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.642 ' CD2' ' HB2' ' A' ' 21' ' ' ALA . 85.4 m-85 57.75 48.27 14.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.447 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.206 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.957 HG13 ' O ' ' A' ' 120' ' ' TYR . 92.5 t -101.03 153.27 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.156 -1.202 . . . . 0.0 110.426 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.841 ' CD1' HG23 ' A' ' 128' ' ' VAL . 92.3 m-85 -116.07 151.41 35.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.507 -0.745 . . . . 0.0 109.895 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -117.33 99.47 7.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 110.246 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.059 ' CD1' HG11 ' A' ' 133' ' ' VAL . 45.6 m-85 -97.18 99.93 11.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 117' ' ' SER . 3.3 mt-10 -109.42 136.3 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.97 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 -171.51 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.386 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' OE1' ' CG2' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -165.21 156.31 14.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 110.705 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.961 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -129.12 173.59 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.329 -0.857 . . . . 0.0 110.155 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.05 143.28 51.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.155 -0.966 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' HD11 ' A' ' 18' ' ' LEU . 8.3 t -140.25 147.48 40.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.101 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -21.35 15.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.615 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 36.7 mm -77.16 145.92 73.98 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.035 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.7 Cg_endo -56.72 157.93 18.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.91 1.479 . . . . 0.0 110.313 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB2' ' OG ' ' A' ' 112' ' ' SER . . . -69.48 -47.93 62.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.471 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -56.33 -44.92 80.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.942 -1.099 . . . . 0.0 110.782 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.563 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 1.3 mtt85 -68.78 -49.95 54.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.936 -1.103 . . . . 0.0 109.777 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.615 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 mt -52.08 -30.86 27.88 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.28 1.038 . . . . 0.0 108.518 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 1.125 ' CE1' HD21 ' A' ' 24' ' ' LEU . 8.9 t80 -72.44 -72.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.2 mtpt -45.1 -20.56 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 112.102 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -115.98 -61.83 1.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.537 -1.352 . . . . 0.0 112.11 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.841 ' HA ' HG11 ' A' ' 147' ' ' VAL . 9.8 t80 -65.51 -80.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.341 -1.475 . . . . 0.0 110.211 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 HD23 ' A' ' 24' ' ' LEU . 2.7 mt -43.98 -71.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.858 -1.151 . . . . 0.0 108.495 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.125 HD21 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -61.68 -179.47 0.19 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.645 ' OD2' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER 66.11 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.126 -0.984 . . . . 0.0 108.95 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' CG ' ' A' ' 25' ' ' ASP . . . 52.4 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 O-C-N 120.723 -1.235 . . . . 0.0 111.08 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.5 p30 -47.46 -20.37 0.23 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -1.092 . . . . 0.0 111.524 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.787 ' O ' HD22 ' A' ' 29' ' ' LEU . 53.5 t30 -110.38 38.89 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 109.779 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.787 HD22 ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -161.07 -49.34 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.465 -0.772 . . . . 0.0 110.56 -179.469 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.79 ' CD1' HD12 ' A' ' 143' ' ' LEU . 8.0 m-30 -56.39 -53.64 61.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 0.0 111.531 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.1 -4.38 8.93 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 O-C-N 123.293 1.154 . . . . 0.0 111.83 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 13.6 mmtt -109.33 -66.24 1.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.801 -1.187 . . . . 0.0 110.692 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.014 HG23 ' HB1' ' A' ' 146' ' ' ALA . 13.7 m -75.72 -14.19 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.87 64.3 27.82 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.04 -1.038 . . . . 0.0 110.849 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.1 -8.5 22.92 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 109.764 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 1.4 tt0 -86.28 -17.4 34.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.564 -0.71 . . . . 0.0 109.432 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.482 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -108.65 -37.99 5.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.656 HD13 ' HB3' ' A' ' 30' ' ' PHE . 2.2 mp -127.7 164.87 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -138.14 -47.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 110.284 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.9 t -161.9 130.17 4.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.118 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.644 HG22 HG13 ' A' ' 56' ' ' ILE . 54.2 t -95.84 129.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.138 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 14.8 tt0 -117.43 139.08 51.36 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.227 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 0.6 OUTLIER 71.05 147.23 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.188 -0.945 . . . . 0.0 110.141 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.804 HD12 ' HB2' ' A' ' 54' ' ' LYS . 1.2 tp 176.73 47.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER 172.74 48.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.809 0.814 . . . . 0.0 109.175 -179.226 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.597 ' N ' HG22 ' A' ' 52' ' ' THR . . . -52.58 -19.63 6.63 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.483 ' CB ' HG21 ' A' ' 52' ' ' THR . 9.7 t-20 -106.62 -59.73 1.76 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -1.13 . . . . 0.0 109.521 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.85 33.53 0.33 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.283 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.77 -95.21 0.29 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 42.2 Cg_endo -71.43 -156.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.301 -1.936 0 O-C-N 124.063 1.56 . . . . 0.0 109.978 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.601 ' H ' HG11 ' A' ' 71' ' ' VAL . . . -84.95 17.61 31.03 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 46' ' ' GLY . 1.1 m -32.48 148.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.745 -0.856 . . . . 0.0 111.641 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.55 ' HB ' ' H ' ' A' ' 46' ' ' GLY . 20.5 mm 33.36 101.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.948 0.88 . . . . 0.0 111.932 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.804 ' HB2' HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -134.43 158.07 44.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -129.39 142.27 50.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.472 -1.393 . . . . 0.0 111.839 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.656 ' HB ' HG13 ' A' ' 67' ' ' VAL . 1.2 mp -121.64 115.85 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 101.03 10.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.831 . . . . 0.0 110.817 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.649 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . 8.6 m-85 -56.46 177.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.229 -0.919 . . . . 0.0 108.933 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -75.85 145.84 29.06 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.387 1.204 . . . . 0.0 109.962 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' PRO . 1.1 tt0 -41.88 165.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.62 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.27 36.13 15.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 58' ' ' PHE . 3.4 mt -106.31 156.03 37.63 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.127 -1.219 . . . . 0.0 110.561 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.74 -30.77 9.17 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.081 1.569 . . . . 0.0 109.199 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 20.0 m-30 -101.23 -96.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.632 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 179.92 -35.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.806 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 51.5 p90 -179.54 -158.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.375 -0.828 . . . . 0.0 109.687 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 67' ' ' VAL . 7.0 p -163.16 108.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.565 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -99.05 160.91 13.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.995 ' HB3' HG12 ' A' ' 85' ' ' VAL . 2.6 p-10 -173.15 139.3 0.79 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.841 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -87.38 146.71 25.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.043 -1.036 . . . . 0.0 110.341 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.601 HG11 ' H ' ' A' ' 51' ' ' GLY . 1.2 t -102.22 167.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.307 -0.87 . . . . 0.0 109.706 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -140.55 56.68 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 110.235 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' C ' HG23 ' A' ' 74' ' ' VAL . 1.9 mt-10 63.19 177.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.927 . . . . 0.0 109.918 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.615 HG22 ' CD1' ' A' ' 81' ' ' TYR . 5.2 t -151.06 137.85 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 111.063 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.453 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -80.43 179.98 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.141 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 4.1 m-70 -136.08 -49.86 0.69 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.786 -1.196 . . . . 0.0 111.114 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -49.91 -57.6 7.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.908 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 79' ' ' PHE . 2.3 m-20 -96.0 21.28 8.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.087 -1.008 . . . . 0.0 110.843 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 11.4 m-85 41.24 73.74 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 0.0 109.912 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 2.6 tttt -117.76 106.74 13.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 110.746 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD1' HG22 ' A' ' 74' ' ' VAL . 11.0 t80 -111.42 105.47 14.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -113.46 153.88 27.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.861 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 33.7 p90 -165.29 173.4 11.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 109.924 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.97 121.94 26.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.187 -0.946 . . . . 0.0 111.086 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.995 HG12 ' HB3' ' A' ' 69' ' ' ASP . 15.5 m -95.51 122.52 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.503 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.1 pp -123.19 -0.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 8.2 mt-10 -158.33 150.85 22.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.493 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 90.6 -179.45 43.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.65 -145.74 31.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 51.0 Cg_endo -85.93 31.49 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.55 . . . . 0.0 110.834 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -33.21 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.468 0.652 . . . . 0.0 110.905 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.02 -168.38 40.22 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 11.2 m-20 -87.68 -9.75 53.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -1.142 . . . . 0.0 110.47 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 58.8 p -101.64 41.68 1.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.95 HD12 ' NE2' ' A' ' 132' ' ' GLN . 1.5 mt 169.16 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.13 -45.94 3.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 110.764 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 14.3 mtpp -131.47 143.13 50.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 110.514 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.73 ' HB ' HG23 ' A' ' 85' ' ' VAL . 81.3 mt -140.21 118.4 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.998 -1.064 . . . . 0.0 110.564 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.51 160.43 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 109.793 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 20.8 t-20 -149.35 145.3 26.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.027 -1.045 . . . . 0.0 111.257 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -132.46 129.2 38.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.522 -0.736 . . . . 0.0 109.078 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 26.8 mm -113.38 135.92 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 0.0 110.396 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 2.4 mtpm? -139.0 105.39 5.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 110.301 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 23' ' ' ILE . 72.1 mt -83.84 148.89 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 110.05 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.95 128.71 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.03 132.93 34.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.128 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -107.43 152.44 41.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.414 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.75 -21.79 44.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.291 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.15 -50.77 69.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 142.35 54.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.46 -167.99 34.65 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.823 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -148.69 145.43 27.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -1.124 . . . . 0.0 109.856 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.515 ' CG2' ' OE1' ' A' ' 8' ' ' GLU . 8.9 mt -109.14 135.19 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.961 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.5 mp -99.18 108.47 21.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -0.906 . . . . 0.0 110.022 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.79 118.76 26.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 109.749 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.3 mt -110.04 121.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.426 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -118.66 100.86 7.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 109.35 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -103.31 115.6 30.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.168 -0.957 . . . . 0.0 111.078 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HG2' ' NE2' ' A' ' 121' ' ' HIS . 1.9 tptt -95.7 115.65 27.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.408 -0.808 . . . . 0.0 108.951 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.957 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.4 m-85 -90.41 147.2 23.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.117 -0.989 . . . . 0.0 111.012 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 73.4 m-70 -133.71 91.48 2.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.604 -0.685 . . . . 0.0 109.21 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 9.7 p -83.03 -179.49 7.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.638 -0.664 . . . . 0.0 110.465 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -84.87 6.1 26.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.094 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 101.72 -166.23 18.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 t0 50.15 -91.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 110.29 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' GLY . 23.9 m80 -66.24 156.63 33.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 110.145 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -107.99 169.45 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 3' ' ' PHE . 55.7 t -59.09 151.27 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.054 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 130' ' ' ALA . 46.0 mtmt -96.06 117.22 30.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 0.0 110.419 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -46.13 -38.24 7.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -56.4 -47.59 78.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.838 . . . . 0.0 109.38 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.95 ' NE2' HD12 ' A' ' 95' ' ' LEU . 21.5 mt-30 -61.78 -38.31 87.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.059 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.1 t -68.78 -19.5 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.768 0.794 . . . . 0.0 109.421 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -85.99 -66.89 0.85 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.463 -0.773 . . . . 0.0 110.921 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -34.47 -40.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.482 -0.761 . . . . 0.0 110.88 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 t -64.36 -52.79 56.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -54.86 -45.88 74.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.128 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 139' ' ' MET . 3.2 mt-10 -56.72 -59.58 4.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.196 -0.94 . . . . 0.0 109.743 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -44.99 -49.19 11.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.058 -1.027 . . . . 0.0 109.651 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.2 92.84 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 142' ' ' THR . 35.2 tt0 -74.78 -65.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.313 . . . . 0.0 110.501 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -42.28 -46.45 4.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.587 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.79 HD12 ' CD1' ' A' ' 30' ' ' PHE . 3.5 mm? -63.88 -55.23 24.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 109.84 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.607 HD13 ' CD2' ' A' ' 114' ' ' LEU . 22.5 tp -40.45 -46.17 2.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.432 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -43.33 92.07 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.804 . . . . 0.0 109.55 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.014 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.2 -61.75 2.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 110.085 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.841 HG11 ' HA ' ' A' ' 22' ' ' PHE . 24.7 t -67.49 -18.26 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.815 . . . . 0.0 110.644 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 18.1 tt0 -70.98 -47.1 60.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 0.0 109.557 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 -21.77 31.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.9 ' HB2' HG11 ' A' ' 33' ' ' VAL . 10.6 t80 -57.6 -49.52 76.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.475 -0.765 . . . . 0.0 109.699 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 150' ' ' TYR . 65.3 mt -54.98 -25.71 31.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.582 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -84.64 -33.16 23.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.892 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.32 -46.82 69.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.22 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 155' ' ' SER . 20.7 m80 -90.27 -24.75 20.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' HIS . 1.4 p 44.24 30.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.312 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -152.34 15.32 0.61 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.598 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' CE2' ' A' ' 158' ' ' TYR . . . -110.5 131.53 54.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.076 -1.015 . . . . 0.0 110.112 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.73 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 37.7 m-85 63.88 9.33 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.397 -0.814 . . . . 0.0 110.458 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.189 -179.803 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.55 HG22 ' HA ' ' A' ' 121' ' ' HIS . 97.2 t -72.62 151.14 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -1.083 . . . . 0.0 110.347 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 56.9 m-85 -109.74 131.7 54.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 109.607 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -95.25 95.53 8.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.886 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.827 ' HE2' HG11 ' A' ' 128' ' ' VAL . 23.2 m-30 -101.6 95.75 6.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.83 . . . . 0.0 110.24 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -88.01 126.37 35.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.303 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 t -145.4 178.33 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.18 . . . . 0.0 111.191 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' OE1' HG21 ' A' ' 113' ' ' ILE . 7.2 pt-20 -168.43 159.19 10.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.543 -0.723 . . . . 0.0 109.688 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.771 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.9 t -132.16 162.63 30.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.417 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -113.48 142.57 45.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.621 ' HB3' HD11 ' A' ' 18' ' ' LEU . 48.0 t -140.73 143.36 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.983 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.47 -2.04 2.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 109.968 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.58 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 19.2 mm -91.95 146.42 32.84 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 110.243 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.8 Cg_endo -57.39 153.82 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 0.0 110.162 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -62.81 -59.47 4.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -0.996 . . . . 0.0 110.479 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -42.96 -59.92 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 1.066 ' CZ ' HD12 ' A' ' 151' ' ' LEU . 6.7 ttp180 -53.03 -57.71 9.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.554 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 11' ' ' SER . 10.7 mt -45.6 -32.71 2.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.811 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -72.41 -55.54 6.88 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 110.687 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -60.1 -33.41 72.07 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.821 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -107.74 -34.78 6.87 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.264 -1.523 . . . . 0.0 112.551 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 81.3 t80 -102.53 9.45 39.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.731 -1.231 . . . . 0.0 111.873 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 29.2 mm -142.98 -26.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.823 -1.173 . . . . 0.0 110.968 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.811 HD21 ' CE1' ' A' ' 19' ' ' PHE . 4.1 mt -103.8 -35.89 8.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.713 -1.242 . . . . 0.0 109.16 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.495 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -112.97 41.08 2.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.585 -0.697 . . . . 0.0 110.535 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.24 -30.36 62.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.994 ' OD1' HG13 ' A' ' 41' ' ' VAL . 3.2 t70 -69.1 -6.41 28.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' CG ' ' O ' ' A' ' 28' ' ' ASN . 2.5 t30 -126.01 13.91 7.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -130.98 -43.91 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.773 ' CD1' HD12 ' A' ' 143' ' ' LEU . 7.6 m-30 -57.58 -54.41 55.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 111.197 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -66.97 -15.21 46.34 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.34 1.179 . . . . 0.0 111.293 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.527 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 4.8 mptt -91.08 -71.81 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 110.736 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.855 HG23 ' HB1' ' A' ' 146' ' ' ALA . 17.4 m -75.52 -18.25 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.839 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -118.59 60.6 4.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.624 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.9 Cg_endo -67.61 -19.91 47.63 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.934 1.492 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 2.2 tt0 -82.62 -16.42 48.41 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.662 0.744 . . . . 0.0 109.073 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.766 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -100.18 -63.15 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.286 -0.884 . . . . 0.0 110.574 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.676 HD13 ' HB3' ' A' ' 30' ' ' PHE . 3.7 mp -115.63 153.94 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.693 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 -38.15 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 109.631 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 57' ' ' SER . 47.7 p -177.64 151.91 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.533 -0.729 . . . . 0.0 109.681 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.994 HG13 ' OD1' ' A' ' 27' ' ' ASP . 3.7 p -141.46 129.15 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.972 . . . . 0.0 110.571 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER 177.23 -176.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.915 . . . . 0.0 110.991 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 1.0 OUTLIER 169.47 -60.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -120.17 -22.81 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.549 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.08 77.2 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 110.365 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.15 -121.31 0.02 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.83 12.57 4.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -1.225 . . . . 0.0 110.475 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.46 133.68 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.745 ' O ' HG21 ' A' ' 71' ' ' VAL . . . 106.36 -135.83 12.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.12 83.76 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.919 1.483 . . . . 0.0 110.91 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.66 32.87 0.54 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.101 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m -84.74 115.09 22.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.254 . . . . 0.0 110.264 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 44' ' ' ILE . 38.6 mm -113.33 108.96 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.271 -0.893 . . . . 0.0 110.251 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -150.17 168.55 23.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 20.5 ttpt -121.4 113.51 19.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 56' ' ' ILE . 2.1 mp -72.75 144.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -131.7 165.52 23.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.58 -0.7 . . . . 0.0 109.697 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 56' ' ' ILE . 30.7 m-85 -137.9 157.04 73.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.042 -1.037 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 60' ' ' GLU . 50.4 Cg_endo -75.48 154.74 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.159 1.61 . . . . 0.0 109.901 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 59' ' ' PRO . 4.7 pt-20 -42.78 157.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.283 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.13 -58.8 0.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 58' ' ' PHE . 11.6 mt -62.18 161.17 26.03 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.161 -1.199 . . . . 0.0 110.35 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.16 -38.6 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.152 1.606 . . . . 0.0 110.4 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 9.2 m-30 -92.91 153.39 18.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -104.19 -17.36 14.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.839 ' O ' HG13 ' A' ' 67' ' ' VAL . 29.1 p90 -174.14 -173.34 0.79 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.718 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.839 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -177.66 115.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 109.947 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -68.98 134.16 49.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.428 ' HB2' HD13 ' A' ' 56' ' ' ILE . 24.3 t0 -128.5 127.27 42.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 110.951 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -127.94 103.32 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.414 -0.804 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.745 HG21 ' O ' ' A' ' 49' ' ' GLY . 32.2 m -57.01 -32.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.287 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 64.08 5.75 2.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -0.917 . . . . 0.0 110.729 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 167.36 177.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.436 HG11 ' HA2' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -179.23 125.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 109.658 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -104.58 -176.74 3.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.24 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.73 -67.28 0.32 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.3 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.8 m -58.12 -36.32 72.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 0.0 110.532 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 5.5 m-80 -93.73 0.77 56.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.006 . . . . 0.0 110.694 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 19.8 m-30 57.06 14.92 2.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 110.552 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HA ' ' CB ' ' A' ' 103' ' ' LYS . 16.5 mttm -71.61 136.53 47.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.086 . . . . 0.0 109.744 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 67.8 t80 -149.72 121.82 8.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 110.462 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.569 ' HA ' ' CB ' ' A' ' 101' ' ' GLU . 4.6 m-20 -125.29 142.94 51.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.88 . . . . 0.0 110.558 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -152.34 149.49 28.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.105 -0.997 . . . . 0.0 111.102 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.58 135.78 54.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.553 -0.717 . . . . 0.0 109.691 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 98' ' ' ILE . 2.2 p -103.62 123.91 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.545 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 1.5 pp -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 1.8 tt0 73.91 138.49 0.06 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 0.0 110.603 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.414 ' CA ' ' CE2' ' A' ' 66' ' ' TYR . . . 81.08 162.85 29.32 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.83 -144.65 17.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.9 Cg_endo -81.9 22.57 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.98 1.516 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -38.83 164.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.359 -0.838 . . . . 0.0 111.116 -179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.6 38.14 7.16 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 90' ' ' PRO . 9.7 t0 -155.37 68.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.812 ' O ' HD22 ' A' ' 95' ' ' LEU . 13.9 p 48.28 38.18 9.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.88 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -159.92 60.38 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -49.09 -72.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -128.35 159.98 33.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.847 ' O ' HG12 ' A' ' 85' ' ' VAL . 71.3 mt -137.39 117.27 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.85 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.45 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 28.8 t -103.92 128.19 51.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 0.0 110.607 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.594 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 19.0 m-20 -129.19 134.07 47.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.603 ' O ' HG12 ' A' ' 102' ' ' ILE . 6.6 pt-20 -175.56 149.09 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 117.881 -1.528 . . . . 0.0 113.312 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.868 HG22 ' N ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -178.58 -95.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.868 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.7 OUTLIER 176.0 -176.49 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 0.0 110.625 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.054 HG23 HD23 ' A' ' 114' ' ' LEU . 36.2 mt -113.76 124.79 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 108.915 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.508 ' CG2' ' HD2' ' A' ' 115' ' ' LYS . 64.6 t -96.92 125.72 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.3 131.78 37.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.668 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 112' ' ' SER . 67.6 p -78.67 162.51 65.23 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 47.7 Cg_endo -66.92 -18.16 52.11 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.066 1.561 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -171.04 -30.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 111.239 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.26 -88.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.533 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . -151.09 -95.45 0.12 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.63 ' HA ' HG23 ' A' ' 107' ' ' THR . 11.9 m -171.12 137.0 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.323 -1.104 . . . . 0.0 109.83 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.472 HG21 ' OE1' ' A' ' 8' ' ' GLU . 2.2 mt -100.95 114.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.095 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.054 HD23 HG23 ' A' ' 104' ' ' ILE . 45.8 mt -71.71 103.01 2.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.58 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.737 ' HB3' HG21 ' A' ' 102' ' ' ILE . 78.6 mttt -86.64 126.16 34.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.853 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.469 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 16.4 mt -137.25 130.27 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 100' ' ' ASN . 36.6 m -96.28 102.48 14.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.082 -1.011 . . . . 0.0 108.963 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.526 ' OD1' ' ND2' ' A' ' 100' ' ' ASN . 1.5 m-80 -83.63 143.74 29.9 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.435 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 117.8 9.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.88 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.7 m-85 -92.98 99.86 12.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.018 -1.051 . . . . 0.0 111.115 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.55 ' HA ' HG22 ' A' ' 2' ' ' VAL . 73.5 m-70 -82.04 83.88 7.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.409 -0.807 . . . . 0.0 109.192 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.564 HG21 HG23 ' A' ' 128' ' ' VAL . 11.7 p -82.21 -146.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.843 . . . . 0.0 110.571 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.79 18.98 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 0.0 110.708 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.67 -143.55 16.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.3 t0 48.53 -144.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -1.148 . . . . 0.0 110.116 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -50.04 149.71 2.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.833 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.53 170.9 13.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 110.492 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.827 HG11 ' HE2' ' A' ' 5' ' ' TYR . 35.4 t -62.27 143.27 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HE3' ' OE1' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -85.91 110.01 19.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.52 -49.03 10.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.154 -0.966 . . . . 0.0 109.795 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.15 -43.25 74.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.011 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.463 ' OE1' ' HE3' ' A' ' 129' ' ' LYS . 42.6 tt0 -58.34 -38.55 77.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -0.753 . . . . 0.0 109.478 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.556 HG22 ' CE2' ' A' ' 120' ' ' TYR . 4.0 t -77.5 -17.6 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 109.798 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.1 tptt -81.35 -61.9 1.81 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -0.791 . . . . 0.0 110.369 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -39.23 -50.49 1.95 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.338 -0.851 . . . . 0.0 110.163 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -48.18 74.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.355 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -36.39 69.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -61.89 -59.95 4.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.144 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -46.13 -42.83 14.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.158 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.53 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.01 -47.53 71.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -1.224 . . . . 0.0 110.907 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -53.5 -38.34 63.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.021 -1.05 . . . . 0.0 109.186 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.773 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.5 mm? -69.99 -50.21 43.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.836 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 114' ' ' LEU . 14.5 tp -51.14 -30.87 17.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 108.792 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -43.73 34.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 110.075 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.855 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.91 -48.32 78.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 109.896 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 29' ' ' LEU . 27.7 t -74.03 -36.5 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.41 -0.806 . . . . 0.0 110.111 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' HD13 ' A' ' 152' ' ' LEU . 19.6 tt0 -57.19 -41.03 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.52 -25.52 21.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.93 . . . . 0.0 110.083 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.778 ' HB2' HG11 ' A' ' 33' ' ' VAL . 7.3 t80 -57.39 -33.71 68.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.746 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.066 HD12 ' CZ ' ' A' ' 17' ' ' ARG . 20.1 mt -79.07 -26.19 43.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.201 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 148' ' ' GLU . 8.1 mp -78.53 -22.38 47.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.22 -45.43 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -72.37 171.9 11.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 110.697 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.6 t -54.01 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 3.8 p-10 -155.53 54.34 0.61 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 110.756 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.618 ' HB3' ' CD2' ' A' ' 151' ' ' LEU . . . -59.08 133.95 56.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.875 -1.14 . . . . 0.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.821 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 53.2 m-85 62.37 62.3 1.17 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.679 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.175 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 120' ' ' TYR . 78.2 t -76.69 151.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -1.195 . . . . 0.0 110.046 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 127' ' ' GLU . 87.1 m-85 -115.28 129.46 56.63 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 110.206 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.25 105.1 16.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.94 ' CD1' HG11 ' A' ' 133' ' ' VAL . 23.5 m-85 -106.58 82.11 1.68 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -88.04 157.41 18.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 0.0 110.937 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.549 ' CG2' ' HB ' ' A' ' 116' ' ' ILE . 11.5 t -173.39 -174.02 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 0.0 109.693 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 7' ' ' THR . 6.9 mt-10 -140.19 149.9 43.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.107 -0.996 . . . . 0.0 110.335 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 1.042 HG23 HD22 ' A' ' 144' ' ' LEU . 0.5 OUTLIER -158.5 136.5 10.59 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.239 -0.913 . . . . 0.0 109.21 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.785 HG21 ' CA ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER 175.88 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 119.778 -1.826 . . . . 0.0 113.967 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.488 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -169.38 -175.52 2.24 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.935 -178.226 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.598 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -72.79 -15.76 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.21 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.57 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 4.6 mm -61.51 140.87 94.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 110.045 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -56.08 158.54 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.029 1.542 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.686 ' HB2' ' OG ' ' A' ' 112' ' ' SER . . . -70.24 -32.84 70.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.685 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.32 90.83 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 110.686 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.491 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 19.2 mtm180 -79.25 -50.33 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.078 . . . . 0.0 109.893 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -57.69 -30.94 65.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.782 ' CE2' HD21 ' A' ' 24' ' ' LEU . 61.8 t80 -79.11 -46.3 18.31 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.624 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -68.19 -20.95 64.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.773 . . . . 0.0 112.155 -178.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -111.71 -31.66 6.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.678 -1.264 . . . . 0.0 112.15 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB2' HG11 ' A' ' 147' ' ' VAL . 86.0 t80 -107.16 -13.25 15.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.682 -1.261 . . . . 0.0 111.934 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.643 HG21 ' CE1' ' A' ' 19' ' ' PHE . 39.4 mm -122.46 -16.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.794 -1.192 . . . . 0.0 110.486 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.782 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -112.38 -29.48 7.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.231 -0.918 . . . . 0.0 110.173 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.508 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -137.15 66.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.886 -179.54 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -83.56 -25.48 46.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.721 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.7 p30 -80.18 13.73 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.515 -0.991 . . . . 0.0 110.834 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 89.7 m-20 -135.97 37.77 2.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.826 -1.171 . . . . 0.0 108.15 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.016 HD21 HG13 ' A' ' 147' ' ' VAL . 0.3 OUTLIER 174.68 -36.42 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.188 -177.033 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 3.2 m-30 -38.79 -62.09 0.79 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.62 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 55.6 Cg_endo -69.83 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.902 1.475 . . . . 0.0 110.725 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.8 mmtt -49.74 -25.9 3.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 111.14 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HB1' ' A' ' 146' ' ' ALA . 3.6 m -120.16 -10.13 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.049 . . . . 0.0 110.789 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -139.05 65.51 36.83 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.045 -1.034 . . . . 0.0 110.459 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 59' ' ' PRO . 41.8 Cg_endo -68.67 -13.63 37.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.05 1.553 . . . . 0.0 109.542 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.724 ' OE1' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -82.98 -14.96 53.03 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.724 ' HB2' ' OE1' ' A' ' 36' ' ' GLN . . . -110.48 -58.53 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.23 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -115.35 125.82 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.008 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.482 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 8.1 t -82.9 -38.74 22.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.826 . . . . 0.0 110.354 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 p -172.45 151.22 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.328 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.721 HG11 ' HB2' ' A' ' 27' ' ' ASP . 7.3 p -99.61 129.49 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.644 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HB3' ' CB ' ' A' ' 55' ' ' LYS . 13.4 tp10 -104.28 170.13 8.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.581 -0.699 . . . . 0.0 109.647 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.541 ' O ' ' C ' ' A' ' 44' ' ' ILE . 1.6 m120 60.86 -92.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.086 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 44' ' ' ILE . 4.8 tp 25.35 59.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-O 121.331 0.586 . . . . 0.0 111.271 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 57.23 4.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.632 -0.668 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.93 -108.6 0.36 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.48 82.46 2.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -1.098 . . . . 0.0 110.135 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.41 -14.33 41.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.73 -161.51 29.56 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.3 83.37 1.49 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.036 1.545 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 53' ' ' ILE . . . 127.73 51.49 0.14 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.844 ' C ' HD12 ' A' ' 53' ' ' ILE . 95.2 m -67.81 151.52 47.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.178 -1.189 . . . . 0.0 110.068 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.844 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -114.93 134.66 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 110.676 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HG2' HD12 ' A' ' 44' ' ' ILE . 26.5 mtpt -123.32 148.06 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.885 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 28.7 mttp -121.76 84.72 2.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.869 . . . . 0.0 110.223 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.6 mp -66.42 125.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.867 -1.146 . . . . 0.0 109.141 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -105.78 126.31 52.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.631 -1.293 . . . . 0.0 111.318 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.643 ' CD2' HD12 ' A' ' 62' ' ' LEU . 10.8 m-30 -84.82 141.93 38.72 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.458 -0.777 . . . . 0.0 110.59 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 39' ' ' SER . 43.7 Cg_endo -70.48 -179.23 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.936 1.493 . . . . 0.0 108.77 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.24 163.82 12.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.723 -1.236 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.61 -47.92 3.9 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.812 HD13 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -49.83 159.07 0.79 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 111.041 -179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.812 ' HD2' HD13 ' A' ' 62' ' ' LEU . 45.0 Cg_endo -72.1 152.37 56.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.187 1.625 . . . . 0.0 108.586 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 52.84 -136.19 1.41 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.158 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -152.25 -3.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.901 -1.124 . . . . 0.0 112.093 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.926 ' O ' HG13 ' A' ' 67' ' ' VAL . 43.9 p90 178.02 -158.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.837 -1.165 . . . . 0.0 110.442 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -173.07 130.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.53 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -95.85 154.12 17.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.566 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.85 127.16 12.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.01 -1.056 . . . . 0.0 111.241 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.68 142.02 31.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 109.127 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 73' ' ' GLU . 46.1 t -110.21 137.97 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 111.157 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -110.98 47.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.379 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' H ' HG12 ' A' ' 71' ' ' VAL . 1.6 mt-10 63.69 110.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 109.863 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.741 HG12 ' CD1' ' A' ' 81' ' ' TYR . 3.8 m -82.72 168.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.329 -0.857 . . . . 0.0 110.499 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -102.89 139.51 38.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.829 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -102.42 -48.8 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.36 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.7 m -53.59 -42.31 67.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.909 -1.119 . . . . 0.0 110.928 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 79' ' ' PHE . 17.9 m120 -105.73 15.2 27.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.053 . . . . 0.0 110.811 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.563 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 12.3 m-30 41.58 59.23 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 110.291 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -115.53 164.85 13.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 0.0 109.942 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.741 ' CD1' HG12 ' A' ' 74' ' ' VAL . 10.1 t80 -147.69 143.0 27.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.913 . . . . 0.0 110.5 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -145.56 100.41 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.824 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.538 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 38.2 p90 -128.59 168.97 14.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.51 135.39 53.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG22 ' HE2' ' A' ' 83' ' ' TYR . 21.4 t -94.92 112.34 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.664 HD12 ' OE1' ' A' ' 87' ' ' GLU . 18.6 pt -132.32 150.67 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.664 ' OE1' HD12 ' A' ' 86' ' ' ILE . 27.7 mp0 58.65 156.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 110.722 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.586 ' CA ' ' CE2' ' A' ' 66' ' ' TYR . . . 61.04 149.06 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.11 -141.45 15.6 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ILE . 50.1 Cg_endo -84.2 26.62 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.022 1.538 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.35 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.531 -0.73 . . . . 0.0 110.517 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.45 -160.23 28.23 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -93.83 -30.74 14.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.463 ' O ' ' HB ' ' A' ' 122' ' ' THR . 71.0 p -59.75 -24.45 64.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 120' ' ' TYR . 1.7 mt -146.18 86.74 1.71 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -81.42 -41.66 21.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.902 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.7 mmtt -123.0 158.49 30.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.997 -1.064 . . . . 0.0 110.527 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.623 ' CG1' HD22 ' A' ' 95' ' ' LEU . 12.9 mt -158.27 115.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.485 -0.759 . . . . 0.0 109.996 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 t -103.69 114.28 28.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 109.96 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 83.3 m-20 -116.67 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.051 -1.03 . . . . 0.0 110.964 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.603 ' C ' HD12 ' A' ' 102' ' ' ILE . 3.9 pt-20 -141.98 145.48 34.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.492 -0.755 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.603 HD12 ' C ' ' A' ' 101' ' ' GLU . 1.3 mp -126.14 135.25 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.832 -1.168 . . . . 0.0 110.193 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 ttpt -115.89 101.33 8.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.375 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.738 HD13 ' CD1' ' A' ' 19' ' ' PHE . 4.7 mp -78.81 135.67 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.964 -1.085 . . . . 0.0 109.785 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.85 125.94 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.25 140.04 35.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.336 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.6 p -100.35 157.43 33.81 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.968 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.07 -16.87 50.33 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.034 1.544 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -161.64 83.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.026 -1.046 . . . . 0.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 168.98 -87.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -173.68 -153.17 9.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.686 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -108.26 143.78 36.64 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.174 -1.192 . . . . 0.0 109.344 179.06 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.785 ' CA ' HG21 ' A' ' 10' ' ' THR . 1.8 mt -119.68 137.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.401 0.62 . . . . 0.0 111.373 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.833 ' HB2' ' O ' ' A' ' 9' ' ' THR . 2.5 mp -101.27 110.33 22.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.447 -0.783 . . . . 0.0 109.513 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 1.8 mptp? -81.14 104.98 11.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.549 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 77.5 mt -93.47 112.83 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.661 0.743 . . . . 0.0 112.23 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.1 111.66 23.41 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.401 ' OD1' HG22 ' A' ' 116' ' ' ILE . 16.5 m120 -110.42 96.58 6.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 111.216 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.711 ' HD3' HG11 ' A' ' 2' ' ' VAL . 1.6 mttt -84.56 99.69 10.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.921 ' CD2' HD11 ' A' ' 95' ' ' LEU . 3.2 m-85 -75.83 132.8 40.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.772 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.679 ' CE1' HG21 ' A' ' 2' ' ' VAL . 55.4 m-70 -114.49 100.07 8.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.839 HG21 HG23 ' A' ' 128' ' ' VAL . 6.3 p -104.6 179.48 4.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 110.332 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 122' ' ' THR . 1.1 ptpm? 175.21 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 159.62 126.47 0.85 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.18 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 47.89 -150.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -1.075 . . . . 0.0 110.824 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 125' ' ' ASP . 4.3 m-70 -42.13 166.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.359 -0.838 . . . . 0.0 110.533 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -107.44 -121.21 0.24 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 110.141 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.839 HG23 HG21 ' A' ' 122' ' ' THR . 97.7 t -103.2 141.8 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.822 -1.174 . . . . 0.0 110.492 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 130' ' ' ALA . 37.5 mtmt -107.29 124.22 49.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.699 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.32 -41.31 5.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.173 -0.955 . . . . 0.0 109.786 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 tm-20 -52.03 -49.53 63.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.209 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.44 ' NE2' ' HB2' ' A' ' 90' ' ' PRO . 7.6 mt-30 -61.87 -43.29 99.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.195 -0.94 . . . . 0.0 109.007 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.94 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.9 t -62.0 -18.33 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.137 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 23.3 ttpt -87.72 -63.61 1.28 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 110.694 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.12 -47.98 0.79 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.697 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -47.22 87.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -64.77 -19.37 65.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 24.4 tt0 -78.7 -45.47 21.21 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 62' ' ' LEU . 44.0 mmm -64.0 -35.18 79.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.532 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.43 -42.62 73.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.17 -33.35 74.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.999 -1.295 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.25 70.4 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.164 -0.96 . . . . 0.0 109.045 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -69.96 -29.31 66.4 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 1.042 HD22 HG23 ' A' ' 9' ' ' THR . 15.9 tp -69.13 -46.07 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -33.4 75.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.39 -0.819 . . . . 0.0 108.945 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.037 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -62.52 -54.65 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.822 . . . . 0.0 109.273 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 1.016 HG13 HD21 ' A' ' 29' ' ' LEU . 39.2 t -70.99 -16.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -0.768 . . . . 0.0 109.968 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 11' ' ' SER . 5.5 tm-20 -75.17 -44.33 47.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.635 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -15.29 32.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.404 -0.81 . . . . 0.0 109.707 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.653 ' CG ' ' CD1' ' A' ' 29' ' ' LEU . 4.1 t80 -64.69 -52.12 58.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.352 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 150' ' ' TYR . 84.8 mt -53.46 -30.71 42.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.706 -0.621 . . . . 0.0 110.167 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.26 -51.76 10.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.701 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 154' ' ' HIS . . . -55.24 -53.76 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.451 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 153' ' ' ALA . 46.2 m-70 -60.01 -122.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.038 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 9.6 t -175.02 -31.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.59 -1.319 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -144.54 39.94 1.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 110.938 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.5 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -85.0 128.4 34.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.776 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.756 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 44.4 m-85 56.16 49.26 15.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.286 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 120' ' ' TYR . 9.2 p -144.66 161.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -1.12 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 76.5 m-85 -132.82 161.4 34.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.382 -0.824 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.59 106.82 10.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -0.963 . . . . 0.0 110.437 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.041 ' CD1' HG11 ' A' ' 133' ' ' VAL . 44.7 m-85 -108.14 86.8 2.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.398 -0.814 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -101.76 156.34 17.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.666 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -166.15 176.63 7.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.972 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 115' ' ' LYS . 29.2 mp0 -146.35 137.05 24.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.883 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.5 t -118.26 166.43 12.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.87 142.31 51.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.698 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.54 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -141.19 147.95 39.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.49 -39.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.433 -0.792 . . . . 0.0 110.174 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.598 HD11 ' CD1' ' A' ' 152' ' ' LEU . 3.4 mm -58.88 141.91 85.17 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.486 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 35.7 Cg_endo -57.89 155.27 33.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.912 1.48 . . . . 0.0 110.804 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -60.68 -36.68 79.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 110.103 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . . . -62.68 -56.24 19.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 110.735 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 51.7 mtt180 -61.3 -55.17 34.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.151 -0.968 . . . . 0.0 110.245 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -52.27 -33.72 43.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.221 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.745 ' CE2' HD21 ' A' ' 24' ' ' LEU . 75.7 t80 -69.88 -52.6 23.43 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 11.5 mtmm -61.26 -25.34 67.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 0.0 111.552 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -105.66 -61.12 1.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 111.522 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' HB2' HG11 ' A' ' 147' ' ' VAL . 80.7 t80 -76.28 -4.9 44.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.304 -0.872 . . . . 0.0 112.253 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.65 ' C ' HD23 ' A' ' 24' ' ' LEU . 34.9 mm -132.95 -20.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.642 -1.286 . . . . 0.0 111.123 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.745 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -111.19 -5.69 14.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -154.75 53.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 110.557 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.36 -21.78 55.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.5 ' HB2' HG11 ' A' ' 41' ' ' VAL . 49.8 p30 -68.21 -15.44 63.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -1.086 . . . . 0.0 110.449 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -122.77 10.75 9.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.77 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.827 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -122.27 -42.68 2.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.339 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.753 ' CD1' HD12 ' A' ' 143' ' ' LEU . 7.3 m-30 -60.7 -51.8 77.12 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.87 . . . . 0.0 111.684 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.9 Cg_endo -65.42 -4.82 10.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.224 1.118 . . . . 0.0 111.741 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -107.93 -64.11 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.898 -1.126 . . . . 0.0 110.5 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 29' ' ' LEU . 18.5 m -71.95 -17.71 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.97 66.3 75.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.101 -0.999 . . . . 0.0 110.872 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.0 Cg_endo -68.39 -19.96 42.78 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 109.466 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -83.9 -9.57 58.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.558 -0.714 . . . . 0.0 109.548 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -105.56 -59.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.968 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.16 161.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.514 ' HB2' ' N ' ' A' ' 59' ' ' PRO . 42.8 t -111.15 -57.44 2.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.055 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.38 144.48 3.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.914 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 27' ' ' ASP . 12.8 p -109.29 139.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.163 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 5.1 mt-10 -102.65 106.05 16.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.129 -0.982 . . . . 0.0 109.87 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.441 ' ND2' HG22 ' A' ' 41' ' ' VAL . 2.3 m-80 -102.18 97.86 8.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.321 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 53' ' ' ILE . 5.8 tp -58.45 -25.32 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 110.013 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 52' ' ' THR . 2.3 mt-10 -116.59 108.11 15.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.097 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.33 -3.02 88.39 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 47' ' ' ASN . 26.9 p-10 -163.08 56.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -1.23 . . . . 0.0 110.312 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.05 1.21 57.62 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.48 -112.9 0.97 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.13 85.62 1.64 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.873 1.459 . . . . 0.0 110.622 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 52' ' ' THR . . . 142.77 -15.23 2.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 45' ' ' GLU . 62.2 m -43.91 101.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -1.201 . . . . 0.0 110.178 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.785 ' O ' HG22 ' A' ' 44' ' ' ILE . 22.8 mm -85.68 121.7 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.099 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -137.76 154.31 49.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.495 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -125.38 107.24 10.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.392 -0.817 . . . . 0.0 110.173 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' A' ' 67' ' ' VAL . 1.7 mp -73.44 136.34 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 109.664 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -119.04 162.16 19.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 110.356 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 19.5 m-85 -128.05 161.57 55.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.514 ' N ' ' HB2' ' A' ' 39' ' ' SER . 43.0 Cg_endo -71.21 159.92 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.981 1.516 . . . . 0.0 110.017 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.69 164.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 110.627 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.61 -45.47 3.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -66.16 145.23 98.98 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.195 -1.179 . . . . 0.0 110.797 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 64' ' ' PHE . 47.5 Cg_endo -75.57 -163.65 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 110.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 5.2 m-30 51.83 103.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.376 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.6 tppt? -56.78 -17.62 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.604 ' CD1' ' C ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 175.6 -175.05 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.53 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 53.8 t -147.64 80.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -79.44 133.59 36.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' SER . 4.8 p-10 -163.39 -177.77 5.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HG3' HD13 ' A' ' 53' ' ' ILE . 6.4 mtp180 -121.8 159.73 26.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 4.6 p -85.93 -25.44 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.933 . . . . 0.0 111.042 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 72.14 -80.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.547 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -168.73 157.77 8.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 178.11 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.824 HG23 ' HD1' ' A' ' 81' ' ' TYR . 14.6 p -128.45 109.79 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.96 154.86 41.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 109.464 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.41 -59.06 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 110.61 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.9 m -63.0 -8.23 6.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 0.0 110.993 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.51 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 73.3 m-20 -121.29 6.87 10.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.91 -1.119 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 8.6 m-30 44.66 67.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.51 ' HE2' ' HB3' ' A' ' 78' ' ' ASN . 3.0 mtmt -137.1 122.29 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.883 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.824 ' HD1' HG23 ' A' ' 74' ' ' VAL . 4.3 t80 -111.05 128.98 56.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.556 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . 3.4 t-20 -101.0 143.85 30.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 1.031 ' CZ ' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -149.3 115.96 5.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.417 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -103.27 127.47 50.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.031 HG22 ' CZ ' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -102.45 95.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.435 -0.791 . . . . 0.0 109.783 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 87' ' ' GLU . 25.0 pt -87.44 -29.6 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 0.0 110.414 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -156.48 102.58 2.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.898 . . . . 0.0 110.363 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 143.79 166.3 11.25 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.554 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 86.1 -121.43 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 91' ' ' ILE . 47.4 Cg_endo -74.24 -52.26 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.788 1.415 . . . . 0.0 110.584 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.554 HD11 ' O ' ' A' ' 89' ' ' GLY . 0.2 OUTLIER 30.03 -156.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.875 0.845 . . . . 0.0 111.862 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.83 -161.67 2.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.58 ' O ' HG23 ' A' ' 94' ' ' THR . 3.4 m-20 51.68 -95.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -1.142 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 93' ' ' ASP . 18.3 p -156.23 22.25 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 110.516 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.698 ' HB3' HD11 ' A' ' 98' ' ' ILE . 9.9 mt -94.93 95.49 8.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.205 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.456 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 4.6 mt-10 -76.6 -43.34 38.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' HG12 ' A' ' 98' ' ' ILE . 9.1 tttp -129.43 152.13 49.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.005 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 95' ' ' LEU . 13.3 mt -153.74 122.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 110.635 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.53 127.34 48.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 109.872 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 2.3 m-80 -121.54 114.65 21.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.621 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.01 159.0 16.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 109.703 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.807 HG23 ' CD1' ' A' ' 116' ' ' ILE . 13.7 mt -141.89 142.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HG3' ' C ' ' A' ' 102' ' ' ILE . 1.8 mtpp -138.09 151.86 48.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.147 -0.971 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.613 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.9 mp -130.84 125.85 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.002 . . . . 0.0 109.927 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.41 133.23 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.02 21.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 p -128.96 152.85 79.89 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.843 . . . . 0.0 110.115 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.99 -32.38 28.55 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.024 1.539 . . . . 0.0 110.706 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 p30 -149.99 43.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.81 14.21 0.89 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.47 -138.07 29.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -128.58 136.56 50.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -1.157 . . . . 0.0 110.571 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.11 125.79 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.803 . . . . 0.0 109.211 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.883 ' HB2' HG22 ' A' ' 9' ' ' THR . 20.1 mt -89.72 108.19 19.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.001 . . . . 0.0 111.134 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 10.2 mttp -81.65 106.47 13.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.807 ' CD1' HG23 ' A' ' 102' ' ' ILE . 43.4 mm -101.38 151.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.08 132.08 35.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 4.9 m120 -129.53 88.17 2.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.125 -0.984 . . . . 0.0 110.725 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -81.29 124.27 29.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.716 ' O ' HG23 ' A' ' 2' ' ' VAL . 3.3 m-85 -103.67 149.38 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.911 -1.118 . . . . 0.0 110.401 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.0 m-70 -134.33 93.48 3.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.561 HG21 HG23 ' A' ' 128' ' ' VAL . 2.0 p -86.14 -162.9 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.87 . . . . 0.0 109.717 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HD3' ' OE1' ' A' ' 96' ' ' GLU . 5.2 ttpp -177.26 97.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.041 . . . . 0.0 110.854 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.42 160.59 12.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 56.08 -161.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -1.021 . . . . 0.0 110.635 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.486 ' N ' HG21 ' A' ' 94' ' ' THR . 81.1 m-70 -48.96 -179.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 110.436 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 5.5 mm-40 -127.32 -112.98 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.931 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.795 HG11 ' HE2' ' A' ' 5' ' ' TYR . 60.5 t -118.23 138.03 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.805 -1.185 . . . . 0.0 110.256 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 130' ' ' ALA . 5.5 mtmt -101.66 111.4 23.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -41.36 -50.31 3.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.696 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -46.44 -48.27 18.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.902 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.401 ' OE1' ' HB2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -63.36 -39.44 94.54 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.041 HG11 ' CD1' ' A' ' 5' ' ' TYR . 79.5 t -65.92 -17.22 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.757 0.789 . . . . 0.0 109.169 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 135' ' ' ALA . 2.0 ttmt -85.54 -58.13 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.499 -0.75 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.38 -50.64 5.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 109.916 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.43 -45.86 69.58 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.13 -31.68 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.701 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.77 -39.68 80.09 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.332 -0.855 . . . . 0.0 109.369 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 1.3 mtp -66.18 -38.43 88.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.21 -0.931 . . . . 0.0 109.05 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.21 -38.18 93.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -74.77 -35.02 62.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.896 -1.355 . . . . 0.0 110.158 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -39.77 90.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 108.743 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.753 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.1 mm? -68.66 -48.97 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.165 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.594 HD22 HG21 ' A' ' 9' ' ' THR . 13.3 tp -49.58 -42.89 45.62 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.204 -0.935 . . . . 0.0 108.849 178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 1.5 ttt-85 -65.79 -42.64 90.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.83 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.776 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.5 -62.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.358 -0.838 . . . . 0.0 109.734 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.65 HG22 HD12 ' A' ' 29' ' ' LEU . 84.6 t -59.01 -28.61 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.555 -0.715 . . . . 0.0 110.09 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -61.95 -53.06 60.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 0.0 109.958 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.4 p -76.7 -18.59 58.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 109.9 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.714 ' CD2' HD11 ' A' ' 29' ' ' LEU . 5.7 t80 -64.44 -47.95 77.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.627 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.617 HD23 ' CD2' ' A' ' 150' ' ' TYR . 68.4 mt -61.38 -24.97 66.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.598 ' CD1' HD11 ' A' ' 13' ' ' ILE . 5.9 mp -81.76 -35.21 29.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.244 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.12 -55.14 6.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.461 ' O ' ' CB ' ' A' ' 155' ' ' SER . 35.9 m-70 -66.14 -44.42 84.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.873 . . . . 0.0 109.808 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER 66.74 20.55 10.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.459 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -159.11 19.9 0.19 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.568 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.464 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.63 130.65 48.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.077 -1.014 . . . . 0.0 110.336 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.789 ' CD2' ' HB2' ' A' ' 21' ' ' ALA . 48.4 m-85 58.24 53.13 6.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.116 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.528 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 120' ' ' TYR . 78.9 t -79.08 156.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.558 ' CD1' HG23 ' A' ' 128' ' ' VAL . 75.9 m-85 -119.61 137.38 53.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.529 -0.732 . . . . 0.0 109.965 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.432 ' OD1' ' HE2' ' A' ' 119' ' ' LYS . 3.6 t30 -101.19 91.53 4.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 0.0 110.358 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.963 ' CE2' HG21 ' A' ' 133' ' ' VAL . 29.3 m-85 -86.97 74.12 9.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -0.92 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 91.54 3.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.549 HG21 ' CE ' ' A' ' 137' ' ' LYS . 14.4 t -112.85 -169.75 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -168.03 167.16 12.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.451 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.922 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -137.16 179.13 6.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 109.911 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.14 141.13 51.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.527 ' OG ' HD11 ' A' ' 18' ' ' LEU . 5.7 t -142.57 143.36 32.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 110.162 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -31.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.755 HG13 HD12 ' A' ' 151' ' ' LEU . 3.3 mm -66.08 140.82 97.16 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 36.2 Cg_endo -60.32 158.34 31.54 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.795 1.419 . . . . 0.0 110.617 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -53.91 -70.08 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 0.0 111.732 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.772 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -37.97 -62.07 0.59 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.309 -0.869 . . . . 0.0 111.808 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.2 mpt_? -52.73 -57.45 10.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.866 -1.146 . . . . 0.0 110.673 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.45 -30.66 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.183 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.738 ' CE2' HD21 ' A' ' 24' ' ' LEU . 68.3 t80 -74.01 -57.09 4.2 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.038 -1.039 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.0 mtmt -59.73 -23.02 62.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.73 . . . . 0.0 111.883 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -107.96 -53.25 2.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.578 -1.327 . . . . 0.0 112.226 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.703 ' CA ' HG11 ' A' ' 147' ' ' VAL . 27.4 t80 -83.89 -14.07 52.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.059 . . . . 0.0 112.38 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.951 HD12 HD11 ' A' ' 104' ' ' ILE . 28.2 mt -124.5 -14.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.573 -1.33 . . . . 0.0 110.868 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.738 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -111.74 -17.01 13.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.032 . . . . 0.0 109.967 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.485 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 4.7 t0 -137.16 43.83 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 110.151 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.36 -23.16 71.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.574 ' CB ' HG11 ' A' ' 41' ' ' VAL . 74.1 m-20 -68.52 -30.53 69.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -1.166 . . . . 0.0 110.365 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 28' ' ' ASN . 10.7 p-10 -105.04 25.15 10.89 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.903 HD23 HG13 ' A' ' 147' ' ' VAL . 3.1 tp -141.56 -63.23 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.668 -0.645 . . . . 0.0 110.354 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.751 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 6.1 m-30 -34.24 -52.96 0.94 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.782 -0.574 . . . . 0.0 110.746 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 50.9 Cg_endo -68.03 -50.25 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.468 1.246 . . . . 0.0 110.742 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -65.82 -69.52 0.29 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.286 -0.884 . . . . 0.0 110.615 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 29' ' ' LEU . 12.2 m -68.05 -11.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 111.409 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -146.73 66.17 10.52 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.3 Cg_endo -69.81 -11.86 31.64 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.846 1.445 . . . . 0.0 109.45 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -83.21 -14.63 52.92 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.332 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.631 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -112.36 -48.04 3.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.044 -1.035 . . . . 0.0 111.126 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.659 ' CD1' HD21 ' A' ' 143' ' ' LEU . 2.2 mp -116.94 163.56 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.985 -1.072 . . . . 0.0 110.596 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -124.07 -33.79 3.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.94 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER 169.95 141.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.536 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG11 ' CB ' ' A' ' 27' ' ' ASP . 3.2 p -103.37 148.03 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.159 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.495 1.795 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.056 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 53' ' ' ILE . 1.3 m . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.215 0.531 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.623 ' H ' HG22 ' A' ' 52' ' ' THR . 1.1 mp -125.27 168.43 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' CG ' ' HB2' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -149.11 147.56 28.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.397 -0.815 . . . . 0.0 109.914 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 2.4 tttp -111.53 92.04 3.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.91 -1.119 . . . . 0.0 110.537 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.691 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.8 mp -79.52 133.03 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.069 -1.019 . . . . 0.0 109.576 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.33 120.25 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 0.0 110.635 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.642 ' HZ ' HG21 ' A' ' 67' ' ' VAL . 16.6 m-85 -83.08 169.62 17.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.588 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 44.7 Cg_endo -71.15 173.96 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.628 1.33 . . . . 0.0 110.023 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' O ' HD23 ' A' ' 62' ' ' LEU . 6.3 tt0 -58.74 179.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.26 2.09 86.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -84.62 138.61 38.14 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -1.219 . . . . 0.0 110.599 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.67 -12.84 26.97 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.023 1.539 . . . . 0.0 109.81 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.542 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 18.8 m-30 -110.77 -139.54 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.96 -37.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.753 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 178.44 -166.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 66' ' ' TYR . 3.5 m -159.92 123.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.562 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -92.36 130.72 37.97 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.528 ' HB2' ' CG ' ' A' ' 54' ' ' LYS . 3.6 m-20 -118.0 151.08 38.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.907 -1.121 . . . . 0.0 111.449 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.56 114.34 27.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.607 HG22 HG23 ' A' ' 74' ' ' VAL . 8.9 p -58.49 -27.74 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 0.3 OUTLIER 42.04 51.28 4.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.0 mt-10 65.14 158.97 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.339 -0.85 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.607 HG23 HG22 ' A' ' 71' ' ' VAL . 90.0 t -144.07 159.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -109.41 -150.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.215 -0.928 . . . . 0.0 110.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.633 ' CE1' ' CD1' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 179.98 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 0.0 110.18 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -55.54 -52.72 62.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.231 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -90.28 15.59 10.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.223 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.772 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 11.6 m-85 47.09 69.32 0.51 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.507 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -126.57 143.83 51.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.929 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.447 ' CE1' HG22 ' A' ' 74' ' ' VAL . 27.1 t80 -141.7 100.77 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 71' ' ' VAL . 9.8 t-20 -96.72 104.17 16.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 109.563 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 8.4 p90 -132.02 -169.5 2.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 109.983 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 t -149.09 165.8 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.218 -0.926 . . . . 0.0 110.772 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 55.3 t -105.03 -26.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.382 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 85' ' ' VAL . 41.8 pt 37.05 -139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.162 0.506 . . . . 0.0 110.81 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.445 ' N ' HG13 ' A' ' 86' ' ' ILE . 1.4 mm-40 -60.61 135.43 57.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.996 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 136.66 142.72 4.49 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.358 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.542 ' HA2' ' CD2' ' A' ' 64' ' ' PHE . . . 88.18 -142.79 17.69 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 91' ' ' ILE . 52.2 Cg_endo -83.16 27.85 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.127 1.593 . . . . 0.0 110.993 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.15 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.474 -0.766 . . . . 0.0 110.581 -179.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 89.84 -163.77 30.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 1.3 m-20 56.44 -91.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -1.077 . . . . 0.0 110.484 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.476 HG21 ' HB2' ' A' ' 126' ' ' HIS . 76.3 p -142.12 47.37 1.62 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.438 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.981 HD22 HD11 ' A' ' 98' ' ' ILE . 1.4 mt -170.2 90.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.49 -49.97 6.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.573 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 1.9 ttpp -113.69 161.2 17.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.981 HD11 HD22 ' A' ' 95' ' ' LEU . 15.5 mt -158.39 113.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.473 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 4.3 m -104.32 122.2 44.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.166 -0.959 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.457 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 50.4 m-20 -116.29 133.5 55.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 111.601 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 82' ' ' ASN . 3.2 tp10 -118.57 129.49 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.438 ' C ' ' HG3' ' A' ' 103' ' ' LYS . 19.6 mt -116.91 146.96 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 0.0 110.783 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 49.4 mtpt -142.69 106.53 4.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.769 . . . . 0.0 109.784 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.951 HD11 HD12 ' A' ' 23' ' ' ILE . 14.5 mt -79.39 144.32 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.645 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 115' ' ' LYS . 22.1 t -130.07 127.52 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 110.157 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.6 132.83 34.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.116 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -111.13 153.03 44.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.386 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.33 -19.96 49.24 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.06 1.558 . . . . 0.0 110.703 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.414 ' O ' ' OD2' ' A' ' 109' ' ' ASP . 3.0 p-10 -158.43 44.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.92 21.59 0.78 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.85 -113.65 5.94 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 72.3 m -152.41 137.21 17.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.449 -1.03 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.4 mt -104.09 133.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.737 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.922 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.2 mp -95.25 99.91 11.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 110.002 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HD2' ' CG2' ' A' ' 105' ' ' VAL . 14.1 mttm -75.29 103.17 5.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.716 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.545 ' HB ' HG23 ' A' ' 7' ' ' THR . 25.8 mt -94.51 137.95 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 110.875 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.84 91.06 3.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.458 -0.776 . . . . 0.0 109.028 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 m-80 -84.48 92.24 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 111.387 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.503 ' HD2' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -84.73 103.37 13.76 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.71 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.2 m-85 -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.007 . . . . 0.0 111.468 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 32.7 m-70 -121.36 84.09 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 109.443 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.658 HG22 ' HG ' ' A' ' 95' ' ' LEU . 11.3 p -84.25 -164.74 0.99 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.357 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -137.42 88.02 2.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.34 -135.04 45.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.417 ' HB3' HG22 ' A' ' 94' ' ' THR . 17.6 t0 50.87 -141.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -1.125 . . . . 0.0 110.142 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.476 ' HB2' HG21 ' A' ' 94' ' ' THR . 43.8 m-70 -83.29 179.48 7.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -95.96 161.03 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.266 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 3' ' ' PHE . 39.6 t -50.4 139.56 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.036 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 31.4 mtmt -94.32 117.63 30.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -46.68 -43.79 18.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.153 -0.967 . . . . 0.0 109.853 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -46.04 64.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.062 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.46 HE21 HD13 ' A' ' 95' ' ' LEU . 1.5 tt0 -59.99 -44.93 94.2 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.963 HG21 ' CE2' ' A' ' 5' ' ' TYR . 54.4 t -59.66 -23.64 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.67 0.747 . . . . 0.0 109.163 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -79.35 -43.64 23.11 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.81 -0.557 . . . . 0.0 110.542 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -53.6 -53.79 46.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 t -61.15 -45.15 95.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.549 ' CE ' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -62.76 -18.42 62.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.865 . . . . 0.0 108.722 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 1.4 tt0 -77.82 -51.21 10.84 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 40.0 mmm -60.22 -33.38 72.19 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.193 -1.003 . . . . 0.0 108.78 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.58 -44.87 69.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -67.08 -39.88 86.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.808 -1.407 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -45.93 90.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.339 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.659 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.1 mm? -60.97 -52.62 64.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.337 -0.852 . . . . 0.0 109.324 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 9' ' ' THR . 10.3 tp -46.81 -43.27 18.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -63.37 -40.46 97.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 0.0 109.657 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -59.4 -61.33 2.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.903 HG13 HD23 ' A' ' 29' ' ' LEU . 9.6 t -62.75 -18.38 20.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.463 -0.773 . . . . 0.0 109.89 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.508 ' O ' HD22 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -72.61 -46.1 55.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 81.1 p -87.18 -15.0 39.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.54 ' CZ ' HD11 ' A' ' 29' ' ' LEU . 3.7 t80 -67.01 -39.89 87.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.995 . . . . 0.0 109.6 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.755 HD12 HG13 ' A' ' 13' ' ' ILE . 42.7 mt -63.1 -36.34 83.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.402 -0.811 . . . . 0.0 110.596 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.523 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -75.96 -51.98 11.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.311 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -53.77 -54.1 43.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -67.28 -163.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 44.8 m -94.09 59.37 2.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 0.1 OUTLIER 61.6 41.21 12.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.472 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -42.41 151.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 110.244 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.789 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 81.9 m-85 57.87 57.38 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.34 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.155 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 3' ' ' PHE . 40.4 t 50.71 170.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.56 -0.965 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.709 ' CD1' HG23 ' A' ' 128' ' ' VAL . 97.4 m-85 -150.93 150.37 30.75 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -111.7 103.8 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.021 ' CE2' HG21 ' A' ' 133' ' ' VAL . 55.3 m-85 -100.79 87.21 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.45 108.51 19.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -127.99 -172.12 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.19 -170.87 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.867 . . . . 0.0 109.943 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.602 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 5.0 t -165.95 173.66 10.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 0.0 109.75 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.76 142.69 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.011 . . . . 0.0 110.491 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.821 ' OG ' HD11 ' A' ' 18' ' ' LEU . 20.2 t -132.13 144.15 50.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.47 -7.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.337 -0.852 . . . . 0.0 110.116 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.592 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 7.2 mm -94.78 145.27 29.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 110.473 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 30.9 Cg_endo -56.25 160.69 10.35 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.789 1.415 . . . . 0.0 110.686 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -63.26 -78.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 111.415 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -32.04 -54.6 0.3 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.664 -0.648 . . . . 0.0 111.421 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.55 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -57.41 -55.7 31.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.0 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.821 HD11 ' OG ' ' A' ' 11' ' ' SER . 5.4 mt -51.01 -28.74 10.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 24' ' ' LEU . 19.0 t80 -73.07 -67.47 0.57 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.68 -25.11 9.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.225 -0.922 . . . . 0.0 112.317 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.794 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -101.33 -58.16 1.94 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.541 -1.349 . . . . 0.0 111.443 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 24.2 t80 -80.59 -83.14 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.03 -1.044 . . . . 0.0 111.47 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.619 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 2.4 mp -46.36 -21.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.18 -0.95 . . . . 0.0 111.876 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.667 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -106.67 -77.81 0.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.664 -1.273 . . . . 0.0 110.043 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.8 t0 -73.15 83.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 0.0 110.212 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.63 -27.94 4.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.14 -12.75 60.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.271 . . . . 0.0 110.278 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -118.79 7.13 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.576 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.757 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -122.36 -40.32 2.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.803 . . . . 0.0 110.228 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.797 ' CD1' HD12 ' A' ' 143' ' ' LEU . 6.1 m-30 -61.39 -54.66 50.67 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.919 . . . . 0.0 111.35 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 44.4 Cg_endo -65.66 -6.13 13.19 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.306 1.161 . . . . 0.0 111.262 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -103.82 -67.61 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 110.592 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.042 HG23 ' HB1' ' A' ' 146' ' ' ALA . 12.0 m -74.76 -20.91 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 110.82 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.4 61.65 15.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 110.675 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.1 Cg_endo -67.86 -23.29 41.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.101 1.58 . . . . 0.0 109.136 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -73.6 -15.87 61.26 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.544 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -108.67 -66.16 1.07 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 110.75 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 39' ' ' SER . 4.0 mp -114.47 172.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.605 ' N ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -163.97 -25.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 111.472 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.4 t -133.45 138.76 46.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.588 -1.32 . . . . 0.0 111.122 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 t -124.57 128.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.587 -0.696 . . . . 0.0 109.41 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.009 . . . . 0.0 110.137 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.323 0.582 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 54' ' ' LYS . 16.5 mm -117.11 165.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.4 pttp -179.66 142.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.006 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -140.58 108.84 5.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.831 -0.543 . . . . 0.0 109.601 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.7 mp -82.87 152.42 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.909 . . . . 0.0 110.59 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -127.38 139.83 52.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.99 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.742 ' HB3' HD12 ' A' ' 62' ' ' LEU . 24.1 m-85 -109.96 103.83 54.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.441 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.606 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 46.1 Cg_endo -72.82 -159.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.031 1.543 . . . . 0.0 110.198 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.565 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER 44.51 -172.53 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.094 -1.004 . . . . 0.0 111.526 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.565 ' N ' ' HG3' ' A' ' 60' ' ' GLU . . . -45.06 -18.26 0.13 Allowed Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.737 -0.602 . . . . 0.0 112.992 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.742 HD12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -42.82 125.75 3.14 Favored Pre-proline 0 N--CA 1.501 2.097 0 CA-C-N 119.672 1.736 . . . . 0.0 110.302 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 64' ' ' PHE . 50.4 Cg_endo -74.99 -156.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 109.846 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 63' ' ' PRO . 3.4 m-85 57.18 168.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.068 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -104.96 -39.82 6.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.89 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 29.1 p90 179.56 -175.11 0.25 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.74 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.554 HG23 ' HB ' ' A' ' 56' ' ' ILE . 8.2 m -150.93 106.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.961 -1.087 . . . . 0.0 110.779 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.1 tttt -107.35 139.41 41.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.93 ' HB3' HG13 ' A' ' 85' ' ' VAL . 2.7 p30 -159.71 166.13 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.907 -1.121 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.459 ' HD2' ' CD1' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -104.69 145.99 29.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.599 -0.688 . . . . 0.0 109.362 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.678 HG23 ' OH ' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -83.11 -38.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.986 -1.072 . . . . 0.0 110.154 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.05 -33.93 0.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.731 -0.606 . . . . 0.0 111.646 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' C ' HG23 ' A' ' 74' ' ' VAL . 6.0 pt-20 174.54 160.42 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.761 -1.212 . . . . 0.0 110.292 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.614 HG22 ' CE1' ' A' ' 81' ' ' TYR . 44.5 t -151.99 92.5 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.827 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -66.56 -169.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.185 -0.947 . . . . 0.0 110.541 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.414 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -153.75 -52.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.5 m -48.38 -34.81 11.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 75.3 m-20 -118.93 6.06 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.388 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 9.0 m-85 58.9 40.6 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.982 . . . . 0.0 110.059 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 1.4 tttt -89.02 117.46 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.988 . . . . 0.0 110.65 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.765 ' O ' HD12 ' A' ' 102' ' ' ILE . 25.1 t80 -118.4 132.93 56.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' VAL . 4.0 t30 -144.19 104.89 4.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 109.956 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.8 p90 -125.0 164.18 20.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.01 136.37 51.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.756 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.93 HG13 ' HB3' ' A' ' 69' ' ' ASP . 1.6 t -108.87 114.3 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.504 -0.748 . . . . 0.0 109.199 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 pt -113.94 6.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.029 -1.044 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.1 144.18 5.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.013 -1.054 . . . . 0.0 110.308 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.911 ' C ' HD11 ' A' ' 91' ' ' ILE . . . 84.0 133.48 2.43 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.476 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 124.18 -134.5 9.2 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' ILE . 45.0 Cg_endo -72.54 -6.32 18.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.919 1.484 . . . . 0.0 110.631 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.911 HD11 ' C ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -35.97 157.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.32 23.91 18.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.1 -146.36 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -1.187 . . . . 0.0 110.089 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 122' ' ' THR . 1.2 p -87.22 44.41 1.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.744 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -132.59 124.14 27.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.9 OUTLIER -105.72 -71.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.93 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -125.7 132.59 52.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.819 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.98 121.81 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.264 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.27 157.16 16.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.975 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.456 HD21 HG23 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -141.13 109.47 5.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.001 -1.062 . . . . 0.0 110.689 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 102' ' ' ILE . 33.6 tt0 -125.95 137.07 53.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.354 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.914 HD12 ' N ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER 175.71 -157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.242 -0.911 . . . . 0.0 112.837 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 80' ' ' LYS . 14.8 ptmt -172.59 179.52 2.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.26 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.815 HG23 HD12 ' A' ' 114' ' ' LEU . 14.8 mm -110.57 146.3 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.614 -0.679 . . . . 0.0 109.832 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.428 HG21 ' HD2' ' A' ' 115' ' ' LYS . 56.8 t -122.12 142.82 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HA ' ' OG ' ' A' ' 112' ' ' SER . . . -110.1 133.03 53.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.0 110.424 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 39.5 p -93.82 164.07 21.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 43.3 Cg_endo -64.91 -22.57 62.89 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.915 1.482 . . . . 0.0 111.149 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 22.4 p-10 -175.58 88.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.027 -1.045 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.82 -30.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.05 -133.77 6.2 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -147.84 140.18 24.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -1.128 . . . . 0.0 110.059 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 mt -95.72 120.48 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.863 . . . . 0.0 110.245 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.815 HD12 HG23 ' A' ' 104' ' ' ILE . 3.8 mp -83.25 108.04 16.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.773 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.747 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 18.1 mttt -94.44 121.68 36.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.683 -1.26 . . . . 0.0 109.17 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.874 ' CA ' HG21 ' A' ' 102' ' ' ILE . 34.1 mm -120.98 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.607 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.551 ' N ' HG21 ' A' ' 102' ' ' ILE . 13.0 m -119.06 126.4 51.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.495 -1.378 . . . . 0.0 109.275 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.7 150.32 40.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.948 . . . . 0.0 111.191 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.49 109.54 12.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.744 ' CD2' HD11 ' A' ' 95' ' ' LEU . 4.6 m-85 -86.9 135.06 33.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 111.556 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 96' ' ' GLU . 76.6 m-70 -123.08 86.49 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.49 HG21 ' CG2' ' A' ' 128' ' ' VAL . 8.9 p -86.9 -179.2 6.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -0.761 . . . . 0.0 110.902 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -60.04 -147.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.437 -0.789 . . . . 0.0 110.449 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.38 77.9 0.38 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.88 -71.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 109.918 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -85.54 173.65 10.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.896 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 52.8 mt-10 -110.25 -174.15 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 110.431 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.709 HG23 ' CD1' ' A' ' 3' ' ' PHE . 46.6 t -83.78 145.18 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.33 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -90.42 112.35 23.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.37 -41.82 14.08 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.168 -0.958 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.49 -46.82 76.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.296 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.464 ' NE2' HD23 ' A' ' 95' ' ' LEU . 5.5 tt0 -58.83 -42.59 89.58 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.021 HG21 ' CE2' ' A' ' 5' ' ' TYR . 70.3 t -62.83 -25.81 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.748 0.785 . . . . 0.0 109.224 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.8 ttmt -73.83 -56.95 4.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.705 -0.622 . . . . 0.0 110.492 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -35.64 -52.1 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.688 -0.633 . . . . 0.0 110.952 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 t -57.49 -47.82 80.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -61.42 -28.63 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 135' ' ' ALA . 14.0 mm-40 -69.88 -57.83 4.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.281 -0.887 . . . . 0.0 109.351 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.544 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 2.7 mtp -54.81 -35.63 64.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.221 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.69 -39.04 95.12 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.79 -45.93 48.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.869 -1.371 . . . . 0.0 110.888 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 -41.01 92.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.027 -1.046 . . . . 0.0 109.49 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.797 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.5 mm? -68.35 -53.8 21.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.511 -0.743 . . . . 0.0 109.887 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 114' ' ' LEU . 16.1 tp -46.21 -43.72 15.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.145 -0.972 . . . . 0.0 108.811 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.509 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 2.2 ttp180 -66.22 -39.94 89.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.388 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.042 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -55.52 -62.36 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -0.843 . . . . 0.0 109.359 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.672 HG22 HD12 ' A' ' 29' ' ' LEU . 60.4 t -62.57 -23.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -61.79 -55.93 24.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.372 -0.83 . . . . 0.0 110.085 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -23.37 53.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.8 ' HB2' HG11 ' A' ' 33' ' ' VAL . 11.3 t80 -56.08 -37.82 69.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.117 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.5 -25.62 62.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.174 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 2.1 mp -88.89 -19.12 26.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.79 -38.41 14.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.838 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.56 156.27 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.846 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 3.3 p -44.26 -53.54 6.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 155' ' ' SER . 23.3 t70 -177.1 64.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.195 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.64 146.29 46.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 110.358 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.794 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 63.0 m-85 54.45 70.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 110.48 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.35 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.613 HG21 ' HD3' ' A' ' 119' ' ' LYS . 7.9 p -88.03 157.16 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -1.103 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.652 ' CD1' HG23 ' A' ' 128' ' ' VAL . 87.7 m-85 -123.6 122.78 39.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 110.03 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.59 98.82 10.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.815 ' CD1' HG11 ' A' ' 133' ' ' VAL . 46.7 m-85 -100.45 103.71 15.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 109.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -108.59 122.28 46.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.953 -1.092 . . . . 0.0 110.109 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 6.2 t -130.54 166.73 19.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 110.541 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 7' ' ' THR . 75.1 mt-10 -155.18 157.69 37.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.887 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -142.37 -178.51 5.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.015 . . . . 0.0 110.27 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.433 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -131.0 141.8 50.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.039 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.538 ' CB ' HD11 ' A' ' 18' ' ' LEU . 19.6 t -134.42 142.25 47.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.46 0.33 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.54 -0.725 . . . . 0.0 110.124 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.652 HD11 HD21 ' A' ' 152' ' ' LEU . 11.1 mm -96.69 147.99 33.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.9 Cg_endo -56.55 157.81 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.885 1.466 . . . . 0.0 110.033 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' ALA . . . -68.5 -64.04 0.94 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.072 -1.017 . . . . 0.0 110.886 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -43.35 -50.52 6.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.732 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.572 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.17 -52.18 65.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.607 HD12 ' OG ' ' A' ' 112' ' ' SER . 6.0 mt -52.31 -24.1 6.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 108.773 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.712 ' CE2' HD21 ' A' ' 24' ' ' LEU . 43.5 t80 -77.66 -55.66 5.17 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.466 -0.772 . . . . 0.0 110.384 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 5.0 mmmt -61.25 -21.76 64.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.569 -0.707 . . . . 0.0 111.884 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -111.39 -47.26 3.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.685 -1.259 . . . . 0.0 112.774 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' HE2' HD21 ' A' ' 114' ' ' LEU . 39.2 t80 -89.68 -22.08 22.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.718 -1.239 . . . . 0.0 112.482 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.638 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 mp -116.56 -13.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.649 -1.282 . . . . 0.0 110.378 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.712 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -111.96 -12.91 13.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.481 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 9.6 t0 -146.67 47.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.547 ' CA ' ' CE1' ' A' ' 30' ' ' PHE . . . -83.25 -31.16 28.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.775 ' HB3' HG11 ' A' ' 41' ' ' VAL . 52.4 m-20 -76.77 2.96 12.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -1.088 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.3 t30 -138.62 50.47 1.86 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.994 HD21 HG13 ' A' ' 147' ' ' VAL . 1.1 tp 173.06 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.581 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' CA ' ' A' ' 26' ' ' GLY . 3.0 m-30 -52.18 -59.29 8.74 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.919 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -67.06 -11.97 34.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 111.211 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -90.06 -31.58 17.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 111.031 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HB1' ' A' ' 146' ' ' ALA . 10.5 m -103.82 -11.81 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -138.94 66.6 40.15 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.808 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.4 -5.37 14.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.967 1.509 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -94.9 -12.61 26.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.411 -0.806 . . . . 0.0 109.625 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.02 -28.93 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.668 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 39' ' ' SER . 6.7 mm -125.75 178.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.967 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.603 ' H ' HG22 ' A' ' 38' ' ' ILE . 4.1 t -136.35 -45.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 t -174.85 165.16 3.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.775 HG11 ' HB3' ' A' ' 27' ' ' ASP . 99.5 t -118.58 124.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 110.034 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 3.5 tp10 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.417 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.1 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.28 0.562 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.9 mp -97.06 136.71 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 84.6 mttt -139.41 148.99 43.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 6.7 tttt -117.45 96.03 5.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.82 . . . . 0.0 110.653 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.563 HD11 ' OD1' ' A' ' 27' ' ' ASP . 1.4 mp -73.47 148.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 27.5 t -124.75 169.38 12.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.271 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 39.4 m-85 -134.33 153.68 79.47 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.601 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 62' ' ' LEU . 48.4 Cg_endo -76.36 169.72 21.39 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.185 1.624 . . . . 0.0 109.615 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 167.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 110.061 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.03 -43.41 3.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 59' ' ' PRO . 8.5 mt -79.96 155.36 75.24 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.083 -1.245 . . . . 0.0 110.65 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HG2' ' CE2' ' A' ' 64' ' ' PHE . 50.8 Cg_endo -81.88 162.36 18.48 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.193 1.628 . . . . 0.0 110.971 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' A' ' 63' ' ' PRO . 11.6 m-85 65.69 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 0.0 110.634 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -69.1 -9.5 52.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 30.1 p90 -175.75 -170.34 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 110.176 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 67' ' ' VAL . 7.3 p -170.93 109.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.3 mtmm -96.15 138.42 33.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.751 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.18 -176.06 4.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.691 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.406 ' HB3' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -138.75 127.91 24.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 109.902 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.533 HG13 ' CZ ' ' A' ' 81' ' ' TYR . 55.7 t -68.25 -44.38 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.323 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.4 m-20 77.98 -38.2 0.25 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.803 -0.56 . . . . 0.0 111.419 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 179.0 -167.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.696 -1.253 . . . . 0.0 111.001 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.2 p -167.91 118.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.628 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -77.26 -49.75 14.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.174 -0.953 . . . . 0.0 110.955 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.566 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 77.94 -71.16 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.634 -0.666 . . . . 0.0 110.506 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -57.77 -42.49 84.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.316 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 79' ' ' PHE . 15.6 m120 -97.03 18.0 15.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 23.2 m-30 43.49 27.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.525 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.5 ttpt -95.29 107.62 19.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.161 -0.962 . . . . 0.0 109.874 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 102' ' ' ILE . 20.4 t80 -110.79 96.82 6.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.596 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.2 m-20 -84.39 161.22 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.839 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 13.4 p90 -179.33 152.42 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.44 -0.787 . . . . 0.0 109.768 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.66 146.66 48.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.206 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.6 t -104.97 73.11 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.257 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.413 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 5.4 pt -62.06 -42.51 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.345 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 2.6 mt-10 -139.66 94.91 2.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.898 -1.126 . . . . 0.0 110.709 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.97 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 167.96 120.35 0.52 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.97 -147.35 16.85 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 91' ' ' ILE . 47.7 Cg_endo -72.43 -3.41 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 124.033 1.544 . . . . 0.0 110.22 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.97 HD11 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -34.85 157.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 121.535 0.683 . . . . 0.0 110.596 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.95 -8.05 59.25 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -108.66 -85.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -1.147 . . . . 0.0 110.396 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 122' ' ' THR . 0.6 OUTLIER -130.1 -18.89 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.931 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.715 HD22 HG12 ' A' ' 98' ' ' ILE . 2.3 mt -80.9 83.35 6.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 110.195 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.88 -52.33 63.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' C ' HG13 ' A' ' 98' ' ' ILE . 3.4 tptt -137.32 165.71 25.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.199 -0.938 . . . . 0.0 110.531 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.715 HG12 HD22 ' A' ' 95' ' ' LEU . 23.1 mt -150.73 122.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.078 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -99.19 135.08 41.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.908 . . . . 0.0 109.761 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 32.9 m120 -137.71 140.89 40.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.75 -1.218 . . . . 0.0 110.972 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 7.0 pt-20 -138.26 154.03 49.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.76 . . . . 0.0 109.546 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 81' ' ' TYR . 2.9 mt -128.13 155.13 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.469 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 22.9 mtmt -149.1 103.77 3.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 109.502 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 2.9 mm -81.53 120.19 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 109.871 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.551 HG21 ' CD ' ' A' ' 115' ' ' LYS . 61.3 t -105.14 123.08 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.99 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.22 140.31 34.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 44.3 p -113.16 162.17 23.3 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.87 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 48.9 Cg_endo -66.62 -30.62 42.27 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.961 1.506 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -162.86 44.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.31 23.39 2.05 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.96 -135.84 26.65 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.607 ' OG ' HD12 ' A' ' 18' ' ' LEU . 6.5 p -132.81 134.62 44.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -1.14 . . . . 0.0 110.326 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 10' ' ' THR . 13.2 mt -95.13 124.06 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.887 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.0 OUTLIER -81.86 96.09 7.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 110.964 -179.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.551 ' CD ' HG21 ' A' ' 105' ' ' VAL . 3.9 mttp -87.47 107.86 18.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.402 ' CG1' HG23 ' A' ' 102' ' ' ILE . 5.2 mt -116.78 132.54 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.22 144.06 36.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.519 -0.738 . . . . 0.0 109.589 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' TYR . 44.2 m-80 -136.78 143.46 43.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 110.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.613 ' HD3' HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -132.47 108.92 9.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.679 ' CD2' HD11 ' A' ' 95' ' ' LEU . 5.4 m-85 -87.12 114.18 23.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.835 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -101.21 92.12 4.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.224 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 128' ' ' VAL . 7.6 p -85.27 -151.75 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.827 . . . . 0.0 110.748 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.42 3.07 15.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 110.566 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 96.45 -157.24 21.33 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -1.017 . . . . 0.0 110.248 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 124' ' ' GLY . 1.6 m-70 -81.1 166.21 20.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.895 -1.128 . . . . 0.0 110.009 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -109.58 167.84 9.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.431 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.652 HG23 ' CD1' ' A' ' 3' ' ' PHE . 23.4 t -63.39 150.51 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 110.248 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 132' ' ' GLN . 40.8 mtmt -83.57 102.79 12.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.87 -56.42 3.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.133 -0.98 . . . . 0.0 109.912 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.3 tt0 -44.83 -45.34 10.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.227 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.533 ' HB2' ' HB2' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -58.11 -44.71 87.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 108.921 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.815 HG11 ' CD1' ' A' ' 5' ' ' TYR . 79.0 t -60.67 -25.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 135' ' ' ALA . 1.9 tttm -81.88 -68.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.966 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.53 -40.76 0.41 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 110.325 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -51.25 68.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.047 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 6.6 mptt -56.07 -30.65 62.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.489 -0.757 . . . . 0.0 109.557 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 109.876 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 57.0 mmm -67.62 -34.34 76.79 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.864 . . . . 0.0 108.813 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -71.01 -43.32 57.66 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -66.48 -33.76 76.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -1.157 . . . . 0.0 110.108 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.512 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 2.0 p -70.59 -43.45 69.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.271 -0.893 . . . . 0.0 109.23 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 143' ' ' LEU . 1.0 OUTLIER -70.08 -25.27 63.44 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.548 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.794 HD22 HD22 ' A' ' 114' ' ' LEU . 17.2 tp -73.3 -43.32 61.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 108.901 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -72.32 -25.64 61.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -70.84 -53.94 13.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 109.028 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.994 HG13 HD21 ' A' ' 29' ' ' LEU . 62.1 t -70.61 -21.86 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.154 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -69.55 -52.39 26.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.315 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.478 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 88.9 p -74.87 -23.13 58.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.333 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.589 ' CG ' HD11 ' A' ' 29' ' ' LEU . 9.1 t80 -59.04 -41.8 88.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.94 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.09 -27.7 69.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.652 HD21 HD11 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -86.35 -23.63 26.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.15 -55.49 5.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.227 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.469 ' O ' ' HB3' ' A' ' 155' ' ' SER . 15.9 m-70 -73.8 -34.11 64.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 110.064 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 23.1 t 59.36 15.02 4.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 156' ' ' ASP . 1.7 p30 -145.48 12.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.95 . . . . 0.0 110.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.571 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.85 131.16 48.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.4 m-85 58.03 48.02 13.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.421 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.209 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 3' ' ' PHE . 47.1 t -105.72 165.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -1.21 . . . . 0.0 110.537 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 53.6 m-85 -125.29 148.4 48.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.785 . . . . 0.0 109.65 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -117.2 110.08 17.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 110.539 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.748 ' CD2' HG11 ' A' ' 133' ' ' VAL . 23.0 m-85 -108.75 76.7 1.03 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.598 -0.689 . . . . 0.0 109.527 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 85.7 mt-10 -84.05 96.72 8.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 110.879 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -106.29 163.17 13.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.836 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -135.33 144.44 46.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.146 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.807 HG22 ' HB3' ' A' ' 114' ' ' LEU . 1.1 t -134.39 161.48 34.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.86 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -123.52 143.64 50.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.99 . . . . 0.0 110.341 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -135.8 147.33 48.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 110.24 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.03 -20.93 19.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 109.772 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.543 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 6.4 mm -75.93 140.0 70.08 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.7 Cg_endo -57.22 148.95 67.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.807 1.425 . . . . 0.0 110.568 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.557 ' HA ' ' CG2' ' A' ' 104' ' ' ILE . . . -55.08 -46.09 75.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 0.0 111.275 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.0 -58.98 5.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 111.009 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.523 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 6.4 mtm180 -53.95 -57.35 11.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 109.671 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.48 -32.11 7.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.561 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 1.022 ' CE1' HD21 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -68.34 -62.77 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.525 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 26.5 mtpp -59.54 -23.06 62.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.519 -0.738 . . . . 0.0 112.842 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.632 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -106.08 -55.73 2.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.481 -1.387 . . . . 0.0 111.943 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 57.7 t80 -79.19 -9.33 59.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 0.0 112.07 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 24' ' ' LEU . 71.4 mt -130.07 -21.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.627 -1.296 . . . . 0.0 111.63 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.022 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.7 mt -106.18 -14.93 15.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.224 . . . . 0.0 109.536 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.524 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -138.39 30.67 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.441 -0.787 . . . . 0.0 110.416 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.3 -36.95 93.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' HG11 ' A' ' 41' ' ' VAL . 52.1 m-20 -60.89 -14.57 23.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -1.047 . . . . 0.0 109.815 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t30 -122.47 52.12 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.655 HD21 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -172.4 -52.26 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.493 -0.755 . . . . 0.0 110.102 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.614 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 7.1 m-30 -43.73 -53.91 11.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 111.093 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -67.02 -29.57 40.19 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.346 1.182 . . . . 0.0 111.065 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -77.42 -71.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 111.17 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 150' ' ' TYR . 22.2 m -71.99 -20.49 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 111.596 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -126.18 63.17 48.99 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.897 -1.127 . . . . 0.0 111.106 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.7 Cg_endo -69.26 -11.42 31.44 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.858 1.451 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.5 OUTLIER -87.08 -8.18 57.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.501 -0.749 . . . . 0.0 109.578 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.626 ' HB3' HD21 ' A' ' 143' ' ' LEU . . . -117.53 -48.53 2.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.974 . . . . 0.0 110.392 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' A' ' 30' ' ' PHE . 2.9 mp -117.69 156.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.077 -1.014 . . . . 0.0 110.199 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -113.55 -31.04 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER 169.53 159.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.81 . . . . 0.0 109.905 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 27' ' ' ASP . 3.4 p -126.9 129.51 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.925 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 110.589 -179.468 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.233 0.54 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.614 HD12 ' CD ' ' A' ' 70' ' ' ARG . 16.2 mm -106.37 116.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.406 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -118.47 162.4 18.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.074 . . . . 0.0 110.708 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -134.21 113.49 12.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.579 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.9 mp -81.49 144.7 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 t -125.9 101.43 6.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.622 -0.674 . . . . 0.0 109.844 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' HB2' HD12 ' A' ' 62' ' ' LEU . 38.6 m-85 -70.06 140.23 88.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 50.5 Cg_endo -82.74 48.28 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.165 1.613 . . . . 0.0 110.4 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.461 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 5.1 tt0 -135.04 -170.82 2.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.382 -0.824 . . . . 0.0 110.357 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.08 37.36 3.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 58' ' ' PHE . 79.1 mt -56.1 163.2 2.4 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.311 -1.111 . . . . 0.0 110.168 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 64' ' ' PHE . 46.6 Cg_endo -73.38 -9.47 23.06 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.021 1.538 . . . . 0.0 110.257 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 3.8 m-85 -114.88 -34.51 5.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.128 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 1.5 ttpt 74.45 -0.41 3.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.603 -0.685 . . . . 0.0 109.997 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 32.9 p90 179.88 -161.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 67' ' ' VAL . 8.7 p -179.45 118.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.308 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 55' ' ' LYS . 2.7 tttt -87.67 138.57 31.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -140.29 163.89 31.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.087 -1.008 . . . . 0.0 110.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.614 ' CD ' HD12 ' A' ' 53' ' ' ILE . 5.8 mtm180 -121.82 139.54 53.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.384 -0.822 . . . . 0.0 109.943 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' ASP . 24.6 t -73.21 -17.92 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.942 . . . . 0.0 110.262 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER 44.99 27.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.959 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.7 mt-10 65.76 148.6 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.679 HG11 ' CD1' ' A' ' 81' ' ' TYR . 27.3 m -123.23 -170.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.545 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.04 152.28 42.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.39 -52.61 2.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.021 -1.05 . . . . 0.0 110.633 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.3 m -61.4 -10.91 8.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.856 -1.152 . . . . 0.0 110.599 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -125.19 6.44 7.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.015 -1.053 . . . . 0.0 110.535 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.553 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.7 m-30 46.83 54.97 8.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 29.3 tttt -124.14 105.52 9.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 111.143 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.679 ' CD1' HG11 ' A' ' 74' ' ' VAL . 74.2 t80 -89.72 178.23 6.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 109.315 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.427 ' N ' ' CG ' ' A' ' 81' ' ' TYR . 5.9 t30 -179.2 129.81 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.788 -1.195 . . . . 0.0 110.642 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 3.8 p90 -137.77 152.46 49.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.802 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.18 132.4 44.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.643 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.0 HG12 HD11 ' A' ' 91' ' ' ILE . 25.4 t -89.55 133.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 109.331 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.3 -14.96 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 111.328 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.625 ' C ' HD12 ' A' ' 91' ' ' ILE . 1.4 mm-40 -150.67 107.57 3.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.93 -1.106 . . . . 0.0 110.917 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 1.127 ' N ' HD12 ' A' ' 91' ' ' ILE . . . 127.04 -137.75 10.12 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 64' ' ' PHE . . . 26.69 -128.22 0.05 OUTLIER Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.567 ' O ' ' C ' ' A' ' 91' ' ' ILE . 42.8 Cg_endo -70.86 -59.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.877 1.462 . . . . 0.0 109.376 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 1.127 HD12 ' N ' ' A' ' 88' ' ' GLY . 1.8 mt 4.59 90.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 121.746 0.784 . . . . 0.0 112.893 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.95 -149.34 6.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.98 -18.82 5.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.287 . . . . 0.0 109.435 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -128.12 136.26 50.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.81 . . . . 0.0 109.964 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 120' ' ' TYR . 4.6 mt 63.38 92.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.294 -0.878 . . . . 0.0 110.063 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.78 -34.88 21.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -140.77 150.01 42.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.017 . . . . 0.0 110.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.556 HD11 ' CG ' ' A' ' 90' ' ' PRO . 58.9 mt -139.59 126.23 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.5 m -117.41 110.44 18.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 118' ' ' ASN . 1.9 m120 -106.86 119.45 39.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.905 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.468 ' O ' HD13 ' A' ' 102' ' ' ILE . 53.7 mt-10 -105.51 132.37 51.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 109.418 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.674 HD12 HG12 ' A' ' 116' ' ' ILE . 20.0 mm -124.31 155.95 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.093 -1.004 . . . . 0.0 110.915 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 2.8 ttmt -148.2 114.5 5.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.796 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.557 ' CG2' ' HA ' ' A' ' 15' ' ' ALA . 1.5 mp -77.41 121.27 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.01 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG23 ' HG2' ' A' ' 115' ' ' LYS . 61.9 t -104.45 133.4 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 110.435 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.26 132.37 44.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.0 p -106.68 157.87 34.12 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.018 . . . . 0.0 110.625 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.509 ' O ' ' HB3' ' A' ' 109' ' ' ASP . 49.6 Cg_endo -67.63 81.88 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.156 1.609 . . . . 0.0 110.218 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 7.6 t70 71.02 49.69 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.567 -0.708 . . . . 0.0 110.275 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.65 13.9 1.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.87 -159.21 34.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 3.4 p -126.38 131.09 51.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -1.129 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.59 HG23 HG23 ' A' ' 10' ' ' THR . 6.1 mt -93.79 116.89 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.807 ' HB3' HG22 ' A' ' 9' ' ' THR . 0.7 OUTLIER -77.69 106.4 9.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 110.703 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.554 ' HG2' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -82.06 115.63 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.881 -1.137 . . . . 0.0 108.952 178.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.674 HG12 HD12 ' A' ' 102' ' ' ILE . 81.7 mt -113.79 127.99 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 111.199 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -126.72 95.55 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.531 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 72.2 m-20 -93.08 108.29 19.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 111.403 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 124.94 39.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 109.322 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.921 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.6 m-85 -103.34 112.22 25.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 111.115 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -96.19 98.15 10.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.68 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.714 ' CG2' HG23 ' A' ' 128' ' ' VAL . 11.3 p -82.69 -173.1 4.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.334 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' THR . 0.0 OUTLIER 170.27 43.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.46 -152.14 5.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.62 -69.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -1.14 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.539 ' HB2' ' CG2' ' A' ' 94' ' ' THR . 7.1 m-70 -80.53 176.28 9.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.182 -0.949 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 11.8 mp0 -106.02 -99.98 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.548 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.714 HG23 ' CG2' ' A' ' 122' ' ' THR . 40.1 t -126.41 151.5 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.704 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 130' ' ' ALA . 6.4 mtmt -104.43 99.3 9.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.02 -42.8 2.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.328 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 9.4 tt0 -54.81 -49.01 72.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.043 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -58.92 -46.37 88.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 109.45 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.92 HG22 ' CE2' ' A' ' 120' ' ' TYR . 38.5 t -62.23 -20.74 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.15 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.0 tttm -81.14 -68.57 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.6 -40.57 0.41 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 110.189 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.45 -51.61 66.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.179 -0.951 . . . . 0.0 109.105 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -54.92 -52.57 62.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 109.981 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -50.27 -46.45 55.08 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -34.99 75.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.29 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.53 -34.46 89.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -71.83 -45.45 61.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -1.192 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -37.1 80.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 108.857 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.626 HD21 ' HB3' ' A' ' 37' ' ' ALA . 1.3 mm? -69.24 -37.92 78.24 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.492 HD13 HD22 ' A' ' 114' ' ' LEU . 13.6 tp -62.08 -34.62 76.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -33.91 61.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.649 -0.657 . . . . 0.0 109.728 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -65.49 -50.06 66.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.844 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 34.4 t -74.74 -27.88 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.793 . . . . 0.0 109.772 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 13' ' ' ILE . 10.7 tt0 -65.61 -44.42 86.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 34.5 m -86.79 -21.32 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 109.939 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.661 ' HB2' HG11 ' A' ' 33' ' ' VAL . 5.3 t80 -58.81 -44.42 90.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 ' CD2' ' A' ' 150' ' ' TYR . 52.6 mt -63.08 -24.41 67.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.96 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.6 mp -82.36 -36.86 26.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 110.361 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.46 -53.86 10.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.0 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.456 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 44.6 m-70 -75.39 -32.35 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.993 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.5 t 46.48 23.68 0.24 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 154' ' ' HIS . 4.7 m-20 -141.51 9.18 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.463 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -113.18 128.81 56.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CE2' HD11 ' A' ' 29' ' ' LEU . 28.2 m-85 61.93 41.72 11.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.477 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.216 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 121' ' ' HIS . 54.8 t -82.63 152.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 83.2 m-85 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -108.18 116.04 31.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.995 -1.065 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.72 ' CD2' HG11 ' A' ' 133' ' ' VAL . 21.3 m-85 -114.98 86.34 2.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 0.0 110.729 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.9 mt-10 -51.25 147.15 5.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 108.917 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.5 ' HB ' ' OD1' ' A' ' 118' ' ' ASN . 12.3 t -141.06 173.52 11.4 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.51 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.603 ' OE1' HG22 ' A' ' 113' ' ' ILE . 0.2 OUTLIER 178.31 126.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.452 0.644 . . . . 0.0 110.07 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.983 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -129.95 158.23 40.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 140.21 49.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.832 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 18' ' ' LEU . 92.7 p -132.48 148.33 52.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.622 -0.674 . . . . 0.0 109.786 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -23.05 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 110.297 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.556 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 14.8 mm -81.85 143.1 49.52 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.576 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -57.17 150.51 56.95 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.04 1.547 . . . . 0.0 110.946 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.74 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -51.84 -49.07 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 110.699 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -54.42 -55.09 32.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.971 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.56 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 9.6 mmt85 -54.9 -55.75 27.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.111 -0.993 . . . . 0.0 110.657 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 11' ' ' SER . 9.9 mt -58.87 -24.49 62.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.908 -1.12 . . . . 0.0 109.483 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.762 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -67.64 -56.02 11.02 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.58 -0.7 . . . . 0.0 109.789 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.5 mtpt -68.9 -25.09 64.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.618 -0.676 . . . . 0.0 112.128 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.784 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -103.89 -55.85 2.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.658 -1.276 . . . . 0.0 111.625 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.4 t80 -84.1 -1.41 54.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 112.203 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 104' ' ' ILE . 12.8 mt -134.4 -22.95 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.555 -1.34 . . . . 0.0 111.38 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.762 HD21 ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -105.87 -22.78 12.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 108.87 178.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -131.98 70.04 1.47 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.699 -0.626 . . . . 0.0 109.899 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -97.44 -43.31 2.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.608 ' HB3' HG11 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -69.9 -9.99 56.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -1.111 . . . . 0.0 110.337 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 11.7 t30 -130.56 52.02 2.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.78 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.964 HD22 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER 173.49 -26.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.675 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.783 ' N ' HD13 ' A' ' 29' ' ' LEU . 3.8 m-30 -56.78 -58.74 15.42 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.253 -0.904 . . . . 0.0 110.601 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.4 Cg_endo -64.67 -29.95 60.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.829 1.436 . . . . 0.0 111.205 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -16.18 63.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.092 -1.005 . . . . 0.0 110.552 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.839 HG23 ' HB1' ' A' ' 146' ' ' ALA . 9.0 m -123.63 -10.75 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.943 . . . . 0.0 110.271 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -138.11 66.66 46.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.803 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.67 -9.71 26.96 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.871 1.458 . . . . 0.0 109.821 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -88.98 -10.87 46.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -118.03 -57.42 2.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 109.946 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG12 HD21 ' A' ' 143' ' ' LEU . 13.5 mm -95.14 170.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 0.0 110.45 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.63 -41.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.2 t -169.13 171.93 7.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.608 HG11 ' HB3' ' A' ' 27' ' ' ASP . 60.1 t -136.8 149.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 55' ' ' LYS . 3.9 tt0 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.463 -0.773 . . . . 0.0 109.498 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.1 m . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.24 0.543 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.46 HD11 ' HD3' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -112.41 156.13 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -139.85 153.3 47.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.866 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' CG ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.81 87.97 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 110.6 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.824 ' HB ' HG13 ' A' ' 67' ' ' VAL . 1.9 mp -69.68 146.92 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.005 -1.06 . . . . 0.0 109.873 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.45 155.52 46.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.607 -0.683 . . . . 0.0 109.885 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 62' ' ' LEU . 30.1 m-85 -119.02 161.46 36.36 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.067 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' GLU . 47.5 Cg_endo -74.9 -164.73 0.24 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.059 1.557 . . . . 0.0 110.08 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER 40.0 -166.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.483 -0.761 . . . . 0.0 111.183 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.542 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -109.48 62.26 0.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 58' ' ' PHE . 13.3 mt -40.84 167.01 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.953 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 42.2 Cg_endo -68.97 -6.68 18.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.88 1.463 . . . . 0.0 110.277 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 18.7 m-30 -114.0 -100.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 166.09 -28.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 108.992 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 30.2 p90 -177.01 -164.55 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.824 HG13 ' HB ' ' A' ' 56' ' ' ILE . 3.6 p -166.25 128.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 0.0 110.547 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -103.03 147.35 27.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.412 ' OD1' HD13 ' A' ' 56' ' ' ILE . 6.9 p-10 -145.01 146.01 31.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HD3' HD11 ' A' ' 53' ' ' ILE . 12.0 ttp180 -117.32 134.4 54.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.3 131.1 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 110.271 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -103.31 52.03 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 16.2 mm-40 59.22 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.297 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 81' ' ' TYR . 35.1 t -105.4 147.84 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.638 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.7 OUTLIER -63.25 -51.64 65.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 73.25 -75.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.546 -0.721 . . . . 0.0 110.887 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -60.53 -11.7 7.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.839 -1.163 . . . . 0.0 110.638 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -122.3 5.06 9.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 0.0 110.474 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.475 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.2 m-30 54.92 65.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.317 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.504 ' HB2' ' CB ' ' A' ' 75' ' ' ASP . 5.1 mttp -142.66 108.82 5.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.658 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.619 ' O ' HD12 ' A' ' 102' ' ' ILE . 7.4 t80 -95.25 123.57 38.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 110.838 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -119.94 123.37 43.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.486 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 84' ' ' SER . 2.7 p90 -148.89 174.06 12.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 110.698 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.41 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 10.5 p -140.2 167.66 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.741 ' C ' HG23 ' A' ' 86' ' ' ILE . 23.5 t -92.64 -54.2 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.741 HG23 ' C ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER 69.67 -18.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 2.1 tt0 170.68 162.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.543 -1.348 . . . . 0.0 110.403 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 81.76 -173.08 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.79 -147.96 47.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 49.4 Cg_endo -81.39 32.67 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.99 1.521 . . . . 0.0 110.94 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.466 ' HA ' HD13 ' A' ' 91' ' ' ILE 0.297 1.5 mm -67.55 138.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 142.89 -165.94 26.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 44.6 -141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.889 HG21 ' HB2' ' A' ' 126' ' ' HIS . 1.8 p -89.06 72.15 8.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.967 HD22 HD11 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -168.36 82.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.333 -0.854 . . . . 0.0 110.044 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.501 ' OE2' ' CE ' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -63.62 -59.0 5.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.434 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.532 ' HG3' ' HB2' ' A' ' 121' ' ' HIS . 1.6 pttm -135.97 162.26 33.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.969 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.967 HD11 HD22 ' A' ' 95' ' ' LEU . 95.7 mt -139.15 122.23 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 111.289 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.6 151.96 20.59 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.517 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 53.6 t30 -154.75 147.48 24.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.873 -1.142 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.754 ' HB2' HG21 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -141.25 152.63 44.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.689 -0.632 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.826 HD12 ' N ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -152.62 144.6 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.294 0.569 . . . . 0.0 110.044 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.664 ' HG3' HG23 ' A' ' 105' ' ' VAL . 4.1 ptmm? -116.13 134.6 54.76 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.901 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.74 HG22 ' CB ' ' A' ' 15' ' ' ALA . 10.9 mm -92.18 90.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.673 -0.642 . . . . 0.0 109.86 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.664 HG23 ' HG3' ' A' ' 103' ' ' LYS . 17.2 t -87.02 133.97 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.349 -0.844 . . . . 0.0 110.372 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.93 133.1 35.99 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.632 -0.668 . . . . 0.0 109.668 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.1 p -87.65 155.93 53.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.297 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.27 -11.55 32.62 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -175.43 86.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 170.48 -88.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.03 -135.18 1.77 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.54 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 5.0 p -124.93 170.42 11.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -1.156 . . . . 0.0 109.889 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.603 HG22 ' OE1' ' A' ' 8' ' ' GLU . 36.5 mt -139.22 123.55 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 111.203 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.983 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.6 mp -93.43 93.83 8.36 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.646 ' HE2' HG21 ' A' ' 105' ' ' VAL . 5.6 pttt -131.45 138.24 48.96 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.821 -1.152 . . . . 0.0 113.589 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.868 HG22 ' N ' ' A' ' 117' ' ' SER . 1.2 mm -178.71 -95.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.868 ' N ' HG22 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -175.07 177.4 1.94 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.835 -1.166 . . . . 0.0 112.686 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.1 m120 -142.44 106.56 4.74 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -92.5 122.88 35.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 111.06 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.744 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.5 m-85 -96.81 109.33 22.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.404 -0.81 . . . . 0.0 109.646 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.532 ' HB2' ' HG3' ' A' ' 97' ' ' LYS . 76.6 m-70 -89.06 104.02 16.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 95' ' ' LEU . 3.0 p -116.43 -158.04 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.491 -0.755 . . . . 0.0 109.881 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.501 ' CE ' ' OE2' ' A' ' 96' ' ' GLU . 3.5 pttp -177.12 143.77 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 129.15 -98.0 0.43 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.19 -48.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.889 ' HB2' HG21 ' A' ' 94' ' ' THR . 80.1 m-70 -56.83 144.5 32.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' VAL . 52.3 mt-10 -89.86 148.86 22.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 110.403 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.565 HG23 ' CD1' ' A' ' 3' ' ' PHE . 13.3 t -41.34 164.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.499 -0.751 . . . . 0.0 110.174 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 133' ' ' VAL . 5.0 mtmt -111.49 131.53 55.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.38 -44.88 84.84 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.033 -1.042 . . . . 0.0 109.413 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -31.51 16.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 25.9 mt-30 -79.23 -40.67 30.09 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.233 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.72 HG11 ' CD2' ' A' ' 5' ' ' TYR . 2.6 t -78.84 -0.3 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.655 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.27 -42.52 4.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.8 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -57.79 -44.91 86.58 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.72 86.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.344 -0.848 . . . . 0.0 109.533 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -64.34 -21.85 66.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 108.984 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 5.7 tm-20 -77.61 -44.92 26.74 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.657 -0.652 . . . . 0.0 109.299 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.484 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 40.2 mmm -64.5 -34.53 78.44 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.13 -42.74 75.21 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.78 -27.52 64.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.092 -1.24 . . . . 0.0 109.877 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -75.76 -35.33 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 108.965 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.663 HD21 HG12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -77.18 -28.15 53.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.136 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 9' ' ' THR . 11.4 tp -70.89 -42.51 69.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 3.1 ttt85 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.839 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -60.06 -58.27 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.053 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.837 HG22 HD11 ' A' ' 29' ' ' LEU . 87.2 t -62.53 -25.09 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.619 -0.676 . . . . 0.0 109.67 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 2.9 mt-10 -65.31 -50.55 65.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -15.74 53.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.636 ' CG ' HG11 ' A' ' 33' ' ' VAL . 10.9 t80 -67.44 -37.42 82.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 109.811 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 65.5 mt -67.87 -18.43 64.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.976 -1.078 . . . . 0.0 109.321 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 mp -89.79 -40.71 12.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.657 -0.652 . . . . 0.0 110.955 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.96 -47.86 14.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 111.03 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.522 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 62.1 m-70 -79.94 81.44 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.274 -0.891 . . . . 0.0 110.936 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 154' ' ' HIS . 58.4 m 38.23 -94.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 111.033 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.511 ' HB3' ' ND2' ' A' ' 159' ' ' ASN . 24.9 m-20 -155.12 51.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.682 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.54 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -49.29 145.12 4.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.961 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.784 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 70.2 m-85 57.03 69.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.257 -0.902 . . . . 0.0 110.273 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 156' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.219 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 120' ' ' TYR . 61.7 t -47.15 156.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.649 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 64.8 m-85 -117.97 96.56 5.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.868 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.5 121.68 19.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.054 -1.029 . . . . 0.0 111.469 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.685 ' CD2' HG11 ' A' ' 133' ' ' VAL . 22.0 m-85 -117.01 112.06 20.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.36 132.84 52.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 111.489 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -157.69 173.32 17.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.3 pp20? -145.68 149.94 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.806 -1.184 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.957 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -124.56 172.86 8.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.88 142.22 51.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.992 -1.068 . . . . 0.0 111.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB3' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -131.81 147.6 52.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.665 -0.647 . . . . 0.0 109.622 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -18.18 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.331 -0.856 . . . . 0.0 109.921 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.498 ' O ' HD12 ' A' ' 18' ' ' LEU . 5.7 mm -83.33 140.86 42.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.479 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 35.6 Cg_endo -59.03 152.61 57.49 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.848 1.446 . . . . 0.0 111.17 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -53.06 -47.92 68.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 111.24 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.55 -59.04 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.564 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.569 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 2.6 mmt180 -47.18 -57.81 4.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 109.904 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -51.4 -37.19 47.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 109.625 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 1.15 ' CE1' HD21 ' A' ' 24' ' ' LEU . 3.8 t80 -62.13 -69.14 0.27 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.851 -1.156 . . . . 0.0 109.848 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 7.1 mtmt -50.99 -24.82 3.99 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 112.1 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.675 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -113.66 -63.53 1.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.584 -1.322 . . . . 0.0 111.459 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.685 ' HD1' HG21 ' A' ' 147' ' ' VAL . 24.7 t80 -60.55 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.742 -1.224 . . . . 0.0 110.207 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.945 HG22 HD23 ' A' ' 24' ' ' LEU . 31.2 mm -48.24 -81.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.763 -1.211 . . . . 0.0 108.129 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.15 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.5 mt -57.76 160.4 4.53 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.244 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER 44.85 54.57 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.107 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -99.74 -35.11 4.72 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HB3' HG11 ' A' ' 41' ' ' VAL . 83.0 m-20 -81.66 15.4 2.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -1.139 . . . . 0.0 110.635 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 8.2 t30 -135.0 42.96 2.74 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.832 HD21 HG13 ' A' ' 147' ' ' VAL . 1.0 OUTLIER 175.26 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.7 m-30 -42.25 -55.55 6.43 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.763 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.7 Cg_endo -65.82 -49.28 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.708 1.373 . . . . 0.0 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -45.47 -52.56 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 111.159 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HB1' ' A' ' 146' ' ' ALA . 9.3 m -86.21 -16.76 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.93 . . . . 0.0 110.847 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -135.69 71.96 63.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.74 -19.51 41.25 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.887 1.467 . . . . 0.0 109.464 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -83.98 -9.74 58.44 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.602 -0.686 . . . . 0.0 109.149 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -105.84 -57.22 2.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 31' ' ' PRO . 2.0 mp -117.62 165.93 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 110.152 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.447 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 4.4 m -130.26 -46.98 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 169.11 24.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.888 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 27' ' ' ASP . 72.0 t -137.34 119.62 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.199 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 7.5 mt-10 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 110.139 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.208 0.528 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 1.1 mt -115.08 118.85 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.859 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 8.8 mttp -143.11 154.08 43.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 42' ' ' GLU . 76.0 mttt -120.36 140.6 51.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.592 -0.693 . . . . 0.0 110.161 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 55' ' ' LYS . 1.4 mp -113.2 123.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -104.69 115.91 31.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.463 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 1.013 ' CD2' HD13 ' A' ' 62' ' ' LEU . 13.1 m-85 -75.22 167.38 37.31 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.183 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 60' ' ' GLU . 49.6 Cg_endo -81.91 66.21 8.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.011 1.532 . . . . 0.0 109.854 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' PRO . 3.8 tt0 44.37 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.473 -0.767 . . . . 0.0 111.103 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.3 -51.98 1.85 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.013 HD13 ' CD2' ' A' ' 58' ' ' PHE . 4.0 mt -60.25 163.55 8.15 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.273 -1.133 . . . . 0.0 110.395 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.4 -25.0 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.934 1.492 . . . . 0.0 109.237 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.2 m-85 -103.44 -148.15 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.336 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.3 tttt -137.93 -10.36 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.971 -1.081 . . . . 0.0 111.402 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 47.5 p90 -176.83 -157.93 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.656 -1.277 . . . . 0.0 111.011 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 67' ' ' VAL . 8.3 p -169.44 113.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 7.1 tttt -87.75 153.1 21.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.982 -1.074 . . . . 0.0 109.809 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.53 ' N ' ' HG2' ' A' ' 68' ' ' LYS . 4.9 p-10 -136.88 148.89 47.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.04 -1.037 . . . . 0.0 110.626 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -128.01 104.27 7.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 52.6 t -73.51 148.88 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.122 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.2 -14.0 8.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.382 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.82 170.8 3.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 74' ' ' VAL . 7.4 p -170.67 108.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 6.0 t0 -74.81 -156.19 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.928 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -159.76 -57.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 0.0 110.796 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.9 m -50.57 -42.05 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.39 3.51 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.571 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 18.8 m-85 57.03 91.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.142 -0.974 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -139.66 106.19 5.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 0.0 110.289 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.664 ' HD1' HG23 ' A' ' 74' ' ' VAL . 1.1 t80 -101.07 152.6 20.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.08 -1.013 . . . . 0.0 109.68 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.74 132.75 13.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.115 -0.99 . . . . 0.0 110.722 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.3 169.26 24.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 109.719 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.458 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -134.57 157.9 45.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 110.281 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.611 HG12 HD11 ' A' ' 91' ' ' ILE . 3.5 t -104.83 136.34 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 109.039 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.488 ' CG2' ' C ' ' A' ' 85' ' ' VAL . 6.0 pt -148.61 14.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.794 -1.191 . . . . 0.0 111.432 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -169.42 89.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.82 -1.175 . . . . 0.0 110.921 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 126.05 -148.79 17.18 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 88' ' ' GLY . . . 29.85 -118.56 0.08 OUTLIER Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.628 ' HG2' HD12 ' A' ' 98' ' ' ILE . 39.3 Cg_endo -69.46 -73.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.975 1.513 . . . . 0.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.611 HD11 HG12 ' A' ' 85' ' ' VAL . 1.5 mm 9.6 59.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.687 0.756 . . . . 0.0 112.863 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' PRO . . . -158.09 152.02 23.18 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' THR . 7.4 t70 63.59 -162.29 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.243 . . . . 0.0 109.954 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.634 HG21 ' CB ' ' A' ' 126' ' ' HIS . 44.1 p -43.01 -44.07 4.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.144 -0.973 . . . . 0.0 110.108 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.797 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -52.49 119.63 4.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.79 -55.4 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.163 -0.96 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.511 ' C ' ' CG1' ' A' ' 98' ' ' ILE . 5.2 mmtt -113.44 157.12 22.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.195 -0.941 . . . . 0.0 109.829 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.628 HD12 ' HG2' ' A' ' 90' ' ' PRO . 8.5 mt -154.11 122.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.147 -0.971 . . . . 0.0 110.406 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 1.4 t -107.31 123.6 48.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 109.856 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.71 108.38 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 111.28 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.54 ' O ' ' CG1' ' A' ' 102' ' ' ILE . 43.2 mt-10 -99.05 165.15 11.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.815 . . . . 0.0 109.37 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 101' ' ' GLU . 12.4 mt -157.17 137.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -138.61 109.52 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 110.173 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.857 HD11 HG13 ' A' ' 23' ' ' ILE . 50.8 mt -75.43 151.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 112' ' ' SER . 3.6 t -131.2 131.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.068 -1.02 . . . . 0.0 110.766 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.69 136.86 36.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.611 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.5 p -121.11 144.66 40.02 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.917 . . . . 0.0 110.581 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.32 -7.96 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.137 1.599 . . . . 0.0 110.739 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 10.5 p30 -166.89 85.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.13 -23.11 0.23 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.26 -139.61 15.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 79.9 p -115.0 172.06 7.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.262 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 4.9 mt -140.47 122.76 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.807 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.957 ' HB2' HG22 ' A' ' 9' ' ' THR . 3.7 mm? -84.85 102.16 12.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.616 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 103' ' ' LYS . 7.0 mmmt -79.11 91.55 4.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.4 mm -79.08 138.32 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.344 -0.847 . . . . 0.0 111.078 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -139.35 139.5 37.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 5' ' ' TYR . 3.8 p-10 -164.58 109.33 0.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.69 -1.256 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.55 ' HD3' ' NE2' ' A' ' 121' ' ' HIS . 12.9 ptpt -98.22 132.08 44.02 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.288 -0.882 . . . . 0.0 109.207 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.903 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.2 m-85 -90.54 141.72 28.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.55 ' NE2' ' HD3' ' A' ' 119' ' ' LYS . 28.3 m-70 -117.38 92.57 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.659 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 p -102.01 -170.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -140.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.961 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.77 33.79 5.96 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 126' ' ' HIS . 1.1 t0 -160.71 163.01 32.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 110.081 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.634 ' CB ' HG21 ' A' ' 94' ' ' THR . 0.2 OUTLIER 53.2 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.109 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' VAL . 3.1 pt-20 -77.6 147.42 35.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.118 -0.989 . . . . 0.0 110.247 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.644 HG23 ' CD1' ' A' ' 3' ' ' PHE . 92.5 t -42.31 155.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 110.248 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.449 ' HB3' ' HE3' ' A' ' 129' ' ' LYS . 8.5 mtpp -101.16 106.79 18.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.87 -40.34 9.82 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.005 -1.06 . . . . 0.0 109.899 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.46 -45.42 80.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.413 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -63.76 -43.9 95.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.685 HG11 ' CD2' ' A' ' 5' ' ' TYR . 5.8 t -67.91 -16.33 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -86.17 -41.44 14.69 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 110.356 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -52.63 -47.97 66.69 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.983 . . . . 0.0 109.55 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 139' ' ' MET . 0.2 OUTLIER -60.71 -49.16 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.724 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -61.86 -20.56 63.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 11.9 tm-20 -76.27 -56.95 4.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.6 -0.687 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.519 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 2.3 ppp? -59.29 -28.66 66.97 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 108.504 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 139' ' ' MET . . . -69.53 -45.28 60.38 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.79 -32.19 73.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.263 . . . . 0.0 109.774 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 2.1 p -69.99 -38.0 75.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.173 -0.955 . . . . 0.0 108.862 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -71.84 -31.57 66.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.708 ' CD2' HG21 ' A' ' 9' ' ' THR . 11.0 tp -67.18 -41.06 86.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -35.03 73.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.536 -0.728 . . . . 0.0 109.289 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -62.22 -50.64 70.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.485 -0.759 . . . . 0.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.832 HG13 HD21 ' A' ' 29' ' ' LEU . 12.8 t -70.74 -30.44 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.84 -55.26 36.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.461 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -74.68 -23.8 58.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.575 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.763 ' CD1' ' CE1' ' A' ' 154' ' ' HIS . 45.0 t80 -58.89 -62.2 2.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.799 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.466 HD23 ' CD2' ' A' ' 150' ' ' TYR . 34.3 mt -44.42 -26.61 0.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.079 . . . . 0.0 110.414 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 149' ' ' SER . 9.1 mp -79.22 -52.61 7.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 110.95 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 154' ' ' HIS . . . -63.31 -27.86 69.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.763 ' CE1' ' CD1' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -122.88 104.16 9.09 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.825 -0.547 . . . . 0.0 109.926 -178.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 58.1 m -88.91 16.33 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 110.156 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -108.72 -22.18 12.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.468 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.48 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -84.6 130.26 34.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.462 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.675 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 37.1 m-85 59.93 48.64 8.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.637 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.226 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.496 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.911 HG13 ' O ' ' A' ' 120' ' ' TYR . 95.6 t -54.6 151.99 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CE1' HG23 ' A' ' 128' ' ' VAL . 80.3 m-85 -114.15 149.14 36.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 110.066 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.98 84.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.016 ' CD1' HG11 ' A' ' 133' ' ' VAL . 45.5 m-85 -88.43 78.62 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.02 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 7' ' ' THR . 98.7 mt-10 -90.02 165.93 13.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.353 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 12.3 t -179.8 172.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.835 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.478 ' OE1' ' HD2' ' A' ' 115' ' ' LYS . 23.5 tt0 -155.89 147.08 22.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.13 -0.981 . . . . 0.0 110.336 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.903 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.92 172.31 11.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.887 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.79 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.965 -1.084 . . . . 0.0 110.132 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.54 ' OG ' ' CD1' ' A' ' 18' ' ' LEU . 63.9 p -129.1 150.83 50.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.26 -22.88 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 109.774 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.57 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 19.3 mm -80.25 142.87 55.37 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 35.5 Cg_endo -58.02 148.58 76.18 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.749 1.394 . . . . 0.0 110.732 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.687 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -55.07 -36.69 65.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.03 70.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -62.88 -50.84 69.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 110.61 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 14.4 mt -57.23 -39.22 75.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.946 -1.096 . . . . 0.0 109.766 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.93 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -61.36 -63.99 1.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.098 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.27 -30.29 50.11 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.552 -0.718 . . . . 0.0 112.223 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -105.69 -64.61 1.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.758 -1.214 . . . . 0.0 111.44 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.844 ' HE2' HD21 ' A' ' 114' ' ' LEU . 63.3 t80 -70.29 5.47 1.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 112.449 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.518 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 28.7 mm -142.81 -26.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.307 -1.495 . . . . 0.0 111.882 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.93 HD21 ' CE1' ' A' ' 19' ' ' PHE . 4.2 mt -102.31 -34.44 9.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.62 -1.3 . . . . 0.0 109.833 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 5.9 t0 -119.64 31.96 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -71.31 -25.14 76.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.93 ' O ' HG11 ' A' ' 41' ' ' VAL . 20.6 m-20 -76.6 3.52 11.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 5.5 t30 -140.16 52.73 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.648 HD11 ' CD2' ' A' ' 150' ' ' TYR . 1.5 tp 170.62 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.516 -0.74 . . . . 0.0 109.26 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.4 m-30 -42.97 -59.82 2.79 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.874 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.1 Cg_endo -66.22 -29.45 47.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.915 1.482 . . . . 0.0 111.189 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -36.3 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.9 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.802 HG23 ' HB1' ' A' ' 146' ' ' ALA . 15.9 m -104.12 -9.21 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.062 -1.024 . . . . 0.0 110.409 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.41 63.89 56.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.965 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.53 -7.82 20.39 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.97 1.51 . . . . 0.0 110.139 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -92.11 -18.33 23.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.424 -0.798 . . . . 0.0 109.167 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.1 -58.41 2.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.654 HG12 HD21 ' A' ' 143' ' ' LEU . 10.0 mm -95.68 179.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.384 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.628 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -159.47 -49.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.959 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.27 142.61 30.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.93 HG11 ' O ' ' A' ' 27' ' ' ASP . 7.6 p -120.99 121.55 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 110.419 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 tt0 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 109.929 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.214 0.53 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.597 HD11 ' HD2' ' A' ' 70' ' ' ARG . 3.6 mp -102.56 143.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.616 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 2.4 mttt -130.76 150.13 52.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -117.9 97.97 6.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.412 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.501 HG22 ' CE1' ' A' ' 58' ' ' PHE . 1.5 mp -78.58 131.81 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -115.28 141.14 48.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.762 ' HD2' HD21 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -107.69 135.19 19.8 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 110.538 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 38' ' ' ILE . 50.9 Cg_endo -84.34 47.93 2.33 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.952 1.501 . . . . 0.0 109.965 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.71 -171.48 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 0.0 110.627 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.36 35.44 4.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.762 HD21 ' HD2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -54.19 -176.49 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -1.052 . . . . 0.0 110.324 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.686 ' HD2' ' HB2' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -82.46 -20.95 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.04 1.021 . . . . 0.0 110.462 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 2.4 m-85 -97.08 -154.92 0.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -131.27 -33.95 1.45 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.448 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 36.6 p90 -169.04 -153.53 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 67' ' ' VAL . 8.9 p -168.37 111.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 111.149 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.7 ttpp -99.7 149.15 23.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.19 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 29.8 p30 -154.26 148.18 25.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.984 -1.072 . . . . 0.0 110.964 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.597 ' HD2' HD11 ' A' ' 53' ' ' ILE . 4.6 ttp180 -103.6 154.27 19.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 109.584 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 15.6 t -99.39 -44.53 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.113 -0.992 . . . . 0.0 110.359 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER 76.94 -38.13 0.3 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.848 -0.532 . . . . 0.0 111.721 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 1.2 pt-20 178.28 155.95 0.4 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.686 -1.259 . . . . 0.0 110.505 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.451 HG13 ' HD1' ' A' ' 81' ' ' TYR . 94.3 t -146.05 153.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.818 . . . . 0.0 109.901 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.65 164.46 15.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.723 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.502 ' NE2' HD11 ' A' ' 24' ' ' LEU . 3.8 m80 -134.4 -40.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.51 -0.744 . . . . 0.0 109.856 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -55.42 -38.55 69.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.253 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -108.25 12.8 26.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.511 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.538 ' O ' HD12 ' A' ' 104' ' ' ILE . 3.8 m-85 52.11 60.59 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 81' ' ' TYR . 1.4 tppt? -123.35 155.51 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.39 -0.819 . . . . 0.0 110.586 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.5 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 64.6 t80 -144.06 162.2 36.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.58 -0.7 . . . . 0.0 109.162 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 71' ' ' VAL . 28.0 t30 -167.52 128.63 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.913 -1.117 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 32.7 p90 -143.23 142.44 31.4 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.383 -0.823 . . . . 0.0 109.941 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.45 126.25 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.775 . . . . 0.0 110.173 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.05 128.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.781 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -124.7 10.64 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.962 . . . . 0.0 109.865 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 2.2 mm-40 -176.65 170.72 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.507 ' O ' HG13 ' A' ' 91' ' ' ILE . . . 73.12 173.33 25.03 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.82 -144.19 27.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.4 Cg_endo -84.8 34.27 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.067 1.561 . . . . 0.0 110.735 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -50.25 172.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.985 . . . . 0.0 110.437 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 45.7 63.48 2.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 7.5 t0 -177.83 82.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -1.164 . . . . 0.0 110.422 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' ASP . 18.8 p 43.65 29.0 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.278 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.904 HD11 ' CD2' ' A' ' 120' ' ' TYR . 1.9 tp -150.61 95.77 2.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.171 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.5 -49.83 44.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.643 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -152.62 165.54 34.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.321 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.734 HD11 HD11 ' A' ' 95' ' ' LEU . 24.2 mm -140.76 116.78 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.833 . . . . 0.0 110.442 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -96.33 143.2 27.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 108.946 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 36.0 t-20 -143.04 149.53 38.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.259 -1.376 . . . . 0.0 112.126 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 25.3 mt-10 -129.03 152.47 48.6 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 12.1 mt -142.0 124.03 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 0.0 110.635 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -115.41 130.96 57.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 0.0 109.738 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 19' ' ' PHE . 1.3 mp -99.43 118.95 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.036 -1.04 . . . . 0.0 109.782 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 112' ' ' SER . 6.6 t -107.34 129.56 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.24 140.92 29.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.757 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -104.47 148.96 36.85 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 110.397 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.0 -8.62 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.09 1.574 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -165.01 83.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.43 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.14 -85.83 0.1 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.91 -113.29 0.3 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.546 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 4.5 p -138.9 176.82 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -1.192 . . . . 0.0 109.972 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.411 HG21 ' OE2' ' A' ' 8' ' ' GLU . 15.9 mt -139.28 123.35 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.271 -0.893 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.903 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.19 90.72 8.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HD2' ' OE1' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -85.22 99.51 11.15 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 114' ' ' LEU . 1.2 mp -99.84 155.02 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.061 -1.024 . . . . 0.0 111.679 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 m -140.14 107.71 5.6 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 100' ' ' ASN . 3.3 t-20 -105.85 105.77 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 112.034 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.486 ' HG3' ' CG1' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -88.47 107.64 18.97 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.911 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.7 m-85 -82.52 142.94 31.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.924 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 97' ' ' LYS . 83.6 m-70 -126.31 100.37 6.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.766 -0.584 . . . . 0.0 109.566 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.518 HG21 ' CG2' ' A' ' 128' ' ' VAL . 4.9 p -110.53 -166.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 110.35 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.69 67.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 -149.67 5.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -68.98 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.448 -1.031 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -75.67 -174.49 2.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 12.2 mp0 -115.46 -171.7 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 110.284 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.643 HG23 ' CE1' ' A' ' 3' ' ' PHE . 88.6 t -54.13 152.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.448 ' NZ ' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -98.85 108.21 20.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -41.91 -59.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 110.422 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 2.5 tt0 -43.17 -45.25 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.782 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -45.23 94.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.016 HG11 ' CD1' ' A' ' 5' ' ' TYR . 76.4 t -58.04 -24.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -76.82 -51.42 11.36 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.751 -0.593 . . . . 0.0 110.108 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -43.8 -43.82 6.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.872 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.1 t -60.45 -54.82 40.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.569 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -53.45 -27.87 27.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.745 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.405 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.72 -46.87 43.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.527 -0.733 . . . . 0.0 110.392 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.455 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 4.6 mtp -63.19 -30.46 71.6 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.846 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.6 -45.43 53.34 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -72.32 -30.07 64.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.359 . . . . 0.0 110.614 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 1.2 p -72.99 -40.35 65.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.794 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.654 HD21 HG12 ' A' ' 38' ' ' ILE . 1.1 mm? -80.03 -25.84 40.02 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.354 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 16.4 tp -70.75 -39.95 72.98 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -44.36 59.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.802 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -55.52 -55.51 31.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.565 HG13 HD21 ' A' ' 29' ' ' LEU . 69.3 t -66.02 -32.31 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 13' ' ' ILE . 1.2 tm-20 -58.48 -52.13 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.3 p -75.99 -26.67 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.677 ' HB2' HG11 ' A' ' 33' ' ' VAL . 8.5 t80 -57.71 -45.75 85.33 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.724 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.7 mt -58.05 -24.81 59.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 6.0 mp -93.01 -19.68 21.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 110.516 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.5 -34.03 23.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 155' ' ' SER . 10.0 m-70 -91.86 166.2 12.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 110.6 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.48 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 22.9 m -43.48 -56.81 3.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 110.608 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 155' ' ' SER . 2.4 m-20 -177.94 65.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -67.76 133.58 49.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.354 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.863 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 56.5 m-85 60.59 19.9 9.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 110.587 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.065 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.56 ' CG2' ' HG3' ' A' ' 119' ' ' LYS . 11.7 p -55.36 154.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.16 . . . . 0.0 110.456 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.67 ' CD1' HG23 ' A' ' 128' ' ' VAL . 53.9 m-85 -115.88 158.75 22.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -117.37 118.69 32.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.03 ' CD1' HG11 ' A' ' 133' ' ' VAL . 37.2 m-85 -122.63 89.51 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -99.82 155.13 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.448 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 11.8 t -171.24 170.21 6.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.171 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HG3' ' C ' ' A' ' 7' ' ' THR . 27.6 mt-10 -148.04 118.97 7.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.972 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -100.58 -177.73 3.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 109.815 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.498 HG22 ' CD1' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -124.0 137.93 54.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.0 110.424 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.897 ' OG ' HD11 ' A' ' 18' ' ' LEU . 36.4 t -125.01 139.44 53.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.5 -2.66 4.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.457 -0.777 . . . . 0.0 110.161 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.687 HG23 ' HD2' ' A' ' 14' ' ' PRO . 7.9 mm -96.11 149.31 35.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.253 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.687 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.8 Cg_endo -56.68 155.66 25.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.019 1.536 . . . . 0.0 110.518 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.723 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -64.17 -71.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 111.268 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -39.3 -51.43 2.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.686 . . . . 0.0 110.951 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.572 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 6.7 ttm180 -57.33 -54.97 40.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.812 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.897 HD11 ' OG ' ' A' ' 11' ' ' SER . 8.7 mt -50.43 -29.2 9.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.184 -1.006 . . . . 0.0 108.822 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 1.121 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -69.76 -67.35 0.49 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.545 -0.722 . . . . 0.0 110.678 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 25.5 mtpt -57.34 -21.36 34.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.377 -0.827 . . . . 0.0 112.717 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.803 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.58 -58.98 2.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.46 -1.4 . . . . 0.0 112.512 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HA ' HG11 ' A' ' 147' ' ' VAL . 34.1 t80 -73.24 -11.51 60.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.893 -1.129 . . . . 0.0 112.353 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.922 HG22 HD23 ' A' ' 24' ' ' LEU . 23.0 mt -121.77 -80.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.674 -1.267 . . . . 0.0 110.393 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.121 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.3 mt -45.44 -56.72 4.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.865 -1.147 . . . . 0.0 110.032 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -100.21 66.54 1.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -101.96 -30.95 5.56 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.595 ' HB3' HG11 ' A' ' 41' ' ' VAL . 99.4 m-20 -81.39 13.49 2.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 110.456 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.5 t30 -138.68 45.06 2.05 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.898 HD21 HG13 ' A' ' 147' ' ' VAL . 1.2 tp 173.55 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 109.441 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CD1' HD12 ' A' ' 143' ' ' LEU . 2.9 m-30 -48.41 -61.01 3.57 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.367 -0.833 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.3 Cg_endo -65.95 -22.96 54.94 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.8 1.421 . . . . 0.0 111.464 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -71.73 -50.91 25.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.818 HG23 ' HB1' ' A' ' 146' ' ' ALA . 19.5 m -89.54 -8.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 110.243 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -134.96 62.43 52.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.505 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.98 -15.7 43.95 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 109.358 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -83.88 -16.74 43.24 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.543 0.687 . . . . 0.0 109.192 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.51 -64.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 110.595 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.87 HG12 HD21 ' A' ' 143' ' ' LEU . 10.5 mm -93.73 169.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.437 ' N ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -136.16 -36.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 109.986 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.39 160.77 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 27' ' ' ASP . 3.7 p -140.57 154.25 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.028 -1.045 . . . . 0.0 110.647 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.459 -0.776 . . . . 0.0 109.603 179.59 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 53' ' ' ILE . 1.2 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.138 0.494 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 53' ' ' ILE . 1.0 OUTLIER 30.55 31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.587 0.708 . . . . 0.0 112.477 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' A' ' 52' ' ' THR . 14.5 mttt -75.53 152.41 37.8 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -124.7 91.5 3.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.892 -1.13 . . . . 0.0 111.053 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.508 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.2 mp -77.51 158.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.586 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.459 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -144.63 171.3 14.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 1.01 ' HB3' HD12 ' A' ' 62' ' ' LEU . 15.9 m-85 -134.72 157.09 77.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 47.3 Cg_endo -77.19 177.62 8.65 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.907 1.477 . . . . 0.0 109.835 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.07 175.43 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.0 110.142 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.34 -47.37 3.29 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.01 HD12 ' HB3' ' A' ' 58' ' ' PHE . 13.5 mt -78.38 139.52 59.81 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.71 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.75 -7.09 19.01 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.009 1.531 . . . . 0.0 110.217 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.472 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 3.6 m-30 -97.32 135.07 39.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 110.155 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -87.94 -42.63 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 0.0 110.365 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.87 ' O ' HG13 ' A' ' 67' ' ' VAL . 30.3 p90 -167.55 -173.76 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.003 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -166.07 124.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -0.786 . . . . 0.0 110.693 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -81.12 92.85 6.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.464 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 22.3 t70 -84.35 96.19 8.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.507 ' HG3' ' HA ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.67 83.64 7.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.872 . . . . 0.0 110.043 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.685 HG12 ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -45.44 -60.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 109.54 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.685 ' N ' HG12 ' A' ' 71' ' ' VAL . 0.1 OUTLIER 73.07 -28.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -167.5 171.84 10.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.211 -1.555 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.2 p -165.56 146.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.671 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.02 -171.53 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 0.0 110.146 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 -56.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 110.376 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 m -59.46 -20.14 52.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.835 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -118.27 8.38 12.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 110.564 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.619 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.6 m-30 54.49 54.21 9.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.994 . . . . 0.0 109.863 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.64 147.3 47.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.556 ' CD1' ' CG2' ' A' ' 23' ' ' ILE . 14.4 t80 -133.2 105.0 6.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -1.0 . . . . 0.0 110.693 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -101.59 115.55 30.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 7.4 p90 -138.91 155.3 48.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.101 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -109.29 136.36 48.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 110.856 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.459 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 73.0 t -111.53 121.12 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.462 HD11 ' CD ' ' A' ' 70' ' ' ARG . 8.4 pt -147.16 164.43 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.962 -1.086 . . . . 0.0 111.281 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 64.76 133.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 110.847 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 66' ' ' TYR . . . 56.29 178.08 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.611 ' HA3' HG12 ' A' ' 67' ' ' VAL . . . 80.89 -133.25 11.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' A' ' 98' ' ' ILE . 48.7 Cg_endo -78.91 1.6 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.054 1.555 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.65 HD11 ' O ' ' A' ' 96' ' ' GLU 0.293 1.3 mm -61.27 140.92 18.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.223 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 159.15 -92.97 0.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -117.68 145.0 44.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -1.15 . . . . 0.0 110.315 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.871 HG22 ' O ' ' A' ' 125' ' ' ASP . 6.5 p 50.79 50.39 19.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.968 HD21 ' CD2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER 167.14 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.341 -0.85 . . . . 0.0 110.379 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.65 ' O ' HD11 ' A' ' 91' ' ' ILE . 8.2 tt0 -96.13 -39.59 9.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.27 136.81 50.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.584 HG23 ' CD1' ' A' ' 120' ' ' TYR . 29.8 mt -131.94 113.06 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.861 . . . . 0.0 110.361 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 135.85 33.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 0.0 109.205 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.519 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 4.9 m120 -132.14 139.23 48.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.786 -1.196 . . . . 0.0 110.88 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 81' ' ' TYR . 2.0 mt-10 -137.05 130.93 32.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.105 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 83' ' ' TYR . 7.4 mt -118.93 127.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 tmtt? -115.14 118.13 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.746 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.723 HG22 ' HB1' ' A' ' 15' ' ' ALA . 38.7 mm -79.36 115.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 110.283 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.407 ' CG2' ' HG3' ' A' ' 115' ' ' LYS . 63.0 t -108.93 123.72 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 110.117 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.69 135.99 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.235 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.6 p -106.76 150.19 39.38 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 48.4 Cg_endo -66.84 81.13 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.181 1.622 . . . . 0.0 110.698 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 18.9 t0 -179.93 -62.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 0.0 110.284 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.19 38.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.33 28.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.551 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -127.95 130.38 48.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -1.217 . . . . 0.0 110.464 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.961 HG23 ' O ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -85.47 143.99 10.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 109.548 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.972 ' HB2' HG22 ' A' ' 9' ' ' THR . 3.8 mm? -97.66 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -85.43 99.77 11.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.094 -1.004 . . . . 0.0 109.425 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.418 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 7.6 mt -98.37 131.19 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.839 -1.163 . . . . 0.0 111.678 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 m -123.56 129.89 51.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 9.9 m-20 -131.25 105.85 7.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.993 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -90.79 107.92 19.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.968 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.8 m-85 -88.19 95.02 10.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 111.864 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.594 ' CE1' ' HG2' ' A' ' 119' ' ' LYS . 72.4 m-70 -79.95 95.95 6.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 108.882 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.61 HG21 ' CG2' ' A' ' 128' ' ' VAL . 5.6 p -102.67 -56.22 2.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.17 -0.956 . . . . 0.0 111.017 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 122' ' ' THR . 18.1 pttm 35.29 72.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.624 -0.673 . . . . 0.0 111.246 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.65 -72.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.871 ' O ' HG22 ' A' ' 94' ' ' THR . 14.8 t70 -153.99 150.62 28.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 51.83 -167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.08 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -121.49 170.09 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.883 . . . . 0.0 110.486 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.67 HG23 ' CD1' ' A' ' 3' ' ' PHE . 64.8 t -61.95 135.31 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.224 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.3 mtmt -82.33 115.57 21.44 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -45.34 -42.01 9.51 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 10.2 tm-20 -54.79 -47.28 74.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.553 HE21 HD13 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -59.41 -39.39 83.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.278 -0.889 . . . . 0.0 108.921 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.03 HG11 ' CD1' ' A' ' 5' ' ' TYR . 84.2 t -66.7 -23.46 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 135' ' ' ALA . 14.5 tttt -79.06 -63.04 1.51 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.684 -0.635 . . . . 0.0 110.499 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.22 -46.06 1.03 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -0.817 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m -60.61 -47.84 84.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.43 ' HE2' HG21 ' A' ' 7' ' ' THR . 36.0 mttt -59.96 -28.55 67.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.43 -39.76 64.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.464 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.0 OUTLIER -65.3 -37.3 86.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 108.783 178.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.47 -42.64 93.6 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -32.19 72.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.214 -1.168 . . . . 0.0 110.182 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.492 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 1.7 p -70.6 -39.18 73.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.324 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.87 HD21 HG12 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -75.14 -28.13 60.04 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.6 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 23.9 tp -71.18 -39.94 71.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 0.0 108.594 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.558 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 1.3 ptm85 -73.76 -32.68 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 109.472 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -65.83 -58.12 6.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.1 -1.0 . . . . 0.0 109.059 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.898 HG13 HD21 ' A' ' 29' ' ' LEU . 47.7 t -64.95 -28.12 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.554 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' HA ' HG13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -63.64 -49.45 73.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.814 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.413 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 1.3 t -78.69 -20.89 49.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 110.044 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.774 ' HB2' HG11 ' A' ' 33' ' ' VAL . 12.0 t80 -62.55 -41.07 98.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 65.9 mt -67.45 -22.29 65.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 109.917 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 mp -82.72 -38.35 23.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.04 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.413 ' HB3' ' HD2' ' A' ' 154' ' ' HIS . . . -71.0 -46.18 62.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 154' ' ' HIS . 19.0 m-70 -81.63 -39.03 25.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.887 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.9 m 58.06 19.54 6.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 2.6 p30 -138.51 -33.45 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 156' ' ' ASP . . . -60.36 131.92 52.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.803 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.5 m-85 55.69 49.3 16.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 110.868 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.22 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' A' ' 119' ' ' LYS . 8.1 p -132.46 165.41 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.189 . . . . 0.0 110.259 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.649 ' CD1' HG23 ' A' ' 128' ' ' VAL . 45.6 m-85 -129.02 148.57 50.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.11 86.8 2.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 0.0 111.004 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.183 ' CD1' HG11 ' A' ' 133' ' ' VAL . 18.3 m-85 -84.82 73.45 10.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.464 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.24 118.17 21.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.917 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -132.13 -168.9 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.88 163.44 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 0.0 110.177 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.785 HG22 ' CB ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -141.51 173.39 11.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.4 141.58 50.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.957 . . . . 0.0 110.662 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 t -136.71 147.1 46.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 109.929 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.76 -20.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 18' ' ' LEU . 5.4 mm -79.03 140.91 57.93 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 110.705 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -57.53 151.91 51.09 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.659 1.573 . . . . 0.0 111.173 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.678 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -56.67 -48.59 77.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 111.455 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -52.31 -61.78 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.037 -1.039 . . . . 0.0 111.045 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.6 ttp180 -54.07 -57.73 10.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.022 . . . . 0.0 109.944 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.08 -29.25 3.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.948 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.09 -63.12 1.12 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 109.326 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.68 -46.05 19.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 110.481 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.888 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -83.94 -70.82 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.725 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 22.0 t80 -76.0 142.61 41.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 108.941 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 14.7 mt 81.29 -46.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 CA-C-O 120.914 0.387 . . . . 0.0 110.922 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.948 HD21 ' CE1' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -86.71 -77.15 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.957 -1.089 . . . . 0.0 109.484 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 29' ' ' LEU . 9.5 t70 -57.5 -96.35 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.05 -1.031 . . . . 0.0 109.193 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.594 ' HA2' ' CE1' ' A' ' 30' ' ' PHE . . . 79.11 -74.0 2.26 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.837 -1.164 . . . . 0.0 110.936 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.54 -4.47 6.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.977 -1.308 . . . . 0.0 111.106 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 12.3 t30 -135.96 51.71 2.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.645 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.88 ' C ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER 171.15 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.89 . . . . 0.0 109.554 -179.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.648 ' N ' HD13 ' A' ' 29' ' ' LEU . 5.3 m-30 -65.14 -58.09 13.5 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.95 . . . . 0.0 110.229 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.574 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 44.0 Cg_endo -65.1 -35.3 42.89 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.808 1.425 . . . . 0.0 110.604 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.55 -37.87 76.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.844 HG23 ' HB1' ' A' ' 146' ' ' ALA . 6.0 m -106.71 2.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -152.83 66.15 6.04 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 59' ' ' PRO . 42.0 Cg_endo -67.91 -24.22 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.903 1.475 . . . . 0.0 109.439 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -81.21 -9.46 59.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.412 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -104.0 -57.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -124.79 168.05 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.168 -0.957 . . . . 0.0 110.984 -179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.503 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 1.4 t -131.48 -37.45 1.21 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.653 -0.654 . . . . 0.0 109.398 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 39' ' ' SER . 7.5 t -177.42 142.79 0.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 0.0 109.862 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.731 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.5 p -132.95 116.04 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.028 -1.045 . . . . 0.0 110.753 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.6 tt0 . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.834 . . . . 0.0 110.504 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 64.5 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.4 mm -53.59 119.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 111.123 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 52' ' ' THR . 21.6 mtmt -144.39 144.27 31.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.567 -0.708 . . . . 0.0 109.327 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 4.2 ttpp -115.01 116.97 29.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.915 . . . . 0.0 110.255 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.022 ' HB ' HG23 ' A' ' 67' ' ' VAL . 2.0 mp -90.52 115.94 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 110.03 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 t -113.84 126.89 55.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 110.561 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.754 ' CB ' HD12 ' A' ' 62' ' ' LEU . 42.5 m-85 -94.5 143.1 25.71 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.5 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 49.1 Cg_endo -88.53 37.88 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.81 1.426 . . . . 0.0 110.638 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -150.41 -177.29 5.87 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.578 0.704 . . . . 0.0 110.084 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.608 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -70.07 -59.01 5.72 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.754 HD12 ' CB ' ' A' ' 58' ' ' PHE . 10.7 mt 53.42 168.25 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.366 -1.079 . . . . 0.0 110.115 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -72.61 -21.68 21.82 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.789 1.415 . . . . 0.0 109.897 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.505 ' CE2' ' HD3' ' A' ' 90' ' ' PRO . 11.0 m-85 -129.53 160.9 31.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.503 -0.748 . . . . 0.0 109.66 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -20.06 30.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.318 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.746 ' O ' HG13 ' A' ' 67' ' ' VAL . 27.6 p90 -173.8 -171.7 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.022 HG23 ' HB ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -161.08 108.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.765 . . . . 0.0 110.602 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -76.81 155.22 33.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.303 -0.873 . . . . 0.0 109.012 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -151.74 131.11 12.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.671 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 84' ' ' SER . 0.7 OUTLIER -104.43 87.76 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.025 HG13 ' HB3' ' A' ' 83' ' ' TYR . 45.1 t -82.05 -104.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' N ' HG12 ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.22 162.96 0.24 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.552 -0.717 . . . . 0.0 110.811 -178.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER 73.75 136.56 0.05 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 74' ' ' VAL . 6.3 p -173.2 103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 3.6 t0 -80.31 161.67 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.13 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.34 -48.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.234 -0.916 . . . . 0.0 110.564 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 m -59.35 -24.13 63.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.753 -1.217 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -118.38 14.96 13.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.962 . . . . 0.0 110.348 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.576 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 8.2 m-30 44.25 63.38 1.66 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.278 -0.888 . . . . 0.0 110.585 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 13.3 tttt -122.05 141.82 50.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.698 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CD2' HG23 ' A' ' 74' ' ' VAL . 22.5 t80 -148.59 98.36 2.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.087 -1.008 . . . . 0.0 110.82 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.521 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -111.76 143.14 43.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.603 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 1.025 ' HB3' HG13 ' A' ' 71' ' ' VAL . 15.8 p90 -134.75 163.53 29.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -104.54 112.08 25.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.535 -0.728 . . . . 0.0 111.143 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.4 t -94.64 104.11 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.538 HG13 ' N ' ' A' ' 87' ' ' GLU . 49.0 pt -93.81 -34.58 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.538 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.8 mt-10 -146.81 169.41 19.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.003 -1.06 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.591 ' CA ' ' HA ' ' A' ' 67' ' ' VAL . . . 112.41 115.9 3.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.504 ' HA2' ' CD2' ' A' ' 64' ' ' PHE . . . 124.48 -143.93 15.0 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.513 ' O ' ' C ' ' A' ' 91' ' ' ILE . 53.1 Cg_endo -83.51 26.87 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.092 1.575 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -27.69 145.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.436 0.636 . . . . 0.0 111.358 -179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.36 -100.45 0.16 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.42 ' O ' ' OG1' ' A' ' 94' ' ' THR . 29.5 m-20 -125.86 -176.28 3.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -1.098 . . . . 0.0 110.395 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 122' ' ' THR . 46.1 p 46.23 22.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.891 HD23 HD11 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -172.16 96.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.419 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -114.02 -21.46 10.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.0 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.782 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -142.18 147.96 37.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 110.083 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.891 HD11 HD23 ' A' ' 95' ' ' LEU . 35.5 mm -145.43 131.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.0 m -116.34 131.37 56.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 109.144 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 1.3 m-20 -126.3 147.63 49.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.043 -1.035 . . . . 0.0 111.267 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 3.8 tt0 -138.02 132.33 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.693 -0.629 . . . . 0.0 109.573 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 103' ' ' LYS . 77.2 mt -118.66 165.7 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 0.9 OUTLIER -157.69 111.86 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 110.551 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.708 HD12 ' H ' ' A' ' 104' ' ' ILE . 2.8 mp -87.93 112.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 0.0 109.944 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.419 HG21 ' NZ ' ' A' ' 115' ' ' LYS . 90.4 t -103.58 139.09 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.078 -1.014 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.72 132.01 41.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.0 109.961 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.4 p -105.57 154.22 39.31 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.428 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 48.3 Cg_endo -66.59 -33.2 36.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.016 1.535 . . . . 0.0 110.509 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 108' ' ' PRO . 5.3 m-20 -151.75 67.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.75 35.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.12 -140.3 46.68 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.549 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 80.0 p -128.06 155.18 44.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -1.14 . . . . 0.0 110.052 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.4 mt -112.53 126.83 69.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 110.43 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.785 ' CB ' HG22 ' A' ' 9' ' ' THR . 1.2 tp -88.53 89.2 7.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.795 -0.566 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' NZ ' HG21 ' A' ' 105' ' ' VAL . 9.1 mttt -73.77 128.77 36.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.404 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 114' ' ' LEU . 2.7 mt -128.23 150.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 111.18 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 t -138.89 120.36 14.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.176 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.506 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 2.5 m-20 -112.79 94.7 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 0.0 111.53 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HG3' ' CG2' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -82.42 106.18 14.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.001 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.716 ' CD2' HD21 ' A' ' 95' ' ' LEU . 1.5 m-85 -85.15 111.14 19.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.962 -1.086 . . . . 0.0 111.461 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.1 m-70 -90.25 102.05 14.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.335 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.565 HG21 HG23 ' A' ' 128' ' ' VAL . 7.5 p -103.23 162.33 13.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -145.97 37.65 1.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.46 -147.44 7.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.88 -65.05 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -56.1 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.348 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 17.3 pt-20 -111.23 -169.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.652 HG11 ' CE2' ' A' ' 5' ' ' TYR . 24.9 t -68.64 163.72 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.1 101.49 10.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 110.004 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.2 -32.25 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 4.3 tt0 -59.96 -50.48 73.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.633 ' OE1' HD13 ' A' ' 95' ' ' LEU . 48.4 tt0 -61.04 -40.79 94.94 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.183 HG11 ' CD1' ' A' ' 5' ' ' TYR . 61.4 t -62.4 -23.66 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 1.8 tptt -78.72 -59.23 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.837 -0.539 . . . . 0.0 110.898 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.37 -45.93 1.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.394 -0.816 . . . . 0.0 110.842 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -59.99 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.095 -1.003 . . . . 0.0 109.652 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 133' ' ' VAL . 16.9 mtmt -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.838 . . . . 0.0 110.318 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.36 -54.3 15.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -0.915 . . . . 0.0 110.135 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.467 ' SD ' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -57.32 -37.77 73.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.061 -1.024 . . . . 0.0 109.287 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.31 -39.8 97.32 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -72.16 -38.72 69.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.999 -1.295 . . . . 0.0 111.003 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.234 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 147' ' ' VAL . 1.3 mm? -77.41 -31.15 53.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.112 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.749 HD22 HG21 ' A' ' 9' ' ' THR . 20.4 tp -68.64 -32.54 72.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 108.696 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -77.62 -41.21 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.527 -0.733 . . . . 0.0 109.517 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.844 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -61.09 -43.88 98.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.506 -0.746 . . . . 0.0 110.012 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 143' ' ' LEU . 21.2 t -75.33 -43.16 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.954 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.502 ' HG2' HG12 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -53.86 -41.89 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -0.825 . . . . 0.0 110.221 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.6 p -85.19 -29.68 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 0.0 110.173 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.676 ' CD1' ' CD2' ' A' ' 154' ' ' HIS . 4.5 t80 -58.17 -35.99 72.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.024 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 11.5 mt -71.11 -22.1 62.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 0.0 110.025 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -91.62 -23.65 19.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.861 . . . . 0.0 110.303 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.93 -49.12 7.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.629 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.676 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 30.1 m-70 -63.25 -97.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.085 -1.01 . . . . 0.0 110.528 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.404 ' OG ' ' C ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -160.51 -70.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 110.385 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.521 ' HB2' ' ND2' ' A' ' 159' ' ' ASN . 3.4 p-10 -142.41 31.49 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.223 -0.923 . . . . 0.0 110.556 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.542 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -52.53 131.08 33.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 0.0 109.767 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.888 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 51.3 m-85 59.25 66.32 1.05 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 156' ' ' ASP . 1.1 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.204 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 3' ' ' PHE . 45.4 t -79.75 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.343 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.599 ' N ' HG12 ' A' ' 2' ' ' VAL . 90.8 m-85 -137.74 144.46 41.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.28 110.0 20.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.421 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.602 ' CD2' HG11 ' A' ' 133' ' ' VAL . 19.2 m-30 -112.3 88.23 2.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.739 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.01 128.3 38.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -147.16 -172.28 3.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 110.765 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -165.68 173.87 10.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.85 . . . . 0.0 110.782 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.582 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 13.1 t -151.58 168.46 24.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -128.45 139.82 52.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.794 -1.191 . . . . 0.0 111.08 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.516 ' OG ' HD11 ' A' ' 18' ' ' LEU . 43.3 t -134.99 153.89 51.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 110.257 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.85 -22.12 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.213 -0.929 . . . . 0.0 110.04 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 18' ' ' LEU . 4.3 mm -75.84 140.98 71.24 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.636 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 33.1 Cg_endo -57.73 154.53 36.88 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.024 1.539 . . . . 0.0 111.196 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -54.65 -64.46 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 111.172 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -40.87 -62.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 0.0 111.113 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.511 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -50.36 -58.56 5.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.083 -1.011 . . . . 0.0 110.761 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -49.39 -31.3 9.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 110.924 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.769 ' CE2' HD21 ' A' ' 24' ' ' LEU . 24.9 t80 -74.21 -55.86 5.57 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.415 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 4.3 mtmm -52.09 -42.98 63.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.07 -1.019 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -83.78 -71.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 108.398 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.692 ' HD1' HG21 ' A' ' 147' ' ' VAL . 27.2 t80 -79.49 147.24 32.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.315 -0.865 . . . . 0.0 108.696 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.056 ' CD1' HD11 ' A' ' 104' ' ' ILE . 38.0 mt 81.93 -44.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.769 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.2 mt -97.97 -56.44 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.982 . . . . 0.0 109.933 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -102.91 80.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.199 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.76 -23.02 10.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.526 ' HA ' HG21 ' A' ' 41' ' ' VAL . 7.8 p-10 -78.24 -22.12 48.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.464 ' OD1' ' OD2' ' A' ' 27' ' ' ASP . 30.5 m-20 -105.75 4.68 30.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -128.27 -42.23 1.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.605 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 8.1 m-30 -54.35 -58.24 14.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.774 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 52.5 Cg_endo -68.45 -5.54 15.38 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.249 1.131 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -106.14 -14.01 15.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 111.308 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.946 HG23 ' HB1' ' A' ' 146' ' ' ALA . 15.8 m -134.41 6.27 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.008 -1.058 . . . . 0.0 110.051 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.11 62.63 2.45 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.26 -20.67 55.55 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.893 1.47 . . . . 0.0 109.623 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -75.43 -19.14 59.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.697 ' HB1' ' SD ' ' A' ' 139' ' ' MET . . . -101.67 -52.45 3.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.547 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 39' ' ' SER . 1.4 mp -109.74 166.0 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.968 . . . . 0.0 110.675 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.472 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -124.51 -46.16 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 109.891 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -165.45 159.06 16.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' A' ' 27' ' ' ASP . 73.1 t -111.41 160.87 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.922 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 10.0 mt-10 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.964 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.0 m . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.244 0.545 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 53' ' ' ILE . 28.2 mm -79.65 125.94 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 111.125 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -133.06 148.8 52.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.46 -0.775 . . . . 0.0 109.288 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 4.7 tttp -124.58 117.1 23.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.902 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.4 mp -94.92 130.62 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.723 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -117.61 124.25 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.1 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CB ' ' CD1' ' A' ' 62' ' ' LEU . 12.7 m-85 -91.11 166.75 17.72 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.15 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -72.83 178.1 6.82 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.854 1.45 . . . . 0.0 110.177 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.77 173.58 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.497 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.23 52.61 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.593 ' CD1' ' CB ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -76.72 152.68 83.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.213 -1.169 . . . . 0.0 110.366 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.07 -22.58 19.24 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.136 1.598 . . . . 0.0 109.889 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 18.6 m-85 -123.28 -159.81 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.47 -0.769 . . . . 0.0 109.655 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -122.26 -26.85 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 110.423 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 16.0 p90 -176.98 -175.73 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.314 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 66' ' ' TYR . 7.5 m -153.81 122.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.732 ' HB3' HD11 ' A' ' 86' ' ' ILE . 18.9 mtmt -93.82 133.61 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -114.93 144.69 43.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.848 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.52 ' NH2' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -113.52 103.9 11.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 110.03 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 74' ' ' VAL . 4.5 t -83.01 125.9 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 110.19 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 70' ' ' ARG . 1.2 m-20 -97.34 52.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.85 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.5 OUTLIER 63.54 77.68 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.081 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 71' ' ' VAL . 5.1 m -56.71 -177.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.375 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 1.8 t0 -123.06 -168.01 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.837 . . . . 0.0 109.748 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.477 ' CE1' HD11 ' A' ' 24' ' ' LEU . 5.0 m80 -144.83 -53.95 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.2 m -51.95 -57.35 9.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.54 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 19.2 m-80 -91.16 17.69 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.542 ' CD2' ' HB1' ' A' ' 15' ' ' ALA . 16.2 m-85 42.47 48.72 4.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 109.997 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.0 tppt? -93.44 123.79 36.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 110.805 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -120.53 112.55 19.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 31.4 t-20 -127.3 108.34 10.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.8 p90 -136.81 165.51 25.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 109.982 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -117.16 141.11 48.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.536 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.2 t -86.39 78.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.734 . . . . 0.0 109.266 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.732 HD11 ' HB3' ' A' ' 68' ' ' LYS . 43.1 pt -59.61 -131.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.503 -0.748 . . . . 0.0 110.751 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.524 ' N ' HG13 ' A' ' 86' ' ' ILE . 28.3 mm-40 -67.64 160.95 26.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 102.8 152.29 23.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.04 -147.0 18.49 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.8 Cg_endo -84.23 29.08 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.984 1.518 . . . . 0.0 110.84 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -41.24 163.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.119 -0.988 . . . . 0.0 109.95 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.4 -170.55 14.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.42 ' CG ' HG23 ' A' ' 94' ' ' THR . 36.7 p-10 -55.12 173.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -1.075 . . . . 0.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 5.4 p 54.23 15.13 0.86 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.719 ' HG ' HG22 ' A' ' 122' ' ' THR . 1.2 mt 167.56 92.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.022 -1.049 . . . . 0.0 110.089 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 2.6 tp10 -91.08 -34.14 15.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 110.332 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 96' ' ' GLU . 13.2 mttp -149.69 153.25 36.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.423 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.552 HD11 HD22 ' A' ' 95' ' ' LEU . 75.5 mt -137.47 150.71 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.85 . . . . 0.0 109.731 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m -134.35 143.91 47.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' TYR . 37.8 t-20 -136.47 133.17 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 0.0 110.244 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.744 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 3.1 pt-20 -151.69 149.72 29.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.128 -0.982 . . . . 0.0 109.794 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.903 HG23 ' N ' ' A' ' 103' ' ' LYS . 8.0 tp 168.46 -138.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.619 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.903 ' N ' HG23 ' A' ' 102' ' ' ILE . 20.5 ptmt -179.82 -171.07 0.17 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.907 -1.121 . . . . 0.0 111.506 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.056 HD11 ' CD1' ' A' ' 23' ' ' ILE . 66.1 mt -120.0 163.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.231 -0.918 . . . . 0.0 109.685 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.53 HG23 ' HD2' ' A' ' 115' ' ' LYS . 3.9 t -132.0 124.4 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.911 -1.118 . . . . 0.0 110.425 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.19 131.9 35.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.6 p -108.92 155.55 40.6 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.668 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 109' ' ' ASP . 47.1 Cg_endo -66.28 82.2 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.251 1.658 . . . . 0.0 110.817 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 1.4 m-20 70.71 25.97 3.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.524 -0.735 . . . . 0.0 110.346 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.73 -2.68 18.96 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.89 -170.74 22.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 14' ' ' PRO . 12.6 m -120.94 130.09 53.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.299 -1.118 . . . . 0.0 109.918 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 10' ' ' THR . 7.3 mt -99.86 121.48 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 109.854 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.842 HD12 HG23 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -86.89 108.48 18.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.651 -0.655 . . . . 0.0 109.672 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.598 ' O ' ' CG1' ' A' ' 102' ' ' ILE . 1.3 ptmt -102.44 133.87 46.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.565 -1.335 . . . . 0.0 108.533 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.847 ' HA ' HG21 ' A' ' 102' ' ' ILE . 6.7 mt -135.8 139.42 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.642 ' HB2' HD13 ' A' ' 102' ' ' ILE . 8.7 t -112.6 107.79 16.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 6.9 m-80 -107.04 108.3 19.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.836 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.541 ' HD2' ' CG1' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.99 132.51 46.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.826 179.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.684 ' HD2' HD11 ' A' ' 95' ' ' LEU . 3.6 m-85 -101.73 129.37 47.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.4 m-70 -110.41 101.68 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.771 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.719 HG22 ' HG ' ' A' ' 95' ' ' LEU . 16.2 p -101.82 -165.19 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.366 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -160.39 126.08 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 128.63 -129.4 6.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -124.11 -53.7 1.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.146 -1.208 . . . . 0.0 110.129 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 125' ' ' ASP . 90.4 m-70 -44.22 168.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 109.929 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.93 163.31 21.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 0.0 110.596 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.608 HG23 HG21 ' A' ' 122' ' ' THR . 24.4 t -53.41 157.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -102.5 108.29 19.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.04 -47.32 8.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -0.981 . . . . 0.0 109.953 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.79 -46.62 59.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -35.55 80.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.863 . . . . 0.0 109.648 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.602 HG11 ' CD2' ' A' ' 5' ' ' TYR . 21.8 t -76.99 -12.22 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.459 -0.775 . . . . 0.0 109.775 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -46.74 7.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.447 -0.783 . . . . 0.0 110.808 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -54.38 -49.47 69.79 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.066 -1.021 . . . . 0.0 109.572 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -57.99 -43.94 86.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.925 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -66.1 -23.66 66.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.166 -0.959 . . . . 0.0 109.361 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 3.1 tt0 -73.07 -43.71 61.51 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.697 ' SD ' ' HB1' ' A' ' 37' ' ' ALA . 5.3 mmm -64.27 -35.94 82.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.41 -44.2 97.97 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.27 -45.97 75.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.053 -1.263 . . . . 0.0 110.262 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -37.65 68.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 108.897 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.7 mm? -68.17 -52.98 28.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.434 -0.791 . . . . 0.0 109.578 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 9' ' ' THR . 9.4 tp -47.6 -36.8 11.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.877 -1.14 . . . . 0.0 108.519 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 15.2 mtt180 -71.76 -38.77 70.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 0.0 109.367 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.946 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -58.51 -57.93 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.521 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.692 HG21 ' HD1' ' A' ' 22' ' ' PHE . 17.7 t -66.92 -27.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.473 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.558 ' O ' HD22 ' A' ' 152' ' ' LEU . 16.3 tp10 -59.43 -54.98 40.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 109.976 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.5 p -75.71 -27.24 58.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.045 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.789 ' CG ' HD11 ' A' ' 29' ' ' LEU . 7.1 t80 -53.8 -45.92 70.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.553 HD12 HG13 ' A' ' 13' ' ' ILE . 79.7 mt -61.1 -29.93 70.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.763 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.558 HD22 ' O ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -89.0 -18.78 26.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 110.703 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.58 -52.75 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 155' ' ' SER . 9.2 m-70 -63.97 -111.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 156' ' ' ASP . 92.0 p -178.11 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.851 -1.155 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 155' ' ' SER . 0.0 OUTLIER 71.94 20.65 4.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 111.457 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -52.45 137.28 30.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.619 -1.301 . . . . 0.0 109.462 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.837 ' OH ' HD23 ' A' ' 29' ' ' LEU . 72.2 m-85 58.72 81.8 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.222 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.501 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 10.9 p -117.71 167.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.631 ' CD1' HG23 ' A' ' 128' ' ' VAL . 29.0 m-85 -132.44 108.64 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.414 -0.803 . . . . 0.0 110.098 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -62.84 142.69 58.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.522 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.891 ' CD1' HG11 ' A' ' 133' ' ' VAL . 23.9 m-85 -150.05 69.05 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.0 109.657 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 72.3 mt-10 -94.72 141.89 28.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.594 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.416 ' C ' ' OE1' ' A' ' 8' ' ' GLU . 15.1 t -159.9 -178.22 6.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.45 -0.781 . . . . 0.0 109.59 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 7' ' ' THR . 1.8 pm0 -155.42 154.75 32.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.057 -1.027 . . . . 0.0 110.425 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.906 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.34 158.58 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.664 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.49 HG22 HG12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -120.41 139.69 52.45 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.05 -1.032 . . . . 0.0 110.48 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.588 ' OG ' HD11 ' A' ' 18' ' ' LEU . 30.1 t -135.05 141.22 46.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.549 -0.719 . . . . 0.0 109.872 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.12 -15.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.635 HG23 ' HD2' ' A' ' 14' ' ' PRO . 15.0 mm -75.72 147.14 80.97 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 110.018 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.0 Cg_endo -56.38 155.23 26.05 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.902 1.475 . . . . 0.0 110.683 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -63.47 -69.29 0.28 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 111.311 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -39.26 -46.43 1.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.29 -0.881 . . . . 0.0 111.538 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.561 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 41.7 mtt180 -64.95 -50.5 66.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.115 . . . . 0.0 110.052 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 9.8 mt -56.1 -25.89 47.6 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.939 0.876 . . . . 0.0 109.547 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.769 ' CE2' HD21 ' A' ' 24' ' ' LEU . 21.4 t80 -79.46 -48.62 13.62 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.2 -0.937 . . . . 0.0 110.902 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -67.46 -27.47 67.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.501 -0.749 . . . . 0.0 112.117 -178.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.872 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.11 -29.84 8.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.553 -1.342 . . . . 0.0 112.165 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 88.2 t80 -109.14 5.0 23.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.785 -1.197 . . . . 0.0 111.582 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.648 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 41.2 mt -141.77 -19.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.942 -1.099 . . . . 0.0 111.23 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.802 HD22 HG21 ' A' ' 74' ' ' VAL . 1.8 mt -110.68 -37.09 5.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.966 -1.084 . . . . 0.0 109.904 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.6 42.43 2.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -40.4 71.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.865 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.2 p30 -70.45 -0.8 9.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -1.127 . . . . 0.0 110.929 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 13.9 t30 -138.93 47.98 1.91 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.017 HD11 HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER 177.37 -30.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.511 -0.743 . . . . 0.0 109.077 -178.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.716 ' N ' HD13 ' A' ' 29' ' ' LEU . 5.9 m-30 -56.24 -59.14 12.78 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.581 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -67.58 -11.28 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.741 1.39 . . . . 0.0 110.635 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -16.33 38.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.605 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.747 HG23 ' HB1' ' A' ' 146' ' ' ALA . 25.7 m -127.19 -3.09 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.328 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -148.77 65.19 8.18 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.055 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.85 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.054 1.555 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -90.13 -14.47 33.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.559 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.29 -29.79 6.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.018 -1.051 . . . . 0.0 110.576 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.505 HG12 HD21 ' A' ' 143' ' ' LEU . 6.5 mm -120.82 161.11 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.49 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.3 OUTLIER -127.6 -49.29 1.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 109.254 179.057 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 39' ' ' SER . 12.5 t 174.19 138.54 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.566 -0.709 . . . . 0.0 110.276 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.865 HG11 ' HB2' ' A' ' 27' ' ' ASP . 8.6 p -109.13 162.54 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 108.979 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 9.8 tt0 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 120.795 -1.191 . . . . 0.0 111.377 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.295 0.569 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.649 HD13 ' CG ' ' A' ' 70' ' ' ARG . 18.3 mm -82.73 148.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 14.0 mtmt -148.17 141.26 24.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 110.421 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -114.23 132.22 56.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 110.251 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.8 mp -107.22 112.33 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.351 -0.843 . . . . 0.0 110.097 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 39' ' ' SER . 9.2 t -103.57 136.42 43.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.952 -1.093 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.693 ' CD2' HD12 ' A' ' 62' ' ' LEU . 17.9 m-85 -103.26 166.02 12.54 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.86 . . . . 0.0 109.763 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -73.14 175.14 10.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.873 1.459 . . . . 0.0 110.413 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.18 178.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 110.374 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.72 -38.29 3.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.693 HD12 ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -62.09 133.13 94.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.139 -1.213 . . . . 0.0 110.29 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.3 -13.76 16.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.175 1.618 . . . . 0.0 110.346 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -101.01 -163.88 1.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -117.88 -39.12 3.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.121 -0.987 . . . . 0.0 110.686 -179.543 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 21.2 p90 -177.31 -171.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.705 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 67' ' ' VAL . 12.2 t -147.08 99.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.485 -0.76 . . . . 0.0 111.043 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -89.99 139.77 30.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.016 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -157.42 162.05 38.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.649 ' CG ' HD13 ' A' ' 53' ' ' ILE . 4.3 mtm105 -112.47 155.97 23.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.204 -0.935 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.35 161.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 5.4 m-20 -124.1 54.03 1.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.6 mt-10 65.88 115.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.802 HG21 HD22 ' A' ' 24' ' ' LEU . 4.4 p -90.68 145.6 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -92.47 -151.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.083 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.495 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -168.1 -62.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 m -50.63 -56.11 13.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.825 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 79' ' ' PHE . 2.1 m-80 -95.84 18.37 13.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 0.0 110.672 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 6.2 m-85 42.47 72.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 0.0 109.924 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.1 tttp -123.92 115.41 21.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.023 -1.048 . . . . 0.0 110.707 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.543 ' HD1' HG23 ' A' ' 74' ' ' VAL . 9.9 t80 -113.4 173.21 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 54.5 t-20 -176.35 123.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 36.7 p90 -135.28 157.58 46.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.2 135.37 55.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 73.3 t -108.01 110.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.253 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.81 -14.06 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 68' ' ' LYS . 5.4 mt-10 -139.68 140.92 36.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.179 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.461 ' C ' HG12 ' A' ' 91' ' ' ILE . . . 103.2 177.23 26.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.18 -135.01 20.64 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.533 ' HG3' ' NE2' ' A' ' 132' ' ' GLN . 51.6 Cg_endo -86.48 29.84 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 111.46 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.474 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -37.66 157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.28 -132.38 4.63 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -114.66 55.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 0.0 110.625 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.824 HG22 ' HB2' ' A' ' 126' ' ' HIS . 0.8 OUTLIER -150.57 -70.26 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.677 HD11 ' CD2' ' A' ' 120' ' ' TYR . 2.6 mt -98.7 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 109.873 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -93.19 -39.8 10.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 110.517 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.533 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.9 tttm -134.47 164.56 27.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 0.0 110.868 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 97' ' ' LYS . 13.0 mt -158.82 132.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -116.28 116.34 27.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.898 -1.127 . . . . 0.0 110.523 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 11.1 t-20 -116.35 126.67 53.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 14.5 tm-20 -116.38 149.24 39.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.461 -0.775 . . . . 0.0 109.673 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.55 HG22 ' CD1' ' A' ' 104' ' ' ILE . 72.5 mt -136.29 134.16 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.469 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -131.62 99.85 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.445 -0.785 . . . . 0.0 109.829 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.58 HD12 ' N ' ' A' ' 104' ' ' ILE . 1.7 mp -77.29 113.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.269 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.428 HG21 ' HE2' ' A' ' 115' ' ' LYS . 95.6 t -102.28 122.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.288 -0.882 . . . . 0.0 109.725 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.61 134.49 37.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.601 -0.687 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 110' ' ' GLY . 71.2 p -104.85 156.1 36.52 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.845 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.36 -2.87 8.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -173.07 -25.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 111.269 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.431 ' C ' ' OG1' ' A' ' 107' ' ' THR . . . -83.55 45.54 3.48 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 52.21 -114.91 3.64 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 3.1 m -150.57 158.52 44.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.409 -1.054 . . . . 0.0 109.557 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 10' ' ' THR . 20.7 mt -126.02 122.32 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.873 -1.142 . . . . 0.0 110.832 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.906 ' HB2' HG22 ' A' ' 9' ' ' THR . 7.1 mp -84.63 105.11 15.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.708 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HE2' HG21 ' A' ' 105' ' ' VAL . 1.1 mptp? -84.32 100.65 11.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.778 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.8 mt -92.76 155.03 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.868 . . . . 0.0 110.864 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 36.3 t -151.34 91.21 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.488 -0.758 . . . . 0.0 109.297 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 99' ' ' SER . 36.3 t-20 -101.82 145.83 28.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 111.444 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.456 ' CG ' HG21 ' A' ' 2' ' ' VAL . 2.1 ttmt -131.96 118.94 20.42 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.7 m-85 -86.14 107.92 18.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.934 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -92.22 96.8 10.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.426 HG21 HG23 ' A' ' 128' ' ' VAL . 20.8 p -92.12 -136.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 110.083 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -40.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 160.68 -149.35 18.47 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 126' ' ' HIS . 5.2 t0 47.09 -92.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -1.082 . . . . 0.0 110.135 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.824 ' HB2' HG22 ' A' ' 94' ' ' THR . 35.9 m170 -87.52 172.0 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -124.21 179.54 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG23 ' CD1' ' A' ' 3' ' ' PHE . 99.3 t -78.13 153.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.123 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -106.95 110.22 22.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.316 -0.865 . . . . 0.0 109.816 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.29 -40.62 3.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.0 tt0 -55.27 -49.1 72.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.533 ' NE2' ' HG3' ' A' ' 90' ' ' PRO . 1.1 tt0 -60.32 -39.7 87.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 108.954 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.891 HG11 ' CD1' ' A' ' 5' ' ' TYR . 64.4 t -64.91 -22.82 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.754 0.787 . . . . 0.0 109.162 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -83.64 -67.63 0.78 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.628 -0.67 . . . . 0.0 110.693 -179.239 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -33.5 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.501 -0.749 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -67.1 -55.18 15.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 108.724 178.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 134' ' ' LYS . 8.9 mptt -53.42 -55.42 25.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.815 . . . . 0.0 109.073 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -46.69 -47.07 20.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.585 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.643 ' SD ' HD23 ' A' ' 143' ' ' LEU . 2.6 tpp -56.19 -44.1 79.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.116 -0.99 . . . . 0.0 108.799 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.54 92.83 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.83 -31.41 66.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.066 -1.255 . . . . 0.0 110.804 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.511 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.1 OUTLIER -68.6 -43.9 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.954 -1.091 . . . . 0.0 109.056 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.643 HD23 ' SD ' ' A' ' 139' ' ' MET . 1.5 mm? -70.5 -33.36 71.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.246 -0.909 . . . . 0.0 109.189 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.581 HD12 HG21 ' A' ' 9' ' ' THR . 0.8 OUTLIER -61.62 -41.53 97.6 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.74 -47.05 76.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.606 -0.684 . . . . 0.0 110.063 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.747 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.68 -59.6 4.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 1.017 HG22 HD11 ' A' ' 29' ' ' LEU . 40.7 t -65.63 -19.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.492 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.53 ' HG3' HG12 ' A' ' 13' ' ' ILE . 22.1 tt0 -71.99 -46.21 58.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.1 -1.0 . . . . 0.0 110.072 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.73 -12.3 37.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 110.291 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.649 ' CG ' HG11 ' A' ' 33' ' ' VAL . 8.5 t80 -69.58 -36.4 76.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.075 -1.016 . . . . 0.0 109.637 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 38.7 mt -72.6 -19.94 61.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.173 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 152' ' ' LEU . 10.2 mp -87.46 -33.26 19.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.42 -48.66 13.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.858 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.518 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 54.8 m-70 -76.71 -22.5 53.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.825 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 154' ' ' HIS . 17.0 p 41.93 51.1 4.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.333 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -168.83 -37.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.604 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB2' ' OH ' ' A' ' 150' ' ' TYR . . . -64.15 130.86 45.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.383 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.872 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 58.4 m-85 55.75 62.85 2.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.261 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 120' ' ' TYR . 12.1 p -132.77 157.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -1.143 . . . . 0.0 110.564 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.571 ' CD1' HG23 ' A' ' 128' ' ' VAL . 68.1 m-85 -130.82 156.7 44.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -120.16 91.44 3.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.162 -0.961 . . . . 0.0 110.234 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.072 ' CD2' HG11 ' A' ' 133' ' ' VAL . 31.3 m-85 -87.52 146.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.059 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.86 149.73 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.398 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.451 ' C ' ' CG ' ' A' ' 8' ' ' GLU . 8.6 t -169.13 167.63 10.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 109.903 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' CG ' ' C ' ' A' ' 7' ' ' THR . 32.0 mt-10 -148.8 146.97 28.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.85 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.9 178.24 5.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 109.853 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.46 149.49 51.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.678 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.694 ' HB3' HD11 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -143.73 142.54 30.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.341 -0.849 . . . . 0.0 109.905 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -6.17 7.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.573 -0.705 . . . . 0.0 110.4 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.587 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 15.6 mm -89.5 143.17 30.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.104 -0.998 . . . . 0.0 109.952 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.507 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 33.0 Cg_endo -56.94 154.75 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.739 1.389 . . . . 0.0 110.06 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -62.02 -39.73 93.29 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.099 -1.001 . . . . 0.0 110.812 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 -60.86 3.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.615 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -55.91 -47.44 77.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 11' ' ' SER . 9.4 mt -53.32 -37.89 62.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.964 -1.085 . . . . 0.0 109.075 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.816 ' HE1' HD21 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -70.17 -69.91 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.027 -1.046 . . . . 0.0 110.227 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.617 ' HA ' HD12 ' A' ' 24' ' ' LEU . 4.7 mtpt -52.37 -19.37 2.09 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.669 -1.269 . . . . 0.0 113.279 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.813 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -114.06 -56.36 2.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.49 -1.381 . . . . 0.0 112.176 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.704 ' HD1' HG21 ' A' ' 147' ' ' VAL . 19.2 t80 -73.64 -85.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.489 -1.382 . . . . 0.0 110.82 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.703 HG23 ' CD2' ' A' ' 81' ' ' TYR . 21.9 mm -37.42 -48.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.512 -0.742 . . . . 0.0 110.221 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.816 HD21 ' HE1' ' A' ' 19' ' ' PHE . 4.5 mt -100.53 -170.64 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 32.88 34.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.726 -0.609 . . . . 0.0 111.588 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA3' ' CE1' ' A' ' 30' ' ' PHE . . . -92.26 -12.95 58.08 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' HB2' HG11 ' A' ' 41' ' ' VAL . 52.2 p30 -67.33 -7.39 24.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.459 -1.024 . . . . 0.0 111.07 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -130.23 16.59 5.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.091 -1.005 . . . . 0.0 108.532 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.901 ' O ' HG22 ' A' ' 33' ' ' VAL . 5.9 tp -131.54 -50.33 0.99 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.452 -0.78 . . . . 0.0 110.746 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.887 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 4.0 m-30 -42.71 -53.74 9.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.419 -0.801 . . . . 0.0 110.315 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -67.04 -38.01 17.41 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.408 1.215 . . . . 0.0 110.957 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 2.4 mtmt -75.23 -73.3 0.26 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.977 -1.077 . . . . 0.0 110.907 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.0 m -62.94 -21.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.729 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -126.16 69.48 67.12 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.049 -1.032 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 43.7 Cg_endo -69.45 -21.92 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.891 1.469 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.496 ' O ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.92 -3.2 57.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.308 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.651 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -114.12 -51.18 2.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 111.124 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.627 HD12 ' CB ' ' A' ' 37' ' ' ALA . 3.9 mp -138.95 172.46 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.871 -1.143 . . . . 0.0 110.761 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.593 ' N ' HG22 ' A' ' 38' ' ' ILE . 29.6 t -133.37 -31.05 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.582 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -158.89 166.7 31.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 27' ' ' ASP . 2.2 p -133.32 140.1 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.021 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 110.655 -179.463 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.216 0.531 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 53' ' ' ILE . 10.1 mm -97.15 129.72 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 1.7 ptmt -127.59 149.05 50.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.34 -0.85 . . . . 0.0 110.082 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' CB ' ' HG2' ' A' ' 68' ' ' LYS . 4.0 mttp -140.4 100.95 4.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.676 -0.64 . . . . 0.0 109.311 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.0 mp -82.74 156.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.82 -1.175 . . . . 0.0 110.206 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 85.1 p -115.55 145.22 42.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.965 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.79 ' HE1' HG22 ' A' ' 67' ' ' VAL . 4.8 m-85 -118.99 72.94 12.06 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.233 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.551 ' CG ' ' HB3' ' A' ' 39' ' ' SER . 45.5 Cg_endo -75.51 68.7 6.11 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.627 1.856 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.0 -163.37 1.76 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.278 -0.889 . . . . 0.0 110.288 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.75 69.62 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.496 HD11 ' O ' ' A' ' 36' ' ' GLN . 27.4 mt -65.37 158.74 71.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.12 -1.223 . . . . 0.0 110.353 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.78 -35.13 4.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.961 1.506 . . . . 0.0 109.959 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 9.4 m-30 -79.94 150.54 30.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.848 . . . . 0.0 110.044 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -113.94 -6.22 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.843 179.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.6 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 20.7 p90 179.23 176.26 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.541 -0.724 . . . . 0.0 109.394 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.79 HG22 ' HE1' ' A' ' 58' ' ' PHE . 35.6 m -159.11 109.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 109.283 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HE2' ' CE1' ' A' ' 66' ' ' TYR . 7.6 mttm -96.2 139.48 32.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 109.503 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.904 ' OD1' HG22 ' A' ' 85' ' ' VAL . 14.3 m-20 -156.78 132.62 9.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 0.0 111.233 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 47.6 mtt180 -73.21 156.46 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.072 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 3.4 p -94.27 -17.7 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.938 -1.101 . . . . 0.0 111.039 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 61.1 -87.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 72' ' ' ASP . 0.1 OUTLIER 179.24 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.085 -1.009 . . . . 0.0 110.351 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.854 HG22 ' CD1' ' A' ' 81' ' ' TYR . 49.7 t -66.87 161.02 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.386 -0.821 . . . . 0.0 110.223 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.618 ' O ' ' HB2' ' A' ' 76' ' ' HIS . 6.3 t70 -103.16 -57.55 2.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER 75.58 -58.9 0.54 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.265 -0.272 . . . . 0.0 111.092 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.736 HG22 HD22 ' A' ' 78' ' ' ASN . 3.2 m -52.08 -55.08 23.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 110.011 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.736 HD22 HG22 ' A' ' 77' ' ' THR . 1.1 m-80 -95.02 16.04 17.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.418 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.7 m-85 52.66 52.59 13.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.182 -0.948 . . . . 0.0 109.867 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 102' ' ' ILE . 17.7 ttpt -124.44 127.24 47.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.854 ' CD1' HG22 ' A' ' 74' ' ' VAL . 70.6 t80 -128.58 125.79 38.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.51 145.2 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.702 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.761 ' HE2' HD11 ' A' ' 102' ' ' ILE . 18.1 p90 -136.11 158.33 44.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -104.31 138.14 41.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.904 HG22 ' OD1' ' A' ' 69' ' ' ASP . 24.9 t -107.42 69.47 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.817 . . . . 0.0 109.823 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.574 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -66.6 -11.19 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER 172.47 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.751 ' O ' HD11 ' A' ' 91' ' ' ILE . . . -106.31 -146.22 13.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . -91.57 -38.28 5.91 Favored Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.334 -1.098 . . . . 0.0 111.382 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -76.46 -9.91 18.81 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.128 1.067 . . . . 0.0 111.981 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.751 HD11 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -41.61 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.997 -1.064 . . . . 0.0 110.706 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.53 -168.07 41.15 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.6 m-20 -66.03 -175.18 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -1.182 . . . . 0.0 110.333 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 122' ' ' THR . 18.6 p 48.83 21.18 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 110.985 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -161.25 133.4 5.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.028 . . . . 0.0 110.143 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.67 -60.4 1.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.482 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' C ' HG13 ' A' ' 98' ' ' ILE . 17.1 ttmt -127.23 160.05 32.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.056 -1.027 . . . . 0.0 110.43 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.909 HD11 HD22 ' A' ' 95' ' ' LEU . 24.0 mt -152.39 142.79 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.5 t -119.1 143.04 47.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -126.02 125.76 43.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 111.124 -179.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.34 135.81 53.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.454 -0.778 . . . . 0.0 109.404 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.761 HD11 ' HE2' ' A' ' 83' ' ' TYR . 22.7 mt -130.54 157.87 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.825 -1.172 . . . . 0.0 110.916 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 13.4 ttmt -151.12 110.83 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.608 HD11 HG13 ' A' ' 23' ' ' ILE . 4.7 mt -84.4 128.94 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.097 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 112' ' ' SER . 6.6 t -119.83 151.58 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.732 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.99 135.3 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 109.754 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 109' ' ' ASP . 11.6 p -138.36 142.61 35.6 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.002 . . . . 0.0 110.768 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.38 -3.59 12.72 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.279 1.673 . . . . 0.0 110.533 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.445 ' CG ' ' HG1' ' A' ' 107' ' ' THR . 10.6 p30 -80.11 2.81 22.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.287 -0.883 . . . . 0.0 111.004 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.85 -82.28 0.15 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.41 -134.47 3.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.685 ' OG ' HD12 ' A' ' 18' ' ' LEU . 60.4 p -113.42 175.63 5.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 9' ' ' THR . 9.8 mt -130.61 132.97 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.85 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.1 tp -91.59 100.44 13.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.568 -0.708 . . . . 0.0 110.419 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 102' ' ' ILE . 45.8 mttt -79.71 130.01 34.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.434 HG13 ' C ' ' A' ' 115' ' ' LYS . 3.8 mt -132.84 140.88 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 111.305 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.62 117.59 16.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 2.0 m-80 -107.93 106.41 16.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 111.423 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.56 ' HD2' ' CG2' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -88.85 122.35 32.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.855 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.9 m-85 -102.97 144.06 31.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.0 111.004 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -131.84 89.08 2.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.644 -0.66 . . . . 0.0 109.708 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.562 HG22 ' HG ' ' A' ' 95' ' ' LEU . 7.3 p -95.81 -159.96 0.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -83.28 -66.75 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.123 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.69 -32.37 0.62 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -69.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -1.154 . . . . 0.0 110.13 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -99.51 -170.72 1.94 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 0.0 110.114 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 mm-40 -115.81 171.15 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.538 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.571 HG23 ' CD1' ' A' ' 3' ' ' PHE . 3.4 t -67.15 156.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 4.2 mppt? -90.86 102.5 15.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.842 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -44.32 -51.17 8.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.44 -44.77 62.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.166 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 2.7 tt0 -56.52 -41.98 77.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 108.753 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.072 HG11 ' CD2' ' A' ' 5' ' ' TYR . 78.6 t -63.26 -30.09 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.825 0.821 . . . . 0.0 108.944 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 4.1 tttt -68.69 -51.53 40.78 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.772 -0.58 . . . . 0.0 110.267 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.55 -56.55 3.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.04 -43.74 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.433 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 4.5 mtpp -60.5 -38.1 83.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.805 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -65.54 -54.63 25.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 110.074 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -35.61 65.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.06 -1.025 . . . . 0.0 109.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.86 -38.95 93.31 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 1.0 OUTLIER -74.22 -35.6 63.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.314 . . . . 0.0 110.934 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.3 p -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.18 -0.95 . . . . 0.0 109.785 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.651 HD21 ' CB ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -73.32 -51.05 18.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.519 HD11 ' OG ' ' A' ' 11' ' ' SER . 15.5 tp -50.7 -44.16 57.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -62.91 -44.48 95.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 109.511 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.559 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -51.27 -58.98 4.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.704 HG21 ' HD1' ' A' ' 22' ' ' PHE . 21.9 t -66.36 -21.81 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.78 -51.05 64.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.07 -1.018 . . . . 0.0 109.736 179.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 3.1 t -75.33 -31.03 60.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.891 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.542 ' CE1' HD11 ' A' ' 29' ' ' LEU . 14.7 t80 -55.96 -50.85 69.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.3 mt -56.13 -29.94 61.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 109.96 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 148' ' ' GLU . 8.6 mp -72.01 -55.67 7.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 110.241 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.655 ' HB3' ' HD2' ' A' ' 154' ' ' HIS . . . -55.32 -41.23 72.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.466 -0.772 . . . . 0.0 110.544 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.655 ' HD2' ' HB3' ' A' ' 153' ' ' ALA . 4.5 m-70 -105.55 122.52 46.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.82 30.57 2.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.855 . . . . 0.0 109.911 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -132.13 -26.9 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.809 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.488 ' HB2' ' OH ' ' A' ' 150' ' ' TYR . . . -69.99 128.49 36.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.964 -1.085 . . . . 0.0 110.589 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.813 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 40.3 m-85 56.68 81.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.264 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 121' ' ' HIS . 56.1 t -44.74 156.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -1.213 . . . . 0.0 110.162 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.771 ' CD1' HG23 ' A' ' 128' ' ' VAL . 97.4 m-85 -120.48 164.62 16.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 110.274 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 4' ' ' ASN . 3.4 t-20 -127.51 105.76 8.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.913 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.041 ' CD1' HG11 ' A' ' 133' ' ' VAL . 25.6 m-85 -99.01 92.75 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.983 . . . . 0.0 110.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 2.2 mp0 -53.8 141.15 27.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.85 . . . . 0.0 109.969 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.737 ' CG2' HG23 ' A' ' 102' ' ' ILE . 4.8 t -125.47 162.94 23.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.804 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.0 tm-20 178.49 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.307 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.932 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -120.64 162.6 19.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 0.0 109.835 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.92 145.89 48.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.753 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.447 ' OG ' HD11 ' A' ' 18' ' ' LEU . 35.4 t -142.19 149.17 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.885 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.86 -25.96 29.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.793 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.631 HD12 ' NH2' ' A' ' 17' ' ' ARG . 5.2 mm -72.5 142.01 83.53 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 34.5 Cg_endo -57.97 151.79 55.28 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.76 1.4 . . . . 0.0 110.521 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.586 ' HA ' HG22 ' A' ' 104' ' ' ILE . . . -58.13 -45.63 87.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.88 . . . . 0.0 110.99 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.473 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -58.43 -59.78 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 110.535 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.632 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -51.0 -59.57 4.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.496 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.55 ' HG ' HG21 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -46.28 -35.57 5.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.364 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CE1' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -65.67 -64.26 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 20.9 mtmt -54.39 -21.66 10.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.458 -0.776 . . . . 0.0 112.305 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.69 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -112.65 -59.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.638 ' CA ' HG11 ' A' ' 147' ' ' VAL . 64.6 t80 -69.22 -44.0 72.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.717 -1.239 . . . . 0.0 111.859 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.594 HG21 ' CE1' ' A' ' 19' ' ' PHE . 46.9 mm -82.8 -82.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 111.296 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.7 mt -40.56 -68.4 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -55.33 -67.6 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.427 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.617 ' HA2' ' CE1' ' A' ' 30' ' ' PHE . . . 49.18 -86.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.709 ' HB2' HG21 ' A' ' 41' ' ' VAL . 4.6 p30 -73.99 27.12 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.586 -0.95 . . . . 0.0 112.349 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 11.5 t30 -139.72 38.16 2.01 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 150' ' ' TYR . 0.8 OUTLIER 174.25 -30.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.609 -177.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CE1' ' HA2' ' A' ' 26' ' ' GLY . 2.6 m-30 -38.92 -62.52 0.74 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.385 -0.822 . . . . 0.0 111.304 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.7 Cg_endo -65.89 -27.44 51.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.762 1.401 . . . . 0.0 110.288 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -72.75 -16.56 61.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.83 . . . . 0.0 110.484 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.653 HG23 ' HB1' ' A' ' 146' ' ' ALA . 19.1 m -124.25 -4.12 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.338 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.69 65.37 12.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 -10.16 27.71 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 123.835 1.439 . . . . 0.0 109.657 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -86.08 -20.42 28.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 109.127 179.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.442 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -107.79 -61.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.593 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 143' ' ' LEU . 7.7 mm -94.55 166.65 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.617 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -131.46 -40.17 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 p -160.16 155.9 25.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 109.944 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 27' ' ' ASP . 2.7 p -121.33 146.63 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 109.966 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 2.4 mm-40 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.642 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.655 ' O ' HD13 ' A' ' 53' ' ' ILE . 7.6 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.176 0.512 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 52' ' ' THR . 45.8 mm -131.4 154.87 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.95 . . . . 0.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' NZ ' ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -141.97 143.51 33.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.52 -0.737 . . . . 0.0 109.869 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 31.2 tttp -118.99 110.4 17.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.628 -0.67 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.545 ' CD1' HG23 ' A' ' 41' ' ' VAL . 9.8 mm -98.72 109.43 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.82 -1.175 . . . . 0.0 110.611 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 39' ' ' SER . 0.8 OUTLIER -103.07 124.87 49.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 110.405 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' HB2' HD12 ' A' ' 62' ' ' LEU . 32.1 m-85 -84.58 164.66 41.69 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.403 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.3 Cg_endo -74.47 -163.23 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.14 1.6 . . . . 0.0 109.726 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER 38.61 -162.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.569 -0.707 . . . . 0.0 111.133 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -99.58 -34.74 4.89 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 58' ' ' PHE . 11.0 mt 55.71 165.4 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.105 -1.232 . . . . 0.0 109.934 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 45.5 Cg_endo -72.15 -24.96 19.6 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.846 1.446 . . . . 0.0 109.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.511 ' HB3' ' CA ' ' A' ' 89' ' ' GLY . 18.0 m-30 -106.45 -140.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.814 . . . . 0.0 109.818 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 22.7 mttt -144.67 -32.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 111.16 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 176.65 177.44 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 89' ' ' GLY . 35.7 m -142.25 117.98 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -93.57 162.81 13.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.945 . . . . 0.0 109.342 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.495 ' OD1' HG22 ' A' ' 85' ' ' VAL . 67.0 m-20 -144.64 154.48 42.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.844 -1.16 . . . . 0.0 111.627 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HG2' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -122.29 134.68 54.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.675 -0.641 . . . . 0.0 109.386 179.392 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.506 ' HB ' ' NZ ' ' A' ' 54' ' ' LYS . 2.6 p -89.89 136.71 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.003 . . . . 0.0 110.671 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -113.94 55.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 109.401 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.4 mt-10 60.28 117.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 0.0 109.842 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.672 HG13 ' HD1' ' A' ' 81' ' ' TYR . 25.2 t -96.97 125.52 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 15.1 t0 -68.63 -170.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.572 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.07 -48.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 110.152 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 m -57.5 -16.1 8.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 110.089 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.538 ' CB ' ' HD2' ' A' ' 80' ' ' LYS . 97.3 m-20 -130.31 6.74 4.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 3.7 m-85 57.56 55.32 5.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 110.737 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.538 ' HD2' ' CB ' ' A' ' 78' ' ' ASN . 6.8 mttt -117.63 121.72 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.366 -0.834 . . . . 0.0 110.026 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.672 ' HD1' HG13 ' A' ' 74' ' ' VAL . 17.9 t80 -114.18 161.2 18.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.456 ' CB ' ' OE2' ' A' ' 101' ' ' GLU . 8.0 p30 -163.83 138.09 5.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.261 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 10.9 p90 -147.5 172.49 13.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 4.6 p -139.42 135.3 33.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.736 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.495 HG22 ' OD1' ' A' ' 69' ' ' ASP . 66.9 t -101.07 81.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.582 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -66.57 -10.88 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -173.4 157.34 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.782 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.564 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 168.38 -137.57 4.66 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.239 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.666 ' H ' HG12 ' A' ' 67' ' ' VAL . . . -95.28 -38.16 4.88 Favored Glycine 0 N--CA 1.489 2.168 0 O-C-N 121.727 -0.866 . . . . 0.0 111.92 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -77.48 -1.59 11.77 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.0 1.0 . . . . 0.0 111.202 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -46.82 176.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.156 -0.965 . . . . 0.0 110.221 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 94' ' ' THR . . . 157.19 74.12 0.02 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.513 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 94' ' ' THR . 2.8 m-20 40.25 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.442 -1.034 . . . . 0.0 111.188 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.569 HG21 ' HB2' ' A' ' 126' ' ' HIS . 3.2 p -31.41 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.789 -0.569 . . . . 0.0 111.102 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.597 HD11 HG12 ' A' ' 98' ' ' ILE . 15.6 tp -64.49 88.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.081 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.78 -49.64 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.542 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -114.62 142.87 45.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.217 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.597 HG12 HD11 ' A' ' 95' ' ' LEU . 44.2 mt -136.24 114.99 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -0.948 . . . . 0.0 110.604 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 1.4 m -112.18 111.56 22.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 109.424 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.549 ' CB ' ' HA ' ' A' ' 118' ' ' ASN . 25.4 m-20 -121.27 147.3 45.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.308 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.456 ' OE2' ' CB ' ' A' ' 82' ' ' ASN . 12.3 mt-10 -136.02 141.48 44.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.532 -0.73 . . . . 0.0 109.68 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.737 HG23 ' CG2' ' A' ' 7' ' ' THR . 0.2 OUTLIER -136.3 177.93 5.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 113' ' ' ILE . 75.1 tttt -140.0 137.42 34.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.349 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.586 HG22 ' HA ' ' A' ' 15' ' ' ALA . 6.1 mm -96.82 80.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 112' ' ' SER . 90.7 t -71.39 130.97 35.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 110.702 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.87 141.28 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.544 HG21 HD11 ' A' ' 113' ' ' ILE . 38.0 p -127.42 156.51 74.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.34 -34.74 34.11 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.071 1.564 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.45 37.49 2.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.295 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.505 ' CA ' ' OG1' ' A' ' 107' ' ' THR . . . -148.43 30.48 1.3 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 45.84 -103.94 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.555 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 2.6 p -142.99 170.25 16.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 110.355 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 114' ' ' LEU . 9.7 mt -138.68 129.77 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.932 ' HB2' HG22 ' A' ' 9' ' ' THR . 8.0 mp -97.55 94.45 7.01 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 116' ' ' ILE . 1.0 OUTLIER -124.1 -176.83 3.59 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.779 -1.168 . . . . 0.0 112.721 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.742 HG22 ' N ' ' A' ' 117' ' ' SER . 21.6 mm 120.63 -102.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.236 1.414 . . . . 0.0 109.853 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.742 ' N ' HG22 ' A' ' 116' ' ' ILE . 4.7 m -168.79 177.22 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.725 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 100' ' ' ASN . 4.6 m120 -139.49 96.71 3.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.505 ' HD3' HG11 ' A' ' 2' ' ' VAL . 4.9 mttt -75.66 129.08 36.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 111.271 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.593 ' CE2' HD21 ' A' ' 95' ' ' LEU . 2.6 m-85 -105.75 106.23 16.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.825 ' HA ' HG22 ' A' ' 2' ' ' VAL . 60.3 m-70 -90.9 95.05 9.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.843 . . . . 0.0 110.307 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p -79.34 -170.88 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 -72.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 110.249 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.88 60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -153.24 -114.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -1.153 . . . . 0.0 109.79 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.569 ' HB2' HG21 ' A' ' 94' ' ' THR . 15.0 m170 -71.13 161.22 31.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.975 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.5 mp0 -77.43 -164.36 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.906 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.771 HG23 ' CD1' ' A' ' 3' ' ' PHE . 55.6 t -90.7 141.42 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -81.65 119.48 23.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -0.91 . . . . 0.0 109.887 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.06 83.24 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.132 -0.98 . . . . 0.0 109.958 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.99 -29.24 59.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -1.0 . . . . 0.0 108.839 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 90' ' ' PRO . 37.3 tt0 -77.8 -40.16 41.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.041 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.7 t -69.25 -14.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.082 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.07 -49.27 6.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.655 -0.653 . . . . 0.0 109.979 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -50.71 -45.46 58.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 t -59.14 -47.58 84.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 109.349 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HE2' ' ND2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -63.3 -22.09 66.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.643 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 74.2 tt0 -75.2 -47.6 27.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.361 -0.837 . . . . 0.0 109.416 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.442 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 42.3 mmm -65.86 -30.83 71.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.25 -0.906 . . . . 0.0 108.867 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.43 -35.5 56.06 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.66 -34.92 65.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.884 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 p -72.23 -37.94 69.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.246 -0.908 . . . . 0.0 108.807 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.597 HD21 HG12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -72.05 -31.4 66.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 9' ' ' THR . 11.7 tp -67.57 -41.96 83.32 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -68.74 -33.1 73.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.653 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -63.84 -60.99 2.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.457 -0.777 . . . . 0.0 109.245 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.638 HG11 ' CA ' ' A' ' 22' ' ' PHE . 63.4 t -60.82 -28.62 43.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.451 -0.78 . . . . 0.0 109.697 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -50.0 72.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.945 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.49 -11.99 56.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.583 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 6.5 t80 -69.53 -37.24 77.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.632 HD13 ' HG2' ' A' ' 17' ' ' ARG . 11.6 mt -73.6 -24.58 60.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 13' ' ' ILE . 4.7 mp -81.64 -36.27 29.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.52 -41.66 45.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 155' ' ' SER . 59.7 m-70 -86.1 -48.44 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.372 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 7.9 t 62.22 14.34 6.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.259 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -131.95 4.08 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.371 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.491 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -106.69 143.36 34.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.288 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.69 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.8 m-85 50.56 33.51 8.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 120' ' ' TYR . 95.7 t -63.63 152.14 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -1.172 . . . . 0.0 110.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.626 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 23.1 m-85 -113.38 164.47 13.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.494 -0.754 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 119' ' ' LYS . 61.9 t-20 -148.99 98.79 2.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.083 -1.011 . . . . 0.0 111.37 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.908 ' OH ' HG21 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -95.59 134.34 38.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.163 -0.961 . . . . 0.0 108.944 178.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -119.01 117.45 28.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 110.779 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.407 HG21 ' HD3' ' A' ' 137' ' ' LYS . 7.9 t -142.6 -161.19 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 109.845 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -173.63 158.92 3.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.011 -1.056 . . . . 0.0 110.538 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.972 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -122.68 175.44 6.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.156 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.44 145.29 51.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 110.242 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.587 ' CB ' HD11 ' A' ' 18' ' ' LEU . 16.5 t -143.52 142.45 31.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.377 -0.827 . . . . 0.0 110.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.11 -10.28 13.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.639 -0.663 . . . . 0.0 110.256 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.692 HG23 ' HD2' ' A' ' 14' ' ' PRO . 15.6 mm -86.72 149.34 48.2 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.568 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.3 Cg_endo -56.19 156.36 21.05 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 121.555 1.503 . . . . 0.0 110.444 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.722 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -69.5 -51.05 39.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.26 -52.57 51.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.937 -1.102 . . . . 0.0 110.298 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -60.63 -55.18 36.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.587 HD11 ' CB ' ' A' ' 11' ' ' SER . 7.7 mt -47.48 -34.69 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.008 . . . . 0.0 109.318 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.894 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.93 -61.9 1.6 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 110.482 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 mtpt -54.44 -25.21 23.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.376 -0.828 . . . . 0.0 112.581 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.826 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.49 -56.4 2.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.446 -1.409 . . . . 0.0 111.904 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 73.6 t80 -78.92 0.79 25.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 112.267 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 4.5 mt -138.81 -22.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.689 -1.257 . . . . 0.0 111.471 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.894 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.8 mt -100.54 -35.84 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.728 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -117.02 88.76 2.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.75 -0.594 . . . . 0.0 109.613 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -113.56 -35.9 1.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.994 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.9 p30 -73.99 0.36 13.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.421 -1.046 . . . . 0.0 110.821 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 2.5 t30 -139.82 7.76 2.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.977 . . . . 0.0 109.935 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.928 HD22 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -142.15 -14.66 0.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.894 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 8.4 m-30 -71.88 -57.04 4.26 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.739 -1.225 . . . . 0.0 110.435 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.21 -34.67 44.56 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.685 1.36 . . . . 0.0 110.732 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -60.14 -15.21 21.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 0.0 109.98 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 146' ' ' ALA . 6.4 m -130.56 -4.05 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.4 62.63 6.63 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.082 -1.011 . . . . 0.0 110.709 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.72 -24.19 41.33 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.844 1.444 . . . . 0.0 109.632 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -74.38 -13.04 60.67 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.573 -0.705 . . . . 0.0 109.227 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.704 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -109.08 -63.05 1.39 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.166 -0.959 . . . . 0.0 110.396 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.48 154.48 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.905 -1.122 . . . . 0.0 110.14 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.531 ' HB3' ' N ' ' A' ' 59' ' ' PRO . 54.4 p -108.49 -45.12 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.777 . . . . 0.0 110.187 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 p -174.59 -169.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.994 HG11 ' HB2' ' A' ' 27' ' ' ASP . 7.6 p -147.84 162.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.953 . . . . 0.0 110.065 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 41' ' ' VAL . 12.1 mt-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 109.895 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.143 0.497 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.567 HD13 ' HG2' ' A' ' 70' ' ' ARG . 19.3 mm -126.74 124.04 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.61 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.864 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -124.52 144.81 49.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 0.0 110.424 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -111.29 111.26 22.19 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.94 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.864 HD11 ' CD ' ' A' ' 54' ' ' LYS . 5.2 mm -89.5 127.92 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.97 -1.081 . . . . 0.0 109.782 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 m -111.19 145.72 38.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 0.0 109.786 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 1.075 ' HB3' HD13 ' A' ' 62' ' ' LEU . 79.2 m-85 -121.18 155.12 58.65 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 110.775 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.531 ' N ' ' HB3' ' A' ' 39' ' ' SER . 48.9 Cg_endo -78.47 -169.05 0.7 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.155 1.608 . . . . 0.0 109.497 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 168.42 10.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 0.0 110.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.58 -52.7 2.36 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.075 HD13 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.11 142.11 86.03 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.147 . . . . 0.0 109.972 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 48.8 Cg_endo -81.84 27.92 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.082 1.569 . . . . 0.0 111.08 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 63' ' ' PRO . 82.3 m-85 -156.08 141.09 17.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.042 -1.036 . . . . 0.0 110.21 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -75.68 -34.68 60.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.572 ' C ' HG13 ' A' ' 67' ' ' VAL . 23.6 p90 -173.09 -178.12 1.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.572 HG13 ' C ' ' A' ' 66' ' ' TYR . 27.8 m -157.71 125.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.307 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 86' ' ' ILE . 7.6 mttt -85.35 131.52 34.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 108.794 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -130.29 141.54 50.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.867 -1.145 . . . . 0.0 111.664 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.567 ' HG2' HD13 ' A' ' 53' ' ' ILE . 60.6 mtm180 -110.69 132.34 54.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.589 -0.694 . . . . 0.0 109.129 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.088 HG13 HG23 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -73.08 -37.48 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.84 -1.163 . . . . 0.0 110.052 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.6 OUTLIER 78.76 -39.76 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.115 -0.366 . . . . 0.0 111.103 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 5.4 pt-20 173.34 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.71 -1.244 . . . . 0.0 111.077 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.088 HG23 HG13 ' A' ' 71' ' ' VAL . 39.3 t 60.59 139.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.37 -0.831 . . . . 0.0 109.657 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.23 164.38 13.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.073 -1.017 . . . . 0.0 110.87 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -142.03 -45.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' OD1' ' A' ' 78' ' ' ASN . 3.0 m -57.45 -34.42 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 78' ' ' ASN . 1.9 m120 -109.42 12.41 24.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.51 39.16 27.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.977 . . . . 0.0 109.786 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HG2' ' HG2' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -105.19 153.47 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.392 -0.817 . . . . 0.0 110.324 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.632 ' HE1' HG22 ' A' ' 74' ' ' VAL . 15.4 t80 -144.62 111.38 5.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.808 . . . . 0.0 109.612 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.509 ' ND2' ' CG ' ' A' ' 101' ' ' GLU . 60.6 t-20 -121.2 126.85 50.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 18.8 p90 -139.67 154.67 47.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.66 164.19 11.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.098 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 86' ' ' ILE . 97.8 t -107.94 -14.88 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.514 HG21 ' NE ' ' A' ' 70' ' ' ARG . 25.9 pt 33.02 -120.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.744 -0.597 . . . . 0.0 111.075 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.0 mp0 -84.47 164.25 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 110.227 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.51 149.66 19.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.63 -146.3 17.85 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.0 Cg_endo -81.86 23.59 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.092 1.575 . . . . 0.0 111.238 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.06 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.448 -0.783 . . . . 0.0 111.015 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' ASP . . . 102.53 -51.28 0.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 92' ' ' GLY . 6.4 m-20 -57.59 -155.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -1.149 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 122' ' ' THR . 73.0 p -81.42 2.37 28.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.559 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.942 HD21 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -106.58 107.61 18.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.988 . . . . 0.0 109.932 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' OE1' ' HE3' ' A' ' 123' ' ' LYS . 20.3 tt0 -94.29 -37.02 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.836 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -135.21 165.29 25.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.975 -1.078 . . . . 0.0 110.655 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.905 HD11 HD22 ' A' ' 95' ' ' LEU . 13.7 mt -155.83 122.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -104.61 131.51 51.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.476 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -123.15 135.43 54.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.973 -1.079 . . . . 0.0 111.216 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.509 ' CG ' ' ND2' ' A' ' 82' ' ' ASN . 11.5 mt-10 -120.98 152.21 38.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 58.1 mt -140.05 159.08 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.919 -1.113 . . . . 0.0 110.482 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 1.1 ttmt -149.42 101.5 3.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.722 HG22 ' HB1' ' A' ' 15' ' ' ALA . 4.1 mp -83.28 111.14 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.371 -0.831 . . . . 0.0 110.182 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.894 HG21 ' HE3' ' A' ' 115' ' ' LYS . 15.5 t -110.52 130.78 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.46 144.54 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -119.7 158.02 50.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.029 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.15 -38.39 21.75 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.988 1.52 . . . . 0.0 110.709 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 14.3 t70 -143.88 36.14 1.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 110.327 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.11 14.6 3.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.55 -101.04 0.86 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 69.8 m -161.52 138.48 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 0.0 110.204 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 114' ' ' LEU . 23.1 mt -109.09 130.13 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.972 ' HB2' HG22 ' A' ' 9' ' ' THR . 6.6 mp -95.84 89.52 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.643 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HE3' HG21 ' A' ' 105' ' ' VAL . 2.1 mttm -64.36 118.05 8.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 108.352 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.613 HG22 ' ND2' ' A' ' 118' ' ' ASN . 43.4 mt -119.65 118.32 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 111.791 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.01 106.2 18.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.613 ' ND2' HG22 ' A' ' 116' ' ' ILE . 1.5 m-80 -90.12 92.99 9.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 111.171 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -87.74 135.2 33.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.942 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.5 m-85 -111.96 167.13 10.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.915 -1.115 . . . . 0.0 110.834 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 16.0 m-70 -139.35 89.53 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.637 HG22 ' HG ' ' A' ' 95' ' ' LEU . 3.0 p -92.8 -170.56 2.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 110.04 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.478 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -111.9 -3.01 14.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 110.091 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 124.67 -141.55 13.3 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' GLY . 3.5 t70 42.69 -139.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.111 . . . . 0.0 110.16 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -48.58 158.86 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.033 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -89.37 -137.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.574 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.908 HG21 ' OH ' ' A' ' 5' ' ' TYR . 90.8 t -105.97 154.23 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.806 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -102.53 117.35 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.863 . . . . 0.0 109.892 179.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.16 -42.04 63.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -49.58 -42.33 44.15 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.109 -0.995 . . . . 0.0 108.692 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 21.7 mt-30 -67.52 -44.55 78.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.571 -0.706 . . . . 0.0 109.315 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 5' ' ' TYR . 21.2 t -70.24 -6.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.738 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.9 tttt -98.0 -65.98 0.93 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.286 -0.884 . . . . 0.0 110.821 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -32.52 -45.75 0.12 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -51.45 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.286 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 134' ' ' LYS . 1.7 ttmt -55.86 -32.49 63.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.961 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.2 -52.93 28.71 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.477 -0.765 . . . . 0.0 109.618 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.704 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 39.7 mmm -54.64 -39.0 67.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.29 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.49 98.03 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.76 -39.52 87.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.283 . . . . 0.0 110.522 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -34.3 76.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.079 -1.013 . . . . 0.0 109.031 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.6 mm? -77.78 -24.09 49.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.335 -0.853 . . . . 0.0 109.085 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 18.3 tp -75.58 -33.89 60.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.488 ' HA ' ' HB3' ' A' ' 148' ' ' GLU . 8.6 ttt180 -80.93 -31.25 35.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -69.17 -45.59 69.61 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.805 HG22 HD11 ' A' ' 29' ' ' LEU . 96.7 t -76.19 -30.33 20.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.507 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.88 -37.82 88.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.444 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.462 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -89.13 -22.45 22.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.632 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.603 ' HB2' HG11 ' A' ' 33' ' ' VAL . 6.9 t80 -63.6 -38.32 90.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 109.672 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.58 HD23 ' CD2' ' A' ' 150' ' ' TYR . 50.9 mt -73.72 -19.9 60.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 4.8 mp -92.94 -19.21 21.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.98 -31.25 13.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.145 -0.972 . . . . 0.0 110.335 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -80.87 -165.0 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.868 . . . . 0.0 110.293 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 1.2 p -86.5 -57.21 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.493 ' N ' ' OG ' ' A' ' 155' ' ' SER . 13.6 m-20 -166.02 54.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.181 -0.95 . . . . 0.0 110.665 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.477 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -68.55 136.41 53.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.168 -0.958 . . . . 0.0 109.919 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.826 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 60.5 m-85 58.81 53.95 5.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.467 ' OD1' ' HD3' ' A' ' 17' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.275 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.617 HG12 ' N ' ' A' ' 3' ' ' PHE . 84.0 t -85.52 171.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -1.214 . . . . 0.0 110.567 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.617 ' N ' HG12 ' A' ' 2' ' ' VAL . 97.9 m-85 -141.98 171.57 13.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.492 -0.755 . . . . 0.0 110.136 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -138.87 122.04 16.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.37 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.943 ' CE2' HG21 ' A' ' 133' ' ' VAL . 36.5 m-85 -116.81 97.81 6.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 109.557 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.58 129.56 37.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.714 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.1 -174.0 4.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 3.0 pt-20 -166.43 166.3 16.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.636 ' O ' ' CB ' ' A' ' 10' ' ' THR . 10.8 t -175.1 -126.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.088 -1.008 . . . . 0.0 111.43 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.857 ' HG1' ' N ' ' A' ' 114' ' ' LEU . 4.4 m 94.7 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 123.069 0.548 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 10' ' ' THR . 0.5 OUTLIER 169.43 -167.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.568 -1.333 . . . . 0.0 111.534 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 110' ' ' GLY . 0.9 OUTLIER -72.89 -16.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.85 -0.531 . . . . 0.0 110.009 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 4.3 mm -63.26 145.56 96.85 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.001 -1.062 . . . . 0.0 109.058 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.555 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 31.6 Cg_endo -54.75 148.53 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.848 1.446 . . . . 0.0 111.266 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -62.29 -43.57 98.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.641 -0.662 . . . . 0.0 110.789 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.46 -51.76 68.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 110.814 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.67 -55.51 29.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 109.769 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.82 HD13 HG22 ' A' ' 10' ' ' THR . 0.3 OUTLIER -53.3 -27.04 20.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.709 179.094 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 1.183 ' CE1' HD21 ' A' ' 24' ' ' LEU . 1.1 t80 -73.45 -70.98 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.589 . . . . 0.0 110.478 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 11.1 mtpt -55.1 -22.43 16.45 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.69 -0.631 . . . . 0.0 112.636 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -102.52 -48.13 4.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.0 112.188 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.0 t80 -95.46 9.79 38.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.807 -1.183 . . . . 0.0 112.017 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.749 HG23 ' CD2' ' A' ' 81' ' ' TYR . 7.1 mt -143.39 -27.89 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.711 -1.243 . . . . 0.0 110.838 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.183 HD21 ' CE1' ' A' ' 19' ' ' PHE . 6.6 mt -106.22 -17.36 14.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.795 -1.19 . . . . 0.0 109.292 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 3.0 t0 -132.11 94.97 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.898 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.505 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -120.16 -35.84 0.85 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.78 6.6 10.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.97 -1.312 . . . . 0.0 110.147 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 5.7 t30 -143.15 25.06 1.77 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.933 HD11 HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -159.33 -32.21 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.136 -178.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.661 ' N ' HD13 ' A' ' 29' ' ' LEU . 12.2 m-30 -60.26 -55.36 46.1 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 0.0 110.233 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.6 Cg_endo -65.53 -35.92 36.3 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.539 1.284 . . . . 0.0 110.823 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -62.92 -15.49 55.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 29' ' ' LEU . 17.8 m -128.66 -2.4 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 110.553 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.43 68.95 6.57 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.949 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.05 -13.59 38.58 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.879 1.463 . . . . 0.0 109.248 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -82.76 -19.77 37.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.474 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -99.66 -54.91 2.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.33 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.61 150.71 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.053 -1.029 . . . . 0.0 110.319 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.411 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 t -110.59 -37.26 5.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.994 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -173.07 -179.58 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 56' ' ' ILE . 91.6 t -143.65 165.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.431 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.935 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.284 0.564 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.0 mm -101.86 119.04 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.955 . . . . 0.0 110.117 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -121.86 147.39 46.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 17.0 tttt -115.93 107.29 14.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.753 ' CD1' HG13 ' A' ' 41' ' ' VAL . 4.8 mm -82.58 147.23 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.479 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.09 140.45 52.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.504 -0.747 . . . . 0.0 109.518 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.606 ' HB3' HD12 ' A' ' 62' ' ' LEU . 69.3 m-85 -116.54 142.06 28.98 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 39' ' ' SER . 48.5 Cg_endo -74.6 -171.18 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.014 1.534 . . . . 0.0 110.143 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.8 160.77 13.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 110.451 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -41.01 2.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.606 HD12 ' HB3' ' A' ' 58' ' ' PHE . 3.0 mt -83.14 164.16 47.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.236 . . . . 0.0 110.321 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 46.0 Cg_endo -76.92 -82.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.238 1.651 . . . . 0.0 111.207 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 m-30 -56.51 161.12 2.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.018 . . . . 0.0 110.716 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.21 -22.74 18.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 110.445 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.689 ' O ' HG13 ' A' ' 67' ' ' VAL . 16.3 p90 -173.78 -176.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.928 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 66' ' ' TYR . 13.5 m -160.42 161.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.396 -0.815 . . . . 0.0 110.734 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -119.72 117.45 28.27 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD2' ' CD1' ' A' ' 83' ' ' TYR . 15.6 t70 -120.37 153.55 36.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.969 -1.082 . . . . 0.0 111.542 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.69 126.99 51.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.67 -0.643 . . . . 0.0 109.409 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 82' ' ' ASN . 6.1 p -61.01 -22.61 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.919 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 45.13 52.07 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.001 . . . . 0.0 109.564 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.5 mt-10 58.25 154.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 110.172 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' HD1' ' A' ' 81' ' ' TYR . 2.9 p -136.45 120.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -74.19 178.05 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.921 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.414 ' O ' ' HD1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -152.65 -41.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 110.773 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -52.22 -48.72 64.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.638 -1.289 . . . . 0.0 110.44 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -105.46 19.72 20.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.623 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 6.7 m-30 51.86 75.04 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.276 -0.89 . . . . 0.0 110.557 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 17.5 mtmt -131.55 124.77 30.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.803 ' HD1' HG23 ' A' ' 74' ' ' VAL . 2.7 t80 -117.08 113.22 22.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' VAL . 88.1 m-20 -112.0 105.33 13.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 110.719 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' OD2' ' A' ' 69' ' ' ASP . 1.4 p90 -122.46 169.55 10.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -151.46 140.92 21.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.868 -1.145 . . . . 0.0 111.708 -179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.499 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 44.5 t -95.93 145.14 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -150.99 24.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.74 -1.225 . . . . 0.0 111.654 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.58 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -172.89 147.66 1.7 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.612 -1.305 . . . . 0.0 111.066 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' GLU . . . 49.79 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 67' ' ' VAL . . . 78.44 -134.31 14.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.27 -17.15 31.23 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.108 1.583 . . . . 0.0 110.634 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 87' ' ' GLU 0.31 4.7 mt -66.66 114.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.13 89.7 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.1 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.1 t0 62.45 5.84 1.75 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -1.087 . . . . 0.0 111.998 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -135.32 -78.74 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.765 -1.209 . . . . 0.0 109.992 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.595 HD11 ' HD2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -78.56 108.42 11.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.974 . . . . 0.0 109.691 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -90.08 -45.4 9.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' C ' HG13 ' A' ' 98' ' ' ILE . 52.4 mttt -119.84 147.4 44.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.578 HG12 HD22 ' A' ' 95' ' ' LEU . 45.9 mt -152.17 110.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.727 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 1.3 t -93.04 157.05 16.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.307 -0.871 . . . . 0.0 109.228 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.65 108.43 3.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 110.407 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 116' ' ' ILE . 17.9 mt-10 -97.91 156.06 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.7 HG13 HG23 ' A' ' 116' ' ' ILE . 4.5 mt -140.84 146.95 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.287 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 7.4 ttmt -139.04 115.67 10.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.446 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 1.3 mp -92.27 129.2 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 ' HE3' ' A' ' 115' ' ' LYS . 25.5 t -132.57 124.5 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 110.629 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.75 142.03 49.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 111' ' ' GLY . 61.0 p -94.18 153.19 40.7 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.82 -7.1 15.65 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -99.3 -85.85 0.38 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.235 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -169.41 87.36 0.09 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 12' ' ' VAL . . . 153.98 146.91 4.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.547 ' O ' ' HB ' ' A' ' 10' ' ' THR . 77.3 p -104.08 152.53 21.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.389 -1.065 . . . . 0.0 109.186 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.527 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 2.9 mt -122.01 156.25 26.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.857 ' N ' ' HG1' ' A' ' 10' ' ' THR . 0.5 OUTLIER -115.05 137.92 51.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.115 -0.991 . . . . 0.0 109.862 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 42.7 mttm -122.68 106.97 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.7 HG23 HG13 ' A' ' 102' ' ' ILE . 3.2 mp -115.67 139.88 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.112 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.33 112.82 22.08 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.56 102.94 14.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 111.43 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.493 ' HE3' HG11 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -83.7 111.74 19.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.94 . . . . 0.0 109.059 178.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.595 ' HD2' HD11 ' A' ' 95' ' ' LEU . 3.4 m-85 -98.32 104.27 16.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 111.048 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.578 ' HA ' HG22 ' A' ' 2' ' ' VAL . 37.6 m-70 -95.76 96.18 8.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.522 -0.736 . . . . 0.0 109.407 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 19.5 p -78.36 -149.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.496 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.97 53.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.635 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 71.48 -83.55 0.45 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 126' ' ' HIS . 10.9 t70 -39.54 115.89 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -1.018 . . . . 0.0 110.514 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.556 ' HB3' ' CG2' ' A' ' 94' ' ' THR . 0.1 OUTLIER 53.98 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.966 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 61.8 mt-10 -123.86 -144.47 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.582 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 98.9 t -95.08 133.03 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.265 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.5 mtmt -98.57 123.57 42.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.944 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -43.96 -46.37 8.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 110.305 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -52.17 -46.27 65.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 109.463 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.7 77.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 108.826 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.943 HG21 ' CE2' ' A' ' 5' ' ' TYR . 72.6 t -72.59 -19.36 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.794 0.807 . . . . 0.0 109.284 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.6 tttp -84.67 -60.13 2.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.507 -0.746 . . . . 0.0 111.2 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.79 -51.81 1.28 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 110.673 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.2 m -57.0 -47.37 80.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 110.162 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -64.44 -21.73 66.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 8.0 tt0 -77.23 -44.64 29.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.728 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 72.1 mmm -66.36 -37.88 86.3 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.69 -39.75 93.79 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -70.96 -40.55 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.814 -1.404 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -62.7 -40.61 97.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 108.971 179.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.474 HD21 ' CB ' ' A' ' 37' ' ' ALA . 1.1 mm? -71.48 -33.39 69.24 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.587 HD21 ' H ' ' A' ' 10' ' ' THR . 45.0 tp -62.28 -40.63 96.9 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.096 -1.002 . . . . 0.0 109.038 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.062 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.454 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -54.83 -55.14 33.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.105 -0.997 . . . . 0.0 109.546 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.933 HG22 HD11 ' A' ' 29' ' ' LEU . 48.5 t -63.36 -37.03 78.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.704 ' OE1' HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -55.99 -46.13 78.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 110.132 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -83.75 -19.25 35.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.59 ' CG ' HG11 ' A' ' 33' ' ' VAL . 9.8 t80 -66.64 -39.71 88.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.539 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.538 HD13 ' HG2' ' A' ' 17' ' ' ARG . 80.8 mt -62.33 -33.11 74.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.027 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 5.2 mp -77.65 -42.53 34.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.569 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.22 80.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.148 -0.97 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.26 -25.43 39.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.7 t 44.79 44.01 7.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 110.029 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -166.2 -41.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.525 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -59.05 133.81 56.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.865 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 48.0 m-85 56.43 68.8 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.341 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.166 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 3' ' ' PHE . 43.3 t -69.21 170.88 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -1.144 . . . . 0.0 110.691 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.592 ' HB2' ' HB2' ' A' ' 120' ' ' TYR . 24.1 m-85 -126.07 154.34 43.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -125.63 97.13 5.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.063 -1.023 . . . . 0.0 111.205 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.003 ' CD2' HG11 ' A' ' 133' ' ' VAL . 37.4 m-85 -100.94 81.63 2.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.286 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -84.15 113.94 21.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.81 . . . . 0.0 110.96 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.536 HG23 ' HB ' ' A' ' 116' ' ' ILE . 5.1 t -132.97 -176.37 4.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.4 -0.812 . . . . 0.0 109.624 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -157.01 153.4 27.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.115 -0.99 . . . . 0.0 110.222 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.912 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.79 156.23 44.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 110.12 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.32 152.84 29.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.87 ' OG ' HD11 ' A' ' 18' ' ' LEU . 45.6 t -142.0 135.72 29.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.72 -3.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.708 -0.62 . . . . 0.0 109.977 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.72 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.8 mm -95.77 149.12 35.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.72 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.0 Cg_endo -56.7 162.72 8.11 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.952 1.501 . . . . 0.0 110.437 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -71.53 -66.43 0.63 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 111.025 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -41.65 -53.63 3.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.581 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -59.63 -51.71 68.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.979 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' OG ' ' A' ' 11' ' ' SER . 5.9 mt -51.15 -27.04 7.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 108.693 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 1.043 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -74.1 -68.63 0.5 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.447 0.642 . . . . 0.0 109.991 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.66 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.6 mtmm -47.66 -36.17 10.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.855 -1.153 . . . . 0.0 111.322 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -90.35 -67.99 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.951 -1.093 . . . . 0.0 109.172 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.723 ' HD1' HG21 ' A' ' 147' ' ' VAL . 20.6 t80 -82.94 150.39 26.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 108.989 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 8.3 mt 82.4 -47.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 CA-C-O 121.24 0.543 . . . . 0.0 110.327 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.043 HD21 ' CE1' ' A' ' 19' ' ' PHE . 17.2 mt -97.74 -50.8 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -104.41 89.81 3.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.031 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -122.14 -33.54 0.89 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.73 ' CG ' HG11 ' A' ' 41' ' ' VAL . 52.8 m-20 -71.82 -1.25 13.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.101 -1.235 . . . . 0.0 110.615 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -123.88 13.02 9.15 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.084 -1.01 . . . . 0.0 108.829 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.766 HD21 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -146.61 -51.41 0.22 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 110.971 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.814 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 5.3 m-30 -29.81 -58.71 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -67.82 -38.99 12.26 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.609 1.321 . . . . 0.0 111.414 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 12.7 mmtt -66.97 -66.61 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.102 -0.999 . . . . 0.0 111.219 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.988 HG23 ' HB1' ' A' ' 146' ' ' ALA . 16.5 m -70.69 -19.94 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.254 -0.904 . . . . 0.0 111.02 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.896 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -127.09 65.75 65.4 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.383 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.69 -6.44 17.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.859 1.452 . . . . 0.0 110.128 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.477 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -96.45 0.75 50.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.02 -50.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 110.778 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.024 HG12 HD21 ' A' ' 143' ' ' LEU . 11.3 mm -109.15 163.17 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 110.613 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.492 ' C ' ' HB3' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -138.07 -43.69 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 0.0 110.138 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 39' ' ' SER . 11.3 t -178.28 133.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.343 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.73 HG11 ' CG ' ' A' ' 27' ' ' ASP . 3.6 p -92.73 146.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 30.6 mt-10 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.112 0.482 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.541 HD11 ' HD2' ' A' ' 70' ' ' ARG . 21.4 mm -83.05 130.69 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.913 . . . . 0.0 109.886 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 2.5 ptpp? -132.98 152.86 51.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.466 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.9 ttmt -120.29 88.57 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.643 HD12 HG23 ' A' ' 41' ' ' VAL . 1.7 mp -64.73 123.13 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.145 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -109.44 102.53 11.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.743 ' HB2' HD12 ' A' ' 62' ' ' LEU . 3.0 m-85 -64.08 173.81 1.31 Allowed Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.099 -1.001 . . . . 0.0 109.231 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -75.72 -172.45 1.32 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.706 1.372 . . . . 0.0 109.715 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.527 ' HG2' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -77.24 168.15 20.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' N ' ' HG2' ' A' ' 60' ' ' GLU . . . 104.43 -39.86 2.67 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.743 HD12 ' HB2' ' A' ' 58' ' ' PHE . 13.2 mt -62.13 157.94 49.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.106 -1.232 . . . . 0.0 110.478 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.55 -18.63 19.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.132 1.596 . . . . 0.0 110.473 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.53 -161.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.93 . . . . 0.0 110.425 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 12.0 tptt -121.44 -24.08 5.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 53.6 p90 -179.32 -152.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 109.906 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.911 HG23 ' CA ' ' A' ' 89' ' ' GLY . 9.1 p -172.04 120.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 111.191 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 2.8 mttp -98.01 137.82 36.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.471 -0.768 . . . . 0.0 109.047 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 1.5 m-20 -142.18 148.84 38.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HD2' HD11 ' A' ' 53' ' ' ILE . 25.9 ttt180 -108.5 130.0 55.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.536 -0.727 . . . . 0.0 109.392 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 -24.18 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 16.3 m-20 45.96 43.79 10.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.972 . . . . 0.0 109.942 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 11.4 mt-10 58.27 151.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.464 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.828 HG11 ' CZ ' ' A' ' 81' ' ' TYR . 6.4 m -138.78 148.98 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' CB ' ' HB3' ' A' ' 80' ' ' LYS . 4.2 t0 -69.08 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.054 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.35 -47.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 m -54.24 -35.91 62.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.411 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 1.9 m-80 -115.31 17.15 16.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 110.199 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.57 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 10.1 m-30 55.46 57.48 5.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HB3' ' CB ' ' A' ' 75' ' ' ASP . 30.1 tttm -118.89 98.54 6.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.833 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.828 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -91.16 177.94 6.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.122 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 81' ' ' TYR . 22.5 p-10 -178.82 142.5 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.501 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 12.4 p90 -154.39 172.87 17.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.388 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -136.1 149.99 48.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.817 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.671 ' O ' HD11 ' A' ' 91' ' ' ILE . 4.2 m -110.21 94.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.461 -0.774 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.471 ' C ' ' CD1' ' A' ' 91' ' ' ILE . 1.3 pp -100.65 -2.63 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.778 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.464 ' N ' HD12 ' A' ' 91' ' ' ILE . 1.9 tt0 -155.83 140.31 16.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . 65.63 -176.02 15.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.911 ' CA ' HG23 ' A' ' 67' ' ' VAL . . . 76.51 -141.56 26.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.6 -6.69 18.6 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.092 1.575 . . . . 0.0 111.019 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.671 HD11 ' O ' ' A' ' 85' ' ' VAL 0.292 1.8 mt -63.31 117.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.104 -0.998 . . . . 0.0 110.362 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 137.23 42.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.19 96.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -1.191 . . . . 0.0 110.546 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 40.0 p 42.35 28.3 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 110.63 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 98' ' ' ILE . 6.5 mt -144.24 74.65 1.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 95' ' ' LEU . 10.3 tp10 -42.42 -58.33 2.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 110.56 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.551 ' CG ' ' HB2' ' A' ' 121' ' ' HIS . 28.8 pttt -144.53 162.37 36.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.827 HD11 HD13 ' A' ' 95' ' ' LEU . 39.7 mt -145.81 138.67 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 110.513 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.9 m -117.23 152.36 34.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 109.175 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -144.08 139.89 29.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.723 -1.236 . . . . 0.0 111.37 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.401 ' O ' HG13 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -117.81 154.58 31.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.396 179.19 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 1.3 mp -144.25 136.8 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -135.79 105.6 6.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.778 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.675 HD12 ' H ' ' A' ' 104' ' ' ILE . 4.4 mp -81.12 109.94 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 110.532 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.447 HG23 ' HD2' ' A' ' 115' ' ' LYS . 86.5 t -101.49 131.19 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.17 129.93 34.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.867 . . . . 0.0 110.053 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 17.7 p -86.46 164.41 37.94 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 49.0 Cg_endo -66.76 81.06 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.114 1.586 . . . . 0.0 110.371 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 60.5 t0 58.01 65.01 1.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 110.166 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.11 27.62 0.13 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.21 -165.48 31.53 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -131.45 174.9 9.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.335 -1.097 . . . . 0.0 110.041 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CG2' ' CD ' ' A' ' 8' ' ' GLU . 26.2 mt -136.75 121.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.989 . . . . 0.0 110.686 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.912 ' HB2' HG22 ' A' ' 9' ' ' THR . 7.6 mt -86.17 93.42 9.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.891 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HD2' HG23 ' A' ' 105' ' ' VAL . 4.1 mttm -69.22 117.99 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.302 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 7' ' ' THR . 94.3 mt -109.2 146.62 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.87 -1.144 . . . . 0.0 111.84 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.18 94.58 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -93.52 100.28 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 112.518 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -82.3 131.2 35.23 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.592 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 3.2 m-85 -110.88 112.85 24.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.775 -1.203 . . . . 0.0 110.715 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 63.2 m-70 -92.83 103.24 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.597 HG22 HD23 ' A' ' 95' ' ' LEU . 4.5 p -102.13 153.35 20.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.813 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 26.39 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.012 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.43 -162.74 14.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.33 -38.25 15.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -1.168 . . . . 0.0 110.309 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -74.34 -172.51 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.387 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.531 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 60.1 mp0 -124.0 -169.98 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 110.346 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.488 HG23 ' CD2' ' A' ' 3' ' ' PHE . 55.7 t -69.27 150.28 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 130' ' ' ALA . 3.9 mtmm -105.01 116.01 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.765 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.64 -52.79 4.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.26 -0.9 . . . . 0.0 110.366 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.6 -46.79 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 109.77 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.401 ' OE1' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -62.14 -45.03 95.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 108.996 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.003 HG11 ' CD2' ' A' ' 5' ' ' TYR . 53.0 t -62.42 -16.29 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.269 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.6 ttmt -86.42 -60.59 1.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.489 -0.757 . . . . 0.0 110.683 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -41.32 -50.16 3.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 110.092 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.6 t -56.11 -44.32 78.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 110.012 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -27.12 68.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -77.25 -33.9 55.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.422 -0.799 . . . . 0.0 109.924 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.485 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.32 -39.63 65.11 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.602 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.17 85.73 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.32 -32.44 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.273 . . . . 0.0 109.743 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 1.3 p -70.4 -34.81 72.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.247 -0.908 . . . . 0.0 108.802 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 1.024 HD21 HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -71.17 -53.69 13.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.188 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 114' ' ' LEU . 9.4 tp -51.4 -39.08 56.51 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -65.09 -38.21 90.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.569 -0.707 . . . . 0.0 109.426 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.988 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -61.48 -60.1 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.723 HG21 ' HD1' ' A' ' 22' ' ' PHE . 21.6 t -61.81 -24.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.512 ' O ' HD13 ' A' ' 152' ' ' LEU . 1.5 tt0 -68.14 -48.02 66.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.05 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.9 t -81.26 -17.05 50.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.766 ' CD2' HD21 ' A' ' 29' ' ' LEU . 9.8 t80 -69.7 -43.93 71.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.713 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.643 HD23 ' HB3' ' A' ' 157' ' ' ALA . 28.1 mt -63.95 -26.05 68.41 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.784 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -80.87 -42.47 21.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.098 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.12 -50.93 66.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.107 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -76.88 -162.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.195 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 6.5 t -92.39 54.19 2.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.537 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER 60.81 53.3 3.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.883 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.643 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -40.91 166.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.716 -0.615 . . . . 0.0 110.761 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.642 ' CD2' ' HB2' ' A' ' 21' ' ' ALA . 85.4 m-85 57.75 48.27 14.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.447 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.206 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.957 HG13 ' O ' ' A' ' 120' ' ' TYR . 92.5 t -101.03 153.27 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.156 -1.202 . . . . 0.0 110.426 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.841 ' CD1' HG23 ' A' ' 128' ' ' VAL . 92.3 m-85 -116.07 151.41 35.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.507 -0.745 . . . . 0.0 109.895 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -117.33 99.47 7.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 110.246 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.059 ' CD1' HG11 ' A' ' 133' ' ' VAL . 45.6 m-85 -97.18 99.93 11.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 117' ' ' SER . 3.3 mt-10 -109.42 136.3 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.97 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 -171.51 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.386 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' OE1' ' CG2' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -165.21 156.31 14.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 110.705 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.961 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -129.12 173.59 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.329 -0.857 . . . . 0.0 110.155 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.05 143.28 51.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.155 -0.966 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' HD11 ' A' ' 18' ' ' LEU . 8.3 t -140.25 147.48 40.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.101 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -21.35 15.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.615 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 36.7 mm -77.16 145.92 73.98 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.035 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.7 Cg_endo -56.72 157.93 18.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.91 1.479 . . . . 0.0 110.313 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB2' ' OG ' ' A' ' 112' ' ' SER . . . -69.48 -47.93 62.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.471 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -56.33 -44.92 80.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.942 -1.099 . . . . 0.0 110.782 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.563 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 1.3 mtt85 -68.78 -49.95 54.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.936 -1.103 . . . . 0.0 109.777 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.615 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 mt -52.08 -30.86 27.88 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.28 1.038 . . . . 0.0 108.518 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 1.125 ' CE1' HD21 ' A' ' 24' ' ' LEU . 8.9 t80 -72.44 -72.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.2 mtpt -45.1 -20.56 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 112.102 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -115.98 -61.83 1.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.537 -1.352 . . . . 0.0 112.11 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.841 ' HA ' HG11 ' A' ' 147' ' ' VAL . 9.8 t80 -65.51 -80.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.341 -1.475 . . . . 0.0 110.211 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 HD23 ' A' ' 24' ' ' LEU . 2.7 mt -43.98 -71.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.858 -1.151 . . . . 0.0 108.495 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.125 HD21 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -61.68 -179.47 0.19 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.645 ' OD2' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER 66.11 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.126 -0.984 . . . . 0.0 108.95 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' CG ' ' A' ' 25' ' ' ASP . . . 52.4 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 O-C-N 120.723 -1.235 . . . . 0.0 111.08 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.5 p30 -47.46 -20.37 0.23 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -1.092 . . . . 0.0 111.524 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.787 ' O ' HD22 ' A' ' 29' ' ' LEU . 53.5 t30 -110.38 38.89 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 109.779 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.787 HD22 ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -161.07 -49.34 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.465 -0.772 . . . . 0.0 110.56 -179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.79 ' CD1' HD12 ' A' ' 143' ' ' LEU . 8.0 m-30 -56.39 -53.64 61.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 0.0 111.531 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.1 -4.38 8.93 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 O-C-N 123.293 1.154 . . . . 0.0 111.83 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 13.6 mmtt -109.33 -66.24 1.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.801 -1.187 . . . . 0.0 110.692 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.014 HG23 ' HB1' ' A' ' 146' ' ' ALA . 13.7 m -75.72 -14.19 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.87 64.3 27.82 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.04 -1.038 . . . . 0.0 110.849 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.1 -8.5 22.92 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 109.764 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.4 tt0 -86.28 -17.4 34.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.564 -0.71 . . . . 0.0 109.432 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.482 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -108.65 -37.99 5.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.656 HD13 ' HB3' ' A' ' 30' ' ' PHE . 2.2 mp -127.7 164.87 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -138.14 -47.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 110.284 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.9 t -161.9 130.17 4.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.118 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.644 HG22 HG13 ' A' ' 56' ' ' ILE . 54.2 t -95.84 129.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.138 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 14.8 tt0 . . . . . 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.227 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 53' ' ' ILE . 1.1 m . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.69 0.757 . . . . 0.0 111.641 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 52' ' ' THR . 20.5 mm 33.36 101.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.948 0.88 . . . . 0.0 111.932 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -134.43 158.07 44.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -129.39 142.27 50.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.472 -1.393 . . . . 0.0 111.839 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.656 ' HB ' HG13 ' A' ' 67' ' ' VAL . 1.2 mp -121.64 115.85 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 101.03 10.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.831 . . . . 0.0 110.817 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.649 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . 8.6 m-85 -56.46 177.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.229 -0.919 . . . . 0.0 108.933 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -75.85 145.84 29.06 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.387 1.204 . . . . 0.0 109.962 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' PRO . 1.1 tt0 -41.88 165.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.62 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.27 36.13 15.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 58' ' ' PHE . 3.4 mt -106.31 156.03 37.63 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.127 -1.219 . . . . 0.0 110.561 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.74 -30.77 9.17 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.081 1.569 . . . . 0.0 109.199 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 20.0 m-30 -101.23 -96.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.632 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 179.92 -35.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.806 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 51.5 p90 -179.54 -158.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.375 -0.828 . . . . 0.0 109.687 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 67' ' ' VAL . 7.0 p -163.16 108.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.565 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -99.05 160.91 13.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.995 ' HB3' HG12 ' A' ' 85' ' ' VAL . 2.6 p-10 -173.15 139.3 0.79 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.841 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -87.38 146.71 25.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.043 -1.036 . . . . 0.0 110.341 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.418 ' H ' ' HA ' ' A' ' 52' ' ' THR . 1.2 t -102.22 167.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.307 -0.87 . . . . 0.0 109.706 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -140.55 56.68 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 110.235 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' C ' HG23 ' A' ' 74' ' ' VAL . 1.9 mt-10 63.19 177.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.927 . . . . 0.0 109.918 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.615 HG22 ' CD1' ' A' ' 81' ' ' TYR . 5.2 t -151.06 137.85 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 111.063 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.453 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -80.43 179.98 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.141 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 4.1 m-70 -136.08 -49.86 0.69 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.786 -1.196 . . . . 0.0 111.114 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -49.91 -57.6 7.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.908 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -96.0 21.28 8.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.087 -1.008 . . . . 0.0 110.843 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 11.4 m-85 41.24 73.74 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 0.0 109.912 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 2.6 tttt -117.76 106.74 13.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 110.746 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD1' HG22 ' A' ' 74' ' ' VAL . 11.0 t80 -111.42 105.47 14.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -113.46 153.88 27.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.861 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 33.7 p90 -165.29 173.4 11.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 109.924 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.97 121.94 26.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.187 -0.946 . . . . 0.0 111.086 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.995 HG12 ' HB3' ' A' ' 69' ' ' ASP . 15.5 m -95.51 122.52 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.503 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.1 pp -123.19 -0.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 8.2 mt-10 -158.33 150.85 22.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.493 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 90.6 -179.45 43.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.65 -145.74 31.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 51.0 Cg_endo -85.93 31.49 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.55 . . . . 0.0 110.834 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -33.21 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.468 0.652 . . . . 0.0 110.905 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.02 -168.38 40.22 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 11.2 m-20 -87.68 -9.75 53.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -1.142 . . . . 0.0 110.47 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 58.8 p -101.64 41.68 1.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.95 HD12 ' NE2' ' A' ' 132' ' ' GLN . 1.5 mt 169.16 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.13 -45.94 3.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 110.764 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 14.3 mtpp -131.47 143.13 50.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 110.514 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.73 ' HB ' HG23 ' A' ' 85' ' ' VAL . 81.3 mt -140.21 118.4 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.998 -1.064 . . . . 0.0 110.564 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.51 160.43 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 109.793 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 20.8 t-20 -149.35 145.3 26.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.027 -1.045 . . . . 0.0 111.257 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -132.46 129.2 38.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.522 -0.736 . . . . 0.0 109.078 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 26.8 mm -113.38 135.92 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 0.0 110.396 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 2.4 mtpm? -139.0 105.39 5.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 110.301 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 23' ' ' ILE . 72.1 mt -83.84 148.89 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 110.05 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.95 128.71 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.03 132.93 34.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.128 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -107.43 152.44 41.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.414 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.75 -21.79 44.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.291 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.15 -50.77 69.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 142.35 54.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.46 -167.99 34.65 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.823 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -148.69 145.43 27.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -1.124 . . . . 0.0 109.856 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.515 ' CG2' ' OE1' ' A' ' 8' ' ' GLU . 8.9 mt -109.14 135.19 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.961 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.5 mp -99.18 108.47 21.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -0.906 . . . . 0.0 110.022 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.79 118.76 26.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 109.749 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.3 mt -110.04 121.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.426 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -118.66 100.86 7.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 109.35 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -103.31 115.6 30.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.168 -0.957 . . . . 0.0 111.078 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HG2' ' NE2' ' A' ' 121' ' ' HIS . 1.9 tptt -95.7 115.65 27.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.408 -0.808 . . . . 0.0 108.951 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.957 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.4 m-85 -90.41 147.2 23.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.117 -0.989 . . . . 0.0 111.012 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 73.4 m-70 -133.71 91.48 2.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.604 -0.685 . . . . 0.0 109.21 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 9.7 p -83.03 -179.49 7.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.638 -0.664 . . . . 0.0 110.465 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -84.87 6.1 26.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.094 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 101.72 -166.23 18.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 t0 50.15 -91.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 110.29 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' GLY . 62.7 m-70 -66.24 156.63 33.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 110.145 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -107.99 169.45 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 3' ' ' PHE . 55.7 t -59.09 151.27 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.054 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 130' ' ' ALA . 46.0 mtmt -96.06 117.22 30.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 0.0 110.419 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -46.13 -38.24 7.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -56.4 -47.59 78.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.838 . . . . 0.0 109.38 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.95 ' NE2' HD12 ' A' ' 95' ' ' LEU . 21.5 mt-30 -61.78 -38.31 87.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.059 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.1 t -68.78 -19.5 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.768 0.794 . . . . 0.0 109.421 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -85.99 -66.89 0.85 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.463 -0.773 . . . . 0.0 110.921 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -34.47 -40.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.482 -0.761 . . . . 0.0 110.88 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 t -64.36 -52.79 56.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -54.86 -45.88 74.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.128 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 139' ' ' MET . 3.2 mt-10 -56.72 -59.58 4.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.196 -0.94 . . . . 0.0 109.743 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -44.99 -49.19 11.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.058 -1.027 . . . . 0.0 109.651 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.2 92.84 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 142' ' ' THR . 35.2 tt0 -74.78 -65.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.313 . . . . 0.0 110.501 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -42.28 -46.45 4.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.587 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.79 HD12 ' CD1' ' A' ' 30' ' ' PHE . 3.5 mm? -63.88 -55.23 24.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 109.84 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.607 HD13 ' CD2' ' A' ' 114' ' ' LEU . 22.5 tp -40.45 -46.17 2.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.432 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -43.33 92.07 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.804 . . . . 0.0 109.55 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.014 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.2 -61.75 2.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 110.085 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.841 HG11 ' HA ' ' A' ' 22' ' ' PHE . 24.7 t -67.49 -18.26 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.815 . . . . 0.0 110.644 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 18.1 tt0 -70.98 -47.1 60.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 0.0 109.557 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 -21.77 31.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.9 ' HB2' HG11 ' A' ' 33' ' ' VAL . 10.6 t80 -57.6 -49.52 76.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.475 -0.765 . . . . 0.0 109.699 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 150' ' ' TYR . 65.3 mt -54.98 -25.71 31.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.582 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -84.64 -33.16 23.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.892 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.477 ' HB3' ' HD2' ' A' ' 154' ' ' HIS . . . -68.32 -46.82 69.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.22 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.477 ' HD2' ' HB3' ' A' ' 153' ' ' ALA . 19.2 m-70 -90.27 -24.75 20.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' HIS . 1.4 p 44.24 30.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.312 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -152.34 15.32 0.61 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.598 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' CE2' ' A' ' 158' ' ' TYR . . . -110.5 131.53 54.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.076 -1.015 . . . . 0.0 110.112 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.73 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 37.7 m-85 63.88 9.33 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.397 -0.814 . . . . 0.0 110.458 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.189 -179.803 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.464 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.55 HG22 ' HA ' ' A' ' 121' ' ' HIS . 97.2 t -72.62 151.14 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -1.083 . . . . 0.0 110.347 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 56.9 m-85 -109.74 131.7 54.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 109.607 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -95.25 95.53 8.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.886 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.827 ' HE2' HG11 ' A' ' 128' ' ' VAL . 23.2 m-30 -101.6 95.75 6.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.83 . . . . 0.0 110.24 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -88.01 126.37 35.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.303 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 t -145.4 178.33 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.18 . . . . 0.0 111.191 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' OE1' HG21 ' A' ' 113' ' ' ILE . 7.2 pt-20 -168.43 159.19 10.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.543 -0.723 . . . . 0.0 109.688 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.771 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.9 t -132.16 162.63 30.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.417 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -113.48 142.57 45.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.621 ' HB3' HD11 ' A' ' 18' ' ' LEU . 48.0 t -140.73 143.36 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.983 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.47 -2.04 2.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 109.968 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.58 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 19.2 mm -91.95 146.42 32.84 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 110.243 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.8 Cg_endo -57.39 153.82 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 0.0 110.162 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.487 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -62.81 -59.47 4.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -0.996 . . . . 0.0 110.479 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -42.96 -59.92 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 1.066 ' CZ ' HD12 ' A' ' 151' ' ' LEU . 6.7 ttp180 -53.03 -57.71 9.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.554 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 11' ' ' SER . 10.7 mt -45.6 -32.71 2.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.811 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -72.41 -55.54 6.88 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 110.687 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -60.1 -33.41 72.07 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.821 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -107.74 -34.78 6.87 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.264 -1.523 . . . . 0.0 112.551 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 81.3 t80 -102.53 9.45 39.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.731 -1.231 . . . . 0.0 111.873 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 29.2 mm -142.98 -26.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.823 -1.173 . . . . 0.0 110.968 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.811 HD21 ' CE1' ' A' ' 19' ' ' PHE . 4.1 mt -103.8 -35.89 8.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.713 -1.242 . . . . 0.0 109.16 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.495 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -112.97 41.08 2.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.585 -0.697 . . . . 0.0 110.535 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.24 -30.36 62.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.994 ' OD1' HG13 ' A' ' 41' ' ' VAL . 3.2 t70 -69.1 -6.41 28.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 2.5 t30 -126.01 13.91 7.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -130.98 -43.91 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.773 ' CD1' HD12 ' A' ' 143' ' ' LEU . 7.6 m-30 -57.58 -54.41 55.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 111.197 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -66.97 -15.21 46.34 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.34 1.179 . . . . 0.0 111.293 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.527 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 4.8 mptt -91.08 -71.81 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 110.736 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.855 HG23 ' HB1' ' A' ' 146' ' ' ALA . 17.4 m -75.52 -18.25 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.839 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -118.59 60.6 4.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.624 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.9 Cg_endo -67.61 -19.91 47.63 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.934 1.492 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.507 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 2.2 tt0 -82.62 -16.42 48.41 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.662 0.744 . . . . 0.0 109.073 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.766 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -100.18 -63.15 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.286 -0.884 . . . . 0.0 110.574 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.676 HD13 ' HB3' ' A' ' 30' ' ' PHE . 3.7 mp -115.63 153.94 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.693 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 -38.15 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 109.631 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 57' ' ' SER . 47.7 p -177.64 151.91 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.533 -0.729 . . . . 0.0 109.681 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.994 HG13 ' OD1' ' A' ' 27' ' ' ASP . 3.7 p -141.46 129.15 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.972 . . . . 0.0 110.571 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.915 . . . . 0.0 110.991 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.179 0.514 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.6 mm -113.33 108.96 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.271 -0.893 . . . . 0.0 110.251 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -150.17 168.55 23.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 20.5 ttpt -121.4 113.51 19.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.639 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.1 mp -72.75 144.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -131.7 165.52 23.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.58 -0.7 . . . . 0.0 109.697 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 56' ' ' ILE . 30.7 m-85 -137.9 157.04 73.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.042 -1.037 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 60' ' ' GLU . 50.4 Cg_endo -75.48 154.74 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.159 1.61 . . . . 0.0 109.901 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 59' ' ' PRO . 4.7 pt-20 -42.78 157.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.283 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.13 -58.8 0.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 58' ' ' PHE . 11.6 mt -62.18 161.17 26.03 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.161 -1.199 . . . . 0.0 110.35 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.16 -38.6 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.152 1.606 . . . . 0.0 110.4 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 9.2 m-30 -92.91 153.39 18.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -104.19 -17.36 14.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.839 ' O ' HG13 ' A' ' 67' ' ' VAL . 29.1 p90 -174.14 -173.34 0.79 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.718 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.839 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -177.66 115.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 109.947 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -68.98 134.16 49.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.428 ' HB2' HD13 ' A' ' 56' ' ' ILE . 24.3 t0 -128.5 127.27 42.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 110.951 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -127.94 103.32 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.414 -0.804 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 83' ' ' TYR . 32.2 m -57.01 -32.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.287 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 64.08 5.75 2.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -0.917 . . . . 0.0 110.729 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 167.36 177.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -179.23 125.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 109.658 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -104.58 -176.74 3.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.24 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.73 -67.28 0.32 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.3 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.8 m -58.12 -36.32 72.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 0.0 110.532 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 5.5 m-80 -93.73 0.77 56.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.006 . . . . 0.0 110.694 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 19.8 m-30 57.06 14.92 2.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 110.552 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HA ' ' CB ' ' A' ' 103' ' ' LYS . 16.5 mttm -71.61 136.53 47.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.086 . . . . 0.0 109.744 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 67.8 t80 -149.72 121.82 8.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 110.462 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.569 ' HA ' ' CB ' ' A' ' 101' ' ' GLU . 4.6 m-20 -125.29 142.94 51.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.88 . . . . 0.0 110.558 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -152.34 149.49 28.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.105 -0.997 . . . . 0.0 111.102 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.58 135.78 54.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.553 -0.717 . . . . 0.0 109.691 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 98' ' ' ILE . 2.2 p -103.62 123.91 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.545 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 1.5 pp -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 1.8 tt0 73.91 138.49 0.06 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 0.0 110.603 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.414 ' CA ' ' CE2' ' A' ' 66' ' ' TYR . . . 81.08 162.85 29.32 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.83 -144.65 17.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.9 Cg_endo -81.9 22.57 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.98 1.516 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -38.83 164.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.359 -0.838 . . . . 0.0 111.116 -179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.6 38.14 7.16 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 90' ' ' PRO . 9.7 t0 -155.37 68.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.812 ' O ' HD22 ' A' ' 95' ' ' LEU . 13.9 p 48.28 38.18 9.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.88 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -159.92 60.38 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -49.09 -72.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -128.35 159.98 33.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.847 ' O ' HG12 ' A' ' 85' ' ' VAL . 71.3 mt -137.39 117.27 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.85 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.45 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 28.8 t -103.92 128.19 51.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 0.0 110.607 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.594 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 19.0 m-20 -129.19 134.07 47.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.603 ' O ' HG12 ' A' ' 102' ' ' ILE . 6.6 pt-20 -175.56 149.09 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 117.881 -1.528 . . . . 0.0 113.312 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.868 HG22 ' N ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -178.58 -95.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.868 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.7 OUTLIER 176.0 -176.49 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 0.0 110.625 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.054 HG23 HD23 ' A' ' 114' ' ' LEU . 36.2 mt -113.76 124.79 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 108.915 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.508 ' CG2' ' HD2' ' A' ' 115' ' ' LYS . 64.6 t -96.92 125.72 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.3 131.78 37.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.668 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 112' ' ' SER . 67.6 p -78.67 162.51 65.23 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 47.7 Cg_endo -66.92 -18.16 52.11 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.066 1.561 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -171.04 -30.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 111.239 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.26 -88.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.533 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . -151.09 -95.45 0.12 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.63 ' HA ' HG23 ' A' ' 107' ' ' THR . 11.9 m -171.12 137.0 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.323 -1.104 . . . . 0.0 109.83 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.472 HG21 ' OE1' ' A' ' 8' ' ' GLU . 2.2 mt -100.95 114.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.095 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 1.054 HD23 HG23 ' A' ' 104' ' ' ILE . 45.8 mt -71.71 103.01 2.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.58 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.737 ' HB3' HG21 ' A' ' 102' ' ' ILE . 78.6 mttt -86.64 126.16 34.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.853 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.469 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 16.4 mt -137.25 130.27 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 100' ' ' ASN . 36.6 m -96.28 102.48 14.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.082 -1.011 . . . . 0.0 108.963 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.526 ' OD1' ' ND2' ' A' ' 100' ' ' ASN . 1.5 m-80 -83.63 143.74 29.9 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.435 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 117.8 9.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.88 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.7 m-85 -92.98 99.86 12.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.018 -1.051 . . . . 0.0 111.115 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.55 ' HA ' HG22 ' A' ' 2' ' ' VAL . 73.5 m-70 -82.04 83.88 7.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.409 -0.807 . . . . 0.0 109.192 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.564 HG21 HG23 ' A' ' 128' ' ' VAL . 11.7 p -82.21 -146.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.843 . . . . 0.0 110.571 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.79 18.98 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 0.0 110.708 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.67 -143.55 16.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.3 t0 48.53 -144.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -1.148 . . . . 0.0 110.116 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -50.04 149.71 2.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.833 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.53 170.9 13.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 110.492 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.827 HG11 ' HE2' ' A' ' 5' ' ' TYR . 35.4 t -62.27 143.27 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HE3' ' OE1' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -85.91 110.01 19.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.52 -49.03 10.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.154 -0.966 . . . . 0.0 109.795 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.15 -43.25 74.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.011 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.463 ' OE1' ' HE3' ' A' ' 129' ' ' LYS . 42.6 tt0 -58.34 -38.55 77.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -0.753 . . . . 0.0 109.478 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.556 HG22 ' CE2' ' A' ' 120' ' ' TYR . 4.0 t -77.5 -17.6 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 109.798 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.1 tptt -81.35 -61.9 1.81 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -0.791 . . . . 0.0 110.369 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -39.23 -50.49 1.95 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.338 -0.851 . . . . 0.0 110.163 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -48.18 74.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.355 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -36.39 69.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -61.89 -59.95 4.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.144 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -46.13 -42.83 14.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.158 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.53 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.01 -47.53 71.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -1.224 . . . . 0.0 110.907 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -53.5 -38.34 63.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.021 -1.05 . . . . 0.0 109.186 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.773 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.5 mm? -69.99 -50.21 43.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.836 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 114' ' ' LEU . 14.5 tp -51.14 -30.87 17.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 108.792 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -43.73 34.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 110.075 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.855 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.91 -48.32 78.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 109.896 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 29' ' ' LEU . 27.7 t -74.03 -36.5 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.41 -0.806 . . . . 0.0 110.111 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' HD13 ' A' ' 152' ' ' LEU . 19.6 tt0 -57.19 -41.03 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.52 -25.52 21.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.93 . . . . 0.0 110.083 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.778 ' HB2' HG11 ' A' ' 33' ' ' VAL . 7.3 t80 -57.39 -33.71 68.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.746 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.066 HD12 ' CZ ' ' A' ' 17' ' ' ARG . 20.1 mt -79.07 -26.19 43.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.201 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 148' ' ' GLU . 8.1 mp -78.53 -22.38 47.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.22 -45.43 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -72.37 171.9 11.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 110.697 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.6 t -54.01 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 3.8 p-10 -155.53 54.34 0.61 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 110.756 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.618 ' HB3' ' CD2' ' A' ' 151' ' ' LEU . . . -59.08 133.95 56.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.875 -1.14 . . . . 0.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.821 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 53.2 m-85 62.37 62.3 1.17 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.679 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.175 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 120' ' ' TYR . 78.2 t -76.69 151.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -1.195 . . . . 0.0 110.046 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 127' ' ' GLU . 87.1 m-85 -115.28 129.46 56.63 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 110.206 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.25 105.1 16.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.94 ' CD1' HG11 ' A' ' 133' ' ' VAL . 23.5 m-85 -106.58 82.11 1.68 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -88.04 157.41 18.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 0.0 110.937 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.549 ' CG2' ' HB ' ' A' ' 116' ' ' ILE . 11.5 t -173.39 -174.02 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 0.0 109.693 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 7' ' ' THR . 6.9 mt-10 -140.19 149.9 43.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.107 -0.996 . . . . 0.0 110.335 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 1.042 HG23 HD22 ' A' ' 144' ' ' LEU . 0.5 OUTLIER -158.5 136.5 10.59 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.239 -0.913 . . . . 0.0 109.21 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.785 HG21 ' CA ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER 175.88 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 119.778 -1.826 . . . . 0.0 113.967 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.488 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -169.38 -175.52 2.24 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.935 -178.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.598 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -72.79 -15.76 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.21 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.57 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 4.6 mm -61.51 140.87 94.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 110.045 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -56.08 158.54 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.029 1.542 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.686 ' HB2' ' OG ' ' A' ' 112' ' ' SER . . . -70.24 -32.84 70.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.685 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.32 90.83 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 110.686 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.491 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 19.2 mtm180 -79.25 -50.33 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.078 . . . . 0.0 109.893 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -57.69 -30.94 65.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.782 ' CE2' HD21 ' A' ' 24' ' ' LEU . 61.8 t80 -79.11 -46.3 18.31 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.624 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -68.19 -20.95 64.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.773 . . . . 0.0 112.155 -178.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -111.71 -31.66 6.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.678 -1.264 . . . . 0.0 112.15 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB2' HG11 ' A' ' 147' ' ' VAL . 86.0 t80 -107.16 -13.25 15.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.682 -1.261 . . . . 0.0 111.934 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.643 HG21 ' CE1' ' A' ' 19' ' ' PHE . 39.4 mm -122.46 -16.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.794 -1.192 . . . . 0.0 110.486 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.782 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -112.38 -29.48 7.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.231 -0.918 . . . . 0.0 110.173 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.508 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -137.15 66.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.886 -179.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -83.56 -25.48 46.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.721 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.7 p30 -80.18 13.73 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.515 -0.991 . . . . 0.0 110.834 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 89.7 m-20 -135.97 37.77 2.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.826 -1.171 . . . . 0.0 108.15 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.016 HD21 HG13 ' A' ' 147' ' ' VAL . 0.3 OUTLIER 174.68 -36.42 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.188 -177.033 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 3.2 m-30 -38.79 -62.09 0.79 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.62 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 55.6 Cg_endo -69.83 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.902 1.475 . . . . 0.0 110.725 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.8 mmtt -49.74 -25.9 3.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 111.14 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HB1' ' A' ' 146' ' ' ALA . 3.6 m -120.16 -10.13 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.049 . . . . 0.0 110.789 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -139.05 65.51 36.83 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.045 -1.034 . . . . 0.0 110.459 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 59' ' ' PRO . 41.8 Cg_endo -68.67 -13.63 37.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.05 1.553 . . . . 0.0 109.542 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.724 ' OE1' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -82.98 -14.96 53.03 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.724 ' HB2' ' OE1' ' A' ' 36' ' ' GLN . . . -110.48 -58.53 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.23 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -115.35 125.82 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.008 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.482 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 8.1 t -82.9 -38.74 22.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.826 . . . . 0.0 110.354 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 p -172.45 151.22 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.328 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.721 HG11 ' HB2' ' A' ' 27' ' ' ASP . 7.3 p -99.61 129.49 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.644 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HB3' ' CB ' ' A' ' 55' ' ' LYS . 13.4 tp10 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.581 -0.699 . . . . 0.0 109.647 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.844 ' C ' HD12 ' A' ' 53' ' ' ILE . 95.2 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.144 0.497 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.844 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -114.93 134.66 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 110.676 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -123.32 148.06 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.885 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 28.7 mttp -121.76 84.72 2.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.869 . . . . 0.0 110.223 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.6 mp -66.42 125.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.867 -1.146 . . . . 0.0 109.141 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -105.78 126.31 52.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.631 -1.293 . . . . 0.0 111.318 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.643 ' CD2' HD12 ' A' ' 62' ' ' LEU . 10.8 m-30 -84.82 141.93 38.72 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.458 -0.777 . . . . 0.0 110.59 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 39' ' ' SER . 43.7 Cg_endo -70.48 -179.23 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.936 1.493 . . . . 0.0 108.77 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.24 163.82 12.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.723 -1.236 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.61 -47.92 3.9 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.812 HD13 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -49.83 159.07 0.79 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 111.041 -179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.812 ' HD2' HD13 ' A' ' 62' ' ' LEU . 45.0 Cg_endo -72.1 152.37 56.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.187 1.625 . . . . 0.0 108.586 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 52.84 -136.19 1.41 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.158 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -152.25 -3.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.901 -1.124 . . . . 0.0 112.093 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.926 ' O ' HG13 ' A' ' 67' ' ' VAL . 43.9 p90 178.02 -158.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.837 -1.165 . . . . 0.0 110.442 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -173.07 130.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.53 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -95.85 154.12 17.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.566 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.85 127.16 12.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.01 -1.056 . . . . 0.0 111.241 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.68 142.02 31.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 109.127 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 73' ' ' GLU . 46.1 t -110.21 137.97 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 111.157 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -110.98 47.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.379 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' H ' HG12 ' A' ' 71' ' ' VAL . 1.6 mt-10 63.69 110.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 109.863 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.741 HG12 ' CD1' ' A' ' 81' ' ' TYR . 3.8 m -82.72 168.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.329 -0.857 . . . . 0.0 110.499 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -102.89 139.51 38.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.829 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -102.42 -48.8 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.36 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.7 m -53.59 -42.31 67.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.909 -1.119 . . . . 0.0 110.928 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 79' ' ' PHE . 17.9 m120 -105.73 15.2 27.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.053 . . . . 0.0 110.811 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.563 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 12.3 m-30 41.58 59.23 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 110.291 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -115.53 164.85 13.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 0.0 109.942 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.741 ' CD1' HG12 ' A' ' 74' ' ' VAL . 10.1 t80 -147.69 143.0 27.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.913 . . . . 0.0 110.5 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -145.56 100.41 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.824 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.538 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 38.2 p90 -128.59 168.97 14.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.51 135.39 53.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.457 HG22 ' HE2' ' A' ' 83' ' ' TYR . 21.4 t -94.92 112.34 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.664 HD12 ' OE1' ' A' ' 87' ' ' GLU . 18.6 pt -132.32 150.67 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.664 ' OE1' HD12 ' A' ' 86' ' ' ILE . 27.7 mp0 58.65 156.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 110.722 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.586 ' CA ' ' CE2' ' A' ' 66' ' ' TYR . . . 61.04 149.06 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.11 -141.45 15.6 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ILE . 50.1 Cg_endo -84.2 26.62 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.022 1.538 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.35 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.531 -0.73 . . . . 0.0 110.517 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.45 -160.23 28.23 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -93.83 -30.74 14.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.463 ' O ' ' HB ' ' A' ' 122' ' ' THR . 71.0 p -59.75 -24.45 64.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 120' ' ' TYR . 1.7 mt -146.18 86.74 1.71 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -81.42 -41.66 21.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.902 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.7 mmtt -123.0 158.49 30.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.997 -1.064 . . . . 0.0 110.527 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.623 ' CG1' HD22 ' A' ' 95' ' ' LEU . 12.9 mt -158.27 115.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.485 -0.759 . . . . 0.0 109.996 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 t -103.69 114.28 28.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 109.96 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 7.1 m120 -116.67 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.051 -1.03 . . . . 0.0 110.964 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.603 ' C ' HD12 ' A' ' 102' ' ' ILE . 3.9 pt-20 -141.98 145.48 34.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.492 -0.755 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.603 HD12 ' C ' ' A' ' 101' ' ' GLU . 1.3 mp -126.14 135.25 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.832 -1.168 . . . . 0.0 110.193 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 ttpt -115.89 101.33 8.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.375 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.738 HD13 ' CD1' ' A' ' 19' ' ' PHE . 4.7 mp -78.81 135.67 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.964 -1.085 . . . . 0.0 109.785 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.85 125.94 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.25 140.04 35.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.336 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.6 p -100.35 157.43 33.81 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.968 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.07 -16.87 50.33 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.034 1.544 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -161.64 83.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.026 -1.046 . . . . 0.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 168.98 -87.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -173.68 -153.17 9.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.686 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -108.26 143.78 36.64 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.174 -1.192 . . . . 0.0 109.344 179.06 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.785 ' CA ' HG21 ' A' ' 10' ' ' THR . 1.8 mt -119.68 137.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.401 0.62 . . . . 0.0 111.373 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.833 ' HB2' ' O ' ' A' ' 9' ' ' THR . 2.5 mp -101.27 110.33 22.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.447 -0.783 . . . . 0.0 109.513 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 1.8 mptp? -81.14 104.98 11.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.549 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 77.5 mt -93.47 112.83 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.661 0.743 . . . . 0.0 112.23 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.1 111.66 23.41 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.401 ' OD1' HG22 ' A' ' 116' ' ' ILE . 16.5 m120 -110.42 96.58 6.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 111.216 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.711 ' HD3' HG11 ' A' ' 2' ' ' VAL . 1.6 mttt -84.56 99.69 10.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.921 ' CD2' HD11 ' A' ' 95' ' ' LEU . 3.2 m-85 -75.83 132.8 40.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.772 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.679 ' CE1' HG21 ' A' ' 2' ' ' VAL . 55.4 m-70 -114.49 100.07 8.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.839 HG21 HG23 ' A' ' 128' ' ' VAL . 6.3 p -104.6 179.48 4.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 110.332 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 122' ' ' THR . 1.1 ptpm? 175.21 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 159.62 126.47 0.85 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.18 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 47.89 -150.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -1.075 . . . . 0.0 110.824 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 125' ' ' ASP . 4.3 m-70 -42.13 166.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.359 -0.838 . . . . 0.0 110.533 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -107.44 -121.21 0.24 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 110.141 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.839 HG23 HG21 ' A' ' 122' ' ' THR . 97.7 t -103.2 141.8 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.822 -1.174 . . . . 0.0 110.492 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 130' ' ' ALA . 37.5 mtmt -107.29 124.22 49.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.699 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.32 -41.31 5.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.173 -0.955 . . . . 0.0 109.786 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 tm-20 -52.03 -49.53 63.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.209 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.44 ' NE2' ' HB2' ' A' ' 90' ' ' PRO . 7.6 mt-30 -61.87 -43.29 99.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.195 -0.94 . . . . 0.0 109.007 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.94 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.9 t -62.0 -18.33 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.137 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 23.3 ttpt -87.72 -63.61 1.28 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 110.694 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.12 -47.98 0.79 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.697 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -47.22 87.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -64.77 -19.37 65.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 24.4 tt0 -78.7 -45.47 21.21 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 62' ' ' LEU . 44.0 mmm -64.0 -35.18 79.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.532 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.43 -42.62 73.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.17 -33.35 74.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.999 -1.295 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.25 70.4 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.164 -0.96 . . . . 0.0 109.045 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -69.96 -29.31 66.4 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 1.042 HD22 HG23 ' A' ' 9' ' ' THR . 15.9 tp -69.13 -46.07 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -33.4 75.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.39 -0.819 . . . . 0.0 108.945 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.037 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -62.52 -54.65 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.822 . . . . 0.0 109.273 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 1.016 HG13 HD21 ' A' ' 29' ' ' LEU . 39.2 t -70.99 -16.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -0.768 . . . . 0.0 109.968 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 11' ' ' SER . 5.5 tm-20 -75.17 -44.33 47.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.635 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -15.29 32.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.404 -0.81 . . . . 0.0 109.707 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.653 ' CG ' ' CD1' ' A' ' 29' ' ' LEU . 4.1 t80 -64.69 -52.12 58.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.352 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 150' ' ' TYR . 84.8 mt -53.46 -30.71 42.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.706 -0.621 . . . . 0.0 110.167 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.26 -51.76 10.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.701 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 154' ' ' HIS . . . -55.24 -53.76 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.451 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 153' ' ' ALA . 46.2 m-70 -60.01 -122.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.038 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 9.6 t -175.02 -31.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.59 -1.319 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -144.54 39.94 1.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 110.938 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.5 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -85.0 128.4 34.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.776 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.756 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 44.4 m-85 56.16 49.26 15.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.286 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 120' ' ' TYR . 9.2 p -144.66 161.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -1.12 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 76.5 m-85 -132.82 161.4 34.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.382 -0.824 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.59 106.82 10.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -0.963 . . . . 0.0 110.437 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.041 ' CD1' HG11 ' A' ' 133' ' ' VAL . 44.7 m-85 -108.14 86.8 2.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.398 -0.814 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -101.76 156.34 17.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.666 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -166.15 176.63 7.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.972 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 115' ' ' LYS . 29.2 mp0 -146.35 137.05 24.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.883 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.5 t -118.26 166.43 12.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.87 142.31 51.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.698 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.54 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -141.19 147.95 39.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.49 -39.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.433 -0.792 . . . . 0.0 110.174 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.598 HD11 ' CD1' ' A' ' 152' ' ' LEU . 3.4 mm -58.88 141.91 85.17 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.486 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 35.7 Cg_endo -57.89 155.27 33.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.912 1.48 . . . . 0.0 110.804 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -60.68 -36.68 79.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 110.103 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . . . -62.68 -56.24 19.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 110.735 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 51.7 mtt180 -61.3 -55.17 34.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.151 -0.968 . . . . 0.0 110.245 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -52.27 -33.72 43.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.221 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.745 ' CE2' HD21 ' A' ' 24' ' ' LEU . 75.7 t80 -69.88 -52.6 23.43 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 11.5 mtmm -61.26 -25.34 67.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 0.0 111.552 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -105.66 -61.12 1.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 111.522 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' HB2' HG11 ' A' ' 147' ' ' VAL . 80.7 t80 -76.28 -4.9 44.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.304 -0.872 . . . . 0.0 112.253 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.65 ' C ' HD23 ' A' ' 24' ' ' LEU . 34.9 mm -132.95 -20.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.642 -1.286 . . . . 0.0 111.123 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.745 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -111.19 -5.69 14.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -154.75 53.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 110.557 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.36 -21.78 55.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.5 ' HB2' HG11 ' A' ' 41' ' ' VAL . 49.8 p30 -68.21 -15.44 63.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -1.086 . . . . 0.0 110.449 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.49 ' ND2' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -122.77 10.75 9.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.77 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.827 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -122.27 -42.68 2.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.339 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.753 ' CD1' HD12 ' A' ' 143' ' ' LEU . 7.3 m-30 -60.7 -51.8 77.12 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.87 . . . . 0.0 111.684 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.9 Cg_endo -65.42 -4.82 10.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.224 1.118 . . . . 0.0 111.741 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -107.93 -64.11 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.898 -1.126 . . . . 0.0 110.5 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 29' ' ' LEU . 18.5 m -71.95 -17.71 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.97 66.3 75.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.101 -0.999 . . . . 0.0 110.872 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.0 Cg_endo -68.39 -19.96 42.78 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 109.466 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -83.9 -9.57 58.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.558 -0.714 . . . . 0.0 109.548 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -105.56 -59.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.968 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.16 161.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.514 ' HB2' ' N ' ' A' ' 59' ' ' PRO . 42.8 t -111.15 -57.44 2.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.055 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.38 144.48 3.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.914 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 27' ' ' ASP . 12.8 p -109.29 139.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.163 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 5.1 mt-10 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.129 -0.982 . . . . 0.0 109.87 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.2 m . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.277 0.561 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.545 HD13 ' HG3' ' A' ' 70' ' ' ARG . 22.8 mm -85.68 121.7 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.099 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -137.76 154.31 49.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.495 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -125.38 107.24 10.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.392 -0.817 . . . . 0.0 110.173 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' A' ' 67' ' ' VAL . 1.7 mp -73.44 136.34 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 109.664 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -119.04 162.16 19.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 110.356 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 19.5 m-85 -128.05 161.57 55.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.514 ' N ' ' HB2' ' A' ' 39' ' ' SER . 43.0 Cg_endo -71.21 159.92 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.981 1.516 . . . . 0.0 110.017 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.69 164.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 110.627 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.61 -45.47 3.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -66.16 145.23 98.98 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.195 -1.179 . . . . 0.0 110.797 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 64' ' ' PHE . 47.5 Cg_endo -75.57 -163.65 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 110.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 5.2 m-30 51.83 103.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.376 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.6 tppt? -56.78 -17.62 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.604 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 175.6 -175.05 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.53 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 53.8 t -147.64 80.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -79.44 133.59 36.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' SER . 4.8 p-10 -163.39 -177.77 5.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HG3' HD13 ' A' ' 53' ' ' ILE . 6.4 mtp180 -121.8 159.73 26.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 4.6 p -85.93 -25.44 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.933 . . . . 0.0 111.042 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 72.14 -80.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -168.73 157.77 8.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 178.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.824 HG23 ' HD1' ' A' ' 81' ' ' TYR . 14.6 p -128.45 109.79 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.96 154.86 41.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 109.464 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.41 -59.06 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 110.61 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.9 m -63.0 -8.23 6.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 0.0 110.993 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.51 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 73.3 m-20 -121.29 6.87 10.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.91 -1.119 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 8.6 m-30 44.66 67.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.51 ' HE2' ' HB3' ' A' ' 78' ' ' ASN . 3.0 mtmt -137.1 122.29 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.883 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.824 ' HD1' HG23 ' A' ' 74' ' ' VAL . 4.3 t80 -111.05 128.98 56.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.556 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . 3.4 t-20 -101.0 143.85 30.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 1.031 ' CZ ' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -149.3 115.96 5.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.417 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -103.27 127.47 50.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.031 HG22 ' CZ ' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -102.45 95.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.435 -0.791 . . . . 0.0 109.783 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 87' ' ' GLU . 25.0 pt -87.44 -29.6 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 0.0 110.414 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -156.48 102.58 2.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.898 . . . . 0.0 110.363 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 143.79 166.3 11.25 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.554 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 86.1 -121.43 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.544 ' HB2' ' NE2' ' A' ' 132' ' ' GLN . 47.4 Cg_endo -74.24 -52.26 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.788 1.415 . . . . 0.0 110.584 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.554 HD11 ' O ' ' A' ' 89' ' ' GLY . 0.2 OUTLIER 30.03 -156.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.875 0.845 . . . . 0.0 111.862 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.83 -161.67 2.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.58 ' O ' HG23 ' A' ' 94' ' ' THR . 3.4 m-20 51.68 -95.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -1.142 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 93' ' ' ASP . 18.3 p -156.23 22.25 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 110.516 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.698 ' HB3' HD11 ' A' ' 98' ' ' ILE . 9.9 mt -94.93 95.49 8.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.205 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 4.6 mt-10 -76.6 -43.34 38.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' HG12 ' A' ' 98' ' ' ILE . 9.1 tttp -129.43 152.13 49.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.005 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 95' ' ' LEU . 13.3 mt -153.74 122.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 110.635 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.53 127.34 48.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 109.872 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 2.3 m-80 -121.54 114.65 21.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.621 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.01 159.0 16.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 109.703 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.807 HG23 ' CD1' ' A' ' 116' ' ' ILE . 13.7 mt -141.89 142.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HG3' ' C ' ' A' ' 102' ' ' ILE . 1.8 mtpp -138.09 151.86 48.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.147 -0.971 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.613 HD12 ' N ' ' A' ' 104' ' ' ILE . 4.9 mp -130.84 125.85 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.002 . . . . 0.0 109.927 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.41 133.23 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.02 21.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 p -128.96 152.85 79.89 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.843 . . . . 0.0 110.115 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.99 -32.38 28.55 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.024 1.539 . . . . 0.0 110.706 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 p30 -149.99 43.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.81 14.21 0.89 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.47 -138.07 29.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -128.58 136.56 50.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -1.157 . . . . 0.0 110.571 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.11 125.79 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.803 . . . . 0.0 109.211 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.883 ' HB2' HG22 ' A' ' 9' ' ' THR . 20.1 mt -89.72 108.19 19.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.001 . . . . 0.0 111.134 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 10.2 mttp -81.65 106.47 13.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.807 ' CD1' HG23 ' A' ' 102' ' ' ILE . 43.4 mm -101.38 151.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.08 132.08 35.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 4.9 m120 -129.53 88.17 2.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.125 -0.984 . . . . 0.0 110.725 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -81.29 124.27 29.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.716 ' O ' HG23 ' A' ' 2' ' ' VAL . 3.3 m-85 -103.67 149.38 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.911 -1.118 . . . . 0.0 110.401 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.0 m-70 -134.33 93.48 3.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.561 HG21 HG23 ' A' ' 128' ' ' VAL . 2.0 p -86.14 -162.9 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.87 . . . . 0.0 109.717 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HD3' ' OE1' ' A' ' 96' ' ' GLU . 5.2 ttpp -177.26 97.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.041 . . . . 0.0 110.854 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.42 160.59 12.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 56.08 -161.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -1.021 . . . . 0.0 110.635 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.486 ' N ' HG21 ' A' ' 94' ' ' THR . 81.1 m-70 -48.96 -179.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 110.436 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 5.5 mm-40 -127.32 -112.98 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.931 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.795 HG11 ' HE2' ' A' ' 5' ' ' TYR . 60.5 t -118.23 138.03 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.805 -1.185 . . . . 0.0 110.256 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 130' ' ' ALA . 5.5 mtmt -101.66 111.4 23.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -41.36 -50.31 3.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.696 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -46.44 -48.27 18.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.902 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 90' ' ' PRO . 2.9 tt0 -63.36 -39.44 94.54 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.041 HG11 ' CD1' ' A' ' 5' ' ' TYR . 79.5 t -65.92 -17.22 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.757 0.789 . . . . 0.0 109.169 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 135' ' ' ALA . 2.0 ttmt -85.54 -58.13 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.499 -0.75 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.38 -50.64 5.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 109.916 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.43 -45.86 69.58 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.13 -31.68 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.701 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.77 -39.68 80.09 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.332 -0.855 . . . . 0.0 109.369 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 1.3 mtp -66.18 -38.43 88.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.21 -0.931 . . . . 0.0 109.05 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.21 -38.18 93.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -74.77 -35.02 62.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.896 -1.355 . . . . 0.0 110.158 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -39.77 90.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 108.743 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.753 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.1 mm? -68.66 -48.97 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.165 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.594 HD22 HG21 ' A' ' 9' ' ' THR . 13.3 tp -49.58 -42.89 45.62 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.204 -0.935 . . . . 0.0 108.849 178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 1.5 ttt-85 -65.79 -42.64 90.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.83 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.776 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.5 -62.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.358 -0.838 . . . . 0.0 109.734 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.65 HG22 HD12 ' A' ' 29' ' ' LEU . 84.6 t -59.01 -28.61 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.555 -0.715 . . . . 0.0 110.09 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -61.95 -53.06 60.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 0.0 109.958 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.4 p -76.7 -18.59 58.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 109.9 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.714 ' CD2' HD11 ' A' ' 29' ' ' LEU . 5.7 t80 -64.44 -47.95 77.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.627 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.617 HD23 ' CD2' ' A' ' 150' ' ' TYR . 68.4 mt -61.38 -24.97 66.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.598 ' CD1' HD11 ' A' ' 13' ' ' ILE . 5.9 mp -81.76 -35.21 29.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.244 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.12 -55.14 6.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.461 ' O ' ' CB ' ' A' ' 155' ' ' SER . 35.9 m-70 -66.14 -44.42 84.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.873 . . . . 0.0 109.808 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER 66.74 20.55 10.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.459 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -159.11 19.9 0.19 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.568 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.464 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.63 130.65 48.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.077 -1.014 . . . . 0.0 110.336 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.789 ' CD2' ' HB2' ' A' ' 21' ' ' ALA . 48.4 m-85 58.24 53.13 6.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.116 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.528 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 120' ' ' TYR . 78.9 t -79.08 156.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.558 ' CD1' HG23 ' A' ' 128' ' ' VAL . 75.9 m-85 -119.61 137.38 53.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.529 -0.732 . . . . 0.0 109.965 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' OD1' ' HE2' ' A' ' 119' ' ' LYS . 3.6 t30 -101.19 91.53 4.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 0.0 110.358 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.963 ' CE2' HG21 ' A' ' 133' ' ' VAL . 29.3 m-85 -86.97 74.12 9.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.229 -0.92 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 91.54 3.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 110.616 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.549 HG21 ' CE ' ' A' ' 137' ' ' LYS . 14.4 t -112.85 -169.75 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -168.03 167.16 12.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.451 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.922 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -137.16 179.13 6.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 109.911 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.14 141.13 51.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.527 ' OG ' HD11 ' A' ' 18' ' ' LEU . 5.7 t -142.57 143.36 32.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 110.162 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.14 -31.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.755 HG13 HD12 ' A' ' 151' ' ' LEU . 3.3 mm -66.08 140.82 97.16 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.815 . . . . 0.0 110.547 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 36.2 Cg_endo -60.32 158.34 31.54 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.795 1.419 . . . . 0.0 110.617 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -53.91 -70.08 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 0.0 111.732 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.772 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -37.97 -62.07 0.59 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.309 -0.869 . . . . 0.0 111.808 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.2 mpt_? -52.73 -57.45 10.07 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.866 -1.146 . . . . 0.0 110.673 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.45 -30.66 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.073 -1.017 . . . . 0.0 110.183 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.738 ' CE2' HD21 ' A' ' 24' ' ' LEU . 68.3 t80 -74.01 -57.09 4.2 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.038 -1.039 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 22.0 mtmt -59.73 -23.02 62.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.73 . . . . 0.0 111.883 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -107.96 -53.25 2.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.578 -1.327 . . . . 0.0 112.226 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.703 ' CA ' HG11 ' A' ' 147' ' ' VAL . 27.4 t80 -83.89 -14.07 52.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.059 . . . . 0.0 112.38 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.951 HD12 HD11 ' A' ' 104' ' ' ILE . 28.2 mt -124.5 -14.54 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.573 -1.33 . . . . 0.0 110.868 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.738 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.8 OUTLIER -111.74 -17.01 13.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.048 -1.032 . . . . 0.0 109.967 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.485 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 4.7 t0 -137.16 43.83 2.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 110.151 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.36 -23.16 71.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.574 ' CB ' HG11 ' A' ' 41' ' ' VAL . 74.1 m-20 -68.52 -30.53 69.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -1.166 . . . . 0.0 110.365 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 28' ' ' ASN . 10.7 p-10 -105.04 25.15 10.89 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.903 HD23 HG13 ' A' ' 147' ' ' VAL . 3.1 tp -141.56 -63.23 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.668 -0.645 . . . . 0.0 110.354 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.751 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 6.1 m-30 -34.24 -52.96 0.94 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.782 -0.574 . . . . 0.0 110.746 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 50.9 Cg_endo -68.03 -50.25 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.468 1.246 . . . . 0.0 110.742 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -65.82 -69.52 0.29 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.286 -0.884 . . . . 0.0 110.615 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 29' ' ' LEU . 12.2 m -68.05 -11.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 111.409 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -146.73 66.17 10.52 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 120.765 -1.209 . . . . 0.0 111.346 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.3 Cg_endo -69.81 -11.86 31.64 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.846 1.445 . . . . 0.0 109.45 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -83.21 -14.63 52.92 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.332 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.631 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -112.36 -48.04 3.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.044 -1.035 . . . . 0.0 111.126 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.659 ' CD1' HD21 ' A' ' 143' ' ' LEU . 2.2 mp -116.94 163.56 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.985 -1.072 . . . . 0.0 110.596 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -124.07 -33.79 3.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.94 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER 169.95 141.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 110.536 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG11 ' CB ' ' A' ' 27' ' ' ASP . 3.2 p -103.37 148.03 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 109.159 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.616 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 3.4 mt-10 -141.53 116.82 10.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.839 -1.163 . . . . 0.0 111.18 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.621 ' HB2' ' HA ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER 147.24 -97.61 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.514 HG22 ' C ' ' A' ' 43' ' ' ASN . 1.3 tp 32.78 38.79 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.516 -0.74 . . . . 0.0 111.298 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 43' ' ' ASN . 13.5 pt-20 -79.34 -176.37 5.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.314 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.98 65.05 0.25 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -108.37 -27.85 9.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.21 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -131.2 1.84 5.41 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.411 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . 46.87 -104.2 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 48' ' ' GLY . 48.5 Cg_endo -73.05 87.0 1.05 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.025 1.54 . . . . 0.0 110.513 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.02 27.02 1.44 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 53' ' ' ILE . 1.3 m -75.31 -171.18 1.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -1.181 . . . . 0.0 110.119 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.623 ' H ' HG22 ' A' ' 52' ' ' THR . 1.1 mp -125.27 168.43 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.621 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -149.11 147.56 28.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.397 -0.815 . . . . 0.0 109.914 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 2.4 tttp -111.53 92.04 3.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.91 -1.119 . . . . 0.0 110.537 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.691 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.8 mp -79.52 133.03 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.069 -1.019 . . . . 0.0 109.576 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.33 120.25 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 0.0 110.635 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.642 ' HZ ' HG21 ' A' ' 67' ' ' VAL . 16.6 m-85 -83.08 169.62 17.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 109.588 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 44.7 Cg_endo -71.15 173.96 11.41 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.628 1.33 . . . . 0.0 110.023 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' O ' HD23 ' A' ' 62' ' ' LEU . 6.3 tt0 -58.74 179.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.519 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.26 2.09 86.87 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD1' ' HB2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -84.62 138.61 38.14 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -1.219 . . . . 0.0 110.599 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.67 -12.84 26.97 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.023 1.539 . . . . 0.0 109.81 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.542 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 18.8 m-30 -110.77 -139.54 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -140.96 -37.25 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 110.192 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.753 ' O ' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 178.44 -166.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 66' ' ' TYR . 3.5 m -159.92 123.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.562 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -92.36 130.72 37.97 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.528 ' HB2' ' CG ' ' A' ' 54' ' ' LYS . 3.6 m-20 -118.0 151.08 38.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.907 -1.121 . . . . 0.0 111.449 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.56 114.34 27.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.604 -0.685 . . . . 0.0 109.448 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.607 HG22 HG23 ' A' ' 74' ' ' VAL . 8.9 p -58.49 -27.74 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.933 . . . . 0.0 110.69 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 83' ' ' TYR . 0.3 OUTLIER 42.04 51.28 4.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.0 mt-10 65.14 158.97 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.339 -0.85 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.607 HG23 HG22 ' A' ' 71' ' ' VAL . 90.0 t -144.07 159.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -109.41 -150.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.215 -0.928 . . . . 0.0 110.519 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.633 ' CE1' ' CD1' ' A' ' 24' ' ' LEU . 0.5 OUTLIER 179.98 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.902 . . . . 0.0 110.18 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -55.54 -52.72 62.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.231 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -90.28 15.59 10.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.199 -0.938 . . . . 0.0 110.223 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.772 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 11.6 m-85 47.09 69.32 0.51 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 110.507 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -126.57 143.83 51.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.929 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.447 ' CE1' HG22 ' A' ' 74' ' ' VAL . 27.1 t80 -141.7 100.77 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.495 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 71' ' ' VAL . 9.8 t-20 -96.72 104.17 16.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -0.847 . . . . 0.0 109.563 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 72' ' ' ASP . 8.4 p90 -132.02 -169.5 2.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 0.0 109.983 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.7 t -149.09 165.8 30.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.218 -0.926 . . . . 0.0 110.772 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 55.3 t -105.03 -26.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.382 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 85' ' ' VAL . 41.8 pt 37.05 -139.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.162 0.506 . . . . 0.0 110.81 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' N ' HG13 ' A' ' 86' ' ' ILE . 1.4 mm-40 -60.61 135.43 57.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.996 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 136.66 142.72 4.49 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.358 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.542 ' HA2' ' CD2' ' A' ' 64' ' ' PHE . . . 88.18 -142.79 17.69 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 91' ' ' ILE . 52.2 Cg_endo -83.16 27.85 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.127 1.593 . . . . 0.0 110.993 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.15 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.474 -0.766 . . . . 0.0 110.581 -179.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 89.84 -163.77 30.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 1.3 m-20 56.44 -91.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -1.077 . . . . 0.0 110.484 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.476 HG21 ' HB2' ' A' ' 126' ' ' HIS . 76.3 p -142.12 47.37 1.62 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.438 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.981 HD22 HD11 ' A' ' 98' ' ' ILE . 1.4 mt -170.2 90.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -91.49 -49.97 6.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.573 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.538 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 1.9 ttpp -113.69 161.2 17.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.981 HD11 HD22 ' A' ' 95' ' ' LEU . 15.5 mt -158.39 113.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.473 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 4.3 m -104.32 122.2 44.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.166 -0.959 . . . . 0.0 109.592 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.457 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 50.4 m-20 -116.29 133.5 55.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.082 -1.011 . . . . 0.0 111.601 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 82' ' ' ASN . 3.2 tp10 -118.57 129.49 55.37 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.438 ' C ' ' HG3' ' A' ' 103' ' ' LYS . 19.6 mt -116.91 146.96 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.964 -1.085 . . . . 0.0 110.783 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 49.4 mtpt -142.69 106.53 4.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.769 . . . . 0.0 109.784 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.951 HD11 HD12 ' A' ' 23' ' ' ILE . 14.5 mt -79.39 144.32 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.645 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 115' ' ' LYS . 22.1 t -130.07 127.52 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 110.157 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.6 132.83 34.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.116 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.2 p -111.13 153.03 44.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.386 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.33 -19.96 49.24 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.06 1.558 . . . . 0.0 110.703 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.414 ' O ' ' OD2' ' A' ' 109' ' ' ASP . 3.0 p-10 -158.43 44.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 0.0 110.255 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -152.92 21.59 0.78 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.85 -113.65 5.94 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 72.3 m -152.41 137.21 17.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.449 -1.03 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.4 mt -104.09 133.39 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.737 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.922 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.2 mp -95.25 99.91 11.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 110.002 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HD2' ' CG2' ' A' ' 105' ' ' VAL . 14.1 mttm -75.29 103.17 5.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.716 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.545 ' HB ' HG23 ' A' ' 7' ' ' THR . 25.8 mt -94.51 137.95 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 110.875 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.84 91.06 3.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.458 -0.776 . . . . 0.0 109.028 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 6.2 m-80 -84.48 92.24 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 111.387 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.503 ' HD2' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -84.73 103.37 13.76 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.71 ' O ' HG13 ' A' ' 2' ' ' VAL . 3.2 m-85 -86.63 138.26 31.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.007 . . . . 0.0 111.468 -178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 32.7 m-70 -121.36 84.09 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 109.443 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.658 HG22 ' HG ' ' A' ' 95' ' ' LEU . 11.3 p -84.25 -164.74 0.99 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 110.357 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -137.42 88.02 2.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.34 -135.04 45.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.417 ' HB3' HG22 ' A' ' 94' ' ' THR . 17.6 t0 50.87 -141.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -1.125 . . . . 0.0 110.142 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.476 ' HB2' HG21 ' A' ' 94' ' ' THR . 43.8 m-70 -83.29 179.48 7.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -95.96 161.03 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 110.266 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 3' ' ' PHE . 39.6 t -50.4 139.56 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.036 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 31.4 mtmt -94.32 117.63 30.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.875 . . . . 0.0 110.054 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -46.68 -43.79 18.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.153 -0.967 . . . . 0.0 109.853 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -46.04 64.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.062 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.46 HE21 HD13 ' A' ' 95' ' ' LEU . 1.5 tt0 -59.99 -44.93 94.2 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.963 HG21 ' CE2' ' A' ' 5' ' ' TYR . 54.4 t -59.66 -23.64 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.67 0.747 . . . . 0.0 109.163 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -79.35 -43.64 23.11 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.81 -0.557 . . . . 0.0 110.542 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -53.6 -53.79 46.81 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 t -61.15 -45.15 95.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.203 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.549 ' CE ' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -62.76 -18.42 62.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.865 . . . . 0.0 108.722 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 1.4 tt0 -77.82 -51.21 10.84 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 40.0 mmm -60.22 -33.38 72.19 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.193 -1.003 . . . . 0.0 108.78 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.58 -44.87 69.77 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -67.08 -39.88 86.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.808 -1.407 . . . . 0.0 110.424 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -45.93 90.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.188 -0.945 . . . . 0.0 109.339 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.659 HD21 ' CD1' ' A' ' 38' ' ' ILE . 1.1 mm? -60.97 -52.62 64.25 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.337 -0.852 . . . . 0.0 109.324 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.611 HD22 HG21 ' A' ' 9' ' ' THR . 10.3 tp -46.81 -43.27 18.25 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -63.37 -40.46 97.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 0.0 109.657 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -59.4 -61.33 2.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.345 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.903 HG13 HD23 ' A' ' 29' ' ' LEU . 9.6 t -62.75 -18.38 20.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.463 -0.773 . . . . 0.0 109.89 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' O ' HD22 ' A' ' 152' ' ' LEU . 0.7 OUTLIER -72.61 -46.1 55.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 81.1 p -87.18 -15.0 39.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.54 ' CZ ' HD11 ' A' ' 29' ' ' LEU . 3.7 t80 -67.01 -39.89 87.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.995 . . . . 0.0 109.6 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.755 HD12 HG13 ' A' ' 13' ' ' ILE . 42.7 mt -63.1 -36.34 83.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.402 -0.811 . . . . 0.0 110.596 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.523 HD13 ' N ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -75.96 -51.98 11.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 110.311 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -53.77 -54.1 43.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -67.28 -163.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.965 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 44.8 m -94.09 59.37 2.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 110.413 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 0.1 OUTLIER 61.6 41.21 12.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.472 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -42.41 151.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 110.244 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.789 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 81.9 m-85 57.87 57.38 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 110.34 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.155 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 3' ' ' PHE . 40.4 t 50.71 170.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.56 -0.965 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.709 ' CD1' HG23 ' A' ' 128' ' ' VAL . 97.4 m-85 -150.93 150.37 30.75 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.37 -0.831 . . . . 0.0 109.759 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -111.7 103.8 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.095 -1.003 . . . . 0.0 110.425 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.021 ' CE2' HG21 ' A' ' 133' ' ' VAL . 55.3 m-85 -100.79 87.21 3.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.45 108.51 19.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.6 t -127.99 -172.12 2.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.389 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.19 -170.87 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.867 . . . . 0.0 109.943 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.602 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 5.0 t -165.95 173.66 10.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 0.0 109.75 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.76 142.69 49.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.011 . . . . 0.0 110.491 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.821 ' OG ' HD11 ' A' ' 18' ' ' LEU . 20.2 t -132.13 144.15 50.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.47 -7.48 10.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.337 -0.852 . . . . 0.0 110.116 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.592 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 7.2 mm -94.78 145.27 29.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 110.473 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 30.9 Cg_endo -56.25 160.69 10.35 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.789 1.415 . . . . 0.0 110.686 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -63.26 -78.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 111.415 -178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -32.04 -54.6 0.3 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.664 -0.648 . . . . 0.0 111.421 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.55 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -57.41 -55.7 31.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 110.0 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.821 HD11 ' OG ' ' A' ' 11' ' ' SER . 5.4 mt -51.01 -28.74 10.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 24' ' ' LEU . 19.0 t80 -73.07 -67.47 0.57 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 110.379 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.68 -25.11 9.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.225 -0.922 . . . . 0.0 112.317 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.794 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -101.33 -58.16 1.94 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.541 -1.349 . . . . 0.0 111.443 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 24.2 t80 -80.59 -83.14 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.03 -1.044 . . . . 0.0 111.47 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.619 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 2.4 mp -46.36 -21.1 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.18 -0.95 . . . . 0.0 111.876 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.667 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -106.67 -77.81 0.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.664 -1.273 . . . . 0.0 110.043 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.8 t0 -73.15 83.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 0.0 110.212 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -109.63 -27.94 4.47 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.14 -12.75 60.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.039 -1.271 . . . . 0.0 110.278 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -118.79 7.13 11.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.576 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.757 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -122.36 -40.32 2.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.803 . . . . 0.0 110.228 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.797 ' CD1' HD12 ' A' ' 143' ' ' LEU . 6.1 m-30 -61.39 -54.66 50.67 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.23 -0.919 . . . . 0.0 111.35 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 44.4 Cg_endo -65.66 -6.13 13.19 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.306 1.161 . . . . 0.0 111.262 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -103.82 -67.61 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 110.592 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.042 HG23 ' HB1' ' A' ' 146' ' ' ALA . 12.0 m -74.76 -20.91 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 110.82 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.4 61.65 15.26 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 110.675 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.1 Cg_endo -67.86 -23.29 41.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.101 1.58 . . . . 0.0 109.136 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -73.6 -15.87 61.26 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.544 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -108.67 -66.16 1.07 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 110.75 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 39' ' ' SER . 4.0 mp -114.47 172.16 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.605 ' N ' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -163.97 -25.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 111.472 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.4 t -133.45 138.76 46.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.588 -1.32 . . . . 0.0 111.122 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.846 HG11 HD13 ' A' ' 44' ' ' ILE . 19.4 t -124.57 128.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.587 -0.696 . . . . 0.0 109.41 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -133.17 148.37 52.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.009 . . . . 0.0 110.137 -179.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.569 ' O ' HG22 ' A' ' 53' ' ' ILE . 0.8 OUTLIER 69.48 22.79 6.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.264 -0.898 . . . . 0.0 110.17 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.846 HD13 HG11 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -71.56 -26.55 26.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.221 -0.925 . . . . 0.0 111.043 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 52' ' ' THR . 2.7 mp0 48.52 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.051 -1.03 . . . . 0.0 109.611 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -86.21 52.22 4.49 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 9.6 p30 178.48 39.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.241 -1.153 . . . . 0.0 110.258 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.32 -12.84 20.77 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.26 -108.87 0.28 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.23 89.87 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.872 1.459 . . . . 0.0 110.702 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.51 5.59 7.72 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.099 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 45' ' ' GLU . 86.2 m -50.07 158.44 0.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.048 -1.266 . . . . 0.0 110.172 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 43' ' ' ASN . 16.5 mm -117.11 165.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 4.4 pttp -179.66 142.8 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.006 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 0.9 OUTLIER -140.58 108.84 5.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.831 -0.543 . . . . 0.0 109.601 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.7 mp -82.87 152.42 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.245 -0.909 . . . . 0.0 110.59 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 m -127.38 139.83 52.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.452 -0.78 . . . . 0.0 109.99 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.742 ' HB3' HD12 ' A' ' 62' ' ' LEU . 24.1 m-85 -109.96 103.83 54.29 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.441 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.606 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 46.1 Cg_endo -72.82 -159.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.031 1.543 . . . . 0.0 110.198 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.565 ' HG3' ' N ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER 44.51 -172.53 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.094 -1.004 . . . . 0.0 111.526 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.565 ' N ' ' HG3' ' A' ' 60' ' ' GLU . . . -45.06 -18.26 0.13 Allowed Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.737 -0.602 . . . . 0.0 112.992 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.742 HD12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -42.82 125.75 3.14 Favored Pre-proline 0 N--CA 1.501 2.097 0 CA-C-N 119.672 1.736 . . . . 0.0 110.302 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 64' ' ' PHE . 50.4 Cg_endo -74.99 -156.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.845 1.445 . . . . 0.0 109.846 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 63' ' ' PRO . 3.4 m-85 57.18 168.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.068 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -104.96 -39.82 6.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.89 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 29.1 p90 179.56 -175.11 0.25 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.399 -0.813 . . . . 0.0 109.74 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.554 HG23 ' HB ' ' A' ' 56' ' ' ILE . 8.2 m -150.93 106.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.961 -1.087 . . . . 0.0 110.779 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 12.1 tttt -107.35 139.41 41.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.93 ' HB3' HG13 ' A' ' 85' ' ' VAL . 2.7 p30 -159.71 166.13 31.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.907 -1.121 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.459 ' HD2' ' CD1' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -104.69 145.99 29.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.599 -0.688 . . . . 0.0 109.362 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.678 HG23 ' OH ' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -83.11 -38.47 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.986 -1.072 . . . . 0.0 110.154 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.05 -33.93 0.23 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.731 -0.606 . . . . 0.0 111.646 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' C ' HG23 ' A' ' 74' ' ' VAL . 6.0 pt-20 174.54 160.42 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.761 -1.212 . . . . 0.0 110.292 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.614 HG22 ' CE1' ' A' ' 81' ' ' TYR . 44.5 t -151.99 92.5 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.827 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -66.56 -169.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.185 -0.947 . . . . 0.0 110.541 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.414 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -153.75 -52.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.343 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.5 m -48.38 -34.81 11.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 75.3 m-20 -118.93 6.06 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.388 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 9.0 m-85 58.9 40.6 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.982 . . . . 0.0 110.059 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 1.4 tttt -89.02 117.46 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.12 -0.988 . . . . 0.0 110.65 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.765 ' O ' HD12 ' A' ' 102' ' ' ILE . 25.1 t80 -118.4 132.93 56.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.787 . . . . 0.0 109.893 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' VAL . 4.0 t30 -144.19 104.89 4.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 109.956 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 50.8 p90 -125.0 164.18 20.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.618 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.01 136.37 51.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 110.756 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.93 HG13 ' HB3' ' A' ' 69' ' ' ASP . 1.6 t -108.87 114.3 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.504 -0.748 . . . . 0.0 109.199 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.0 pt -113.94 6.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.029 -1.044 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.1 144.18 5.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.013 -1.054 . . . . 0.0 110.308 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.911 ' C ' HD11 ' A' ' 91' ' ' ILE . . . 84.0 133.48 2.43 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.476 ' HA2' HG12 ' A' ' 67' ' ' VAL . . . 124.18 -134.5 9.2 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 91' ' ' ILE . 45.0 Cg_endo -72.54 -6.32 18.82 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.919 1.484 . . . . 0.0 110.631 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.911 HD11 ' C ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -35.97 157.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 121.523 0.678 . . . . 0.0 110.367 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.32 23.91 18.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -153.1 -146.36 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -1.187 . . . . 0.0 110.089 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' A' ' 122' ' ' THR . 1.2 p -87.22 44.41 1.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.14 -0.975 . . . . 0.0 110.049 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.744 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -132.59 124.14 27.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 121' ' ' HIS . 0.9 OUTLIER -105.72 -71.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.93 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -125.7 132.59 52.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.954 . . . . 0.0 110.819 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.98 121.81 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 0.0 110.264 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.27 157.16 16.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.975 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.456 HD21 HG23 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -141.13 109.47 5.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.001 -1.062 . . . . 0.0 110.689 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 102' ' ' ILE . 33.6 tt0 -125.95 137.07 53.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.354 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.914 HD12 ' N ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER 175.71 -157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.242 -0.911 . . . . 0.0 112.837 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 80' ' ' LYS . 14.8 ptmt -172.59 179.52 2.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.26 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.815 HG23 HD12 ' A' ' 114' ' ' LEU . 14.8 mm -110.57 146.3 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.614 -0.679 . . . . 0.0 109.832 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.428 HG21 ' HD2' ' A' ' 115' ' ' LYS . 56.8 t -122.12 142.82 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HA ' ' OG ' ' A' ' 112' ' ' SER . . . -110.1 133.03 53.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.0 110.424 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 39.5 p -93.82 164.07 21.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 43.3 Cg_endo -64.91 -22.57 62.89 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.915 1.482 . . . . 0.0 111.149 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 22.4 p-10 -175.58 88.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.027 -1.045 . . . . 0.0 110.494 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.82 -30.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.05 -133.77 6.2 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -147.84 140.18 24.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -1.128 . . . . 0.0 110.059 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.2 mt -95.72 120.48 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.863 . . . . 0.0 110.245 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.815 HD12 HG23 ' A' ' 104' ' ' ILE . 3.8 mp -83.25 108.04 16.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.773 . . . . 0.0 109.887 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.747 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 18.1 mttt -94.44 121.68 36.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.683 -1.26 . . . . 0.0 109.17 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.874 ' CA ' HG21 ' A' ' 102' ' ' ILE . 34.1 mm -120.98 126.72 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.607 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.551 ' N ' HG21 ' A' ' 102' ' ' ILE . 13.0 m -119.06 126.4 51.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.495 -1.378 . . . . 0.0 109.275 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.7 150.32 40.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.948 . . . . 0.0 111.191 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.49 109.54 12.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.744 ' CD2' HD11 ' A' ' 95' ' ' LEU . 4.6 m-85 -86.9 135.06 33.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 111.556 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 96' ' ' GLU . 76.6 m-70 -123.08 86.49 2.59 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.49 HG21 ' CG2' ' A' ' 128' ' ' VAL . 8.9 p -86.9 -179.2 6.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.482 -0.761 . . . . 0.0 110.902 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -60.04 -147.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.437 -0.789 . . . . 0.0 110.449 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.38 77.9 0.38 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.88 -71.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -1.154 . . . . 0.0 109.918 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -85.54 173.65 10.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 109.896 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 52.8 mt-10 -110.25 -174.15 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 110.431 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.709 HG23 ' CD1' ' A' ' 3' ' ' PHE . 46.6 t -83.78 145.18 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.33 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -90.42 112.35 23.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.37 -41.82 14.08 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.168 -0.958 . . . . 0.0 110.143 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.49 -46.82 76.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 109.296 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.464 ' NE2' HD23 ' A' ' 95' ' ' LEU . 5.5 tt0 -58.83 -42.59 89.58 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.021 HG21 ' CE2' ' A' ' 5' ' ' TYR . 70.3 t -62.83 -25.81 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.748 0.785 . . . . 0.0 109.224 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.8 ttmt -73.83 -56.95 4.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.705 -0.622 . . . . 0.0 110.492 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.483 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -35.64 -52.1 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.688 -0.633 . . . . 0.0 110.952 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 t -57.49 -47.82 80.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.088 -1.007 . . . . 0.0 109.822 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -61.42 -28.63 69.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.072 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 135' ' ' ALA . 14.0 mm-40 -69.88 -57.83 4.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.281 -0.887 . . . . 0.0 109.351 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.544 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 2.7 mtp -54.81 -35.63 64.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.221 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.69 -39.04 95.12 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.79 -45.93 48.54 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.869 -1.371 . . . . 0.0 110.888 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 -41.01 92.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.027 -1.046 . . . . 0.0 109.49 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.797 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.5 mm? -68.35 -53.8 21.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.511 -0.743 . . . . 0.0 109.887 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 114' ' ' LEU . 16.1 tp -46.21 -43.72 15.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.145 -0.972 . . . . 0.0 108.811 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.509 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 2.2 ttp180 -66.22 -39.94 89.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.388 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.042 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -55.52 -62.36 1.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -0.843 . . . . 0.0 109.359 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.672 HG22 HD12 ' A' ' 29' ' ' LEU . 60.4 t -62.57 -23.81 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.485 -0.76 . . . . 0.0 109.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -61.79 -55.93 24.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.372 -0.83 . . . . 0.0 110.085 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.46 -23.37 53.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.256 -0.902 . . . . 0.0 109.943 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.8 ' HB2' HG11 ' A' ' 33' ' ' VAL . 11.3 t80 -56.08 -37.82 69.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.117 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mt -71.5 -25.62 62.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.174 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 2.1 mp -88.89 -19.12 26.24 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.79 -38.41 14.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.838 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.56 156.27 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.347 -0.846 . . . . 0.0 110.005 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 3.3 p -44.26 -53.54 6.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.186 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 155' ' ' SER . 23.3 t70 -177.1 64.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.195 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.64 146.29 46.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 110.358 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.794 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 63.0 m-85 54.45 70.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.444 -0.785 . . . . 0.0 110.48 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.35 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.613 HG21 ' HD3' ' A' ' 119' ' ' LYS . 7.9 p -88.03 157.16 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -1.103 . . . . 0.0 110.458 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.652 ' CD1' HG23 ' A' ' 128' ' ' VAL . 87.7 m-85 -123.6 122.78 39.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 110.03 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.59 98.82 10.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.815 ' CD1' HG11 ' A' ' 133' ' ' VAL . 46.7 m-85 -100.45 103.71 15.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.38 -0.825 . . . . 0.0 109.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -108.59 122.28 46.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.953 -1.092 . . . . 0.0 110.109 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 6.2 t -130.54 166.73 19.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 110.541 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 7' ' ' THR . 75.1 mt-10 -155.18 157.69 37.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.52 -0.738 . . . . 0.0 109.688 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.887 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -142.37 -178.51 5.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.015 . . . . 0.0 110.27 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.433 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -131.0 141.8 50.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 110.039 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.538 ' CB ' HD11 ' A' ' 18' ' ' LEU . 19.6 t -134.42 142.25 47.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.46 0.33 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.54 -0.725 . . . . 0.0 110.124 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.652 HD11 HD21 ' A' ' 152' ' ' LEU . 11.1 mm -96.69 147.99 33.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.9 Cg_endo -56.55 157.81 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.885 1.466 . . . . 0.0 110.033 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' ALA . . . -68.5 -64.04 0.94 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.072 -1.017 . . . . 0.0 110.886 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -43.35 -50.52 6.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.959 . . . . 0.0 110.732 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.572 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.17 -52.18 65.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.607 HD12 ' OG ' ' A' ' 112' ' ' SER . 6.0 mt -52.31 -24.1 6.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.127 -0.983 . . . . 0.0 108.773 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.712 ' CE2' HD21 ' A' ' 24' ' ' LEU . 43.5 t80 -77.66 -55.66 5.17 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.466 -0.772 . . . . 0.0 110.384 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 5.0 mmmt -61.25 -21.76 64.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.569 -0.707 . . . . 0.0 111.884 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -111.39 -47.26 3.2 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.685 -1.259 . . . . 0.0 112.774 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' HE2' HD21 ' A' ' 114' ' ' LEU . 39.2 t80 -89.68 -22.08 22.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.718 -1.239 . . . . 0.0 112.482 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.638 ' C ' HD23 ' A' ' 24' ' ' LEU . 2.1 mp -116.56 -13.44 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.649 -1.282 . . . . 0.0 110.378 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.712 HD21 ' CE2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -111.96 -12.91 13.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.481 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 9.6 t0 -146.67 47.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 110.308 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.547 ' CA ' ' CE1' ' A' ' 30' ' ' PHE . . . -83.25 -31.16 28.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.775 ' HB3' HG11 ' A' ' 41' ' ' VAL . 52.4 m-20 -76.77 2.96 12.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.35 -1.088 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.3 t30 -138.62 50.47 1.86 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.994 HD21 HG13 ' A' ' 147' ' ' VAL . 1.1 tp 173.06 -28.93 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.581 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' CA ' ' A' ' 26' ' ' GLY . 3.0 m-30 -52.18 -59.29 8.74 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 110.919 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.539 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 48.3 Cg_endo -67.06 -11.97 34.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.92 1.484 . . . . 0.0 111.211 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -90.06 -31.58 17.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.043 -1.036 . . . . 0.0 111.031 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HB1' ' A' ' 146' ' ' ALA . 10.5 m -103.82 -11.81 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -138.94 66.6 40.15 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.808 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.4 -5.37 14.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.967 1.509 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -94.9 -12.61 26.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.411 -0.806 . . . . 0.0 109.625 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.02 -28.93 6.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.023 . . . . 0.0 110.668 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 39' ' ' SER . 6.7 mm -125.75 178.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.967 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.603 ' H ' HG22 ' A' ' 38' ' ' ILE . 4.1 t -136.35 -45.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 t -174.85 165.16 3.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.304 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.775 HG11 ' HB3' ' A' ' 27' ' ' ASP . 99.5 t -118.58 124.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 110.034 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 3.5 tp10 -97.06 124.21 41.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.252 -0.905 . . . . 0.0 110.417 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.84 91.12 8.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.205 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 tp -81.52 -24.7 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 110.31 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' HB3' ' HB ' ' A' ' 53' ' ' ILE . 6.5 tp10 -159.49 75.77 0.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.171 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.78 98.78 1.32 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -81.19 -70.64 0.52 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -1.149 . . . . 0.0 110.196 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.07 68.14 0.09 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 129.03 -137.83 9.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.99 102.97 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.935 1.492 . . . . 0.0 110.389 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' HA2' ' NH2' ' A' ' 70' ' ' ARG . . . 126.51 31.39 0.78 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.1 m -103.43 117.24 34.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.114 -1.227 . . . . 0.0 110.107 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.9 mp -97.06 136.71 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.461 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 84.6 mttt -139.41 148.99 43.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 6.7 tttt -117.45 96.03 5.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.82 . . . . 0.0 110.653 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.563 HD11 ' OD1' ' A' ' 27' ' ' ASP . 1.4 mp -73.47 148.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' TYR . 27.5 t -124.75 169.38 12.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.18 -0.95 . . . . 0.0 110.271 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 39.4 m-85 -134.33 153.68 79.47 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.601 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 62' ' ' LEU . 48.4 Cg_endo -76.36 169.72 21.39 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.185 1.624 . . . . 0.0 109.615 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 167.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 110.061 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.03 -43.41 3.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 59' ' ' PRO . 8.5 mt -79.96 155.36 75.24 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.083 -1.245 . . . . 0.0 110.65 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HG2' ' CE2' ' A' ' 64' ' ' PHE . 50.8 Cg_endo -81.88 162.36 18.48 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.193 1.628 . . . . 0.0 110.971 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' A' ' 63' ' ' PRO . 11.6 m-85 65.69 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 0.0 110.634 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -69.1 -9.5 52.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.228 -0.92 . . . . 0.0 110.034 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 30.1 p90 -175.75 -170.34 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 110.176 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 67' ' ' VAL . 7.3 p -170.93 109.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.431 -0.793 . . . . 0.0 110.08 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 3.3 mtmm -96.15 138.42 33.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 0.0 109.751 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.18 -176.06 4.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.691 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.445 ' NH2' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -138.75 127.91 24.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.467 -0.771 . . . . 0.0 109.902 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.533 HG13 ' CZ ' ' A' ' 81' ' ' TYR . 55.7 t -68.25 -44.38 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.912 . . . . 0.0 110.323 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.4 m-20 77.98 -38.2 0.25 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.803 -0.56 . . . . 0.0 111.419 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 179.0 -167.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.696 -1.253 . . . . 0.0 111.001 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 74' ' ' VAL . 12.2 p -167.91 118.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.548 -0.72 . . . . 0.0 109.628 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -77.26 -49.75 14.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.174 -0.953 . . . . 0.0 110.955 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.566 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 77.94 -71.16 0.11 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.634 -0.666 . . . . 0.0 110.506 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 m -57.77 -42.49 84.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.316 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 79' ' ' PHE . 15.6 m120 -97.03 18.0 15.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.923 . . . . 0.0 110.256 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 23.2 m-30 43.49 27.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.525 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 11.5 ttpt -95.29 107.62 19.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.161 -0.962 . . . . 0.0 109.874 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.644 ' O ' HD12 ' A' ' 102' ' ' ILE . 20.4 t80 -110.79 96.82 6.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.864 . . . . 0.0 110.596 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.2 m-20 -84.39 161.22 20.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.839 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.627 ' CZ ' ' CB ' ' A' ' 100' ' ' ASN . 13.4 p90 -179.33 152.42 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.44 -0.787 . . . . 0.0 109.768 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.66 146.66 48.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.959 -1.088 . . . . 0.0 111.206 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.6 t -104.97 73.11 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.257 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.413 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 5.4 pt -62.06 -42.51 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.345 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' LYS . 2.6 mt-10 -139.66 94.91 2.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.898 -1.126 . . . . 0.0 110.709 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.97 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 167.96 120.35 0.52 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.97 -147.35 16.85 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' A' ' 91' ' ' ILE . 47.7 Cg_endo -72.43 -3.41 13.36 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 124.033 1.544 . . . . 0.0 110.22 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.97 HD11 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -34.85 157.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 121.535 0.683 . . . . 0.0 110.596 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.95 -8.05 59.25 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -108.66 -85.52 0.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -1.147 . . . . 0.0 110.396 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 122' ' ' THR . 0.6 OUTLIER -130.1 -18.89 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.16 -0.963 . . . . 0.0 110.931 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.715 HD22 HG12 ' A' ' 98' ' ' ILE . 2.3 mt -80.9 83.35 6.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 110.195 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.88 -52.33 63.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' C ' HG13 ' A' ' 98' ' ' ILE . 3.4 tptt -137.32 165.71 25.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.199 -0.938 . . . . 0.0 110.531 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.715 HG12 HD22 ' A' ' 95' ' ' LEU . 23.1 mt -150.73 122.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 110.078 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.8 m -99.19 135.08 41.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.908 . . . . 0.0 109.761 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.627 ' CB ' ' CZ ' ' A' ' 83' ' ' TYR . 32.9 m120 -137.71 140.89 40.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.75 -1.218 . . . . 0.0 110.972 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 7.0 pt-20 -138.26 154.03 49.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.483 -0.76 . . . . 0.0 109.546 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 81' ' ' TYR . 2.9 mt -128.13 155.13 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 110.469 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 22.9 mtmt -149.1 103.77 3.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.375 -0.828 . . . . 0.0 109.502 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 2.9 mm -81.53 120.19 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 109.871 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.551 HG21 ' CD ' ' A' ' 115' ' ' LYS . 61.3 t -105.14 123.08 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.99 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.22 140.31 34.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.289 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 44.3 p -113.16 162.17 23.3 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.309 -0.87 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 48.9 Cg_endo -66.62 -30.62 42.27 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.961 1.506 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -162.86 44.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.178 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.31 23.39 2.05 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.96 -135.84 26.65 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.607 ' OG ' HD12 ' A' ' 18' ' ' LEU . 6.5 p -132.81 134.62 44.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -1.14 . . . . 0.0 110.326 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 10' ' ' THR . 13.2 mt -95.13 124.06 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.933 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.887 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.0 OUTLIER -81.86 96.09 7.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 110.964 -179.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.551 ' CD ' HG21 ' A' ' 105' ' ' VAL . 3.9 mttp -87.47 107.86 18.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.402 ' CG1' HG23 ' A' ' 102' ' ' ILE . 5.2 mt -116.78 132.54 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 111.113 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.22 144.06 36.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.519 -0.738 . . . . 0.0 109.589 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 5' ' ' TYR . 44.2 m-80 -136.78 143.46 43.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.03 -1.044 . . . . 0.0 110.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.613 ' HD3' HG21 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -132.47 108.92 9.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.679 ' CD2' HD11 ' A' ' 95' ' ' LEU . 5.4 m-85 -87.12 114.18 23.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.569 -0.707 . . . . 0.0 110.835 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -101.21 92.12 4.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.364 -0.835 . . . . 0.0 109.224 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 128' ' ' VAL . 7.6 p -85.27 -151.75 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.376 -0.827 . . . . 0.0 110.748 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.42 3.07 15.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 110.566 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 96.45 -157.24 21.33 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.471 -1.017 . . . . 0.0 110.248 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 124' ' ' GLY . 1.6 m-70 -81.1 166.21 20.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.895 -1.128 . . . . 0.0 110.009 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -109.58 167.84 9.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.431 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.652 HG23 ' CD1' ' A' ' 3' ' ' PHE . 23.4 t -63.39 150.51 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 110.248 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 132' ' ' GLN . 40.8 mtmt -83.57 102.79 12.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.87 -56.42 3.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.133 -0.98 . . . . 0.0 109.912 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 130' ' ' ALA . 3.3 tt0 -44.83 -45.34 10.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.227 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.533 ' HB2' ' HB2' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -58.11 -44.71 87.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 108.921 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.815 HG11 ' CD1' ' A' ' 5' ' ' TYR . 79.0 t -60.67 -25.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 135' ' ' ALA . 1.9 tttm -81.88 -68.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.966 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.53 -40.76 0.41 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.414 -0.804 . . . . 0.0 110.325 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -51.25 68.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.047 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 6.6 mptt -56.07 -30.65 62.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.489 -0.757 . . . . 0.0 109.557 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 109.876 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 57.0 mmm -67.62 -34.34 76.79 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.317 -0.864 . . . . 0.0 108.813 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -71.01 -43.32 57.66 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -66.48 -33.76 76.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -1.157 . . . . 0.0 110.108 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.512 ' O ' ' HG3' ' A' ' 145' ' ' ARG . 2.0 p -70.59 -43.45 69.35 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.271 -0.893 . . . . 0.0 109.23 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 143' ' ' LEU . 1.0 OUTLIER -70.08 -25.27 63.44 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.548 179.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.794 HD22 HD22 ' A' ' 114' ' ' LEU . 17.2 tp -73.3 -43.32 61.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 108.901 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 0.0 OUTLIER -72.32 -25.64 61.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -70.84 -53.94 13.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 109.028 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.994 HG13 HD21 ' A' ' 29' ' ' LEU . 62.1 t -70.61 -21.86 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.51 -0.744 . . . . 0.0 109.154 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 145' ' ' ARG . 0.4 OUTLIER -69.55 -52.39 26.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.315 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.478 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 88.9 p -74.87 -23.13 58.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.333 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.589 ' CG ' HD11 ' A' ' 29' ' ' LEU . 9.1 t80 -59.04 -41.8 88.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.94 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.09 -27.7 69.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.335 -0.853 . . . . 0.0 110.205 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.652 HD21 HD11 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -86.35 -23.63 26.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.734 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.15 -55.49 5.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.876 . . . . 0.0 110.227 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.469 ' O ' ' HB3' ' A' ' 155' ' ' SER . 15.9 m-70 -73.8 -34.11 64.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 110.064 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 23.1 t 59.36 15.02 4.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 110.399 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 156' ' ' ASP . 1.7 p30 -145.48 12.12 1.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.95 . . . . 0.0 110.609 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.571 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.85 131.16 48.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.076 -1.015 . . . . 0.0 110.287 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.4 m-85 58.03 48.02 13.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.421 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.209 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 3' ' ' PHE . 47.1 t -105.72 165.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -1.21 . . . . 0.0 110.537 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 53.6 m-85 -125.29 148.4 48.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.785 . . . . 0.0 109.65 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -117.2 110.08 17.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.057 -1.027 . . . . 0.0 110.539 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.748 ' CD2' HG11 ' A' ' 133' ' ' VAL . 23.0 m-85 -108.75 76.7 1.03 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.598 -0.689 . . . . 0.0 109.527 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 85.7 mt-10 -84.05 96.72 8.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 110.879 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -106.29 163.17 13.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.836 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -135.33 144.44 46.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 110.146 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.807 HG22 ' HB3' ' A' ' 114' ' ' LEU . 1.1 t -134.39 161.48 34.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.86 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.59 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -123.52 143.64 50.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.99 . . . . 0.0 110.341 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 t -135.8 147.33 48.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 110.24 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.03 -20.93 19.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 109.772 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.543 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 6.4 mm -75.93 140.0 70.08 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.399 -0.813 . . . . 0.0 110.312 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.7 Cg_endo -57.22 148.95 67.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.807 1.425 . . . . 0.0 110.568 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.557 ' HA ' ' CG2' ' A' ' 104' ' ' ILE . . . -55.08 -46.09 75.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.467 -0.771 . . . . 0.0 111.275 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.0 -58.98 5.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 111.009 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 6.4 mtm180 -53.95 -57.35 11.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.861 -1.149 . . . . 0.0 109.671 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.48 -32.11 7.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.561 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 1.022 ' CE1' HD21 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -68.34 -62.77 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.525 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 26.5 mtpp -59.54 -23.06 62.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.519 -0.738 . . . . 0.0 112.842 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.632 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -106.08 -55.73 2.29 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.481 -1.387 . . . . 0.0 111.943 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 57.7 t80 -79.19 -9.33 59.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 0.0 112.07 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 24' ' ' LEU . 71.4 mt -130.07 -21.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.627 -1.296 . . . . 0.0 111.63 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.022 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.7 mt -106.18 -14.93 15.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.224 . . . . 0.0 109.536 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.524 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -138.39 30.67 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.441 -0.787 . . . . 0.0 110.416 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.3 -36.95 93.85 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' HB3' HG11 ' A' ' 41' ' ' VAL . 52.1 m-20 -60.89 -14.57 23.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -1.047 . . . . 0.0 109.815 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 25' ' ' ASP . 9.1 t30 -122.47 52.12 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.655 HD21 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -172.4 -52.26 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.493 -0.755 . . . . 0.0 110.102 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.614 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 7.1 m-30 -43.73 -53.91 11.59 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.405 -0.809 . . . . 0.0 111.093 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.5 Cg_endo -67.02 -29.57 40.19 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.346 1.182 . . . . 0.0 111.065 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -77.42 -71.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.0 111.17 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' A' ' 150' ' ' TYR . 22.2 m -71.99 -20.49 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.321 -0.862 . . . . 0.0 111.596 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -126.18 63.17 48.99 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.897 -1.127 . . . . 0.0 111.106 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.7 Cg_endo -69.26 -11.42 31.44 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.858 1.451 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 36' ' ' GLN . 0.5 OUTLIER -87.08 -8.18 57.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.501 -0.749 . . . . 0.0 109.578 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.626 ' HB3' HD21 ' A' ' 143' ' ' LEU . . . -117.53 -48.53 2.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.974 . . . . 0.0 110.392 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' A' ' 30' ' ' PHE . 2.9 mp -117.69 156.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.077 -1.014 . . . . 0.0 110.199 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -113.55 -31.04 6.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER 169.53 159.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.81 . . . . 0.0 109.905 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 27' ' ' ASP . 3.4 p -126.9 129.51 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.925 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -105.65 141.41 37.15 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.19 -0.944 . . . . 0.0 110.589 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -99.9 108.7 21.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.978 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -85.08 -33.02 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 110.499 -179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -149.06 92.21 1.94 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.173 -0.954 . . . . 0.0 110.54 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.92 161.76 9.53 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -125.04 22.53 7.95 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.262 -1.14 . . . . 0.0 110.313 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.34 147.51 18.47 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.88 -166.39 20.28 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.471 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . 45.7 Cg_endo -72.35 126.9 12.06 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.074 1.565 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.29 7.54 55.91 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.4 m -91.09 132.39 36.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -1.17 . . . . 0.0 110.353 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.614 HD12 ' CD ' ' A' ' 70' ' ' ARG . 16.2 mm -106.37 116.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.731 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.406 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -118.47 162.4 18.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.982 -1.074 . . . . 0.0 110.708 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -134.21 113.49 12.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.579 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.9 mp -81.49 144.7 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.387 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.1 t -125.9 101.43 6.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.622 -0.674 . . . . 0.0 109.844 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' HB2' HD12 ' A' ' 62' ' ' LEU . 38.6 m-85 -70.06 140.23 88.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 50.5 Cg_endo -82.74 48.28 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.165 1.613 . . . . 0.0 110.4 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.461 ' HB3' ' HG ' ' A' ' 62' ' ' LEU . 5.1 tt0 -135.04 -170.82 2.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.382 -0.824 . . . . 0.0 110.357 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.08 37.36 3.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 58' ' ' PHE . 79.1 mt -56.1 163.2 2.4 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.311 -1.111 . . . . 0.0 110.168 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 64' ' ' PHE . 46.6 Cg_endo -73.38 -9.47 23.06 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.021 1.538 . . . . 0.0 110.257 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.54 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 3.8 m-85 -114.88 -34.51 5.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 110.128 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 1.5 ttpt 74.45 -0.41 3.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.603 -0.685 . . . . 0.0 109.997 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 32.9 p90 179.88 -161.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.748 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 67' ' ' VAL . 8.7 p -179.45 118.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.308 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 55' ' ' LYS . 2.7 tttt -87.67 138.57 31.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -140.29 163.89 31.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.087 -1.008 . . . . 0.0 110.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.614 ' CD ' HD12 ' A' ' 53' ' ' ILE . 5.8 mtm180 -121.82 139.54 53.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.384 -0.822 . . . . 0.0 109.943 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' ASP . 24.6 t -73.21 -17.92 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.942 . . . . 0.0 110.262 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER 44.99 27.8 0.31 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.959 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' OE2' ' HB2' ' A' ' 50' ' ' PRO . 1.7 mt-10 65.76 148.6 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.337 -0.852 . . . . 0.0 110.015 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.679 HG11 ' CD1' ' A' ' 81' ' ' TYR . 27.3 m -123.23 -170.9 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.242 -0.911 . . . . 0.0 110.545 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.04 152.28 42.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.39 -52.61 2.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.021 -1.05 . . . . 0.0 110.633 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.3 m -61.4 -10.91 8.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.856 -1.152 . . . . 0.0 110.599 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -125.19 6.44 7.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.015 -1.053 . . . . 0.0 110.535 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.553 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.7 m-30 46.83 54.97 8.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 103' ' ' LYS . 29.3 tttt -124.14 105.52 9.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 0.0 111.143 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.679 ' CD1' HG11 ' A' ' 74' ' ' VAL . 74.2 t80 -89.72 178.23 6.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 109.315 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.427 ' N ' ' CG ' ' A' ' 81' ' ' TYR . 5.9 t30 -179.2 129.81 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.788 -1.195 . . . . 0.0 110.642 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 3.8 p90 -137.77 152.46 49.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.802 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.18 132.4 44.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.643 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.0 HG12 HD11 ' A' ' 91' ' ' ILE . 25.4 t -89.55 133.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 109.331 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.3 -14.96 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.081 -1.012 . . . . 0.0 111.328 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.625 ' C ' HD12 ' A' ' 91' ' ' ILE . 1.4 mm-40 -150.67 107.57 3.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.93 -1.106 . . . . 0.0 110.917 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 1.127 ' N ' HD12 ' A' ' 91' ' ' ILE . . . 127.04 -137.75 10.12 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 64' ' ' PHE . . . 26.69 -128.22 0.05 OUTLIER Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.567 ' O ' ' C ' ' A' ' 91' ' ' ILE . 42.8 Cg_endo -70.86 -59.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.877 1.462 . . . . 0.0 109.376 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.127 HD12 ' N ' ' A' ' 88' ' ' GLY . 1.8 mt 4.59 90.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 121.746 0.784 . . . . 0.0 112.893 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.95 -149.34 6.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.98 -18.82 5.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.012 -1.287 . . . . 0.0 109.435 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -128.12 136.26 50.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.81 . . . . 0.0 109.964 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 120' ' ' TYR . 4.6 mt 63.38 92.26 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.294 -0.878 . . . . 0.0 110.063 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.78 -34.88 21.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -140.77 150.01 42.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.017 . . . . 0.0 110.439 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.556 HD11 ' CG ' ' A' ' 90' ' ' PRO . 58.9 mt -139.59 126.23 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.5 m -117.41 110.44 18.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 109.976 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 118' ' ' ASN . 1.9 m120 -106.86 119.45 39.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.905 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' O ' HD13 ' A' ' 102' ' ' ILE . 53.7 mt-10 -105.51 132.37 51.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 109.418 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.674 HD12 HG12 ' A' ' 116' ' ' ILE . 20.0 mm -124.31 155.95 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.093 -1.004 . . . . 0.0 110.915 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 2.8 ttmt -148.2 114.5 5.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.885 . . . . 0.0 109.796 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.557 ' CG2' ' HA ' ' A' ' 15' ' ' ALA . 1.5 mp -77.41 121.27 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.01 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG23 ' HG2' ' A' ' 115' ' ' LYS . 61.9 t -104.45 133.4 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 110.435 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -99.26 132.37 44.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.0 p -106.68 157.87 34.12 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.018 . . . . 0.0 110.625 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.509 ' O ' ' HB3' ' A' ' 109' ' ' ASP . 49.6 Cg_endo -67.63 81.88 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.156 1.609 . . . . 0.0 110.218 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 7.6 t70 71.02 49.69 0.34 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.567 -0.708 . . . . 0.0 110.275 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -148.65 13.9 1.19 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.87 -159.21 34.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 3.4 p -126.38 131.09 51.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -1.129 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.59 HG23 HG23 ' A' ' 10' ' ' THR . 6.1 mt -93.79 116.89 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.993 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.807 ' HB3' HG22 ' A' ' 9' ' ' THR . 0.7 OUTLIER -77.69 106.4 9.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.439 -0.788 . . . . 0.0 110.703 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.554 ' HG2' HG23 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -82.06 115.63 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.881 -1.137 . . . . 0.0 108.952 178.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.674 HG12 HD12 ' A' ' 102' ' ' ILE . 81.7 mt -113.79 127.99 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 111.199 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -126.72 95.55 4.37 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.531 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 72.2 m-20 -93.08 108.29 19.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 111.403 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 124.94 39.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.356 -0.84 . . . . 0.0 109.322 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.921 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.6 m-85 -103.34 112.22 25.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 111.115 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -96.19 98.15 10.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.68 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.714 ' CG2' HG23 ' A' ' 128' ' ' VAL . 11.3 p -82.69 -173.1 4.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 110.334 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 122' ' ' THR . 0.0 OUTLIER 170.27 43.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.46 -152.14 5.59 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.62 -69.44 0.27 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -1.14 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.539 ' HB2' ' CG2' ' A' ' 94' ' ' THR . 7.1 m-70 -80.53 176.28 9.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.182 -0.949 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 11.8 mp0 -106.02 -99.98 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -0.951 . . . . 0.0 110.548 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.714 HG23 ' CG2' ' A' ' 122' ' ' THR . 40.1 t -126.41 151.5 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.704 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 130' ' ' ALA . 6.4 mtmt -104.43 99.3 9.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.02 -42.8 2.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.146 -0.971 . . . . 0.0 110.328 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 9.4 tt0 -54.81 -49.01 72.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.138 -0.976 . . . . 0.0 109.043 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -58.92 -46.37 88.1 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 109.45 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.92 HG22 ' CE2' ' A' ' 120' ' ' TYR . 38.5 t -62.23 -20.74 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.15 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.0 tttm -81.14 -68.57 0.68 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.6 -40.57 0.41 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.343 -0.848 . . . . 0.0 110.189 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.45 -51.61 66.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.179 -0.951 . . . . 0.0 109.105 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -54.92 -52.57 62.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.382 -0.824 . . . . 0.0 109.981 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -50.27 -46.45 55.08 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -34.99 75.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.29 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -65.53 -34.46 89.18 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -71.83 -45.45 61.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -1.192 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.74 -37.1 80.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 108.857 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.626 HD21 ' HB3' ' A' ' 37' ' ' ALA . 1.3 mm? -69.24 -37.92 78.24 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.425 -0.797 . . . . 0.0 109.145 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.492 HD13 HD22 ' A' ' 114' ' ' LEU . 13.6 tp -62.08 -34.62 76.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -33.91 61.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.649 -0.657 . . . . 0.0 109.728 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.661 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -65.49 -50.06 66.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.844 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 150' ' ' TYR . 34.4 t -74.74 -27.88 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.793 . . . . 0.0 109.772 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 13' ' ' ILE . 10.7 tt0 -65.61 -44.42 86.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.91 . . . . 0.0 109.703 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 34.5 m -86.79 -21.32 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 109.939 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.661 ' HB2' HG11 ' A' ' 33' ' ' VAL . 5.3 t80 -58.81 -44.42 90.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.91 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 ' CD2' ' A' ' 150' ' ' TYR . 52.6 mt -63.08 -24.41 67.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.96 . . . . 0.0 109.985 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.6 mp -82.36 -36.86 26.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 110.361 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.46 -53.86 10.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.0 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.456 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 44.6 m-70 -75.39 -32.35 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.993 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.5 t 46.48 23.68 0.24 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 110.259 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 154' ' ' HIS . 4.7 m-20 -141.51 9.18 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.415 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.463 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -113.18 128.81 56.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 110.425 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CE2' HD11 ' A' ' 29' ' ' LEU . 28.2 m-85 61.93 41.72 11.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.477 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.216 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.486 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 121' ' ' HIS . 54.8 t -82.63 152.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -1.19 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 83.2 m-85 -115.99 143.46 45.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -108.18 116.04 31.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.995 -1.065 . . . . 0.0 109.955 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.72 ' CD2' HG11 ' A' ' 133' ' ' VAL . 21.3 m-85 -114.98 86.34 2.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 0.0 110.729 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 4.9 mt-10 -51.25 147.15 5.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 108.917 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.5 ' HB ' ' OD1' ' A' ' 118' ' ' ASN . 12.3 t -141.06 173.52 11.4 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.51 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.603 ' OE1' HG22 ' A' ' 113' ' ' ILE . 0.2 OUTLIER 178.31 126.27 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.452 0.644 . . . . 0.0 110.07 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.983 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.1 t -129.95 158.23 40.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 140.21 49.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.212 -0.93 . . . . 0.0 110.832 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 18' ' ' LEU . 92.7 p -132.48 148.33 52.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.622 -0.674 . . . . 0.0 109.786 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -23.05 21.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.441 -0.787 . . . . 0.0 110.297 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.556 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 14.8 mm -81.85 143.1 49.52 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.576 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 33.5 Cg_endo -57.17 150.51 56.95 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.04 1.547 . . . . 0.0 110.946 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.74 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -51.84 -49.07 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 110.699 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -54.42 -55.09 32.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 110.971 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 9.6 mmt85 -54.9 -55.75 27.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.111 -0.993 . . . . 0.0 110.657 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 11' ' ' SER . 9.9 mt -58.87 -24.49 62.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.908 -1.12 . . . . 0.0 109.483 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.762 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -67.64 -56.02 11.02 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.58 -0.7 . . . . 0.0 109.789 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 40.5 mtpt -68.9 -25.09 64.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.618 -0.676 . . . . 0.0 112.128 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.784 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -103.89 -55.85 2.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.658 -1.276 . . . . 0.0 111.625 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.4 t80 -84.1 -1.41 54.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 0.0 112.203 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.706 HD11 HD11 ' A' ' 104' ' ' ILE . 12.8 mt -134.4 -22.95 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.555 -1.34 . . . . 0.0 111.38 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.762 HD21 ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -105.87 -22.78 12.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.969 -1.082 . . . . 0.0 108.87 178.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' CB ' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -131.98 70.04 1.47 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.699 -0.626 . . . . 0.0 109.899 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -97.44 -43.31 2.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.608 ' HB3' HG11 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -69.9 -9.99 56.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -1.111 . . . . 0.0 110.337 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 11.7 t30 -130.56 52.02 2.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.78 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.964 HD22 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER 173.49 -26.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.887 . . . . 0.0 109.675 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.783 ' N ' HD13 ' A' ' 29' ' ' LEU . 3.8 m-30 -56.78 -58.74 15.42 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.253 -0.904 . . . . 0.0 110.601 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.4 Cg_endo -64.67 -29.95 60.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.829 1.436 . . . . 0.0 111.205 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -16.18 63.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.092 -1.005 . . . . 0.0 110.552 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.839 HG23 ' HB1' ' A' ' 146' ' ' ALA . 9.0 m -123.63 -10.75 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.943 . . . . 0.0 110.271 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -138.11 66.66 46.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.374 -0.829 . . . . 0.0 109.803 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.67 -9.71 26.96 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.871 1.458 . . . . 0.0 109.821 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -88.98 -10.87 46.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.463 -0.773 . . . . 0.0 109.264 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -118.03 -57.42 2.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -0.871 . . . . 0.0 109.946 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG12 HD21 ' A' ' 143' ' ' LEU . 13.5 mm -95.14 170.99 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 0.0 110.45 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.63 -41.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.103 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.2 t -169.13 171.93 7.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.608 HG11 ' HB3' ' A' ' 27' ' ' ASP . 60.1 t -136.8 149.99 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 55' ' ' LYS . 3.9 tt0 -119.1 104.14 10.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.463 -0.773 . . . . 0.0 109.498 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 1.6 m-20 -90.16 104.77 17.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.333 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.4 HG23 ' OE1' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -65.89 -21.52 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 110.058 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 6.4 pt-20 -172.92 129.24 0.49 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 0.0 109.916 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.58 58.44 0.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -144.72 11.97 1.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -1.181 . . . . 0.0 110.231 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.79 -154.49 18.43 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.27 -80.75 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.79 60.07 7.42 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.24 1.653 . . . . 0.0 110.44 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.893 ' O ' HD12 ' A' ' 53' ' ' ILE . . . 168.79 -25.61 0.11 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.125 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 51' ' ' GLY . 77.1 m -39.39 128.3 1.84 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.273 -1.133 . . . . 0.0 110.752 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -112.41 156.13 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -139.85 153.3 47.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.866 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HG2' ' CG ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.81 87.97 2.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 110.6 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.824 ' HB ' HG13 ' A' ' 67' ' ' VAL . 1.9 mp -69.68 146.92 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.005 -1.06 . . . . 0.0 109.873 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.45 155.52 46.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.607 -0.683 . . . . 0.0 109.885 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 62' ' ' LEU . 30.1 m-85 -119.02 161.46 36.36 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.067 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' GLU . 47.5 Cg_endo -74.9 -164.73 0.24 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.059 1.557 . . . . 0.0 110.08 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER 40.0 -166.96 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.483 -0.761 . . . . 0.0 111.183 179.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.542 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -109.48 62.26 0.29 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' A' ' 58' ' ' PHE . 13.3 mt -40.84 167.01 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.953 . . . . 0.0 110.614 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 42.2 Cg_endo -68.97 -6.68 18.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.88 1.463 . . . . 0.0 110.277 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 18.7 m-30 -114.0 -100.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.88 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 166.09 -28.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 108.992 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 30.2 p90 -177.01 -164.55 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.577 -0.702 . . . . 0.0 109.364 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.824 HG13 ' HB ' ' A' ' 56' ' ' ILE . 3.6 p -166.25 128.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 0.0 110.547 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -103.03 147.35 27.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.412 ' OD1' HD13 ' A' ' 56' ' ' ILE . 6.9 p-10 -145.01 146.01 31.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HD3' HD11 ' A' ' 53' ' ' ILE . 12.0 ttp180 -117.32 134.4 54.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.285 -0.884 . . . . 0.0 110.058 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.3 131.1 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.39 -0.819 . . . . 0.0 110.271 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -103.31 52.03 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.407 -0.808 . . . . 0.0 109.726 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 16.2 mm-40 59.22 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.722 . . . . 0.0 110.297 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 81' ' ' TYR . 35.1 t -105.4 147.84 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.203 -0.936 . . . . 0.0 110.638 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.7 OUTLIER -63.25 -51.64 65.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 73.25 -75.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.546 -0.721 . . . . 0.0 110.887 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -60.53 -11.7 7.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.839 -1.163 . . . . 0.0 110.638 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -122.3 5.06 9.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.044 -1.035 . . . . 0.0 110.474 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.475 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.2 m-30 54.92 65.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 110.317 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.504 ' HB2' ' CB ' ' A' ' 75' ' ' ASP . 5.1 mttp -142.66 108.82 5.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.46 -0.775 . . . . 0.0 109.658 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.619 ' O ' HD12 ' A' ' 102' ' ' ILE . 7.4 t80 -95.25 123.57 38.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 110.838 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -119.94 123.37 43.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.486 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 84' ' ' SER . 2.7 p90 -148.89 174.06 12.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 110.698 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.41 ' N ' ' CD1' ' A' ' 83' ' ' TYR . 10.5 p -140.2 167.66 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.741 ' C ' HG23 ' A' ' 86' ' ' ILE . 23.5 t -92.64 -54.2 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.741 HG23 ' C ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER 69.67 -18.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 2.1 tt0 170.68 162.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.543 -1.348 . . . . 0.0 110.403 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 81.76 -173.08 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.79 -147.96 47.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 49.4 Cg_endo -81.39 32.67 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.99 1.521 . . . . 0.0 110.94 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.466 ' HA ' HD13 ' A' ' 91' ' ' ILE 0.297 1.5 mm -67.55 138.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 121.08 -1.013 . . . . 0.0 110.263 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 142.89 -165.94 26.75 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 44.6 -141.25 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -1.157 . . . . 0.0 109.777 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.889 HG21 ' HB2' ' A' ' 126' ' ' HIS . 1.8 p -89.06 72.15 8.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.978 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.967 HD22 HD11 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -168.36 82.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.333 -0.854 . . . . 0.0 110.044 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.501 ' OE2' ' CE ' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -63.62 -59.0 5.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 110.434 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.532 ' HG3' ' HB2' ' A' ' 121' ' ' HIS . 1.6 pttm -135.97 162.26 33.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.969 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.967 HD11 HD22 ' A' ' 95' ' ' LEU . 95.7 mt -139.15 122.23 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 111.289 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.6 151.96 20.59 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.517 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 53.6 t30 -154.75 147.48 24.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.873 -1.142 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.754 ' HB2' HG21 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -141.25 152.63 44.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.689 -0.632 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.826 HD12 ' N ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -152.62 144.6 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 121.294 0.569 . . . . 0.0 110.044 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.664 ' HG3' HG23 ' A' ' 105' ' ' VAL . 4.1 ptmm? -116.13 134.6 54.76 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.901 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.74 HG22 ' CB ' ' A' ' 15' ' ' ALA . 10.9 mm -92.18 90.49 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.673 -0.642 . . . . 0.0 109.86 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.664 HG23 ' HG3' ' A' ' 103' ' ' LYS . 17.2 t -87.02 133.97 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.349 -0.844 . . . . 0.0 110.372 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.93 133.1 35.99 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.632 -0.668 . . . . 0.0 109.668 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.1 p -87.65 155.93 53.31 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.297 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.27 -11.55 32.62 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.022 1.538 . . . . 0.0 110.497 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -175.43 86.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 170.48 -88.08 0.09 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.03 -135.18 1.77 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.54 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 5.0 p -124.93 170.42 11.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.235 -1.156 . . . . 0.0 109.889 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.603 HG22 ' OE1' ' A' ' 8' ' ' GLU . 36.5 mt -139.22 123.55 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.108 -0.995 . . . . 0.0 111.203 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.983 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.6 mp -93.43 93.83 8.36 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.646 ' HE2' HG21 ' A' ' 105' ' ' VAL . 5.6 pttt -131.45 138.24 48.96 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.821 -1.152 . . . . 0.0 113.589 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.868 HG22 ' N ' ' A' ' 117' ' ' SER . 1.2 mm -178.71 -95.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.868 ' N ' HG22 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -175.07 177.4 1.94 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.835 -1.166 . . . . 0.0 112.686 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 1.1 m120 -142.44 106.56 4.74 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -92.5 122.88 35.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 111.06 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.744 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.5 m-85 -96.81 109.33 22.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.404 -0.81 . . . . 0.0 109.646 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.532 ' HB2' ' HG3' ' A' ' 97' ' ' LYS . 76.6 m-70 -89.06 104.02 16.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 95' ' ' LEU . 3.0 p -116.43 -158.04 0.67 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.491 -0.755 . . . . 0.0 109.881 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.501 ' CE ' ' OE2' ' A' ' 96' ' ' GLU . 3.5 pttp -177.12 143.77 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 129.15 -98.0 0.43 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.19 -48.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.889 ' HB2' HG21 ' A' ' 94' ' ' THR . 80.1 m-70 -56.83 144.5 32.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 128' ' ' VAL . 52.3 mt-10 -89.86 148.86 22.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 110.403 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.565 HG23 ' CD1' ' A' ' 3' ' ' PHE . 13.3 t -41.34 164.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.499 -0.751 . . . . 0.0 110.174 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 133' ' ' VAL . 5.0 mtmt -111.49 131.53 55.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.38 -44.88 84.84 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.033 -1.042 . . . . 0.0 109.413 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.7 -31.51 16.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 25.9 mt-30 -79.23 -40.67 30.09 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.233 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.72 HG11 ' CD2' ' A' ' 5' ' ' TYR . 2.6 t -78.84 -0.3 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.655 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.27 -42.52 4.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.312 -0.867 . . . . 0.0 109.8 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -57.79 -44.91 86.58 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -43.72 86.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.344 -0.848 . . . . 0.0 109.533 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -64.34 -21.85 66.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.188 -0.945 . . . . 0.0 108.984 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 5.7 tm-20 -77.61 -44.92 26.74 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.657 -0.652 . . . . 0.0 109.299 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.484 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 40.2 mmm -64.5 -34.53 78.44 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.13 -42.74 75.21 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.78 -27.52 64.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.092 -1.24 . . . . 0.0 109.877 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -75.76 -35.33 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.174 -0.954 . . . . 0.0 108.965 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.663 HD21 HG12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -77.18 -28.15 53.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.136 178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 9' ' ' THR . 11.4 tp -70.89 -42.51 69.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 3.1 ttt85 -67.95 -39.24 83.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.653 -0.654 . . . . 0.0 109.332 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.839 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -60.06 -58.27 9.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 109.053 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.837 HG22 HD11 ' A' ' 29' ' ' LEU . 87.2 t -62.53 -25.09 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.619 -0.676 . . . . 0.0 109.67 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 2.9 mt-10 -65.31 -50.55 65.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -15.74 53.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.636 ' CG ' HG11 ' A' ' 33' ' ' VAL . 10.9 t80 -67.44 -37.42 82.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.132 -0.98 . . . . 0.0 109.811 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 65.5 mt -67.87 -18.43 64.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.976 -1.078 . . . . 0.0 109.321 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 mp -89.79 -40.71 12.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.657 -0.652 . . . . 0.0 110.955 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.96 -47.86 14.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.339 -0.85 . . . . 0.0 111.03 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.522 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 62.1 m-70 -79.94 81.44 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.274 -0.891 . . . . 0.0 110.936 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 154' ' ' HIS . 58.4 m 38.23 -94.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 111.033 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.511 ' HB3' ' ND2' ' A' ' 159' ' ' ASN . 24.9 m-20 -155.12 51.39 0.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.682 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.54 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -49.29 145.12 4.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.135 -0.978 . . . . 0.0 109.961 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.784 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 70.2 m-85 57.03 69.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.257 -0.902 . . . . 0.0 110.273 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 156' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.219 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 120' ' ' TYR . 61.7 t -47.15 156.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -1.191 . . . . 0.0 110.025 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.649 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 64.8 m-85 -117.97 96.56 5.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.868 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.5 121.68 19.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.054 -1.029 . . . . 0.0 111.469 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.685 ' CD2' HG11 ' A' ' 133' ' ' VAL . 22.0 m-85 -117.01 112.06 20.44 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -125.36 132.84 52.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.098 -1.001 . . . . 0.0 111.489 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -157.69 173.32 17.02 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.3 pp20? -145.68 149.94 35.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.806 -1.184 . . . . 0.0 110.989 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.957 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -124.56 172.86 8.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 179.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.88 142.22 51.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.992 -1.068 . . . . 0.0 111.145 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.465 ' HB3' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -131.81 147.6 52.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.665 -0.647 . . . . 0.0 109.622 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -18.18 21.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.331 -0.856 . . . . 0.0 109.921 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.498 ' O ' HD12 ' A' ' 18' ' ' LEU . 5.7 mm -83.33 140.86 42.15 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.479 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 35.6 Cg_endo -59.03 152.61 57.49 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.848 1.446 . . . . 0.0 111.17 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -53.06 -47.92 68.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 0.0 111.24 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.55 -59.04 5.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.564 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.569 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 2.6 mmt180 -47.18 -57.81 4.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 109.904 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -51.4 -37.19 47.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 109.625 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 1.15 ' CE1' HD21 ' A' ' 24' ' ' LEU . 3.8 t80 -62.13 -69.14 0.27 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.851 -1.156 . . . . 0.0 109.848 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 7.1 mtmt -50.99 -24.82 3.99 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 112.1 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.675 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -113.66 -63.53 1.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.584 -1.322 . . . . 0.0 111.459 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.685 ' HD1' HG21 ' A' ' 147' ' ' VAL . 24.7 t80 -60.55 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.742 -1.224 . . . . 0.0 110.207 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.945 HG22 HD23 ' A' ' 24' ' ' LEU . 31.2 mm -48.24 -81.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.763 -1.211 . . . . 0.0 108.129 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.15 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.5 mt -57.76 160.4 4.53 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.244 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER 44.85 54.57 6.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.107 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -99.74 -35.11 4.72 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HB3' HG11 ' A' ' 41' ' ' VAL . 83.0 m-20 -81.66 15.4 2.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -1.139 . . . . 0.0 110.635 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 8.2 t30 -135.0 42.96 2.74 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.832 HD21 HG13 ' A' ' 147' ' ' VAL . 1.0 OUTLIER 175.26 -38.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 4.7 m-30 -42.25 -55.55 6.43 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.763 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.7 Cg_endo -65.82 -49.28 2.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.708 1.373 . . . . 0.0 111.098 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -45.47 -52.56 10.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.195 -0.941 . . . . 0.0 111.159 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HB1' ' A' ' 146' ' ' ALA . 9.3 m -86.21 -16.76 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.213 -0.93 . . . . 0.0 110.847 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -135.69 71.96 63.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.174 -0.954 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.74 -19.51 41.25 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.887 1.467 . . . . 0.0 109.464 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.484 ' OE1' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -83.98 -9.74 58.44 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.602 -0.686 . . . . 0.0 109.149 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' N ' ' OE1' ' A' ' 36' ' ' GLN . . . -105.84 -57.22 2.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 31' ' ' PRO . 2.0 mp -117.62 165.93 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 110.152 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.447 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 4.4 m -130.26 -46.98 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.62 169.11 24.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.888 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 27' ' ' ASP . 72.0 t -137.34 119.62 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.199 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 7.5 mt-10 -86.91 116.07 24.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 110.139 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -94.32 99.44 11.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.409 -0.807 . . . . 0.0 110.212 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 45' ' ' GLU . 1.5 tp -71.47 -3.96 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 0.0 110.019 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER 68.81 111.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.852 . . . . 0.0 110.286 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.97 -117.59 1.7 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -81.04 -38.22 27.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 0.0 110.084 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.17 -26.34 11.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.46 -81.25 0.03 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.27 88.81 0.83 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.164 1.612 . . . . 0.0 110.257 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 71' ' ' VAL . . . 102.77 38.36 2.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 m -81.42 146.37 30.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -1.063 . . . . 0.0 110.455 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.458 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 1.1 mt -115.08 118.85 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.859 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 8.8 mttp -143.11 154.08 43.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.923 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 42' ' ' GLU . 76.0 mttt -120.36 140.6 51.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.592 -0.693 . . . . 0.0 110.161 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 55' ' ' LYS . 1.4 mp -113.2 123.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 109.736 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 m -104.69 115.91 31.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.463 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 1.013 ' CD2' HD13 ' A' ' 62' ' ' LEU . 13.1 m-85 -75.22 167.38 37.31 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.183 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 60' ' ' GLU . 49.6 Cg_endo -81.91 66.21 8.43 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.011 1.532 . . . . 0.0 109.854 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 59' ' ' PRO . 3.8 tt0 44.37 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.473 -0.767 . . . . 0.0 111.103 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.3 -51.98 1.85 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.013 HD13 ' CD2' ' A' ' 58' ' ' PHE . 4.0 mt -60.25 163.55 8.15 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.273 -1.133 . . . . 0.0 110.395 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.4 -25.0 26.12 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.934 1.492 . . . . 0.0 109.237 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.2 m-85 -103.44 -148.15 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.336 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.3 tttt -137.93 -10.36 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.971 -1.081 . . . . 0.0 111.402 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 47.5 p90 -176.83 -157.93 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.656 -1.277 . . . . 0.0 111.011 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 67' ' ' VAL . 8.3 p -169.44 113.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.33 -0.856 . . . . 0.0 110.766 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 7.1 tttt -87.75 153.1 21.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.982 -1.074 . . . . 0.0 109.809 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.53 ' N ' ' HG2' ' A' ' 68' ' ' LYS . 4.9 p-10 -136.88 148.89 47.33 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.04 -1.037 . . . . 0.0 110.626 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -128.01 104.27 7.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.425 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 52.6 t -73.51 148.88 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.236 -0.915 . . . . 0.0 110.122 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.2 -14.0 8.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 110.382 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.82 170.8 3.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 110.146 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 74' ' ' VAL . 7.4 p -170.67 108.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 6.0 t0 -74.81 -156.19 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.928 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -159.76 -57.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 0.0 110.796 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.9 m -50.57 -42.05 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -104.39 3.51 32.4 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.22 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.571 ' CB ' ' HB ' ' A' ' 104' ' ' ILE . 18.8 m-85 57.03 91.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.142 -0.974 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -139.66 106.19 5.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 0.0 110.289 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.664 ' HD1' HG23 ' A' ' 74' ' ' VAL . 1.1 t80 -101.07 152.6 20.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.08 -1.013 . . . . 0.0 109.68 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.74 132.75 13.39 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.115 -0.99 . . . . 0.0 110.722 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -159.3 169.26 24.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.385 -0.822 . . . . 0.0 109.719 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.458 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -134.57 157.9 45.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 110.281 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.611 HG12 HD11 ' A' ' 91' ' ' ILE . 3.5 t -104.83 136.34 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 109.039 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.488 ' CG2' ' C ' ' A' ' 85' ' ' VAL . 6.0 pt -148.61 14.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.794 -1.191 . . . . 0.0 111.432 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -169.42 89.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.82 -1.175 . . . . 0.0 110.921 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 126.05 -148.79 17.18 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 88' ' ' GLY . . . 29.85 -118.56 0.08 OUTLIER Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.628 ' HG2' HD12 ' A' ' 98' ' ' ILE . 39.3 Cg_endo -69.46 -73.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.975 1.513 . . . . 0.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.611 HD11 HG12 ' A' ' 85' ' ' VAL . 1.5 mm 9.6 59.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.687 0.756 . . . . 0.0 112.863 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' PRO . . . -158.09 152.02 23.18 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 94' ' ' THR . 7.4 t70 63.59 -162.29 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.243 . . . . 0.0 109.954 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.634 HG21 ' CB ' ' A' ' 126' ' ' HIS . 44.1 p -43.01 -44.07 4.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.144 -0.973 . . . . 0.0 110.108 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.797 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -52.49 119.63 4.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.79 -55.4 2.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.163 -0.96 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.511 ' C ' ' CG1' ' A' ' 98' ' ' ILE . 5.2 mmtt -113.44 157.12 22.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.195 -0.941 . . . . 0.0 109.829 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.628 HD12 ' HG2' ' A' ' 90' ' ' PRO . 8.5 mt -154.11 122.08 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.147 -0.971 . . . . 0.0 110.406 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 1.4 t -107.31 123.6 48.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.169 -0.957 . . . . 0.0 109.856 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.71 108.38 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 111.28 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.54 ' O ' ' CG1' ' A' ' 102' ' ' ILE . 43.2 mt-10 -99.05 165.15 11.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.815 . . . . 0.0 109.37 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 101' ' ' GLU . 12.4 mt -157.17 137.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -138.61 109.52 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 110.173 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.857 HD11 HG13 ' A' ' 23' ' ' ILE . 50.8 mt -75.43 151.72 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 112' ' ' SER . 3.6 t -131.2 131.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.068 -1.02 . . . . 0.0 110.766 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.69 136.86 36.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.611 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.5 p -121.11 144.66 40.02 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.917 . . . . 0.0 110.581 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -66.32 -7.96 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.137 1.599 . . . . 0.0 110.739 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 10.5 p30 -166.89 85.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 110.447 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.13 -23.11 0.23 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.26 -139.61 15.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 79.9 p -115.0 172.06 7.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.055 -1.262 . . . . 0.0 110.159 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 4.9 mt -140.47 122.76 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.807 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.957 ' HB2' HG22 ' A' ' 9' ' ' THR . 3.7 mm? -84.85 102.16 12.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.616 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 103' ' ' LYS . 7.0 mmmt -79.11 91.55 4.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.4 mm -79.08 138.32 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.344 -0.847 . . . . 0.0 111.078 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -139.35 139.5 37.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 5' ' ' TYR . 3.8 p-10 -164.58 109.33 0.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.69 -1.256 . . . . 0.0 111.356 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.55 ' HD3' ' NE2' ' A' ' 121' ' ' HIS . 12.9 ptpt -98.22 132.08 44.02 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.288 -0.882 . . . . 0.0 109.207 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.903 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.2 m-85 -90.54 141.72 28.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.55 ' NE2' ' HD3' ' A' ' 119' ' ' LYS . 28.3 m-70 -117.38 92.57 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.659 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 p -102.01 -170.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.521 -0.737 . . . . 0.0 110.098 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 -140.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 109.961 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.77 33.79 5.96 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 126' ' ' HIS . 1.1 t0 -160.71 163.01 32.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 110.081 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.634 ' CB ' HG21 ' A' ' 94' ' ' THR . 0.2 OUTLIER 53.2 104.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.109 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' VAL . 3.1 pt-20 -77.6 147.42 35.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.118 -0.989 . . . . 0.0 110.247 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.644 HG23 ' CD1' ' A' ' 3' ' ' PHE . 92.5 t -42.31 155.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.314 -0.866 . . . . 0.0 110.248 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.449 ' HB3' ' HE3' ' A' ' 129' ' ' LYS . 8.5 mtpp -101.16 106.79 18.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.87 -40.34 9.82 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.005 -1.06 . . . . 0.0 109.899 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -56.46 -45.42 80.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.413 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -63.76 -43.9 95.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 0.0 109.524 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.685 HG11 ' CD2' ' A' ' 5' ' ' TYR . 5.8 t -67.91 -16.33 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.186 -0.946 . . . . 0.0 109.478 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -86.17 -41.44 14.69 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 110.356 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -52.63 -47.97 66.69 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.983 . . . . 0.0 109.55 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 139' ' ' MET . 0.2 OUTLIER -60.71 -49.16 78.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.307 -0.871 . . . . 0.0 109.724 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -61.86 -20.56 63.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 11.9 tm-20 -76.27 -56.95 4.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.6 -0.687 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.519 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 2.3 ppp? -59.29 -28.66 66.97 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.135 -0.978 . . . . 0.0 108.504 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 139' ' ' MET . . . -69.53 -45.28 60.38 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.79 -32.19 73.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.053 -1.263 . . . . 0.0 109.774 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 2.1 p -69.99 -38.0 75.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.173 -0.955 . . . . 0.0 108.862 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 147' ' ' VAL . 0.8 OUTLIER -71.84 -31.57 66.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.708 ' CD2' HG21 ' A' ' 9' ' ' THR . 11.0 tp -67.18 -41.06 86.54 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -35.03 73.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.536 -0.728 . . . . 0.0 109.289 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.891 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -62.22 -50.64 70.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.485 -0.759 . . . . 0.0 109.927 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.832 HG13 HD21 ' A' ' 29' ' ' LEU . 12.8 t -70.74 -30.44 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 109.568 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.84 -55.26 36.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.461 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -74.68 -23.8 58.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.575 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.763 ' CD1' ' CE1' ' A' ' 154' ' ' HIS . 45.0 t80 -58.89 -62.2 2.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.799 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.466 HD23 ' CD2' ' A' ' 150' ' ' TYR . 34.3 mt -44.42 -26.61 0.36 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.079 . . . . 0.0 110.414 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 149' ' ' SER . 9.1 mp -79.22 -52.61 7.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.043 -1.036 . . . . 0.0 110.95 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 154' ' ' HIS . . . -63.31 -27.86 69.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.763 ' CE1' ' CD1' ' A' ' 150' ' ' TYR . 0.4 OUTLIER -122.88 104.16 9.09 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.825 -0.547 . . . . 0.0 109.926 -178.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 58.1 m -88.91 16.33 7.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 110.156 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -108.72 -22.18 12.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.298 -0.877 . . . . 0.0 110.468 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.48 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -84.6 130.26 34.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.462 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.675 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 37.1 m-85 59.93 48.64 8.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.637 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.226 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.911 HG13 ' O ' ' A' ' 120' ' ' TYR . 95.6 t -54.6 151.99 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.254 . . . . 0.0 110.004 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.643 ' CE1' HG23 ' A' ' 128' ' ' VAL . 80.3 m-85 -114.15 149.14 36.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 110.066 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.98 84.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.956 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.016 ' CD1' HG11 ' A' ' 133' ' ' VAL . 45.5 m-85 -88.43 78.62 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 110.02 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 7' ' ' THR . 98.7 mt-10 -90.02 165.93 13.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.353 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 6' ' ' GLU . 12.3 t -179.8 172.83 1.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.835 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.478 ' OE1' ' HD2' ' A' ' 115' ' ' LYS . 23.5 tt0 -155.89 147.08 22.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.13 -0.981 . . . . 0.0 110.336 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.903 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.92 172.31 11.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.887 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.79 140.36 52.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.965 -1.084 . . . . 0.0 110.132 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.54 ' OG ' ' CD1' ' A' ' 18' ' ' LEU . 63.9 p -129.1 150.83 50.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.373 -0.829 . . . . 0.0 110.769 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.26 -22.88 21.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.586 -0.696 . . . . 0.0 109.774 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.57 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 19.3 mm -80.25 142.87 55.37 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 35.5 Cg_endo -58.02 148.58 76.18 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.749 1.394 . . . . 0.0 110.732 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.687 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -55.07 -36.69 65.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.484 -0.76 . . . . 0.0 110.83 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.03 70.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -62.88 -50.84 69.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 110.61 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 14.4 mt -57.23 -39.22 75.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.946 -1.096 . . . . 0.0 109.766 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.93 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -61.36 -63.99 1.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 110.098 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.27 -30.29 50.11 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.552 -0.718 . . . . 0.0 112.223 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -105.69 -64.61 1.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.758 -1.214 . . . . 0.0 111.44 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.844 ' HE2' HD21 ' A' ' 114' ' ' LEU . 63.3 t80 -70.29 5.47 1.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.294 -0.879 . . . . 0.0 112.449 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.518 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 28.7 mm -142.81 -26.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.307 -1.495 . . . . 0.0 111.882 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.93 HD21 ' CE1' ' A' ' 19' ' ' PHE . 4.2 mt -102.31 -34.44 9.21 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.62 -1.3 . . . . 0.0 109.833 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 5.9 t0 -119.64 31.96 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -71.31 -25.14 76.05 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.93 ' O ' HG11 ' A' ' 41' ' ' VAL . 20.6 m-20 -76.6 3.52 11.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.419 -1.048 . . . . 0.0 110.13 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.495 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 5.5 t30 -140.16 52.73 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.648 HD11 ' CD2' ' A' ' 150' ' ' TYR . 1.5 tp 170.62 -35.6 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.516 -0.74 . . . . 0.0 109.26 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 2.4 m-30 -42.97 -59.82 2.79 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.533 -0.729 . . . . 0.0 110.874 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.553 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 46.1 Cg_endo -66.22 -29.45 47.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.915 1.482 . . . . 0.0 111.189 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -36.3 83.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.9 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.802 HG23 ' HB1' ' A' ' 146' ' ' ALA . 15.9 m -104.12 -9.21 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.062 -1.024 . . . . 0.0 110.409 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.41 63.89 56.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.965 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.53 -7.82 20.39 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.97 1.51 . . . . 0.0 110.139 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -92.11 -18.33 23.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.424 -0.798 . . . . 0.0 109.167 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.1 -58.41 2.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.654 HG12 HD21 ' A' ' 143' ' ' LEU . 10.0 mm -95.68 179.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.384 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.628 ' H ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -159.47 -49.16 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.959 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.27 142.61 30.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.93 HG11 ' O ' ' A' ' 27' ' ' ASP . 7.6 p -120.99 121.55 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 110.419 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 9.1 tt0 -92.02 102.51 15.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -0.881 . . . . 0.0 109.929 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' ILE . 89.2 m-20 -90.88 72.97 6.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.498 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.691 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -44.84 -26.48 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 109.408 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 44' ' ' ILE . 2.1 tt0 40.55 79.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.485 -0.759 . . . . 0.0 110.754 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.5 -55.15 6.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 64.2 t-20 -128.86 -14.8 4.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.267 -1.137 . . . . 0.0 110.471 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.42 4.85 83.03 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.56 -103.18 0.32 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.31 78.96 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.959 1.505 . . . . 0.0 110.461 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.08 32.96 0.29 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m -95.23 104.95 16.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -1.223 . . . . 0.0 109.739 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.597 HD11 ' HD2' ' A' ' 70' ' ' ARG . 3.6 mp -102.56 143.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.616 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 2.4 mttt -130.76 150.13 52.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -117.9 97.97 6.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.412 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.501 HG22 ' CE1' ' A' ' 58' ' ' PHE . 1.5 mp -78.58 131.81 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 110.133 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -115.28 141.14 48.43 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.762 ' HD2' HD21 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -107.69 135.19 19.8 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 110.538 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 38' ' ' ILE . 50.9 Cg_endo -84.34 47.93 2.33 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.952 1.501 . . . . 0.0 109.965 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.71 -171.48 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -0.801 . . . . 0.0 110.627 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.36 35.44 4.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.762 HD21 ' HD2' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -54.19 -176.49 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -1.052 . . . . 0.0 110.324 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.686 ' HD2' ' HB2' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -82.46 -20.95 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.04 1.021 . . . . 0.0 110.462 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 2.4 m-85 -97.08 -154.92 0.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -131.27 -33.95 1.45 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.0 109.448 179.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 36.6 p90 -169.04 -153.53 0.12 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 67' ' ' VAL . 8.9 p -168.37 111.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.963 -1.086 . . . . 0.0 111.149 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.7 ttpp -99.7 149.15 23.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.347 -0.846 . . . . 0.0 109.19 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 29.8 p30 -154.26 148.18 25.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.984 -1.072 . . . . 0.0 110.964 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.597 ' HD2' HD11 ' A' ' 53' ' ' ILE . 4.6 ttp180 -103.6 154.27 19.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.453 -0.779 . . . . 0.0 109.584 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 15.6 t -99.39 -44.53 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.113 -0.992 . . . . 0.0 110.359 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER 76.94 -38.13 0.3 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.848 -0.532 . . . . 0.0 111.721 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 1.2 pt-20 178.28 155.95 0.4 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.686 -1.259 . . . . 0.0 110.505 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.451 HG13 ' HD1' ' A' ' 81' ' ' TYR . 94.3 t -146.05 153.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.818 . . . . 0.0 109.901 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.65 164.46 15.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.723 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.502 ' NE2' HD11 ' A' ' 24' ' ' LEU . 3.8 m80 -134.4 -40.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.51 -0.744 . . . . 0.0 109.856 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -55.42 -38.55 69.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 110.253 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -108.25 12.8 26.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.511 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.538 ' O ' HD12 ' A' ' 104' ' ' ILE . 3.8 m-85 52.11 60.59 3.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 81' ' ' TYR . 1.4 tppt? -123.35 155.51 37.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.39 -0.819 . . . . 0.0 110.586 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.5 ' N ' ' HG3' ' A' ' 80' ' ' LYS . 64.6 t80 -144.06 162.2 36.83 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.58 -0.7 . . . . 0.0 109.162 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 71' ' ' VAL . 28.0 t30 -167.52 128.63 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.913 -1.117 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 32.7 p90 -143.23 142.44 31.4 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.383 -0.823 . . . . 0.0 109.941 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.45 126.25 54.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.459 -0.775 . . . . 0.0 110.173 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.05 128.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.781 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -124.7 10.64 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.162 -0.962 . . . . 0.0 109.865 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 2.2 mm-40 -176.65 170.72 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.507 ' O ' HG13 ' A' ' 91' ' ' ILE . . . 73.12 173.33 25.03 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.82 -144.19 27.41 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.4 Cg_endo -84.8 34.27 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.067 1.561 . . . . 0.0 110.735 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -50.25 172.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.985 . . . . 0.0 110.437 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . 45.7 63.48 2.79 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 92' ' ' GLY . 7.5 t0 -177.83 82.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -1.164 . . . . 0.0 110.422 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' ASP . 18.8 p 43.65 29.0 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.278 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.904 HD11 ' CD2' ' A' ' 120' ' ' TYR . 1.9 tp -150.61 95.77 2.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.171 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.5 -49.83 44.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.643 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.512 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -152.62 165.54 34.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.321 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.734 HD11 HD11 ' A' ' 95' ' ' LEU . 24.2 mm -140.76 116.78 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -0.833 . . . . 0.0 110.442 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.8 t -96.33 143.2 27.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.123 -0.986 . . . . 0.0 108.946 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 36.0 t-20 -143.04 149.53 38.36 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.259 -1.376 . . . . 0.0 112.126 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 25.3 mt-10 -129.03 152.47 48.6 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 12.1 mt -142.0 124.03 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 0.0 110.635 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -115.41 130.96 57.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 0.0 109.738 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 19' ' ' PHE . 1.3 mp -99.43 118.95 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.036 -1.04 . . . . 0.0 109.782 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 112' ' ' SER . 6.6 t -107.34 129.56 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.24 140.92 29.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 109.757 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 p -104.47 148.96 36.85 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 110.397 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.0 -8.62 22.29 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.09 1.574 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -165.01 83.83 0.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.913 . . . . 0.0 110.43 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.14 -85.83 0.1 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.91 -113.29 0.3 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.546 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 4.5 p -138.9 176.82 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -1.192 . . . . 0.0 109.972 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.411 HG21 ' OE2' ' A' ' 8' ' ' GLU . 15.9 mt -139.28 123.35 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.271 -0.893 . . . . 0.0 110.417 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.903 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.19 90.72 8.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.506 -0.746 . . . . 0.0 110.332 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HD2' ' OE1' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -85.22 99.51 11.15 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 114' ' ' LEU . 1.2 mp -99.84 155.02 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.061 -1.024 . . . . 0.0 111.679 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.5 m -140.14 107.71 5.6 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 100' ' ' ASN . 3.3 t-20 -105.85 105.77 15.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 112.034 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.486 ' HG3' ' CG1' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -88.47 107.64 18.97 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.911 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.7 m-85 -82.52 142.94 31.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.924 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 97' ' ' LYS . 83.6 m-70 -126.31 100.37 6.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.766 -0.584 . . . . 0.0 109.566 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.518 HG21 ' CG2' ' A' ' 128' ' ' VAL . 4.9 p -110.53 -166.61 1.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.45 -0.781 . . . . 0.0 110.35 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.69 67.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.6 -149.67 5.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -68.98 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.448 -1.031 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -75.67 -174.49 2.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.105 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 12.2 mp0 -115.46 -171.7 2.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 110.284 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.643 HG23 ' CE1' ' A' ' 3' ' ' PHE . 88.6 t -54.13 152.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.448 ' NZ ' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -98.85 108.21 20.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 110.005 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -41.91 -59.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.868 . . . . 0.0 110.422 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 2.5 tt0 -43.17 -45.25 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 109.782 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -45.23 94.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.016 HG11 ' CD1' ' A' ' 5' ' ' TYR . 76.4 t -58.04 -24.61 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -76.82 -51.42 11.36 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.751 -0.593 . . . . 0.0 110.108 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -43.8 -43.82 6.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.872 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.1 t -60.45 -54.82 40.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.569 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -53.45 -27.87 27.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.36 -0.837 . . . . 0.0 109.745 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.405 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.72 -46.87 43.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.527 -0.733 . . . . 0.0 110.392 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.455 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 4.6 mtp -63.19 -30.46 71.6 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.846 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.6 -45.43 53.34 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -72.32 -30.07 64.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.89 -1.359 . . . . 0.0 110.614 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 1.2 p -72.99 -40.35 65.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.794 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.654 HD21 HG12 ' A' ' 38' ' ' ILE . 1.1 mm? -80.03 -25.84 40.02 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.354 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 16.4 tp -70.75 -39.95 72.98 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -44.36 59.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.476 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.802 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -55.52 -55.51 31.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.469 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.565 HG13 HD21 ' A' ' 29' ' ' LEU . 69.3 t -66.02 -32.31 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.51 ' HG2' HG12 ' A' ' 13' ' ' ILE . 1.2 tm-20 -58.48 -52.13 66.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.413 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.3 p -75.99 -26.67 56.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 109.982 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.677 ' HB2' HG11 ' A' ' 33' ' ' VAL . 8.5 t80 -57.71 -45.75 85.33 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.339 -0.851 . . . . 0.0 109.724 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.7 mt -58.05 -24.81 59.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 6.0 mp -93.01 -19.68 21.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.552 -0.717 . . . . 0.0 110.516 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.5 -34.03 23.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.068 -1.02 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 155' ' ' SER . 10.0 m-70 -91.86 166.2 12.86 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.934 . . . . 0.0 110.6 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.48 ' O ' ' OD1' ' A' ' 156' ' ' ASP . 22.9 m -43.48 -56.81 3.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 110.608 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 155' ' ' SER . 2.4 m-20 -177.94 65.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.588 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -67.76 133.58 49.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.354 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.863 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 56.5 m-85 60.59 19.9 9.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.366 -0.834 . . . . 0.0 110.587 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.065 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.56 ' CG2' ' HG3' ' A' ' 119' ' ' LYS . 11.7 p -55.36 154.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.16 . . . . 0.0 110.456 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.67 ' CD1' HG23 ' A' ' 128' ' ' VAL . 53.9 m-85 -115.88 158.75 22.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 0.0 110.256 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -117.37 118.69 32.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.03 ' CD1' HG11 ' A' ' 133' ' ' VAL . 37.2 m-85 -122.63 89.51 3.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -99.82 155.13 17.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.448 ' C ' ' HG3' ' A' ' 8' ' ' GLU . 11.8 t -171.24 170.21 6.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.898 . . . . 0.0 110.171 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' HG3' ' C ' ' A' ' 7' ' ' THR . 27.6 mt-10 -148.04 118.97 7.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.438 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.972 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -100.58 -177.73 3.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 109.815 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.498 HG22 ' CD1' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -124.0 137.93 54.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.0 110.424 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.897 ' OG ' HD11 ' A' ' 18' ' ' LEU . 36.4 t -125.01 139.44 53.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.487 -0.758 . . . . 0.0 110.404 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.5 -2.66 4.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.457 -0.777 . . . . 0.0 110.161 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.687 HG23 ' HD2' ' A' ' 14' ' ' PRO . 7.9 mm -96.11 149.31 35.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.253 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.687 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.8 Cg_endo -56.68 155.66 25.85 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.019 1.536 . . . . 0.0 110.518 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.723 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -64.17 -71.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 111.268 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -39.3 -51.43 2.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.603 -0.686 . . . . 0.0 110.951 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.572 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 6.7 ttm180 -57.33 -54.97 40.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.812 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.897 HD11 ' OG ' ' A' ' 11' ' ' SER . 8.7 mt -50.43 -29.2 9.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.184 -1.006 . . . . 0.0 108.822 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 1.121 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.8 OUTLIER -69.76 -67.35 0.49 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.545 -0.722 . . . . 0.0 110.678 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 25.5 mtpt -57.34 -21.36 34.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.377 -0.827 . . . . 0.0 112.717 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.803 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.58 -58.98 2.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.46 -1.4 . . . . 0.0 112.512 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' HA ' HG11 ' A' ' 147' ' ' VAL . 34.1 t80 -73.24 -11.51 60.54 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.893 -1.129 . . . . 0.0 112.353 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.922 HG22 HD23 ' A' ' 24' ' ' LEU . 23.0 mt -121.77 -80.17 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 120.674 -1.267 . . . . 0.0 110.393 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.121 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.3 mt -45.44 -56.72 4.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.865 -1.147 . . . . 0.0 110.032 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -100.21 66.54 1.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . -101.96 -30.95 5.56 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.595 ' HB3' HG11 ' A' ' 41' ' ' VAL . 99.4 m-20 -81.39 13.49 2.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.358 -1.084 . . . . 0.0 110.456 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 10.5 t30 -138.68 45.06 2.05 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.898 HD21 HG13 ' A' ' 147' ' ' VAL . 1.2 tp 173.55 -29.74 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.751 -0.593 . . . . 0.0 109.441 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CD1' HD12 ' A' ' 143' ' ' LEU . 2.9 m-30 -48.41 -61.01 3.57 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.367 -0.833 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 47.3 Cg_endo -65.95 -22.96 54.94 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.8 1.421 . . . . 0.0 111.464 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -71.73 -50.91 25.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.068 -1.02 . . . . 0.0 110.628 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.818 HG23 ' HB1' ' A' ' 146' ' ' ALA . 19.5 m -89.54 -8.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 110.243 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -134.96 62.43 52.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.505 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.98 -15.7 43.95 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 109.358 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -83.88 -16.74 43.24 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.543 0.687 . . . . 0.0 109.192 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.51 -64.21 1.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 110.595 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.87 HG12 HD21 ' A' ' 143' ' ' LEU . 10.5 mm -93.73 169.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.437 ' N ' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -136.16 -36.63 0.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 109.986 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.39 160.77 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.271 -0.893 . . . . 0.0 109.86 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 27' ' ' ASP . 3.7 p -140.57 154.25 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.028 -1.045 . . . . 0.0 110.647 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -107.29 138.77 42.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.459 -0.776 . . . . 0.0 109.603 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' HA ' ' HG2' ' A' ' 54' ' ' LYS . 4.9 m-20 -121.91 106.94 11.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 0.0 110.748 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.71 HG22 ' CG2' ' A' ' 53' ' ' ILE . 0.4 OUTLIER -127.1 -41.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.104 -0.998 . . . . 0.0 109.589 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.541 ' HA ' HG22 ' A' ' 53' ' ' ILE . 4.1 tt0 56.29 155.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.937 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' C ' ' OD1' ' A' ' 47' ' ' ASN . . . -120.94 -69.82 0.28 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 46' ' ' GLY . 4.5 m120 -148.61 22.51 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -1.092 . . . . 0.0 109.755 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.61 -152.65 12.23 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' O ' ' OE2' ' A' ' 45' ' ' GLU . . . -54.35 -179.6 0.17 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -82.27 43.33 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.089 1.573 . . . . 0.0 110.99 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 71' ' ' VAL . . . -171.08 24.11 0.09 OUTLIER Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.007 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 53' ' ' ILE . 1.2 m -76.38 175.08 9.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -1.19 . . . . 0.0 110.31 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.71 ' CG2' HG22 ' A' ' 44' ' ' ILE . 1.0 OUTLIER 30.55 31.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.587 0.708 . . . . 0.0 112.477 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' N ' ' O ' ' A' ' 52' ' ' THR . 14.5 mttt -75.53 152.41 37.8 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -124.7 91.5 3.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.892 -1.13 . . . . 0.0 111.053 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.508 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.2 mp -77.51 158.31 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.586 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.459 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -144.63 171.3 14.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 1.01 ' HB3' HD12 ' A' ' 62' ' ' LEU . 15.9 m-85 -134.72 157.09 77.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.468 -0.77 . . . . 0.0 110.034 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 39' ' ' SER . 47.3 Cg_endo -77.19 177.62 8.65 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.907 1.477 . . . . 0.0 109.835 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.07 175.43 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.0 110.142 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.34 -47.37 3.29 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.01 HD12 ' HB3' ' A' ' 58' ' ' PHE . 13.5 mt -78.38 139.52 59.81 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.71 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.75 -7.09 19.01 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.009 1.531 . . . . 0.0 110.217 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.472 ' CD2' ' HA2' ' A' ' 89' ' ' GLY . 3.6 m-30 -97.32 135.07 39.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 110.155 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -87.94 -42.63 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 0.0 110.365 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.87 ' O ' HG13 ' A' ' 67' ' ' VAL . 30.3 p90 -167.55 -173.76 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.003 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -166.07 124.29 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.442 -0.786 . . . . 0.0 110.693 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -81.12 92.85 6.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.464 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 22.3 t70 -84.35 96.19 8.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.055 -1.028 . . . . 0.0 110.788 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.507 ' HG3' ' HA ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.67 83.64 7.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.872 . . . . 0.0 110.043 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.685 HG12 ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -45.44 -60.59 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.074 -1.016 . . . . 0.0 109.54 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.685 ' N ' HG12 ' A' ' 71' ' ' VAL . 0.1 OUTLIER 73.07 -28.4 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -167.5 171.84 10.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.211 -1.555 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.2 p -165.56 146.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.369 -0.832 . . . . 0.0 109.671 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.02 -171.53 2.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 0.0 110.146 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.3 -56.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 110.376 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.0 m -59.46 -20.14 52.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.0 110.835 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -118.27 8.38 12.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.044 . . . . 0.0 110.564 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.619 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.6 m-30 54.49 54.21 9.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.109 -0.994 . . . . 0.0 109.863 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.64 147.3 47.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.556 ' CD1' ' CG2' ' A' ' 23' ' ' ILE . 14.4 t80 -133.2 105.0 6.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.101 -1.0 . . . . 0.0 110.693 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -101.59 115.55 30.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.012 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 7.4 p90 -138.91 155.3 48.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.869 . . . . 0.0 110.101 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER -109.29 136.36 48.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 110.856 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.459 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 73.0 t -111.53 121.12 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.462 HD11 ' CD ' ' A' ' 70' ' ' ARG . 8.4 pt -147.16 164.43 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.962 -1.086 . . . . 0.0 111.281 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 64.76 133.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.502 -0.749 . . . . 0.0 110.847 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 66' ' ' TYR . . . 56.29 178.08 0.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.611 ' HA3' HG12 ' A' ' 67' ' ' VAL . . . 80.89 -133.25 11.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' A' ' 98' ' ' ILE . 48.7 Cg_endo -78.91 1.6 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.054 1.555 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.65 HD11 ' O ' ' A' ' 96' ' ' GLU 0.293 1.3 mm -61.27 140.92 18.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.223 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 159.15 -92.97 0.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -117.68 145.0 44.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -1.15 . . . . 0.0 110.315 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.871 HG22 ' O ' ' A' ' 125' ' ' ASP . 6.5 p 50.79 50.39 19.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 110.239 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.968 HD21 ' CD2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER 167.14 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.341 -0.85 . . . . 0.0 110.379 179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.65 ' O ' HD11 ' A' ' 91' ' ' ILE . 8.2 tt0 -96.13 -39.59 9.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.27 136.81 50.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.584 HG23 ' CD1' ' A' ' 120' ' ' TYR . 29.8 mt -131.94 113.06 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.861 . . . . 0.0 110.361 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 135.85 33.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.904 . . . . 0.0 109.205 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.519 ' HB3' ' OH ' ' A' ' 83' ' ' TYR . 4.9 m120 -132.14 139.23 48.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.786 -1.196 . . . . 0.0 110.88 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 81' ' ' TYR . 2.0 mt-10 -137.05 130.93 32.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.321 -0.862 . . . . 0.0 110.105 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 83' ' ' TYR . 7.4 mt -118.93 127.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.502 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 tmtt? -115.14 118.13 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.746 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.723 HG22 ' HB1' ' A' ' 15' ' ' ALA . 38.7 mm -79.36 115.83 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.884 . . . . 0.0 110.283 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.407 ' CG2' ' HG3' ' A' ' 115' ' ' LYS . 63.0 t -108.93 123.72 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 110.117 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -87.69 135.99 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.185 -0.947 . . . . 0.0 110.235 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.6 p -106.76 150.19 39.38 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.226 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 48.4 Cg_endo -66.84 81.13 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.181 1.622 . . . . 0.0 110.698 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 18.9 t0 -179.93 -62.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 0.0 110.284 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.19 38.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.34 158.33 28.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.551 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -127.95 130.38 48.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -1.217 . . . . 0.0 110.464 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.961 HG23 ' O ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -85.47 143.99 10.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.422 -0.799 . . . . 0.0 109.548 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.972 ' HB2' HG22 ' A' ' 9' ' ' THR . 3.8 mm? -97.66 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.17 -0.956 . . . . 0.0 110.075 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -85.43 99.77 11.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.094 -1.004 . . . . 0.0 109.425 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.418 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 7.6 mt -98.37 131.19 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.839 -1.163 . . . . 0.0 111.678 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.0 m -123.56 129.89 51.86 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 9.9 m-20 -131.25 105.85 7.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.993 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -90.79 107.92 19.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.968 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.8 m-85 -88.19 95.02 10.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 111.864 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.594 ' CE1' ' HG2' ' A' ' 119' ' ' LYS . 72.4 m-70 -79.95 95.95 6.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 108.882 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.61 HG21 ' CG2' ' A' ' 128' ' ' VAL . 5.6 p -102.67 -56.22 2.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.17 -0.956 . . . . 0.0 111.017 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 122' ' ' THR . 18.1 pttm 35.29 72.74 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.624 -0.673 . . . . 0.0 111.246 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.65 -72.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.871 ' O ' HG22 ' A' ' 94' ' ' THR . 14.8 t70 -153.99 150.62 28.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.88 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 51.83 -167.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.08 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -121.49 170.09 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.883 . . . . 0.0 110.486 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.67 HG23 ' CD1' ' A' ' 3' ' ' PHE . 64.8 t -61.95 135.31 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.224 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.3 mtmt -82.33 115.57 21.44 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -45.34 -42.01 9.51 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 10.2 tm-20 -54.79 -47.28 74.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.553 HE21 HD13 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -59.41 -39.39 83.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.278 -0.889 . . . . 0.0 108.921 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.03 HG11 ' CD1' ' A' ' 5' ' ' TYR . 84.2 t -66.7 -23.46 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 109.161 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 135' ' ' ALA . 14.5 tttt -79.06 -63.04 1.51 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.684 -0.635 . . . . 0.0 110.499 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.22 -46.06 1.03 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -0.817 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m -60.61 -47.84 84.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.43 ' HE2' HG21 ' A' ' 7' ' ' THR . 36.0 mttt -59.96 -28.55 67.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 109.788 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.43 -39.76 64.75 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.464 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.0 OUTLIER -65.3 -37.3 86.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 108.783 178.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.47 -42.64 93.6 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -32.19 72.6 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.214 -1.168 . . . . 0.0 110.182 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.492 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 1.7 p -70.6 -39.18 73.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.324 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.87 HD21 HG12 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -75.14 -28.13 60.04 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.6 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 23.9 tp -71.18 -39.94 71.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.066 -1.021 . . . . 0.0 108.594 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.558 ' HG3' ' N ' ' A' ' 146' ' ' ALA . 1.3 ptm85 -73.76 -32.68 63.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.461 -0.774 . . . . 0.0 109.472 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -65.83 -58.12 6.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.1 -1.0 . . . . 0.0 109.059 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.898 HG13 HD21 ' A' ' 29' ' ' LEU . 47.7 t -64.95 -28.12 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.554 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' HA ' HG13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -63.64 -49.45 73.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.814 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.413 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 1.3 t -78.69 -20.89 49.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 110.044 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.774 ' HB2' HG11 ' A' ' 33' ' ' VAL . 12.0 t80 -62.55 -41.07 98.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.613 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 65.9 mt -67.45 -22.29 65.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 109.917 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.8 mp -82.72 -38.35 23.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -0.809 . . . . 0.0 110.04 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.413 ' HB3' ' HD2' ' A' ' 154' ' ' HIS . . . -71.0 -46.18 62.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 154' ' ' HIS . 19.0 m-70 -81.63 -39.03 25.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.887 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.9 m 58.06 19.54 6.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 110.498 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 157' ' ' ALA . 2.6 p30 -138.51 -33.45 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.593 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 156' ' ' ASP . . . -60.36 131.92 52.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.803 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.5 m-85 55.69 49.3 16.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.834 . . . . 0.0 110.868 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.22 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' A' ' 119' ' ' LYS . 8.1 p -132.46 165.41 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.189 . . . . 0.0 110.259 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.649 ' CD1' HG23 ' A' ' 128' ' ' VAL . 45.6 m-85 -129.02 148.57 50.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.395 -0.816 . . . . 0.0 109.904 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.11 86.8 2.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.066 -1.021 . . . . 0.0 111.004 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.183 ' CD1' HG11 ' A' ' 133' ' ' VAL . 18.3 m-85 -84.82 73.45 10.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 109.464 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.24 118.17 21.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.887 . . . . 0.0 110.917 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -132.13 -168.9 2.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.595 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.88 163.44 3.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 0.0 110.177 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.785 HG22 ' CB ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -141.51 173.39 11.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.4 141.58 50.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.957 . . . . 0.0 110.662 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 t -136.71 147.1 46.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 109.929 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.76 -20.5 19.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.366 -0.834 . . . . 0.0 110.202 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 18' ' ' LEU . 5.4 mm -79.03 140.91 57.93 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 110.705 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 34.2 Cg_endo -57.53 151.91 51.09 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 121.659 1.573 . . . . 0.0 111.173 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.678 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -56.67 -48.59 77.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.593 -0.692 . . . . 0.0 111.455 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -52.31 -61.78 2.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.037 -1.039 . . . . 0.0 111.045 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 3.6 ttp180 -54.07 -57.73 10.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.064 -1.022 . . . . 0.0 109.944 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER -48.08 -29.25 3.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -0.936 . . . . 0.0 109.305 179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.948 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.09 -63.12 1.12 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.353 -0.842 . . . . 0.0 109.326 178.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -46.68 -46.05 19.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 110.481 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.888 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -83.94 -70.82 0.54 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.725 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 22.0 t80 -76.0 142.61 41.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.376 -0.828 . . . . 0.0 108.941 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 14.7 mt 81.29 -46.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 CA-C-O 120.914 0.387 . . . . 0.0 110.922 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.948 HD21 ' CE1' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -86.71 -77.15 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.957 -1.089 . . . . 0.0 109.484 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 29' ' ' LEU . 9.5 t70 -57.5 -96.35 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.05 -1.031 . . . . 0.0 109.193 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.594 ' HA2' ' CE1' ' A' ' 30' ' ' PHE . . . 79.11 -74.0 2.26 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.837 -1.164 . . . . 0.0 110.936 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.54 -4.47 6.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.977 -1.308 . . . . 0.0 111.106 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 12.3 t30 -135.96 51.71 2.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.022 -1.049 . . . . 0.0 109.645 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.88 ' C ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER 171.15 -24.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.277 -0.89 . . . . 0.0 109.554 -179.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.648 ' N ' HD13 ' A' ' 29' ' ' LEU . 5.3 m-30 -65.14 -58.09 13.5 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.181 -0.95 . . . . 0.0 110.229 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.574 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 44.0 Cg_endo -65.1 -35.3 42.89 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.808 1.425 . . . . 0.0 110.604 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.55 -37.87 76.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.198 -0.939 . . . . 0.0 110.128 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.844 HG23 ' HB1' ' A' ' 146' ' ' ALA . 6.0 m -106.71 2.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -152.83 66.15 6.04 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 59' ' ' PRO . 42.0 Cg_endo -67.91 -24.22 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.903 1.475 . . . . 0.0 109.439 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -81.21 -9.46 59.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.412 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -104.0 -57.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.124 -0.985 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -124.79 168.05 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.168 -0.957 . . . . 0.0 110.984 -179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.503 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 1.4 t -131.48 -37.45 1.21 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.653 -0.654 . . . . 0.0 109.398 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 39' ' ' SER . 7.5 t -177.42 142.79 0.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 0.0 109.862 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.731 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.5 p -132.95 116.04 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.028 -1.045 . . . . 0.0 110.753 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.6 tt0 178.82 156.12 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.365 -0.834 . . . . 0.0 110.504 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.895 ' HB3' HG22 ' A' ' 53' ' ' ILE . 1.3 m-20 -143.69 -63.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 109.365 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.658 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -119.16 -26.54 2.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.976 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 1.8 tt0 48.12 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.813 . . . . 0.0 110.15 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' ASN . . . 177.57 35.3 0.05 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 46' ' ' GLY . 4.7 m120 42.03 66.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -1.126 . . . . 0.0 110.271 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.497 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . -46.56 -42.76 14.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 72' ' ' ASP . . . 115.27 -63.12 0.33 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 51.7 Cg_endo -96.4 53.45 0.14 Allowed 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 121.368 1.379 . . . . 0.0 109.495 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.526 ' CA ' ' C ' ' A' ' 70' ' ' ARG . . . 105.47 77.92 1.16 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 64.5 m -41.12 109.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.518 -0.989 . . . . 0.0 108.974 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.895 HG22 ' HB3' ' A' ' 43' ' ' ASN . 44.4 mm -53.59 119.1 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.39 -0.819 . . . . 0.0 111.123 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 21.6 mtmt -144.39 144.27 31.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.567 -0.708 . . . . 0.0 109.327 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 4.2 ttpp -115.01 116.97 29.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.235 -0.915 . . . . 0.0 110.255 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.022 ' HB ' HG23 ' A' ' 67' ' ' VAL . 2.0 mp -90.52 115.94 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.856 . . . . 0.0 110.03 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.9 t -113.84 126.89 55.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 110.561 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.754 ' CB ' HD12 ' A' ' 62' ' ' LEU . 42.5 m-85 -94.5 143.1 25.71 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.367 -0.833 . . . . 0.0 110.076 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.5 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 49.1 Cg_endo -88.53 37.88 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.81 1.426 . . . . 0.0 110.638 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -150.41 -177.29 5.87 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.578 0.704 . . . . 0.0 110.084 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.608 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -70.07 -59.01 5.72 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.754 HD12 ' CB ' ' A' ' 58' ' ' PHE . 10.7 mt 53.42 168.25 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.366 -1.079 . . . . 0.0 110.115 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 44.0 Cg_endo -72.61 -21.68 21.82 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.789 1.415 . . . . 0.0 109.897 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.505 ' CE2' ' HD3' ' A' ' 90' ' ' PRO . 11.0 m-85 -129.53 160.9 31.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.503 -0.748 . . . . 0.0 109.66 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.63 -20.06 30.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.318 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.746 ' O ' HG13 ' A' ' 67' ' ' VAL . 27.6 p90 -173.8 -171.7 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 110.156 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.022 HG23 ' HB ' ' A' ' 56' ' ' ILE . 0.9 OUTLIER -161.08 108.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.477 -0.765 . . . . 0.0 110.602 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -76.81 155.22 33.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.303 -0.873 . . . . 0.0 109.012 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -151.74 131.11 12.88 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.671 -179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.526 ' C ' ' CA ' ' A' ' 51' ' ' GLY . 0.7 OUTLIER -104.43 87.76 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.025 HG13 ' HB3' ' A' ' 83' ' ' TYR . 45.1 t -82.05 -104.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' N ' HG12 ' A' ' 71' ' ' VAL . 0.2 OUTLIER 76.22 162.96 0.24 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.552 -0.717 . . . . 0.0 110.811 -178.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 82' ' ' ASN . 0.0 OUTLIER 73.75 136.56 0.05 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 109.748 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 74' ' ' VAL . 6.3 p -173.2 103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.184 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 3.6 t0 -80.31 161.67 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 110.13 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.34 -48.03 0.99 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.234 -0.916 . . . . 0.0 110.564 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 m -59.35 -24.13 63.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.753 -1.217 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -118.38 14.96 13.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.962 . . . . 0.0 110.348 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.576 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 8.2 m-30 44.25 63.38 1.66 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.278 -0.888 . . . . 0.0 110.585 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 13.3 tttt -122.05 141.82 50.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 109.698 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.57 ' CD2' HG23 ' A' ' 74' ' ' VAL . 22.5 t80 -148.59 98.36 2.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.087 -1.008 . . . . 0.0 110.82 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.521 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -111.76 143.14 43.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.603 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 1.025 ' HB3' HG13 ' A' ' 71' ' ' VAL . 15.8 p90 -134.75 163.53 29.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.14 -0.975 . . . . 0.0 110.105 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -104.54 112.08 25.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.535 -0.728 . . . . 0.0 111.143 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.4 t -94.64 104.11 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.538 HG13 ' N ' ' A' ' 87' ' ' GLU . 49.0 pt -93.81 -34.58 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.538 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.8 mt-10 -146.81 169.41 19.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.003 -1.06 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.591 ' CA ' ' HA ' ' A' ' 67' ' ' VAL . . . 112.41 115.9 3.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.504 ' HA2' ' CD2' ' A' ' 64' ' ' PHE . . . 124.48 -143.93 15.0 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.513 ' O ' ' C ' ' A' ' 91' ' ' ILE . 53.1 Cg_endo -83.51 26.87 0.63 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.092 1.575 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -27.69 145.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.436 0.636 . . . . 0.0 111.358 -179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.36 -100.45 0.16 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.42 ' O ' ' OG1' ' A' ' 94' ' ' THR . 29.5 m-20 -125.86 -176.28 3.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -1.098 . . . . 0.0 110.395 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 122' ' ' THR . 46.1 p 46.23 22.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.891 HD23 HD11 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -172.16 96.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.041 -1.037 . . . . 0.0 110.419 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -114.02 -21.46 10.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.377 -0.827 . . . . 0.0 110.0 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.782 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -142.18 147.96 37.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 110.083 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.891 HD11 HD23 ' A' ' 95' ' ' LEU . 35.5 mm -145.43 131.15 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 0.0 110.609 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.0 m -116.34 131.37 56.96 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 109.144 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 1.3 m-20 -126.3 147.63 49.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.043 -1.035 . . . . 0.0 111.267 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' ASN . 3.8 tt0 -138.02 132.33 32.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.693 -0.629 . . . . 0.0 109.573 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 103' ' ' LYS . 77.2 mt -118.66 165.7 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 0.9 OUTLIER -157.69 111.86 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 110.551 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.708 HD12 ' H ' ' A' ' 104' ' ' ILE . 2.8 mp -87.93 112.0 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 0.0 109.944 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.419 HG21 ' NZ ' ' A' ' 115' ' ' LYS . 90.4 t -103.58 139.09 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.078 -1.014 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.72 132.01 41.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.0 109.961 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.4 p -105.57 154.22 39.31 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.428 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 48.3 Cg_endo -66.59 -33.2 36.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.016 1.535 . . . . 0.0 110.509 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 108' ' ' PRO . 5.3 m-20 -151.75 67.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 178.75 35.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.12 -140.3 46.68 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.549 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 80.0 p -128.06 155.18 44.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -1.14 . . . . 0.0 110.052 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 18.4 mt -112.53 126.83 69.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 110.43 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.785 ' CB ' HG22 ' A' ' 9' ' ' THR . 1.2 tp -88.53 89.2 7.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.795 -0.566 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' NZ ' HG21 ' A' ' 105' ' ' VAL . 9.1 mttt -73.77 128.77 36.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.404 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 114' ' ' LEU . 2.7 mt -128.23 150.35 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.059 -1.026 . . . . 0.0 111.18 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 t -138.89 120.36 14.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 109.176 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.506 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 2.5 m-20 -112.79 94.7 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 0.0 111.53 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HG3' ' CG2' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -82.42 106.18 14.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.001 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.716 ' CD2' HD21 ' A' ' 95' ' ' LEU . 1.5 m-85 -85.15 111.14 19.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.962 -1.086 . . . . 0.0 111.461 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 97.1 m-70 -90.25 102.05 14.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.335 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.565 HG21 HG23 ' A' ' 128' ' ' VAL . 7.5 p -103.23 162.33 13.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -145.97 37.65 1.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.809 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.46 -147.44 7.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.88 -65.05 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -56.1 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.348 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 17.3 pt-20 -111.23 -169.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.652 HG11 ' CE2' ' A' ' 5' ' ' TYR . 24.9 t -68.64 163.72 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.158 -0.964 . . . . 0.0 110.173 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -109.1 101.49 10.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 110.004 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.2 -32.25 1.2 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.19 -0.944 . . . . 0.0 109.89 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 4.3 tt0 -59.96 -50.48 73.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.269 -0.894 . . . . 0.0 109.13 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.633 ' OE1' HD13 ' A' ' 95' ' ' LEU . 48.4 tt0 -61.04 -40.79 94.94 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.183 HG11 ' CD1' ' A' ' 5' ' ' TYR . 61.4 t -62.4 -23.66 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 1.8 tptt -78.72 -59.23 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.837 -0.539 . . . . 0.0 110.898 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -38.37 -45.93 1.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.394 -0.816 . . . . 0.0 110.842 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.2 m -59.99 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.095 -1.003 . . . . 0.0 109.652 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 133' ' ' VAL . 16.9 mtmt -61.49 -31.63 71.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.838 . . . . 0.0 110.318 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -69.36 -54.3 15.21 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.235 -0.915 . . . . 0.0 110.135 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.467 ' SD ' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -57.32 -37.77 73.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.061 -1.024 . . . . 0.0 109.287 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.31 -39.8 97.32 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -72.16 -38.72 69.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.999 -1.295 . . . . 0.0 111.003 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.234 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 147' ' ' VAL . 1.3 mm? -77.41 -31.15 53.89 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.112 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.749 HD22 HG21 ' A' ' 9' ' ' THR . 20.4 tp -68.64 -32.54 72.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 108.696 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -77.62 -41.21 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.527 -0.733 . . . . 0.0 109.517 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.844 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -61.09 -43.88 98.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.506 -0.746 . . . . 0.0 110.012 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 143' ' ' LEU . 21.2 t -75.33 -43.16 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 109.954 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' HG2' HG12 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -53.86 -41.89 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.38 -0.825 . . . . 0.0 110.221 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.6 p -85.19 -29.68 24.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 0.0 110.173 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.676 ' CD1' ' CD2' ' A' ' 154' ' ' HIS . 4.5 t80 -58.17 -35.99 72.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.024 . . . . 0.0 109.777 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 11.5 mt -71.11 -22.1 62.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 0.0 110.025 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.4 HD22 ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -91.62 -23.65 19.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.323 -0.861 . . . . 0.0 110.303 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.93 -49.12 7.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.629 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.676 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 30.1 m-70 -63.25 -97.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.085 -1.01 . . . . 0.0 110.528 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.404 ' OG ' ' C ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -160.51 -70.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.056 -1.028 . . . . 0.0 110.385 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.521 ' HB2' ' ND2' ' A' ' 159' ' ' ASN . 3.4 p-10 -142.41 31.49 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.223 -0.923 . . . . 0.0 110.556 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.542 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -52.53 131.08 33.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.028 -1.045 . . . . 0.0 109.767 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.888 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 51.3 m-85 59.25 66.32 1.05 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 110.274 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 156' ' ' ASP . 1.1 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.204 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.531 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 3' ' ' PHE . 45.4 t -79.75 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.343 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.599 ' N ' HG12 ' A' ' 2' ' ' VAL . 90.8 m-85 -137.74 144.46 41.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 110.068 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.28 110.0 20.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.421 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.602 ' CD2' HG11 ' A' ' 133' ' ' VAL . 19.2 m-30 -112.3 88.23 2.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.739 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -93.01 128.3 38.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 110.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -147.16 -172.28 3.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.057 -1.027 . . . . 0.0 110.765 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -165.68 173.87 10.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.85 . . . . 0.0 110.782 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.582 ' CG2' ' HB2' ' A' ' 114' ' ' LEU . 13.1 t -151.58 168.46 24.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -128.45 139.82 52.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.794 -1.191 . . . . 0.0 111.08 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.516 ' OG ' HD11 ' A' ' 18' ' ' LEU . 43.3 t -134.99 153.89 51.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.537 -0.727 . . . . 0.0 110.257 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.85 -22.12 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.213 -0.929 . . . . 0.0 110.04 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 18' ' ' LEU . 4.3 mm -75.84 140.98 71.24 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.636 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 33.1 Cg_endo -57.73 154.53 36.88 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.024 1.539 . . . . 0.0 111.196 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HB1' ' CD2' ' A' ' 79' ' ' PHE . . . -54.65 -64.46 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 111.172 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -40.87 -62.93 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 0.0 111.113 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.511 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -50.36 -58.56 5.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.083 -1.011 . . . . 0.0 110.761 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -49.39 -31.3 9.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.399 -0.813 . . . . 0.0 110.924 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.769 ' CE2' HD21 ' A' ' 24' ' ' LEU . 24.9 t80 -74.21 -55.86 5.57 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.415 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 4.3 mtmm -52.09 -42.98 63.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.07 -1.019 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -83.78 -71.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 108.398 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.692 ' HD1' HG21 ' A' ' 147' ' ' VAL . 27.2 t80 -79.49 147.24 32.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.315 -0.865 . . . . 0.0 108.696 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.056 ' CD1' HD11 ' A' ' 104' ' ' ILE . 38.0 mt 81.93 -44.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.769 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.2 mt -97.97 -56.44 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.13 -0.982 . . . . 0.0 109.933 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -102.91 80.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.99 -1.069 . . . . 0.0 110.199 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.76 -23.02 10.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.526 ' HA ' HG21 ' A' ' 41' ' ' VAL . 7.8 p-10 -78.24 -22.12 48.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 110.262 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.464 ' OD1' ' OD2' ' A' ' 27' ' ' ASP . 30.5 m-20 -105.75 4.68 30.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -0.951 . . . . 0.0 110.251 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -128.27 -42.23 1.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . 8.1 m-30 -54.35 -58.24 14.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 110.774 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 52.5 Cg_endo -68.45 -5.54 15.38 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.249 1.131 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -106.14 -14.01 15.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 111.308 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.946 HG23 ' HB1' ' A' ' 146' ' ' ALA . 15.8 m -134.41 6.27 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.008 -1.058 . . . . 0.0 110.051 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.11 62.63 2.45 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.26 -20.67 55.55 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.893 1.47 . . . . 0.0 109.623 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -75.43 -19.14 59.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.447 -0.783 . . . . 0.0 109.499 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.697 ' HB1' ' SD ' ' A' ' 139' ' ' MET . . . -101.67 -52.45 3.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 110.547 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 39' ' ' SER . 1.4 mp -109.74 166.0 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.968 . . . . 0.0 110.675 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.472 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -124.51 -46.16 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.451 -0.781 . . . . 0.0 109.891 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -165.45 159.06 16.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' A' ' 27' ' ' ASP . 73.1 t -111.41 160.87 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.922 . . . . 0.0 110.346 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 10.0 mt-10 -143.33 -179.75 6.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.964 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 44' ' ' ILE . 0.8 OUTLIER 67.51 -87.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.527 -0.733 . . . . 0.0 109.421 -179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.811 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER 25.68 58.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-O 121.954 0.883 . . . . 0.0 111.433 179.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 5.7 pt-20 -115.16 123.18 48.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.902 -1.124 . . . . 0.0 110.398 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.92 -61.52 0.3 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 51.53 87.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 110.129 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.94 7.26 8.71 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.13 165.93 19.83 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.45 82.3 1.9 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.141 1.601 . . . . 0.0 110.524 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' O ' HG12 ' A' ' 53' ' ' ILE . . . 122.17 29.98 1.27 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 51' ' ' GLY . 64.0 m -43.93 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.19 -1.183 . . . . 0.0 109.693 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 51' ' ' GLY . 28.2 mm -79.65 125.94 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 111.125 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 43' ' ' ASN . 14.3 mtpt -133.06 148.8 52.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.46 -0.775 . . . . 0.0 109.288 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 4.7 tttp -124.58 117.1 23.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 110.902 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.4 mp -94.92 130.62 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.723 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -117.61 124.25 48.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 110.1 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CB ' ' CD1' ' A' ' 62' ' ' LEU . 12.7 m-85 -91.11 166.75 17.72 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.326 -0.859 . . . . 0.0 110.15 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -72.83 178.1 6.82 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.854 1.45 . . . . 0.0 110.177 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.77 173.58 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.141 -0.974 . . . . 0.0 110.497 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.23 52.61 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.593 ' CD1' ' CB ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -76.72 152.68 83.1 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.213 -1.169 . . . . 0.0 110.366 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.07 -22.58 19.24 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 124.136 1.598 . . . . 0.0 109.889 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 18.6 m-85 -123.28 -159.81 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.47 -0.769 . . . . 0.0 109.655 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -122.26 -26.85 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 110.423 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 16.0 p90 -176.98 -175.73 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.314 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 66' ' ' TYR . 7.5 m -153.81 122.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 110.067 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.732 ' HB3' HD11 ' A' ' 86' ' ' ILE . 18.9 mtmt -93.82 133.61 37.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -114.93 144.69 43.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.848 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.52 ' NH2' ' OD1' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -113.52 103.9 11.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 110.03 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 74' ' ' VAL . 4.5 t -83.01 125.9 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 110.19 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 70' ' ' ARG . 1.2 m-20 -97.34 52.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.85 . . . . 0.0 109.949 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.5 OUTLIER 63.54 77.68 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.081 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG13 HG13 ' A' ' 71' ' ' VAL . 5.1 m -56.71 -177.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.375 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 1.8 t0 -123.06 -168.01 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.837 . . . . 0.0 109.748 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.477 ' CE1' HD11 ' A' ' 24' ' ' LEU . 5.0 m80 -144.83 -53.95 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.2 m -51.95 -57.35 9.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.54 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 79' ' ' PHE . 19.2 m-80 -91.16 17.69 7.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.542 ' CD2' ' HB1' ' A' ' 15' ' ' ALA . 16.2 m-85 42.47 48.72 4.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.153 -0.967 . . . . 0.0 109.997 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 75' ' ' ASP . 4.0 tppt? -93.44 123.79 36.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 110.805 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -120.53 112.55 19.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.321 -0.862 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 31.4 t-20 -127.3 108.34 10.77 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' ASN . 8.8 p90 -136.81 165.51 25.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.3 -0.875 . . . . 0.0 109.982 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -117.16 141.11 48.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 110.536 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 40.2 t -86.39 78.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.734 . . . . 0.0 109.266 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.732 HD11 ' HB3' ' A' ' 68' ' ' LYS . 43.1 pt -59.61 -131.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.503 -0.748 . . . . 0.0 110.751 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.524 ' N ' HG13 ' A' ' 86' ' ' ILE . 28.3 mm-40 -67.64 160.95 26.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 102.8 152.29 23.85 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.04 -147.0 18.49 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 64' ' ' PHE . 51.8 Cg_endo -84.23 29.08 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.984 1.518 . . . . 0.0 110.84 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -41.24 163.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.119 -0.988 . . . . 0.0 109.95 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.4 -170.55 14.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.42 ' CG ' HG23 ' A' ' 94' ' ' THR . 36.7 p-10 -55.12 173.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -1.075 . . . . 0.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 5.4 p 54.23 15.13 0.86 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.719 ' HG ' HG22 ' A' ' 122' ' ' THR . 1.2 mt 167.56 92.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.022 -1.049 . . . . 0.0 110.089 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 2.6 tp10 -91.08 -34.14 15.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 110.332 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 96' ' ' GLU . 13.2 mttp -149.69 153.25 36.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.423 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.552 HD11 HD22 ' A' ' 95' ' ' LEU . 75.5 mt -137.47 150.71 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.341 -0.85 . . . . 0.0 109.731 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 m -134.35 143.91 47.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.892 . . . . 0.0 110.187 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 83' ' ' TYR . 37.8 t-20 -136.47 133.17 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 0.0 110.244 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.744 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 3.1 pt-20 -151.69 149.72 29.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.128 -0.982 . . . . 0.0 109.794 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.903 HG23 ' N ' ' A' ' 103' ' ' LYS . 8.0 tp 168.46 -138.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.619 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.903 ' N ' HG23 ' A' ' 102' ' ' ILE . 20.5 ptmt -179.82 -171.07 0.17 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.907 -1.121 . . . . 0.0 111.506 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.056 HD11 ' CD1' ' A' ' 23' ' ' ILE . 66.1 mt -120.0 163.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.231 -0.918 . . . . 0.0 109.685 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.53 HG23 ' HD2' ' A' ' 115' ' ' LYS . 3.9 t -132.0 124.4 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.911 -1.118 . . . . 0.0 110.425 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.19 131.9 35.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.164 -0.96 . . . . 0.0 109.957 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.6 p -108.92 155.55 40.6 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.052 -1.03 . . . . 0.0 110.668 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 109' ' ' ASP . 47.1 Cg_endo -66.28 82.2 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.251 1.658 . . . . 0.0 110.817 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 108' ' ' PRO . 1.4 m-20 70.71 25.97 3.95 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.524 -0.735 . . . . 0.0 110.346 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -116.73 -2.68 18.96 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.89 -170.74 22.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 14' ' ' PRO . 12.6 m -120.94 130.09 53.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.299 -1.118 . . . . 0.0 109.918 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 10' ' ' THR . 7.3 mt -99.86 121.48 50.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.386 -0.821 . . . . 0.0 109.854 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.842 HD12 HG23 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -86.89 108.48 18.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.651 -0.655 . . . . 0.0 109.672 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.598 ' O ' ' CG1' ' A' ' 102' ' ' ILE . 1.3 ptmt -102.44 133.87 46.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.565 -1.335 . . . . 0.0 108.533 179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.847 ' HA ' HG21 ' A' ' 102' ' ' ILE . 6.7 mt -135.8 139.42 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.642 ' HB2' HD13 ' A' ' 102' ' ' ILE . 8.7 t -112.6 107.79 16.63 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 6.9 m-80 -107.04 108.3 19.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.836 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.541 ' HD2' ' CG1' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.99 132.51 46.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.826 179.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.684 ' HD2' HD11 ' A' ' 95' ' ' LEU . 3.6 m-85 -101.73 129.37 47.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 83.4 m-70 -110.41 101.68 10.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.771 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.719 HG22 ' HG ' ' A' ' 95' ' ' LEU . 16.2 p -101.82 -165.19 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.366 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -160.39 126.08 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.114 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 128.63 -129.4 6.19 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.1 OUTLIER -124.11 -53.7 1.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.146 -1.208 . . . . 0.0 110.129 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 125' ' ' ASP . 90.4 m-70 -44.22 168.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.892 . . . . 0.0 109.929 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.93 163.31 21.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 0.0 110.596 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.608 HG23 HG21 ' A' ' 122' ' ' THR . 24.4 t -53.41 157.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.419 -0.8 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -102.5 108.29 19.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.361 -0.837 . . . . 0.0 109.649 179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.04 -47.32 8.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.13 -0.981 . . . . 0.0 109.953 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.79 -46.62 59.77 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.164 -0.96 . . . . 0.0 109.448 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -35.55 80.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.318 -0.863 . . . . 0.0 109.648 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.602 HG11 ' CD2' ' A' ' 5' ' ' TYR . 21.8 t -76.99 -12.22 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.459 -0.775 . . . . 0.0 109.775 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.0 -46.74 7.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.447 -0.783 . . . . 0.0 110.808 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -54.38 -49.47 69.79 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.066 -1.021 . . . . 0.0 109.572 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.4 t -57.99 -43.94 86.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.925 . . . . 0.0 109.838 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -66.1 -23.66 66.55 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.166 -0.959 . . . . 0.0 109.361 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 3.1 tt0 -73.07 -43.71 61.51 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.697 ' SD ' ' HB1' ' A' ' 37' ' ' ALA . 5.3 mmm -64.27 -35.94 82.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -62.41 -44.2 97.97 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.27 -45.97 75.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.053 -1.263 . . . . 0.0 110.262 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -37.65 68.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 108.897 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.7 mm? -68.17 -52.98 28.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.434 -0.791 . . . . 0.0 109.578 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 9' ' ' THR . 9.4 tp -47.6 -36.8 11.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.877 -1.14 . . . . 0.0 108.519 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 15.2 mtt180 -71.76 -38.77 70.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 0.0 109.367 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.946 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -58.51 -57.93 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.482 -0.761 . . . . 0.0 109.521 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.692 HG21 ' HD1' ' A' ' 22' ' ' PHE . 17.7 t -66.92 -27.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.473 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.558 ' O ' HD22 ' A' ' 152' ' ' LEU . 16.3 tp10 -59.43 -54.98 40.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 109.976 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.5 p -75.71 -27.24 58.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.045 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.789 ' CG ' HD11 ' A' ' 29' ' ' LEU . 7.1 t80 -53.8 -45.92 70.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.553 HD12 HG13 ' A' ' 13' ' ' ILE . 79.7 mt -61.1 -29.93 70.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.763 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.558 HD22 ' O ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -89.0 -18.78 26.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 110.703 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.58 -52.75 5.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 110.369 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 155' ' ' SER . 9.2 m-70 -63.97 -111.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 156' ' ' ASP . 92.0 p -178.11 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.851 -1.155 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 155' ' ' SER . 0.0 OUTLIER 71.94 20.65 4.36 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 111.457 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 158' ' ' TYR . . . -52.45 137.28 30.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.619 -1.301 . . . . 0.0 109.462 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.837 ' OH ' HD23 ' A' ' 29' ' ' LEU . 72.2 m-85 58.72 81.8 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.222 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.501 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 10.9 p -117.71 167.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 0.0 110.383 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.631 ' CD1' HG23 ' A' ' 128' ' ' VAL . 29.0 m-85 -132.44 108.64 9.28 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.414 -0.803 . . . . 0.0 110.098 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -62.84 142.69 58.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 110.522 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.891 ' CD1' HG11 ' A' ' 133' ' ' VAL . 23.9 m-85 -150.05 69.05 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.0 109.657 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 117' ' ' SER . 72.3 mt-10 -94.72 141.89 28.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.594 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.416 ' C ' ' OE1' ' A' ' 8' ' ' GLU . 15.1 t -159.9 -178.22 6.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.45 -0.781 . . . . 0.0 109.59 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 7' ' ' THR . 1.8 pm0 -155.42 154.75 32.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.057 -1.027 . . . . 0.0 110.425 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.906 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.34 158.58 38.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.664 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.49 HG22 HG12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -120.41 139.69 52.45 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.05 -1.032 . . . . 0.0 110.48 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.588 ' OG ' HD11 ' A' ' 18' ' ' LEU . 30.1 t -135.05 141.22 46.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.549 -0.719 . . . . 0.0 109.872 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.12 -15.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.505 -0.747 . . . . 0.0 110.416 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.635 HG23 ' HD2' ' A' ' 14' ' ' PRO . 15.0 mm -75.72 147.14 80.97 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 110.018 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.0 Cg_endo -56.38 155.23 26.05 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.902 1.475 . . . . 0.0 110.683 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -63.47 -69.29 0.28 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 111.311 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . . . -39.26 -46.43 1.54 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.29 -0.881 . . . . 0.0 111.538 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.561 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 41.7 mtt180 -64.95 -50.5 66.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.115 . . . . 0.0 110.052 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 22' ' ' PHE . 9.8 mt -56.1 -25.89 47.6 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.939 0.876 . . . . 0.0 109.547 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.769 ' CE2' HD21 ' A' ' 24' ' ' LEU . 21.4 t80 -79.46 -48.62 13.62 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.2 -0.937 . . . . 0.0 110.902 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -67.46 -27.47 67.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.501 -0.749 . . . . 0.0 112.117 -178.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.872 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.11 -29.84 8.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.553 -1.342 . . . . 0.0 112.165 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 88.2 t80 -109.14 5.0 23.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.785 -1.197 . . . . 0.0 111.582 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.648 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 41.2 mt -141.77 -19.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.942 -1.099 . . . . 0.0 111.23 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.802 HD22 HG21 ' A' ' 74' ' ' VAL . 1.8 mt -110.68 -37.09 5.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.966 -1.084 . . . . 0.0 109.904 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -114.6 42.43 2.13 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.327 -0.858 . . . . 0.0 110.512 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -40.4 71.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.865 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.2 p30 -70.45 -0.8 9.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.284 -1.127 . . . . 0.0 110.929 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 13.9 t30 -138.93 47.98 1.91 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.017 HD11 HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER 177.37 -30.5 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.511 -0.743 . . . . 0.0 109.077 -178.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.716 ' N ' HD13 ' A' ' 29' ' ' LEU . 5.9 m-30 -56.24 -59.14 12.78 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.154 -0.966 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.581 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -67.58 -11.28 31.58 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.741 1.39 . . . . 0.0 110.635 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -16.33 38.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.223 -0.923 . . . . 0.0 110.605 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.747 HG23 ' HB1' ' A' ' 146' ' ' ALA . 25.7 m -127.19 -3.09 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.193 -0.942 . . . . 0.0 110.328 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -148.77 65.19 8.18 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 110.055 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.85 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.054 1.555 . . . . 0.0 110.289 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -90.13 -14.47 33.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.559 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.29 -29.79 6.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.018 -1.051 . . . . 0.0 110.576 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.505 HG12 HD21 ' A' ' 143' ' ' LEU . 6.5 mm -120.82 161.11 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.49 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 40' ' ' SER . 0.3 OUTLIER -127.6 -49.29 1.39 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 109.254 179.057 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 39' ' ' SER . 12.5 t 174.19 138.54 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.566 -0.709 . . . . 0.0 110.276 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.865 HG11 ' HB2' ' A' ' 27' ' ' ASP . 8.6 p -109.13 162.54 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 108.979 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.597 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 9.8 tt0 -175.62 144.69 0.67 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.795 -1.191 . . . . 0.0 111.377 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.738 ' HB2' ' HA ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER 148.74 -79.76 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.627 ' HA ' HG22 ' A' ' 52' ' ' THR . 3.7 tp 36.68 46.12 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.723 -0.611 . . . . 0.0 111.261 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 44' ' ' ILE . 7.2 tp10 -44.99 140.14 2.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.109 -0.994 . . . . 0.0 109.739 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.73 99.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.21 -67.08 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 0.0 110.317 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.93 -9.24 4.85 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.521 ' O ' ' CG1' ' A' ' 71' ' ' VAL . . . 145.31 -85.21 0.18 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' HG3' ' OE2' ' A' ' 73' ' ' GLU . 50.1 Cg_endo -73.33 99.28 1.1 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.924 1.486 . . . . 0.0 110.648 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.37 -9.06 7.83 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 44' ' ' ILE . 2.5 m -65.47 122.39 17.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -1.163 . . . . 0.0 110.078 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.649 HD13 ' CG ' ' A' ' 70' ' ' ARG . 18.3 mm -82.73 148.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.376 -0.827 . . . . 0.0 110.19 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 14.0 mtmt -148.17 141.26 24.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 110.421 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -114.23 132.22 56.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.95 -1.094 . . . . 0.0 110.251 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.8 mp -107.22 112.33 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.351 -0.843 . . . . 0.0 110.097 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 39' ' ' SER . 9.2 t -103.57 136.42 43.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.952 -1.093 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.693 ' CD2' HD12 ' A' ' 62' ' ' LEU . 17.9 m-85 -103.26 166.02 12.54 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.325 -0.86 . . . . 0.0 109.763 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 45.4 Cg_endo -73.14 175.14 10.92 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.873 1.459 . . . . 0.0 110.413 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.18 178.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.083 -1.01 . . . . 0.0 110.374 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.72 -38.29 3.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.693 HD12 ' CD2' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -62.09 133.13 94.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.139 -1.213 . . . . 0.0 110.29 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.3 -13.76 16.75 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.175 1.618 . . . . 0.0 110.346 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -101.01 -163.88 1.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 110.26 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -117.88 -39.12 3.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.121 -0.987 . . . . 0.0 110.686 -179.543 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 65' ' ' LYS . 21.2 p90 -177.31 -171.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.705 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 67' ' ' VAL . 12.2 t -147.08 99.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 O-C-N 121.485 -0.76 . . . . 0.0 111.043 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -89.99 139.77 30.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 110.016 179.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -157.42 162.05 38.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.649 ' CG ' HD13 ' A' ' 53' ' ' ILE . 4.3 mtm105 -112.47 155.97 23.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.204 -0.935 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 49' ' ' GLY . 2.6 p -98.35 161.69 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 110.388 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 5.4 m-20 -124.1 54.03 1.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.6 mt-10 65.88 115.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.802 HG21 HD22 ' A' ' 24' ' ' LEU . 4.4 p -90.68 145.6 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.053 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -92.47 -151.58 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.083 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.495 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -168.1 -62.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 m -50.63 -56.11 13.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.825 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 79' ' ' PHE . 2.1 m-80 -95.84 18.37 13.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 0.0 110.672 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 16' ' ' ALA . 6.2 m-85 42.47 72.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.15 -0.969 . . . . 0.0 109.924 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.1 tttp -123.92 115.41 21.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.023 -1.048 . . . . 0.0 110.707 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.543 ' HD1' HG23 ' A' ' 74' ' ' VAL . 9.9 t80 -113.4 173.21 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.07 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 54.5 t-20 -176.35 123.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 100' ' ' ASN . 36.7 p90 -135.28 157.58 46.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.78 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.2 135.37 55.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 98' ' ' ILE . 73.3 t -108.01 110.6 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.253 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.81 -14.06 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 68' ' ' LYS . 5.4 mt-10 -139.68 140.92 36.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.114 -0.991 . . . . 0.0 110.179 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.461 ' C ' HG12 ' A' ' 91' ' ' ILE . . . 103.2 177.23 26.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.18 -135.01 20.64 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.533 ' HG3' ' NE2' ' A' ' 132' ' ' GLN . 51.6 Cg_endo -86.48 29.84 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.882 1.464 . . . . 0.0 111.46 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.474 ' C ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -37.66 157.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.341 -0.849 . . . . 0.0 110.391 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.28 -132.38 4.63 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -114.66 55.53 0.75 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -1.115 . . . . 0.0 110.625 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.824 HG22 ' HB2' ' A' ' 126' ' ' HIS . 0.8 OUTLIER -150.57 -70.26 0.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.677 HD11 ' CD2' ' A' ' 120' ' ' TYR . 2.6 mt -98.7 108.59 21.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 0.0 109.873 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -93.19 -39.8 10.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.952 . . . . 0.0 110.517 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.533 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.9 tttm -134.47 164.56 27.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 0.0 110.868 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 97' ' ' LYS . 13.0 mt -158.82 132.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -116.28 116.34 27.57 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.898 -1.127 . . . . 0.0 110.523 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 83' ' ' TYR . 11.1 t-20 -116.35 126.67 53.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 116' ' ' ILE . 14.5 tm-20 -116.38 149.24 39.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.461 -0.775 . . . . 0.0 109.673 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.55 HG22 ' CD1' ' A' ' 104' ' ' ILE . 72.5 mt -136.29 134.16 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.964 -1.085 . . . . 0.0 110.469 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -131.62 99.85 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.445 -0.785 . . . . 0.0 109.829 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.58 HD12 ' N ' ' A' ' 104' ' ' ILE . 1.7 mp -77.29 113.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.269 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.428 HG21 ' HE2' ' A' ' 115' ' ' LYS . 95.6 t -102.28 122.38 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.288 -0.882 . . . . 0.0 109.725 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.61 134.49 37.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.601 -0.687 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 110' ' ' GLY . 71.2 p -104.85 156.1 36.52 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.845 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.36 -2.87 8.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.021 1.537 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -173.07 -25.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.983 -1.073 . . . . 0.0 111.269 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.431 ' C ' ' OG1' ' A' ' 107' ' ' THR . . . -83.55 45.54 3.48 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 52.21 -114.91 3.64 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 3.1 m -150.57 158.52 44.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.409 -1.054 . . . . 0.0 109.557 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 10' ' ' THR . 20.7 mt -126.02 122.32 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.873 -1.142 . . . . 0.0 110.832 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.906 ' HB2' HG22 ' A' ' 9' ' ' THR . 7.1 mp -84.63 105.11 15.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.708 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HE2' HG21 ' A' ' 105' ' ' VAL . 1.1 mptp? -84.32 100.65 11.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.778 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 3.8 mt -92.76 155.03 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.868 . . . . 0.0 110.864 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 36.3 t -151.34 91.21 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.488 -0.758 . . . . 0.0 109.297 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 99' ' ' SER . 36.3 t-20 -101.82 145.83 28.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 111.444 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.456 ' CG ' HG21 ' A' ' 2' ' ' VAL . 2.1 ttmt -131.96 118.94 20.42 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.7 m-85 -86.14 107.92 18.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.934 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -92.22 96.8 10.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.96 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.426 HG21 HG23 ' A' ' 128' ' ' VAL . 20.8 p -92.12 -136.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.85 . . . . 0.0 110.083 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -40.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.058 -1.026 . . . . 0.0 110.511 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 160.68 -149.35 18.47 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 126' ' ' HIS . 5.2 t0 47.09 -92.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -1.082 . . . . 0.0 110.135 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.824 ' HB2' HG22 ' A' ' 94' ' ' THR . 35.9 m170 -87.52 172.0 10.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.385 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -124.21 179.54 4.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.971 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG23 ' CD1' ' A' ' 3' ' ' PHE . 99.3 t -78.13 153.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.123 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -106.95 110.22 22.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.316 -0.865 . . . . 0.0 109.816 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -43.29 -40.62 3.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 110.059 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.0 tt0 -55.27 -49.1 72.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.533 ' NE2' ' HG3' ' A' ' 90' ' ' PRO . 1.1 tt0 -60.32 -39.7 87.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 108.954 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.891 HG11 ' CD1' ' A' ' 5' ' ' TYR . 64.4 t -64.91 -22.82 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.754 0.787 . . . . 0.0 109.162 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.504 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -83.64 -67.63 0.78 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.628 -0.67 . . . . 0.0 110.693 -179.239 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -33.5 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.501 -0.749 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -67.1 -55.18 15.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 108.724 178.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 134' ' ' LYS . 8.9 mptt -53.42 -55.42 25.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.815 . . . . 0.0 109.073 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -46.69 -47.07 20.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 109.585 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.643 ' SD ' HD23 ' A' ' 143' ' ' LEU . 2.6 tpp -56.19 -44.1 79.12 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.116 -0.99 . . . . 0.0 108.799 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.54 92.83 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -71.83 -31.41 66.5 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.066 -1.255 . . . . 0.0 110.804 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.511 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.1 OUTLIER -68.6 -43.9 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.954 -1.091 . . . . 0.0 109.056 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.643 HD23 ' SD ' ' A' ' 139' ' ' MET . 1.5 mm? -70.5 -33.36 71.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.246 -0.909 . . . . 0.0 109.189 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.581 HD12 HG21 ' A' ' 9' ' ' THR . 0.8 OUTLIER -61.62 -41.53 97.6 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.74 -47.05 76.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.606 -0.684 . . . . 0.0 110.063 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.747 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.68 -59.6 4.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 1.017 HG22 HD11 ' A' ' 29' ' ' LEU . 40.7 t -65.63 -19.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.739 . . . . 0.0 110.492 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.53 ' HG3' HG12 ' A' ' 13' ' ' ILE . 22.1 tt0 -71.99 -46.21 58.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.1 -1.0 . . . . 0.0 110.072 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.73 -12.3 37.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 110.291 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.649 ' CG ' HG11 ' A' ' 33' ' ' VAL . 8.5 t80 -69.58 -36.4 76.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.075 -1.016 . . . . 0.0 109.637 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 38.7 mt -72.6 -19.94 61.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.173 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 152' ' ' LEU . 10.2 mp -87.46 -33.26 19.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.233 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.42 -48.66 13.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.858 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.518 ' CD2' ' CD1' ' A' ' 150' ' ' TYR . 54.8 m-70 -76.71 -22.5 53.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.825 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 154' ' ' HIS . 17.0 p 41.93 51.1 4.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.404 -0.81 . . . . 0.0 110.333 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -168.83 -37.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.158 -0.964 . . . . 0.0 110.604 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.615 ' HB2' ' OH ' ' A' ' 150' ' ' TYR . . . -64.15 130.86 45.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.162 -0.961 . . . . 0.0 110.383 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.872 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 58.4 m-85 55.75 62.85 2.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 110.414 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.261 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 120' ' ' TYR . 12.1 p -132.77 157.8 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -1.143 . . . . 0.0 110.564 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.571 ' CD1' HG23 ' A' ' 128' ' ' VAL . 68.1 m-85 -130.82 156.7 44.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.482 -0.761 . . . . 0.0 109.917 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -120.16 91.44 3.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.162 -0.961 . . . . 0.0 110.234 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.072 ' CD2' HG11 ' A' ' 133' ' ' VAL . 31.3 m-85 -87.52 146.28 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.059 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -147.86 149.73 32.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.398 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.451 ' C ' ' CG ' ' A' ' 8' ' ' GLU . 8.6 t -169.13 167.63 10.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 109.903 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.451 ' CG ' ' C ' ' A' ' 7' ' ' THR . 32.0 mt-10 -148.8 146.97 28.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.85 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.9 178.24 5.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.192 -0.942 . . . . 0.0 109.853 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.46 149.49 51.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.678 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.694 ' HB3' HD11 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -143.73 142.54 30.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.341 -0.849 . . . . 0.0 109.905 179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -6.17 7.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.573 -0.705 . . . . 0.0 110.4 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.587 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 15.6 mm -89.5 143.17 30.22 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.104 -0.998 . . . . 0.0 109.952 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.507 ' HG2' ' HG3' ' A' ' 17' ' ' ARG . 33.0 Cg_endo -56.94 154.75 31.07 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.739 1.389 . . . . 0.0 110.06 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 104' ' ' ILE . . . -62.02 -39.73 93.29 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.099 -1.001 . . . . 0.0 110.812 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 -60.86 3.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.615 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.507 ' HG3' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -55.91 -47.44 77.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 11' ' ' SER . 9.4 mt -53.32 -37.89 62.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.964 -1.085 . . . . 0.0 109.075 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.816 ' HE1' HD21 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -70.17 -69.91 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.027 -1.046 . . . . 0.0 110.227 179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.617 ' HA ' HD12 ' A' ' 24' ' ' LEU . 4.7 mtpt -52.37 -19.37 2.09 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.669 -1.269 . . . . 0.0 113.279 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.813 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -114.06 -56.36 2.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.49 -1.381 . . . . 0.0 112.176 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.704 ' HD1' HG21 ' A' ' 147' ' ' VAL . 19.2 t80 -73.64 -85.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.489 -1.382 . . . . 0.0 110.82 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.703 HG23 ' CD2' ' A' ' 81' ' ' TYR . 21.9 mm -37.42 -48.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.512 -0.742 . . . . 0.0 110.221 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.816 HD21 ' HE1' ' A' ' 19' ' ' PHE . 4.5 mt -100.53 -170.64 1.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 32.88 34.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.726 -0.609 . . . . 0.0 111.588 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA3' ' CE1' ' A' ' 30' ' ' PHE . . . -92.26 -12.95 58.08 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' HB2' HG11 ' A' ' 41' ' ' VAL . 52.2 p30 -67.33 -7.39 24.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.459 -1.024 . . . . 0.0 111.07 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -130.23 16.59 5.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.091 -1.005 . . . . 0.0 108.532 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.901 ' O ' HG22 ' A' ' 33' ' ' VAL . 5.9 tp -131.54 -50.33 0.99 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.452 -0.78 . . . . 0.0 110.746 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.887 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 4.0 m-30 -42.71 -53.74 9.36 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.419 -0.801 . . . . 0.0 110.315 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 49.1 Cg_endo -67.04 -38.01 17.41 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.408 1.215 . . . . 0.0 110.957 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 2.4 mtmt -75.23 -73.3 0.26 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.977 -1.077 . . . . 0.0 110.907 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 29' ' ' LEU . 26.0 m -62.94 -21.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 110.729 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -126.16 69.48 67.12 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.049 -1.032 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 43.7 Cg_endo -69.45 -21.92 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.891 1.469 . . . . 0.0 109.664 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.496 ' O ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.92 -3.2 57.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.602 -0.686 . . . . 0.0 109.308 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.651 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -114.12 -51.18 2.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.063 . . . . 0.0 111.124 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.627 HD12 ' CB ' ' A' ' 37' ' ' ALA . 3.9 mp -138.95 172.46 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.871 -1.143 . . . . 0.0 110.761 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.593 ' N ' HG22 ' A' ' 38' ' ' ILE . 29.6 t -133.37 -31.05 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.582 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -158.89 166.7 31.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 0.0 110.556 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 27' ' ' ASP . 2.2 p -133.32 140.1 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.021 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -110.56 102.22 10.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.945 . . . . 0.0 110.655 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -99.3 91.14 4.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 110.243 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -51.17 -40.49 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.875 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.499 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -112.95 142.12 46.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.837 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 47' ' ' ASN . . . -84.12 86.64 1.53 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 46' ' ' GLY . 19.2 p30 36.08 48.23 0.51 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.662 -0.905 . . . . 0.0 110.977 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.67 68.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 147.75 -137.52 6.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 45.8 Cg_endo -72.84 94.56 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.026 1.54 . . . . 0.0 110.172 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 52' ' ' THR . . . 145.82 -16.49 1.78 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 51' ' ' GLY . 46.8 m -42.28 116.59 0.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.331 -1.1 . . . . 0.0 109.991 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 53' ' ' ILE . 10.1 mm -97.15 129.72 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 68' ' ' LYS . 1.7 ptmt -127.59 149.05 50.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.34 -0.85 . . . . 0.0 110.082 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' CB ' ' HG2' ' A' ' 68' ' ' LYS . 4.0 mttp -140.4 100.95 4.01 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.676 -0.64 . . . . 0.0 109.311 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.667 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.0 mp -82.74 156.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.82 -1.175 . . . . 0.0 110.206 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' A' ' 59' ' ' PRO . 85.1 p -115.55 145.22 42.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.965 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.79 ' HE1' HG22 ' A' ' 67' ' ' VAL . 4.8 m-85 -118.99 72.94 12.06 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.233 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.551 ' CG ' ' HB3' ' A' ' 39' ' ' SER . 45.5 Cg_endo -75.51 68.7 6.11 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 O-C-N 124.627 1.856 . . . . 0.0 110.565 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.0 -163.37 1.76 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.278 -0.889 . . . . 0.0 110.288 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.75 69.62 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.496 HD11 ' O ' ' A' ' 36' ' ' GLN . 27.4 mt -65.37 158.74 71.38 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.12 -1.223 . . . . 0.0 110.353 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.78 -35.13 4.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.961 1.506 . . . . 0.0 109.959 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 90' ' ' PRO . 9.4 m-30 -79.94 150.54 30.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.848 . . . . 0.0 110.044 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -113.94 -6.22 13.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.843 179.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.6 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 20.7 p90 179.23 176.26 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.541 -0.724 . . . . 0.0 109.394 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.79 HG22 ' HE1' ' A' ' 58' ' ' PHE . 35.6 m -159.11 109.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 109.283 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HE2' ' CE1' ' A' ' 66' ' ' TYR . 7.6 mttm -96.2 139.48 32.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.41 -0.806 . . . . 0.0 109.503 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.904 ' OD1' HG22 ' A' ' 85' ' ' VAL . 14.3 m-20 -156.78 132.62 9.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.095 -1.003 . . . . 0.0 111.233 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 84' ' ' SER . 47.6 mtt180 -73.21 156.46 38.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.072 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 3.4 p -94.27 -17.7 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.938 -1.101 . . . . 0.0 111.039 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 61.1 -87.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 -179.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' CG ' ' O ' ' A' ' 72' ' ' ASP . 0.1 OUTLIER 179.24 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.085 -1.009 . . . . 0.0 110.351 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.854 HG22 ' CD1' ' A' ' 81' ' ' TYR . 49.7 t -66.87 161.02 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.386 -0.821 . . . . 0.0 110.223 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.618 ' O ' ' HB2' ' A' ' 76' ' ' HIS . 6.3 t70 -103.16 -57.55 2.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.618 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER 75.58 -58.9 0.54 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.265 -0.272 . . . . 0.0 111.092 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.736 HG22 HD22 ' A' ' 78' ' ' ASN . 3.2 m -52.08 -55.08 23.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 110.011 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.736 HD22 HG22 ' A' ' 77' ' ' THR . 1.1 m-80 -95.02 16.04 17.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.151 -0.968 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.418 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.7 m-85 52.66 52.59 13.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.182 -0.948 . . . . 0.0 109.867 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 102' ' ' ILE . 17.7 ttpt -124.44 127.24 47.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.854 ' CD1' HG22 ' A' ' 74' ' ' VAL . 70.6 t80 -128.58 125.79 38.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.51 145.2 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.702 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.761 ' HE2' HD11 ' A' ' 102' ' ' ILE . 18.1 p90 -136.11 158.33 44.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . 0.2 OUTLIER -104.31 138.14 41.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.904 HG22 ' OD1' ' A' ' 69' ' ' ASP . 24.9 t -107.42 69.47 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.817 . . . . 0.0 109.823 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.574 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -66.6 -11.19 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.295 -0.878 . . . . 0.0 110.28 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER 172.47 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.987 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.751 ' O ' HD11 ' A' ' 91' ' ' ILE . . . -106.31 -146.22 13.54 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . -91.57 -38.28 5.91 Favored Glycine 0 N--CA 1.489 2.167 0 O-C-N 121.334 -1.098 . . . . 0.0 111.382 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -76.46 -9.91 18.81 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 O-C-N 123.128 1.067 . . . . 0.0 111.981 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.751 HD11 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -41.61 167.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.997 -1.064 . . . . 0.0 110.706 -179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.53 -168.07 41.15 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 3.6 m-20 -66.03 -175.18 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -1.182 . . . . 0.0 110.333 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 122' ' ' THR . 18.6 p 48.83 21.18 0.42 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.405 -0.81 . . . . 0.0 110.985 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -161.25 133.4 5.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.028 . . . . 0.0 110.143 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.67 -60.4 1.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 110.482 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' C ' HG13 ' A' ' 98' ' ' ILE . 17.1 ttmt -127.23 160.05 32.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.056 -1.027 . . . . 0.0 110.43 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.909 HD11 HD22 ' A' ' 95' ' ' LEU . 24.0 mt -152.39 142.79 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.304 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.5 t -119.1 143.04 47.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.179 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -126.02 125.76 43.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.869 -1.144 . . . . 0.0 111.124 -179.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -116.34 135.81 53.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.454 -0.778 . . . . 0.0 109.404 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.761 HD11 ' HE2' ' A' ' 83' ' ' TYR . 22.7 mt -130.54 157.87 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.825 -1.172 . . . . 0.0 110.916 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 13.4 ttmt -151.12 110.83 4.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.608 HD11 HG13 ' A' ' 23' ' ' ILE . 4.7 mt -84.4 128.94 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 0.0 110.097 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 112' ' ' SER . 6.6 t -119.83 151.58 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 110.732 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.99 135.3 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.007 -1.058 . . . . 0.0 109.754 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 109' ' ' ASP . 11.6 p -138.36 142.61 35.6 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.002 . . . . 0.0 110.768 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.38 -3.59 12.72 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.279 1.673 . . . . 0.0 110.533 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.445 ' CG ' ' HG1' ' A' ' 107' ' ' THR . 10.6 p30 -80.11 2.81 22.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.287 -0.883 . . . . 0.0 111.004 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.85 -82.28 0.15 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.41 -134.47 3.26 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.685 ' OG ' HD12 ' A' ' 18' ' ' LEU . 60.4 p -113.42 175.63 5.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 9' ' ' THR . 9.8 mt -130.61 132.97 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.85 ' HB2' HG22 ' A' ' 9' ' ' THR . 1.1 tp -91.59 100.44 13.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.568 -0.708 . . . . 0.0 110.419 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 102' ' ' ILE . 45.8 mttt -79.71 130.01 34.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.434 HG13 ' C ' ' A' ' 115' ' ' LYS . 3.8 mt -132.84 140.88 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.098 -1.001 . . . . 0.0 111.305 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.62 117.59 16.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 2.0 m-80 -107.93 106.41 16.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 111.423 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.56 ' HD2' ' CG2' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -88.85 122.35 32.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.855 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.9 m-85 -102.97 144.06 31.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.0 111.004 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -131.84 89.08 2.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.644 -0.66 . . . . 0.0 109.708 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.562 HG22 ' HG ' ' A' ' 95' ' ' LEU . 7.3 p -95.81 -159.96 0.76 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.622 -0.674 . . . . 0.0 110.161 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -83.28 -66.75 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 110.123 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.69 -32.37 0.62 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.06 -69.39 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -1.154 . . . . 0.0 110.13 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -99.51 -170.72 1.94 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 0.0 110.114 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 3' ' ' PHE . 4.4 mm-40 -115.81 171.15 7.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.538 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.571 HG23 ' CD1' ' A' ' 3' ' ' PHE . 3.4 t -67.15 156.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 132' ' ' GLN . 4.2 mppt? -90.86 102.5 15.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.842 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -44.32 -51.17 8.66 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.44 -44.77 62.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.166 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 2.7 tt0 -56.52 -41.98 77.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 108.753 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.072 HG11 ' CD2' ' A' ' 5' ' ' TYR . 78.6 t -63.26 -30.09 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.825 0.821 . . . . 0.0 108.944 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 4.1 tttt -68.69 -51.53 40.78 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.772 -0.58 . . . . 0.0 110.267 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.55 -56.55 3.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.04 -43.74 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.433 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 4.5 mtpp -60.5 -38.1 83.23 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.411 -0.805 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -65.54 -54.63 25.32 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 110.074 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -35.61 65.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.06 -1.025 . . . . 0.0 109.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.86 -38.95 93.31 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 145' ' ' ARG . 1.0 OUTLIER -74.22 -35.6 63.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.967 -1.314 . . . . 0.0 110.934 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.3 p -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.18 -0.95 . . . . 0.0 109.785 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.651 HD21 ' CB ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -73.32 -51.05 18.89 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.416 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.519 HD11 ' OG ' ' A' ' 11' ' ' SER . 15.5 tp -50.7 -44.16 57.95 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -62.91 -44.48 95.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 109.511 178.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.559 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -51.27 -58.98 4.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.582 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.704 HG21 ' HD1' ' A' ' 22' ' ' PHE . 21.9 t -66.36 -21.81 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.78 -51.05 64.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.07 -1.018 . . . . 0.0 109.736 179.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 3.1 t -75.33 -31.03 60.47 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.381 -0.824 . . . . 0.0 109.891 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.542 ' CE1' HD11 ' A' ' 29' ' ' LEU . 14.7 t80 -55.96 -50.85 69.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 147' ' ' VAL . 81.3 mt -56.13 -29.94 61.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 109.96 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 148' ' ' GLU . 8.6 mp -72.01 -55.67 7.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.401 -0.812 . . . . 0.0 110.241 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.655 ' HB3' ' HD2' ' A' ' 154' ' ' HIS . . . -55.32 -41.23 72.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.466 -0.772 . . . . 0.0 110.544 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.655 ' HD2' ' HB3' ' A' ' 153' ' ' ALA . 4.5 m-70 -105.55 122.52 46.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 110.26 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.82 30.57 2.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.855 . . . . 0.0 109.911 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -132.13 -26.9 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 110.809 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.488 ' HB2' ' OH ' ' A' ' 150' ' ' TYR . . . -69.99 128.49 36.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.964 -1.085 . . . . 0.0 110.589 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.813 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 40.3 m-85 56.68 81.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.264 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 121' ' ' HIS . 56.1 t -44.74 156.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -1.213 . . . . 0.0 110.162 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.771 ' CD1' HG23 ' A' ' 128' ' ' VAL . 97.4 m-85 -120.48 164.62 16.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 110.274 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.409 ' OD1' ' C ' ' A' ' 4' ' ' ASN . 3.4 t-20 -127.51 105.76 8.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.913 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.041 ' CD1' HG11 ' A' ' 133' ' ' VAL . 25.6 m-85 -99.01 92.75 5.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.983 . . . . 0.0 110.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.45 ' HA ' ' OG ' ' A' ' 117' ' ' SER . 2.2 mp0 -53.8 141.15 27.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.85 . . . . 0.0 109.969 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.737 ' CG2' HG23 ' A' ' 102' ' ' ILE . 4.8 t -125.47 162.94 23.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.804 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 7' ' ' THR . 4.0 tm-20 178.49 102.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.424 -0.798 . . . . 0.0 110.307 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.932 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -120.64 162.6 19.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 0.0 109.835 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.92 145.89 48.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.753 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.447 ' OG ' HD11 ' A' ' 18' ' ' LEU . 35.4 t -142.19 149.17 39.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.885 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.86 -25.96 29.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 109.793 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.631 HD12 ' NH2' ' A' ' 17' ' ' ARG . 5.2 mm -72.5 142.01 83.53 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 110.356 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HG2' ' CB ' ' A' ' 17' ' ' ARG . 34.5 Cg_endo -57.97 151.79 55.28 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.76 1.4 . . . . 0.0 110.521 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.586 ' HA ' HG22 ' A' ' 104' ' ' ILE . . . -58.13 -45.63 87.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.291 -0.88 . . . . 0.0 110.99 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.473 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -58.43 -59.78 4.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 110.535 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.632 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -51.0 -59.57 4.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.496 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.55 ' HG ' HG21 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -46.28 -35.57 5.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.364 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CE1' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -65.67 -64.26 0.9 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 110.157 179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 20.9 mtmt -54.39 -21.66 10.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.458 -0.776 . . . . 0.0 112.305 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.69 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -112.65 -59.96 1.94 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.638 ' CA ' HG11 ' A' ' 147' ' ' VAL . 64.6 t80 -69.22 -44.0 72.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.717 -1.239 . . . . 0.0 111.859 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.594 HG21 ' CE1' ' A' ' 19' ' ' PHE . 46.9 mm -82.8 -82.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.976 -1.078 . . . . 0.0 111.296 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.7 mt -40.56 -68.4 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -55.33 -67.6 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.427 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.617 ' HA2' ' CE1' ' A' ' 30' ' ' PHE . . . 49.18 -86.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.709 ' HB2' HG21 ' A' ' 41' ' ' VAL . 4.6 p30 -73.99 27.12 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.586 -0.95 . . . . 0.0 112.349 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 11.5 t30 -139.72 38.16 2.01 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 150' ' ' TYR . 0.8 OUTLIER 174.25 -30.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.609 -177.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.617 ' CE1' ' HA2' ' A' ' 26' ' ' GLY . 2.6 m-30 -38.92 -62.52 0.74 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.385 -0.822 . . . . 0.0 111.304 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 44.7 Cg_endo -65.89 -27.44 51.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.762 1.401 . . . . 0.0 110.288 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -72.75 -16.56 61.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.83 . . . . 0.0 110.484 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.653 HG23 ' HB1' ' A' ' 146' ' ' ALA . 19.1 m -124.25 -4.12 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.338 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.69 65.37 12.51 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 110.224 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.38 -10.16 27.71 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 123.835 1.439 . . . . 0.0 109.657 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -86.08 -20.42 28.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.466 -0.771 . . . . 0.0 109.127 179.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.442 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -107.79 -61.04 1.63 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.438 -0.789 . . . . 0.0 109.593 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.597 HG12 HD21 ' A' ' 143' ' ' LEU . 7.7 mm -94.55 166.65 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.521 -0.737 . . . . 0.0 109.617 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -131.46 -40.17 1.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 p -160.16 155.9 25.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 109.944 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 27' ' ' ASP . 2.7 p -121.33 146.63 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.0 109.966 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 2.4 mm-40 -138.41 -174.03 3.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.642 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' C ' HG22 ' A' ' 44' ' ' ILE . 0.7 OUTLIER 65.24 -88.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.333 -179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.504 HD13 ' OD1' ' A' ' 27' ' ' ASP . 5.3 tp 32.45 36.15 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.62 -0.675 . . . . 0.0 111.246 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 18.9 tp10 -40.32 131.93 2.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.868 . . . . 0.0 110.152 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -77.33 136.08 17.84 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 17.8 t-20 61.91 65.99 0.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.27 -1.135 . . . . 0.0 110.183 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 49' ' ' GLY . . . -105.75 -16.08 16.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 48' ' ' GLY . . . 43.39 -131.78 5.86 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.92 81.8 1.86 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.826 1.435 . . . . 0.0 110.408 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.2 -12.85 0.94 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.655 ' O ' HD13 ' A' ' 53' ' ' ILE . 7.6 m -45.04 150.32 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.017 -1.284 . . . . 0.0 110.156 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 52' ' ' THR . 45.8 mm -131.4 154.87 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.179 -0.95 . . . . 0.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' NZ ' ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -141.97 143.51 33.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.52 -0.737 . . . . 0.0 109.869 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 42' ' ' GLU . 31.2 tttp -118.99 110.4 17.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.628 -0.67 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.545 ' CD1' HG23 ' A' ' 41' ' ' VAL . 9.8 mm -98.72 109.43 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.82 -1.175 . . . . 0.0 110.611 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 39' ' ' SER . 0.8 OUTLIER -103.07 124.87 49.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 110.405 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' HB2' HD12 ' A' ' 62' ' ' LEU . 32.1 m-85 -84.58 164.66 41.69 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.403 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.3 Cg_endo -74.47 -163.23 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.14 1.6 . . . . 0.0 109.726 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.4 OUTLIER 38.61 -162.36 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.569 -0.707 . . . . 0.0 111.133 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -99.58 -34.74 4.89 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 58' ' ' PHE . 11.0 mt 55.71 165.4 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.105 -1.232 . . . . 0.0 109.934 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 45.5 Cg_endo -72.15 -24.96 19.6 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.846 1.446 . . . . 0.0 109.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.511 ' HB3' ' CA ' ' A' ' 89' ' ' GLY . 18.0 m-30 -106.45 -140.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.397 -0.814 . . . . 0.0 109.818 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 22.7 mttt -144.67 -32.34 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.018 -1.051 . . . . 0.0 111.16 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 176.65 177.44 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 89' ' ' GLY . 35.7 m -142.25 117.98 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.58 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -93.57 162.81 13.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.945 . . . . 0.0 109.342 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.495 ' OD1' HG22 ' A' ' 85' ' ' VAL . 67.0 m-20 -144.64 154.48 42.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.844 -1.16 . . . . 0.0 111.627 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HG2' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -122.29 134.68 54.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.675 -0.641 . . . . 0.0 109.386 179.392 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.506 ' HB ' ' NZ ' ' A' ' 54' ' ' LYS . 2.6 p -89.89 136.71 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.003 . . . . 0.0 110.671 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -113.94 55.54 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 109.401 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 1.4 mt-10 60.28 117.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.438 -0.789 . . . . 0.0 109.842 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.672 HG13 ' HD1' ' A' ' 81' ' ' TYR . 25.2 t -96.97 125.52 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 110.699 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 15.1 t0 -68.63 -170.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.572 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -166.07 -48.93 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.137 -0.977 . . . . 0.0 110.152 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 m -57.5 -16.1 8.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 110.089 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.538 ' CB ' ' HD2' ' A' ' 80' ' ' LYS . 97.3 m-20 -130.31 6.74 4.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 3.7 m-85 57.56 55.32 5.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 110.737 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.538 ' HD2' ' CB ' ' A' ' 78' ' ' ASN . 6.8 mttt -117.63 121.72 41.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.366 -0.834 . . . . 0.0 110.026 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.672 ' HD1' HG13 ' A' ' 74' ' ' VAL . 17.9 t80 -114.18 161.2 18.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.353 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.456 ' CB ' ' OE2' ' A' ' 101' ' ' GLU . 8.0 p30 -163.83 138.09 5.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.261 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 83' ' ' TYR . 10.9 p90 -147.5 172.49 13.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 110.254 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 4.6 p -139.42 135.3 33.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.736 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.495 HG22 ' OD1' ' A' ' 69' ' ' ASP . 66.9 t -101.07 81.17 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.887 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.582 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -66.57 -10.88 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.441 -0.787 . . . . 0.0 110.705 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -173.4 157.34 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.782 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.564 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 168.38 -137.57 4.66 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.239 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.666 ' H ' HG12 ' A' ' 67' ' ' VAL . . . -95.28 -38.16 4.88 Favored Glycine 0 N--CA 1.489 2.168 0 O-C-N 121.727 -0.866 . . . . 0.0 111.92 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.2 Cg_endo -77.48 -1.59 11.77 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.0 1.0 . . . . 0.0 111.202 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -46.82 176.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.156 -0.965 . . . . 0.0 110.221 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 94' ' ' THR . . . 157.19 74.12 0.02 OUTLIER Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.513 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 94' ' ' THR . 2.8 m-20 40.25 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.442 -1.034 . . . . 0.0 111.188 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.569 HG21 ' HB2' ' A' ' 126' ' ' HIS . 3.2 p -31.41 -84.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.789 -0.569 . . . . 0.0 111.102 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.597 HD11 HG12 ' A' ' 98' ' ' ILE . 15.6 tp -64.49 88.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.081 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -90.78 -49.64 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.542 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -114.62 142.87 45.88 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.068 -1.02 . . . . 0.0 110.217 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.597 HG12 HD11 ' A' ' 95' ' ' LEU . 44.2 mt -136.24 114.99 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -0.948 . . . . 0.0 110.604 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 1.4 m -112.18 111.56 22.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 109.424 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.549 ' CB ' ' HA ' ' A' ' 118' ' ' ASN . 25.4 m-20 -121.27 147.3 45.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 110.308 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.456 ' OE2' ' CB ' ' A' ' 82' ' ' ASN . 12.3 mt-10 -136.02 141.48 44.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.532 -0.73 . . . . 0.0 109.68 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.737 HG23 ' CG2' ' A' ' 7' ' ' THR . 0.2 OUTLIER -136.3 177.93 5.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 113' ' ' ILE . 75.1 tttt -140.0 137.42 34.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.562 -0.711 . . . . 0.0 109.349 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.586 HG22 ' HA ' ' A' ' 15' ' ' ALA . 6.1 mm -96.82 80.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 112' ' ' SER . 90.7 t -71.39 130.97 35.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 110.702 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.87 141.28 28.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.544 HG21 HD11 ' A' ' 113' ' ' ILE . 38.0 p -127.42 156.51 74.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.34 -34.74 34.11 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.071 1.564 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -137.45 37.49 2.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.295 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.505 ' CA ' ' OG1' ' A' ' 107' ' ' THR . . . -148.43 30.48 1.3 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 45.84 -103.94 0.06 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.555 ' HB3' ' N ' ' A' ' 15' ' ' ALA . 2.6 p -142.99 170.25 16.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -1.186 . . . . 0.0 110.355 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 114' ' ' LEU . 9.7 mt -138.68 129.77 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.932 ' HB2' HG22 ' A' ' 9' ' ' THR . 8.0 mp -97.55 94.45 7.01 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 116' ' ' ILE . 1.0 OUTLIER -124.1 -176.83 3.59 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.779 -1.168 . . . . 0.0 112.721 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.742 HG22 ' N ' ' A' ' 117' ' ' SER . 21.6 mm 120.63 -102.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.236 1.414 . . . . 0.0 109.853 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.742 ' N ' HG22 ' A' ' 116' ' ' ILE . 4.7 m -168.79 177.22 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.725 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.549 ' HA ' ' CB ' ' A' ' 100' ' ' ASN . 4.6 m120 -139.49 96.71 3.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.505 ' HD3' HG11 ' A' ' 2' ' ' VAL . 4.9 mttt -75.66 129.08 36.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 111.271 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.593 ' CE2' HD21 ' A' ' 95' ' ' LEU . 2.6 m-85 -105.75 106.23 16.64 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.537 -0.727 . . . . 0.0 109.652 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.825 ' HA ' HG22 ' A' ' 2' ' ' VAL . 60.3 m-70 -90.9 95.05 9.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.843 . . . . 0.0 110.307 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.8 p -79.34 -170.88 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 -72.27 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.011 . . . . 0.0 110.249 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.88 60.78 0.07 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -153.24 -114.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -1.153 . . . . 0.0 109.79 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.569 ' HB2' HG21 ' A' ' 94' ' ' THR . 15.0 m170 -71.13 161.22 31.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.975 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.5 mp0 -77.43 -164.36 0.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.906 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.771 HG23 ' CD1' ' A' ' 3' ' ' PHE . 55.6 t -90.7 141.42 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 109.998 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -81.65 119.48 23.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -0.91 . . . . 0.0 109.887 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.06 83.24 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.132 -0.98 . . . . 0.0 109.958 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.99 -29.24 59.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -1.0 . . . . 0.0 108.839 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 90' ' ' PRO . 37.3 tt0 -77.8 -40.16 41.49 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.041 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.7 t -69.25 -14.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.082 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.07 -49.27 6.3 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.655 -0.653 . . . . 0.0 109.979 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 138' ' ' GLU . . . -50.71 -45.46 58.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.1 t -59.14 -47.58 84.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 0.0 109.349 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HE2' ' ND2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -63.3 -22.09 66.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.643 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 74.2 tt0 -75.2 -47.6 27.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.361 -0.837 . . . . 0.0 109.416 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.442 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 42.3 mmm -65.86 -30.83 71.5 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.25 -0.906 . . . . 0.0 108.867 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.43 -35.5 56.06 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.66 -34.92 65.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -1.182 . . . . 0.0 109.884 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.1 p -72.23 -37.94 69.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.246 -0.908 . . . . 0.0 108.807 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.597 HD21 HG12 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -72.05 -31.4 66.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 9' ' ' THR . 11.7 tp -67.57 -41.96 83.32 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -68.74 -33.1 73.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.653 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -63.84 -60.99 2.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.457 -0.777 . . . . 0.0 109.245 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.638 HG11 ' CA ' ' A' ' 22' ' ' PHE . 63.4 t -60.82 -28.62 43.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.451 -0.78 . . . . 0.0 109.697 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -50.0 72.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.945 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.49 -11.99 56.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 110.064 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.583 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 6.5 t80 -69.53 -37.24 77.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.632 HD13 ' HG2' ' A' ' 17' ' ' ARG . 11.6 mt -73.6 -24.58 60.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 13' ' ' ILE . 4.7 mp -81.64 -36.27 29.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 109.961 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.52 -41.66 45.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 155' ' ' SER . 59.7 m-70 -86.1 -48.44 8.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.372 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 7.9 t 62.22 14.34 6.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.259 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -131.95 4.08 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.371 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.491 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -106.69 143.36 34.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.288 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.69 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 41.8 m-85 50.56 33.51 8.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.569 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.422 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 120' ' ' TYR . 95.7 t -63.63 152.14 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -1.172 . . . . 0.0 110.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.626 ' HB3' ' CE1' ' A' ' 5' ' ' TYR . 23.1 m-85 -113.38 164.47 13.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.494 -0.754 . . . . 0.0 109.938 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 119' ' ' LYS . 61.9 t-20 -148.99 98.79 2.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.083 -1.011 . . . . 0.0 111.37 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.908 ' OH ' HG21 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -95.59 134.34 38.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.163 -0.961 . . . . 0.0 108.944 178.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -119.01 117.45 28.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 110.779 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.407 HG21 ' HD3' ' A' ' 137' ' ' LYS . 7.9 t -142.6 -161.19 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 109.845 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -173.63 158.92 3.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.011 -1.056 . . . . 0.0 110.538 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.972 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -122.68 175.44 6.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.981 . . . . 0.0 110.156 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.44 145.29 51.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 110.242 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.587 ' CB ' HD11 ' A' ' 18' ' ' LEU . 16.5 t -143.52 142.45 31.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.377 -0.827 . . . . 0.0 110.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.11 -10.28 13.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.639 -0.663 . . . . 0.0 110.256 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.692 HG23 ' HD2' ' A' ' 14' ' ' PRO . 15.6 mm -86.72 149.34 48.2 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.568 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.3 Cg_endo -56.19 156.36 21.05 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 121.555 1.503 . . . . 0.0 110.444 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.722 ' HB1' HG22 ' A' ' 104' ' ' ILE . . . -69.5 -51.05 39.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.26 -52.57 51.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.937 -1.102 . . . . 0.0 110.298 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -60.63 -55.18 36.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 110.206 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.587 HD11 ' CB ' ' A' ' 11' ' ' SER . 7.7 mt -47.48 -34.69 7.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.008 . . . . 0.0 109.318 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.894 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -69.93 -61.9 1.6 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 110.482 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 mtpt -54.44 -25.21 23.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.376 -0.828 . . . . 0.0 112.581 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.826 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -110.49 -56.4 2.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.446 -1.409 . . . . 0.0 111.904 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 18' ' ' LEU . 73.6 t80 -78.92 0.79 25.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.018 -1.051 . . . . 0.0 112.267 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 4.5 mt -138.81 -22.86 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.689 -1.257 . . . . 0.0 111.471 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.894 HD21 ' CE1' ' A' ' 19' ' ' PHE . 2.8 mt -100.54 -35.84 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.728 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -117.02 88.76 2.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.75 -0.594 . . . . 0.0 109.613 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -113.56 -35.9 1.51 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.994 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.9 p30 -73.99 0.36 13.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.421 -1.046 . . . . 0.0 110.821 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 2.5 t30 -139.82 7.76 2.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.136 -0.977 . . . . 0.0 109.935 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.928 HD22 ' O ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -142.15 -14.66 0.79 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.894 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 8.4 m-30 -71.88 -57.04 4.26 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.739 -1.225 . . . . 0.0 110.435 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.21 -34.67 44.56 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.685 1.36 . . . . 0.0 110.732 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -60.14 -15.21 21.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 0.0 109.98 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' HB1' ' A' ' 146' ' ' ALA . 6.4 m -130.56 -4.05 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.429 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.4 62.63 6.63 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.082 -1.011 . . . . 0.0 110.709 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.72 -24.19 41.33 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.844 1.444 . . . . 0.0 109.632 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -74.38 -13.04 60.67 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.573 -0.705 . . . . 0.0 109.227 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.704 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -109.08 -63.05 1.39 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.166 -0.959 . . . . 0.0 110.396 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -100.48 154.48 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.905 -1.122 . . . . 0.0 110.14 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.531 ' HB3' ' N ' ' A' ' 59' ' ' PRO . 54.4 p -108.49 -45.12 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.777 . . . . 0.0 110.187 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 p -174.59 -169.73 0.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.994 HG11 ' HB2' ' A' ' 27' ' ' ASP . 7.6 p -147.84 162.54 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.953 . . . . 0.0 110.065 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 12.1 mt-10 -141.06 175.13 9.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 109.895 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.526 ' O ' ' C ' ' A' ' 44' ' ' ILE . 5.5 m-20 62.41 -87.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.601 -0.687 . . . . 0.0 110.038 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.778 ' O ' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER 24.96 50.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-O 121.761 0.791 . . . . 0.0 110.872 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 43' ' ' ASN . 2.0 mt-10 -79.52 134.95 36.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.111 -0.993 . . . . 0.0 110.157 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.06 65.67 3.42 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -147.46 -36.24 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -1.132 . . . . 0.0 110.573 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -62.56 -21.74 62.99 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.24 -106.73 0.22 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 48' ' ' GLY . 48.4 Cg_endo -74.97 77.72 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.86 1.452 . . . . 0.0 110.603 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 52' ' ' THR . . . 134.17 0.05 3.88 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.437 ' C ' ' O ' ' A' ' 51' ' ' GLY . 24.3 m -42.14 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -1.165 . . . . 0.0 110.037 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.567 HD13 ' HG2' ' A' ' 70' ' ' ARG . 19.3 mm -126.74 124.04 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 110.61 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.864 ' CD ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -124.52 144.81 49.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 0.0 110.424 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -111.29 111.26 22.19 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.94 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.864 HD11 ' CD ' ' A' ' 54' ' ' LYS . 5.2 mm -89.5 127.92 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.97 -1.081 . . . . 0.0 109.782 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.7 m -111.19 145.72 38.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 0.0 109.786 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 1.075 ' HB3' HD13 ' A' ' 62' ' ' LEU . 79.2 m-85 -121.18 155.12 58.65 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 110.775 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.531 ' N ' ' HB3' ' A' ' 39' ' ' SER . 48.9 Cg_endo -78.47 -169.05 0.7 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.155 1.608 . . . . 0.0 109.497 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 168.42 10.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 0.0 110.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.58 -52.7 2.36 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.075 HD13 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.11 142.11 86.03 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.147 . . . . 0.0 109.972 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.577 ' O ' ' CG ' ' A' ' 64' ' ' PHE . 48.8 Cg_endo -81.84 27.92 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.082 1.569 . . . . 0.0 111.08 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 63' ' ' PRO . 82.3 m-85 -156.08 141.09 17.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.042 -1.036 . . . . 0.0 110.21 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -75.68 -34.68 60.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.572 ' C ' HG13 ' A' ' 67' ' ' VAL . 23.6 p90 -173.09 -178.12 1.71 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.572 HG13 ' C ' ' A' ' 66' ' ' TYR . 27.8 m -157.71 125.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.307 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 86' ' ' ILE . 7.6 mttt -85.35 131.52 34.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.382 -0.824 . . . . 0.0 108.794 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -130.29 141.54 50.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.867 -1.145 . . . . 0.0 111.664 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.567 ' HG2' HD13 ' A' ' 53' ' ' ILE . 60.6 mtm180 -110.69 132.34 54.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.589 -0.694 . . . . 0.0 109.129 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.088 HG13 HG23 ' A' ' 74' ' ' VAL . 1.0 OUTLIER -73.08 -37.48 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.84 -1.163 . . . . 0.0 110.052 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 0.6 OUTLIER 78.76 -39.76 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.115 -0.366 . . . . 0.0 111.103 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' O ' ' HB ' ' A' ' 74' ' ' VAL . 5.4 pt-20 173.34 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.71 -1.244 . . . . 0.0 111.077 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.088 HG23 HG13 ' A' ' 71' ' ' VAL . 39.3 t 60.59 139.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.37 -0.831 . . . . 0.0 109.657 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.23 164.38 13.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.073 -1.017 . . . . 0.0 110.87 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -142.03 -45.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.022 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' OD1' ' A' ' 78' ' ' ASN . 3.0 m -57.45 -34.42 68.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.182 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 78' ' ' ASN . 1.9 m120 -109.42 12.41 24.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.51 39.16 27.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.977 . . . . 0.0 109.786 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HG2' ' HG2' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -105.19 153.47 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.392 -0.817 . . . . 0.0 110.324 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.632 ' HE1' HG22 ' A' ' 74' ' ' VAL . 15.4 t80 -144.62 111.38 5.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.808 . . . . 0.0 109.612 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.509 ' ND2' ' CG ' ' A' ' 101' ' ' GLU . 60.6 t-20 -121.2 126.85 50.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 110.692 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 18.8 p90 -139.67 154.67 47.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.66 164.19 11.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.098 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 86' ' ' ILE . 97.8 t -107.94 -14.88 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.514 HG21 ' NE ' ' A' ' 70' ' ' ARG . 25.9 pt 33.02 -120.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.744 -0.597 . . . . 0.0 111.075 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 86' ' ' ILE . 2.0 mp0 -84.47 164.25 18.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 110.227 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.51 149.66 19.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.63 -146.3 17.85 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.0 Cg_endo -81.86 23.59 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.092 1.575 . . . . 0.0 111.238 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.06 157.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.448 -0.783 . . . . 0.0 111.015 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 93' ' ' ASP . . . 102.53 -51.28 0.88 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 92' ' ' GLY . 6.4 m-20 -57.59 -155.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -1.149 . . . . 0.0 110.265 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 122' ' ' THR . 73.0 p -81.42 2.37 28.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.559 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.942 HD21 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -106.58 107.61 18.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.988 . . . . 0.0 109.932 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' OE1' ' HE3' ' A' ' 123' ' ' LYS . 20.3 tt0 -94.29 -37.02 11.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.836 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 0.0 OUTLIER -135.21 165.29 25.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.975 -1.078 . . . . 0.0 110.655 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.905 HD11 HD22 ' A' ' 95' ' ' LEU . 13.7 mt -155.83 122.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -104.61 131.51 51.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 0.0 109.449 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.476 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -123.15 135.43 54.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.973 -1.079 . . . . 0.0 111.216 -179.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.509 ' CG ' ' ND2' ' A' ' 82' ' ' ASN . 11.5 mt-10 -120.98 152.21 38.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 81' ' ' TYR . 58.1 mt -140.05 159.08 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.919 -1.113 . . . . 0.0 110.482 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 1.1 ttmt -149.42 101.5 3.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.722 HG22 ' HB1' ' A' ' 15' ' ' ALA . 4.1 mp -83.28 111.14 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.371 -0.831 . . . . 0.0 110.182 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.894 HG21 ' HE3' ' A' ' 115' ' ' LYS . 15.5 t -110.52 130.78 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.165 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.46 144.54 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -119.7 158.02 50.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.925 . . . . 0.0 110.029 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.15 -38.39 21.75 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.988 1.52 . . . . 0.0 110.709 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 14.3 t70 -143.88 36.14 1.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 110.327 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.11 14.6 3.53 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 70.55 -101.04 0.86 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 69.8 m -161.52 138.48 8.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 0.0 110.204 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 114' ' ' LEU . 23.1 mt -109.09 130.13 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.972 ' HB2' HG22 ' A' ' 9' ' ' THR . 6.6 mp -95.84 89.52 5.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.643 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.894 ' HE3' HG21 ' A' ' 105' ' ' VAL . 2.1 mttm -64.36 118.05 8.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 108.352 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.613 HG22 ' ND2' ' A' ' 118' ' ' ASN . 43.4 mt -119.65 118.32 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 111.791 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.01 106.2 18.43 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.613 ' ND2' HG22 ' A' ' 116' ' ' ILE . 1.5 m-80 -90.12 92.99 9.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 111.171 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -87.74 135.2 33.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 109.027 178.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.942 ' CD2' HD21 ' A' ' 95' ' ' LEU . 2.5 m-85 -111.96 167.13 10.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.915 -1.115 . . . . 0.0 110.834 -178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 97' ' ' LYS . 16.0 m-70 -139.35 89.53 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.637 HG22 ' HG ' ' A' ' 95' ' ' LEU . 3.0 p -92.8 -170.56 2.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 110.04 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.478 ' HE3' ' OE1' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -111.9 -3.01 14.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 110.091 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 124.67 -141.55 13.3 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 124' ' ' GLY . 3.5 t70 42.69 -139.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -1.111 . . . . 0.0 110.16 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -48.58 158.86 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.033 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -89.37 -137.65 0.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.574 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.908 HG21 ' OH ' ' A' ' 5' ' ' TYR . 90.8 t -105.97 154.23 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.077 -1.014 . . . . 0.0 110.806 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -102.53 117.35 34.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.863 . . . . 0.0 109.892 179.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.16 -42.04 63.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.126 -0.984 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -49.58 -42.33 44.15 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.109 -0.995 . . . . 0.0 108.692 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 21.7 mt-30 -67.52 -44.55 78.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.571 -0.706 . . . . 0.0 109.315 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 5' ' ' TYR . 21.2 t -70.24 -6.52 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.738 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.472 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.9 tttt -98.0 -65.98 0.93 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.286 -0.884 . . . . 0.0 110.821 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -32.52 -45.75 0.12 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.592 -0.693 . . . . 0.0 110.97 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.24 -51.45 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.286 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 134' ' ' LYS . 1.7 ttmt -55.86 -32.49 63.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 109.961 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -68.2 -52.93 28.71 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.477 -0.765 . . . . 0.0 109.618 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.704 ' CE ' ' HB1' ' A' ' 37' ' ' ALA . 39.7 mmm -54.64 -39.0 67.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.29 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.49 98.03 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.76 -39.52 87.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.283 . . . . 0.0 110.522 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -34.3 76.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.079 -1.013 . . . . 0.0 109.031 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.6 mm? -77.78 -24.09 49.01 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.335 -0.853 . . . . 0.0 109.085 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 148' ' ' GLU . 18.3 tp -75.58 -33.89 60.62 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.488 ' HA ' ' HB3' ' A' ' 148' ' ' GLU . 8.6 ttt180 -80.93 -31.25 35.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.797 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -69.17 -45.59 69.61 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.805 HG22 HD11 ' A' ' 29' ' ' LEU . 96.7 t -76.19 -30.33 20.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.507 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -64.88 -37.82 88.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.444 179.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.462 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -89.13 -22.45 22.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.544 -0.722 . . . . 0.0 109.632 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.603 ' HB2' HG11 ' A' ' 33' ' ' VAL . 6.9 t80 -63.6 -38.32 90.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.386 -0.821 . . . . 0.0 109.672 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.58 HD23 ' CD2' ' A' ' 150' ' ' TYR . 50.9 mt -73.72 -19.9 60.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 4.8 mp -92.94 -19.21 21.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.52 -0.738 . . . . 0.0 110.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.98 -31.25 13.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.145 -0.972 . . . . 0.0 110.335 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -80.87 -165.0 0.81 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.868 . . . . 0.0 110.293 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 1.2 p -86.5 -57.21 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.493 ' N ' ' OG ' ' A' ' 155' ' ' SER . 13.6 m-20 -166.02 54.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.181 -0.95 . . . . 0.0 110.665 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.477 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -68.55 136.41 53.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.168 -0.958 . . . . 0.0 109.919 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.826 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 60.5 m-85 58.81 53.95 5.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.467 ' OD1' ' HD3' ' A' ' 17' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.275 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.539 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.617 HG12 ' N ' ' A' ' 3' ' ' PHE . 84.0 t -85.52 171.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.137 -1.214 . . . . 0.0 110.567 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.617 ' N ' HG12 ' A' ' 2' ' ' VAL . 97.9 m-85 -141.98 171.57 13.87 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.492 -0.755 . . . . 0.0 110.136 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -138.87 122.04 16.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 110.37 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.943 ' CE2' HG21 ' A' ' 133' ' ' VAL . 36.5 m-85 -116.81 97.81 6.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 109.557 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.58 129.56 37.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.714 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.1 -174.0 4.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.424 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 3.0 pt-20 -166.43 166.3 16.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.636 ' O ' ' CB ' ' A' ' 10' ' ' THR . 10.8 t -175.1 -126.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.088 -1.008 . . . . 0.0 111.43 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.857 ' HG1' ' N ' ' A' ' 114' ' ' LEU . 4.4 m 94.7 -126.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 123.069 0.548 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 10' ' ' THR . 0.5 OUTLIER 169.43 -167.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.568 -1.333 . . . . 0.0 111.534 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 110' ' ' GLY . 0.9 OUTLIER -72.89 -16.93 18.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.85 -0.531 . . . . 0.0 110.009 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 4.3 mm -63.26 145.56 96.85 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.001 -1.062 . . . . 0.0 109.058 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.555 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 31.6 Cg_endo -54.75 148.53 45.03 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.848 1.446 . . . . 0.0 111.266 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -62.29 -43.57 98.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.641 -0.662 . . . . 0.0 110.789 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' PHE . . . -57.46 -51.76 68.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 110.814 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -61.67 -55.51 29.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 109.769 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.82 HD13 HG22 ' A' ' 10' ' ' THR . 0.3 OUTLIER -53.3 -27.04 20.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.956 0.884 . . . . 0.0 109.709 179.094 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 1.183 ' CE1' HD21 ' A' ' 24' ' ' LEU . 1.1 t80 -73.45 -70.98 0.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.589 . . . . 0.0 110.478 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HA ' ' CG ' ' A' ' 24' ' ' LEU . 11.1 mtpt -55.1 -22.43 16.45 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.69 -0.631 . . . . 0.0 112.636 -178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -102.52 -48.13 4.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.471 -1.393 . . . . 0.0 112.188 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 88.0 t80 -95.46 9.79 38.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.807 -1.183 . . . . 0.0 112.017 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.749 HG23 ' CD2' ' A' ' 81' ' ' TYR . 7.1 mt -143.39 -27.89 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.711 -1.243 . . . . 0.0 110.838 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.183 HD21 ' CE1' ' A' ' 19' ' ' PHE . 6.6 mt -106.22 -17.36 14.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.795 -1.19 . . . . 0.0 109.292 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 3.0 t0 -132.11 94.97 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.478 -0.764 . . . . 0.0 109.898 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.505 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -120.16 -35.84 0.85 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.78 6.6 10.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.97 -1.312 . . . . 0.0 110.147 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 5.7 t30 -143.15 25.06 1.77 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.933 HD11 HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -159.33 -32.21 0.06 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.136 -178.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.661 ' N ' HD13 ' A' ' 29' ' ' LEU . 12.2 m-30 -60.26 -55.36 46.1 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 0.0 110.233 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.6 Cg_endo -65.53 -35.92 36.3 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.539 1.284 . . . . 0.0 110.823 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -62.92 -15.49 55.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 29' ' ' LEU . 17.8 m -128.66 -2.4 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 110.553 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -153.43 68.95 6.57 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.13 -0.981 . . . . 0.0 110.949 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.05 -13.59 38.58 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.879 1.463 . . . . 0.0 109.248 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -82.76 -19.77 37.19 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.474 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -99.66 -54.91 2.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.0 110.33 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.61 150.71 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.053 -1.029 . . . . 0.0 110.319 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.411 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 t -110.59 -37.26 5.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.994 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -173.07 -179.58 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 56' ' ' ILE . 91.6 t -143.65 165.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.431 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -130.75 79.79 1.91 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.0 109.935 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.475 ' OD1' ' HB3' ' A' ' 54' ' ' LYS . 2.1 m-80 -95.91 108.42 20.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.406 -0.809 . . . . 0.0 109.466 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 45' ' ' GLU . 9.7 tp -167.37 -32.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.0 111.443 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.475 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 5.8 pt-20 -100.33 157.53 16.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.065 . . . . 0.0 110.4 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.15 -115.81 1.83 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.62 -44.82 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.128 . . . . 0.0 110.272 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.78 74.29 1.25 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 144.83 -117.9 1.07 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -77.02 74.4 5.02 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.776 1.409 . . . . 0.0 110.41 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.37 77.47 0.53 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.481 ' H ' HG12 ' A' ' 71' ' ' VAL . 54.9 m -105.04 149.09 26.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.093 -1.239 . . . . 0.0 110.104 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 45' ' ' GLU . 5.0 mm -101.86 119.04 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.955 . . . . 0.0 110.117 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 1.2 mttm -121.86 147.39 46.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.109 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . 17.0 tttt -115.93 107.29 14.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.025 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.753 ' CD1' HG13 ' A' ' 41' ' ' VAL . 4.8 mm -82.58 147.23 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.479 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.09 140.45 52.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.504 -0.747 . . . . 0.0 109.518 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.606 ' HB3' HD12 ' A' ' 62' ' ' LEU . 69.3 m-85 -116.54 142.06 28.98 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 39' ' ' SER . 48.5 Cg_endo -74.6 -171.18 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.014 1.534 . . . . 0.0 110.143 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -62.8 160.77 13.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 110.451 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -41.01 2.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.606 HD12 ' HB3' ' A' ' 58' ' ' PHE . 3.0 mt -83.14 164.16 47.31 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.236 . . . . 0.0 110.321 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 62' ' ' LEU . 46.0 Cg_endo -76.92 -82.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.238 1.651 . . . . 0.0 111.207 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 m-30 -56.51 161.12 2.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.07 -1.018 . . . . 0.0 110.716 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.21 -22.74 18.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 110.445 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.689 ' O ' HG13 ' A' ' 67' ' ' VAL . 16.3 p90 -173.78 -176.68 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.928 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 66' ' ' TYR . 13.5 m -160.42 161.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.396 -0.815 . . . . 0.0 110.734 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -119.72 117.45 28.27 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD2' ' CD1' ' A' ' 83' ' ' TYR . 15.6 t70 -120.37 153.55 36.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.969 -1.082 . . . . 0.0 111.542 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.69 126.99 51.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.67 -0.643 . . . . 0.0 109.409 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 52' ' ' THR . 6.1 p -61.01 -22.61 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.919 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 45.13 52.07 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.001 . . . . 0.0 109.564 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 3.5 mt-10 58.25 154.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 110.172 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' HD1' ' A' ' 81' ' ' TYR . 2.9 p -136.45 120.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -74.19 178.05 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.921 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.414 ' O ' ' HD1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -152.65 -41.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 110.773 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.9 m -52.22 -48.72 64.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.638 -1.289 . . . . 0.0 110.44 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -105.46 19.72 20.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.623 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 6.7 m-30 51.86 75.04 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.276 -0.89 . . . . 0.0 110.557 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 17.5 mtmt -131.55 124.77 30.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.803 ' HD1' HG23 ' A' ' 74' ' ' VAL . 2.7 t80 -117.08 113.22 22.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 71' ' ' VAL . 88.1 m-20 -112.0 105.33 13.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.17 -0.956 . . . . 0.0 110.719 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CD1' ' OD2' ' A' ' 69' ' ' ASP . 1.4 p90 -122.46 169.55 10.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.418 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -151.46 140.92 21.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.868 -1.145 . . . . 0.0 111.708 -179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.499 ' C ' ' CG2' ' A' ' 86' ' ' ILE . 44.5 t -95.93 145.14 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.755 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -150.99 24.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.74 -1.225 . . . . 0.0 111.654 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.58 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 0.1 OUTLIER -172.89 147.66 1.7 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.612 -1.305 . . . . 0.0 111.066 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' GLU . . . 49.79 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 67' ' ' VAL . . . 78.44 -134.31 14.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.27 -17.15 31.23 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 124.108 1.583 . . . . 0.0 110.634 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 87' ' ' GLU 0.31 4.7 mt -66.66 114.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.13 89.7 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.279 -1.438 . . . . 0.0 111.1 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.1 t0 62.45 5.84 1.75 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.352 -1.087 . . . . 0.0 111.998 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -135.32 -78.74 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.765 -1.209 . . . . 0.0 109.992 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.595 HD11 ' HD2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -78.56 108.42 11.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.974 . . . . 0.0 109.691 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -90.08 -45.4 9.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' C ' HG13 ' A' ' 98' ' ' ILE . 52.4 mttt -119.84 147.4 44.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.772 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.578 HG12 HD22 ' A' ' 95' ' ' LEU . 45.9 mt -152.17 110.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.727 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 1.3 t -93.04 157.05 16.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.307 -0.871 . . . . 0.0 109.228 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -151.65 108.43 3.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 110.407 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 116' ' ' ILE . 17.9 mt-10 -97.91 156.06 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.7 HG13 HG23 ' A' ' 116' ' ' ILE . 4.5 mt -140.84 146.95 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.049 -1.032 . . . . 0.0 110.287 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 7.4 ttmt -139.04 115.67 10.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.07 -1.019 . . . . 0.0 110.446 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 1.3 mp -92.27 129.2 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG21 ' HE3' ' A' ' 115' ' ' LYS . 25.5 t -132.57 124.5 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.197 -0.939 . . . . 0.0 110.629 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.75 142.03 49.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 109.999 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 111' ' ' GLY . 61.0 p -94.18 153.19 40.7 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.82 -7.1 15.65 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.079 1.568 . . . . 0.0 110.828 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -99.3 -85.85 0.38 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.235 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 12' ' ' VAL . . . -169.41 87.36 0.09 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 12' ' ' VAL . . . 153.98 146.91 4.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.547 ' O ' ' HB ' ' A' ' 10' ' ' THR . 77.3 p -104.08 152.53 21.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.389 -1.065 . . . . 0.0 109.186 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.527 ' HA ' ' HB ' ' A' ' 10' ' ' THR . 2.9 mt -122.01 156.25 26.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.857 ' N ' ' HG1' ' A' ' 10' ' ' THR . 0.5 OUTLIER -115.05 137.92 51.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.115 -0.991 . . . . 0.0 109.862 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 42.7 mttm -122.68 106.97 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.7 HG23 HG13 ' A' ' 102' ' ' ILE . 3.2 mp -115.67 139.88 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.112 -177.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.33 112.82 22.08 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -97.56 102.94 14.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 111.43 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.493 ' HE3' HG11 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -83.7 111.74 19.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.94 . . . . 0.0 109.059 178.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.595 ' HD2' HD11 ' A' ' 95' ' ' LEU . 3.4 m-85 -98.32 104.27 16.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.094 -1.004 . . . . 0.0 111.048 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.578 ' HA ' HG22 ' A' ' 2' ' ' VAL . 37.6 m-70 -95.76 96.18 8.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.522 -0.736 . . . . 0.0 109.407 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 19.5 p -78.36 -149.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.496 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.97 53.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.635 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 125' ' ' ASP . . . 71.48 -83.55 0.45 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 126' ' ' HIS . 10.9 t70 -39.54 115.89 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.469 -1.018 . . . . 0.0 110.514 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.556 ' HB3' ' CG2' ' A' ' 94' ' ' THR . 0.1 OUTLIER 53.98 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.475 -0.766 . . . . 0.0 109.966 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 61.8 mt-10 -123.86 -144.47 0.33 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 110.275 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.582 HG11 ' CZ ' ' A' ' 5' ' ' TYR . 98.9 t -95.08 133.03 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.265 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 130' ' ' ALA . 2.5 mtmt -98.57 123.57 42.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.944 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.431 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -43.96 -46.37 8.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.098 -1.001 . . . . 0.0 110.305 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -52.17 -46.27 65.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 0.0 109.463 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.7 77.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.302 -0.874 . . . . 0.0 108.826 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.943 HG21 ' CE2' ' A' ' 5' ' ' TYR . 72.6 t -72.59 -19.36 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 121.794 0.807 . . . . 0.0 109.284 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 135' ' ' ALA . 13.6 tttp -84.67 -60.13 2.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.507 -0.746 . . . . 0.0 111.2 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.477 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.79 -51.81 1.28 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 110.673 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.2 m -57.0 -47.37 80.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.165 -0.959 . . . . 0.0 110.162 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -64.44 -21.73 66.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 8.0 tt0 -77.23 -44.64 29.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.252 -0.905 . . . . 0.0 109.728 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 72.1 mmm -66.36 -37.88 86.3 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.69 -39.75 93.79 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -70.96 -40.55 71.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.814 -1.404 . . . . 0.0 110.444 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -62.7 -40.61 97.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 108.971 179.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.474 HD21 ' CB ' ' A' ' 37' ' ' ALA . 1.1 mm? -71.48 -33.39 69.24 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.587 HD21 ' H ' ' A' ' 10' ' ' THR . 45.0 tp -62.28 -40.63 96.9 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.096 -1.002 . . . . 0.0 109.038 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.062 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.454 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -54.83 -55.14 33.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.105 -0.997 . . . . 0.0 109.546 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.933 HG22 HD11 ' A' ' 29' ' ' LEU . 48.5 t -63.36 -37.03 78.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.704 ' OE1' HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -55.99 -46.13 78.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 110.132 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -83.75 -19.25 35.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.372 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.59 ' CG ' HG11 ' A' ' 33' ' ' VAL . 9.8 t80 -66.64 -39.71 88.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.539 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.538 HD13 ' HG2' ' A' ' 17' ' ' ARG . 80.8 mt -62.33 -33.11 74.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.027 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 5.2 mp -77.65 -42.53 34.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.569 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.22 80.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.148 -0.97 . . . . 0.0 110.23 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.26 -25.43 39.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.7 t 44.79 44.01 7.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 110.029 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -166.2 -41.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.525 ' CB ' ' OH ' ' A' ' 150' ' ' TYR . . . -59.05 133.81 56.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.865 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 48.0 m-85 56.43 68.8 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.907 . . . . 0.0 110.341 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.166 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 3' ' ' PHE . 43.3 t -69.21 170.88 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -1.144 . . . . 0.0 110.691 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.592 ' HB2' ' HB2' ' A' ' 120' ' ' TYR . 24.1 m-85 -126.07 154.34 43.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -125.63 97.13 5.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.063 -1.023 . . . . 0.0 111.205 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.003 ' CD2' HG11 ' A' ' 133' ' ' VAL . 37.4 m-85 -100.94 81.63 2.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.286 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -84.15 113.94 21.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.403 -0.81 . . . . 0.0 110.96 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.536 HG23 ' HB ' ' A' ' 116' ' ' ILE . 5.1 t -132.97 -176.37 4.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.4 -0.812 . . . . 0.0 109.624 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -157.01 153.4 27.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.115 -0.99 . . . . 0.0 110.222 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.912 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -129.79 156.23 44.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.162 -0.961 . . . . 0.0 110.12 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.32 152.84 29.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.87 ' OG ' HD11 ' A' ' 18' ' ' LEU . 45.6 t -142.0 135.72 29.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.72 -3.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.708 -0.62 . . . . 0.0 109.977 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.72 HG23 ' HD2' ' A' ' 14' ' ' PRO . 8.8 mm -95.77 149.12 35.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.72 ' HD2' HG23 ' A' ' 13' ' ' ILE . 33.0 Cg_endo -56.7 162.72 8.11 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.952 1.501 . . . . 0.0 110.437 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -71.53 -66.43 0.63 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 111.025 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -41.65 -53.63 3.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.581 ' CB ' ' HG2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -59.63 -51.71 68.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.979 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' OG ' ' A' ' 11' ' ' SER . 5.9 mt -51.15 -27.04 7.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.887 -1.133 . . . . 0.0 108.693 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 1.043 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -74.1 -68.63 0.5 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.447 0.642 . . . . 0.0 109.991 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.66 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.6 mtmm -47.66 -36.17 10.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.855 -1.153 . . . . 0.0 111.322 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.642 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -90.35 -67.99 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.951 -1.093 . . . . 0.0 109.172 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.723 ' HD1' HG21 ' A' ' 147' ' ' VAL . 20.6 t80 -82.94 150.39 26.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 108.989 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 22' ' ' PHE . 8.3 mt 82.4 -47.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 CA-C-O 121.24 0.543 . . . . 0.0 110.327 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.043 HD21 ' CE1' ' A' ' 19' ' ' PHE . 17.2 mt -97.74 -50.8 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.166 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -104.41 89.81 3.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.031 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 30' ' ' PHE . . . -122.14 -33.54 0.89 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.73 ' CG ' HG11 ' A' ' 41' ' ' VAL . 52.8 m-20 -71.82 -1.25 13.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.101 -1.235 . . . . 0.0 110.615 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -123.88 13.02 9.15 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.084 -1.01 . . . . 0.0 108.829 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.766 HD21 ' CD2' ' A' ' 150' ' ' TYR . 0.3 OUTLIER -146.61 -51.41 0.22 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 110.971 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.814 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 5.3 m-30 -29.81 -58.71 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' CD ' ' HB2' ' A' ' 30' ' ' PHE . 51.8 Cg_endo -67.82 -38.99 12.26 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.609 1.321 . . . . 0.0 111.414 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 12.7 mmtt -66.97 -66.61 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.102 -0.999 . . . . 0.0 111.219 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.988 HG23 ' HB1' ' A' ' 146' ' ' ALA . 16.5 m -70.69 -19.94 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.254 -0.904 . . . . 0.0 111.02 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.896 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -127.09 65.75 65.4 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.383 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.69 -6.44 17.88 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.859 1.452 . . . . 0.0 110.128 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.477 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -96.45 0.75 50.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.02 -50.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 110.778 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.024 HG12 HD21 ' A' ' 143' ' ' LEU . 11.3 mm -109.15 163.17 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 110.613 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.492 ' C ' ' HB3' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -138.07 -43.69 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 0.0 110.138 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 39' ' ' SER . 11.3 t -178.28 133.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.316 -0.865 . . . . 0.0 110.343 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.73 HG11 ' CG ' ' A' ' 27' ' ' ASP . 3.6 p -92.73 146.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.194 -0.941 . . . . 0.0 110.255 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 30.6 mt-10 -124.6 -153.25 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.651 ' OD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER 69.62 -149.87 0.11 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.192 -0.943 . . . . 0.0 109.728 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.5 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -61.61 -37.76 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.866 -1.146 . . . . 0.0 109.955 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 43' ' ' ASN . 2.2 pt-20 24.68 100.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.432 0.634 . . . . 0.0 112.178 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.66 67.95 1.73 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -122.1 -37.07 2.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -1.165 . . . . 0.0 109.966 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.77 -94.75 0.1 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.26 -78.25 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.543 ' HB3' ' CG ' ' A' ' 73' ' ' GLU . 48.3 Cg_endo -73.9 98.3 1.06 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.038 1.546 . . . . 0.0 110.692 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' HG12 ' A' ' 53' ' ' ILE . . . 116.06 -4.91 20.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.472 ' HA ' HG21 ' A' ' 44' ' ' ILE . 99.3 m -53.56 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -1.172 . . . . 0.0 110.356 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.651 HG22 ' OD1' ' A' ' 43' ' ' ASN . 21.4 mm -83.05 130.69 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.913 . . . . 0.0 109.886 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 2.5 ptpp? -132.98 152.86 51.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 110.377 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.466 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 6.9 ttmt -120.29 88.57 2.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.311 -0.868 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.643 HD12 HG23 ' A' ' 41' ' ' VAL . 1.7 mp -64.73 123.13 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 110.145 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.6 p -109.44 102.53 11.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.743 ' HB2' HD12 ' A' ' 62' ' ' LEU . 3.0 m-85 -64.08 173.81 1.31 Allowed Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.099 -1.001 . . . . 0.0 109.231 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -75.72 -172.45 1.32 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.706 1.372 . . . . 0.0 109.715 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.527 ' HG2' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -77.24 168.15 20.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.308 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' N ' ' HG2' ' A' ' 60' ' ' GLU . . . 104.43 -39.86 2.67 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.743 HD12 ' HB2' ' A' ' 58' ' ' PHE . 13.2 mt -62.13 157.94 49.21 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.106 -1.232 . . . . 0.0 110.478 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.55 -18.63 19.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.132 1.596 . . . . 0.0 110.473 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -105.53 -161.79 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.93 . . . . 0.0 110.425 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HB3' ' CD2' ' A' ' 66' ' ' TYR . 12.0 tptt -121.44 -24.08 5.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 67' ' ' VAL . 53.6 p90 -179.32 -152.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 109.906 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.911 HG23 ' CA ' ' A' ' 89' ' ' GLY . 9.1 p -172.04 120.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 111.191 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 2.8 mttp -98.01 137.82 36.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.471 -0.768 . . . . 0.0 109.047 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 1.5 m-20 -142.18 148.84 38.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.541 ' HD2' HD11 ' A' ' 53' ' ' ILE . 25.9 ttt180 -108.5 130.0 55.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.536 -0.727 . . . . 0.0 109.392 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 -24.18 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.414 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 16.3 m-20 45.96 43.79 10.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.972 . . . . 0.0 109.942 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' CG ' ' HB3' ' A' ' 50' ' ' PRO . 11.4 mt-10 58.27 151.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.886 . . . . 0.0 110.464 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.828 HG11 ' CZ ' ' A' ' 81' ' ' TYR . 6.4 m -138.78 148.98 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.234 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' CB ' ' HB3' ' A' ' 80' ' ' LYS . 4.2 t0 -69.08 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.054 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 179.35 -47.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.57 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 m -54.24 -35.91 62.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 110.411 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 1.9 m-80 -115.31 17.15 16.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 110.199 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.57 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 10.1 m-30 55.46 57.48 5.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.079 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HB3' ' CB ' ' A' ' 75' ' ' ASP . 30.1 tttm -118.89 98.54 6.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.833 . . . . 0.0 110.102 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.828 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -91.16 177.94 6.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.122 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 81' ' ' TYR . 22.5 p-10 -178.82 142.5 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.501 ' C ' ' CD1' ' A' ' 83' ' ' TYR . 12.4 p90 -154.39 172.87 17.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.388 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -136.1 149.99 48.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.817 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.671 ' O ' HD11 ' A' ' 91' ' ' ILE . 4.2 m -110.21 94.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.461 -0.774 . . . . 0.0 109.81 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.471 ' C ' ' CD1' ' A' ' 91' ' ' ILE . 1.3 pp -100.65 -2.63 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.778 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.464 ' N ' HD12 ' A' ' 91' ' ' ILE . 1.9 tt0 -155.83 140.31 16.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.076 -1.015 . . . . 0.0 110.655 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 91' ' ' ILE . . . 65.63 -176.02 15.62 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.911 ' CA ' HG23 ' A' ' 67' ' ' VAL . . . 76.51 -141.56 26.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.6 -6.69 18.6 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.092 1.575 . . . . 0.0 111.019 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.671 HD11 ' O ' ' A' ' 85' ' ' VAL 0.292 1.8 mt -63.31 117.07 3.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.104 -0.998 . . . . 0.0 110.362 -179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 137.23 42.34 0.1 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 179.19 96.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.175 -1.191 . . . . 0.0 110.546 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 40.0 p 42.35 28.3 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 0.0 110.63 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 98' ' ' ILE . 6.5 mt -144.24 74.65 1.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 95' ' ' LEU . 10.3 tp10 -42.42 -58.33 2.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 110.56 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.551 ' CG ' ' HB2' ' A' ' 121' ' ' HIS . 28.8 pttt -144.53 162.37 36.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 110.291 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.827 HD11 HD13 ' A' ' 95' ' ' LEU . 39.7 mt -145.81 138.67 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 110.513 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.9 m -117.23 152.36 34.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 109.175 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -144.08 139.89 29.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.723 -1.236 . . . . 0.0 111.37 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.401 ' O ' HG13 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -117.81 154.58 31.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.396 179.19 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 1.3 mp -144.25 136.8 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -135.79 105.6 6.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.886 . . . . 0.0 109.778 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.675 HD12 ' H ' ' A' ' 104' ' ' ILE . 4.4 mp -81.12 109.94 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 110.532 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.447 HG23 ' HD2' ' A' ' 115' ' ' LYS . 86.5 t -101.49 131.19 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.17 129.93 34.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.312 -0.867 . . . . 0.0 110.053 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 108' ' ' PRO . 17.7 p -86.46 164.41 37.94 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.834 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 49.0 Cg_endo -66.76 81.06 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.114 1.586 . . . . 0.0 110.371 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 60.5 t0 58.01 65.01 1.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 110.166 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.11 27.62 0.13 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.21 -165.48 31.53 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -131.45 174.9 9.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.335 -1.097 . . . . 0.0 110.041 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CG2' ' CD ' ' A' ' 8' ' ' GLU . 26.2 mt -136.75 121.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.117 -0.989 . . . . 0.0 110.686 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.912 ' HB2' HG22 ' A' ' 9' ' ' THR . 7.6 mt -86.17 93.42 9.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.891 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' HD2' HG23 ' A' ' 105' ' ' VAL . 4.1 mttm -69.22 117.99 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.081 -1.012 . . . . 0.0 109.302 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 7' ' ' THR . 94.3 mt -109.2 146.62 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.87 -1.144 . . . . 0.0 111.84 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.18 94.58 3.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -93.52 100.28 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 112.518 -177.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -82.3 131.2 35.23 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.592 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 3.2 m-85 -110.88 112.85 24.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.775 -1.203 . . . . 0.0 110.715 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 97' ' ' LYS . 63.2 m-70 -92.83 103.24 15.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.165 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.597 HG22 HD23 ' A' ' 95' ' ' LEU . 4.5 p -102.13 153.35 20.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.813 . . . . 0.0 110.092 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.14 26.39 3.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.012 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.43 -162.74 14.29 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.33 -38.25 15.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -1.168 . . . . 0.0 110.309 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -74.34 -172.51 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 110.387 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.531 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 60.1 mp0 -124.0 -169.98 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.328 -0.857 . . . . 0.0 110.346 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.488 HG23 ' CD2' ' A' ' 3' ' ' PHE . 55.7 t -69.27 150.28 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 130' ' ' ALA . 3.9 mtmm -105.01 116.01 31.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.765 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -42.64 -52.79 4.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.26 -0.9 . . . . 0.0 110.366 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.6 -46.79 14.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 109.77 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.401 ' OE1' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -62.14 -45.03 95.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.312 -0.867 . . . . 0.0 108.996 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.003 HG11 ' CD2' ' A' ' 5' ' ' TYR . 53.0 t -62.42 -16.29 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.269 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 135' ' ' ALA . 9.6 ttmt -86.42 -60.59 1.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.489 -0.757 . . . . 0.0 110.683 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -41.32 -50.16 3.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 110.092 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.6 t -56.11 -44.32 78.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 110.012 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -27.12 68.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.302 -0.874 . . . . 0.0 110.261 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -77.25 -33.9 55.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.422 -0.799 . . . . 0.0 109.924 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.485 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 0.1 OUTLIER -73.32 -39.63 65.11 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.602 178.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.17 85.73 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -74.32 -32.44 62.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.273 . . . . 0.0 109.743 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 1.3 p -70.4 -34.81 72.98 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.247 -0.908 . . . . 0.0 108.802 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 1.024 HD21 HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -71.17 -53.69 13.61 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.188 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 114' ' ' LEU . 9.4 tp -51.4 -39.08 56.51 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -65.09 -38.21 90.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.569 -0.707 . . . . 0.0 109.426 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.988 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -61.48 -60.1 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.723 HG21 ' HD1' ' A' ' 22' ' ' PHE . 21.6 t -61.81 -24.66 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.95 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' O ' HD13 ' A' ' 152' ' ' LEU . 1.5 tt0 -68.14 -48.02 66.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 110.05 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.9 t -81.26 -17.05 50.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 110.244 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.766 ' CD2' HD21 ' A' ' 29' ' ' LEU . 9.8 t80 -69.7 -43.93 71.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.713 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.643 HD23 ' HB3' ' A' ' 157' ' ' ALA . 28.1 mt -63.95 -26.05 68.41 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.784 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -80.87 -42.47 21.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 110.098 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.12 -50.93 66.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 110.107 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -76.88 -162.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 110.195 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 156' ' ' ASP . 6.5 t -92.39 54.19 2.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.537 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER 60.81 53.3 3.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.883 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.643 ' HB3' HD23 ' A' ' 151' ' ' LEU . . . -40.91 166.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.716 -0.615 . . . . 0.0 110.761 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.642 ' CD2' ' HB2' ' A' ' 21' ' ' ALA . 85.4 m-85 57.75 48.27 14.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.318 -0.864 . . . . 0.0 110.447 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.206 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.957 HG13 ' O ' ' A' ' 120' ' ' TYR . 92.5 t -101.03 153.27 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.156 -1.202 . . . . 0.0 110.426 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.841 ' CD1' HG23 ' A' ' 128' ' ' VAL . 92.3 m-85 -116.07 151.41 35.61 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.507 -0.745 . . . . 0.0 109.895 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -117.33 99.47 7.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.05 -1.031 . . . . 0.0 110.246 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.059 ' CD1' HG11 ' A' ' 133' ' ' VAL . 45.6 m-85 -97.18 99.93 11.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 109.813 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 117' ' ' SER . 3.3 mt-10 -109.42 136.3 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 110.97 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 -171.51 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.386 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' OE1' ' CG2' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -165.21 156.31 14.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.998 -1.064 . . . . 0.0 110.705 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.961 HG22 ' HB2' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -129.12 173.59 10.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.329 -0.857 . . . . 0.0 110.155 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.05 143.28 51.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.155 -0.966 . . . . 0.0 110.564 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' HD11 ' A' ' 18' ' ' LEU . 8.3 t -140.25 147.48 40.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 110.101 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -21.35 15.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.615 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 36.7 mm -77.16 145.92 73.98 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.035 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.7 Cg_endo -56.72 157.93 18.02 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.91 1.479 . . . . 0.0 110.313 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB2' ' OG ' ' A' ' 112' ' ' SER . . . -69.48 -47.93 62.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.023 -1.048 . . . . 0.0 111.471 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' A' ' 79' ' ' PHE . . . -56.33 -44.92 80.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.942 -1.099 . . . . 0.0 110.782 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.563 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 1.3 mtt85 -68.78 -49.95 54.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.936 -1.103 . . . . 0.0 109.777 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.615 ' HG ' ' CG2' ' A' ' 13' ' ' ILE . 7.9 mt -52.08 -30.86 27.88 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 122.28 1.038 . . . . 0.0 108.518 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 1.125 ' CE1' HD21 ' A' ' 24' ' ' LEU . 8.9 t80 -72.44 -72.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' A' ' 24' ' ' LEU . 11.2 mtpt -45.1 -20.56 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 112.102 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -115.98 -61.83 1.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.537 -1.352 . . . . 0.0 112.11 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.841 ' HA ' HG11 ' A' ' 147' ' ' VAL . 9.8 t80 -65.51 -80.73 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.341 -1.475 . . . . 0.0 110.211 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.031 HG22 HD23 ' A' ' 24' ' ' LEU . 2.7 mt -43.98 -71.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.858 -1.151 . . . . 0.0 108.495 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.125 HD21 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -61.68 -179.47 0.19 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.645 ' OD2' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER 66.11 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.126 -0.984 . . . . 0.0 108.95 -178.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' N ' ' CG ' ' A' ' 25' ' ' ASP . . . 52.4 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.387 0 O-C-N 120.723 -1.235 . . . . 0.0 111.08 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.5 p30 -47.46 -20.37 0.23 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.344 -1.092 . . . . 0.0 111.524 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.787 ' O ' HD22 ' A' ' 29' ' ' LEU . 53.5 t30 -110.38 38.89 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 0.0 109.779 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.787 HD22 ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -161.07 -49.34 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.465 -0.772 . . . . 0.0 110.56 -179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.79 ' CD1' HD12 ' A' ' 143' ' ' LEU . 8.0 m-30 -56.39 -53.64 61.83 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 0.0 111.531 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 43.6 Cg_endo -65.1 -4.38 8.93 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 O-C-N 123.293 1.154 . . . . 0.0 111.83 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 13.6 mmtt -109.33 -66.24 1.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.801 -1.187 . . . . 0.0 110.692 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.014 HG23 ' HB1' ' A' ' 146' ' ' ALA . 13.7 m -75.72 -14.19 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.87 64.3 27.82 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.04 -1.038 . . . . 0.0 110.849 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 41.6 Cg_endo -68.1 -8.5 22.92 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.896 1.472 . . . . 0.0 109.764 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.4 tt0 -86.28 -17.4 34.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.564 -0.71 . . . . 0.0 109.432 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.482 ' HB1' ' CE ' ' A' ' 139' ' ' MET . . . -108.65 -37.99 5.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.615 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.656 HD13 ' HB3' ' A' ' 30' ' ' PHE . 2.2 mp -127.7 164.87 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -138.14 -47.86 0.54 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.351 -0.843 . . . . 0.0 110.284 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.9 t -161.9 130.17 4.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.0 110.118 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.644 HG22 HG13 ' A' ' 56' ' ' ILE . 54.2 t -95.84 129.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.138 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 55' ' ' LYS . 14.8 tt0 -117.43 139.08 51.36 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.227 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 0.6 OUTLIER 71.05 147.23 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.188 -0.945 . . . . 0.0 110.141 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.804 HD12 ' HB2' ' A' ' 54' ' ' LYS . 1.2 tp 176.73 47.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER 172.74 48.52 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.809 0.814 . . . . 0.0 109.175 -179.226 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.597 ' N ' HG22 ' A' ' 52' ' ' THR . . . -52.58 -19.63 6.63 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.483 ' CB ' HG21 ' A' ' 52' ' ' THR . 9.7 t-20 -106.62 -59.73 1.76 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -1.13 . . . . 0.0 109.521 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.85 33.53 0.33 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.283 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.77 -95.21 0.29 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 42.2 Cg_endo -71.43 -156.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.301 -1.936 0 O-C-N 124.063 1.56 . . . . 0.0 109.978 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.601 ' H ' HG11 ' A' ' 71' ' ' VAL . . . -84.95 17.61 31.03 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 46' ' ' GLY . 1.1 m -32.48 148.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.745 -0.856 . . . . 0.0 111.641 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.55 ' HB ' ' H ' ' A' ' 46' ' ' GLY . 20.5 mm 33.36 101.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 121.948 0.88 . . . . 0.0 111.932 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.804 ' HB2' HD12 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -134.43 158.07 44.84 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -129.39 142.27 50.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.472 -1.393 . . . . 0.0 111.839 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.656 ' HB ' HG13 ' A' ' 67' ' ' VAL . 1.2 mp -121.64 115.85 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 101.03 10.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.831 . . . . 0.0 110.817 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.649 ' HB3' ' HD2' ' A' ' 59' ' ' PRO . 8.6 m-85 -56.46 177.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.229 -0.919 . . . . 0.0 108.933 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -75.85 145.84 29.06 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.387 1.204 . . . . 0.0 109.962 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' PRO . 1.1 tt0 -41.88 165.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.0 110.62 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.27 36.13 15.62 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 58' ' ' PHE . 3.4 mt -106.31 156.03 37.63 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.127 -1.219 . . . . 0.0 110.561 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.74 -30.77 9.17 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.081 1.569 . . . . 0.0 109.199 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 20.0 m-30 -101.23 -96.64 0.27 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.632 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 179.92 -35.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.806 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' CD2' ' N ' ' A' ' 67' ' ' VAL . 51.5 p90 -179.54 -158.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.375 -0.828 . . . . 0.0 109.687 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 67' ' ' VAL . 7.0 p -163.16 108.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.565 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -99.05 160.91 13.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.42 -0.8 . . . . 0.0 110.028 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.995 ' HB3' HG12 ' A' ' 85' ' ' VAL . 2.6 p-10 -173.15 139.3 0.79 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.909 . . . . 0.0 109.841 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -87.38 146.71 25.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.043 -1.036 . . . . 0.0 110.341 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.601 HG11 ' H ' ' A' ' 51' ' ' GLY . 1.2 t -102.22 167.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.307 -0.87 . . . . 0.0 109.706 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -140.55 56.68 1.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 110.235 179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' C ' HG23 ' A' ' 74' ' ' VAL . 1.9 mt-10 63.19 177.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.927 . . . . 0.0 109.918 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.615 HG22 ' CD1' ' A' ' 81' ' ' TYR . 5.2 t -151.06 137.85 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.143 -0.973 . . . . 0.0 111.063 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.453 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -80.43 179.98 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.141 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.48 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 4.1 m-70 -136.08 -49.86 0.69 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.786 -1.196 . . . . 0.0 111.114 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.8 m -49.91 -57.6 7.14 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.908 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.449 ' O ' ' C ' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -96.0 21.28 8.9 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.087 -1.008 . . . . 0.0 110.843 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 16' ' ' ALA . 11.4 m-85 41.24 73.74 0.12 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 0.0 109.912 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 2.6 tttt -117.76 106.74 13.36 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 110.746 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD1' HG22 ' A' ' 74' ' ' VAL . 11.0 t80 -111.42 105.47 14.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 0.0 110.14 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -113.46 153.88 27.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 0.0 110.861 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' A' ' 100' ' ' ASN . 33.7 p90 -165.29 173.4 11.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 109.924 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.97 121.94 26.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.187 -0.946 . . . . 0.0 111.086 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.995 HG12 ' HB3' ' A' ' 69' ' ' ASP . 15.5 m -95.51 122.52 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.503 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 1.1 pp -123.19 -0.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 8.2 mt-10 -158.33 150.85 22.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.05 . . . . 0.0 110.493 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 90.6 -179.45 43.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.65 -145.74 31.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.474 ' O ' ' C ' ' A' ' 91' ' ' ILE . 51.0 Cg_endo -85.93 31.49 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.046 1.55 . . . . 0.0 110.834 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -33.21 153.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.468 0.652 . . . . 0.0 110.905 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.02 -168.38 40.22 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 11.2 m-20 -87.68 -9.75 53.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -1.142 . . . . 0.0 110.47 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 95' ' ' LEU . 58.8 p -101.64 41.68 1.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.95 HD12 ' NE2' ' A' ' 132' ' ' GLN . 1.5 mt 169.16 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.13 -45.94 3.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 110.764 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 121' ' ' HIS . 14.3 mtpp -131.47 143.13 50.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.005 -1.059 . . . . 0.0 110.514 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.73 ' HB ' HG23 ' A' ' 85' ' ' VAL . 81.3 mt -140.21 118.4 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.998 -1.064 . . . . 0.0 110.564 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.51 160.43 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.092 -1.005 . . . . 0.0 109.793 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 20.8 t-20 -149.35 145.3 26.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.027 -1.045 . . . . 0.0 111.257 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -132.46 129.2 38.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.522 -0.736 . . . . 0.0 109.078 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 26.8 mm -113.38 135.92 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 0.0 110.396 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HG2' ' HG3' ' A' ' 80' ' ' LYS . 2.4 mtpm? -139.0 105.39 5.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 110.301 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 23' ' ' ILE . 72.1 mt -83.84 148.89 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.17 -0.956 . . . . 0.0 110.05 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.95 128.71 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.969 . . . . 0.0 110.526 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -85.03 132.93 34.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.128 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -107.43 152.44 41.31 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.225 -0.922 . . . . 0.0 110.414 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.75 -21.79 44.35 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.958 1.504 . . . . 0.0 110.291 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.15 -50.77 69.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.265 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 142.35 54.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.46 -167.99 34.65 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.823 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -148.69 145.43 27.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.289 -1.124 . . . . 0.0 109.856 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.515 ' CG2' ' OE1' ' A' ' 8' ' ' GLU . 8.9 mt -109.14 135.19 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.84 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.961 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.5 mp -99.18 108.47 21.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -0.906 . . . . 0.0 110.022 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.79 118.76 26.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 109.749 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.3 mt -110.04 121.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 110.763 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.426 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -118.66 100.86 7.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 109.35 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -103.31 115.6 30.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.168 -0.957 . . . . 0.0 111.078 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HG2' ' NE2' ' A' ' 121' ' ' HIS . 1.9 tptt -95.7 115.65 27.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.408 -0.808 . . . . 0.0 108.951 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.957 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.4 m-85 -90.41 147.2 23.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.117 -0.989 . . . . 0.0 111.012 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 73.4 m-70 -133.71 91.48 2.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.604 -0.685 . . . . 0.0 109.21 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 9.7 p -83.03 -179.49 7.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.638 -0.664 . . . . 0.0 110.465 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -84.87 6.1 26.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.094 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 126' ' ' HIS . . . 101.72 -166.23 18.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 t0 50.15 -91.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -1.14 . . . . 0.0 110.29 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' GLY . 62.7 m-70 -66.24 156.63 33.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.227 -0.921 . . . . 0.0 110.145 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -107.99 169.45 8.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 3' ' ' PHE . 55.7 t -59.09 151.27 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 110.054 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 130' ' ' ALA . 46.0 mtmt -96.06 117.22 30.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 0.0 110.419 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -46.13 -38.24 7.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -56.4 -47.59 78.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.36 -0.838 . . . . 0.0 109.38 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.95 ' NE2' HD12 ' A' ' 95' ' ' LEU . 21.5 mt-30 -61.78 -38.31 87.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.059 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.1 t -68.78 -19.5 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.768 0.794 . . . . 0.0 109.421 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.482 ' O ' ' C ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -85.99 -66.89 0.85 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.463 -0.773 . . . . 0.0 110.921 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -34.47 -40.71 0.11 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.482 -0.761 . . . . 0.0 110.88 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.0 t -64.36 -52.79 56.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -54.86 -45.88 74.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.55 -0.719 . . . . 0.0 110.128 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 139' ' ' MET . 3.2 mt-10 -56.72 -59.58 4.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.196 -0.94 . . . . 0.0 109.743 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -44.99 -49.19 11.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.058 -1.027 . . . . 0.0 109.651 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.2 92.84 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 142' ' ' THR . 35.2 tt0 -74.78 -65.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.968 -1.313 . . . . 0.0 110.501 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 141' ' ' GLU . 0.1 OUTLIER -42.28 -46.45 4.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.587 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.79 HD12 ' CD1' ' A' ' 30' ' ' PHE . 3.5 mm? -63.88 -55.23 24.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.186 -0.946 . . . . 0.0 109.84 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.607 HD13 ' CD2' ' A' ' 114' ' ' LEU . 22.5 tp -40.45 -46.17 2.37 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.432 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -43.33 92.07 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.413 -0.804 . . . . 0.0 109.55 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.014 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.2 -61.75 2.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 110.085 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.841 HG11 ' HA ' ' A' ' 22' ' ' PHE . 24.7 t -67.49 -18.26 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.815 . . . . 0.0 110.644 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 18.1 tt0 -70.98 -47.1 60.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.086 -1.009 . . . . 0.0 109.557 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 -21.77 31.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.868 . . . . 0.0 109.578 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.9 ' HB2' HG11 ' A' ' 33' ' ' VAL . 10.6 t80 -57.6 -49.52 76.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.475 -0.765 . . . . 0.0 109.699 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 150' ' ' TYR . 65.3 mt -54.98 -25.71 31.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.419 -0.801 . . . . 0.0 109.582 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 7.7 mp -84.64 -33.16 23.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.892 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.477 ' HB3' ' HD2' ' A' ' 154' ' ' HIS . . . -68.32 -46.82 69.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.22 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.477 ' HD2' ' HB3' ' A' ' 153' ' ' ALA . 19.2 m-70 -90.27 -24.75 20.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' HIS . 1.4 p 44.24 30.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.312 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -152.34 15.32 0.61 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 110.598 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' CE2' ' A' ' 158' ' ' TYR . . . -110.5 131.53 54.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.076 -1.015 . . . . 0.0 110.112 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.73 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 37.7 m-85 63.88 9.33 4.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.397 -0.814 . . . . 0.0 110.458 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.189 -179.803 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.55 HG22 ' HA ' ' A' ' 121' ' ' HIS . 97.2 t -72.62 151.14 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -1.083 . . . . 0.0 110.347 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 5' ' ' TYR . 56.9 m-85 -109.74 131.7 54.82 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 109.607 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -95.25 95.53 8.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.886 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.827 ' HE2' HG11 ' A' ' 128' ' ' VAL . 23.2 m-30 -101.6 95.75 6.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.83 . . . . 0.0 110.24 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -88.01 126.37 35.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.303 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 t -145.4 178.33 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.18 . . . . 0.0 111.191 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' OE1' HG21 ' A' ' 113' ' ' ILE . 7.2 pt-20 -168.43 159.19 10.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.543 -0.723 . . . . 0.0 109.688 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.771 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.9 t -132.16 162.63 30.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.417 HG23 HG23 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -113.48 142.57 45.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 110.213 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.621 ' HB3' HD11 ' A' ' 18' ' ' LEU . 48.0 t -140.73 143.36 34.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.326 -0.859 . . . . 0.0 109.983 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.47 -2.04 2.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 109.968 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.58 ' CG2' ' HG ' ' A' ' 18' ' ' LEU . 19.2 mm -91.95 146.42 32.84 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.197 -0.94 . . . . 0.0 110.243 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.572 ' HD2' HG23 ' A' ' 13' ' ' ILE . 32.8 Cg_endo -57.39 153.82 38.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.034 1.544 . . . . 0.0 110.162 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -62.81 -59.47 4.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -0.996 . . . . 0.0 110.479 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 15' ' ' ALA . . . -42.96 -59.92 1.82 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.445 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 1.066 ' CZ ' HD12 ' A' ' 151' ' ' LEU . 6.7 ttp180 -53.03 -57.71 9.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.554 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 11' ' ' SER . 10.7 mt -45.6 -32.71 2.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.14 -0.975 . . . . 0.0 109.501 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.811 ' CE1' HD21 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -72.41 -55.54 6.88 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 110.687 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp -60.1 -33.41 72.07 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.821 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -107.74 -34.78 6.87 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.264 -1.523 . . . . 0.0 112.551 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 81.3 t80 -102.53 9.45 39.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.731 -1.231 . . . . 0.0 111.873 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 19' ' ' PHE . 29.2 mm -142.98 -26.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.823 -1.173 . . . . 0.0 110.968 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.811 HD21 ' CE1' ' A' ' 19' ' ' PHE . 4.1 mt -103.8 -35.89 8.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.713 -1.242 . . . . 0.0 109.16 178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.495 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER -112.97 41.08 2.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.585 -0.697 . . . . 0.0 110.535 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.24 -30.36 62.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.994 ' OD1' HG13 ' A' ' 41' ' ' VAL . 3.2 t70 -69.1 -6.41 28.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.246 -1.15 . . . . 0.0 110.125 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.458 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 2.5 t30 -126.01 13.91 7.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -130.98 -43.91 1.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.933 . . . . 0.0 110.844 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.773 ' CD1' HD12 ' A' ' 143' ' ' LEU . 7.6 m-30 -57.58 -54.41 55.38 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 111.197 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 30' ' ' PHE . 50.0 Cg_endo -66.97 -15.21 46.34 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.34 1.179 . . . . 0.0 111.293 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.527 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 4.8 mptt -91.08 -71.81 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.02 -1.05 . . . . 0.0 110.736 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.855 HG23 ' HB1' ' A' ' 146' ' ' ALA . 17.4 m -75.52 -18.25 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.839 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -118.59 60.6 4.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.145 -0.972 . . . . 0.0 110.624 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 40.9 Cg_endo -67.61 -19.91 47.63 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.934 1.492 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.507 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 2.2 tt0 -82.62 -16.42 48.41 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.662 0.744 . . . . 0.0 109.073 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.766 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -100.18 -63.15 1.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.286 -0.884 . . . . 0.0 110.574 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.676 HD13 ' HB3' ' A' ' 30' ' ' PHE . 3.7 mp -115.63 153.94 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.693 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 -38.15 7.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 109.631 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.434 ' O ' ' HB3' ' A' ' 57' ' ' SER . 47.7 p -177.64 151.91 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.533 -0.729 . . . . 0.0 109.681 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.994 HG13 ' OD1' ' A' ' 27' ' ' ASP . 3.7 p -141.46 129.15 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.972 . . . . 0.0 110.571 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER 177.23 -176.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.915 . . . . 0.0 110.991 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER 169.47 -60.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -120.17 -22.81 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.549 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.08 77.2 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 110.365 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.15 -121.31 0.02 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.83 12.57 4.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -1.225 . . . . 0.0 110.475 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.46 133.68 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.745 ' O ' HG21 ' A' ' 71' ' ' VAL . . . 106.36 -135.83 12.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.12 83.76 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.919 1.483 . . . . 0.0 110.91 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.66 32.87 0.54 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.101 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 m -84.74 115.09 22.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.069 -1.254 . . . . 0.0 110.264 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 44' ' ' ILE . 38.6 mm -113.33 108.96 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.271 -0.893 . . . . 0.0 110.251 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -150.17 168.55 23.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' VAL . 20.5 ttpt -121.4 113.51 19.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.0 110.274 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.639 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.1 mp -72.75 144.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -131.7 165.52 23.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.58 -0.7 . . . . 0.0 109.697 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 56' ' ' ILE . 30.7 m-85 -137.9 157.04 73.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.042 -1.037 . . . . 0.0 110.807 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 60' ' ' GLU . 50.4 Cg_endo -75.48 154.74 40.48 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.159 1.61 . . . . 0.0 109.901 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 59' ' ' PRO . 4.7 pt-20 -42.78 157.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.283 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.13 -58.8 0.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 58' ' ' PHE . 11.6 mt -62.18 161.17 26.03 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.161 -1.199 . . . . 0.0 110.35 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.16 -38.6 1.45 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.152 1.606 . . . . 0.0 110.4 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 9.2 m-30 -92.91 153.39 18.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -104.19 -17.36 14.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.839 ' O ' HG13 ' A' ' 67' ' ' VAL . 29.1 p90 -174.14 -173.34 0.79 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.979 . . . . 0.0 110.718 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.839 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -177.66 115.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.508 -0.745 . . . . 0.0 109.947 179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -68.98 134.16 49.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.428 ' HB2' HD13 ' A' ' 56' ' ' ILE . 24.3 t0 -128.5 127.27 42.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 110.951 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -127.94 103.32 7.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.414 -0.804 . . . . 0.0 109.677 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.745 HG21 ' O ' ' A' ' 49' ' ' GLY . 32.2 m -57.01 -32.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.287 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 64.08 5.75 2.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -0.917 . . . . 0.0 110.729 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER 167.36 177.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.436 HG11 ' HA2' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -179.23 125.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 109.658 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -104.58 -176.74 3.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.24 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.73 -67.28 0.32 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 110.3 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.8 m -58.12 -36.32 72.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -0.843 . . . . 0.0 110.532 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' PHE . 5.5 m-80 -93.73 0.77 56.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.006 . . . . 0.0 110.694 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 19.8 m-30 57.06 14.92 2.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.242 -0.911 . . . . 0.0 110.552 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HA ' ' CB ' ' A' ' 103' ' ' LYS . 16.5 mttm -71.61 136.53 47.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.963 -1.086 . . . . 0.0 109.744 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 19' ' ' PHE . 67.8 t80 -149.72 121.82 8.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 110.462 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.569 ' HA ' ' CB ' ' A' ' 101' ' ' GLU . 4.6 m-20 -125.29 142.94 51.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.293 -0.88 . . . . 0.0 110.558 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.594 ' CE2' ' HB2' ' A' ' 100' ' ' ASN . 0.6 OUTLIER -152.34 149.49 28.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.105 -0.997 . . . . 0.0 111.102 179.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.58 135.78 54.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.553 -0.717 . . . . 0.0 109.691 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 98' ' ' ILE . 2.2 p -103.62 123.91 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.488 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.545 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 1.5 pp -131.33 138.61 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 1.8 tt0 73.91 138.49 0.06 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 0.0 110.603 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.414 ' CA ' ' CE2' ' A' ' 66' ' ' TYR . . . 81.08 162.85 29.32 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.83 -144.65 17.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 91' ' ' ILE . 52.9 Cg_endo -81.9 22.57 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.98 1.516 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.488 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -38.83 164.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.359 -0.838 . . . . 0.0 111.116 -179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.6 38.14 7.16 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 90' ' ' PRO . 9.7 t0 -155.37 68.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.812 ' O ' HD22 ' A' ' 95' ' ' LEU . 13.9 p 48.28 38.18 9.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.322 -0.861 . . . . 0.0 110.321 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.88 HD11 ' CD2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -159.92 60.38 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 110.396 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -49.09 -72.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -128.35 159.98 33.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.169 -0.957 . . . . 0.0 110.215 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.847 ' O ' HG12 ' A' ' 85' ' ' VAL . 71.3 mt -137.39 117.27 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.85 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.45 ' C ' ' OD1' ' A' ' 100' ' ' ASN . 28.8 t -103.92 128.19 51.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 0.0 110.607 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.594 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 19.0 m-20 -129.19 134.07 47.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.603 ' O ' HG12 ' A' ' 102' ' ' ILE . 6.6 pt-20 -175.56 149.09 0.96 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 117.881 -1.528 . . . . 0.0 113.312 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.868 HG22 ' N ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -178.58 -95.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.868 ' N ' HG22 ' A' ' 102' ' ' ILE . 0.7 OUTLIER 176.0 -176.49 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.165 -0.959 . . . . 0.0 110.625 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.054 HG23 HD23 ' A' ' 114' ' ' LEU . 36.2 mt -113.76 124.79 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 108.915 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.508 ' CG2' ' HD2' ' A' ' 115' ' ' LYS . 64.6 t -96.92 125.72 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.05 -1.031 . . . . 0.0 110.854 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.3 131.78 37.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.209 -0.932 . . . . 0.0 109.668 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 112' ' ' SER . 67.6 p -78.67 162.51 65.23 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 107' ' ' THR . 47.7 Cg_endo -66.92 -18.16 52.11 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.066 1.561 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -171.04 -30.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.967 -1.083 . . . . 0.0 111.239 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.26 -88.68 0.03 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.533 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . -151.09 -95.45 0.12 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.63 ' HA ' HG23 ' A' ' 107' ' ' THR . 11.9 m -171.12 137.0 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.323 -1.104 . . . . 0.0 109.83 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.472 HG21 ' OE1' ' A' ' 8' ' ' GLU . 2.2 mt -100.95 114.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 110.095 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.054 HD23 HG23 ' A' ' 104' ' ' ILE . 45.8 mt -71.71 103.01 2.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.58 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.737 ' HB3' HG21 ' A' ' 102' ' ' ILE . 78.6 mttt -86.64 126.16 34.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.853 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.469 ' HA ' ' HB ' ' A' ' 102' ' ' ILE . 16.4 mt -137.25 130.27 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 100' ' ' ASN . 36.6 m -96.28 102.48 14.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.082 -1.011 . . . . 0.0 108.963 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.526 ' OD1' ' ND2' ' A' ' 100' ' ' ASN . 1.5 m-80 -83.63 143.74 29.9 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.435 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 117.8 9.66 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.88 ' CD2' HD11 ' A' ' 95' ' ' LEU . 2.7 m-85 -92.98 99.86 12.41 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.018 -1.051 . . . . 0.0 111.115 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.55 ' HA ' HG22 ' A' ' 2' ' ' VAL . 73.5 m-70 -82.04 83.88 7.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.409 -0.807 . . . . 0.0 109.192 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.564 HG21 HG23 ' A' ' 128' ' ' VAL . 11.7 p -82.21 -146.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.843 . . . . 0.0 110.571 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.79 18.98 3.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 0.0 110.708 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.67 -143.55 16.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.3 t0 48.53 -144.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -1.148 . . . . 0.0 110.116 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -50.04 149.71 2.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.833 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -83.53 170.9 13.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 110.492 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.827 HG11 ' HE2' ' A' ' 5' ' ' TYR . 35.4 t -62.27 143.27 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HE3' ' OE1' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -85.91 110.01 19.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 109.799 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.52 -49.03 10.2 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.154 -0.966 . . . . 0.0 109.795 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -55.15 -43.25 74.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.011 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.463 ' OE1' ' HE3' ' A' ' 129' ' ' LYS . 42.6 tt0 -58.34 -38.55 77.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -0.753 . . . . 0.0 109.478 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.556 HG22 ' CE2' ' A' ' 120' ' ' TYR . 4.0 t -77.5 -17.6 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 109.798 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 135' ' ' ALA . 5.1 tptt -81.35 -61.9 1.81 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -0.791 . . . . 0.0 110.369 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -39.23 -50.49 1.95 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.338 -0.851 . . . . 0.0 110.163 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -48.18 74.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.353 -0.842 . . . . 0.0 109.355 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 -36.39 69.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.219 -0.926 . . . . 0.0 109.432 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 139' ' ' MET . 0.0 OUTLIER -61.89 -59.95 4.36 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.289 -0.882 . . . . 0.0 109.144 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -46.13 -42.83 14.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.158 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.71 91.53 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.01 -47.53 71.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -1.224 . . . . 0.0 110.907 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 139' ' ' MET . 0.2 OUTLIER -53.5 -38.34 63.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.021 -1.05 . . . . 0.0 109.186 179.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.773 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.5 mm? -69.99 -50.21 43.85 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.836 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 114' ' ' LEU . 14.5 tp -51.14 -30.87 17.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.07 -1.019 . . . . 0.0 108.792 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.93 -43.73 34.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 110.075 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.855 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.91 -48.32 78.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 109.896 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 29' ' ' LEU . 27.7 t -74.03 -36.5 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.41 -0.806 . . . . 0.0 110.111 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' HD13 ' A' ' 152' ' ' LEU . 19.6 tt0 -57.19 -41.03 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.52 -25.52 21.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.93 . . . . 0.0 110.083 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.778 ' HB2' HG11 ' A' ' 33' ' ' VAL . 7.3 t80 -57.39 -33.71 68.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.746 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.066 HD12 ' CZ ' ' A' ' 17' ' ' ARG . 20.1 mt -79.07 -26.19 43.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 109.201 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 148' ' ' GLU . 8.1 mp -78.53 -22.38 47.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.22 -45.43 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -72.37 171.9 11.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 110.697 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.6 t -54.01 -78.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 3.8 p-10 -155.53 54.34 0.61 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.267 -0.895 . . . . 0.0 110.756 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.618 ' HB3' ' CD2' ' A' ' 151' ' ' LEU . . . -59.08 133.95 56.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.875 -1.14 . . . . 0.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.821 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 53.2 m-85 62.37 62.3 1.17 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 110.679 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 156' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.175 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 120' ' ' TYR . 78.2 t -76.69 151.76 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -1.195 . . . . 0.0 110.046 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 127' ' ' GLU . 87.1 m-85 -115.28 129.46 56.63 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 110.206 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.25 105.1 16.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.267 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.94 ' CD1' HG11 ' A' ' 133' ' ' VAL . 23.5 m-85 -106.58 82.11 1.68 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -88.04 157.41 18.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 0.0 110.937 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.549 ' CG2' ' HB ' ' A' ' 116' ' ' ILE . 11.5 t -173.39 -174.02 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.763 . . . . 0.0 109.693 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 7' ' ' THR . 6.9 mt-10 -140.19 149.9 43.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.107 -0.996 . . . . 0.0 110.335 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 1.042 HG23 HD22 ' A' ' 144' ' ' LEU . 0.5 OUTLIER -158.5 136.5 10.59 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.239 -0.913 . . . . 0.0 109.21 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.785 HG21 ' CA ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER 175.88 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 119.778 -1.826 . . . . 0.0 113.967 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.488 ' HB3' ' HG3' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -169.38 -175.52 2.24 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.744 -1.182 . . . . 0.0 111.935 -178.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.598 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -72.79 -15.76 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.21 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.57 ' HB ' ' CD1' ' A' ' 18' ' ' LEU . 4.6 mm -61.51 140.87 94.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 110.045 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 33.3 Cg_endo -56.08 158.54 14.4 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.029 1.542 . . . . 0.0 111.08 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.686 ' HB2' ' OG ' ' A' ' 112' ' ' SER . . . -70.24 -32.84 70.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.685 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.32 90.83 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.245 -0.909 . . . . 0.0 110.686 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.491 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . 19.2 mtm180 -79.25 -50.33 11.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.078 . . . . 0.0 109.893 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -57.69 -30.94 65.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.782 ' CE2' HD21 ' A' ' 24' ' ' LEU . 61.8 t80 -79.11 -46.3 18.31 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.624 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -68.19 -20.95 64.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.464 -0.773 . . . . 0.0 112.155 -178.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB2' ' CG ' ' A' ' 158' ' ' TYR . . . -111.71 -31.66 6.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.678 -1.264 . . . . 0.0 112.15 -178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' HB2' HG11 ' A' ' 147' ' ' VAL . 86.0 t80 -107.16 -13.25 15.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.682 -1.261 . . . . 0.0 111.934 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.643 HG21 ' CE1' ' A' ' 19' ' ' PHE . 39.4 mm -122.46 -16.77 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.794 -1.192 . . . . 0.0 110.486 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.782 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -112.38 -29.48 7.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.231 -0.918 . . . . 0.0 110.173 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.508 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -137.15 66.65 1.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 110.886 -179.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 30' ' ' PHE . . . -83.56 -25.48 46.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.721 ' HB2' HG11 ' A' ' 41' ' ' VAL . 2.7 p30 -80.18 13.73 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.515 -0.991 . . . . 0.0 110.834 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 89.7 m-20 -135.97 37.77 2.8 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.826 -1.171 . . . . 0.0 108.15 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.016 HD21 HG13 ' A' ' 147' ' ' VAL . 0.3 OUTLIER 174.68 -36.42 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.188 -177.033 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.579 ' CB ' ' CD ' ' A' ' 31' ' ' PRO . 3.2 m-30 -38.79 -62.09 0.79 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.62 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 30' ' ' PHE . 55.6 Cg_endo -69.83 -43.83 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.902 1.475 . . . . 0.0 110.725 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.8 mmtt -49.74 -25.9 3.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 111.14 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HB1' ' A' ' 146' ' ' ALA . 3.6 m -120.16 -10.13 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.049 . . . . 0.0 110.789 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' PHE . . . -139.05 65.51 36.83 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.045 -1.034 . . . . 0.0 110.459 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 59' ' ' PRO . 41.8 Cg_endo -68.67 -13.63 37.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.05 1.553 . . . . 0.0 109.542 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.724 ' OE1' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -82.98 -14.96 53.03 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.724 ' HB2' ' OE1' ' A' ' 36' ' ' GLN . . . -110.48 -58.53 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.23 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' A' ' 31' ' ' PRO . 0.7 OUTLIER -115.35 125.82 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.008 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.482 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 8.1 t -82.9 -38.74 22.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.826 . . . . 0.0 110.354 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 p -172.45 151.22 2.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.982 -1.073 . . . . 0.0 110.328 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.721 HG11 ' HB2' ' A' ' 27' ' ' ASP . 7.3 p -99.61 129.49 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 110.644 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HB3' ' CB ' ' A' ' 55' ' ' LYS . 13.4 tp10 -104.28 170.13 8.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.581 -0.699 . . . . 0.0 109.647 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.541 ' O ' ' C ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER 60.86 -92.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.086 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 44' ' ' ILE . 4.8 tp 25.35 59.0 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 CA-C-O 121.331 0.586 . . . . 0.0 111.271 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 57.23 4.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.632 -0.668 . . . . 0.0 110.143 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.93 -108.6 0.36 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.48 82.46 2.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -1.098 . . . . 0.0 110.135 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.41 -14.33 41.04 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.73 -161.51 29.56 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.3 83.37 1.49 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 124.036 1.545 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 53' ' ' ILE . . . 127.73 51.49 0.14 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.844 ' C ' HD12 ' A' ' 53' ' ' ILE . 95.2 m -67.81 151.52 47.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.178 -1.189 . . . . 0.0 110.068 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.844 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -114.93 134.66 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.169 -0.957 . . . . 0.0 110.676 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HG2' HD12 ' A' ' 44' ' ' ILE . 26.5 mtpt -123.32 148.06 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.441 -0.787 . . . . 0.0 109.885 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 28.7 mttp -121.76 84.72 2.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.309 -0.869 . . . . 0.0 110.223 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' A' ' 67' ' ' VAL . 1.6 mp -66.42 125.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.867 -1.146 . . . . 0.0 109.141 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.6 m -105.78 126.31 52.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.631 -1.293 . . . . 0.0 111.318 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.643 ' CD2' HD12 ' A' ' 62' ' ' LEU . 10.8 m-30 -84.82 141.93 38.72 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.458 -0.777 . . . . 0.0 110.59 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 39' ' ' SER . 43.7 Cg_endo -70.48 -179.23 3.08 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.936 1.493 . . . . 0.0 108.77 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.24 163.82 12.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.723 -1.236 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.61 -47.92 3.9 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.812 HD13 ' HD2' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -49.83 159.07 0.79 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.243 -1.151 . . . . 0.0 111.041 -179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.812 ' HD2' HD13 ' A' ' 62' ' ' LEU . 45.0 Cg_endo -72.1 152.37 56.55 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 124.187 1.625 . . . . 0.0 108.586 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 52.84 -136.19 1.41 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.659 -1.217 . . . . 0.0 108.158 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -152.25 -3.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.901 -1.124 . . . . 0.0 112.093 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.926 ' O ' HG13 ' A' ' 67' ' ' VAL . 43.9 p90 178.02 -158.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.837 -1.165 . . . . 0.0 110.442 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -173.07 130.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.53 179.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -95.85 154.12 17.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.956 . . . . 0.0 109.566 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.85 127.16 12.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.01 -1.056 . . . . 0.0 111.241 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.68 142.02 31.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.391 -0.818 . . . . 0.0 109.127 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 73' ' ' GLU . 46.1 t -110.21 137.97 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 111.157 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -110.98 47.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.498 -0.751 . . . . 0.0 109.379 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' H ' HG12 ' A' ' 71' ' ' VAL . 1.6 mt-10 63.69 110.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 109.863 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.741 HG12 ' CD1' ' A' ' 81' ' ' TYR . 3.8 m -82.72 168.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.329 -0.857 . . . . 0.0 110.499 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -102.89 139.51 38.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.829 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.556 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -102.42 -48.8 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.36 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.7 m -53.59 -42.31 67.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.909 -1.119 . . . . 0.0 110.928 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 79' ' ' PHE . 17.9 m120 -105.73 15.2 27.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.053 . . . . 0.0 110.811 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.563 ' HD2' ' HB1' ' A' ' 15' ' ' ALA . 12.3 m-30 41.58 59.23 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.167 -0.958 . . . . 0.0 110.291 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -115.53 164.85 13.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.413 -0.804 . . . . 0.0 109.942 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.741 ' CD1' HG12 ' A' ' 74' ' ' VAL . 10.1 t80 -147.69 143.0 27.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.913 . . . . 0.0 110.5 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -145.56 100.41 3.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 109.824 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.538 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 38.2 p90 -128.59 168.97 14.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.51 135.39 53.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG22 ' HE2' ' A' ' 83' ' ' TYR . 21.4 t -94.92 112.34 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.113 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.664 HD12 ' OE1' ' A' ' 87' ' ' GLU . 18.6 pt -132.32 150.67 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.92 . . . . 0.0 110.445 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.664 ' OE1' HD12 ' A' ' 86' ' ' ILE . 27.7 mp0 58.65 156.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.596 -0.69 . . . . 0.0 110.722 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.586 ' CA ' ' CE2' ' A' ' 66' ' ' TYR . . . 61.04 149.06 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.11 -141.45 15.6 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 91' ' ' ILE . 50.1 Cg_endo -84.2 26.62 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.022 1.538 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -36.35 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.531 -0.73 . . . . 0.0 110.517 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.45 -160.23 28.23 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -93.83 -30.74 14.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.463 ' O ' ' HB ' ' A' ' 122' ' ' THR . 71.0 p -59.75 -24.45 64.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.242 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.921 HD11 ' CD2' ' A' ' 120' ' ' TYR . 1.7 mt -146.18 86.74 1.71 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.222 -0.924 . . . . 0.0 109.873 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -81.42 -41.66 21.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.902 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' O ' ' CG1' ' A' ' 98' ' ' ILE . 4.7 mmtt -123.0 158.49 30.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.997 -1.064 . . . . 0.0 110.527 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.623 ' CG1' HD22 ' A' ' 95' ' ' LEU . 12.9 mt -158.27 115.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.485 -0.759 . . . . 0.0 109.996 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 t -103.69 114.28 28.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 109.96 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 83' ' ' TYR . 7.1 m120 -116.67 145.36 43.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.051 -1.03 . . . . 0.0 110.964 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.603 ' C ' HD12 ' A' ' 102' ' ' ILE . 3.9 pt-20 -141.98 145.48 34.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.492 -0.755 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.603 HD12 ' C ' ' A' ' 101' ' ' GLU . 1.3 mp -126.14 135.25 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.832 -1.168 . . . . 0.0 110.193 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 115' ' ' LYS . 2.3 ttpt -115.89 101.33 8.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.799 . . . . 0.0 110.375 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.738 HD13 ' CD1' ' A' ' 19' ' ' PHE . 4.7 mp -78.81 135.67 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.964 -1.085 . . . . 0.0 109.785 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.85 125.94 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 110.915 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.25 140.04 35.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 110.336 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.6 p -100.35 157.43 33.81 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.968 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -67.07 -16.87 50.33 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.034 1.544 . . . . 0.0 110.903 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -161.64 83.57 0.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.026 -1.046 . . . . 0.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 168.98 -87.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 12' ' ' VAL . . . -173.68 -153.17 9.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.686 ' OG ' ' HB2' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -108.26 143.78 36.64 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.174 -1.192 . . . . 0.0 109.344 179.06 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.785 ' CA ' HG21 ' A' ' 10' ' ' THR . 1.8 mt -119.68 137.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.401 0.62 . . . . 0.0 111.373 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.833 ' HB2' ' O ' ' A' ' 9' ' ' THR . 2.5 mp -101.27 110.33 22.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.447 -0.783 . . . . 0.0 109.513 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 1.8 mptp? -81.14 104.98 11.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.549 ' HB ' ' CG2' ' A' ' 7' ' ' THR . 77.5 mt -93.47 112.83 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.661 0.743 . . . . 0.0 112.23 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.1 111.66 23.41 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.401 ' OD1' HG22 ' A' ' 116' ' ' ILE . 16.5 m120 -110.42 96.58 6.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 111.216 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.711 ' HD3' HG11 ' A' ' 2' ' ' VAL . 1.6 mttt -84.56 99.69 10.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.411 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.921 ' CD2' HD11 ' A' ' 95' ' ' LEU . 3.2 m-85 -75.83 132.8 40.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.358 -0.839 . . . . 0.0 110.772 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.679 ' CE1' HG21 ' A' ' 2' ' ' VAL . 55.4 m-70 -114.49 100.07 8.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 0.0 109.981 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.839 HG21 HG23 ' A' ' 128' ' ' VAL . 6.3 p -104.6 179.48 4.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 110.332 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 122' ' ' THR . 1.1 ptpm? 175.21 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 159.62 126.47 0.85 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.18 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 47.89 -150.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -1.075 . . . . 0.0 110.824 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 125' ' ' ASP . 4.3 m-70 -42.13 166.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.359 -0.838 . . . . 0.0 110.533 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -107.44 -121.21 0.24 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 110.141 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.839 HG23 HG21 ' A' ' 122' ' ' THR . 97.7 t -103.2 141.8 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.822 -1.174 . . . . 0.0 110.492 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 130' ' ' ALA . 37.5 mtmt -107.29 124.22 49.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.699 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 129' ' ' LYS . . . -44.32 -41.31 5.92 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.173 -0.955 . . . . 0.0 109.786 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 tm-20 -52.03 -49.53 63.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.209 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.44 ' NE2' ' HB2' ' A' ' 90' ' ' PRO . 7.6 mt-30 -61.87 -43.29 99.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.195 -0.94 . . . . 0.0 109.007 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.94 HG11 ' CD1' ' A' ' 5' ' ' TYR . 96.9 t -62.0 -18.33 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.474 -0.766 . . . . 0.0 109.137 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 131' ' ' GLU . 23.3 ttpt -87.72 -63.61 1.28 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.643 -0.661 . . . . 0.0 110.694 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -37.12 -47.98 0.79 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.697 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -47.22 87.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.864 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -64.77 -19.37 65.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 135' ' ' ALA . 24.4 tt0 -78.7 -45.47 21.21 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.484 -0.76 . . . . 0.0 109.177 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 62' ' ' LEU . 44.0 mmm -64.0 -35.18 79.87 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.532 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.43 -42.62 73.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.17 -33.35 74.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.999 -1.295 . . . . 0.0 110.475 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.23 -41.25 70.4 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.164 -0.96 . . . . 0.0 109.045 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -69.96 -29.31 66.4 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 1.042 HD22 HG23 ' A' ' 9' ' ' THR . 15.9 tp -69.13 -46.07 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -33.4 75.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.39 -0.819 . . . . 0.0 108.945 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.037 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -62.52 -54.65 36.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.822 . . . . 0.0 109.273 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 1.016 HG13 HD21 ' A' ' 29' ' ' LEU . 39.2 t -70.99 -16.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -0.768 . . . . 0.0 109.968 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 11' ' ' SER . 5.5 tm-20 -75.17 -44.33 47.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.635 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -15.29 32.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.404 -0.81 . . . . 0.0 109.707 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.653 ' CG ' ' CD1' ' A' ' 29' ' ' LEU . 4.1 t80 -64.69 -52.12 58.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 0.0 109.352 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 150' ' ' TYR . 84.8 mt -53.46 -30.71 42.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.706 -0.621 . . . . 0.0 110.167 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.26 -51.76 10.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.701 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 154' ' ' HIS . . . -55.24 -53.76 51.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.451 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 153' ' ' ALA . 46.2 m-70 -60.01 -122.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.122 -0.986 . . . . 0.0 110.038 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 9.6 t -175.02 -31.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.59 -1.319 . . . . 0.0 110.9 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -144.54 39.94 1.29 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 110.938 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.5 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -85.0 128.4 34.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.991 -1.068 . . . . 0.0 109.776 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.756 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 44.4 m-85 56.16 49.26 15.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 110.404 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.286 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 120' ' ' TYR . 9.2 p -144.66 161.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -1.12 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 76.5 m-85 -132.82 161.4 34.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.382 -0.824 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -125.59 106.82 10.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.158 -0.963 . . . . 0.0 110.437 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.041 ' CD1' HG11 ' A' ' 133' ' ' VAL . 44.7 m-85 -108.14 86.8 2.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.398 -0.814 . . . . 0.0 110.135 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -101.76 156.34 17.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.666 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -166.15 176.63 7.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.972 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 115' ' ' LYS . 29.2 mp0 -146.35 137.05 24.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.208 -0.933 . . . . 0.0 110.25 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.883 HG22 ' HB2' ' A' ' 114' ' ' LEU . 1.5 t -118.26 166.43 12.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.87 142.31 51.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.191 -0.943 . . . . 0.0 110.698 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.54 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -141.19 147.95 39.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.39 -0.819 . . . . 0.0 110.127 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.49 -39.16 61.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.433 -0.792 . . . . 0.0 110.174 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.598 HD11 ' CD1' ' A' ' 152' ' ' LEU . 3.4 mm -58.88 141.91 85.17 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.486 ' HG2' ' CG ' ' A' ' 17' ' ' ARG . 35.7 Cg_endo -57.89 155.27 33.8 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.912 1.48 . . . . 0.0 110.804 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' N ' ' OG ' ' A' ' 112' ' ' SER . . . -60.68 -36.68 79.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 110.103 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 79' ' ' PHE . . . -62.68 -56.24 19.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 110.735 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' CG ' ' HG2' ' A' ' 14' ' ' PRO . 51.7 mtt180 -61.3 -55.17 34.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.151 -0.968 . . . . 0.0 110.245 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 0.4 OUTLIER -52.27 -33.72 43.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.221 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.745 ' CE2' HD21 ' A' ' 24' ' ' LEU . 75.7 t80 -69.88 -52.6 23.43 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 24' ' ' LEU . 11.5 mtmm -61.26 -25.34 67.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 0.0 111.552 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' A' ' 158' ' ' TYR . . . -105.66 -61.12 1.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 111.522 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' HB2' HG11 ' A' ' 147' ' ' VAL . 80.7 t80 -76.28 -4.9 44.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.304 -0.872 . . . . 0.0 112.253 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.65 ' C ' HD23 ' A' ' 24' ' ' LEU . 34.9 mm -132.95 -20.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.642 -1.286 . . . . 0.0 111.123 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.745 HD21 ' CE2' ' A' ' 19' ' ' PHE . 1.6 mt -111.19 -5.69 14.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -154.75 53.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.226 -0.921 . . . . 0.0 110.557 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.36 -21.78 55.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.5 ' HB2' HG11 ' A' ' 41' ' ' VAL . 49.8 p30 -68.21 -15.44 63.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -1.086 . . . . 0.0 110.449 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.49 ' ND2' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -122.77 10.75 9.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.77 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.827 ' O ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -122.27 -42.68 2.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.339 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.753 ' CD1' HD12 ' A' ' 143' ' ' LEU . 7.3 m-30 -60.7 -51.8 77.12 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.87 . . . . 0.0 111.684 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 30' ' ' PHE . 44.9 Cg_endo -65.42 -4.82 10.14 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.224 1.118 . . . . 0.0 111.741 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -107.93 -64.11 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.898 -1.126 . . . . 0.0 110.5 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 29' ' ' LEU . 18.5 m -71.95 -17.71 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.97 66.3 75.87 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.101 -0.999 . . . . 0.0 110.872 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 42.0 Cg_endo -68.39 -19.96 42.78 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.0 1.526 . . . . 0.0 109.466 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -83.9 -9.57 58.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.558 -0.714 . . . . 0.0 109.548 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 143' ' ' LEU . . . -105.56 -59.53 1.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.968 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.16 161.4 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.514 ' HB2' ' N ' ' A' ' 59' ' ' PRO . 42.8 t -111.15 -57.44 2.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.055 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.38 144.48 3.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.348 -0.845 . . . . 0.0 109.914 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 27' ' ' ASP . 12.8 p -109.29 139.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.276 -0.89 . . . . 0.0 110.163 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 5.1 mt-10 -102.65 106.05 16.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.129 -0.982 . . . . 0.0 109.87 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.441 ' ND2' HG22 ' A' ' 41' ' ' VAL . 2.3 m-80 -102.18 97.86 8.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.321 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 53' ' ' ILE . 5.8 tp -58.45 -25.32 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 110.013 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 52' ' ' THR . 2.3 mt-10 -116.59 108.11 15.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.097 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.33 -3.02 88.39 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.502 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 26.9 p-10 -163.08 56.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -1.23 . . . . 0.0 110.312 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.05 1.21 57.62 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 46.48 -112.9 0.97 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.13 85.62 1.64 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.873 1.459 . . . . 0.0 110.622 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 52' ' ' THR . . . 142.77 -15.23 2.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 45' ' ' GLU . 62.2 m -43.91 101.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.158 -1.201 . . . . 0.0 110.178 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.785 ' O ' HG22 ' A' ' 44' ' ' ILE . 22.8 mm -85.68 121.7 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.099 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -137.76 154.31 49.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 110.495 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -125.38 107.24 10.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.392 -0.817 . . . . 0.0 110.173 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' A' ' 67' ' ' VAL . 1.7 mp -73.44 136.34 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 109.664 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -119.04 162.16 19.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 110.356 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 19.5 m-85 -128.05 161.57 55.22 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.514 ' N ' ' HB2' ' A' ' 39' ' ' SER . 43.0 Cg_endo -71.21 159.92 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.981 1.516 . . . . 0.0 110.017 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.69 164.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 0.0 110.627 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.61 -45.47 3.47 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -66.16 145.23 98.98 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.195 -1.179 . . . . 0.0 110.797 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 64' ' ' PHE . 47.5 Cg_endo -75.57 -163.65 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.028 1.541 . . . . 0.0 110.135 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 5.2 m-30 51.83 103.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.376 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 1.6 tppt? -56.78 -17.62 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.604 ' C ' ' CD1' ' A' ' 66' ' ' TYR . 0.1 OUTLIER 175.6 -175.05 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.53 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 53.8 t -147.64 80.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -79.44 133.59 36.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' SER . 4.8 p-10 -163.39 -177.77 5.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HG3' HD13 ' A' ' 53' ' ' ILE . 6.4 mtp180 -121.8 159.73 26.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 110.095 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 72' ' ' ASP . 4.6 p -85.93 -25.44 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -0.933 . . . . 0.0 111.042 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER 72.14 -80.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -177.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -168.73 157.77 8.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.328 -0.858 . . . . 0.0 109.788 178.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.824 HG23 ' HD1' ' A' ' 81' ' ' TYR . 14.6 p -128.45 109.79 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 -178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.96 154.86 41.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 109.464 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.41 -59.06 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 110.61 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.9 m -63.0 -8.23 6.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.412 -0.805 . . . . 0.0 110.993 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.51 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 73.3 m-20 -121.29 6.87 10.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.91 -1.119 . . . . 0.0 110.48 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 8.6 m-30 44.66 67.66 0.66 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.51 ' HE2' ' HB3' ' A' ' 78' ' ' ASN . 3.0 mtmt -137.1 122.29 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.364 -0.835 . . . . 0.0 109.883 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.824 ' HD1' HG23 ' A' ' 74' ' ' VAL . 4.3 t80 -111.05 128.98 56.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.556 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . 3.4 t-20 -101.0 143.85 30.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 1.031 ' CZ ' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -149.3 115.96 5.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.582 -179.417 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -103.27 127.47 50.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 0.0 110.517 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.031 HG22 ' CZ ' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -102.45 95.02 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.435 -0.791 . . . . 0.0 109.783 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 87' ' ' GLU . 25.0 pt -87.44 -29.6 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 0.0 110.414 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' N ' HG13 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -156.48 102.58 2.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.898 . . . . 0.0 110.363 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 67' ' ' VAL . . . 143.79 166.3 11.25 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.554 ' O ' HD11 ' A' ' 91' ' ' ILE . . . 86.1 -121.43 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.544 ' HB2' ' NE2' ' A' ' 132' ' ' GLN . 47.4 Cg_endo -74.24 -52.26 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.788 1.415 . . . . 0.0 110.584 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.554 HD11 ' O ' ' A' ' 89' ' ' GLY . 0.2 OUTLIER 30.03 -156.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.875 0.845 . . . . 0.0 111.862 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.83 -161.67 2.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.58 ' O ' HG23 ' A' ' 94' ' ' THR . 3.4 m-20 51.68 -95.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -1.142 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 93' ' ' ASP . 18.3 p -156.23 22.25 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.052 -1.03 . . . . 0.0 110.516 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.698 ' HB3' HD11 ' A' ' 98' ' ' ILE . 9.9 mt -94.93 95.49 8.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.205 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.456 ' OE1' ' HD3' ' A' ' 123' ' ' LYS . 4.6 mt-10 -76.6 -43.34 38.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 110.507 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.507 ' O ' HG12 ' A' ' 98' ' ' ILE . 9.1 tttp -129.43 152.13 49.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.005 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 95' ' ' LEU . 13.3 mt -153.74 122.54 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.156 -0.965 . . . . 0.0 110.635 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.53 127.34 48.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.141 -0.974 . . . . 0.0 109.872 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 118' ' ' ASN . 2.3 m-80 -121.54 114.65 21.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.621 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -107.01 159.0 16.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 109.703 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.807 HG23 ' CD1' ' A' ' 116' ' ' ILE . 13.7 mt -141.89 142.23 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.124 -0.985 . . . . 0.0 110.434 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HG3' ' C ' ' A' ' 102' ' ' ILE . 1.8 mtpp -138.09 151.86 48.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.147 -0.971 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.613 HD12 ' N ' ' A' ' 104' ' ' ILE . 4.9 mp -130.84 125.85 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.002 . . . . 0.0 109.927 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.41 133.23 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 110.226 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.21 153.02 21.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.4 p -128.96 152.85 79.89 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.843 . . . . 0.0 110.115 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.99 -32.38 28.55 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.024 1.539 . . . . 0.0 110.706 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.0 p30 -149.99 43.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.81 14.21 0.89 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 69.47 -138.07 29.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -128.58 136.56 50.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -1.157 . . . . 0.0 110.571 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.9 mt -107.11 125.79 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.803 . . . . 0.0 109.211 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.883 ' HB2' HG22 ' A' ' 9' ' ' THR . 20.1 mt -89.72 108.19 19.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.001 . . . . 0.0 111.134 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 10.2 mttp -81.65 106.47 13.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.807 ' CD1' HG23 ' A' ' 102' ' ' ILE . 43.4 mm -101.38 151.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 111.301 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.08 132.08 35.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 100' ' ' ASN . 4.9 m120 -129.53 88.17 2.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.125 -0.984 . . . . 0.0 110.725 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -81.29 124.27 29.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.716 ' O ' HG23 ' A' ' 2' ' ' VAL . 3.3 m-85 -103.67 149.38 25.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.911 -1.118 . . . . 0.0 110.401 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.0 m-70 -134.33 93.48 3.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.561 HG21 HG23 ' A' ' 128' ' ' VAL . 2.0 p -86.14 -162.9 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.87 . . . . 0.0 109.717 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HD3' ' OE1' ' A' ' 96' ' ' GLU . 5.2 ttpp -177.26 97.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.041 . . . . 0.0 110.854 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.42 160.59 12.88 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.4 OUTLIER 56.08 -161.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -1.021 . . . . 0.0 110.635 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.486 ' N ' HG21 ' A' ' 94' ' ' THR . 81.1 m-70 -48.96 -179.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 110.436 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 5.5 mm-40 -127.32 -112.98 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.931 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.795 HG11 ' HE2' ' A' ' 5' ' ' TYR . 60.5 t -118.23 138.03 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.805 -1.185 . . . . 0.0 110.256 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 130' ' ' ALA . 5.5 mtmt -101.66 111.4 23.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.846 . . . . 0.0 109.703 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' O ' ' HB ' ' A' ' 133' ' ' VAL . . . -41.36 -50.31 3.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.696 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -46.44 -48.27 18.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.902 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 90' ' ' PRO . 2.9 tt0 -63.36 -39.44 94.54 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.041 HG11 ' CD1' ' A' ' 5' ' ' TYR . 79.5 t -65.92 -17.22 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.757 0.789 . . . . 0.0 109.169 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 135' ' ' ALA . 2.0 ttmt -85.54 -58.13 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.499 -0.75 . . . . 0.0 110.459 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 134' ' ' LYS . . . -42.38 -50.64 5.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 109.916 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.43 -45.86 69.58 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.13 -31.68 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.701 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.77 -39.68 80.09 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.332 -0.855 . . . . 0.0 109.369 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 1.3 mtp -66.18 -38.43 88.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.21 -0.931 . . . . 0.0 109.05 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.21 -38.18 93.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -74.77 -35.02 62.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.896 -1.355 . . . . 0.0 110.158 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -39.77 90.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 108.743 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.753 HD12 ' CD1' ' A' ' 30' ' ' PHE . 1.1 mm? -68.66 -48.97 62.63 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.165 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.594 HD22 HG21 ' A' ' 9' ' ' THR . 13.3 tp -49.58 -42.89 45.62 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.204 -0.935 . . . . 0.0 108.849 178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 1.5 ttt-85 -65.79 -42.64 90.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.83 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.776 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -56.5 -62.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.358 -0.838 . . . . 0.0 109.734 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.65 HG22 HD12 ' A' ' 29' ' ' LEU . 84.6 t -59.01 -28.61 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.555 -0.715 . . . . 0.0 110.09 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -61.95 -53.06 60.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 0.0 109.958 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.4 p -76.7 -18.59 58.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 109.9 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.714 ' CD2' HD11 ' A' ' 29' ' ' LEU . 5.7 t80 -64.44 -47.95 77.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.627 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.617 HD23 ' CD2' ' A' ' 150' ' ' TYR . 68.4 mt -61.38 -24.97 66.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.598 ' CD1' HD11 ' A' ' 13' ' ' ILE . 5.9 mp -81.76 -35.21 29.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.358 -0.839 . . . . 0.0 110.244 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.12 -55.14 6.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.069 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.461 ' O ' ' CB ' ' A' ' 155' ' ' SER . 35.9 m-70 -66.14 -44.42 84.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.873 . . . . 0.0 109.808 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 154' ' ' HIS . 0.7 OUTLIER 66.74 20.55 10.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 110.459 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -159.11 19.9 0.19 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.568 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.464 ' CB ' ' CE2' ' A' ' 150' ' ' TYR . . . -101.63 130.65 48.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.077 -1.014 . . . . 0.0 110.336 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.789 ' CD2' ' HB2' ' A' ' 21' ' ' ALA . 48.4 m-85 58.24 53.13 6.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.285 -0.884 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.116 179.96 . . . . . . . . 1 1 . 1 stop_ save_